Citrus Sinensis ID: 005649
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 686 | 2.2.26 [Sep-21-2011] | |||||||
| Q9M0X5 | 675 | Cysteine-rich receptor-li | yes | no | 0.877 | 0.891 | 0.365 | 1e-109 | |
| Q8S9L6 | 679 | Cysteine-rich receptor-li | no | no | 0.890 | 0.899 | 0.361 | 1e-107 | |
| Q9T0J1 | 665 | Cysteine-rich receptor-li | no | no | 0.849 | 0.876 | 0.384 | 1e-106 | |
| O65405 | 683 | Cysteine-rich receptor-li | no | no | 0.903 | 0.907 | 0.363 | 1e-103 | |
| Q9LDQ3 | 669 | Putative cysteine-rich re | no | no | 0.879 | 0.901 | 0.367 | 1e-101 | |
| O65479 | 666 | Putative cysteine-rich re | no | no | 0.860 | 0.885 | 0.372 | 1e-101 | |
| O65468 | 676 | Cysteine-rich receptor-li | no | no | 0.896 | 0.909 | 0.365 | 1e-101 | |
| O65472 | 690 | Putative cysteine-rich re | no | no | 0.921 | 0.915 | 0.346 | 1e-100 | |
| Q9C5S8 | 659 | Cysteine-rich receptor-li | no | no | 0.845 | 0.880 | 0.378 | 1e-100 | |
| Q8GWJ7 | 645 | Cysteine-rich receptor-li | no | no | 0.852 | 0.906 | 0.368 | 5e-99 |
| >sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 396 bits (1017), Expect = e-109, Method: Compositional matrix adjust.
Identities = 231/632 (36%), Positives = 357/632 (56%), Gaps = 30/632 (4%)
Query: 33 LSFLFIFAFIHQTSAEDDPRI--KVCDSSTNNTLDSAFSSNLGIALKTLQNNTAQTGFSF 90
+S +F F+ + DP +C ++T + +S++ +NL L +L + A F
Sbjct: 9 VSLFSVFLFMILKTVTSDPTYLYHICPNTTTYSRNSSYLTNLRTVLSSLSSPNAAYASLF 68
Query: 91 TTISAS--NSSQPVTALALCRATITQSECQECMDSAVLSIRRVCPDQTTAQIWHTYCMIR 148
+A N S V + LCR ++ C++C+ A + CP + A IW+ CM+R
Sbjct: 69 DNAAAGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWYDECMVR 128
Query: 149 YSSRKFIDNADSSLAFSLFDQREVPNP--TTFDQTVNSLTVNLAVLAGKSGKRFAVAKMK 206
YS++ + L +++ + + F++++ +L +++AV A S ++FA K
Sbjct: 129 YSNQSIVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAALSSRKFATEKAN 188
Query: 207 VISSDIYLYGYVECTRDVNGESCTKCLLSLRSYMMTCCSGRWAIWVGAPTCSVQVNLDPV 266
+Y V+CT D+ + C CL + +Y+ CC V AP+CS + L P
Sbjct: 189 FTVFQT-IYSLVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPF 247
Query: 267 HKD-----WETAVDISTLLAPEMPPESETESETGGSHRKLIYLKIGAVAGVGGAVMTIIV 321
+ + ST+ AP + SE G + L + + A+A V +V +++
Sbjct: 248 YNETIAAAPMAPPPSSTVTAPPLNIPSEK-----GKGKNLTVI-VTAIA-VPVSVCVLLL 300
Query: 322 VVLIAVLTRKGRSMRFVGD----DANALTNNQGIDMRSFLFNLDVLIAATDNFSTKNMLG 377
+ +L R+ R+ + + D + +T+ + + F + AAT+ FS N LG
Sbjct: 301 GAMCWLLARR-RNNKLSAETEDLDEDGITSTETLQ-----FQFSAIEAATNKFSESNKLG 354
Query: 378 RGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER 437
GGFG VYKG+L G +A+K+L+ S QG EEF+NEV V+ K+QHRNL +L G C+
Sbjct: 355 HGGFGEVYKGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGE 414
Query: 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIK 497
E+ILVYE++PNKSLD FLFD K +LDW +R II G+ARG+LYLHRDS L IIHRD+K
Sbjct: 415 EKILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLK 474
Query: 498 ASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFS 557
ASNILLD M PKISDFG+A++F +Q++ T +I GT+GYM+PEYAI G SVKSDV+S
Sbjct: 475 ASNILLDADMHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYS 534
Query: 558 FGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI-GTYPEEIALRFM 616
FGVL+LE+I+G+KN E +L+ +L E +ELVD + G + +R +
Sbjct: 535 FGVLVLELITGKKNSSFYEEDGLGDLVTYVWKLWVENSPLELVDEAMRGNFQTNEVIRCI 594
Query: 617 QIALLCTEDFIEDRPTMSATLSMLSNSSVPIP 648
IALLC ++ +RP+M L M+++ +V +P
Sbjct: 595 HIALLCVQEDSSERPSMDDILVMMNSFTVTLP 626
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q8S9L6|CRK29_ARATH Cysteine-rich receptor-like protein kinase 29 OS=Arabidopsis thaliana GN=CRK29 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 391 bits (1004), Expect = e-107, Method: Compositional matrix adjust.
Identities = 234/648 (36%), Positives = 359/648 (55%), Gaps = 37/648 (5%)
Query: 27 KMLFQLLSFLFI---FAFIHQTSAEDDPRIKVCDSSTNNTLDSAFSSNLGIALKTLQNNT 83
+++F FL + AF S E DP D N T +S F+ NL + +L +
Sbjct: 5 RVIFFFACFLTLAPFHAFAQVDSYEFDPDFNCVDRG-NFTANSTFAGNLNRLVSSLSSLK 63
Query: 84 AQTGFSFTTISASNSS-QPVTALALCRATITQSECQECMDSAVLSIRRVCPDQTTAQIWH 142
+Q + F +S+ +SS + A+ LCR + + +C C+ +A ++ + CP A +W+
Sbjct: 64 SQA-YGFYNLSSGDSSGERAYAIGLCRREVKRDDCVSCIQTAARNLTKQCPLTKQAVVWY 122
Query: 143 TYCMIRYSSRKFIDNADSSLAFSLFDQREV-PNPTTFDQTVNSLTVNLAVLAGKSGKRFA 201
T+CM RYS+R +++ + E+ N F++ L L +A G
Sbjct: 123 THCMFRYSNRTIYGRKETNPTKAFIAGEEISANRDDFERLQRGLLDRLKGIAAAGGPNRK 182
Query: 202 VAKMKVISSDIY--LYGYVECTRDVNGESCTKCLLSLRSYMMTCCSGRWAIWVGAPTCSV 259
A+ +S Y YG V+CT D++ + C CL+ + +CC + +P+C+
Sbjct: 183 YAQGNGSASAGYRRFYGTVQCTPDLSEQDCNDCLVFGFENIPSCCDAEIGLRWFSPSCNF 242
Query: 260 QVNLDPVHKDWETAVDIST---LLAPEMPPESETESETGGSHRKLIYLKIGAVAGVGGAV 316
+ + +E D+ + P P+S +E G + G + V
Sbjct: 243 RFE---TWRFYEFDADLEPDPPAIQPADSPQSAARTERTGKGK-------GGSKVIIAIV 292
Query: 317 MTIIVVVLIAVL---------TRKGRSMRFVGDD--ANALTNNQGIDMRSFLFNLDVLIA 365
+ I++V L+A+ + G + +G + ++ ++ + S L + + L
Sbjct: 293 IPILLVALLAICLCLVLKWRKNKSGYKNKVLGKSPLSGSIAEDEFSNTESLLVHFETLKT 352
Query: 366 ATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN 425
ATDNFS++N LGRGGFG+VYKG G+EIAVK+L+ NS QG EF+NE+ +L K+QHRN
Sbjct: 353 ATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLSGNSGQGDNEFKNEILLLAKLQHRN 412
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
LV+L G C+Q ER+LVYE++ N SLD+F+FD K +LDW R +I G+ARGLLYLH
Sbjct: 413 LVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQLLDWVVRYKMIGGIARGLLYLHE 472
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS-RHR-THQIAGTFGYMAPEY 543
DS RIIHRD+KASNILLD +M PKI+DFGLAKLF Q+ HR T +IAGT+GYMAPEY
Sbjct: 473 DSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMTHRFTSRIAGTYGYMAPEY 532
Query: 544 AIRGFLSVKSDVFSFGVLLLEIISGRKNYD--RQLEAENQELLKLARRLEEEGRLMELVD 601
A+ G SVK+DVFSFGVL++EII+G++N + + + ++LL R E ++ ++D
Sbjct: 533 AMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGDEDAEDLLSWVWRSWREDTILSVID 592
Query: 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPS 649
+ LR + I LLC ++ RPTM+ ML++ S +P+
Sbjct: 593 PSLTAGSRNEILRCIHIGLLCVQESAATRPTMATVSLMLNSYSFTLPT 640
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9T0J1|CRK26_ARATH Cysteine-rich receptor-like protein kinase 26 OS=Arabidopsis thaliana GN=CRK26 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 387 bits (994), Expect = e-106, Method: Compositional matrix adjust.
Identities = 236/614 (38%), Positives = 359/614 (58%), Gaps = 31/614 (5%)
Query: 51 PRIKVCDSSTNN-TLDSAFSSNLG---IALKTLQNNTAQTGFSFTTISASNSSQPVTALA 106
P ++C + T N T+++ ++ NL +L +L+ N F IS +S + V +++
Sbjct: 26 PLNQICSNVTGNFTVNTPYAVNLDRLISSLSSLRRNVN----GFYNISVGDSDEKVNSIS 81
Query: 107 LCRATITQSECQECMDSAVLSIRRVCPDQTTAQIWHTYCMIRYSSRKFIDNADSSLAFSL 166
CR + C C+ A + +CP Q A IW+ C RYS+R + + S S+
Sbjct: 82 QCRGDVKLEVCINCIAMAGKRLVTLCPVQKEAIIWYDKCTFRYSNRTIFNRLEISPHTSI 141
Query: 167 FDQRE-VPNPTTFDQTVNSLT---VNLAVLAGKSGKRFAVAKMKVISSDIYLYGYVECTR 222
R + ++++++ L N A + G+S K F V + S L+G V+CT
Sbjct: 142 TGTRNFTGDRDSWEKSLRGLLEGLKNRASVIGRSKKNFVVGETSGPSFQT-LFGLVQCTP 200
Query: 223 DVNGESCTKCLLSLRSYMMTCCSGRWAIWVGAPTCSVQVN----LDPVHKDWETAVDIST 278
D++ E C+ CL + + +CC + +V +P+C + DPV D ++V +
Sbjct: 201 DISEEDCSYCLSQGIAKIPSCCDMKMGSYVMSPSCMLAYAPWRFYDPVDTDDPSSVPAT- 259
Query: 279 LLAPEMPPESETESET-GGSHRKLIYLKIGAVAGVGGAVMTIIVVVLIAVLTRKGRSMRF 337
P PP++ET S T G +R + I A A V V+ I+++V+ L RK ++R
Sbjct: 260 ---PSRPPKNETRSVTQGDKNRGVPKALIFASASVAIVVLFIVLLVVFLKLRRK-ENIR- 314
Query: 338 VGDDANALTNNQGIDMRSFLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAV 397
++ N+ I S F+ VL AT +FS +N LG GGFG VYKG L DG++IAV
Sbjct: 315 ---NSENKHENENISTDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVLSDGQKIAV 371
Query: 398 KKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFD 457
K+L+ N+ QG+ EF+NE ++ K+QHRNLV+L G ++ ER+LVYE+LP+ SLDKF+FD
Sbjct: 372 KRLSKNAQQGETEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSLDKFIFD 431
Query: 458 KSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517
+ L+W R II GVARGLLYLH+DS LRIIHRD+KASNILLD +M PKI+DFG+A
Sbjct: 432 PIQGNELEWEIRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGMA 491
Query: 518 KLFH-DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQL 576
+LF D ++ T++I GTFGYMAPEY + G S K+DV+SFGVL+LEIISG+KN
Sbjct: 492 RLFDIDHTTQRYTNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEIISGKKNSGFSS 551
Query: 577 EAENQELLKLARRLEEEGRLMELVD---VRIGTYPEEIALRFMQIALLCTEDFIEDRPTM 633
E +L+ A R +EG + LVD + + +Y + +R + I LLC ++ + +RP+M
Sbjct: 552 EDSMGDLISFAWRNWKEGVALNLVDKILMTMSSYSSNMIMRCINIGLLCVQEKVAERPSM 611
Query: 634 SATLSMLSNSSVPI 647
++ + ML ++ +
Sbjct: 612 ASVVLMLDGHTIAL 625
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65405|CRK28_ARATH Cysteine-rich receptor-like protein kinase 28 OS=Arabidopsis thaliana GN=CRK28 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 375 bits (963), Expect = e-103, Method: Compositional matrix adjust.
Identities = 234/644 (36%), Positives = 343/644 (53%), Gaps = 24/644 (3%)
Query: 26 RKMLFQLLSFLFIFAFI---HQTSAEDDPRIKVCDSSTNNTLDSAFSSNL-GIALKTLQN 81
R + F L I FI + E P S N T +S+F+ NL G+
Sbjct: 5 RVIFFFFACVLKIVPFICLAQKDKYEFPPGFNCVASGGNFTANSSFAGNLNGLVSSLSSL 64
Query: 82 NTAQTGFSFTTISASNSSQPVTALALCRATITQSECQECMDSAVLSIRRVCPDQTTAQIW 141
+ GF + S +S + A+ LCR + + +C C+ A ++ CP A +W
Sbjct: 65 TSKPYGF-YNLSSGDSSGERAYAIGLCRREVKRDDCLSCIQIAARNLIEQCPLTNQAVVW 123
Query: 142 HTYCMIRYSSRKFIDNADSSLAFSLFDQREV-PNPTTFDQTVNSLTVNLAVLAGKSG--K 198
+T+CM RYS+ +++ S + + N FD+ L L +A G +
Sbjct: 124 YTHCMFRYSNMIIYGRKETTPTLSFQAGKNISANRDEFDRLQIELLDRLKGIAAAGGPNR 183
Query: 199 RFAVAKMKVISSDIYLYGYVECTRDVNGESCTKCLLSLRSYMMTCCSGRWAIWVGAPTCS 258
++A ++ YG CT D++ + C CL+ + CC+G+ + P+CS
Sbjct: 184 KYAQGSGSGVAGYPQFYGSAHCTPDLSEQDCNDCLVFGFEKIPGCCAGQVGLRWFFPSCS 243
Query: 259 VQVNLDPVHKDWETAVDIST---LLAPEMPPESETESETGGSHRKLIYLKIGAVAGVGGA 315
+ + +E D+ + P P S +E G + + + V +
Sbjct: 244 YRFE---TWRFYEFDADLEPDPPAIQPADSPTSAARTERTGKGKGGSKVIVAIVIPIVFV 300
Query: 316 VMTIIVVVLIAVLTRKGRSMRFVGDDANALTNNQGIDMR------SFLFNLDVLIAATDN 369
+ I + L+ + R G+ N L I ++ S + + + L AATDN
Sbjct: 301 ALFAICLCLLLKWKKNKSVGRVKGNKHNLLLLVIVILLQKDEFSDSLVVDFETLKAATDN 360
Query: 370 FSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQL 429
FS +N LGRGGFG+VYKG G+EIAVK+L+ S QG EF+NE+ +L K+QHRNLV+L
Sbjct: 361 FSPENELGRGGFGSVYKGVFSGGQEIAVKRLSCTSGQGDSEFKNEILLLAKLQHRNLVRL 420
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
G C++ +ERILVYE++ N SLD F+FD K +LDW R +I GVARGLLYLH DS
Sbjct: 421 LGFCIEGQERILVYEFIKNASLDNFIFDLKKRQLLDWGVRYKMIGGVARGLLYLHEDSRY 480
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFH-DEQSRHR-THQIAGTFGYMAPEYAIRG 547
RIIHRD+KASNILLD +M PKI+DFGLAKL+ D+ S HR T +IAGT+GYMAPEYAI G
Sbjct: 481 RIIHRDLKASNILLDQEMNPKIADFGLAKLYDTDQTSTHRFTSKIAGTYGYMAPEYAIYG 540
Query: 548 FLSVKSDVFSFGVLLLEIISGRKNYDRQL--EAENQELLKLARRLEEEGRLMELVDVRIG 605
SVK+DVFSFGVL++EII+G+ N + + + E + LL R E ++ ++D +
Sbjct: 541 QFSVKTDVFSFGVLVIEIITGKGNNNGRSNDDEEAENLLSWVWRCWREDIILSVIDPSLT 600
Query: 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPS 649
T LR + I LLC ++ RPTM + ML++ S +P+
Sbjct: 601 TGSRSEILRCIHIGLLCVQESPASRPTMDSVALMLNSYSYTLPT 644
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 370 bits (951), Expect = e-101, Method: Compositional matrix adjust.
Identities = 237/645 (36%), Positives = 351/645 (54%), Gaps = 42/645 (6%)
Query: 65 DSAFSSNLGIALKTLQNN-TAQTGFSFTTISASNSSQPVTALALCRATITQSECQECMDS 123
+S + N L TL +N T+ GF + + + V +C C +C+
Sbjct: 35 NSTYDLNRRQILSTLSSNVTSHNGFFNSKFGQAPNR--VFINGMCIPGTKPETCSDCIKG 92
Query: 124 AVLSIRRVCPDQTTAQIWHTYCMIRYSSRKFIDNADSSLAFSLFDQREVP----NPTTFD 179
A I CP++T A W CM+RYS+ F + + +L+ ++ N T FD
Sbjct: 93 ASDKISESCPNKTDAYTWPDCCMVRYSNVSFSGSLVMEPSETLYHTGDIEDTGTNLTVFD 152
Query: 180 QTVNSLTVNLAVLAGKS-------GKRFAVAKMKVISSDIYLYGYVECTRDVNGESCTKC 232
+ L + A S G+++ A++ +++ +Y ++CT DV+ + C C
Sbjct: 153 RIWEELMLRTITAASLSSSNGSSFGQKYFAAEVASLTTFQTMYAMMQCTPDVSSKDCEFC 212
Query: 233 LLSLRSYMMTCCSGRWAIWVGAPTCSVQVNLDPVHKDWETAV----------DISTLLAP 282
L + +CC G+ V P+C V+ +L P +E L P
Sbjct: 213 LKTSVGDYESCCRGKQGGAVIRPSCFVRWDLYPYAGAFENVTFPPPPPQSLPQPPVSLIP 272
Query: 283 EMPPESETESETGGSHRKLIYLKIGAVAGVGGAVMTIIVVVLIAVLTRKGRSMRFVGDDA 342
PP S+ + T +K VA V ++ ++ +V++ V+ R+ +S +
Sbjct: 273 --PPVSDRANTT---------IKGIIVAIVVPIIVILVSLVVLLVVCRRKKSYK----TT 317
Query: 343 NALTNNQGIDMRSFLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLAT 402
++ S F+ + AATD FS NM+GRGGFG VY+G+L G E+AVK+L+
Sbjct: 318 EVQATDEITTTHSLQFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSK 377
Query: 403 NSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSA 462
S QG EEF+NE ++ K+QH+NLV+L G C++ E+ILVYE++PNKSLD FLFD +K
Sbjct: 378 TSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQG 437
Query: 463 ILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522
LDW +R NII G+ARG+LYLH+DS L IIHRD+KASNILLD M PKI+DFG+A++F
Sbjct: 438 ELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGV 497
Query: 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYD-RQLEAENQ 581
+QS+ T +IAGTFGYM+PEYA+RG S+KSDV+SFGVL+LEIISG+KN ++
Sbjct: 498 DQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSGS 557
Query: 582 ELLKLARRLEEEGRLMELVDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640
L+ A RL G +ELVD IG +Y A R + IALLC ++ DRP + A + ML
Sbjct: 558 NLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCVQEDPADRPLLPAIIMML 617
Query: 641 SNSSVPIPSVTESPDHYEGDDDAGDNAGRREQFTRNSITFSLQDG 685
++S+ + V +P D + + T SI S+ D
Sbjct: 618 TSSTTTL-HVPRAPGFCLSGRDLEQDGVEYTESTSRSIPGSINDA 661
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65479|CRK20_ARATH Putative cysteine-rich receptor-like protein kinase 20 OS=Arabidopsis thaliana GN=CRK20 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 370 bits (950), Expect = e-101, Method: Compositional matrix adjust.
Identities = 228/612 (37%), Positives = 330/612 (53%), Gaps = 22/612 (3%)
Query: 56 CDSSTNNTLDSAFSSNLGIALKTLQNNTAQTGFSFTTISASNSSQPVTALALCRATITQS 115
C +T + +S +S+NL L +L + A F +A + VT L LCR ++
Sbjct: 33 CSITTTYSSNSTYSTNLKTLLSSLSSRNASYSTGFQNATAGQAPDMVTGLFLCRGNVSPE 92
Query: 116 ECQECMDSAVLSIRRVCPDQTTAQIWHTYCMIRYSSRKFIDNADSSLAFSLFDQREVPNP 175
C+ C+ +V CP++ A ++ CM+RYS+R + ++ + + R NP
Sbjct: 93 VCRSCIALSVNESLSRCPNEREAVFYYEQCMLRYSNRNILSTLNTDGGVFMQNAR---NP 149
Query: 176 TTFDQT-VNSLTVN----LAVLAGKSGKRFAVAKMKVISSDIYLYGYVECTRDVNGESCT 230
+ Q L +N A+ A +S KRFAV K +++ LYG V+CT D+ + C
Sbjct: 150 ISVKQDRFRDLVLNPMNLAAIEAARSIKRFAVTKFD-LNALQSLYGMVQCTPDLTEQDCL 208
Query: 231 KCLL-SLRSYMMTCCSGRWAIWVGAPTCSVQVNLDPVHKDWETAVDISTLLAPEMPPESE 289
CL S+ GR + P+C+ + + + ++ + P S
Sbjct: 209 DCLQQSINQVTYDKIGGRTFL----PSCTSRYDNYEFYNEFNVGTPQDSSPRPGKGGNSS 264
Query: 290 TESETGGSHRKLIYLKIGAVAGVGGAV--MTIIVVVLIAVLTRKGRSMRFVGDDANALTN 347
+++L A V A TI + L V K + A
Sbjct: 265 VIVIAVVVPITVLFLLFVAFFSVRRAKRKKTIGAIPLFKV---KRKETEVTEPPAETTDG 321
Query: 348 NQGIDMRSFLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQG 407
+ S F+ ++AATD F N LG+GGFG VYKG G ++AVK+L+ NS QG
Sbjct: 322 DDITTAGSLQFDFKAIVAATDIFLPINKLGQGGFGEVYKGTFPSGVQVAVKRLSKNSGQG 381
Query: 408 KEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWP 467
++EFENEV V+ K+QHRNLV+L G C++ E+ILVYE++PNKSLD FLFD + LDW
Sbjct: 382 EKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDYFLFDPTMQGQLDWS 441
Query: 468 KRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH 527
+R II G+ARG+LYLH+DS L IIHRD+KA NILLD M PK++DFG+A++F +Q+
Sbjct: 442 RRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFGMDQTEA 501
Query: 528 RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYD-RQLEAENQELLKL 586
T ++ GT+GYMAPEYA+ G S+KSDV+SFGVL+LEI+SG KN Q++ L+
Sbjct: 502 NTRRVVGTYGYMAPEYAMYGKFSMKSDVYSFGVLVLEIVSGMKNSSLDQMDGSISNLVTY 561
Query: 587 ARRLEEEGRLMELVDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSV 645
RL G ELVD G Y R + IALLC ++ DRPTMSA + ML+ SS+
Sbjct: 562 TWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDANDRPTMSAIVQMLTTSSI 621
Query: 646 PIPSVTESPDHY 657
+ +V P +
Sbjct: 622 AL-AVPRPPGFF 632
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 368 bits (945), Expect = e-101, Method: Compositional matrix adjust.
Identities = 233/638 (36%), Positives = 339/638 (53%), Gaps = 23/638 (3%)
Query: 56 CDSSTNNTLDSAFSSNLGIALKTLQNNTAQTGFSFTTISASNSSQPVTALALCRATITQS 115
C + T + +S +S+NL L + + A F I A + VT L LCR ++
Sbjct: 44 CPNRTTYSSNSTYSTNLKTLLSSFASRNASYSTGFQNIRAGQTPDRVTGLFLCRGDLSPE 103
Query: 116 ECQECMDSAVLSIRRVCPDQTTAQIWHTYCMIRYSSRKFIDNADSSLAFSLFDQREVPN- 174
C C+ +V CP+Q A ++ C++RYS + F+ + + + +
Sbjct: 104 VCSNCVAFSVNESLTRCPNQREAVFYYEECILRYSHKNFLSTVTYEGELIMRNPNNISSI 163
Query: 175 PTTFDQTVNSLTVNL---AVLAGKSGKRFAVAKMKVISSDIYLYGYVECTRDVNGESCTK 231
DQ ++ + N+ A A S ++F+ K ++ S LYG V+CT D+ + C
Sbjct: 164 QNQRDQFIDLVQSNMNQAANEAANSSRKFSTIKTELTSLQT-LYGLVQCTPDLARQDCFS 222
Query: 232 CLLSLRSYMMTCCS-GRWAIWVGAPTCSVQVNLDPVHKDWETAVDISTLLAPEMPPESET 290
CL S + MM G W P+C+ + L + + L P P +
Sbjct: 223 CLTSSINRMMPLFRIGARQFW---PSCNSRYELYAFYNETAIGTPSPPPLFPGSTPPLTS 279
Query: 291 ESETGGSHRKLIYLKIGAVAGVGGAVMTIIVVVLIAVLTRKG---RSMRFVGDDANALTN 347
S G S L + V + ++ +A T+K S VGDD A +
Sbjct: 280 PSIPGKSGNS-TVLVVAIVVLAVLLFIALVGYCFLAQRTKKTFDTASASEVGDDM-ATAD 337
Query: 348 NQGIDMRSFLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQG 407
+ +D R+ + AT++F+ N +GRGGFG VYKG +G+E+AVK+L+ NS QG
Sbjct: 338 SLQLDYRT-------IQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQG 390
Query: 408 KEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWP 467
+ EF+ EV V+ K+QHRNLV+L G +Q ERILVYEY+PNKSLD LFD +K LDW
Sbjct: 391 EAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWM 450
Query: 468 KRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH 527
+R NII G+ARG+LYLH+DS L IIHRD+KASNILLD + PKI+DFG+A++F +Q++
Sbjct: 451 QRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQD 510
Query: 528 RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLA 587
T +I GT+GYMAPEYA+ G S+KSDV+SFGVL+LEIISGRKN Q+LL
Sbjct: 511 NTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDLLTHT 570
Query: 588 RRLEEEGRLMELVDVRIGTYPEEI-ALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVP 646
RL ++LVD I + +R + I LLC ++ RPT+S ML++++V
Sbjct: 571 WRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLTSNTVT 630
Query: 647 IPSVTESPDHYEGDDDAGDNAGRREQFTRNSITFSLQD 684
+P V P + D + T S S+ D
Sbjct: 631 LP-VPRQPGFFIQSSPVKDPTDSDQSTTTKSTPASIDD 667
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65472|CRK12_ARATH Putative cysteine-rich receptor-like protein kinase 12 OS=Arabidopsis thaliana GN=CRK12 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 367 bits (942), Expect = e-100, Method: Compositional matrix adjust.
Identities = 247/712 (34%), Positives = 366/712 (51%), Gaps = 80/712 (11%)
Query: 33 LSFLFIFAFIHQTSAEDDPRIKVCDSSTNNTLDSAFSSNLGIALKTLQNNTAQTGFSFTT 92
+ LF++ F+ TS + C ++T +S + +N + L L +N + F F
Sbjct: 1 MPLLFLWFFLTSTSLVSALQTLPCINTTYFIPNSTYDTNRRVILSLLPSNVT-SHFGFFN 59
Query: 93 ISASNSSQPVTALALCRATITQSECQECMDSAVLSIRRVCPDQTTAQIW---HTYCMIRY 149
S + V A+ +C + C C+ SA ++ C + A IW T CMIRY
Sbjct: 60 GSIGQAPNRVYAVGMCLPGTEEESCIGCLLSASNTLLETCLTEENALIWIANRTICMIRY 119
Query: 150 SSRKFIDNADSSLAFSLFDQREV-------PNPTTFDQTVNSLTVNLAVLAGKS------ 196
S F+ +F L RE N T F+ + LT + A S
Sbjct: 120 SDTSFVG------SFELEPHREFLSIHGYKTNETEFNTVWSRLTQRMVQEASSSTDATWS 173
Query: 197 GKRFAVAKMKVISSDIYLYGYVECTRDVNGESCTKCLLSLRSYMMTCCSGRWAIWVGAPT 256
G ++ A + + LY ++CT D++ C CL +CC GR + +
Sbjct: 174 GAKYYTADVAALPDSQTLYAMMQCTPDLSPAECNLCLTESVVNYQSCCLGRQGGSIVRLS 233
Query: 257 CSVQVNLDPVHKDWETAVDISTLLAPEMPPES-----------ETESETGGSHRKLIYLK 305
C+ + L P + A + T PP S + S+ + +Y+
Sbjct: 234 CAFRAELYP----FGGAFTVMTARPLSQPPPSLIKKGEFFAKFMSNSQEPVKMIQNLYVV 289
Query: 306 IGAVAGVGGAVMT------------------IIVVVLIAVLTRKGRSMRFVGDDANALT- 346
+ + + ++++VL + R+ +S + + D + +T
Sbjct: 290 VLIFYFLDSGKFSTETIAAIVVPIIVVAIIFLVLLVLSRLFARRRKSYQEIDLDQSGITT 349
Query: 347 -NNQGIDMRSFLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSM 405
+ Q +D ++ + AT+NF+ N LG+GGFG VYKG L +G E+AVK+L+ S
Sbjct: 350 LHFQQLDFKT-------IEVATENFAKTNKLGQGGFGEVYKGTLVNGTEVAVKRLSKTSE 402
Query: 406 QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILD 465
QG +EF+NEV ++ K+QHRNLV+L G C++ E+ILVYE++PNKSLD FLFD +K LD
Sbjct: 403 QGAQEFKNEVVLVAKLQHRNLVKLLGYCLEPEEKILVYEFVPNKSLDYFLFDPTKQGQLD 462
Query: 466 WPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525
W KR NII G+ RG+LYLH+DS L IIHRD+KASNILLD M PKI+DFG+A++ +QS
Sbjct: 463 WTKRYNIIGGITRGILYLHQDSRLTIIHRDLKASNILLDADMIPKIADFGMARISGIDQS 522
Query: 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKN---YDRQLEAENQE 582
T +IAGTFGYM PEY I G S+KSDV+SFGVL+LEII G+KN Y +AEN
Sbjct: 523 VANTKRIAGTFGYMPPEYVIHGQFSMKSDVYSFGVLILEIICGKKNRSFYQADTKAEN-- 580
Query: 583 LLKLARRLEEEGRLMELVDVRIGTYPE-EIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641
L+ RL G +ELVD+ I + E +R + IALLC ++ +DRP +S + ML+
Sbjct: 581 LVTYVWRLWTNGSPLELVDLTISENCQTEEVIRCIHIALLCVQEDPKDRPNLSTIMMMLT 640
Query: 642 NSSVPIPSVTESPDHYEGDDDAGDNAGRREQF-------TRNSITFSLQDGR 686
NSS+ I SV + P + + D+ QF T+N +T + D R
Sbjct: 641 NSSL-ILSVPQPPGFFVPQNKERDSF-LSSQFTMGCTSQTKNDVTITNLDPR 690
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S8|CRK5_ARATH Cysteine-rich receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 365 bits (938), Expect = e-100, Method: Compositional matrix adjust.
Identities = 227/599 (37%), Positives = 332/599 (55%), Gaps = 19/599 (3%)
Query: 65 DSAFSSNLGIALKTLQNNTAQTGFSFTTISASNSSQPVTALALCRATITQSECQECMDSA 124
+S + SNL L +L +N A +++ +S V L LC+ ++ C+EC+ A
Sbjct: 43 NSIYFSNLQTLLTSLSSNNAYFSLGSHSLTKGQNSDMVFGLYLCKGDLSPESCRECVIFA 102
Query: 125 VLSIRRVCPDQTTAQIWHTYCMIRYSSRK-FIDNADSSLAFSLFDQREVPNPTT-FDQTV 182
R CP I + CM+ YS R F+D ++ + Q+ + + F+ V
Sbjct: 103 AKDTRSRCPGGKEFLIQYDECMLGYSDRNIFMDTVTTTTIITWNTQKVTADQSDRFNDAV 162
Query: 183 NSLTVNLAVLAGKS-GKRFAVAKMKVISSDIYLYGYVECTRDVNGESCTKCLL-SLRSYM 240
SL A A S K+FAV K SS LY V+C D+ E C CL S++
Sbjct: 163 LSLMKKSAEEAANSTSKKFAVKKSD-FSSSQSLYASVQCIPDLTSEDCVMCLQQSIKELY 221
Query: 241 MTCCSGRWAIWVGAPTCSVQVNLDPVHKDWETAVDISTLLAPEMPPESETESETGGSHRK 300
GR+ + P+C+ + + P +K+ + ++ P T S G +
Sbjct: 222 FNKVGGRFLV----PSCNSRYEVYPFYKETIEGTVLPPPVSAPPLPLVSTPSFPPGKGKN 277
Query: 301 LIYLKIGAVAGVGGAVMTIIVVVLIAVLTRKGRSMRFVGDDANALTNNQGIDMRSFLFNL 360
+ I V V +V+ + V R ++ +D S F+
Sbjct: 278 STVIIIAIVVPVAISVLICVAVFSFHASKRAKKTYDTPEEDDITTAG-------SLQFDF 330
Query: 361 DVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLK 420
V+ AATD FS N LG+GGFG VYKG L +G ++AVK+L+ S QG++EF+NEV V+ K
Sbjct: 331 KVIEAATDKFSMCNKLGQGGFGQVYKGTLPNGVQVAVKRLSKTSGQGEKEFKNEVVVVAK 390
Query: 421 MQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGL 480
+QHRNLV+L G C++ E+ILVYE++ NKSLD FLFD + LDW R II G+ARG+
Sbjct: 391 LQHRNLVKLLGFCLEREEKILVYEFVSNKSLDYFLFDSRMQSQLDWTTRYKIIGGIARGI 450
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMA 540
LYLH+DS L IIHRD+KA NILLD M PK++DFG+A++F +Q+ T ++ GT+GYM+
Sbjct: 451 LYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFEIDQTEAHTRRVVGTYGYMS 510
Query: 541 PEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYD-RQLEAENQELLKLARRLEEEGRLMEL 599
PEYA+ G S+KSDV+SFGVL+LEIISGRKN Q++A L+ RL +G ++L
Sbjct: 511 PEYAMYGQFSMKSDVYSFGVLVLEIISGRKNSSLYQMDASFGNLVTYTWRLWSDGSPLDL 570
Query: 600 VDVRI-GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPSVTESPDHY 657
VD +Y +R + IALLC ++ E+RPTMSA + ML+ SS+ + +V + P +
Sbjct: 571 VDSSFRDSYQRNEIIRCIHIALLCVQEDTENRPTMSAIVQMLTTSSIAL-AVPQPPGFF 628
|
Involved in multiple distinct defense responses. May function as a disease resistance (R) protein. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GWJ7|CRK19_ARATH Cysteine-rich receptor-like protein kinase 19 OS=Arabidopsis thaliana GN=CRK19 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 362 bits (929), Expect = 5e-99, Method: Compositional matrix adjust.
Identities = 233/633 (36%), Positives = 348/633 (54%), Gaps = 48/633 (7%)
Query: 32 LLSFLFIFAFIHQTSAEDDP--RIKVCDSSTNNTLDSAFSSNLGIALKTLQNNTAQTGFS 89
L+SF+F+F F T++ + C +T + +S +S+NL L +L + A + +
Sbjct: 4 LISFIFLFLFSSITASAQNTFYLYHNCSVTTTFSSNSTYSTNLKTLLSSLSSLNASSYST 63
Query: 90 -FTTISASNSSQPVTALALCRATITQSECQECMDSAVLSIRRVCPDQTTAQIWHTYCMIR 148
F T +A + VT L LCR ++ C+ C+ AV CP ++ C++R
Sbjct: 64 GFQTATAGQAPDRVTGLFLCRVDVSSEVCRSCVTFAVNETLTRCPKDKEGVFYYEQCLLR 123
Query: 149 YSSRKFIDNADSSLAFSLFDQREVPNPTTFDQT----VNSLTVNLA-VLAGKSGKRFAVA 203
YS+R + ++ + R NP + Q + +NLA V A +S K++AV
Sbjct: 124 YSNRNIVATLNTDGGMFMQSAR---NPLSVKQDQFRDLVLTPMNLAAVEAARSFKKWAVR 180
Query: 204 KMKVISSDIYLYGYVECTRDVNGESCTKCL-LSLRSYMMTCCSGRWAIWVGAPTCSVQVN 262
K+ + +S LYG V CT D+ + C CL + + GR + P+C+ + +
Sbjct: 181 KIDLNASQ-SLYGMVRCTPDLREQDCLDCLKIGINQVTYDKIGGRILL----PSCASRYD 235
Query: 263 LDPVHKDWETAVDISTLLAPEMPPESETESETGGSHRKLIYLKIGAVAGVGGAVMTIIVV 322
+ + P +S GG+ +I + +T++ +
Sbjct: 236 NYAFYNESNVGT----------PQDSSPRPGKGGNSSVIIIAVV--------VPITVLFL 277
Query: 323 VLIAVLTRKGRSMRF------VGDDANALTNNQGIDMRSFLFNLDVLIAATDNFSTKNML 376
+L+AV + + ++ R V +D N +T S F+ + AAT+ F N L
Sbjct: 278 LLVAVFSVRAKNKRTLNEKEPVAEDGNDITT-----AGSLQFDFKAIEAATNCFLPINKL 332
Query: 377 GRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE 436
G+GGFG VYKG L G ++AVK+L+ S QG++EFENEV V+ K+QHRNLV+L G C++
Sbjct: 333 GQGGFGEVYKGTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEG 392
Query: 437 RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDI 496
E+ILVYE++PNKSLD FLFD + LDW +R II G+ARG+LYLH+DS L IIHRD+
Sbjct: 393 EEKILVYEFVPNKSLDHFLFDSTMKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDL 452
Query: 497 KASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVF 556
KA NILLD M PKI+DFG+A++F +Q+ T ++ GT+GYM+PEYA+ G S+KSDV+
Sbjct: 453 KAGNILLDDDMNPKIADFGMARIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVY 512
Query: 557 SFGVLLLEIISGRKNYD-RQLEAENQELLKLARRLEEEGRLMELVDVRIG-TYPEEIALR 614
SFGVL+LEIISG KN Q++ L+ RL G ELVD G Y R
Sbjct: 513 SFGVLVLEIISGMKNSSLYQMDESVGNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITR 572
Query: 615 FMQIALLCTEDFIEDRPTMSATLSMLSNSSVPI 647
+ IALLC ++ EDRPTMS+ + ML+ S + +
Sbjct: 573 CIHIALLCVQEDAEDRPTMSSIVQMLTTSLIAL 605
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 686 | ||||||
| 225452061 | 672 | PREDICTED: cysteine-rich receptor-like p | 0.956 | 0.976 | 0.526 | 0.0 | |
| 225452063 | 660 | PREDICTED: cysteine-rich receptor-like p | 0.934 | 0.971 | 0.524 | 0.0 | |
| 147791345 | 632 | hypothetical protein VITISV_026923 [Viti | 0.895 | 0.971 | 0.513 | 1e-176 | |
| 225452065 | 662 | PREDICTED: cysteine-rich receptor-like p | 0.769 | 0.797 | 0.556 | 1e-166 | |
| 225455970 | 641 | PREDICTED: putative cysteine-rich recept | 0.887 | 0.950 | 0.470 | 1e-158 | |
| 224076400 | 666 | predicted protein [Populus trichocarpa] | 0.830 | 0.855 | 0.405 | 1e-117 | |
| 359484020 | 662 | PREDICTED: cysteine-rich receptor-like p | 0.881 | 0.913 | 0.397 | 1e-116 | |
| 255555051 | 1390 | serine-threonine protein kinase, plant-t | 0.930 | 0.458 | 0.375 | 1e-114 | |
| 413945846 | 668 | putative DUF26-domain receptor-like prot | 0.887 | 0.911 | 0.387 | 1e-114 | |
| 226500408 | 668 | uncharacterized protein LOC100280312 pre | 0.887 | 0.911 | 0.385 | 1e-114 |
| >gi|225452061|ref|XP_002280456.1| PREDICTED: cysteine-rich receptor-like protein kinase 29 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 692 bits (1787), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/674 (52%), Positives = 462/674 (68%), Gaps = 18/674 (2%)
Query: 28 MLFQLLSFLFIFAFIHQTSAEDDPRIKVCDSSTNNTLDSAFSSNLGIALKTLQNNTAQTG 87
M LL I + + A +DPR + C +T +S FSSNL +AL+TL N TA TG
Sbjct: 2 MSIPLLCCCLISLAAYLSLAYEDPRGQSCGETTYYAPNSTFSSNLDLALETLSNTTASTG 61
Query: 88 FSFTTISASNSSQPVTALALCRATITQSECQECMDSAVLSIRRVCPDQTTAQIWHTYCMI 147
F+ TT A +SSQ VTALALCRATIT S+CQ C+D+A +R CP+QT AQ+W+T CM+
Sbjct: 62 FATTT--AGDSSQTVTALALCRATITPSDCQLCVDAAASGVRSACPNQTVAQVWYTLCML 119
Query: 148 RYSSRKFIDNADSSLAFSLFDQREVPNPTTFDQTVNSLTVNLAVLAGKSGKRFAVAKMKV 207
RYS F++ D ++AF+L+D R P+P +D V L NL+ AG S KR+AV +
Sbjct: 120 RYSGYYFVNKTDYTIAFTLYDTRHAPDPDAYDVKVKMLMRNLSSTAGASEKRYAVGRTAA 179
Query: 208 ISSDIYLYGYVECTRDVNGESCTKCLLSLRSYMMTCCSGRWAIWVGAPTCSVQVNLDPVH 267
++ LYGYV+CTRD++G+SC+ CLL+ S + +CC G+WA W+ PTC++Q N+DPVH
Sbjct: 180 -PENLTLYGYVDCTRDIDGDSCSGCLLAATSAINSCCLGQWAGWIATPTCNIQFNMDPVH 238
Query: 268 KDWETAVDISTLLAPEMPPESETES----ETGGSHRKLIYLKIGAVAGVGGAVMTIIVVV 323
+DW ++T P + TE G+ + +KI + VG V+ +V+
Sbjct: 239 EDWVNGPYVNTDTTPALASSPTTEPVMGPAGNGAGGGGLAIKISVILTVGTVVLVAVVLG 298
Query: 324 LIAVLTRKGRSMR----FVGDDANALTNNQGIDMRSFLFNLDVLIAATDNFSTKNMLGRG 379
+ ++ R + +D + + I R+F+++LD L+AATDNF N LG G
Sbjct: 299 VAMKWRKRERVEKGGSGISDEDNDQEIMRERIGTRNFIYDLDALVAATDNFCLANRLGAG 358
Query: 380 GFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERER 439
GFGTVYKG +++G EIAVKKL S QG+EEF NEVR+LLK+QHRNLV+LFGCCV+ R
Sbjct: 359 GFGTVYKGIMENGEEIAVKKLTPGSTQGREEFSNEVRLLLKLQHRNLVRLFGCCVEGENR 418
Query: 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKAS 499
+LVYEYL NKSL+ FLFDKSKSA+LDWPKR NIIMGVARGLLYLH DS LRIIHRDIKAS
Sbjct: 419 VLVYEYLQNKSLNYFLFDKSKSALLDWPKRYNIIMGVARGLLYLHEDSQLRIIHRDIKAS 478
Query: 500 NILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFG 559
NILLD M PKI+DFGLA+LF DEQ+ HRT +IAGTFGYMAPEYAIRGF++ K DVFSFG
Sbjct: 479 NILLDEGMNPKIADFGLARLFKDEQTHHRTRRIAGTFGYMAPEYAIRGFMTAKIDVFSFG 538
Query: 560 VLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIA 619
VL+LEIISGRKNYD QL +N+ELLKLA RLE+EGR+MELVD IG++ ++ L+ +++
Sbjct: 539 VLILEIISGRKNYDPQLNEQNRELLKLAWRLEQEGRIMELVDATIGSFSQDNVLKCVRVG 598
Query: 620 LLCTEDFIEDRPTMSATLSMLSNSSVPIP-----SVTESP-DHYEGDDDAGDNAG-RREQ 672
LLC + +DRPTMS+ + MLSN SV IP ++P D D +A E
Sbjct: 599 LLCCQQLTQDRPTMSSAMLMLSNDSVTIPVAGRHGYQDTPCDPVAPHDSINTSADLENES 658
Query: 673 FTRNSITFSLQDGR 686
F++NSITFSL +GR
Sbjct: 659 FSKNSITFSLPNGR 672
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452063|ref|XP_002280482.1| PREDICTED: cysteine-rich receptor-like protein kinase 29-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 655 bits (1691), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/661 (52%), Positives = 446/661 (67%), Gaps = 20/661 (3%)
Query: 37 FIFAFIHQTSAEDDPRIKVCDSSTNNTLDSAFSSNLGIALKTLQNNTAQTGFSFTTISAS 96
+F F + A +DPR +CD + +S FSSNL AL+TLQN TA GF+ TTI+ S
Sbjct: 9 LVFLFPLLSLAYEDPRANLCDGTITYAPNSTFSSNLDRALQTLQNTTASNGFA-TTIAGS 67
Query: 97 NSSQPVTALALCRATITQSECQECMDSAVLSIRRVCPDQTTAQIWHTYCMIRYSSRKFID 156
SQ VTALALCRATIT S+CQ C+D+A IR VCP+ T AQ+W+T CM+RYSS+ F++
Sbjct: 68 -ISQTVTALALCRATITPSDCQLCIDAATSGIRNVCPNGTAAQVWYTLCMLRYSSQNFVN 126
Query: 157 NADSSLAFSLFDQREVPNPTTFDQTVNSLTVNLAVLAGKSGKRFAVAKMKVISSDIYLYG 216
D ++AF L D R+ P+P +D L NL+ AG S +R+AV + + LYG
Sbjct: 127 KTDYTIAFILVDTRDAPDPDHYDAKTKMLMQNLSSTAGVSERRYAVGRTTA-PENRTLYG 185
Query: 217 YVECTRDVNGESCTKCLLSLRSYMMTCCSGRWAIWVGAPTCSVQVNLDPVHKDWETAVDI 276
YV+CTRDV+G+SC +CLL+ S + +CC RWA+W+ PTC++Q ++DPVH DW I
Sbjct: 186 YVDCTRDVDGDSCKRCLLTTTSAVDSCCLDRWAVWIATPTCNIQFDMDPVHDDWVNGPYI 245
Query: 277 STLLAPEMPPESETES-ETGGSHRKLIYLKIGAVAGVGGAVMTIIVVVLIAVLTRKGRSM 335
+T P + GS ++I + + G G V+ +VV+ + ++
Sbjct: 246 NTDTTPSPALAPALAAYNHAGSGSRVIKIAVALTVGTVGIVVLAVVVLCVVKWRKRDEVE 305
Query: 336 RFVGDDANALTNNQGIDMRSFLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREI 395
R + A +++GI RSFL++L+VL+AATDNF N LG GGFG+VYKG +++G EI
Sbjct: 306 REGFEVAEE--DSEGIGTRSFLYDLEVLVAATDNFCLANRLGAGGFGSVYKGVMENGEEI 363
Query: 396 AVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFL 455
AVKKLA S QG+EEF EVR+LLK+QHRNLV+LFGCCV+ +LVYEYL NKSLD+ +
Sbjct: 364 AVKKLAPGSTQGREEFSTEVRLLLKLQHRNLVRLFGCCVEGENMMLVYEYLHNKSLDRLI 423
Query: 456 FDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFG 515
FDKSKSA+LDW KR NII+GVARGLLYLH DS LRIIHRDIKASNILLD M KISDFG
Sbjct: 424 FDKSKSALLDWTKRYNIIIGVARGLLYLHEDSQLRIIHRDIKASNILLDGLMNAKISDFG 483
Query: 516 LAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQ 575
LAKL +DEQ+ HRT +I GTFGYMAPEYA RGF+S K DVFSFGVL+LEIISGRKNYD +
Sbjct: 484 LAKLINDEQTHHRTQRIVGTFGYMAPEYASRGFMSSKIDVFSFGVLILEIISGRKNYDME 543
Query: 576 LEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSA 635
+ ++ ELLKLA RLEEEGRL +LVDV IG++P + L+ ++I LLC + I RPTMS+
Sbjct: 544 FDEQDWELLKLAWRLEEEGRLTDLVDVTIGSFPLDHVLKCIRIGLLCCQRSIRARPTMSS 603
Query: 636 TLSMLSNSSVPIP----------SVTESPDHYEGDDDAGDNAGRREQFTRNSITFSLQDG 685
T+ ML N S + S SP H + A G F+ NSITFS +G
Sbjct: 604 TILMLLNDSATMSNGGTHDYQNISDRVSP-HNNSNAPANPENG---SFSMNSITFSSANG 659
Query: 686 R 686
R
Sbjct: 660 R 660
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147791345|emb|CAN61842.1| hypothetical protein VITISV_026923 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 624 bits (1610), Expect = e-176, Method: Compositional matrix adjust.
Identities = 339/660 (51%), Positives = 433/660 (65%), Gaps = 46/660 (6%)
Query: 37 FIFAFIHQTSAEDDPRIKVCDSSTNNTLDSAFSSNLGIALKTLQNNTAQTGFSFTTISAS 96
+F F + A +DPR +CD + +S FSSNL AL+TLQN TA GF+ TTI S
Sbjct: 9 LVFLFPLLSLAYEDPRANLCDGTITYAPNSTFSSNLDRALQTLQNTTASNGFA-TTIXGS 67
Query: 97 NSSQPVTALALCRATITQSECQECMDSAVLSIRRVCPDQTTAQIWHTYCMIRYSSRKFID 156
SQ VTALALCRATIT S+CQ C+D+A IR VCP+ T AQ+W+T CM+RYSS+ F++
Sbjct: 68 -ISQTVTALALCRATITPSDCQLCIDAATSGIRNVCPNGTAAQVWYTLCMLRYSSQNFVN 126
Query: 157 NADSSLAFSLFDQREVPNPTTFDQTVNSLTVNLAVLAGKSGKRFAVAKMKVISSDIYLYG 216
D ++AF L D R+ P+P +D L NL+ AG S +R+AV + + LYG
Sbjct: 127 KTDYTIAFILVDTRDAPDPDHYDAKTKMLMQNLSSTAGVSERRYAVGRTTA-PENRTLYG 185
Query: 217 YVECTRDVNGESCTKCLLSLRSYMMTCCSGRWAIWVGAPTCSVQVNLDPVHKDWETAVDI 276
YV+CTRDV+G+SC +CLL+ S + +CC RWA+W+ PT
Sbjct: 186 YVDCTRDVDGDSCKRCLLTTTSAVDSCCLDRWAVWIATPTS------------------- 226
Query: 277 STLLAPEMPPESETESETGGSHRKLIYLKIGAVAGVGGAVMTIIVVVLIAVLTRKGRSMR 336
LAP + + GS ++I + + G G V+ +VV+ + ++ R
Sbjct: 227 ---LAPALAAYNH-----AGSGSRVIKIAVALTVGTVGIVVLAVVVLCVVKWRKRDEVER 278
Query: 337 FVGDDANALTNNQGIDMRSFLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIA 396
+ A +++GI RSFL++L+VL+AATDNF N LG GGFG+VYKG +++G EIA
Sbjct: 279 EGFEVAEE--DSEGIGTRSFLYDLEVLVAATDNFCLANRLGAGGFGSVYKGVMENGEEIA 336
Query: 397 VKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLF 456
VKKLA S QG+EEF EVR+LLK+QHRNLV+LFGCCV+ +LVYEYL NKSLD+ +F
Sbjct: 337 VKKLAPGSTQGREEFSTEVRLLLKLQHRNLVRLFGCCVEGENMMLVYEYLHNKSLDRLIF 396
Query: 457 DKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGL 516
DKSKSA+LDW KR NII+GVARGLLYLH DS LRIIHRDIKASNILLD M KISDFGL
Sbjct: 397 DKSKSALLDWTKRYNIIIGVARGLLYLHEDSQLRIIHRDIKASNILLDGLMNAKISDFGL 456
Query: 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQL 576
AKL +DEQ+ HRT +I GTFGYMAPEYA RGF+S K DVFSFGVL+LEIISGRKNYD +
Sbjct: 457 AKLINDEQTHHRTQRIVGTFGYMAPEYASRGFMSSKIDVFSFGVLILEIISGRKNYDMEF 516
Query: 577 EAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSAT 636
+ ++ ELLKLA RLEEEGRL +LVDV IG++P + L+ ++I LLC + I RPTMS+T
Sbjct: 517 DEQDWELLKLAWRLEEEGRLTDLVDVTIGSFPLDHVLKCIRIGLLCCQRSIRARPTMSST 576
Query: 637 LSMLSNSSVPIP----------SVTESPDHYEGDDDAGDNAGRREQFTRNSITFSLQDGR 686
+ ML N S + S SP H + A G F+ NSITFS +GR
Sbjct: 577 ILMLLNDSATMSNGGTHDYQNISDRVSP-HNNSNAPANPXNG---SFSMNSITFSSANGR 632
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452065|ref|XP_002280493.1| PREDICTED: cysteine-rich receptor-like protein kinase 26-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1522), Expect = e-166, Method: Compositional matrix adjust.
Identities = 305/548 (55%), Positives = 382/548 (69%), Gaps = 20/548 (3%)
Query: 146 MIRYSSRKFIDNADSSLAFSLFDQREVPNPTTFDQTVNSLTVNLAVLAGKSGKRFAVAKM 205
M+RYS R F++ D +L F L+D R P+P +D V L NL+ AG S KR+AV +
Sbjct: 1 MLRYSHRNFVNKTDYTLTFRLYDTRNAPDPDIYDAKVQRLMQNLSSTAGASEKRYAVGRT 60
Query: 206 KVISSDIYLYGYVECTRDVNGESCTKCLLSLRSYMMTCCSGRWAIWVGAPTCSVQVNLDP 265
+ LYGYV+CTRD++G+SC CLL+ S + TCC G+WA W+ PTC++Q N+DP
Sbjct: 61 TA-PENFTLYGYVDCTRDIDGDSCKGCLLATTSAIDTCCLGQWAGWLATPTCNIQFNMDP 119
Query: 266 VHKDWETAVDISTLLAPE--MPPESETESETGGSHRKLIYLKIGAVAGVGGAVMTIIVVV 323
VH+DW I+T + P + P E++ G R L+ +KI VG V+ V+V
Sbjct: 120 VHEDWVNGPYINTDITPSSTLAPLPVAENDAGS--RSLV-IKISVALTVGTVVLA--VLV 174
Query: 324 LIAVLTRKGRSMRFVGDD--ANALTNNQGIDMRSFLFNLDVLIAATDNFSTKNMLGRGGF 381
L AV RK + G + + ++GI RSF+++L+VL+AAT NF N LG GGF
Sbjct: 175 LCAVKWRKRDEVETGGSEIIEDNEEMSEGIGKRSFMYDLEVLVAATGNFCLANRLGAGGF 234
Query: 382 GTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441
GTVYKG + DG EIAVKKLA S QG+EEF NEVR+LLK+QHRNLV+LFGCCV+ R+L
Sbjct: 235 GTVYKGMMADGEEIAVKKLAPGSTQGREEFSNEVRLLLKLQHRNLVRLFGCCVEGENRLL 294
Query: 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNI 501
VYEYL NKSLD F+FDKSKSA+LDWPKR NII+GVARGLLYLH DS LRIIHRDIKASNI
Sbjct: 295 VYEYLQNKSLDHFIFDKSKSALLDWPKRYNIIIGVARGLLYLHEDSQLRIIHRDIKASNI 354
Query: 502 LLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVL 561
LLD M PKISDFGLAKLF DEQ+ HRT +I G FGYMAPEYA RGF+S K DVFSFGVL
Sbjct: 355 LLDELMNPKISDFGLAKLFKDEQTHHRTRRIVGIFGYMAPEYATRGFMSSKIDVFSFGVL 414
Query: 562 LLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALL 621
+LEIISGR+NYD + + ++ ELLKLA RLEEEG+L +LVDV IG++P++ L+ ++I LL
Sbjct: 415 ILEIISGRRNYDMEFDEQDWELLKLAWRLEEEGQLTDLVDVTIGSFPQDQVLKCIRIGLL 474
Query: 622 CTEDFIEDRPTMSATLSMLSNSSVPIPSVTESPDHYEGDDDAGD-----NA---GRREQF 673
C + I DRPTMS+T+ MLSN SV +P E Y+ D D NA E F
Sbjct: 475 CCQQSIRDRPTMSSTVLMLSNDSVTMP--IEGTHGYQNIRDPVDPHNNINALANPENESF 532
Query: 674 TRNSITFS 681
++NSITFS
Sbjct: 533 SKNSITFS 540
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455970|ref|XP_002276601.1| PREDICTED: putative cysteine-rich receptor-like protein kinase 20-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 567 bits (1460), Expect = e-158, Method: Compositional matrix adjust.
Identities = 322/685 (47%), Positives = 420/685 (61%), Gaps = 76/685 (11%)
Query: 27 KMLFQLLSFLFIFAFIHQTSAEDDPRIKVC----DSSTNNTLDSAFSSNLGIALKTLQNN 82
+ +F + F +F ++ T A + PR + C D TNN+L F++NL AL ++
Sbjct: 8 QQMFLSIFFALVFFSVNLTGAYESPRFQECGVDADKYTNNSL---FAANLAHALNNIRTY 64
Query: 83 TAQTGFSFTTISASNSSQPVTALALCRATITQSECQECMDSAVLSIRRVCPDQTTAQIWH 142
TA TGF+ TT++ N ++PVTAL CR T ECQ C+DSA I VC Q TAQIW+
Sbjct: 65 TAHTGFNTTTVA--NGTEPVTALGFCRPDQTPMECQACIDSATSGILEVCLYQKTAQIWY 122
Query: 143 TYCMIRYSSRKFIDNADSSLAFSLFDQREVPNPTTFDQTVNSLTVNLAVLAGKSGKRFAV 202
CMIRYS F+ D + FSL+ E + + QT+ ++ NL+ L S +R+AV
Sbjct: 123 NLCMIRYSFMDFLSLVDRTPIFSLWTDFETQSSDVYYQTLLAMVKNLSSLDAVSKRRYAV 182
Query: 203 AKMKVISSDIYLYGYVECTRDVNGESCTKCLLSLRSYMMTCCSGRWAIWVGAPTCSVQVN 262
+V + +YGY +CT D++GESC+ CL T + +N
Sbjct: 183 GWSRV-NEATKVYGYAQCTPDLSGESCSSCL-------------------SIDTPEILLN 222
Query: 263 LDPVHKDWETAVDISTLLAPEMPPESETESETGGSHRKLIYLKIGAVAGVGGAVM-TIIV 321
L P D ET ++E +TG R + V GV GAV+ T+I+
Sbjct: 223 L-PSKTDSET--------------QAEEAPKTGRRGRSSM------VIGVSGAVVGTVIL 261
Query: 322 VVLIAVLTRKGR------SMRFVGDDANALTN-NQGIDMRSFLFNLDVLIAATDNFSTKN 374
VV + KGR R GD+ +A + +G+ MR+FL++++ L+AATDNFS+ N
Sbjct: 262 VVAAGWMIMKGRHKTNKGQRRGSGDEEDAEESIREGLGMRNFLYDMEALVAATDNFSSAN 321
Query: 375 MLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCV 434
LG GGFG VYKGR+ +G EIAVKKL S QG EEF NEV VL+KM+HRNLV+L GCC
Sbjct: 322 RLGGGGFGFVYKGRMHNGEEIAVKKLTVGSTQGVEEFSNEVEVLVKMRHRNLVKLLGCCT 381
Query: 435 QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHR 494
Q E++LVYEYLPNKSL+ FLFDKS+SA+LDW KR NI++GVARGLLYLH DS +RIIHR
Sbjct: 382 QGDEKMLVYEYLPNKSLNYFLFDKSRSALLDWQKRSNIMVGVARGLLYLHEDSQIRIIHR 441
Query: 495 DIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSD 554
DIK SNILLD M PKISDFGLAKLF DEQS RT +IAGT GYMAPEYAIRG +S K D
Sbjct: 442 DIKTSNILLDEHMNPKISDFGLAKLFPDEQSHLRTRRIAGTVGYMAPEYAIRGLMSTKID 501
Query: 555 VFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALR 614
VFSFGVL+LEIISGRKNYD QL+ + +ELL L RRLE +GRLMELVD IG++PE+ +
Sbjct: 502 VFSFGVLMLEIISGRKNYDPQLDDQRRELLNLTRRLERQGRLMELVDTTIGSFPEDEVKK 561
Query: 615 FMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPSVTESPDHYEGDDDAGDNAG------ 668
+ I LLC +D +++R TMS+ L +L N+ V +P P G + +N
Sbjct: 562 CIHIGLLCCQDNMQERLTMSSALMLLLNNPVTMP-----PPGRLGFQGSRENTNESSTSN 616
Query: 669 -------RREQFTRNSITFSLQDGR 686
E + N++T SL GR
Sbjct: 617 SGSSIVLENENVSNNTMTTSLTSGR 641
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076400|ref|XP_002304937.1| predicted protein [Populus trichocarpa] gi|222847901|gb|EEE85448.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 427 bits (1098), Expect = e-117, Method: Compositional matrix adjust.
Identities = 240/592 (40%), Positives = 349/592 (58%), Gaps = 22/592 (3%)
Query: 68 FSSNLGIALKTLQNNTAQTGFSFTTISASNSSQPVTALALCRATITQSECQECMDSAVLS 127
+ NL L +L +N F SA V L CR ++ CQ C+ +A
Sbjct: 52 YKDNLNTLLSSLASNATSNSIGFFNASAGLEPDDVYGLFFCRGDLSTDVCQNCVANATKD 111
Query: 128 I-RRVCPDQTTAQIWHTYCMIRYSSRKFIDNADSSLAFSLFDQREVPNPTTFD-QTVNSL 185
I +R CP Q A IW+ C +RYS++ + ++L++ V F+ + +N++
Sbjct: 112 IVQRRCPTQKVAFIWYDECFLRYSNKIMFSTMERDPNYTLWNPENVAVHADFNRELLNTI 171
Query: 186 --TVNLAVLAGKSGKRFAVAKMKVISSDIYLYGYVECTRDVNGESCTKCLLSLRSYMMTC 243
VN A K+F K +++ YLY V+CT D++ C +CLL+ S + C
Sbjct: 172 FTAVNRAANMPAGAKKFRATKANY-TTEHYLYVLVQCTPDLSSGDCEQCLLAAYSGLEIC 230
Query: 244 CSGRWAIWVGAPTCSVQVNLDPVHKDWETAVDISTLLAPEMPPESETESETG--GSHRKL 301
C+ + + P+C V N + ET V+ S LAP P+ + G GS +K
Sbjct: 231 CNEKRGGRILFPSCIV--NFETYINYNETYVE-SAALAPSPVPQEKHFCYAGDKGSSKKT 287
Query: 302 IYLKIGAVAGVGGAVMTIIVVVLIAVLTRKGRSMRFVGDDANALTNNQGIDMRSFLFNLD 361
+ +G + TI+ V+L++ + D +N + + SFL LD
Sbjct: 288 WII-------IGATLSTIVGVLLLSSFAYTMWRRKKRDDCSNEIMYGEVKSQDSFLIQLD 340
Query: 362 VLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKM 421
+++ AT+ +S +N LG+GGFG VYKG ++DG+EIAVK+L+ S QG EF NEV ++ ++
Sbjct: 341 IVLKATNQYSNENKLGQGGFGPVYKGVMEDGKEIAVKRLSRTSGQGLREFMNEVNLIARL 400
Query: 422 QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLL 481
QHRNLV+L GCC+++ E++LVYEY+PNKSLD FLFD + LDW +RL+II G+ARGLL
Sbjct: 401 QHRNLVKLLGCCLEKNEKLLVYEYMPNKSLDVFLFDSAMRVQLDWQRRLSIINGIARGLL 460
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP 541
YLH DS LRIIHRD+KASNILLD++M PKISDFG+A++F S T++I GT+GYMAP
Sbjct: 461 YLHEDSRLRIIHRDLKASNILLDYEMNPKISDFGMARIFGGNHSEANTNRIVGTYGYMAP 520
Query: 542 EYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601
EYA+ G SVKSDVFSFGVL+LEIISG++N L E + LL +L EG+ +EL+D
Sbjct: 521 EYAMEGLSSVKSDVFSFGVLMLEIISGKRNGGFHLSEEGKSLLNFTWKLWSEGKGLELMD 580
Query: 602 --VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS--NSSVPIPS 649
+ + E+ L+ + I LLC ++ DRPTMS+ + ML+ N +PIP+
Sbjct: 581 SLLEKSSVATEV-LKCIHIGLLCVQEDPVDRPTMSSVVVMLAGDNFKIPIPT 631
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484020|ref|XP_002273323.2| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 425 bits (1092), Expect = e-116, Method: Compositional matrix adjust.
Identities = 249/626 (39%), Positives = 361/626 (57%), Gaps = 21/626 (3%)
Query: 35 FLFIFAFIHQTSAEDDPRIKVCDSSTNNTLDSAFSSNLGIALKTLQNNTAQ-TGFSFTTI 93
F+ + I S + D +C + N +S + NL + L +L +N A G F
Sbjct: 12 LFFLSSLIIHGSPKPDLFYSLCTENGNYEPNSTYQYNLNLLLTSLSSNAATLNGRKFHNQ 71
Query: 94 SASNSSQPVTALALCRATITQSECQECMDSAVLSIRRVCPDQTTAQIWHTYCMIRYSSRK 153
+A + V L LCR +T + CQ C+ +A I CP++ W+ CM RYS+R
Sbjct: 72 TAGQAPDMVYGLYLCRGDVTDAVCQNCVQTASQEILTKCPNRKEVISWYDQCMFRYSNRS 131
Query: 154 FIDNADSSLAFSLFDQREVPNPTTFDQTVNSLTVNL---AVLAGKSGKRFAVAKMKVISS 210
+ + + ++ E+ +P FDQ VN V + A F + K ++
Sbjct: 132 IFSIMEERPSVTGSNELEMEDPDRFDQIVNETMVGMIEKATYNSSERDMFETGEAK-FNA 190
Query: 211 DIYLYGYVECTRDVNGESCTKCLLSLRSYMMTCCSGRWAIWVGAPTCSVQVNLDPVHKDW 270
+YG +CT D++G C +CL ++ S + CC G+ + P+C+ + + P + D+
Sbjct: 191 STKIYGLAQCTPDLSGSDCRRCLENIFSRIPNCCYGKQGARILGPSCNFRYEVYPFYGDF 250
Query: 271 ETAVDISTLLAPEMP--PESETESETGGSHRKLIYLKIGAVAGVGGAVMTIIVVVLIAVL 328
A ++ SE++ + G S R LI + + V V I + L
Sbjct: 251 AAAAPLAPSPLSPPGNNTASESKGKKGNSSRLLIVIIVPVVGTV-----IIFGFLYSCWL 305
Query: 329 TRKGR--SMRFVGDDANALTNNQGIDMRSFLFNLDVLIAATDNFSTKNMLGRGGFGTVYK 386
RK R + G+D+ ++ + M S LF+L L AAT+NFS N +G GGFG VYK
Sbjct: 306 NRKMRKSTPSAFGEDSQSMDST----MDSLLFDLKTLRAATNNFSDANKIGEGGFGAVYK 361
Query: 387 GRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446
G L G EIA+K+L+ NS QG EEF+NE+ +L K+QHRNLV+L G C++ +E+ILVYE++
Sbjct: 362 GLLSSGLEIAIKRLSRNSGQGTEEFKNEIALLAKLQHRNLVRLLGFCLEAKEKILVYEFV 421
Query: 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ 506
PNKSLD FLFD K + LDWP R II+G+ARGLLYLH +S L+IIHRD+KASNILLD +
Sbjct: 422 PNKSLDYFLFDTDKQSQLDWPTRHKIIVGIARGLLYLHEESRLKIIHRDLKASNILLDSK 481
Query: 507 MKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEII 566
+ PKISDFG+A++F EQS+ T +I GT+GYM+PEYA+ G SVKSDVFSFGVLLLEI+
Sbjct: 482 LNPKISDFGMARIFFMEQSQANTTRIVGTYGYMSPEYAMHGQFSVKSDVFSFGVLLLEIL 541
Query: 567 SGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI-GTYPEEIALRFMQIALLCTED 625
SG+KN +Q+LL A R ++ +EL+D + G Y +R + I LLC ++
Sbjct: 542 SGKKNSCFNNSECSQDLLSYAWRQWKDRTALELIDPIVGGEYSRSEVMRCIHIGLLCVQE 601
Query: 626 FIEDRPTMSATLSMLSNSSV--PIPS 649
DRPTM++ ML++ SV P+PS
Sbjct: 602 DAADRPTMASVALMLNSYSVTLPLPS 627
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555051|ref|XP_002518563.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223542408|gb|EEF43950.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 420 bits (1079), Expect = e-114, Method: Compositional matrix adjust.
Identities = 246/655 (37%), Positives = 363/655 (55%), Gaps = 17/655 (2%)
Query: 1 MGYFRAIVLDTQTLALGVFSISYYNRKMLFQLLSFLFIFAFIHQTSAEDDPRIKVCDSST 60
+G R I L ++ L I + + K + + I A + +C +
Sbjct: 721 IGRNRGITLTSKHAELQDKVIMFLHHKSNALIFLLIIISALASSIDCQATYNAHICLGAA 780
Query: 61 NNTLDSAFSSNLGIALKTLQNNTAQTGFSFTTISASNSSQPVTALALCRATITQSECQEC 120
N+T + F SNL L +L ++ A SF ++SS V +L LCR ++ CQ C
Sbjct: 781 NDTASANFKSNLTALLNSL-SSKATLNNSF----YNDSSNGVYSLYLCRGDVSSGTCQLC 835
Query: 121 MDSAVLSIRRVCPDQTTAQIWHTYCMIRYSSRKFIDNADSSLAFSLFDQREVPNPTTFDQ 180
+++A+ I+R CP +A IW+ CM+RYS+ KF A +S +++ + +P D
Sbjct: 836 VETAIQEIQRQCPSNKSAIIWYDQCMLRYSNTKFFGLAQTSPRVLMWNIQNNTSPDEPDY 895
Query: 181 TVNSLTVNLAVLAGKSGKRFAVAKMKVISSDIYLYGYVECTRDVNGESCTKCLLSLRSYM 240
L L F + + + Y V+CTRD++ +C+ CL L +
Sbjct: 896 GALGLIYTLTGSVPYKAMMFGTEESETNNGSQKRYALVQCTRDIDSSACSSCLGELIDSI 955
Query: 241 MTCCSGRWAIWVGAPTCSVQVNLDPVHKDWETAVDISTLLAPEMPPESETESETGGSHRK 300
CC G+ + AP+C+++ + + +W +A +S PE + +E GGS+
Sbjct: 956 TDCCQGKKGWRILAPSCNLRYE-ETLFFEWPSAPPVS---EPEPENDYYVVNEGGGSNTA 1011
Query: 301 LIYLKIGAVAGVGGAVMTIIVVVLIAVLTRKGRSMRFVGDDANALTNNQGIDMRSFLFNL 360
I + + A + T+++ L+ R D +N + FNL
Sbjct: 1012 TIAIAVAASS-------TVVIGALLGFWYYSCYYKRRRPTDGEMHASNDDNNGGMHYFNL 1064
Query: 361 DVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLK 420
+ +AT+NFST N LG GGFG VYKG+L +G+EIAVK+L+ S QG +EF NEV V++K
Sbjct: 1065 TTIRSATNNFSTANKLGEGGFGPVYKGKLPNGQEIAVKRLSMTSKQGLDEFRNEVMVIVK 1124
Query: 421 MQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGL 480
+QH+NLV+L G C + E++L+YEYL N SLD FLFD +S L W R NII G ARGL
Sbjct: 1125 LQHKNLVRLLGYCTEGDEKLLIYEYLANTSLDAFLFDPKRSKELYWEMRANIITGTARGL 1184
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMA 540
LYLH DS L+IIHRD+KASN+LLD+ M PKISDFG A++F Q T ++ GTFGYMA
Sbjct: 1185 LYLHEDSRLKIIHRDMKASNVLLDNDMNPKISDFGTARIFGGNQIEANTDRVVGTFGYMA 1244
Query: 541 PEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600
PEYA+ G +S+KSDV+SFG+L+LEIISG+KN LL A +L EG+ +L+
Sbjct: 1245 PEYALEGVISIKSDVYSFGILMLEIISGKKNRGFYNPEHAPSLLLHAWQLWNEGKGEDLI 1304
Query: 601 DVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPSVTESP 654
D I + P LR++QIALLC +D +RPTMS+ + ML + S+ +P + +P
Sbjct: 1305 DPDIVFSCPTSEVLRWIQIALLCVQDDPAERPTMSSVVLMLGSKSMILPQPSTAP 1359
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|413945846|gb|AFW78495.1| putative DUF26-domain receptor-like protein kinase family protein [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 419 bits (1076), Expect = e-114, Method: Compositional matrix adjust.
Identities = 246/635 (38%), Positives = 356/635 (56%), Gaps = 26/635 (4%)
Query: 29 LFQLLSFLFIFAFIHQTSAEDDPRIKVCDSSTNNTLDSAFSSNLGIALKTLQNNTAQTGF 88
+ LL L + + D+P C ++TN T SAF +NL L +L + A +
Sbjct: 1 MHSLLPILLCSFLLATAANADNPFYTGCPNNTNYTRGSAFQANLNALLASLPSAAAAS-A 59
Query: 89 SFTTISASNSSQPVTALALCRATITQSECQECMDSAVLSIRRVCPDQTTAQIWHTYCMIR 148
F T + + LA CRA + S+C+ C+D + + RVCP Q +A + + C +R
Sbjct: 60 GFATNTTGTAPDQAYGLAQCRADVNASDCRACLDGSTRDMARVCPGQKSAMLIYDACQLR 119
Query: 149 YSSRKFIDNADSSLAFSLFDQREVPNPTTFDQTVNSLTVNLAVLAGK--------SGKRF 200
+S+ F D+S+ + Q N T +Q T L L G S +RF
Sbjct: 120 HSNASFFGAVDASV---VVWQPNAQNATQQEQ----FTTRLGALMGSVTERAAYASPRRF 172
Query: 201 AVAKMKVISSDIYLYGYVECTRDVNGESCTKCLLSLRSYMMTCCSGRWAIWVGAPTCSVQ 260
AV V + + +YG +CTRD+ G+ C +CL+ S++ TCC GR + P+CS++
Sbjct: 173 AVGSAAV-TPFVNVYGMAQCTRDLAGDDCNRCLVGAVSFIPTCCDGRQGARIVYPSCSIR 231
Query: 261 VNLDPVHKDWETAVDISTLLAPEMPPESETESETGGSHRKLIY-LKIGAVAGVGGAVMTI 319
+ P + +S AP + ++ G + ++ + + AV +
Sbjct: 232 FEVYPFYDAQAADAAMSPAPAPGAGSVNGSDQSGLGESGSGSHKVRAALLVAIPVAVALL 291
Query: 320 IVVVLIAVLTRKGRSMRFVGDDANALTNNQGIDMRS---FLFNLDVLIAATDNFSTKNML 376
V V + + R + + V +N + + DM S L++L L AATDNFS +N L
Sbjct: 292 QVAVFLFLRKRNRQPHKHVQVASNVHEDEE--DMTSSEYLLYDLSTLRAATDNFSEENKL 349
Query: 377 GRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE 436
G GGFG VYKG LQDG+EIAVK+L+ S QG+ E +NEV +L K+QHRNLV+L GCC +E
Sbjct: 350 GEGGFGPVYKGTLQDGQEIAVKRLSATSQQGQVEMKNEVVLLAKLQHRNLVRLLGCCTEE 409
Query: 437 RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDI 496
ER+LVYE+L N SLDK LFD ++ L W R II G+ RGLLYLH +S L IIHRD+
Sbjct: 410 HERLLVYEFLTNNSLDKILFDPARRQELGWGLRQRIIEGIGRGLLYLHEESRLTIIHRDL 469
Query: 497 KASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVF 556
KASNILLD M PKISDFGLAKLF + S T IAGT+GYMAPEYA+ G S KSDVF
Sbjct: 470 KASNILLDADMNPKISDFGLAKLFSLDSSVGNTSHIAGTYGYMAPEYAMHGLFSAKSDVF 529
Query: 557 SFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD--VRIGTYPEEIALR 614
S+GVL+LEI++GR+N +++LL G + L++ G +E+ LR
Sbjct: 530 SYGVLVLEIVTGRRNSYTHASGPSEDLLTFVWTHWSRGSVQPLLEGCPDEGLRAQEM-LR 588
Query: 615 FMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPS 649
+ +ALLC ++ DRP+M++ + ML++ S+ +P+
Sbjct: 589 CIHVALLCVQEDPLDRPSMASVVVMLNSRSITLPA 623
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|226500408|ref|NP_001146710.1| uncharacterized protein LOC100280312 precursor [Zea mays] gi|219888451|gb|ACL54600.1| unknown [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 419 bits (1076), Expect = e-114, Method: Compositional matrix adjust.
Identities = 245/635 (38%), Positives = 356/635 (56%), Gaps = 26/635 (4%)
Query: 29 LFQLLSFLFIFAFIHQTSAEDDPRIKVCDSSTNNTLDSAFSSNLGIALKTLQNNTAQTGF 88
+ LL L + + D+P C ++TN T SAF +NL L +L + + +
Sbjct: 1 MHSLLPILLCSFLLATAANADNPFYTGCPNNTNYTRGSAFQANLNALLASLPSAASAS-A 59
Query: 89 SFTTISASNSSQPVTALALCRATITQSECQECMDSAVLSIRRVCPDQTTAQIWHTYCMIR 148
F T + + LA CRA + S+C+ C+D + + RVCP Q +A + + C +R
Sbjct: 60 GFATNTTGTAPDQAYGLAQCRADVNASDCRACLDGSTRDMARVCPGQKSAMLIYDACQLR 119
Query: 149 YSSRKFIDNADSSLAFSLFDQREVPNPTTFDQTVNSLTVNLAVLAGK--------SGKRF 200
+S+ F D+S+ + Q N T +Q T L L G S +RF
Sbjct: 120 HSNASFFGAVDASV---VVWQPNAQNATQQEQ----FTTRLGALMGSVTERAAYASPRRF 172
Query: 201 AVAKMKVISSDIYLYGYVECTRDVNGESCTKCLLSLRSYMMTCCSGRWAIWVGAPTCSVQ 260
AV V + + +YG +CTRD+ G+ C +CL+ S++ TCC GR + P+CS++
Sbjct: 173 AVGSAAV-TPFVNVYGMAQCTRDLAGDDCNRCLVGAVSFIPTCCDGRQGARIVYPSCSIR 231
Query: 261 VNLDPVHKDWETAVDISTLLAPEMPPESETESETGGSHRKLIY-LKIGAVAGVGGAVMTI 319
+ P + +S AP + ++ G + ++ + + AV +
Sbjct: 232 FEVYPFYDAQAADAAMSPAPAPGAGSVNGSDQSGLGESGSGSHKVRAALLVAIPVAVALL 291
Query: 320 IVVVLIAVLTRKGRSMRFVGDDANALTNNQGIDMRS---FLFNLDVLIAATDNFSTKNML 376
V V + + R + + V +N + + DM S L++L L AATDNFS +N L
Sbjct: 292 QVAVFLFLRKRNRQPHKHVQVASNVHEDEE--DMTSSEYLLYDLSTLRAATDNFSEENKL 349
Query: 377 GRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE 436
G GGFG VYKG LQDG+EIAVK+L+ S QG+ E +NEV +L K+QHRNLV+L GCC +E
Sbjct: 350 GEGGFGPVYKGTLQDGQEIAVKRLSATSQQGQVEMKNEVVLLAKLQHRNLVRLLGCCTEE 409
Query: 437 RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDI 496
ER+LVYE+L N SLDK LFD ++ L W R II G+ RGLLYLH +S L IIHRD+
Sbjct: 410 HERLLVYEFLTNNSLDKILFDPARRQELGWGLRQRIIEGIGRGLLYLHEESRLTIIHRDL 469
Query: 497 KASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVF 556
KASNILLD M PKISDFGLAKLF + S T IAGT+GYMAPEYA+ G S KSDVF
Sbjct: 470 KASNILLDADMNPKISDFGLAKLFSLDSSVGNTSHIAGTYGYMAPEYAMHGLFSAKSDVF 529
Query: 557 SFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD--VRIGTYPEEIALR 614
S+GVL+LEI++GR+N +++LL G + L++ G +E+ LR
Sbjct: 530 SYGVLVLEIVTGRRNSYTHASGPSEDLLTFVWTHWSRGSVQPLLEGCPDEGLRAQEM-LR 588
Query: 615 FMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPS 649
+ +ALLC ++ DRP+M++ + ML++ S+ +P+
Sbjct: 589 CIHVALLCVQEDPLDRPSMASVVVMLNSRSITLPA 623
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 686 | ||||||
| TAIR|locus:2115728 | 675 | CRK25 "cysteine-rich RLK (RECE | 0.440 | 0.447 | 0.493 | 4.2e-98 | |
| TAIR|locus:2141201 | 679 | CRK29 "cysteine-rich RLK (RECE | 0.447 | 0.452 | 0.495 | 2.3e-97 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.479 | 0.491 | 0.484 | 1.6e-94 | |
| TAIR|locus:2121636 | 659 | CRK7 "cysteine-rich RLK (RECEP | 0.494 | 0.514 | 0.440 | 5.4e-94 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.444 | 0.472 | 0.490 | 6.9e-94 | |
| TAIR|locus:2141762 | 665 | CRK26 "cysteine-rich RLK (RECE | 0.437 | 0.451 | 0.483 | 8.9e-94 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.492 | 0.5 | 0.456 | 1.1e-93 | |
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.450 | 0.461 | 0.476 | 1.1e-93 | |
| TAIR|locus:2127323 | 642 | CRK27 "cysteine-rich RLK (RECE | 0.428 | 0.457 | 0.493 | 4.9e-91 | |
| TAIR|locus:2121626 | 830 | CRK23 "cysteine-rich RLK (RECE | 0.440 | 0.363 | 0.485 | 2.1e-90 |
| TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 729 (261.7 bits), Expect = 4.2e-98, Sum P(2) = 4.2e-98
Identities = 150/304 (49%), Positives = 198/304 (65%)
Query: 347 NNQGIDMRSFL-FNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSM 405
+ GI L F + AAT+ FS N LG GGFG VYKG+L G +A+K+L+ S
Sbjct: 323 DEDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGST 382
Query: 406 QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILD 465
QG EEF+NEV V+ K+QHRNL +L G C+ E+ILVYE++PNKSLD FLFD K +LD
Sbjct: 383 QGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLD 442
Query: 466 WPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525
W +R II G+ARG+LYLHRDS L IIHRD+KASNILLD M PKISDFG+A++F +Q+
Sbjct: 443 WQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQT 502
Query: 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQXXXX 585
+ T +I GT+GYM+PEYAI G SVKSDV+SFGVL+LE+I+G+KN E
Sbjct: 503 QANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDGLGDLVT 562
Query: 586 XXXXXXXXXXXXXXVDVRI-GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644
VD + G + +R + IALLC ++ +RP+M L M+++ +
Sbjct: 563 YVWKLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMDDILVMMNSFT 622
Query: 645 VPIP 648
V +P
Sbjct: 623 VTLP 626
|
|
| TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 744 (267.0 bits), Expect = 2.3e-97, Sum P(2) = 2.3e-97
Identities = 155/313 (49%), Positives = 208/313 (66%)
Query: 342 ANALTNNQGIDMRSFLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLA 401
+ ++ ++ + S L + + L ATDNFS++N LGRGGFG+VYKG G+EIAVK+L+
Sbjct: 329 SGSIAEDEFSNTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLS 388
Query: 402 TNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKS 461
NS QG EF+NE+ +L K+QHRNLV+L G C+Q ER+LVYE++ N SLD+F+FD K
Sbjct: 389 GNSGQGDNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKR 448
Query: 462 AILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521
+LDW R +I G+ARGLLYLH DS RIIHRD+KASNILLD +M PKI+DFGLAKLF
Sbjct: 449 QLLDWVVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFD 508
Query: 522 DEQSR-HR-THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE 579
Q+ HR T +IAGT+GYMAPEYA+ G SVK+DVFSFGVL++EII+G++N + +
Sbjct: 509 SGQTMTHRFTSRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGD 568
Query: 580 NQXXXXXXXXXXX--XXXXXXXVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATL 637
+D + LR + I LLC ++ RPTM AT+
Sbjct: 569 EDAEDLLSWVWRSWREDTILSVIDPSLTAGSRNEILRCIHIGLLCVQESAATRPTM-ATV 627
Query: 638 SMLSNS-SVPIPS 649
S++ NS S +P+
Sbjct: 628 SLMLNSYSFTLPT 640
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 769 (275.8 bits), Expect = 1.6e-94, Sum P(2) = 1.6e-94
Identities = 161/332 (48%), Positives = 214/332 (64%)
Query: 355 SFLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENE 414
S F+ + AATD FS NM+GRGGFG VY+G+L G E+AVK+L+ S QG EEF+NE
Sbjct: 330 SLQFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQGAEEFKNE 389
Query: 415 VRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIM 474
++ K+QH+NLV+L G C++ E+ILVYE++PNKSLD FLFD +K LDW +R NII
Sbjct: 390 AVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWTRRYNIIG 449
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAG 534
G+ARG+LYLH+DS L IIHRD+KASNILLD M PKI+DFG+A++F +QS+ T +IAG
Sbjct: 450 GIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQANTRRIAG 509
Query: 535 TFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYD-RQLEAENQXXXXXXXXXXXX 593
TFGYM+PEYA+RG S+KSDV+SFGVL+LEIISG+KN ++
Sbjct: 510 TFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSGSNLVTHAWRLWRN 569
Query: 594 XXXXXXVDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPSVTE 652
VD IG +Y A R + IALLC ++ DRP + A + ML++S+ + V
Sbjct: 570 GSPLELVDPTIGESYQSSEATRCIHIALLCVQEDPADRPLLPAIIMMLTSSTTTL-HVPR 628
Query: 653 SPDHYEXXXXXXXXXXRREQFTRNSITFSLQD 684
+P + T SI S+ D
Sbjct: 629 APGFCLSGRDLEQDGVEYTESTSRSIPGSIND 660
|
|
| TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 710 (255.0 bits), Expect = 5.4e-94, Sum P(2) = 5.4e-94
Identities = 151/343 (44%), Positives = 214/343 (62%)
Query: 344 ALTNNQGIDMRSFLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATN 403
AL + + S + + AAT++FS N +GRGGFG VYKG +G E+AVK+L+
Sbjct: 310 ALDEDDKTTIESLQLDYRAIQAATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKT 369
Query: 404 SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAI 463
S QG EF+NEV V+ ++H+NLV++ G ++ ERILVYEY+ NKSLD FLFD +K
Sbjct: 370 SEQGDTEFKNEVVVVANLRHKNLVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQ 429
Query: 464 LDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523
L W +R +II G+ARG+LYLH+DS L IIHRD+KASNILLD M PKI+DFG+A++F +
Sbjct: 430 LYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMD 489
Query: 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAEN-QX 582
Q++ T +I GT+GYM+PEYA+RG S+KSDV+SFGVL+LEIISGRKN + +E ++ Q
Sbjct: 490 QTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKN-NSFIETDDAQD 548
Query: 583 XXXXXXXXXXXXXXXXXVDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641
VD I + + +R I LLC ++ RP MS ML+
Sbjct: 549 LVTHAWRLWRNGTALDLVDPFIADSCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISVMLT 608
Query: 642 NSSVPIPSVTESPDHYEXXXXXXXXXXRREQFTRNSITFSLQD 684
++++ +P+ + P + + T S+T S+ D
Sbjct: 609 SNTMALPA-PQQPGFFVRSRPGTNRLDSDQSTTNKSVTVSIDD 650
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 727 (261.0 bits), Expect = 6.9e-94, Sum P(2) = 6.9e-94
Identities = 153/312 (49%), Positives = 203/312 (65%)
Query: 338 VGDDANALTNNQGIDMRSFLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAV 397
V +D N +T G S F+ + AAT+ F N LG+GGFG VYKG L G ++AV
Sbjct: 299 VAEDGNDITT-AG----SLQFDFKAIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAV 353
Query: 398 KKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFD 457
K+L+ S QG++EFENEV V+ K+QHRNLV+L G C++ E+ILVYE++PNKSLD FLFD
Sbjct: 354 KRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFD 413
Query: 458 KSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517
+ LDW +R II G+ARG+LYLH+DS L IIHRD+KA NILLD M PKI+DFG+A
Sbjct: 414 STMKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMA 473
Query: 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDR-QL 576
++F +Q+ T ++ GT+GYM+PEYA+ G S+KSDV+SFGVL+LEIISG KN Q+
Sbjct: 474 RIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQM 533
Query: 577 EAENQXXXXXXXXXXXXXXXXXXVDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSA 635
+ VD G Y R + IALLC ++ EDRPTMS+
Sbjct: 534 DESVGNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSS 593
Query: 636 TLSMLSNSSVPI 647
+ ML+ S + +
Sbjct: 594 IVQMLTTSLIAL 605
|
|
| TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 720 (258.5 bits), Expect = 8.9e-94, Sum P(2) = 8.9e-94
Identities = 147/304 (48%), Positives = 202/304 (66%)
Query: 348 NQGIDMRSFLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQG 407
N+ I S F+ VL AT +FS +N LG GGFG VYKG L DG++IAVK+L+ N+ QG
Sbjct: 322 NENISTDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVLSDGQKIAVKRLSKNAQQG 381
Query: 408 KEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWP 467
+ EF+NE ++ K+QHRNLV+L G ++ ER+LVYE+LP+ SLDKF+FD + L+W
Sbjct: 382 ETEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSLDKFIFDPIQGNELEWE 441
Query: 468 KRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH-DEQSR 526
R II GVARGLLYLH+DS LRIIHRD+KASNILLD +M PKI+DFG+A+LF D ++
Sbjct: 442 IRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGMARLFDIDHTTQ 501
Query: 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQXXXXX 586
T++I GTFGYMAPEY + G S K+DV+SFGVL+LEIISG+KN E
Sbjct: 502 RYTNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEIISGKKNSGFSSEDSMGDLISF 561
Query: 587 XXXXXXXXXXXXXVD---VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643
VD + + +Y + +R + I LLC ++ + +RP+M++ + ML
Sbjct: 562 AWRNWKEGVALNLVDKILMTMSSYSSNMIMRCINIGLLCVQEKVAERPSMASVVLMLDGH 621
Query: 644 SVPI 647
++ +
Sbjct: 622 TIAL 625
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 725 (260.3 bits), Expect = 1.1e-93, Sum P(2) = 1.1e-93
Identities = 159/348 (45%), Positives = 214/348 (61%)
Query: 338 VGDDANALTNNQGIDMRSFLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAV 397
VGDD A ++ +D R+ + AT++F+ N +GRGGFG VYKG +G+E+AV
Sbjct: 329 VGDDM-ATADSLQLDYRT-------IQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAV 380
Query: 398 KKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFD 457
K+L+ NS QG+ EF+ EV V+ K+QHRNLV+L G +Q ERILVYEY+PNKSLD LFD
Sbjct: 381 KRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFD 440
Query: 458 KSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517
+K LDW +R NII G+ARG+LYLH+DS L IIHRD+KASNILLD + PKI+DFG+A
Sbjct: 441 PTKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMA 500
Query: 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLE 577
++F +Q++ T +I GT+GYMAPEYA+ G S+KSDV+SFGVL+LEIISGRKN
Sbjct: 501 RIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDES 560
Query: 578 AENQXXXXXXXXXXXXXXXXXXVDVRIGTYPEEI-ALRFMQIALLCTEDFIEDRPTMSAT 636
Q VD I + +R + I LLC ++ RPT+S
Sbjct: 561 DGAQDLLTHTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTV 620
Query: 637 LSMLSNSSVPIPSVTESPDHYEXXXXXXXXXXRREQFTRNSITFSLQD 684
ML++++V +P V P + + T S S+ D
Sbjct: 621 FMMLTSNTVTLP-VPRQPGFFIQSSPVKDPTDSDQSTTTKSTPASIDD 667
|
|
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 722 (259.2 bits), Expect = 1.1e-93, Sum P(2) = 1.1e-93
Identities = 152/319 (47%), Positives = 206/319 (64%)
Query: 337 FVGDDANALTNNQGIDMRSFLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIA 396
F GDD + Q +D R+ + ATD+F N +G+GGFG VYKG L DG E+A
Sbjct: 323 FAGDDITTADSLQ-LDYRT-------IQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVA 374
Query: 397 VKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLF 456
VK+L+ +S QG+ EF+NEV ++ K+QHRNLV+L G C+ ER+LVYEY+PNKSLD FLF
Sbjct: 375 VKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLF 434
Query: 457 DKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGL 516
D +K LDW +R II GVARG+LYLH+DS L IIHRD+KASNILLD M PKI+DFG+
Sbjct: 435 DPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGM 494
Query: 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYD-RQ 575
A++F +Q+ T +I GT+GYM+PEYA+ G S+KSDV+SFGVL+LEIISG+KN Q
Sbjct: 495 ARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQ 554
Query: 576 LEAENQXXXXXXXXXXXXXXXXXXVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSA 635
+ + + +R + I LLC ++ +RPT+S
Sbjct: 555 TDGAHDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLST 614
Query: 636 TLSMLSNSSVPIPSVTESP 654
+ ML++++V +P V P
Sbjct: 615 IVLMLTSNTVTLP-VPRQP 632
|
|
| TAIR|locus:2127323 CRK27 "cysteine-rich RLK (RECEPTOR-like protein kinase) 27" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 724 (259.9 bits), Expect = 4.9e-91, Sum P(2) = 4.9e-91
Identities = 148/300 (49%), Positives = 204/300 (68%)
Query: 355 SFLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENE 414
S F+ + + ATD+FS N +G GGFG VYKG L DG EIAVK+L+ +S QG EF+ E
Sbjct: 318 SLHFDFETIRVATDDFSLTNKIGEGGFGVVYKGHLPDGLEIAVKRLSIHSGQGNAEFKTE 377
Query: 415 VRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIM 474
V ++ K+QH+NLV+LFG ++E ER+LVYE++PN SLD+FLFD K LDW KR NII+
Sbjct: 378 VLLMTKLQHKNLVKLFGFSIKESERLLVYEFIPNTSLDRFLFDPIKQKQLDWEKRYNIIV 437
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAG 534
GV+RGLLYLH S IIHRD+K+SN+LLD QM PKISDFG+A+ F + ++ T ++ G
Sbjct: 438 GVSRGLLYLHEGSEFPIIHRDLKSSNVLLDEQMLPKISDFGMARQFDFDNTQAVTRRVVG 497
Query: 535 TFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQXXXXXXXXXXXXX 594
T+GYMAPEYA+ G SVK+DV+SFGVL+LEII+G++N L E
Sbjct: 498 TYGYMAPEYAMHGRFSVKTDVYSFGVLVLEIITGKRNSGLGL-GEGTDLPTFAWQNWIEG 556
Query: 595 XXXXXVD-VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS----VPIPS 649
+D V + T+ ++ +++ ++IAL C ++ RPTM + +SMLS+ S +P PS
Sbjct: 557 TSMELIDPVLLQTHDKKESMQCLEIALSCVQENPTKRPTMDSVVSMLSSDSESRQLPKPS 616
|
|
| TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 727 (261.0 bits), Expect = 2.1e-90, Sum P(2) = 2.1e-90
Identities = 148/305 (48%), Positives = 200/305 (65%)
Query: 355 SFLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENE 414
S F+ ++AAT+NF N LG+GGFG VYKG G ++AVK+L+ S QG+ EFENE
Sbjct: 493 SLQFDFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSGVQVAVKRLSKTSGQGEREFENE 552
Query: 415 VRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIM 474
V V+ K+QHRNLV+L G C++ E+ILVYE++ NKSLD FLFD + LDW +R II
Sbjct: 553 VVVVAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLDYFLFDTTMKRQLDWTRRYKIIG 612
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAG 534
G+ARG+LYLH+DS L IIHRD+KA NILLD M PK++DFG+A++F +Q+ T ++ G
Sbjct: 613 GIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFGMDQTEANTRRVVG 672
Query: 535 TFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDR-QLEAENQXXXXXXXXXXXX 593
T+GYMAPEYA+ G S+KSDV+SFGVL+ EIISG KN Q++
Sbjct: 673 TYGYMAPEYAMYGQFSMKSDVYSFGVLVFEIISGMKNSSLYQMDDSVSNLVTYTWRLWSN 732
Query: 594 XXXXXXVDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPSVTE 652
VD G Y R + IALLC ++ ++DRP MSA + ML+ SS+ + +V +
Sbjct: 733 GSQLDLVDPSFGDNYQTHDITRCIHIALLCVQEDVDDRPNMSAIVQMLTTSSIVL-AVPK 791
Query: 653 SPDHY 657
P +
Sbjct: 792 QPGFF 796
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9M0X5 | CRK25_ARATH | 2, ., 7, ., 1, 1, ., - | 0.3655 | 0.8775 | 0.8918 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00038237001 | SubName- Full=Chromosome chr14 scaffold_9, whole genome shotgun sequence; (672 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 686 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-56 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-54 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-54 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-54 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-42 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-34 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-34 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-33 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-32 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-32 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-31 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-31 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-31 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-30 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-30 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-30 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-29 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-28 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-27 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-27 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-27 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-26 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-26 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-26 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-25 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-24 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-24 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-24 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-24 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-23 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-22 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-22 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-22 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-21 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 2e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-20 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-20 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-20 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-20 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-20 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-19 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-14 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 3e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (486), Expect = 8e-56
Identities = 91/283 (32%), Positives = 138/283 (48%), Gaps = 38/283 (13%)
Query: 374 NMLGRGGFGTVYKGRLQDG----REIAVKKL-ATNSMQGKEEFENEVRVLLKMQHRNLVQ 428
LG G FG VYKG+L+ E+AVK L S + +++F E RV+ K+ H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 429 LFGCCVQERERILVYEYLPNKSLDKFL------FDKSKSAILDWPKRLNIIMGVARGLLY 482
L G C +E LV EY+ L +L F + + L L+ + +A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQ----IAGTFGY 538
L + +HRD+ A N L+ + KISDFGL++ +D+ + I +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 539 MAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLM 597
MAPE G + KSDV+SFGVLL EI + G Y N+E+L+ R +G +
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP---GLSNEEVLEYLR----KGYRL 226
Query: 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640
+ P+E+ ++ L C + EDRPT S + L
Sbjct: 227 PKPE----YCPDELY----ELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 186 bits (476), Expect = 2e-54
Identities = 91/268 (33%), Positives = 135/268 (50%), Gaps = 29/268 (10%)
Query: 375 MLGRGGFGTVYKGRLQDG-----REIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQ 428
LG G FG VYKG L+ E+AVK L ++ Q EEF E R++ K+ H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 429 LFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488
L G C +E ++V EY+P L +L K++ L L+ + +ARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLES--- 121
Query: 489 LRIIHRDIKASNILLDHQMKPKISDFGLAK-LFHDEQSRHRTHQIAGTFGYMAPEYAIRG 547
IHRD+ A N L+ + KISDFGL++ L+ D+ + + ++ +MAPE G
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEG 179
Query: 548 FLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606
+ KSDV+SFGVLL EI + G + Y N E+L+ ++G +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYP---GMSNAEVLEYL----KKGYRLPK------- 225
Query: 607 YPEEIALRFMQIALLCTEDFIEDRPTMS 634
P ++ L C + EDRPT S
Sbjct: 226 -PPNCPPELYKLMLQCWAEDPEDRPTFS 252
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 186 bits (476), Expect = 2e-54
Identities = 93/272 (34%), Positives = 131/272 (48%), Gaps = 34/272 (12%)
Query: 373 KNMLGRGGFGTVYKGRLQD-----GREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNL 426
LG G FG VYKG+L+ E+AVK L ++ Q EEF E R++ K+ H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 427 VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD 486
V+L G C +E +V EY+ L +L + L L+ + +ARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLES- 120
Query: 487 SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ---SRHRTHQIAGTFGYMAPEY 543
IHRD+ A N L+ + KISDFGL++ +D+ R I +MAPE
Sbjct: 121 --KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAPES 174
Query: 544 AIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602
G + KSDV+SFGVLL EI + G + Y N+E+L L+ RL
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYP---GMSNEEVL---EYLKNGYRLP----- 223
Query: 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMS 634
+ P E+ + L C + EDRPT S
Sbjct: 224 QPPNCPPELY----DLMLQCWAEDPEDRPTFS 251
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 2e-54
Identities = 93/276 (33%), Positives = 135/276 (48%), Gaps = 35/276 (12%)
Query: 376 LGRGGFGTVYKGRL-----QDGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQL 429
LG G FG VYKG L ++AVK L + + +EEF E ++ K+ H N+V+L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
G C Q +V EY+P L FL + L L + + +A+G+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLES---K 121
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAK-LFHDEQSRHRTHQIAGTFG---YMAPEYAI 545
+HRD+ A N L+ + KISDFGL++ ++ D+ R R G +MAPE
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG----GGKLPIKWMAPESLK 177
Query: 546 RGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604
G + KSDV+SFGVLL EI + G + Y N+E+L+ LE+ RL +
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYP---GMSNEEVLE---LLEDGYRLPRPENC-- 229
Query: 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640
P+E+ ++ L C EDRPT S + L
Sbjct: 230 ---PDELY----ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 3e-54
Identities = 80/194 (41%), Positives = 111/194 (57%), Gaps = 11/194 (5%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKL-ATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCC 433
LG GGFGTVY R + G+++A+K + +S EE E+ +L K+ H N+V+L+G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 434 VQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIH 493
E LV EY SL L K L + L I++ + GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 494 RDIKASNILLDH-QMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI-RGFLSV 551
RD+K NILLD K K++DFGL+KL ++S +T I GT YMAPE + +G+ S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 552 KSDVFSFGVLLLEI 565
KSD++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 1e-49
Identities = 74/199 (37%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 376 LGRGGFGTVYKGRLQ-DGREIAVKKLA--TNSMQGKEEFENEVRVLLKMQHRNLVQLFGC 432
LG G FGTVYK + + G+ +AVK L + + + E+R+L ++ H N+V+L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 433 CVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRII 492
+ LV EY L +L S+ L + I + + RGL YLH II
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS---NGII 120
Query: 493 HRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL--S 550
HRD+K NILLD KI+DFGLAK S T GT YMAPE + G
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPE-VLLGGNGYG 177
Query: 551 VKSDVFSFGVLLLEIISGR 569
K DV+S GV+L E+++G+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 3e-47
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 370 FSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE-FENEVRVLLKMQHRNLV 427
+ LG G FG VY R + G+ +A+K + ++ E E+++L K++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
+L+ E + LV EY L L + + L + + + L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR---LSEDEARFYLRQILSALEYLHS-- 115
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG 547
I+HRD+K NILLD K++DFGLA+ + + GT YMAPE +
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGK 171
Query: 548 FLSVKSDVFSFGVLLLEIISGR 569
D++S GV+L E+++G+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 3e-43
Identities = 66/205 (32%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 374 NMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGK--EEFENEVRVLLKMQHRNLVQLF 430
+LGRG FG+VY +D G +AVK + + + E E E+R+L +QH N+V+ +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 431 GCCVQERER-ILVY-EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR----GLLYLH 484
G E + + ++ EY+ SL L K + +I R GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKL-----PEPVIRKYTRQILEGLAYLH 118
Query: 485 RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYA 544
I+HRDIK +NIL+D K++DFG AK D ++ T + GT +MAPE
Sbjct: 119 S---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 545 IRGFLSVKSDVFSFGVLLLEIISGR 569
+D++S G ++E+ +G+
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 3e-42
Identities = 68/207 (32%), Positives = 110/207 (53%), Gaps = 21/207 (10%)
Query: 370 FSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQ 428
F +G+GGFG VYK R + G+E+A+K + S + KE+ NE+++L K +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 429 LFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN------IIMGVARGLLY 482
+G +++ E +V E+ SL K + + L + + +GL Y
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSL--------KDLLKSTNQTLTESQIAYVCKELLKGLEY 113
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
LH IIHRDIKA+NILL + K+ DFGL+ D ++R+ + GT +MAPE
Sbjct: 114 LHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAPE 167
Query: 543 YAIRGFLSVKSDVFSFGVLLLEIISGR 569
K+D++S G+ +E+ G+
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 81/275 (29%), Positives = 135/275 (49%), Gaps = 22/275 (8%)
Query: 370 FSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQL 429
F+ + LG G FG V++G ++ +A+K L ++ + +++F+ EV+ L +++H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
F C ++ E + SL FL + +L +++ VA G+ YL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL 549
IHRD+ A NIL+ + K++DFGLA+L ++ +I + + APE A G
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAASHGTF 181
Query: 550 SVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYP 608
S KSDV+SFG+LL E+ + G+ Y N E+ ++ R+ P
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYP---GMNNHEVY---DQITAGYRM-----PCPAKCP 230
Query: 609 EEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643
+EI +I L C EDRP+ A L N
Sbjct: 231 QEI----YKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 66/209 (31%), Positives = 110/209 (52%), Gaps = 19/209 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRN 425
+ +LG+G G VYK R + G+ A+KK+ + + +++ E++ L +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR----GLL 481
+V+ +G +E E +V EY+ SL L K P+ ++ +AR GL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK-----IPE--PVLAYIARQILKGLD 113
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP 541
YLH IIHRDIK SN+L++ + + KI+DFG++K+ E + + + GT YM+P
Sbjct: 114 YLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSP 169
Query: 542 EYAIRG-FLSVKSDVFSFGVLLLEIISGR 569
E I+G S +D++S G+ LLE G+
Sbjct: 170 E-RIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 87/261 (33%), Positives = 127/261 (48%), Gaps = 28/261 (10%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ 435
LG G FG V+ G ++AVK L +M E F E +++ K++H LVQL+ C +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 436 ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRD 495
E +V EY+ SL FL L P+ +++ +A G+ YL IHRD
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKK-LRLPQLVDMAAQIAEGMAYLES---RNYIHRD 128
Query: 496 IKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGT---FGYMAPEYAIRGFLSVK 552
+ A NIL+ + KI+DFGLA+L D++ R G + APE A G ++K
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANYGRFTIK 184
Query: 553 SDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEI 611
SDV+SFG+LL EI++ GR Y E E ++ R+ R PEE+
Sbjct: 185 SDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM-----------PRPPNCPEEL 233
Query: 612 ALRFMQIALLCTEDFIEDRPT 632
+ L C + E+RPT
Sbjct: 234 ----YDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 83/281 (29%), Positives = 127/281 (45%), Gaps = 34/281 (12%)
Query: 374 NMLGRGGFGTVYKGRL-----QDGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLV 427
LG G FG V R G ++AVK L + Q + +FE E+ +L + H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 428 QLFGCCVQERERI--LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+ G C + R L+ EYLP+ SL +L + ++ + L + +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH--DEQSRHRTHQIAGTFGYMAPEY 543
R IHRD+ A NIL++ + KISDFGLAK+ + + + F Y APE
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 544 AIRGFLSVKSDVFSFGVLLLEIIS-GRKNYD--------RQLEAENQELLKLARRLEEEG 594
S SDV+SFGV L E+ + G + + + +L L+E
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243
Query: 595 RLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSA 635
RL R + P+E+ + LC E +DRP+ +
Sbjct: 244 RLP-----RPPSCPDEV----YDLMKLCWEAEPQDRPSFAD 275
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 92/275 (33%), Positives = 130/275 (47%), Gaps = 31/275 (11%)
Query: 376 LGRGGFGTVYKG--RLQDGREI--AVKKLATNSMQ-GKEEFENEVRVLLKMQHRNLVQLF 430
LG G FG+V KG ++ G+E+ AVK L + GK+EF E V+ ++ H +V+L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 431 GCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLR 490
G C E +LV E P L K+L + + + D + VA G+ YL
Sbjct: 63 GVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESK---H 115
Query: 491 IIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF--GYMAPEYAIRGF 548
+HRD+ A N+LL ++ + KISDFG+++ +R AG + + APE G
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT-AGRWPLKWYAPECINYGK 174
Query: 549 LSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTY 607
S KSDV+S+GV L E S G K Y E + E++ + LE RL
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYG---EMKGAEVIAM---LESGERLPR--------- 219
Query: 608 PEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
PEE I L C + EDRPT S S
Sbjct: 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 1e-33
Identities = 79/270 (29%), Positives = 131/270 (48%), Gaps = 29/270 (10%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ 435
+G G FG V+ G + R++A+K + +M +E+F E +V++K+ H LVQL+G C +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 436 ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRD 495
LV+E++ + L +L +++ L + + V G+ YL +V IHRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSNV---IHRD 125
Query: 496 IKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGT---FGYMAPEYAIRGFLSVK 552
+ A N L+ K+SDFG+ + D+Q T GT + +PE S K
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSSK 181
Query: 553 SDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEI 611
SDV+SFGVL+ E+ S G+ Y+ + +E E + RL + P
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK---------------PRLA 226
Query: 612 ALRFMQIALLCTEDFIEDRPTMSATLSMLS 641
+ ++ C ++ EDRP+ S L L+
Sbjct: 227 SQSVYELMQHCWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 84/271 (30%), Positives = 126/271 (46%), Gaps = 33/271 (12%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ 435
LG G FG V+ G+ + ++A+K + +M +++F E +V++K+ H NLVQL+G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 436 ERERILVYEYLPNKSLDKFLFD---KSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRII 492
+R +V EY+ N L +L + K + L L++ V + YL + I
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWL-----LDMCSDVCEAMEYLESNGF---I 122
Query: 493 HRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF--GYMAPEYAIRGFLS 550
HRD+ A N L+ K+SDFGLA+ D+Q T F + PE S
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY---TSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 551 VKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPE 609
KSDV+SFGVL+ E+ S G+ Y+R +E E + RL P+
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR---------------PK 224
Query: 610 EIALRFMQIALLCTEDFIEDRPTMSATLSML 640
I C + EDRP LS L
Sbjct: 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 4e-32
Identities = 86/305 (28%), Positives = 128/305 (41%), Gaps = 20/305 (6%)
Query: 369 NFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEE---FENEVRVLLKMQH-R 424
++ LG G FG VY R D + +A+K LA +E F E+++L + H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLH 484
N+V+L+ E LV EY+ SL+ L + L + L I+ + L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 485 RDSVLRIIHRDIKASNILLDHQ-MKPKISDFGLAKLFHDEQS----RHRTHQIAGTFGYM 539
IIHRDIK NILLD K+ DFGLAKL D S GT GYM
Sbjct: 119 S---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 540 APEYAIRGFL---SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL 596
APE + L S SD++S G+ L E+++G + E + + + + E
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLP--PFEGEKNSSATSQTLKIILELPTP 233
Query: 597 MELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPSVTESPDH 656
+ PE I+ + ++R + S+ LS + + + S
Sbjct: 234 SLASPLSPS-NPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292
Query: 657 YEGDD 661
D
Sbjct: 293 KPDDS 297
|
Length = 384 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 90/271 (33%), Positives = 138/271 (50%), Gaps = 29/271 (10%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ 435
LG G FG V+ G ++A+K L SM E F E ++ ++QH LV+L+ Q
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 436 ERERILVYEYLPNKSLDKFLFDKSKSAI-LDWPKRLNIIMGVARGLLYLHRDSVLRIIHR 494
E I + EY+ N SL FL K+ I L K +++ +A G+ ++ R + IHR
Sbjct: 73 EPIYI-ITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHR 126
Query: 495 DIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF--GYMAPEYAIRGFLSVK 552
D++A+NIL+ + KI+DFGLA+L D + T + F + APE G ++K
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 553 SDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEI 611
SDV+SFG+LL EI++ GR Y E + + LE R+ R PEE+
Sbjct: 184 SDVWSFGILLTEIVTYGRIPYPGMTNPE------VIQNLERGYRM-----PRPDNCPEEL 232
Query: 612 ALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
++ LC ++ E+RPT S+L +
Sbjct: 233 ----YELMRLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 79/261 (30%), Positives = 126/261 (48%), Gaps = 28/261 (10%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ 435
LG G FG V++G + +AVK L +M ++F E +++ K++H L+QL+ C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 436 ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRD 495
E +V E + SL ++L + A L P+ +++ VA G+ YL + IHRD
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQN---YIHRD 128
Query: 496 IKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGT---FGYMAPEYAIRGFLSVK 552
+ A N+L+ K++DFGLA++ ++ R G + APE A+ S+K
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSIK 184
Query: 553 SDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEI 611
SDV+SFG+LL EI++ GR Y AE + + R+ P
Sbjct: 185 SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC---------------PPGC 229
Query: 612 ALRFMQIALLCTEDFIEDRPT 632
I L C ++ +DRPT
Sbjct: 230 PKELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 72/206 (34%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 373 KNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGC 432
+G+G FG V G + G+++AVK L +S + F E V+ ++H NLVQL G
Sbjct: 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 433 CVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRII 492
+Q +V EY+ SL +L + ++ I ++L + V G+ YL +
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVI-TLAQQLGFALDVCEGMEYLEEK---NFV 124
Query: 493 HRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF--GYMAPEYAIR-GFL 549
HRD+ A N+L+ + K+SDFGLAK + + G + APE A+R
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDS----GKLPVKWTAPE-ALREKKF 176
Query: 550 SVKSDVFSFGVLLLEIIS-GRKNYDR 574
S KSDV+SFG+LL EI S GR Y R
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPR 202
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 5e-31
Identities = 89/268 (33%), Positives = 136/268 (50%), Gaps = 23/268 (8%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ 435
LG G FG V+ G ++AVK L +M E F E +++ K++H LVQL+ V
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAV-VS 71
Query: 436 ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRD 495
E +V EY+ SL FL D A L P +++ VA G+ Y+ R + IHRD
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIER---MNYIHRD 127
Query: 496 IKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDV 555
++++NIL+ + KI+DFGLA+L D + R + APE A+ G ++KSDV
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 556 FSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALR 614
+SFG+LL E+++ GR Y N+E+L+ R G M P++ +
Sbjct: 187 WSFGILLTELVTKGRVPYPGM---NNREVLEQVER----GYRMPC--------PQDCPIS 231
Query: 615 FMQIALLCTEDFIEDRPTMSATLSMLSN 642
++ L C + E+RPT S L +
Sbjct: 232 LHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 8e-31
Identities = 83/266 (31%), Positives = 128/266 (48%), Gaps = 27/266 (10%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ 435
LG G FG V G+ + ++A+K + SM ++EF E +V++K+ H LVQL+G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 436 ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRD 495
+R +V EY+ N L +L + K + L + V G+ YL + IHRD
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIHRD 125
Query: 496 IKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF--GYMAPEYAIRGFLSVKS 553
+ A N L+D Q K+SDFGL++ D++ T + F + PE + S KS
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 554 DVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIA 612
DV++FGVL+ E+ S G+ Y+R +E E + RL P +
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR---------------PHLAS 227
Query: 613 LRFMQIALLCTEDFIEDRPTMSATLS 638
+ I C + E+RPT LS
Sbjct: 228 EKVYAIMYSCWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-30
Identities = 88/280 (31%), Positives = 128/280 (45%), Gaps = 34/280 (12%)
Query: 375 MLGRGGFGTVYKGR---LQD--GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQL 429
LG+G FG+V R LQD G +AVKKL ++ + +FE E+ +L +QH N+V+
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 430 FGCCVQ--ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
G C R LV EYLP SL +L K + LD K L + +G+ YL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRER-LDHRKLLLYASQICKGMEYL---G 125
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGT--FGYMAPEYAI 545
R +HRD+ NIL++ + + KI DFGL K+ ++ ++ + + F Y APE
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLT 184
Query: 546 RGFLSVKSDVFSFGVLLLEII-------SGRKNYDRQLEAENQE---LLKLARRLEEEGR 595
SV SDV+SFGV+L E+ S + R + + Q + L L+ GR
Sbjct: 185 ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGR 244
Query: 596 LMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSA 635
L P I C + RP+ S
Sbjct: 245 LPA---------PPGCPAEIYAIMKECWNNDPSQRPSFSE 275
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 71/207 (34%), Positives = 96/207 (46%), Gaps = 30/207 (14%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFE---NEVRVLLKMQHRNLVQLFG 431
LG+G FG V R G+ A+K L + ++E E E +L ++ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 432 CCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR--------GLLY 482
Q E++ LV EY P L L SK AR L Y
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFS--------EERARFYAAEIVLALEY 108
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
LH L II+RD+K NILLD K++DFGLAK E S RT+ GT Y+APE
Sbjct: 109 LHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPE 163
Query: 543 YAIRGFLSVKSDVFSFGVLLLEIISGR 569
+ D +S GVLL E+++G+
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 369 NFSTKNMLGRGGFGTVYKG-RLQDGREIAVKKLATNSMQGKE--EFENEVRVLLKMQHRN 425
N+ +++GRG FG VYKG L+ G +A+K+++ ++ + E+ +L ++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFL-----FDKSKSAILDWPKRLNIIMGVARGL 480
+V+ G ++ EY N SL + + F +S A+ + V +GL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVY--------VYQVLQGL 112
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMA 540
YLH V IHRDIKA+NIL K++DFG+A +D + GT +MA
Sbjct: 113 AYLHEQGV---IHRDIKAANILTTKDGVVKLADFGVATKLNDV--SKDDASVVGTPYWMA 167
Query: 541 PEYAIRGFLSVKSDVFSFGVLLLEIISGRKNY 572
PE S SD++S G ++E+++G Y
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGNPPY 199
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 80/270 (29%), Positives = 132/270 (48%), Gaps = 26/270 (9%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ 435
LG G FG V+ G + ++AVK L +M + F E ++ +QH LV+L+ +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 436 ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRD 495
E ++ EY+ SL FL +L PK ++ +A G+ Y+ R + IHRD
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY---IHRD 128
Query: 496 IKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF--GYMAPEYAIRGFLSVKS 553
++A+N+L+ + KI+DFGLA++ D + R F + APE G ++KS
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTARE---GAKFPIKWTAPEAINFGSFTIKS 185
Query: 554 DVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIA 612
DV+SFG+LL EI++ G+ Y ++ L+ R+ R+ P+E+
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP-----------RMENCPDEL- 233
Query: 613 LRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
I C ++ E+RPT S+L +
Sbjct: 234 ---YDIMKTCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 33/214 (15%)
Query: 373 KNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKE--EFENEVRVLLKMQHRNLVQL 429
+G+G FG VY R DG+ +K++ ++M KE + NEV++L K+ H N+++
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSA-------ILDWPKRLNIIMGVARGLLY 482
+ ++ + +V EY L + + + K ILDW + + + L Y
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW--FVQLCLA----LKY 118
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
LH +I+HRDIK NI L K+ DFG++K+ +T + GT Y++PE
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPE 173
Query: 543 ------YAIRGFLSVKSDVFSFGVLLLEIISGRK 570
Y + KSD++S G +L E+ + +
Sbjct: 174 LCQNKPY------NYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 8e-30
Identities = 86/268 (32%), Positives = 124/268 (46%), Gaps = 24/268 (8%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKL-ATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCV 434
+G+G FG VYKG L+ E+AVK +T K +F E +L + H N+V+L G CV
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 435 QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHR 494
Q++ +V E +P SL FL + K L K L + + A G+ YL + IHR
Sbjct: 63 QKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKNC---IHR 117
Query: 495 DIKASNILLDHQMKPKISDFGLAKLFHDE--QSRHRTHQIAGTFGYMAPEYAIRGFLSVK 552
D+ A N L+ KISDFG+++ QI + APE G + +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP--IKWTAPEALNYGRYTSE 175
Query: 553 SDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIA 612
SDV+S+G+LL E S + NQ+ R E G M + PEEI
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPGM--SNQQ----TRERIESGYRMPAPQL----CPEEI- 224
Query: 613 LRFMQIALLCTEDFIEDRPTMSATLSML 640
++ L C E+RP+ S + L
Sbjct: 225 ---YRLMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 83/258 (32%), Positives = 127/258 (49%), Gaps = 23/258 (8%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ 435
LG+G FG V+ G +A+K L +M E F E +V+ K++H LVQL+ V
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV-VS 71
Query: 436 ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRD 495
E +V EY+ SL FL + L P+ +++ +A G+ Y+ R + +HRD
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 127
Query: 496 IKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDV 555
++A+NIL+ + K++DFGLA+L D + R + APE A+ G ++KSDV
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 556 FSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALR 614
+SFG+LL E+ + GR Y + N+E+L R G M P E
Sbjct: 187 WSFGILLTELTTKGRVPYPGMV---NREVLDQVER----GYRMPC--------PPECPES 231
Query: 615 FMQIALLCTEDFIEDRPT 632
+ C E+RPT
Sbjct: 232 LHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 367 TDNFSTKNMLGRGGFGTVYKG-RLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN 425
+ + +G G G VYK G+E+A+KK+ Q KE NE+ ++ +H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDW-PKRLN------IIMGVAR 478
+V + + E +V EY+ SL + I+ R+N + V +
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSL---------TDIITQNFVRMNEPQIAYVCREVLQ 127
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY 538
GL YLH +IHRDIK+ NILL K++DFG A E+S+ + + GT +
Sbjct: 128 GLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYW 182
Query: 539 MAPEYAIRGFLSVKSDVFSFGVLLLEIISG 568
MAPE R K D++S G++ +E+ G
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 69/212 (32%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 376 LGRGGFGTVYKGRL--QDGRE----IAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQ 428
LG G FG VYKG L + R +A+K L N + ++EF E ++ +QH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 429 LFGCCVQERERILVYEYLPNKSLDKFLF-------------DKSKSAILDWPKRLNIIMG 475
L G C +E+ +++EYL + L +FL D++ + LD L+I +
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 476 VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGT 535
+A G+ YL S +HRD+ A N L+ + KISDFGL++ + +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 536 FGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS 567
+M PE + G + +SD++SFGV+L EI S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 28/213 (13%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFEN----EVRVLLKMQ 422
D+ LG G G V K + G+ +AVK + E + E+ +L K
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCN 57
Query: 423 HRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRL--NIIMGVARGL 480
+V +G + + EY+ SLDK L K P+R+ I + V +GL
Sbjct: 58 SPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL----KEVQGRIPERILGKIAVAVLKGL 113
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF---- 536
YLH +IIHRD+K SNIL++ + + K+ DFG+ S + +A TF
Sbjct: 114 TYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGV--------SGQLVNSLAKTFVGTS 163
Query: 537 GYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
YMAPE SVKSD++S G+ L+E+ +GR
Sbjct: 164 SYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 74/228 (32%), Positives = 118/228 (51%), Gaps = 21/228 (9%)
Query: 369 NFSTKNMLGRGGFGTVYKG-RLQDGREIAVKKLATNSMQGKEEFE--NEVRVLLKMQHRN 425
+F N +G+G FG V+K R D R A+K++ + M +E E +E RVL K+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILD---WPKRLNIIMGVARGLLY 482
+++ + + + + +V EY N L K L + + + W + I++G+A +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
LH +I+HRDIK+ N+ LD KI D G+AKL D + T I GT Y++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 543 YAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQE--LLKLAR 588
+ KSDV++ GV+L E +G+ +D A NQ +LK+ R
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD----ANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-28
Identities = 66/225 (29%), Positives = 116/225 (51%), Gaps = 13/225 (5%)
Query: 375 MLGRGGFGTVYKGR-LQDGR----EIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQ 428
+LG G FGTVYKG + +G +A+K L + + +E +E V+ + H ++V+
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 429 LFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488
L G C+ + L+ + +P L ++ ++ + LN + +A+G+ YL
Sbjct: 74 LLGICLSSQ-VQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQIAKGMSYLEEK-- 128
Query: 489 LRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGF 548
R++HRD+ A N+L+ KI+DFGLAKL ++ + +MA E +
Sbjct: 129 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI 187
Query: 549 LSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEE 592
+ KSDV+S+GV + E+++ G K Y+ E +LL+ RL +
Sbjct: 188 YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ 232
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 74/255 (29%), Positives = 121/255 (47%), Gaps = 39/255 (15%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRL------QDGREIAVKKLA-TNSMQGKEEFENEVRVLLK 420
D K LG G FG V+ G D +AVK L T S +++FE E +L
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64
Query: 421 MQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSA-ILDWPKR---------- 469
QH N+V+ +G C + I+V+EY+ + L+KFL A L P
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 470 LNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRT 529
L I + +A G++YL + +HRD+ N L+ + + KI DFG+++ +
Sbjct: 125 LQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD----Y 177
Query: 530 HQIAGT----FGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQ--LEAENQEL 583
+++ G +M PE + + +SDV+SFGV+L EI + Y +Q N+E+
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT----YGKQPWYGLSNEEV 233
Query: 584 LKLARRLEEEGRLME 598
++ +GRL++
Sbjct: 234 IECIT----QGRLLQ 244
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 370 FSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQ 428
F LG G +G+VYK + G+ +A+K + +E E+ +L + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 429 LFGCCVQERERILVYEYLPN-------KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLL 481
+G + + +V EY K +K L ++ +AIL +GL
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAIL---------YQTLKGLE 113
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP 541
YLH + IHRDIKA NILL+ + + K++DFG++ D ++ T + GT +MAP
Sbjct: 114 YLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAP 168
Query: 542 EYAIRGFLSVKSDVFSFGVLLLEIISGRKNY 572
E + K+D++S G+ +E+ G+ Y
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPPY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 86/294 (29%), Positives = 127/294 (43%), Gaps = 41/294 (13%)
Query: 366 ATDNFSTKNMLGRGGFGTVYKG----RLQDGRE--IAVKKLATNSMQGKEE-FENEVRVL 418
D+ + LG G FG VY+G R D E +AVK L + + E F E ++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 419 LKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFD----KSKSAILDWPKRLNIIM 474
K H+N+V+L G + R ++ E + L FL + + + L L
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILLDH---QMKPKISDFGLAKLFHDEQSRHRTHQ 531
VA+G YL + IHRDI A N LL KI+DFG+A+ + R ++
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYR 176
Query: 532 IAGT----FGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKL 586
G +M PE + G + K+DV+SFGVLL EI S G Y + NQE+++
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR---TNQEVMEF 233
Query: 587 ARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640
+ GRL P+ +I C + EDRP + L +
Sbjct: 234 ---VTGGGRL---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 86/277 (31%), Positives = 147/277 (53%), Gaps = 30/277 (10%)
Query: 374 NMLGRGGFGTVYKGRLQ-DGRE---IAVKKL-ATNSMQGKEEFENEVRVLLKMQHRNLVQ 428
++G G FG V +GRL+ G++ +A+K L A +S + + +F E ++ + H N+++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 429 LFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488
L G + R +++ EY+ N SLDKFL + + + ++ G+A G+ YL S
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SE 124
Query: 489 LRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI--R 546
+ +HRD+ A NIL++ + K+SDFGL++ D ++ + T + APE AI R
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE-AIAYR 183
Query: 547 GFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605
F S SDV+SFG+++ E++S G + Y + NQ+++K +E+ RL +D
Sbjct: 184 KFTSA-SDVWSFGIVMWEVMSYGERPY---WDMSNQDVIK---AVEDGYRLPPPMDCPSA 236
Query: 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
Y Q+ L C + +RPT S +S L
Sbjct: 237 LY---------QLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 83/268 (30%), Positives = 135/268 (50%), Gaps = 23/268 (8%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ 435
LG+G FG V+ G ++A+K L +M E F E +++ K++H LV L+ V
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAV-VS 71
Query: 436 ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRD 495
E +V E++ SL FL + L P+ +++ +A G+ Y+ R + IHRD
Sbjct: 72 EEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRD 127
Query: 496 IKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDV 555
++A+NIL+ + KI+DFGLA+L D + R + APE A+ G ++KSDV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 556 FSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALR 614
+SFG+LL E+++ GR Y + N+E+L+ R G M P+
Sbjct: 187 WSFGILLTELVTKGRVPYPGMV---NREVLEQVER----GYRMPC--------PQGCPES 231
Query: 615 FMQIALLCTEDFIEDRPTMSATLSMLSN 642
++ LC + ++RPT S L +
Sbjct: 232 LHELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 69/213 (32%), Positives = 109/213 (51%), Gaps = 30/213 (14%)
Query: 370 FSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFE----NEVRVLLKMQHR 424
+ LG G +G VYK R + G +A+KK+ + +E E+ +L +++H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHP 58
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMG-VARGLLYL 483
N+V+L ER+ LV+EY + L K+L DK + P + IM + RGL Y
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYC-DMDLKKYL-DKRPGPLS--PNLIKSIMYQLLRGLAYC 114
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE- 542
H RI+HRD+K NIL++ K++DFGLA+ F + TH++ T Y APE
Sbjct: 115 HSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAPEI 169
Query: 543 ------YAIRGFLSVKSDVFSFGVLLLEIISGR 569
Y+ +V D++S G + E+I+G+
Sbjct: 170 LLGSKHYST----AV--DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 63/198 (31%), Positives = 105/198 (53%), Gaps = 11/198 (5%)
Query: 371 STKNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQL 429
+ K+ LG G +G VY+G + +AVK L ++M+ EEF E V+ +++H NLVQL
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQL 67
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
G C +E ++ E++ +L +L + ++ ++ L + ++ + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF--GYMAPEYAIRG 547
IHRD+ A N L+ K++DFGL++L + T F + APE
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYN 180
Query: 548 FLSVKSDVFSFGVLLLEI 565
S+KSDV++FGVLL EI
Sbjct: 181 KFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 69/218 (31%), Positives = 115/218 (52%), Gaps = 12/218 (5%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ 435
LG G FG V+ G+ + ++A+K + +M +E+F E +V++K+ H LVQL+G C Q
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 436 ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRD 495
++ +V E++ N L +L + + L L++ V G+ YL R+S IHRD
Sbjct: 71 QKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRD 125
Query: 496 IKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF--GYMAPEYAIRGFLSVKS 553
+ A N L+ K+SDFG+ + D++ T F + PE S KS
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEY---TSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 554 DVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRL 590
DV+SFGVL+ E+ + G+ ++++ E E++ RL
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 31/226 (13%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEF-ENEVRVLLKM-Q 422
D+F ++G G F TV + + +E A+K L + + K ++ + E VL ++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 423 HRNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLL 481
H +++L+ Q+ E + V EY PN L +++ K LD + L
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALE 116
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS---------------- 525
YLH IIHRD+K NILLD M KI+DFG AK+ S
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 526 --RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
R R GT Y++PE SD+++ G ++ ++++G+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 85/278 (30%), Positives = 131/278 (47%), Gaps = 38/278 (13%)
Query: 374 NMLGRGGFGTVYKGRLQD----GRE---IAVKKLATNSM-QGKEEFENEVRVLLKMQHRN 425
N LG G FG VY+G D G +AVK L + Q K+EF E ++ H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFD----KSKSAILDWPKRLNIIMGVARGLL 481
+V+L G C+ + ++ E + L +L D + +L + L+I + VA+G +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 482 YLHRDSVLRIIHRDIKASNILL-----DHQMKPKISDFGLAK-LFHDEQSRHRTHQIAGT 535
YL + + IHRD+ A N L+ D KI DFGLA+ ++ + R +
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL-P 176
Query: 536 FGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEG 594
+MAPE + G + +SDV+SFGVL+ EI++ G++ Y NQE+L+ G
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL---NNQEVLQHVT---AGG 230
Query: 595 RLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPT 632
RL + PE + Q+ C +RPT
Sbjct: 231 RLQK---------PENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 376 LGRGGFGTVYK-GRLQDGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGC 432
+G+G FGTV K R DG+ + K++ +M + K++ +EV +L +++H N+V+ +
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 433 CV-QERERI-LVYEYLPNKSLDKFL--FDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488
+ + + + +V EY L + + K + I + I+ + L H S
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI-EEEFIWRILTQLLLALYECHNRSD 126
Query: 489 L--RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR 546
++HRD+K +NI LD K+ DFGLAK+ + S +T+ GT YM+PE
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY--VGTPYYMSPEQLNH 184
Query: 547 GFLSVKSDVFSFGVLLLEIISGR 569
KSD++S G L+ E+ +
Sbjct: 185 MSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 85/269 (31%), Positives = 131/269 (48%), Gaps = 25/269 (9%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ 435
LG G FG V+ ++AVK + SM E F E V+ +QH LV+L V
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHA--VV 70
Query: 436 ERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHR 494
+E I ++ E++ SL FL S PK ++ +A G+ ++ + + IHR
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRNY---IHR 126
Query: 495 DIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSD 554
D++A+NIL+ + KI+DFGLA++ D + R + APE G ++KSD
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAR-EGAKFPIKWTAPEAINFGSFTIKSD 185
Query: 555 VFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIAL 613
V+SFG+LL+EI++ GR Y E + R LE R+ R PEE+
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGMSNPE------VIRALERGYRMP-----RPENCPEEL-- 232
Query: 614 RFMQIALLCTEDFIEDRPTMSATLSMLSN 642
I + C ++ E+RPT S+L +
Sbjct: 233 --YNIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 369 NFSTKNMLGRGGFGTVYKGRLQDGRE------IAVKKLATNSMQG-KEEFENEVRVLLKM 421
N LGRG FG V+ + + E + VK L + + EF E+ + K+
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 422 QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFL------FDKSKSAILDWPKRLNIIMG 475
H+N+V+L G C + ++ EY L +FL +K K L +++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 476 VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK-LFHDEQSRHRTHQIAG 534
+A G+ +L R +HRD+ A N L+ Q + K+S L+K +++ E + R I
Sbjct: 126 IALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP- 181
Query: 535 TFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS 567
++APE S KSDV+SFGVL+ E+ +
Sbjct: 182 -LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 65/216 (30%), Positives = 114/216 (52%), Gaps = 15/216 (6%)
Query: 369 NFSTKNMLGRGGFGTVYK-GRLQDGREIAVKKLATNSMQGKEEF--ENEVRVLLKMQHRN 425
+ ++GRG FG V+ R D + + +K++ M E +NE +VL + H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+++ + ++++ ++V EY P +L +++ + S +LD L+ + + LL LH
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS-LLDEDTILHFFVQI---LLALHH 116
Query: 486 DSVLRIIHRDIKASNILLD-HQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYA 544
I+HRD+K NILLD H+M KI DFG++K+ S+ + + + GT Y++PE
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYISPELC 173
Query: 545 IRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAEN 580
+ KSD+++ G +L E+ S R EA N
Sbjct: 174 EGKPYNQKSDIWALGCVLYELAS----LKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 81/271 (29%), Positives = 127/271 (46%), Gaps = 32/271 (11%)
Query: 375 MLGRGGFGTVYKG-RLQDGREIAVK--KLATNSMQGKE---EFENEVRVLLKMQHRNLVQ 428
+LG G FG+VY+G L DG AVK LA + G+E + E E+ +L K+QH N+VQ
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 429 LFGCCVQERERILVY-EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
G +E + + ++ E +P SL K L K P + GL YLH
Sbjct: 67 YLGT-EREEDNLYIFLELVPGGSLAKLL---KKYGSFPEPVIRLYTRQILLGLEYLHDR- 121
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR- 546
+HRDIK +NIL+D K++DFG+AK E S ++ G+ +MAPE +
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKS--FKGSPYWMAPEVIAQQ 176
Query: 547 GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606
G + +D++S G +LE+ +G+ + + + K+ R L +
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAVFKIGR----SKELPPI------- 223
Query: 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATL 637
P+ ++ L C + RPT + L
Sbjct: 224 -PDHLSDEAKDFILKCLQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 80/273 (29%), Positives = 114/273 (41%), Gaps = 26/273 (9%)
Query: 376 LGRGGFGTVYKGRLQD--GREI--AVKKLATNSMQG-KEEFENEVRVLLKMQHRNLVQLF 430
LG G FG V +G G+ I AVK L ++ + ++F E ++ + H NL++L+
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 431 GCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLR 490
G V ++V E P SL L K + + +A G+ YL R
Sbjct: 63 GV-VLTHPLMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMRYLESK---R 117
Query: 491 IIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTH-QIAGTFGYMAPEYAIRGFL 549
IHRD+ A NILL K KI DFGL + + + + F + APE
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177
Query: 550 SVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYP 608
S SDV+ FGV L E+ + G + + L Q L K+ + E RL P
Sbjct: 178 SHASDVWMFGVTLWEMFTYGEEPW-AGLSGS-QILKKIDKEGE---RL---------ERP 223
Query: 609 EEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641
E + L C DRPT +A L
Sbjct: 224 EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 65/212 (30%), Positives = 93/212 (43%), Gaps = 22/212 (10%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKL---ATNSMQGKEEFENEVRVLLKMQHR 424
+ + LG G G+V K RL++ I K N K+ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-ELEINKSCKSP 59
Query: 425 NLVQLFGCCVQERERIL--VYEYLPNKSLDKFLFD-KSKSAILDWPKRLNIIMGVARGLL 481
+V+ +G + E + EY SLD K + + I V +GL
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFG---- 537
YLH +IIHRDIK SNILL + + K+ DFG+ S + +AGTF
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGV--------SGELVNSLAGTFTGTSF 168
Query: 538 YMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
YMAPE S+ SDV+S G+ LLE+ R
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 66/222 (29%), Positives = 112/222 (50%), Gaps = 26/222 (11%)
Query: 375 MLGRGGFGTVYKG-RLQDGREIAVKKLATNSMQGKEE---------FENEVRVLLKMQHR 424
++G G FG+VY G G +AVK++ S+ + E+ +L ++QH
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLH 484
N+VQ G + + EY+P S+ L + + N + + +GL YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 485 -RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK-----LFHDEQSRHRTHQIAGTFGY 538
R IIHRDIK +NIL+D++ KISDFG++K + + R + G+ +
Sbjct: 124 NRG----IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP-SLQGSVFW 178
Query: 539 MAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDR--QLEA 578
MAPE + + K+D++S G L++E+++G+ + QL+A
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 67/221 (30%), Positives = 127/221 (57%), Gaps = 17/221 (7%)
Query: 373 KNMLGRGGFGTVYKGRLQ-DGRE---IAVKKL-ATNSMQGKEEFENEVRVLLKMQHRNLV 427
+ ++G G FG V++G L+ GR+ +A+K L + + +++F +E ++ + H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
+L G + + +++ EY+ N +LDK+L D + + ++ G+A G+ YL S
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE--FSSYQLVGMLRGIAAGMKYL---S 124
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE-QSRHRTHQIAGTFGYMAPE-YAI 545
+ +HRD+ A NIL++ ++ K+SDFGL+++ D+ + + T + APE A
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 546 RGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLK 585
R F S SDV+SFG+++ E++S G + Y + N E++K
Sbjct: 185 RKFTSA-SDVWSFGIVMWEVMSFGERPY---WDMSNHEVMK 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 14/201 (6%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ 435
+G+G FG V G + G ++AVK + ++ + F E V+ +++H NLVQL G V+
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 436 ERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHR 494
E+ + +V EY+ SL +L + +S +L L + V + YL ++ +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 495 DIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSD 554
D+ A N+L+ K+SDFGL K + S T ++ + APE S KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLP--VKWTAPEALREKKFSTKSD 181
Query: 555 VFSFGVLLLEIIS-GRKNYDR 574
V+SFG+LL EI S GR Y R
Sbjct: 182 VWSFGILLWEIYSFGRVPYPR 202
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 73/235 (31%), Positives = 115/235 (48%), Gaps = 27/235 (11%)
Query: 376 LGRGGFGTVYKGRL-----QDGREIAVKKLAT-NSMQGKEEFENEVRVLLKMQHRNLVQL 429
LG FG +YKG L + +A+K L N+ Q EF+ E ++ ++ H N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLF--------------DKSKSAILDWPKRLNIIMG 475
G QE+ +++EYL L +FL D + + LD L+I +
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 476 VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGT 535
+A G+ YL S +H+D+ A NIL+ Q+ KISD GL++ + +
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 536 FGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARR 589
+M PE + G S SD++SFGV+L EI S G + Y NQE++++ R+
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY---YGFSNQEVIEMVRK 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 69/210 (32%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 374 NMLGRGGFGTVYKG-RLQDGREIAVKKLATNSMQGK--EEFENEVRVLLKMQHRNLVQLF 430
N +G G FG VY L G +AVK++ K +E +E++VL ++H NLV+ +
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 431 GCCVQERERILVY-EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVA----RGLLYLHR 485
G V RE++ ++ EY +L++ L ILD ++I GL YLH
Sbjct: 66 GVEV-HREKVYIFMEYCSGGTLEELLEHGR---ILD----EHVIRVYTLQLLEGLAYLHS 117
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQ--IAGTFGYMAPEY 543
I+HRDIK +NI LDH K+ DFG A + + +AGT YMAPE
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 544 AIRGFLSVK---SDVFSFGVLLLEIISGRK 570
G +D++S G ++LE+ +G++
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 82/280 (29%), Positives = 141/280 (50%), Gaps = 29/280 (10%)
Query: 369 NFSTKNMLGRGGFGTVYKGRL--QDGREI--AVKKLATNSMQG-KEEFENEVRVLLKMQH 423
+ ++G G FG V GRL REI A+K L + + +F +E ++ + H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL 483
N++ L G + + ++V EY+ N SLD FL + + + ++ G+A G+ YL
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASGMKYL 122
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE-QSRHRTHQIAGTFGYMAPE 542
S + +HRD+ A NIL++ + K+SDFGL+++ D+ ++ + T + APE
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179
Query: 543 -YAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600
A R F S SDV+S+G+++ E++S G + Y E NQ+++K +EE RL +
Sbjct: 180 AIAYRKFTSA-SDVWSYGIVMWEVMSYGERPY---WEMSNQDVIK---AIEEGYRLPAPM 232
Query: 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640
D + Q+ L C + +RP +S+L
Sbjct: 233 DCPAALH---------QLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN--EVRVLLKMQHRNLVQLFGC 432
+G G +G VYK R G +A+KK+ E+++L ++ H N+++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 433 CVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRII 492
+ + LV+E++ + L K + K + L + + + +GL + H I+
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSH---GIL 120
Query: 493 HRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSV 551
HRD+K N+L++ + K++DFGLA+ F R TH + T Y APE + S
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVV-TRWYRAPELLLGDKGYST 178
Query: 552 KSDVFSFGVLLLEIISGR-----KNYDRQL 576
D++S G + E++S R K+ QL
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEIDQL 208
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 64/235 (27%), Positives = 113/235 (48%), Gaps = 22/235 (9%)
Query: 376 LGRGGFGTVYKGRL------QDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQL 429
LG G FG V+ QD +AVK L S +++F+ E +L +QH+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 430 FGCCVQERERILVYEYLPNKSLDKFL---------FDKSKSAI---LDWPKRLNIIMGVA 477
+G C + R ++V+EY+ + L++FL + L + L I +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 478 RGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFG 537
G++YL + L +HRD+ N L+ + KI DFG+++ + +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 538 YMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLE 591
+M PE + + +SD++SFGV+L EI + G++ + + E E + R LE
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELE 244
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 50/289 (17%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN 425
D + +LG+G +G VY R L IA+K++ + + E+ + ++HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 426 LVQLFGCCVQERERILVY-EYLPNKSLDKFLFDK------SKSAILDWPKRLNIIMGVAR 478
+VQ G E ++ E +P SL L K ++ I+ + K+ +
Sbjct: 67 IVQYLGSDS-ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ------ILE 119
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLD-HQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFG 537
GL YLH +I+HRDIK N+L++ + KISDFG +K T GT
Sbjct: 120 GLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQ 174
Query: 538 YMAPE---YAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEG 594
YMAPE RG+ +D++S G ++E+ +G+ + L E
Sbjct: 175 YMAPEVIDKGPRGY-GAPADIWSLGCTIVEMATGKPPF---------------IELGEPQ 218
Query: 595 RLMELVDVRIGTY------PEEIALRFMQIALLCTEDFIEDRPTMSATL 637
M ++G + PE ++ L C E + R + L
Sbjct: 219 AAM----FKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 86/296 (29%), Positives = 136/296 (45%), Gaps = 49/296 (16%)
Query: 369 NFSTKNMLGRGGFGTVYKG---RLQDGR----EIAVKKLATNSMQGK-EEFENEVRVLLK 420
N LG G FG V K RL+ GR +AVK L N+ + + +E +L +
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLK-GRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQ 59
Query: 421 MQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSK-------------SAILDWP 467
+ H ++++L+G C Q+ +L+ EY SL FL + K S+ LD P
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 468 KRLNIIMG--------VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519
+ MG ++RG+ YL + ++++HRD+ A N+L+ K KISDFGL++
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 520 FHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE 579
++E S + + +MA E + +SDV+SFGVLL EI++ N + E
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236
Query: 580 NQ-ELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMS 634
LLK R+E PE + + L C + + RPT +
Sbjct: 237 RLFNLLKTGYRMER---------------PENCSEEMYNLMLTCWKQEPDKRPTFA 277
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 71/206 (34%), Positives = 109/206 (52%), Gaps = 13/206 (6%)
Query: 369 NFSTKNMLGRGGFGTVYK-GRLQDGREIAVKKLATNSMQGKEEFE--NEVRVLLKMQHRN 425
+F LG+G +G+VYK RL D + A+K++ SM KE + NE+R+L + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRL--NIIMGVARGLLYL 483
++ + + +V EY P L K + K K P++ I + + RGL L
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAI-SKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEY 543
H +I+HRD+K++NILL KI D G++K+ +++ +T QI GT YMAPE
Sbjct: 120 HE---QKILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKT-QI-GTPHYMAPEV 172
Query: 544 AIRGFLSVKSDVFSFGVLLLEIISGR 569
S KSD++S G LL E+ +
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 69/217 (31%), Positives = 108/217 (49%), Gaps = 14/217 (6%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ 435
+G G FG V +G G+++AVK + + + F E V+ K+ H+NLV+L G +
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 436 ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRD 495
I V E + +L FL + + A++ + L + VA G+ YL +++HRD
Sbjct: 71 NGLYI-VMELMSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRD 125
Query: 496 IKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDV 555
+ A NIL+ K+SDFGLA++ + APE S KSDV
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARV-----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDV 180
Query: 556 FSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLE 591
+S+GVLL E+ S GR Y + E +E ++ R+E
Sbjct: 181 WSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME 217
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 82/297 (27%), Positives = 138/297 (46%), Gaps = 35/297 (11%)
Query: 369 NFSTKNMLGRGGFGTVYKGRL------QDGREIAVKKLATNSMQGKEEFENEVRVLLKMQ 422
N K LG G FG V+ QD +AVK L S +++F E +L +Q
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 423 HRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAI----------LDWPKRLNI 472
H ++V+ +G CV+ I+V+EY+ + L+KFL A+ L + L+I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 473 IMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK-LFHDEQSRHRTHQ 531
+A G++YL + +HRD+ N L+ + KI DFG+++ ++ + R H
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 532 IAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLE 591
+ +M PE + + +SDV+S GV+L EI + K QL N E+++
Sbjct: 183 ML-PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL--SNNEVIECI---- 235
Query: 592 EEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIP 648
+GR+++ R T P+E+ + L C + R + S+L N + P
Sbjct: 236 TQGRVLQ----RPRTCPKEV----YDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGK-EEFENEVRVLLKMQHRNLVQLFGCC 433
+G G VY L + ++A+K++ Q +E EV+ + + H N+V+ +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 434 VQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIH 493
V E LV YL SL + LD ++ V +GL YLH + IH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIH 125
Query: 494 RDIKASNILLDHQMKPKISDFGL-AKLFHDEQSRHRT-HQIAGTFGYMAPE--YAIRGFL 549
RDIKA NILL KI+DFG+ A L + GT +MAPE + G+
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY- 184
Query: 550 SVKSDVFSFGVLLLEIISGRKNY 572
K+D++SFG+ +E+ +G Y
Sbjct: 185 DFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-23
Identities = 74/292 (25%), Positives = 124/292 (42%), Gaps = 40/292 (13%)
Query: 370 FSTKNMLGRGGFGTVYKGRL--QDGR--EIAVK--KLATNSMQGKEEFENEVRVLLKMQH 423
+LG G FG+V +G+L DG ++AVK KL ++ EEF +E + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 424 RNLVQLFGCCVQERER------ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIM--- 474
N+++L G C + +++ ++ + L FL S + P++L +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL---YSRLGGLPEKLPLQTLLK 117
Query: 475 ---GVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQ 531
+A G+ YL S IHRD+ A N +L M ++DFGL+K + +
Sbjct: 118 FMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI 174
Query: 532 IAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRL 590
++A E + KSDV++FGV + EI + G+ Y E + L+ RL
Sbjct: 175 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL 234
Query: 591 EEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
++ PE+ + C +DRPT + +L N
Sbjct: 235 KQ---------------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-23
Identities = 85/263 (32%), Positives = 124/263 (47%), Gaps = 25/263 (9%)
Query: 375 MLGRGGFGTVYKGRLQDGREIAVKKLATNSMQG-KEEFENEVRVLLKMQHRNLVQLFGCC 433
+LG+G FG V+KG L+D +AVK + Q K +F +E R+L + H N+V+L G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 434 VQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIH 493
Q + +V E +P FL + K L + + + A G+ YL + IH
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKNC---IH 116
Query: 494 RDIKASNILLDHQMKPKISDFGLAKLFHDE-QSRHRTHQIAGTFGYMAPEYAIRGFLSVK 552
RD+ A N L+ KISDFG+++ D S QI + APE G S +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP--IKWTAPEALNYGRYSSE 174
Query: 553 SDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEI 611
SDV+S+G+LL E S G Y NQ+ AR E+G M P+++
Sbjct: 175 SDVWSYGILLWETFSLGVCPYPGM---TNQQ----AREQVEKGYRMSCPQ----KCPDDV 223
Query: 612 ALRFMQIALLCTEDFIEDRPTMS 634
+ MQ C + E+RP S
Sbjct: 224 Y-KVMQ---RCWDYKPENRPKFS 242
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 73/250 (29%), Positives = 108/250 (43%), Gaps = 36/250 (14%)
Query: 369 NFSTKNMLGRGGFGTVYKGRLQDGREI----------AVKKLATNSMQGKEEFENEVRVL 418
+F ++G+G FG V + +D +++ V+K + ++ NE R+L
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL------NERRIL 54
Query: 419 LKMQHRNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSK---SAILDWPKRLNIIM 474
++ H LV L+ Q+ E + LV + L L L K K + W I
Sbjct: 55 QELNHPFLVNLWYS-FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFW------IC 107
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAG 534
+ L YLH IIHRDIK NILLD Q I+DF +A + T +G
Sbjct: 108 EIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSG 161
Query: 535 TFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNY---DRQLEAENQELLKLARRLE 591
T GYMAPE R SV D +S GV E + G++ Y R + + + + A L
Sbjct: 162 TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLY 221
Query: 592 EEGRLMELVD 601
E +D
Sbjct: 222 PATWSTEAID 231
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 12/205 (5%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN---EVRVLLKMQ 422
NF + +G+G F VYK L DGR +A+KK+ M + ++ E+ +L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 423 HRNLVQLFGCCVQERERILVYEYLPNKSLDKFL--FDKSKSAILDWPKRLNIIMGVARGL 480
H N+++ ++ E +V E L + + F K K I + + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLI-PERTIWKYFVQLCSAL 119
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMA 540
++H RI+HRDIK +N+ + K+ D GL + F + + H + GT YM+
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMS 174
Query: 541 PEYAIRGFLSVKSDVFSFGVLLLEI 565
PE + KSD++S G LL E+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 5e-23
Identities = 66/209 (31%), Positives = 112/209 (53%), Gaps = 19/209 (9%)
Query: 369 NFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLAT--NSMQGKEE---FENEVRVLLKMQ 422
N+ +LG+G FG VY D GRE+AVK++ +S + K+E E E+++L +Q
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 423 HRNLVQLFGCCVQERERILVY-EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLL 481
H +VQ +GC +++ E + ++ EY+P S+ L K+ A+ + R + G+
Sbjct: 63 HERIVQYYGC-LRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTR-KYTRQILEGVE 118
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK---LFHDEQSRHRTHQIAGTFGY 538
YLH + I+HRDIK +NIL D K+ DFG +K + ++ + GT +
Sbjct: 119 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS--VTGTPYW 173
Query: 539 MAPEYAIRGFLSVKSDVFSFGVLLLEIIS 567
M+PE K+DV+S G ++E+++
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 8e-23
Identities = 66/227 (29%), Positives = 106/227 (46%), Gaps = 46/227 (20%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFE----NEVRVLLKMQHRNLVQLF 430
+G G +G VYK R + G +A+KK+ KE F E+++L K++H N+V+L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 431 GCCVQERER---ILVYEYLP---NKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLH 484
+ + +V+EY+ LD ++S I + K+L GL YLH
Sbjct: 65 EIVT-SKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQL------LEGLQYLH 117
Query: 485 RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE-- 542
+ I+HRDIK SNIL+++ K++DFGLA+ + S T+++ T Y PE
Sbjct: 118 SN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELL 173
Query: 543 -------YAIRGFLSVKSDVFSFGVLLLEIISGR-----KNYDRQLE 577
+ D++S G +L E+ G+ QLE
Sbjct: 174 LGATRYGPEV--------DMWSVGCILAELFLGKPIFQGSTELEQLE 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 9e-23
Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 12/223 (5%)
Query: 376 LGRGGFGTVYKGRLQD-GREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFG 431
LG+GGFG V +++ G+ A KKL + +G++ NE ++L K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 432 CCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRI 491
+ + LV + L K+ + + + GL +LH+ RI
Sbjct: 61 AFETKDDLCLVMTLMNGGDL-KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRI 116
Query: 492 IHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSV 551
++RD+K N+LLD +ISD GLA + + AGT GYMAPE
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 552 KSDVFSFGVLLLEIISGRKNY-DRQLEAENQELLKLARRLEEE 593
D F+ G L E+I+GR + R+ + E +EL + + E
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVE 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 9e-23
Identities = 70/236 (29%), Positives = 109/236 (46%), Gaps = 19/236 (8%)
Query: 376 LGRGGFGTVYKGRLQ-----DGREIAVKKL-ATNSMQGKEEFENEVRVLLKMQHRNLVQL 429
LG G FG V G +AVK L Q ++ E+ +L + H N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 430 FGCCVQERERI--LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
GCC ++ + L+ EY+P SL +L L+ + L + G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGT--FGYMAPEYAI 545
IHRD+ A N+LLD+ KI DFGLAK + +R + + F Y A E
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLK 183
Query: 546 RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601
S SDV+SFGV L E+++ + + + +E++ + RL+EL++
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 1e-22
Identities = 73/266 (27%), Positives = 128/266 (48%), Gaps = 28/266 (10%)
Query: 373 KNMLGRGGFGTVYKGR------LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL 426
K LG G FG V+ +D +AVK L ++ +++F+ E +L +QH ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 427 VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAI-------------LDWPKRLNII 473
V+ +G C I+V+EY+ + L+KFL A+ L + L+I
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 474 MGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK-LFHDEQSRHRTHQI 532
+A G++YL + +HRD+ N L+ + KI DFG+++ ++ + R H +
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 533 AGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLE 591
+M PE + + +SDV+SFGV+L EI + G++ + + E E + R LE
Sbjct: 187 L-PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLE 245
Query: 592 EEGRL--MELVDVRIGTYPEEIALRF 615
R+ E+ D+ +G + E R
Sbjct: 246 RP-RVCPKEVYDIMLGCWQREPQQRL 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 62/202 (30%), Positives = 106/202 (52%), Gaps = 17/202 (8%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN-----EVRVLLKMQHRNLVQL 429
LG G + VYK R + GR +A+KK+ + ++ N E+++L +++H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
+ LV+E++ L+K + K KS +L + ++ RGL YLH + +L
Sbjct: 68 LDVFGHKSNINLVFEFMET-DLEKVI--KDKSIVLTPADIKSYMLMTLRGLEYLHSNWIL 124
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE--YAIRG 547
HRD+K +N+L+ K++DFGLA+ F +R THQ+ T Y APE + R
Sbjct: 125 ---HRDLKPNNLLIASDGVLKLADFGLARSFGSP-NRKMTHQVV-TRWYRAPELLFGARH 179
Query: 548 FLSVKSDVFSFGVLLLEIISGR 569
+ V D++S G + E++
Sbjct: 180 Y-GVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 71/211 (33%), Positives = 111/211 (52%), Gaps = 24/211 (11%)
Query: 376 LGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEE--FENEVRVLLKMQH-RNLVQLFG 431
+GRG FGTV K + G +AVK++ + KE+ ++ V+++ +V+ +G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTV-DEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 432 CCVQERERILVYEYLPNKSLDKF---LFDKSKSAILDWPKRL--NIIMGVARGLLYLHRD 486
+E + + E L + SLDKF +++ KS I P+ + I + + L YL +
Sbjct: 71 ALFREGDCWICME-LMDISLDKFYKYVYEVLKSVI---PEEILGKIAVATVKALNYLKEE 126
Query: 487 SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE---- 542
L+IIHRD+K SNILLD K+ DFG++ S +T AG YMAPE
Sbjct: 127 --LKIIHRDVKPSNILLDRNGNIKLCDFGISG--QLVDSIAKTRD-AGCRPYMAPERIDP 181
Query: 543 YAIRGFLSVKSDVFSFGVLLLEIISGRKNYD 573
A G+ V+SDV+S G+ L E+ +G+ Y
Sbjct: 182 SARDGY-DVRSDVWSLGITLYEVATGKFPYP 211
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 70/218 (32%), Positives = 115/218 (52%), Gaps = 20/218 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKL-ATNSMQGKEEFENEVRVLLKMQH-R 424
D+ LGRG +G V K R + G +AVK++ AT + Q ++ ++ + ++
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDKF---LFDKSKSAILDWPKRLNIIMGVARGLL 481
V +G +E + + E + + SLDKF ++DK + D + I + + + L
Sbjct: 61 YTVTFYGALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALE 117
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP 541
YLH S L +IHRD+K SN+L++ + K+ DFG++ D S +T AG YMAP
Sbjct: 118 YLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTID-AGCKPYMAP 172
Query: 542 E-----YAIRGFLSVKSDVFSFGVLLLEIISGRKNYDR 574
E +G+ VKSDV+S G+ ++E+ +GR YD
Sbjct: 173 ERINPELNQKGY-DVKSDVWSLGITMIELATGRFPYDS 209
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 63/228 (27%), Positives = 114/228 (50%), Gaps = 17/228 (7%)
Query: 375 MLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGK-EEFENEVRVLLKMQH---RNLVQL 429
++GRG +G VY+G+ + GR +A+K + ++ + + EV +L +++ N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
+G ++ ++ EY S+ + K+ + II V L Y+H+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG-- 121
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG-F 548
+IHRDIKA+NIL+ + K+ DFG+A L + S+ T GT +MAPE G +
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGKY 178
Query: 549 LSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR--RLEEEG 594
K+D++S G+ + E+ +G Y L+ ++ RLE+ G
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNG 226
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 370 FSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN---EVRVLLKMQHRN 425
F+ +G+G FG VYK + + +A+K + + + ++E E+ E++ L + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI--DLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+ + +G ++ + ++ EY S D K LD I+ V GL YLH
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHE 116
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI 545
+ IHRDIKA+NILL + K++DFG++ S+ T GT +MAPE
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIK 171
Query: 546 RGFLSVKSDVFSFGVLLLEIISG 568
+ K+D++S G+ +E+ G
Sbjct: 172 QSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 33/217 (15%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEEFEN-------EVRVLL 419
+ + ++G G +G V K R + G +A+KK + E+ E+ EV+VL
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKK-----FKESEDDEDVKKTALREVKVLR 55
Query: 420 KMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARG 479
+++H N+V L ++ LV+EY+ L+ L + S L + I + +
Sbjct: 56 QLRHENIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGG-LPPDAVRSYIWQLLQA 112
Query: 480 LLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYM 539
+ Y H IIHRDIK NIL+ K+ DFG A+ + T +A T Y
Sbjct: 113 IAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYR 168
Query: 540 APEYAIRGFLSVKS-------DVFSFGVLLLEIISGR 569
APE L V DV++ G ++ E++ G
Sbjct: 169 APE------LLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 25/206 (12%)
Query: 374 NMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE-----FENEVRVLLKMQ---HR 424
+G G +GTVYK R L GR +A+KK+ + EE E+ +L +++ H
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKV---RVPLSEEGIPLSTLREIALLKQLESFEHP 61
Query: 425 NLVQLFGCC-VQERERI----LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARG 479
N+V+L C +R LV+E++ ++ L +L K L +++ + RG
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLRG 119
Query: 480 LLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYM 539
+ +LH RI+HRD+K NIL+ + KI+DFGLA+++ E + T + T Y
Sbjct: 120 VDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVV-TLWYR 173
Query: 540 APEYAIRGFLSVKSDVFSFGVLLLEI 565
APE ++ + D++S G + E+
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 28/221 (12%)
Query: 366 ATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHR 424
T F ++G G +G VYK R + ++ K+ +EE + E +L K H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHP 63
Query: 425 NLVQLFGCCVQERERI------LVYEYLPNKSLDKFLFDKSKSAILDWPKRLN------I 472
N+ +G +++ LV E S+ D K + KRL I
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVT----DLVKG-LRKKGKRLKEEWIAYI 118
Query: 473 IMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQI 532
+ RGL YLH + ++IHRDIK NILL + K+ DFG++ + + R +
Sbjct: 119 LRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTF 173
Query: 533 AGTFGYMAPE-----YAIRGFLSVKSDVFSFGVLLLEIISG 568
GT +MAPE +SDV+S G+ +E+ G
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 69/232 (29%), Positives = 127/232 (54%), Gaps = 22/232 (9%)
Query: 375 MLGRGGFGTVYKGRL-QDGRE---IAVKKL-ATNSMQGKEEFENEVRVLLKMQHRNLVQL 429
++G G FG V +GRL G+ +A+K L + + + + +F +E ++ + H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
G + R +++ E++ N +LD FL + + + ++ G+A G+ YL S +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYL---SEM 125
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR-HRTHQIAGTFG--YMAPE-YAI 545
+HRD+ A NIL++ + K+SDFGL++ D+ S T + G + APE A
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 546 RGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRL 596
R F S SDV+S+G+++ E++S G + Y + NQ+++ +E++ RL
Sbjct: 186 RKFTSA-SDVWSYGIVMWEVMSYGERPY---WDMSNQDVIN---AIEQDYRL 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-21
Identities = 35/103 (33%), Positives = 56/103 (54%), Gaps = 4/103 (3%)
Query: 56 CDSSTNNTL---DSAFSSNLGIALKTLQNNTAQT-GFSFTTISASNSSQPVTALALCRAT 111
C S+T+ +S F SNL L +L +N A + G F ++ + V LA CR
Sbjct: 4 CSSNTSGNYTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGD 63
Query: 112 ITQSECQECMDSAVLSIRRVCPDQTTAQIWHTYCMIRYSSRKF 154
++ S+C+ C+ +AV +RR CP++ +IW+ C +RY S F
Sbjct: 64 LSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 70/282 (24%), Positives = 125/282 (44%), Gaps = 33/282 (11%)
Query: 376 LGRGGFGTVYKGRLQD------GREIAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQ 428
LG+G FG VY+G + +A+K + N SM+ + EF NE V+ + ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 429 LFGCCVQERERILVYEYLPNKSLDKFL-------FDKSKSAILDWPKRLNIIMGVARGLL 481
L G + ++V E + L +L + K + + +A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP 541
YL + +HRD+ A N ++ + KI DFG+ + ++ + + +MAP
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 542 EYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600
E G + KSDV+SFGV+L E+ + + Y N+E+LK +G ++L
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL---SNEEVLKFVI----DGGHLDLP 243
Query: 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
+ + L M+ +C + + RPT +S L +
Sbjct: 244 EN-----CPDKLLELMR---MCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 78/250 (31%), Positives = 115/250 (46%), Gaps = 33/250 (13%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRL-----QDGR-EIAVKKLATNSMQGKE--EFENEVRVLL 419
D + LG G FG V K + +AVK L ++ + K+ + +E+ ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE-KDLSDLVSEMEMM- 69
Query: 420 KM--QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDK-----SKSAILDWPKRLNI 472
KM +H+N++ L G C QE +V EY + +L FL + S P +
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 473 IM--------GVARGLLYLHRDSVLRIIHRDIKASNILL--DHQMKPKISDFGLAKLFHD 522
VARG+ +L + IHRD+ A N+L+ DH M KI+DFGLA+ H
Sbjct: 130 TQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVM--KIADFGLARDIHH 184
Query: 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQ 581
+T +MAPE + +SDV+SFGVLL EI + G Y E
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244
Query: 582 ELLKLARRLE 591
+LLK R+E
Sbjct: 245 KLLKEGYRME 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 3e-21
Identities = 77/305 (25%), Positives = 144/305 (47%), Gaps = 31/305 (10%)
Query: 353 MRSFLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLA-TNSMQGKEE 410
+S N D+L + + N++ RG G YKG+ +++G + VK++ NS+
Sbjct: 680 SKSITIN-DILSSLKEE----NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP---- 730
Query: 411 FENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRL 470
+E+ + K+QH N+V+L G C E+ L++EY+ K+L + L + L W +R
Sbjct: 731 -SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRR 783
Query: 471 NIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTH 530
I +G+A+ L +LH ++ ++ I++D + +P + L L + +
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS 842
Query: 531 QIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL 590
Y+APE ++ KSD++ FG++L+E+++G+ D + + +++ AR
Sbjct: 843 ------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYC 895
Query: 591 EEEGRLMELVDVRI----GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVP 646
+ L +D I EI + M +AL CT RP + L L ++S
Sbjct: 896 YSDCHLDMWIDPSIRGDVSVNQNEI-VEVMNLALHCTATDPTARPCANDVLKTLESASRS 954
Query: 647 IPSVT 651
S
Sbjct: 955 SSSCV 959
|
Length = 968 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 3e-21
Identities = 72/228 (31%), Positives = 118/228 (51%), Gaps = 19/228 (8%)
Query: 375 MLGRGGFGTVYKG-RLQDGREI----AVKKL-ATNSMQGKEEFENEVRVLLKMQHRNLVQ 428
+LG G FGTVYKG + +G + A+K L T + EF +E ++ M H +LV+
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 429 LFGCCVQERERILVYEYLPNKSLDKFLF---DKSKSAILDWPKRLNIIMGVARGLLYLHR 485
L G C+ + LV + +P+ L ++ D S +L LN + +A+G++YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLL-----LNWCVQIAKGMMYLEE 127
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI 545
R++HRD+ A N+L+ KI+DFGLA+L ++ + +MA E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 546 RGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEE 592
+ +SDV+S+GV + E+++ G K YD E +LL+ RL +
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ 232
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 375 MLGRGGFGTVYKG-RLQDGREIAVKKL---ATNSMQGKEE-------FENEVRVLLKMQH 423
++G+G +G VY + G +AVK++ AT + + +E+ L + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL 483
N+VQ G E + EY+P S+ L + V GL YL
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEY 543
H I+HRD+KA N+L+D KISDFG++K D + + G+ +MAPE
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 544 ---AIRGFLSVKSDVFSFGVLLLEIISGRKNYDR 574
+G+ S K D++S G ++LE+ +GR+ +
Sbjct: 182 IHSYSQGY-SAKVDIWSLGCVVLEMFAGRRPWSD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 5e-21
Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 38/217 (17%)
Query: 374 NMLGRGGFGTVYKGRLQDGREIAVKKLA---TNSMQGKEEFEN---EVRVLLKMQHRNLV 427
+LG+G +GTVY G G+ IAVK++ +N + ++E+E EV +L ++H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFL----------FDKSKSAILDWPKRLNIIMGVA 477
Q G C+ + + E++P S+ L F K ILD
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD------------ 113
Query: 478 RGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTH-----QI 532
G+ YLH + V +HRDIK +N++L K+ DFG A+ H TH +
Sbjct: 114 -GVAYLHNNCV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLA-WVGLHGTHSNMLKSM 168
Query: 533 AGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
GT +MAPE KSD++S G + E+ +G+
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 7e-21
Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 376 LGRGGFGTVYKGR---LQDGRE---IAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQ 428
+G+G FG V++ R L +AVK L S + +F+ E ++ + H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 429 LFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAI-------------------LDWPKR 469
L G C + L++EY+ L++FL +S A L ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 470 LNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRT 529
L I VA G+ YL S + +HRD+ N L+ M KI+DFGL++ + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 530 HQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS 567
A +M PE + +SDV+++GV+L EI S
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 7e-21
Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 10/198 (5%)
Query: 376 LGRGGFGTVYKG-RLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCV 434
+G+G GTVY + G+E+A+K++ KE NE+ V+ + +H N+V +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 435 QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHR 494
E +V EYL SL D +D + + + L +LH + V IHR
Sbjct: 87 VGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSNQV---IHR 139
Query: 495 DIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSD 554
DIK+ NILL K++DFG EQS+ T + GT +MAPE R K D
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVD 197
Query: 555 VFSFGVLLLEIISGRKNY 572
++S G++ +E++ G Y
Sbjct: 198 IWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 8e-21
Identities = 72/221 (32%), Positives = 107/221 (48%), Gaps = 12/221 (5%)
Query: 376 LGRGGFGTVYKGRLQ-DGREIAVKKL-ATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCC 433
+GRG FG V+ GRL+ D +AVK T K +F E R+L + H N+V+L G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 434 VQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIH 493
Q++ +V E + FL +++ L + + ++ A G+ YL IH
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKHC---IH 117
Query: 494 RDIKASNILLDHQMKPKISDFGLAKLFHD--EQSRHRTHQIAGTFGYMAPEYAIRGFLSV 551
RD+ A N L+ + KISDFG+++ D S QI + APE G S
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP--VKWTAPEALNYGRYSS 175
Query: 552 KSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLE 591
+SDV+SFG+LL E S G Y + +E ++ RL
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLP 216
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 8e-21
Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL 426
DNF +G G G V GR++AVKK+ Q +E NEV ++ QH N+
Sbjct: 22 DNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 427 VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD 486
V+++ + E +V E+L +L D ++ + + + V + L +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ 134
Query: 487 SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR 546
V IHRDIK+ +ILL + K+SDFG E R ++ + GT +MAPE R
Sbjct: 135 GV---IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVISR 189
Query: 547 GFLSVKSDVFSFGVLLLEIISGRKNY 572
+ D++S G++++E++ G Y
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 19/205 (9%)
Query: 374 NMLGRGGFGTVYKGRL--QDGREI--AVKKLA-TNSMQGKEEFENEVRVLLKMQHRNLVQ 428
++G+G FG VY G L DG++I AVK L ++ E+F E ++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 429 LFGCCV-QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNII---MGVARGLLYLH 484
L G C+ E ++V Y+ + L F+ ++ + P ++I + VA+G+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN-----PTVKDLIGFGLQVAKGMEYLA 115
Query: 485 RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ--SRHRTHQIAGTFGYMAPE 542
+ +HRD+ A N +LD K++DFGLA+ +D++ S H +MA E
Sbjct: 116 SK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 543 YAIRGFLSVKSDVFSFGVLLLEIIS 567
+ KSDV+SFGVLL E+++
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 68/212 (32%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 375 MLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFE---NEVRVL-LKMQHRNLVQL 429
+LG+G FG V L+ E+ AVK L + + ++ E E RVL L +H L QL
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 430 FGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488
C Q ++R+ V EY+ L +F +S D P+ + GL +LH
Sbjct: 62 H-SCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG- 116
Query: 489 LRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGF 548
II+RD+K N+LLD + KI+DFG+ K T GT Y+APE +
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPE-ILSYQ 171
Query: 549 LSVKS-DVFSFGVLLLEIISGRKNYDRQLEAE 579
+ D ++ GVLL E+++G+ ++ E E
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE 203
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 11/205 (5%)
Query: 370 FSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGK-EEFENEVRVLLKMQHRNLV 427
F+ +G+G FG VYKG +E+ A+K + + + E+ + E+ VL + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
+ +G ++ + ++ EYL S D K L+ I+ + +GL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG 547
R IHRDIKA+N+LL Q K++DFG+A D Q + T GT +MAPE +
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176
Query: 548 FLSVKSDVFSFGVLLLEIISGRKNY 572
K+D++S G+ +E+ G
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 25/205 (12%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGK--EEFENEVRVLLKMQHRNLVQLF-- 430
+G G G V+K + + G +A+KK+A ++G + E++ L QH +V+L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 431 ---GCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
G +LV EY+P+ L + L D+ + K ++ +G+ Y+H
Sbjct: 68 FPHGSGF-----VLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRML--LKGVAYMHA-- 117
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE--YAI 545
I+HRD+K +N+L+ KI+DFGLA+LF +E+ R +HQ+A T Y APE Y
Sbjct: 118 -NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPELLYGA 175
Query: 546 RGF-LSVKSDVFSFGVLLLEIISGR 569
R + V D+++ G + E+++G
Sbjct: 176 RKYDPGV--DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 29/206 (14%)
Query: 376 LGRGGFGTVYKGRLQ-DGREIA---VKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFG 431
LG GGFG V +++ R A VKK +E +E +L + H +V+L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 432 CCVQERERI-LVYEYLPNKSL-----DKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
++++ I ++ EY L D+ LFD+ + I V YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARF--------YIACVVLAFEYLHN 111
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI 545
II+RD+K N+LLD K+ DFG AK +S +T GT Y+APE +
Sbjct: 112 ---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVAPEIIL 165
Query: 546 -RGF-LSVKSDVFSFGVLLLEIISGR 569
+G+ SV D +S G+LL E+++GR
Sbjct: 166 NKGYDFSV--DYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 69/204 (33%), Positives = 97/204 (47%), Gaps = 33/204 (16%)
Query: 376 LGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFEN---EVRVLLKMQHRNLVQLFG 431
+G G FG VY R E+ A+KK++ + Q E++++ EVR L +++H N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 432 CCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKR-------LNIIMGVARGLLYLH 484
C ++E LV EY S S IL+ K+ I G +GL YLH
Sbjct: 83 CYLREHTAWLVMEYCLG----------SASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 485 RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYA 544
IHRDIKA NILL K++DFG A L S GT +MAPE
Sbjct: 133 S---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPEVI 183
Query: 545 I---RGFLSVKSDVFSFGVLLLEI 565
+ G K DV+S G+ +E+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYK------GRLQDGREIAVKKL-ATNSMQGKEEFENEVRVLLK 420
+N S LG G FG V + + ++AVK L T +E +E++++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 421 M-QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARG 479
+ H N+V L G C +++ EY L FL K +S L L+ VA+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES-FLTLEDLLSFSYQVAKG 153
Query: 480 LLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK-LFHDEQSRHRTHQIAGTF-- 536
+ +L + IHRD+ A N+LL H KI DFGLA+ + +D +
Sbjct: 154 MAFLASKNC---IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVK----GNARLP 206
Query: 537 -GYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS 567
+MAPE + +SDV+S+G+LL EI S
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 63/234 (26%), Positives = 116/234 (49%), Gaps = 27/234 (11%)
Query: 376 LGRGGFGTVYKGRL------QDGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQ 428
LG FG VYKG L + + +A+K L + +EEF++E + ++QH N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 429 LFGCCVQERERILVYEYLPNKSLDKFLF-------------DKSKSAILDWPKRLNIIMG 475
L G +E+ +++ Y + L +FL DK+ + L+ ++I+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 476 VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGT 535
+A G+ +L S ++H+D+ N+L+ ++ KISD GL + +
Sbjct: 133 IAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 536 FGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLAR 588
+M+PE + G S+ SD++S+GV+L E+ S G + Y NQ+++++ R
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY---CGYSNQDVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCV 434
LG G FG VYK + + G A K + S + E+F E+ +L + +H N+V L+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 435 QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHR 494
E + ++ E+ +LD + + + L P+ + + L +LH ++IHR
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFLHSH---KVIHR 127
Query: 495 DIKASNILLDHQMKPKISDFGL-AKLFHDEQSRHRTHQIAGTFGYMAPEY-AIRGFLS-- 550
D+KA NILL K++DFG+ AK Q R GT +MAPE A F
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR---DTFIGTPYWMAPEVVACETFKDNP 184
Query: 551 --VKSDVFSFGVLLLEIISGR 569
K+D++S G+ L+E+
Sbjct: 185 YDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 62/201 (30%), Positives = 106/201 (52%), Gaps = 17/201 (8%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE-----FENEVRVLLKMQHRNLVQL 429
+G G +G VYK R G +A+KK+ ++ ++E E+ +L ++ H N+V+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI---RLETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
E + LV+E+L + L K++ D S LD P + + + +G+ Y H
Sbjct: 64 LDVVHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHSH--- 118
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG-F 548
R++HRD+K N+L+D + K++DFGLA+ F R TH++ T Y APE +
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGSRQ 176
Query: 549 LSVKSDVFSFGVLLLEIISGR 569
S D++S G + E+++ R
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 6e-20
Identities = 81/278 (29%), Positives = 125/278 (44%), Gaps = 37/278 (13%)
Query: 376 LGRGGFGTVYKGRLQ---DGREIAVKKLA--TNSMQGKEEFENEVRVLLKMQHRNLVQLF 430
LG G FGTV KG + + +AVK L N K+E E V+ ++ + +V++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 431 GCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLR 490
G C E +LV E L+KFL K+ + ++ V+ G+ YL +
Sbjct: 63 GICEAE-SWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN--- 115
Query: 491 IIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFG-----YMAPEYAI 545
+HRD+ A N+LL Q KISDFGL+K +++ ++ A T G + APE
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK----AKTHGKWPVKWYAPECMN 171
Query: 546 RGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604
S KSDV+SFGVL+ E S G+K Y E ++++ R+E
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC------------ 219
Query: 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
P+ + LC +++RP + L N
Sbjct: 220 ---PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 6e-20
Identities = 79/244 (32%), Positives = 115/244 (47%), Gaps = 35/244 (14%)
Query: 373 KNMLGRGGFGTVYKGRL-QDGREI--AVKKLATNSMQGKE-EFENEVRVLLKM-QHRNLV 427
++++G G FG V K R+ +DG + A+K++ + + +F E+ VL K+ H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFL-------------FDKSKSAILDWPKRLNIIM 474
L G C L EY P+ +L FL S ++ L + L+
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAG 534
VARG+ YL S + IHRD+ A NIL+ KI+DFGL SR + +
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL--------SRGQEVYVKK 180
Query: 535 TFG-----YMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLAR 588
T G +MA E + SDV+S+GVLL EI+S G Y AE E L
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 240
Query: 589 RLEE 592
RLE+
Sbjct: 241 RLEK 244
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 369 NFSTKNMLGRGGFGTVYKGR-LQDGREIAVKK--LATNSMQGKEEFENEVRVLLKMQHRN 425
NF +G G +G VYK R G +A+KK L T + E+ +L ++ H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+V+L E + LV+E+L ++ L KF+ D S + + P + + + +GL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI 545
R++HRD+K N+L++ + K++DFGLA+ F R TH++ T Y APE +
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILL 173
Query: 546 -RGFLSVKSDVFSFGVLLLEIISGR 569
+ S D++S G + E+++ R
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 8e-20
Identities = 74/238 (31%), Positives = 124/238 (52%), Gaps = 35/238 (14%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEEFE----NEVRVLLKMQ 422
D F +G G +G VYK R +D G +A+KK+ ++ KE F E+++L ++
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE--KEGFPITAIREIKILRQLN 64
Query: 423 HRNLVQLFGCCVQERERI----------LVYEYLPNK---SLDKFLFDKSKSAILDWPKR 469
HRN+V L +++ + LV+EY+ + L+ L S+ I + K+
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQ 124
Query: 470 LNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRT 529
L GL Y H+ + L HRDIK SNILL+++ + K++DFGLA+L++ E+SR T
Sbjct: 125 L------LEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 530 HQIAGTFGYMAPEYAI---RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELL 584
+++ T Y PE + R ++ DV+S G +L E+ + + + E EL+
Sbjct: 176 NKVI-TLWYRPPELLLGEERYGPAI--DVWSCGCILGELFTKKPIFQANQELAQLELI 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 8e-20
Identities = 53/174 (30%), Positives = 84/174 (48%), Gaps = 35/174 (20%)
Query: 369 NFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFE----NEVRVLLKMQH 423
K LG G FG VYK R ++ GR +A+KK+ ++ K+ F E+++L K++H
Sbjct: 11 EILGK--LGEGTFGEVYKARQIKTGRVVALKKILMHNE--KDGFPITALREIKILKKLKH 66
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLF-------DKSKSAILDWPK-RL----- 470
N+V L + E + D S +L+ P +L
Sbjct: 67 PNVVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQI 117
Query: 471 -NIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523
++ + G+ YLH + I+HRDIKA+NIL+D+Q KI+DFGLA+ +
Sbjct: 118 KCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 90.2 bits (223), Expect = 9e-20
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCV 434
+G+G GTV+ + G+E+A+K++ KE NE+ V+ ++++ N+V +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 435 QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHR 494
E +V EYL SL D +D + + + L +LH + V IHR
Sbjct: 87 VGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFLHANQV---IHR 139
Query: 495 DIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSD 554
DIK+ N+LL K++DFG EQS+ T + GT +MAPE R K D
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVD 197
Query: 555 VFSFGVLLLEIISGRKNY 572
++S G++ +E++ G Y
Sbjct: 198 IWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 72/218 (33%), Positives = 106/218 (48%), Gaps = 23/218 (10%)
Query: 375 MLGRGGFGTVYKGRL-QDGREIAVKKLATNSMQGKEEFE---NEVRVL-LKMQHRNLVQL 429
+LG+G FG V RL + GR AVK L + + ++ E E R+L L H L QL
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 430 FGCCVQERERIL-VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488
+ CC Q +R+ V E++ L +F KS D + + L++LH
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG- 116
Query: 489 LRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH--RTHQIAGTFGYMAPEYAIR 546
II+RD+K N+LLDH+ K++DFG+ K E + T GT Y+APE
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCK----EGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 547 GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELL 584
D ++ GVLL E++ G + EAEN++ L
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPF----EAENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 69/215 (32%), Positives = 109/215 (50%), Gaps = 13/215 (6%)
Query: 376 LGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFEN---EVRVLLKMQHRNLVQLFG 431
LG+GGFG V +++ G+ A KKL ++ ++ +E E R+L K+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 432 CCVQERERI-LVYEYLPNKSLDKFLFD-KSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
Q + + LV + L +++ ++ P+ + GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL 549
RII+RD+K N+LLD+ +ISD GLA D QS+ + + AGT G+MAPE
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY--AGTPGFMAPELLQGEEY 174
Query: 550 SVKSDVFSFGVLLLEIISGRKNYDRQLE-AENQEL 583
D F+ GV L E+I+ R + + E EN+EL
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 72/271 (26%), Positives = 134/271 (49%), Gaps = 35/271 (12%)
Query: 375 MLGRGGFGTVYKGR-LQDGREIAVKKLA----TNSMQGK--EEFENEVRVLLKMQHRNLV 427
LG G F + Y+ R ++ G +AVK++ T+S Q + E E+R++ ++ H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFL--FDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
++ G ++ L E++ S+ L + K A++ +N + RGL YLH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHE 121
Query: 486 DSVLRIIHRDIKASNILLDHQ-MKPKISDFGLAKLFHDEQSR--HRTHQIAGTFGYMAPE 542
+ +IIHRD+K +N+L+D + +I+DFG A + + Q+ GT +MAPE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 543 YAIRGFLSVKS-DVFSFGVLLLEIISGRKNYDRQLEAENQELL-KLARRLEEEGRLMELV 600
+RG +S DV+S G +++E+ + + ++ + + + L+ K+A
Sbjct: 179 -VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP------- 230
Query: 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRP 631
+ PE ++ + L C E EDRP
Sbjct: 231 -----SIPEHLSPGLRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 10/198 (5%)
Query: 376 LGRGGFGTVYKG-RLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCV 434
+G+G GTVY + G+E+A+K++ KE NE+ V+ + ++ N+V +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 435 QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHR 494
E +V EYL SL D +D + + + L +LH + V IHR
Sbjct: 87 VGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSNQV---IHR 139
Query: 495 DIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSD 554
DIK+ NILL K++DFG EQS+ T + GT +MAPE R K D
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVD 197
Query: 555 VFSFGVLLLEIISGRKNY 572
++S G++ +E++ G Y
Sbjct: 198 IWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 376 LGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFEN---EVRVLLKMQHRNLVQLFG 431
+ +G +G V+ + + +I A+K + M K + + E +L + Q +V+L+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 432 CCVQERERILVYEYLPNKSLDKFL-----FDKSKSAILDWPKRLNIIMGVARGLLYLHRD 486
++ LV EYLP L L D+ D + I + L YLH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDE------DVAR--IYIAEIVLALEYLHS- 111
Query: 487 SVLRIIHRDIKASNILLDHQMKPKISDFGLAK-------LFHDEQSRHRTHQIAGTFGYM 539
IIHRD+K NIL+D K++DFGL+K + ++ + +I GT Y+
Sbjct: 112 --NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE-DKRIVGTPDYI 168
Query: 540 APEYAIRGFLSVKSDVFSFGVLLLEIISG 568
APE + S D +S G +L E + G
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 78/255 (30%), Positives = 114/255 (44%), Gaps = 34/255 (13%)
Query: 368 DNFSTKNMLGRGGFGTVY--------KGRLQDGREIAVKKLATNSM-QGKEEFENEVRVL 418
D LG G FG V K R +AVK L N+ + + +E+ ++
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 419 LKM-QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFL-----------FD--KSKSAIL 464
+ +H+N++ L G C QE ++ EY +L +FL FD K L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 465 DWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524
+ ++ VARG+ YL R IHRD+ A N+L+ KI+DFGLA+ HD
Sbjct: 132 SFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQEL 583
+T +MAPE + +SDV+SFG+L+ EI + G Y +EL
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP---GIPVEEL 245
Query: 584 LKLARRLEEEGRLME 598
KL R EG M+
Sbjct: 246 FKLLR----EGHRMD 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 78/282 (27%), Positives = 119/282 (42%), Gaps = 60/282 (21%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKLATNS--------MQGKEEFENE-VRVLLKMQHRN- 425
LG G G+V K VK + T + + K + +R L M
Sbjct: 13 LGAGNGGSVSK----------VKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS 62
Query: 426 --LVQLFGCCVQERERILVYEYLPNKSLDKFL--FDKSKSAILDWPKRLNIIMGVARGLL 481
+V +G + E + E++ SLD+ IL I + V GL
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLT 117
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF----G 537
YL+ +V RI+HRDIK SNIL++ + + K+ DFG+ S + IA TF
Sbjct: 118 YLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGV--------SGELINSIADTFVGTST 167
Query: 538 YMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR-----KNYDRQLEAENQELLKLARRL-- 590
YM+PE G +VKSDV+S G+ ++E+ G+ N D + + +L L +++
Sbjct: 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ 227
Query: 591 EEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPT 632
E RL +P E F+ LL +RPT
Sbjct: 228 EPPPRLPS------SDFP-EDLRDFVDACLLKDPT---ERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 5e-19
Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 370 FSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN---EVRVLLKMQHRN 425
FS +G G FG VY R +++ +A+KK++ + Q E++++ EVR L K++H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+Q GC ++E LV EY + D L + K + + + + G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEV-EIAAVTHGALQGLAYLHS 133
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI 545
+ +IHRD+KA NILL K+ DFG A + GT +MAPE +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVIL 184
Query: 546 ---RGFLSVKSDVFSFGVLLLEI 565
G K DV+S G+ +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 6e-19
Identities = 65/230 (28%), Positives = 118/230 (51%), Gaps = 13/230 (5%)
Query: 370 FSTKNMLGRGGFGTVYKGR-LQDGREI----AVKKL-ATNSMQGKEEFENEVRVLLKMQH 423
F +LG G FGTVYKG + +G ++ A+K+L S + +E +E V+ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL 483
++ +L G C+ + L+ + +P L ++ + + + LN + +A+G+ YL
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYL 125
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEY 543
R++HRD+ A N+L+ KI+DFGLAKL ++ + +MA E
Sbjct: 126 EER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 544 AIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEE 592
+ + +SDV+S+GV + E+++ G K YD +E +L+ RL +
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 232
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 7e-19
Identities = 65/229 (28%), Positives = 114/229 (49%), Gaps = 26/229 (11%)
Query: 376 LGRGGFGTVYKG--RLQDGR-EIAVKKLATNSMQG-KEEFENEVRVLLKMQHRNLVQLFG 431
LG G FG V KG +++ + ++A+K L + + ++E E ++ ++ + +V++ G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 432 CCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIM---GVARGLLYLHRDSV 488
C + +LV E L+KFL K + N++ V+ G+ YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVS-----NVVELMHQVSMGMKYLEGKN- 115
Query: 489 LRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFG-----YMAPEY 543
+HRD+ A N+LL +Q KISDFGL+K + S ++ A + G + APE
Sbjct: 116 --FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK----ARSAGKWPLKWYAPEC 169
Query: 544 AIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLE 591
S +SDV+S+G+ + E S G+K Y + E ++ +RL+
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLD 218
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-19
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 13/206 (6%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL 426
DNF +G G G V ++ G+ +AVKK+ Q +E NEV ++ QH N+
Sbjct: 23 DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 427 VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD 486
V+++ + E +V E+L +L D ++ + + + V + L LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 487 SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR 546
V IHRDIK+ +ILL H + K+SDFG E R ++ + GT +MAPE R
Sbjct: 136 GV---IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISR 190
Query: 547 GFLSVKSDVFSFGVLLLEIISGRKNY 572
+ D++S G++++E++ G Y
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 361 DVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATN-SMQGKEEFENEVRVLL 419
+V + D + L +AVK L + S +E+F EV++L
Sbjct: 20 EVHLCEADGLQDFSEKAFAENDNADAPVL-----VAVKVLRPDASDNAREDFLKEVKILS 74
Query: 420 KMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFL--------FDKSKSAILDWPKRLN 471
++ N+ +L G C + ++ EY+ N L++FL S L + L
Sbjct: 75 RLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLY 134
Query: 472 IIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK-LFHDEQSRHRTH 530
+ +A G+ YL L +HRD+ N L+ KI+DFG+++ L+ + R +
Sbjct: 135 MATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGR 191
Query: 531 QIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS 567
+MA E + G + KSDV++FGV L EI++
Sbjct: 192 APL-PIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 8e-19
Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 370 FSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN---EVRVLLKMQHRN 425
F+ +G G FG VY R ++ +A+KK++ + Q E++++ EV+ L +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
++ GC ++E LV EY + D K L + I G +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAITHGALQGLAYLHS 143
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI 545
+ +IHRDIKA NILL + K++DFG A + S GT +MAPE +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVIL 194
Query: 546 ---RGFLSVKSDVFSFGVLLLEI 565
G K DV+S G+ +E+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 8e-19
Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCV 434
+G+G GTVY + G+E+A++++ KE NE+ V+ + ++ N+V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 435 QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHR 494
E +V EYL SL D +D + + + L +LH + V IHR
Sbjct: 88 VGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSNQV---IHR 140
Query: 495 DIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSD 554
DIK+ NILL K++DFG EQS+ + GT +MAPE R K D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 555 VFSFGVLLLEIISGRKNY 572
++S G++ +E+I G Y
Sbjct: 199 IWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRN 425
+ +G G FG +Y + + D +K++ M + KE + EV +L KM+H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDK-------FLFDKSKSAILDWPKRLNIIMGVAR 478
+V F + +V EY L K LF S+ IL W + ++
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF--SEDQILSW------FVQISL 112
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLDHQ-MKPKISDFGLAKLFHDEQSRHRTHQIAGTFG 537
GL ++H +I+HRDIK+ NI L M K+ DFG+A+ +D T GT
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPY 167
Query: 538 YMAPEYAIRGFLSVKSDVFSFGVLLLEI 565
Y++PE + K+D++S G +L E+
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 27/211 (12%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGRE-IAVKKLATN---SMQGKEEFENEVRVLLKMQH 423
D+ +G G FG V+ R + A+K +A ++ ++ NE RVL ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMG------VA 477
+++LF +R ++ EY+P L +L + R + G +
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS---------GRFSNSTGLFYASEIV 111
Query: 478 RGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFG 537
L YLH I++RD+K NILLD + K++DFG AK D RT + GT
Sbjct: 112 CALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGTPE 163
Query: 538 YMAPEYAIRGFLSVKSDVFSFGVLLLEIISG 568
Y+APE + D ++ G+L+ E++ G
Sbjct: 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 71/286 (24%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 373 KNMLGRGGFGTVY----KGRL---------QDGRE--IAVKKLATNSMQ-GKEEFENEVR 416
K LG G FG V+ +G DG+ +AVK L + + + +F E++
Sbjct: 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69
Query: 417 VLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDK---SKSAI------LDWP 467
++ ++++ N+++L G CV + ++ EY+ N L++FL + S +
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 468 KRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK-LFHDEQSR 526
L + + +A G+ YL + L +HRD+ N L+ + KI+DFG+++ L+ + R
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186
Query: 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKL 586
+ + +MA E + G + SDV++FGV L E+ + K L ++ Q +
Sbjct: 187 IQGRAVL-PIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENT 245
Query: 587 ARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPT 632
+GR + L + P ++ + C I+DRPT
Sbjct: 246 GEFFRNQGRQIYLSQTPLCPSP------VFKLMMRCWSRDIKDRPT 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 70/226 (30%), Positives = 116/226 (51%), Gaps = 15/226 (6%)
Query: 375 MLGRGGFGTVYKG-RLQDGREI----AVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQ 428
+LG G FGTVYKG + DG + A+K L N S + +E +E V+ + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 429 LFGCCVQERERILVYEYLPNKSL-DKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
L G C+ + LV + +P L D +K + D LN + +A+G+ YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDL---LNWCVQIAKGMSYLEE-- 127
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG 547
+R++HRD+ A N+L+ KI+DFGLA+L +++ + +MA E +
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 548 FLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEE 592
+ +SDV+S+GV + E+++ G K YD E +LL+ RL +
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ 232
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-18
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 10/198 (5%)
Query: 376 LGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCV 434
+G G G V R + GR++AVK + Q +E NEV ++ QH+N+V+++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 435 QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHR 494
E ++ E+L +L D L+ + + V + L YLH V IHR
Sbjct: 89 VGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQGV---IHR 141
Query: 495 DIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSD 554
DIK+ +ILL + K+SDFG + + ++ + GT +MAPE R + D
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEVD 199
Query: 555 VFSFGVLLLEIISGRKNY 572
++S G++++E++ G Y
Sbjct: 200 IWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 59/203 (29%), Positives = 105/203 (51%), Gaps = 15/203 (7%)
Query: 370 FSTKNMLGRGGFGTVYKG---RLQDGREIAVKKLATNSMQGK-EEFENEVRVLLKMQHRN 425
F+ +G+G FG V+KG R Q + +A+K + + + E+ + E+ VL +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQ--KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+ + +G +++ + ++ EYL S D + LD + I+ + +GL YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHS 119
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI 545
+ + IHRDIKA+N+LL + K++DFG+A D Q + + GT +MAPE
Sbjct: 120 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIK 174
Query: 546 RGFLSVKSDVFSFGVLLLEIISG 568
+ K+D++S G+ +E+ G
Sbjct: 175 QSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 16/218 (7%)
Query: 376 LGRGGFGTV-YKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCV 434
+G G G V G+++AVKK+ Q +E NEV ++ H N+V ++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 435 QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHR 494
E +V E+L +L D ++ + + + V R L YLH V IHR
Sbjct: 90 VGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQGV---IHR 142
Query: 495 DIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSD 554
DIK+ +ILL + K+SDFG E + ++ + GT +MAPE R + D
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTEVD 200
Query: 555 VFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEE 592
++S G++++E+I G Y N+ L+ RR+ +
Sbjct: 201 IWSLGIMVIEMIDGEPPY------FNEPPLQAMRRIRD 232
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 14/207 (6%)
Query: 369 NFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFEN--EVRVLLKMQHRN 425
F N +G G +G VY+ R EI A+KK+ ++ + + E+ +LL ++H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 426 LVQLFGCCVQER-ERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL 483
+V+L V + + I LV EY + L L + + +++ + RGL YL
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYC-EQDLASLL--DNMPTPFSESQVKCLMLQLLRGLQYL 124
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEY 543
H + IIHRD+K SN+LL + KI+DFGLA+ + + T ++ T Y APE
Sbjct: 125 HENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KPMTPKVV-TLWYRAPEL 179
Query: 544 AIRGFLSVKS-DVFSFGVLLLEIISGR 569
+ + D+++ G +L E+++ +
Sbjct: 180 LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 70/227 (30%), Positives = 115/227 (50%), Gaps = 17/227 (7%)
Query: 375 MLGRGGFGTVYKG-RLQDGREI----AVKKLATNSMQGKEEFENEVRVLLKM---QHRNL 426
+LG G FGTV+KG + +G I A+K + S G++ F+ +L M H +
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYI 71
Query: 427 VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD 486
V+L G C + LV + P SL + S LD + LN + +A+G+ YL
Sbjct: 72 VRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYYLEEH 128
Query: 487 SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR 546
R++HR++ A NILL +I+DFG+A L + + ++ + +MA E +
Sbjct: 129 ---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185
Query: 547 GFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEE 592
G + +SDV+S+GV + E++S G + Y E +LL+ RL +
Sbjct: 186 GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ 232
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 7e-18
Identities = 92/310 (29%), Positives = 136/310 (43%), Gaps = 50/310 (16%)
Query: 375 MLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFEN---EVRVL-LKMQHRNLVQL 429
MLG+G FG V+ L+ + A+K L + + ++ E E RVL L +H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 430 FGCCVQERERIL-VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488
+ C Q +E + V EYL L +F D P+ + GL +LH
Sbjct: 62 Y-CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG- 116
Query: 489 LRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGF 548
I++RD+K NILLD KI+DFG+ K + +T GT Y+APE +
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQK 172
Query: 549 LSVKSDVFSFGVLLLEIISGRKN-------------------YDRQLEAENQELLKLARR 589
+ D +SFGVLL E++ G+ Y R L E +++L
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFV 232
Query: 590 LEEEGRLMELVDVRIGTYPEEI---ALRFMQI----------ALLCT---EDFIEDRPTM 633
E E RL D+R + EI AL +I A C+ ++F+ ++P +
Sbjct: 233 REPERRLGVKGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRL 292
Query: 634 SATLSMLSNS 643
S T ML NS
Sbjct: 293 SVTDRMLINS 302
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 71/236 (30%), Positives = 119/236 (50%), Gaps = 26/236 (11%)
Query: 376 LGRGGFGTVYKGRL-QDGR--EIAVK--KLATNSMQGKEEFENEVRVLLKMQHRNLVQLF 430
LG G FG+V +G+L QD ++AVK K+A + E+F +E + + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 431 GCCVQERER------ILVYEYLPNKSLDKFLFDKSKSAILDWPKRL------NIIMGVAR 478
G C+Q E +++ ++ + L FL S + D P+ L + +A
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL---YSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGT-FG 537
G+ YL S IHRD+ A N +L+ M ++DFGL+K ++ +R +IA
Sbjct: 124 GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYN-GDYYRQGRIAKMPVK 179
Query: 538 YMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEE 592
++A E + KSDV+SFGV + EI + G+ Y +E + L+ RL++
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ 235
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 9e-18
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 370 FSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN--------EVRVLLK 420
+ LG G FG+VY R + G +A+KK+ K++F + EV+ L K
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRK 53
Query: 421 MQ-HRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARG 479
+ H N+V+L + E V+EY+ +L + + D+ +II + +G
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKP-FSESVIRSIIYQILQG 111
Query: 480 LLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYM 539
L ++H+ HRD+K N+L+ KI+DFGLA+ T + T Y
Sbjct: 112 LAHIHKHGFF---HRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYV-STRWYR 165
Query: 540 APEYAIR-GFLSVKSDVFSFGVLLLEIISGR 569
APE +R S D+++ G ++ E+ + R
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 9e-18
Identities = 61/202 (30%), Positives = 106/202 (52%), Gaps = 16/202 (7%)
Query: 376 LGRGGFGTVYKGRL-----QDGREIAVKKLATNSMQGK-EEFENEVRVLLKMQHRNLVQL 429
LG G FG V R G ++AVK L S + + E+ +L + H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 430 FGCCVQERER--ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
G C ++ L+ E+LP+ SL ++L ++K+ I + ++L + + +G+ YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKI-NLKQQLKYAVQICKGMDYL---G 126
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH--RTHQIAGTFGYMAPEYAI 545
+ +HRD+ A N+L++ + + KI DFGL K ++ + + + F Y APE I
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLI 185
Query: 546 RGFLSVKSDVFSFGVLLLEIIS 567
+ + SDV+SFGV L E+++
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 9e-18
Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFEN----EVRVLLKMQH 423
D+F LG G G V K + I +KL ++ K N E++VL +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLI--HLEIKPAIRNQIIRELKVLHECNS 58
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRL--NIIMGVARGLL 481
+V +G + E + E++ SLD+ L K I P+ + I + V RGL
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRI---PENILGKISIAVLRGLT 113
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP 541
YL R+ +I+HRD+K SNIL++ + + K+ DFG++ D + + GT YM+P
Sbjct: 114 YL-RE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSP 167
Query: 542 EYAIRGFLSVKSDVFSFGVLLLEIISGR 569
E +V+SD++S G+ L+E+ GR
Sbjct: 168 ERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 59/203 (29%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 370 FSTKNMLGRGGFGTVYKG---RLQDGREIAVKKLATNSMQGK-EEFENEVRVLLKMQHRN 425
F+ +G+G FG V+KG R Q + +A+K + + + E+ + E+ VL +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQ--QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+ + +G ++ + ++ EYL S D ++ D + ++ + +GL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI 545
+ + IHRDIKA+N+LL Q K++DFG+A D Q + T GT +MAPE
Sbjct: 120 E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQ 174
Query: 546 RGFLSVKSDVFSFGVLLLEIISG 568
+ K+D++S G+ +E+ G
Sbjct: 175 QSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 73/237 (30%), Positives = 116/237 (48%), Gaps = 32/237 (13%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGRE-IAVKKLATNSMQGKEEFEN-------EVRVLL 419
D + +G G +G VYK R + E IA+KK+ ++E E E+ +L
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRL-----EQEDEGVPSTAIREISLLK 56
Query: 420 KMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMG---- 475
+MQH N+V+L E+ LV+EYL LD K + D+ K +I
Sbjct: 57 EMQHGNIVRLQDVVHSEKRLYLVFEYL---DLD---LKKHMDSSPDFAKNPRLIKTYLYQ 110
Query: 476 VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP-KISDFGLAKLFHDEQSRHRTHQIAG 534
+ RG+ Y H R++HRD+K N+L+D + K++DFGLA+ F R TH++
Sbjct: 111 ILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV- 165
Query: 535 TFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL 590
T Y APE + S D++S G + E+++ + + ++E EL K+ R L
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG--DSEIDELFKIFRIL 220
|
Length = 294 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 65/261 (24%), Positives = 122/261 (46%), Gaps = 31/261 (11%)
Query: 369 NFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHR 424
NF + +GRG F VY+ L DG +A+KK+ + + + + E+ +L ++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDKFL--FDKSKSAILDWPKRL--NIIMGVARGL 480
N+++ + +++ E +V E L + + F K K I P++ + + L
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI---PEKTVWKYFVQLCSAL 119
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMA 540
++H R++HRDIK +N+ + K+ D GL + F + + H + GT YM+
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMS 174
Query: 541 PEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEE-------- 592
PE + KSD++S G LL E+ + + + + L L +++E+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLCKKIEQCDYPPLPS 230
Query: 593 ---EGRLMELVDVRIGTYPEE 610
L +LV++ I PE+
Sbjct: 231 DHYSEELRQLVNMCINPDPEK 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 373 KNMLGRGGFGTVYKG-RLQDGREIAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQLF 430
+ +LG G GTVYK L R +AVK + + +++ +++ +E+ +L K ++ +
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 431 GCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLR 490
G E + E++ SLD ++ K +L I + V +GL YL L+
Sbjct: 66 GAFFVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---LK 115
Query: 491 IIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIA----GTFGYMAPEYAIR 546
I+HRD+K SN+L++ + + K+ DFG+ S + IA GT YMAPE
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGV--------STQLVNSIAKTYVGTNAYMAPERISG 167
Query: 547 GFLSVKSDVFSFGVLLLEIISGRKNY 572
+ SDV+S G+ +E+ GR Y
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 65/197 (32%), Positives = 96/197 (48%), Gaps = 19/197 (9%)
Query: 376 LGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFEN---EVRVLLKMQHRNLVQLFG 431
+G G FG VY E+ AVKK++ + Q E++++ EV+ L +++H N ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 432 CCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRI 491
C ++E LV EY + D K L + I G +GL YLH + +
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAITHGALQGLAYLHSHN---M 142
Query: 492 IHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI---RGF 548
IHRDIKA NILL + K++DFG A S GT +MAPE + G
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAMDEGQ 196
Query: 549 LSVKSDVFSFGVLLLEI 565
K DV+S G+ +E+
Sbjct: 197 YDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 66/222 (29%), Positives = 119/222 (53%), Gaps = 18/222 (8%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE-----FENEVRVLLKMQHRNLVQL 429
+G G +G VYKGR + G+ +A+KK+ ++ +EE E+ +L ++QH N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI---RLESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
+QE L++E+L + L K+L K +D + + + +G+L+ H
Sbjct: 65 QDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR--- 120
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL 549
R++HRD+K N+L+D++ K++DFGLA+ F R TH++ T Y APE +
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLLGSPR 178
Query: 550 -SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL 590
S D++S G + E+ + + + ++E +L ++ R L
Sbjct: 179 YSTPVDIWSIGTIFAEMATKKPLF--HGDSEIDQLFRIFRIL 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 37/216 (17%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN---EVRVLLKMQHR--NLVQL 429
+G G G VYK R + G +AVK++ KEE + ++ V+LK H +V+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLK-SHDCPYIVKC 79
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRL--NIIMGVARGLLYLHRDS 487
+G + + + + E L + LDK L + + I P+ + + + + + L YL
Sbjct: 80 YGYFITDSDVFICME-LMSTCLDK-LLKRIQGPI---PEDILGKMTVAIVKALHYLKEKH 134
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE----- 542
+IHRD+K SNILLD K+ DFG++ D +++ R+ AG YMAPE
Sbjct: 135 --GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS---AGCAAYMAPERIDPP 189
Query: 543 -----YAIRGFLSVKSDVFSFGVLLLEIISGRKNYD 573
Y IR +DV+S G+ L+E+ +G+ Y
Sbjct: 190 DPNPKYDIR------ADVWSLGISLVELATGQFPYK 219
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 71/270 (26%), Positives = 125/270 (46%), Gaps = 28/270 (10%)
Query: 376 LGRGGFG--TVYKGRLQDGREIAVKK--LATNSMQGKEEFENEVRVLLKMQHRNLVQLFG 431
LG+G FG T+Y+ R +D + K+ L S + + + NE+ +L +QH N++ +
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 432 CCVQERERILVYEYLPNKSL-DKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLR 490
+ + ++ EY +L DK + + K + + L + + + Y+H+ +L
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIV--RQKGQLFEEEMVLWYLFQIVSAVSYIHKAGIL- 123
Query: 491 IIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLS 550
HRDIK NI L K+ DFG++K+ E S T + GT YM+PE +
Sbjct: 124 --HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKYN 179
Query: 551 VKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEE 610
KSD+++ G +L E+++ ++ +D A N L L ++ + + Y E
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFD----ATN--PLNLVVKIVQGNYTPVV-----SVYSSE 228
Query: 611 IALRFMQIALLCTEDFIEDRPTMSATLSML 640
L + +LL + E RPT L
Sbjct: 229 --LISLVHSLLQQDP--EKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 78/250 (31%), Positives = 115/250 (46%), Gaps = 37/250 (14%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREI--AVKKLAT-NSMQGKEEFENEVRVLLKM-Q 422
++ ++++G G FG V + ++ DG ++ A+K L S +F E+ VL K+
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 423 HRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSK--------------SAILDWPK 468
H N++ L G C + EY P +L FL KS+ ++ L +
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 469 RLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528
L VA G+ YL S + IHRD+ A N+L+ + KI+DFGL SR
Sbjct: 121 LLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGL--------SRGE 169
Query: 529 THQIAGTFG-----YMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQE 582
+ T G +MA E + KSDV+SFGVLL EI+S G Y AE E
Sbjct: 170 EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229
Query: 583 LLKLARRLEE 592
L R+E+
Sbjct: 230 KLPQGYRMEK 239
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 68/230 (29%), Positives = 115/230 (50%), Gaps = 14/230 (6%)
Query: 370 FSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ---GKEEFENEVRVLLKMQHRN 425
F +LG+GGFG V +++ G+ A KKL ++ G+ NE ++L K+ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+V L + ++ + + L N KF A + + + + GL LH+
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS-RHRTHQIAGTFGYMAPEYA 544
+ RI++RD+K NILLD +ISD GLA + Q+ + R GT GYMAPE
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV----GTVGYMAPEVV 173
Query: 545 IRGFLSVKSDVFSFGVLLLEIISGRKNY-DRQLEAENQELLKLARRLEEE 593
+ D ++ G LL E+I+G+ + R+ + + +E+ +L + ++EE
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEE 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 66/210 (31%), Positives = 105/210 (50%), Gaps = 15/210 (7%)
Query: 369 NFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLATN--SMQGKEE---FENEVRVLLKMQ 422
N+ +LG+G FG VY D GRE+AVK++ + S + +E E E+++L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 423 HRNLVQLFGCCVQERERIL--VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGL 480
H +VQ +GC ER L E++P S+ L KS A+ + R + G+
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTR-KYTRQILEGV 119
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE-QSRHRTHQIAGTFGYM 539
YLH + I+HRDIK +NIL D K+ DFG +K S + GT +M
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176
Query: 540 APEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
+PE K+D++S G ++E+++ +
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 64/225 (28%), Positives = 111/225 (49%), Gaps = 27/225 (12%)
Query: 376 LGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCV 434
LG G FG VYK + ++ G A K + T S + E++ E+ +L H +V+L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 435 QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHR 494
+ + ++ E+ P ++D + + + L P+ I + L YLH ++IIHR
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQYLHS---MKIIHR 134
Query: 495 DIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLS---- 550
D+KA N+LL K++DFG++ + ++ R GT +MAPE + +
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPY 192
Query: 551 -VKSDVFSFGVLLLEIISGRKNYDRQLEAENQE------LLKLAR 588
K+D++S G+ L+E+ Q+E + E LLK+A+
Sbjct: 193 DYKADIWSLGITLIEMA--------QIEPPHHELNPMRVLLKIAK 229
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 15/210 (7%)
Query: 369 NFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLA--TNSMQGKEE---FENEVRVLLKMQ 422
N+ +LG+G FG VY D GRE+A K++ S + +E E E+++L +Q
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 423 HRNLVQLFGCCVQERERILV--YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGL 480
H +VQ +GC E+ L EY+P S+ L K+ A+ + R + G+
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTR-KYTRQILEGM 119
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE-QSRHRTHQIAGTFGYM 539
YLH + I+HRDIK +NIL D K+ DFG +K S + GT +M
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176
Query: 540 APEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
+PE K+DV+S G ++E+++ +
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFE---NEVRVLLKMQH 423
+++ +G G +G VYK R + G +A+K + ++ ++FE E+ +L + +H
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRH 59
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR----G 479
N+V FG ++ + +V EY SL + P I V R G
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIY------QVTRGPLSELQIAYVCRETLKG 113
Query: 480 LLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYM 539
L YLH IHRDIK +NILL K++DFG++ ++ ++ GT +M
Sbjct: 114 LAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWM 168
Query: 540 APEYA---IRGFLSVKSDVFSFGVLLLE 564
APE A +G K D+++ G+ +E
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 66/208 (31%), Positives = 105/208 (50%), Gaps = 15/208 (7%)
Query: 369 NFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLA--TNSMQGKEE---FENEVRVLLKMQ 422
N+ +LGRG FG VY D GRE+AVK++ +S + +E E E+++L ++
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 423 HRNLVQLFGCCVQERERIL--VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGL 480
H +VQ +GC E+ L EY+P S+ L K+ A+ + R + +G+
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTR-RYTRQILQGV 119
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD-EQSRHRTHQIAGTFGYM 539
YLH + I+HRDIK +NIL D K+ DFG +K S + GT +M
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 540 APEYAIRGFLSVKSDVFSFGVLLLEIIS 567
+PE K+DV+S ++E+++
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 59/232 (25%), Positives = 112/232 (48%), Gaps = 20/232 (8%)
Query: 369 NFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHR 424
NF + +GRG F VY+ L D + +A+KK+ M + +++ E+ +L ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDKFL--FDKSKSAILDWPKRL--NIIMGVARGL 480
N+++ +++ E +V E L + + F K K I P+R + + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLI---PERTVWKYFVQLCSAV 119
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMA 540
++H R++HRDIK +N+ + K+ D GL + F + + H + GT YM+
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMS 174
Query: 541 PEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEE 592
PE + KSD++S G LL E+ + + + + L L +++E+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLFSLCQKIEQ 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 60/203 (29%), Positives = 89/203 (43%), Gaps = 16/203 (7%)
Query: 376 LGRGGFGTVYKGRLQDGREIA---VKKL-ATNSMQGKEEFENEVRVLLKMQHRNLVQLFG 431
+G G FG V G G A VK+L A+ + + F EV+ ++ H N++Q G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 432 CCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMG--VARGLLYLHRDSVL 489
C++ +LV E+ P L +L K + M VA GLL+LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---A 119
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYA-IRG- 547
IH D+ N L + KI D+GLA + E A ++APE IRG
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 548 -FLSVK----SDVFSFGVLLLEI 565
L S+++S GV + E+
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 68/232 (29%), Positives = 102/232 (43%), Gaps = 21/232 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGR----EIAVKKLATNSMQG-KEEFENEVRVLLKMQ 422
++ + +G G FG VY+G +AVK + +E+F E ++ +
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 423 HRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLY 482
H ++V+L G + I V E P L +L S LD + ++ L Y
Sbjct: 66 HPHIVKLIGVITENPVWI-VMELAPLGELRSYLQVNKYS--LDLASLILYSYQLSTALAY 122
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
L R +HRDI A N+L+ K+ DFGL++ DE S ++ + +MAPE
Sbjct: 123 LES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE-SYYKASKGKLPIKWMAPE 178
Query: 543 YA-IRGFLSVKSDVFSFGVLLLEIIS-------GRKNYDRQLEAENQELLKL 586
R F S SDV+ FGV + EI+ G KN D EN E L +
Sbjct: 179 SINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPM 229
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 35/211 (16%)
Query: 374 NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQG-KEEFENEVRVLLKMQHRNLVQLFG 431
N +G G GTVYK + GR A+K + N + + E+ +L + H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 432 CCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRI 491
E ++ E++ SL+ + I D ++ + G+ YLHR I
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEG-------THIADEQFLADVARQILSGIAYLHRR---HI 189
Query: 492 IHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE--------- 542
+HRDIK SN+L++ KI+DFG++++ Q+ + GT YM+PE
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRIL--AQTMDPCNSSVGTIAYMSPERINTDLNHG 247
Query: 543 ----YAIRGFLSVKSDVFSFGVLLLEIISGR 569
YA D++S GV +LE GR
Sbjct: 248 AYDGYA--------GDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-16
Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQG--KEEFENEVRVLLKMQHRN 425
D+F + LG G G V K + + I +KL ++ + + E++VL +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRL--NIIMGVARGLLYL 483
+V +G + E + E++ SLD+ L + + P+ + + + V RGL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRI-----PEEILGKVSIAVLRGLAYL 119
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEY 543
+I+HRD+K SNIL++ + + K+ DFG++ D + + GT YM+PE
Sbjct: 120 REKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPER 173
Query: 544 AIRGFLSVKSDVFSFGVLLLEIISGR 569
SV+SD++S G+ L+E+ GR
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 80/243 (32%), Positives = 113/243 (46%), Gaps = 35/243 (14%)
Query: 374 NMLGRGGFGTVYKGRLQ-DGREI--AVKKLAT-NSMQGKEEFENEVRVLLKM-QHRNLVQ 428
+++G G FG V K R++ DG + A+K++ S +F E+ VL K+ H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 429 LFGCCVQERERILVYEYLPNKSLDKFLF-------------DKSKSAILDWPKRLNIIMG 475
L G C L EY P+ +L FL S ++ L + L+
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 476 VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGT 535
VARG+ YL S + IHRD+ A NIL+ KI+DFGL SR + + T
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL--------SRGQEVYVKKT 169
Query: 536 FG-----YMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARR 589
G +MA E + SDV+S+GVLL EI+S G Y AE E L R
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 229
Query: 590 LEE 592
LE+
Sbjct: 230 LEK 232
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 376 LGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGK-EEFENEVRVLLKMQHRNLVQLFGCC 433
LG+G +G+VYK + G +A+K++ + K + E+ +L K +V +G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 434 VQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIH 493
E + EY+ SLDK + + I V +GL +L + IIH
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIH 126
Query: 494 RDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEY------AIRG 547
RD+K +N+L++ + K+ DFG++ S +T+ G YMAPE
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNL--VASLAKTN--IGCQSYMAPERIKSGGPNQNP 182
Query: 548 FLSVKSDVFSFGVLLLEIISGRKNY 572
+V+SDV+S G+ +LE+ GR Y
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 3e-16
Identities = 71/218 (32%), Positives = 100/218 (45%), Gaps = 41/218 (18%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNS---MQGKEEFENEVRVLLKMQH 423
D+F LG G FG V R + + A+K L+ ++ E NE R+L ++H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKF-LFDKSKSAILDWPKRLNIIMGVAR---- 478
LV L+G + LV EY+P L F KS R VAR
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGEL--FSHLRKS--------GRFPE--PVARFYAA 108
Query: 479 ----GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAG 534
L YLH L I++RD+K N+LLD KI+DFG AK RT+ + G
Sbjct: 109 QVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCG 160
Query: 535 TFGYMAPEYAIRGFLSV---KS-DVFSFGVLLLEIISG 568
T Y+APE LS K+ D ++ G+L+ E+++G
Sbjct: 161 TPEYLAPEI----ILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 19/216 (8%)
Query: 375 MLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFE---NEVRVL-LKMQHRNLVQL 429
+LG+G FG V L+ E+ A+K L + + ++ + E R+L L +H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 430 FGCCVQERERIL-VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488
CC Q ++R+ V EY+ L +F +S D P+ V L++LHR V
Sbjct: 62 H-CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGV 117
Query: 489 LRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGF 548
I+RD+K NILLD + K++DFG+ K + T GT Y+APE
Sbjct: 118 ---IYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELE 172
Query: 549 LSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELL 584
D ++ GVL+ E+++G+ + EA+N++ L
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPF----EADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 68/250 (27%), Positives = 119/250 (47%), Gaps = 29/250 (11%)
Query: 368 DNFSTKNMLGRGGFGTVY--------KGRLQDGREIAVKKLATNSMQGK-EEFENEVRVL 418
D + LG G FG V K + ++ +AVK L ++ + + +E+ +
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME-M 73
Query: 419 LKM--QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFL-----------FDKSK--SAI 463
+KM +H+N++ L G C Q+ ++ EY +L ++L +D ++
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 464 LDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523
+ + ++ VARG+ YL + + IHRD+ A N+L+ KI+DFGLA+ ++
Sbjct: 134 MTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNI 190
Query: 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQE 582
+T +MAPE + +SDV+SFGVL+ EI + G Y E +
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250
Query: 583 LLKLARRLEE 592
LLK R+++
Sbjct: 251 LLKEGHRMDK 260
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 7e-16
Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 17/204 (8%)
Query: 376 LGRGGFGTVY----KGRLQDGRE--IAVKKL-ATNSMQGKEEFENEVRVLLKMQHRNLVQ 428
LG+G FG VY KG ++D E +A+K + SM+ + EF NE V+ + ++V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 429 LFGCCVQERERILVYEYLPNKSLDKFLF----DKSKSAILDWP---KRLNIIMGVARGLL 481
L G Q + +++ E + L +L + + + P K + + +A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP 541
YL+ + + +HRD+ A N ++ KI DFG+ + ++ + + +M+P
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 542 EYAIRGFLSVKSDVFSFGVLLLEI 565
E G + SDV+SFGV+L EI
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 60/205 (29%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 369 NFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFE-NEVRVLLKMQHRNL 426
NF LG G + TVYKGR + EI A+K++ ++ +G E+ ++ +++H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 427 VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD 486
V+L E + +LV+EY+ +K L K++ LD + + +G+ + H +
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 487 SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI- 545
R++HRD+K N+L++ + + K++DFGLA+ F + + T Y AP+ +
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLG 174
Query: 546 -RGFLSVKSDVFSFGVLLLEIISGR 569
R + S D++S G ++ E+I+GR
Sbjct: 175 SRTY-STSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 9e-16
Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 39/230 (16%)
Query: 373 KNMLGRGGFGTVYKGRLQDGRE-----------------IAVKKL-ATNSMQGKEEFENE 414
K LG G FG V+ + + ++ +AVK L + + +F E
Sbjct: 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKE 69
Query: 415 VRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKF-----LFDKSKSA------- 462
V++L +++ N+++L G CV E ++ EY+ N L++F L DK ++
Sbjct: 70 VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129
Query: 463 ----ILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518
+ + L++ + +A G+ YL S L +HRD+ N L+ + KI+DFG+++
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186
Query: 519 -LFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS 567
L+ + R + + +MA E + G + SDV++FGV L EI+
Sbjct: 187 NLYAGDYYRIQGRAVL-PIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 72/242 (29%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 376 LGRGGFGTVY--------KGRLQDGREIAVKKLATNSM-QGKEEFENEVRVLLKM--QHR 424
LG G FG V K + +AVK L ++ + + +E+ ++KM +H+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEME-MMKMIGKHK 78
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDKFL-----------FDKSK--SAILDWPKRLN 471
N++ L G C Q+ ++ EY +L ++L FD K L + ++
Sbjct: 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 472 IIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQ 531
VARG+ YL + + IHRD+ A N+L+ KI+DFGLA+ H+ +T
Sbjct: 139 CAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 532 IAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRL 590
+MAPE + +SDV+SFGVLL EI + G Y E +LLK R+
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRM 255
Query: 591 EE 592
++
Sbjct: 256 DK 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 47/237 (19%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEE---FENEVRVLLKMQH 423
D+F ++GRG FG V+ R +D ++ A+K L + M + + E +L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 424 RNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILD--WPKRL--NIIMGVAR 478
+V+L+ Q+ E + LV EY+P L L + + + +++ +
Sbjct: 61 PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEETARFYIAELVLALD- 115
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD---------------- 522
+H+ L IHRDIK NIL+D K++DFGL K +
Sbjct: 116 ---SVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 523 -----------EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISG 568
+Q R R + GT Y+APE ++ D +S GV+L E++ G
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 73/302 (24%), Positives = 143/302 (47%), Gaps = 44/302 (14%)
Query: 376 LGRGGFGTVYKGR-LQDG-REIAVKKLATNSMQGKEEFE-----NEVRVLLKMQ---HRN 425
+G G +G V+K R L++G R +A+K++ +Q EE EV VL ++ H N
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 426 LVQLFGCCV-----QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGL 480
+V+LF C +E + LV+E++ ++ L +L DK + +++ + RGL
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGL 123
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMA 540
+LH R++HRD+K NIL+ + K++DFGLA+++ + + + T Y A
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRA 177
Query: 541 PEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600
PE ++ + D++S G + E+ + L + + +++ G++++++
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFRRKP------------LFRGSSDVDQLGKILDVI 225
Query: 601 DV-RIGTYPEEIAL---RFMQIALLCTEDFIEDRPTM--SATLSMLSNSSVPIPSVTESP 654
+ +P ++AL F + E F+ D + L L+ + S +
Sbjct: 226 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285
Query: 655 DH 656
H
Sbjct: 286 SH 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 1e-15
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 370 FSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQ 428
F ++G G +G VYKGR ++A K+ + +EE + E+ +L K HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 429 LFGCCVQER------ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLY 482
+G +++ + LV E+ S+ L +K L I + RGL +
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
LH+ ++IHRDIK N+LL + K+ DFG++ +++ R + GT +MAPE
Sbjct: 127 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPE 181
Query: 543 YAI-----RGFLSVKSDVFSFGVLLLEIISG 568
KSD++S G+ +E+ G
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 71/217 (32%), Positives = 105/217 (48%), Gaps = 27/217 (12%)
Query: 375 MLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFEN---EVRVL-LKMQHRNLVQL 429
+LG+G FG V L+ E A+K L + + ++ E E RVL L +H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 430 FGCCVQERERIL-VYEYLPNKSL-----DKFLFDKSKSAILDWPKRLNIIMGVARGLLYL 483
F C Q +E + V EYL L FD++++ II G L +L
Sbjct: 62 F-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYA----AEIICG----LQFL 112
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEY 543
H+ II+RD+K N+LLD KI+DFG+ K + + GT Y+APE
Sbjct: 113 HKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKE--NMNGEGKASTFCGTPDYIAPE- 166
Query: 544 AIRGFLSVKS-DVFSFGVLLLEIISGRKNYDRQLEAE 579
++G +S D +SFGVLL E++ G+ + + E E
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 375 MLGRGGFGTVYKGRLQDGRE------IAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQ 428
+LG+G FG V+ R G + + V K AT ++ + + E +L ++ H +V+
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 429 LFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488
L E + L+ ++L L L SK + + +A L +LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHS--- 116
Query: 489 LRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGF 548
L II+RD+K NILLD + K++DFGL+K D + + + GT YMAPE R
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRG 174
Query: 549 LSVKSDVFSFGVLLLEIISG 568
+ +D +SFGVL+ E+++G
Sbjct: 175 HTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 64/226 (28%), Positives = 108/226 (47%), Gaps = 29/226 (12%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKK-LATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCV 434
LG G FG VYK + ++ +A K + T S + E++ E+ +L H N+V+L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 435 QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHR 494
E ++ E+ ++D + + + L P+ + L YLH + +IIHR
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN---KIIHR 127
Query: 495 DIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI------RGF 548
D+KA NIL K++DFG++ + ++ R GT +MAPE + R +
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 549 LSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQE------LLKLAR 588
K+DV+S G+ L+E+ Q+E + E LLK+A+
Sbjct: 186 -DYKADVWSLGITLIEMA--------QIEPPHHELNPMRVLLKIAK 222
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 69/242 (28%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 376 LGRGGFGTVY--------KGRLQDGREIAVKKLATNSMQGK-EEFENEVRVLLKM--QHR 424
LG G FG V K + ++AVK L +++ + + +E+ ++KM +H+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME-MMKMIGKHK 84
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAI-------------LDWPKRLN 471
N++ L G C Q+ ++ EY +L ++L + + L + ++
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 472 IIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQ 531
VARG+ YL + + IHRD+ A N+L+ KI+DFGLA+ H +T
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 532 IAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRL 590
+MAPE + +SDV+SFGVLL EI + G Y E +LLK R+
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM 261
Query: 591 EE 592
++
Sbjct: 262 DK 263
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 12/222 (5%)
Query: 376 LGRGGFGTVYKGRLQD-GREIAVKKLATNSMQ---GKEEFENEVRVLLKMQHRNLVQLFG 431
LG+GGFG V ++++ G+ A KKL ++ G++ E +L K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 432 CCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRI 491
+ LV + L +++ + L+ + ++ + G+L+LH + I
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILHLHS---MDI 116
Query: 492 IHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSV 551
++RD+K N+LLD Q ++SD GLA D ++ Q AGT GYMAPE S
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYSY 173
Query: 552 KSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEE 593
D F+ G + E+++GR + E +E LK R LE+E
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK-RRTLEDE 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 25/203 (12%)
Query: 376 LGRGGFGT--VYKGRLQDGREIAVKKLATNSMQGKE--EFENEVRVLLKMQHRNLVQLFG 431
+G G FG + K + +DG++ +K++ + M KE E EV VL M+H N+VQ
Sbjct: 8 IGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 432 CCVQERERILVYEYLPNKSLDK-------FLFDKSKSAILDWPKRLNIIMGVARGLLYLH 484
+ +V +Y L K LF + ILDW + + L ++H
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLF--PEDQILDW------FVQICLALKHVH 118
Query: 485 RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYA 544
+I+HRDIK+ NI L K+ DFG+A++ + RT GT Y++PE
Sbjct: 119 DR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEIC 173
Query: 545 IRGFLSVKSDVFSFGVLLLEIIS 567
+ KSD+++ G +L E+ +
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 65/248 (26%), Positives = 115/248 (46%), Gaps = 25/248 (10%)
Query: 370 FSTKNMLGRGGFGTVYKGRLQ----DGREIAVKKLAT--NSMQGKEEFENEVRVLLKMQH 423
F+ MLG+G FG+V + +L+ +++AVK L S EEF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 424 RNLVQLFGCCVQERER------ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNI----- 472
N+++L G ++ R + +++ ++ + L FL S I + P L +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL---MSRIGEEPFTLPLQTLVR 117
Query: 473 -IMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQ 531
++ +A G+ YL S IHRD+ A N +L+ M ++DFGL+K + +
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 532 IAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRL 590
++A E + SDV++FGV + EI++ G+ Y +E L RL
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL 234
Query: 591 EEEGRLME 598
++ +E
Sbjct: 235 KQPPDCLE 242
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 369 NFSTKNMLGRGGFGTVYKGRLQDGRE--IAVKKL-ATNSMQGKEEFE---------NEVR 416
++ LG G FG VYK R ++ + +A+K++ N GK++ E +EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 417 VLLK-MQHRNLVQLFGCCVQERERILVYEYLPNKSL-DKFLFDKSKSAILDWPKRLNIIM 474
++ + ++H N+V+ + ++ +V + + L + F K K + NI +
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAG 534
+ L YLH++ RI+HRD+ +NI+L K I+DFGLAK +Q + + G
Sbjct: 121 QMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVG 175
Query: 535 TFGYMAPEYAIRGFLSVKSDVFSFGVLLLEI 565
T Y PE K+DV++FG +L ++
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 62/201 (30%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 376 LGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFEN---EVRVLL---KMQHRNLVQ 428
LGRG FG V + E+ A+K L + ++E E+ E R+ +H LV
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 429 LFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
LF C Q + + V EY L + S P+ + V GL YLH +
Sbjct: 67 LF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSE----PRAVFYAACVVLGLQYLHEN- 120
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG 547
+I++RD+K N+LLD + KI+DFGL K RT GT ++APE
Sbjct: 121 --KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAPEVLTET 176
Query: 548 FLSVKSDVFSFGVLLLEIISG 568
+ D + GVL+ E++ G
Sbjct: 177 SYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 370 FSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQ 428
F ++G G +G VYKGR ++A K+ + +EE + E+ +L K HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 429 LFGCCV------QERERILVYEYLPNKSLDKFLFDKSKSAIL--DWPKRLNIIMGVARGL 480
+G + + + LV E+ S+ L +K L DW I + RGL
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAY--ICREILRGL 134
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMA 540
+LH ++IHRDIK N+LL + K+ DFG++ R T GT +MA
Sbjct: 135 AHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMA 189
Query: 541 PEYAI-----RGFLSVKSDVFSFGVLLLEIISG 568
PE +SD++S G+ +E+ G
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 375 MLGRGGFGTVYKGRLQD-GREIAVKKL---ATNSMQGKEEFENEVRVLLKMQHRNLVQLF 430
++G G +G V K + ++ G+ +A+KK + M K E+R+L +++H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLI 66
Query: 431 GCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLR 490
+++ LV+E++ + LD +K + LD + + + RG+ + H +
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDL--EKYPNG-LDESRVRKYLFQILRGIEFCHSHN--- 120
Query: 491 IIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLS 550
IIHRDIK NIL+ K+ DFG A+ + T +A T Y APE +
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-TDYVA-TRWYRAPELLVGDTKY 178
Query: 551 VKS-DVFSFGVLLLEIISG 568
++ D+++ G L+ E+++G
Sbjct: 179 GRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 15/229 (6%)
Query: 370 FSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ---GKEEFENEVRVLLKMQHRN 425
F +LG+GGFG V +++ G+ A KKL ++ G+ NE R+L K+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+V L + ++ + + + N KF + D + + + GL L R
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLA-KLFHDEQSRHRTHQIAGTFGYMAPEYA 544
+ RI++RD+K NILLD + +ISD GLA ++ E R R GT GYMAPE
Sbjct: 121 E---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV----GTVGYMAPEVI 173
Query: 545 IRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEE 593
+ D + G L+ E+I G+ + ++ E +E ++ RR++E+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE--EVDRRVKED 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 60/221 (27%), Positives = 106/221 (47%), Gaps = 33/221 (14%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDG-----REIAVKKLATNSMQGK-EEFENEVRVLLKM 421
D + ++L G FG ++ G L D E+ VK + ++ + + E +L +
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 422 QHRNLVQLFGCCVQERERILVYEYLPNKS-LDKFLFDKSKSAILDWPKRLNII----MG- 475
H+N++ + C+++ E V N L FL + + + P+ L+ M
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL-QQCRLGEANNPQALSTQQLVHMAI 124
Query: 476 -VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK-LF----H---DEQSR 526
+A G+ YLH+ +IH+DI A N ++D +++ KI+D L++ LF H D ++R
Sbjct: 125 QIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181
Query: 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS 567
+MA E + S SDV+SFGVLL E+++
Sbjct: 182 --------PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 72/284 (25%)
Query: 376 LGRGGFGTVYKGRLQD-GREIAVKKLA---TNSMQGKEEFENEVRVLLKMQHRNLVQLFG 431
+G G +G V GR++A+KKL+ +++ K + E+R+L M H N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLD 81
Query: 432 CCVQERERILVYEYLPNKSLDKF--------LFDKSKSAILDWPKRLN------IIMGVA 477
+ P SL+ F L + I+ ++L+ ++ +
Sbjct: 82 V------------FTPASSLEDFQDVYLVTHLMGADLNNIVK-CQKLSDDHIQFLVYQIL 128
Query: 478 RGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFG 537
RGL Y+H S IIHRD+K SNI ++ + KI DFGLA+ DE + + T
Sbjct: 129 RGLKYIH--SA-GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY-----VATRW 180
Query: 538 YMAPEYAI-RGFLSVKSDVFSFGVLLLEIISGR-----KNYDRQLEAENQELLKLARRLE 591
Y APE + + D++S G ++ E+++G+ ++ QL+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLK-------------- 226
Query: 592 EEGRLMELVDVRIGTYPEEIALRFMQ-IALLCTEDFIEDRPTMS 634
R+M LV GT EE +Q I+ ++I+ P M
Sbjct: 227 ---RIMNLV----GTPDEE----LLQKISSESARNYIQSLPQMP 259
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQG--KEEFENEVRVLLKMQHRN 425
D+F + LG G G V+K + I +KL ++ + + E++VL +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRL--NIIMGVARGLLYL 483
+V +G + E + E++ SLD+ L + P+++ + + V +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI-----PEQILGKVSIAVIKGLTYL 119
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEY 543
+I+HRD+K SNIL++ + + K+ DFG++ D + + GT YM+PE
Sbjct: 120 REKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPER 173
Query: 544 AIRGFLSVKSDVFSFGVLLLEIISGR 569
SV+SD++S G+ L+E+ GR
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 59/169 (34%), Positives = 79/169 (46%), Gaps = 20/169 (11%)
Query: 476 VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGT 535
VARG+ +L + + IHRD+ A NILL KI DFGLA+ + + R
Sbjct: 182 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 536 FGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNY-DRQLEAENQELLKLARRLEEE 593
+MAPE + +SDV+SFGVLL EI S G Y Q++ E RRL+E
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEG 292
Query: 594 GRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
R+ PE I L C + EDRPT S + +L +
Sbjct: 293 TRMRA---------PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGD 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 78/290 (26%), Positives = 130/290 (44%), Gaps = 41/290 (14%)
Query: 368 DNFSTK--NMLGRGGFGTVYKGRLQ--DGRE--IAVKKL-ATNSMQGKEEFENEVRVLLK 420
DN S K +LG G FG + +G L+ RE +A+ L A S + + F E L +
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 421 MQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGL 480
H N+V+L G + ++V EY+ N +LD FL + L + + ++ G+A G+
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGM 120
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFG--- 537
YL S + +H+ + A +L++ + KIS F + ++ I T
Sbjct: 121 KYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ-------EDKSEAIYTTMSGKS 170
Query: 538 ---YMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEE 593
+ APE S SDV+SFG+++ E++S G + Y + Q+++K +E+
Sbjct: 171 PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY---WDMSGQDVIK---AVEDG 224
Query: 594 GRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643
RL P Q+ L C + +RP S S+LS
Sbjct: 225 FRL---------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 376 LGRGGFGTVYKGR--LQDGREIAVKKLATNSMQGKE-EFENEVRVLLKMQHRNLVQLFGC 432
LG G + TVYKGR L D +A+K++ +G EV +L ++H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 433 CVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRII 492
E+ LV+EYL +K L ++L D S + K + + RGL Y HR VL
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCHRRKVL--- 126
Query: 493 HRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGF-LSV 551
HRD+K N+L++ + + K++DFGLA+ + + T Y P+ + S
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYST 184
Query: 552 KSDVFSFGVLLLEIISGR 569
+ D++ G + E+ +GR
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 45/148 (30%), Positives = 86/148 (58%), Gaps = 9/148 (6%)
Query: 376 LGRGGFGTVYKGRLQDGREI-AVKKLA-TNSMQGKEEFE-NEVRVLLKMQHRNLVQLFGC 432
+G G +GTV+K + ++ EI A+K++ + +G E+ +L +++H+N+V+L+
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 433 CVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRII 492
+++ LV+EY ++ L K+ FD I D + + + +GL + H +VL
Sbjct: 68 LHSDKKLTLVFEYC-DQDLKKY-FDSCNGDI-DPEIVKSFMFQLLKGLAFCHSHNVL--- 121
Query: 493 HRDIKASNILLDHQMKPKISDFGLAKLF 520
HRD+K N+L++ + K++DFGLA+ F
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 58/242 (23%), Positives = 102/242 (42%), Gaps = 72/242 (29%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN---------EVRVLLKMQHRN 425
+G G +G V + GR++A+KK++ F++ E+++L ++H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKF--------LFDKSKSAILDWPKRLN------ 471
++ L + L S + F L + ++ P+ L
Sbjct: 61 IIGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQY 107
Query: 472 IIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF--HDEQSRHRT 529
+ + RGL YLH + +IHRD+K SNIL++ KI DFGLA+ +++ T
Sbjct: 108 FLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 530 HQIAGTFGYMAPE---------YAIRGFLSVKSDVFSFGVLLLEIISGR-----KNYDRQ 575
+ T Y APE AI D++S G + E+++ + ++Y Q
Sbjct: 165 EYVV-TRWYRAPELLLSSSRYTKAI--------DIWSVGCIFAELLTRKPLFPGRDYIDQ 215
Query: 576 LE 577
L
Sbjct: 216 LN 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 56/201 (27%), Positives = 101/201 (50%), Gaps = 19/201 (9%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN--EVRVLLKMQ---HRNLVQL 429
+G G +GTVYK R G +A+K + + + EV +L +++ H N+V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 430 FGCCV-----QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLH 484
C +E + LV+E++ ++ L +L DK L +++ RGL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 485 RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYA 544
+ I+HRD+K NIL+ + K++DFGLA+++ + + + T Y APE
Sbjct: 126 AN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVL 179
Query: 545 IRGFLSVKSDVFSFGVLLLEI 565
++ + D++S G + E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 69/235 (29%), Positives = 110/235 (46%), Gaps = 27/235 (11%)
Query: 376 LGRGGFGTVYKGRLQDG---REIAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQLFG 431
+G G FG V G + G ++ VK+L + S+Q + +F E + +QH NL+Q G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 432 CCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMG--VARGLLYLHRDSVL 489
C + +LV E+ P L +L K+ ++ M +A GLL+LH+++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYA--IRG 547
IH D+ N LL + KI D+GL+ + E Q+ ++APE + G
Sbjct: 121 -FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 548 FLSV-----KSDVFSFGVLLLEIIS-GRKNY----DRQLEA----ENQELLKLAR 588
L V +S+V+S GV + E+ G + Y D Q+ E Q LKL +
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ--LKLPK 232
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 66/217 (30%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 369 NFSTKNMLGRGGFGTVY----KGRLQDGREIAVKKLATNSMQGKE---EFENEVRVLLKM 421
NF +LG G +G V+ G G+ A+K L ++ K E R +L+
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 422 QHRN--LVQLFGCCVQERERILVYEYLPNKSLDKFL-----FDKSKSAILDWPKRLNIIM 474
R LV L + + L+ +Y+ L L F +S+ + I
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRV--------YIA 112
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAG 534
+ L +LH+ L II+RDIK NILLD + ++DFGL+K F E R + G
Sbjct: 113 EIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-EEERAYSFCG 168
Query: 535 TFGYMAPEYAIRGFLSVKSDV---FSFGVLLLEIISG 568
T YMAPE IRG +S GVL E+++G
Sbjct: 169 TIEYMAPE-VIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 376 LGRGGFGTVY---------KGRLQDGREIAVKKLATN-SMQGKEEFENEVRVLLKMQHRN 425
LG+G FGTVY + RL+ +EI V +L N ++Q +E ++L K+ H
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE----AQLLSKLDHPA 63
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLD-KFLFDKSKSAILDWPKRLNIIMGVARGLLYLH 484
+V+ ++ ++ EY + LD K K L + + + G+ Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 485 RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYA 544
RI+HRD+KA NI L + + KI DFG+++L T GT YM+PE
Sbjct: 124 ---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEAL 177
Query: 545 IRGFLSVKSDVFSFGVLLLEI 565
KSD++S G +L E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 56/183 (30%), Positives = 93/183 (50%), Gaps = 25/183 (13%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFE----NEVRVLLKMQHRNLVQLF 430
+G+G FG V+K R + + +A+KK+ KE F E+++L ++H N+V L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLME--NEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 431 GCC-----VQERER---ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLY 482
C R + LV+E+ + L L +K+ L K+ ++ + GL Y
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKK--VMKMLLNGLYY 134
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH--DEQSRHR-THQIAGTFGYM 539
+HR+ +L HRD+KA+NIL+ K++DFGLA+ F +R T+++ T Y
Sbjct: 135 IHRNKIL---HRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWYR 190
Query: 540 APE 542
PE
Sbjct: 191 PPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 68/230 (29%), Positives = 111/230 (48%), Gaps = 14/230 (6%)
Query: 370 FSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ---GKEEFENEVRVLLKMQHRN 425
F +LG+GGFG V +++ G+ A KKL ++ G+ NE ++L K+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+V L + ++ + + L N KF + D + + + GL LHR
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLA-KLFHDEQSRHRTHQIAGTFGYMAPEYA 544
+ RI++RD+K NILLD +ISD GLA ++ E R R GT GYMAPE
Sbjct: 121 E---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV----GTVGYMAPEVV 173
Query: 545 IRGFLSVKSDVFSFGVLLLEIISGRKNY-DRQLEAENQELLKLARRLEEE 593
+ D + G L+ E+I G+ + R+ + + +E+ + + +EE
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEE 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 66/219 (30%), Positives = 106/219 (48%), Gaps = 19/219 (8%)
Query: 369 NFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFE---NEVRVL-LKMQH 423
+F+ +LG+G FG V + E+ A+K L + + ++ E E RVL L +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 424 RNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLY 482
L QL C Q +R+ V EY+ L ++ + P + +A GL +
Sbjct: 61 PFLTQLH-SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIGLFF 116
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK--LFHDEQSRHRTHQIAGTFGYMA 540
LH II+RD+K N++LD + KI+DFG+ K +F + +R GT Y+A
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR----TFCGTPDYIA 169
Query: 541 PEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE 579
PE D ++FGVLL E+++G+ +D + E E
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 72/288 (25%), Positives = 128/288 (44%), Gaps = 37/288 (12%)
Query: 376 LGRGGFGTVYKGRLQD------GREIAVKKL-ATNSMQGKEEFENEVRVLLKMQHRNLVQ 428
LG+G FG VY+G +D +AVK + + S++ + EF NE V+ ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 429 LFGCCVQERERILVYEYLPNKSLDKFLF----DKSKSAILDWPKRLNIIM---GVARGLL 481
L G + + ++V E + + L +L + + P +I +A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP 541
YL+ + +HRD+ A N ++ H KI DFG+ + ++ + + +MAP
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 542 EYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601
E G + SD++SFGV+L EI S + + L N+++LK
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL--SNEQVLKF--------------- 233
Query: 602 VRIGTY---PEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVP 646
V G Y P+ R + +C + + RPT +++L + P
Sbjct: 234 VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 63/235 (26%), Positives = 105/235 (44%), Gaps = 46/235 (19%)
Query: 368 DNFSTKNMLGRGGFGTVYKG-RLQDGREIAVKKLATNSMQGKEEFEN---------EVRV 417
+ + +G G +G V G ++A+KK+ FE+ E+++
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI--------SPFEHQTFCQRTLREIKI 56
Query: 418 LLKMQHRNLVQLFGCCVQE-------RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRL 470
L + +H N++ + + + +V E + L K + K+ L
Sbjct: 57 LRRFKHENIIGILD--IIRPPSFESFNDVYIVQELMET-DLYKLI----KTQHLSNDHIQ 109
Query: 471 NIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR-- 528
+ + RGL Y+H +VL HRD+K SN+LL+ KI DFGLA++ D + H
Sbjct: 110 YFLYQILRGLKYIHSANVL---HRDLKPSNLLLNTNCDLKICDFGLARI-ADPEHDHTGF 165
Query: 529 -THQIAGTFGYMAPEYAIRGFLSVKS-DVFSFGVLLLEIISGR-----KNYDRQL 576
T +A T Y APE + K+ D++S G +L E++S R K+Y QL
Sbjct: 166 LTEYVA-TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL 219
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 37/215 (17%)
Query: 376 LGRGGFGTVYKGRLQD---------GREIAV-KKLATNSMQGKEEFENEVRVLLKMQHRN 425
LG+G F +YKG L+ G+E++V K+ + + F ++ ++ H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
LV+L+G CV++ E I+V EY+ LD FL + + L W +L++ +A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 486 DSVLRIIHRDIKASNILL-----DHQMKP--KISDFGLAK--LFHDEQSRHRTHQIAGTF 536
+++H ++ NIL+ + P K+SD G+ L +E R +I
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE----RVERIP--- 169
Query: 537 GYMAPEYAIRG---FLSVKSDVFSFGVLLLEIISG 568
++APE IR L++ +D +SFG LLEI S
Sbjct: 170 -WIAPEC-IRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 15/218 (6%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFEN---EVRVLLKMQ 422
NF +LG+G FG V + E+ A+K L + + ++ E E RVL
Sbjct: 1 DFNFLM--VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 423 HRNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLL 481
+ C Q +R+ V EY+ L ++ + P+ + ++ GL
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLF 115
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP 541
+LHR II+RD+K N++LD + KI+DFG+ K + RT GT Y+AP
Sbjct: 116 FLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT--FCGTPDYIAP 170
Query: 542 EYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE 579
E D +++GVLL E+++G+ +D + E E
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 69/233 (29%), Positives = 107/233 (45%), Gaps = 29/233 (12%)
Query: 354 RSFLFNLDVLIAATDNFSTKNMLGRGGFGTVYK-GRLQDGREIAVKKLATNSMQGKEEFE 412
S + L+ L TD + +G+G +G VYK +DG AVK L S EE E
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIE 66
Query: 413 NEVRVLLKM-QHRNLVQLFGCCVQERERI-----LVYEYLPNKSLDKFLFDKSKSAILDW 466
E +L + H N+V+ +G + + + LV E S+ + + +L
Sbjct: 67 AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLIC 121
Query: 467 PKRLN------IIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520
+RL+ I+ G GL +LH + RIIHRD+K +NILL + K+ DFG++
Sbjct: 122 GQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178
Query: 521 HDEQSRHRTHQIAGTFGYMAPEY-----AIRGFLSVKSDVFSFGVLLLEIISG 568
+R R + GT +MAPE + DV+S G+ +E+ G
Sbjct: 179 --TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 75/270 (27%), Positives = 114/270 (42%), Gaps = 49/270 (18%)
Query: 373 KNMLGRGGFGTVYKGRLQDGRE------IAVKKLATNSMQGKEEFEN--EVRVLLKMQHR 424
+LG+GG+G V++ R G + + V K AT K+ E +L ++H
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSL-------DKFLFDKSKSAILDWPKRLNIIMGVA 477
+V L + L+ EYL L F+ D + + + I +
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE------ISLA-- 112
Query: 478 RGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFG 537
L +LH+ II+RD+K NILLD Q K++DFGL K E + TH GT
Sbjct: 113 --LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIE 165
Query: 538 YMAPEYAIRGFLSVKSDVFSFGVLLLEIISG---------RKNYDRQLEAENQELLKLAR 588
YMAPE +R D +S G L+ ++++G +K D+ L+ + L L
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK----LNLPP 221
Query: 589 RLEEEGR------LMELVDVRIGTYPEEIA 612
L E R L R+G P + A
Sbjct: 222 YLTPEARDLLKKLLKRNPSSRLGAGPGDAA 251
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 51/184 (27%), Positives = 90/184 (48%), Gaps = 25/184 (13%)
Query: 377 GRGGFGTVYKGRLQ---DGREIAVKKLATNSMQGKEEFEN-------EVRVLLKMQHRNL 426
GRG +G VYK + + DG+E A+KK + KE++ E+ +L +++H N+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGD----KEQYTGISQSACREIALLRELKHENV 64
Query: 427 VQLFGCCVQERERI--LVYEYLPNKSLDKFLFDKSKSAILDWPKRL-NIIMGVARGLLYL 483
V L ++ ++ L+++Y + F + + P + +++ + G+ YL
Sbjct: 65 VSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124
Query: 484 HRDSVLRIIHRDIKASNILL----DHQMKPKISDFGLAKLFHDE-QSRHRTHQIAGTFGY 538
H + VL HRD+K +NIL+ + KI D GLA+LF+ + + T Y
Sbjct: 125 HSNWVL---HRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181
Query: 539 MAPE 542
APE
Sbjct: 182 RAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 70/226 (30%), Positives = 110/226 (48%), Gaps = 50/226 (22%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFE----NEVRVLLKMQ 422
D + N + G +G VY+ R + G +A+KKL KE F E+ +LLK+Q
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE--KEGFPITSLREINILLKLQ 62
Query: 423 HRNLVQLFGCCVQE------RERI-LVYEYLPN--KSL-----DKFLFDKSKSAILDWPK 468
H N+V V+E ++I +V EY+ + KSL FL + K +
Sbjct: 63 HPNIVT-----VKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLM----- 112
Query: 469 RLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528
L ++ GVA +LH + +L HRD+K SN+LL+++ KI DFGLA+ + +
Sbjct: 113 -LQLLSGVA----HLHDNWIL---HRDLKTSNLLLNNRGILKICDFGLAREYGSP-LKPY 163
Query: 529 THQIAGTFGYMAPEYAIRGFLSVKS-----DVFSFGVLLLEIISGR 569
T Q+ T Y APE L K D++S G + E+++ +
Sbjct: 164 T-QLVVTLWYRAPEL----LLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 58/197 (29%), Positives = 88/197 (44%), Gaps = 19/197 (9%)
Query: 378 RGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFEN---EVRVLLKMQHR-NLVQLFGC 432
+G FG+VY + + G A+K L + M K + N E +++ + +L+
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 433 CVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRII 492
+ LV EYL L DW K I V G+ LH+ II
Sbjct: 66 FQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAK--QYIAEVVLGVEDLHQRG---II 119
Query: 493 HRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVK 552
HRDIK N+L+D K++DFGL++ + + + GT Y+APE I G K
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPE-TILGVGDDK 172
Query: 553 -SDVFSFGVLLLEIISG 568
SD +S G ++ E + G
Sbjct: 173 MSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 20/209 (9%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLA---TNSMQGKEEFENEVRVLLKMQ 422
T+ + +G G FG V R Q G+ +A+KK+ + + K + E+++L ++
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLR 67
Query: 423 HRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLY 482
H N++ L + E I L L + L S L+ + + RGL Y
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGTDLHRLL----TSRPLEKQFIQYFLYQILRGLKY 123
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
+H V +HRD+K SNIL++ KI DFGLA++ Q T ++ + Y APE
Sbjct: 124 VHSAGV---VHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRY-YRAPE 175
Query: 543 YAI--RGFLSVKSDVFSFGVLLLEIISGR 569
+ + + V+ D++S G + E++ G+
Sbjct: 176 IMLTWQKY-DVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 58/198 (29%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 376 LGRGGFGTVYKGR--LQDGREIAVKKLATNSMQGKE-EFENEVRVLLKMQHRNLVQLFGC 432
LG G + TV+KGR L + +A+K++ +G EV +L ++H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 433 CVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRII 492
++ LV+EYL +K L +++ D I+ + + RGL Y HR VL
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRRKVL--- 126
Query: 493 HRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI-RGFLSV 551
HRD+K N+L++ + + K++DFGLA+ ++ ++++ T Y P+ + S
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184
Query: 552 KSDVFSFGVLLLEIISGR 569
+ D++ G + E+ SGR
Sbjct: 185 QIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 17/214 (7%)
Query: 373 KNMLGRGGFGTV-YKGRLQDGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQL 429
+LG G GTV R+ DG AVK + M K + EV LL ++V+
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 430 FGCCVQERER--------ILVYEYLPNKSLDKFLFDKSKS--AILDWPKRLNIIMGVARG 479
++ R LV +Y L + + ++K+ + L I +
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI----QV 152
Query: 480 LLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYM 539
LL +H +IHRDIK++NILL K+ DFG +K++ S GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 540 APEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYD 573
APE R S K+D+FS GVLL E+++ ++ +D
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 68/246 (27%), Positives = 112/246 (45%), Gaps = 21/246 (8%)
Query: 370 FSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ---GKEEFENEVRVLLKMQHRN 425
F +LG+GGFG V +++ G+ A K+L ++ G+ NE ++L K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+V L + LV + L +++ + + L + GL LHR
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLEDLHR 120
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLA-KLFHDEQSRHRTHQIAGTFGYMAPEYA 544
++ ++RD+K NILLD +ISD GLA K+ E R R GT GYMAPE
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV----GTVGYMAPEVL 173
Query: 545 IRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604
++ D + G L+ E+I G+ + + E +R E + R++E +V
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK--------VKREEVDRRVLETEEVYS 225
Query: 605 GTYPEE 610
+ EE
Sbjct: 226 AKFSEE 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 66/240 (27%), Positives = 108/240 (45%), Gaps = 29/240 (12%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFE----NEVRVLLKMQ 422
D + +G G +G VYK R G+ +A+KK T +E E+ +L +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK--TRLEMDEEGIPPTALREISLLQMLS 58
Query: 423 HRN-LVQLFGCCVQERER-------ILVYEYLPNKSLDKFL--FDKSKSAILDWPKRLNI 472
+V+L V+ E LV+EYL + L KF+ + L +
Sbjct: 59 ESIYIVRLL--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 473 IMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ-MKPKISDFGLAKLFHDEQSRHRTHQ 531
+ + +G+ + H+ V +HRD+K N+L+D Q KI+D GL + F + TH+
Sbjct: 116 MYQLLKGVAHCHKHGV---MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY-THE 171
Query: 532 IAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL 590
I T Y APE + S D++S G + E+ RK ++E Q+LL + + L
Sbjct: 172 IV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS--RKQPLFPGDSELQQLLHIFKLL 228
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 69/235 (29%), Positives = 111/235 (47%), Gaps = 24/235 (10%)
Query: 369 NFSTKNMLGRGGFGTVYKGRLQDGRE------IAVKKLATNSMQGK--EEFENEVRVLLK 420
NF +LG G +G V+ R G + + V K AT + K E E +VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 421 M-QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMG-VAR 478
+ Q LV L + + L+ +Y+ L L + + + + I G +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEIVL 116
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY 538
L +LH+ L II+RDIK NILLD ++DFGL+K FH+++ R + GT Y
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-ERAYSFCGTIEY 172
Query: 539 MAPEYAIRGFLSVKS---DVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL 590
MAP+ +RG D +S GVL+ E+++G + ++ E +++RR+
Sbjct: 173 MAPD-IVRGGDGGHDKAVDWWSMGVLMYELLTGASPF--TVDGEKNSQAEISRRI 224
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 7e-13
Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 45/211 (21%)
Query: 414 EVRVLLKMQHRNLVQLFG--------CCVQERERILVYEYLPNKSLDKFLFDKSKSAILD 465
E +L + H +++QL G C + R + +Y YL K AI D
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLA---------AKRNIAICD 183
Query: 466 WPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525
L I V R + YLH + RIIHRDIKA NI ++H + DFG A F + +
Sbjct: 184 I---LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDIN 236
Query: 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISG------RKNYDRQLEAE 579
++ + AGT APE R D++S G++L E+ + + D +++
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSD 296
Query: 580 NQELLKLARRLEEEGRLMELVDVRIGTYPEE 610
Q ++L+ R GT+P E
Sbjct: 297 RQ---------------IKLIIRRSGTHPNE 312
|
Length = 391 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-13
Identities = 54/227 (23%), Positives = 108/227 (47%), Gaps = 31/227 (13%)
Query: 368 DNFSTKNMLGRGGFGTVY----KGRLQDGRE-------------IAVKKLATNSMQ-GKE 409
+ K LG G FG V+ +G + + +AVK L ++ + +
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 410 EFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFL--------FDKSKS 461
+F E++++ +++ N+++L C+ ++ EY+ N L++FL +K+
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 462 AILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK-LF 520
+ + + + +A G+ YL S L +HRD+ N L+ KI+DFG+++ L+
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS 567
+ R + + +M+ E + G + SDV++FGV L EI++
Sbjct: 182 SGDYYRIQGRAVL-PIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 8e-13
Identities = 73/261 (27%), Positives = 106/261 (40%), Gaps = 48/261 (18%)
Query: 375 MLGRGGFGTVYKGRLQD-GREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFG 431
++GRGGFG VY R D G+ A+K L M+ E R++L +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 432 CCVQERERILVYEYLPNKSLDK--FLFDK----------SKSAILDWPKRLNIIMGVARG 479
C + Y + + DK F+ D S+ + + + G
Sbjct: 61 C--------MSYAF---HTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILG 109
Query: 480 LLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYM 539
L ++H V ++RD+K +NILLD +ISD GLA F S+ + H GT GYM
Sbjct: 110 LEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYM 162
Query: 540 APEYAIRGFLSVKS-DVFSFGVLLLEIISGRKNY-----------DRQLEAENQEL---L 584
APE +G S D FS G +L +++ G + DR EL
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 222
Query: 585 KLARRLEEEGRLMELVDVRIG 605
R EG L V+ R+G
Sbjct: 223 SPELRSLLEGLLQRDVNRRLG 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 37/213 (17%)
Query: 376 LGRGGFGTVYK-GRLQDGREIAVKKLAT---NSMQGKEEFENEVRVLLKMQHRNLVQLFG 431
+G G FG V+ +DG+ +A+KK+ N + K F E+++L +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALD 66
Query: 432 C-------CVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN------IIMGVAR 478
+E I V L L K I+ P+ L+ + + R
Sbjct: 67 ILQPPHIDPFEE---IYVVTELMQSDLHK---------IIVSPQPLSSDHVKVFLYQILR 114
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY 538
GL YLH I+HRDIK N+L++ KI DFGLA++ ++S+H T ++ + Y
Sbjct: 115 GLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-Y 170
Query: 539 MAPEYAI--RGFLSVKSDVFSFGVLLLEIISGR 569
APE + R + S D++S G + E++ R
Sbjct: 171 RAPEILMGSRHYTS-AVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 71/238 (29%), Positives = 110/238 (46%), Gaps = 31/238 (13%)
Query: 369 NFSTKNMLGRGGFGTVYKGRLQDGRE----IAVKKLATNSMQGK----EEFENEVRVL-L 419
NF +LG G +G V+ R G + A+K L ++ K E E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 420 KMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMG-VAR 478
Q LV L E + L+ +Y+ + L+ + + + G +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS----EDEVRFYSGEIIL 116
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY 538
L +LH+ L I++RDIK NILLD + ++DFGL+K F E+ + RT+ GT Y
Sbjct: 117 ALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEY 172
Query: 539 MAPEYAIRGFLSVKS------DVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL 590
MAPE IRG K D +S G+L+ E+++G + LE E +++RR+
Sbjct: 173 MAPE-IIRG----KGGHGKAVDWWSLGILIFELLTGASPF--TLEGERNTQSEVSRRI 223
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 65/235 (27%), Positives = 104/235 (44%), Gaps = 34/235 (14%)
Query: 375 MLGRGGFGTVYKGRLQD-GREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLF 430
++GRGGFG VY R D G+ A+K L + QG+ NE R++L +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFI 59
Query: 431 GCCVQERERILVYEY-LPNKSLDKFLFDKSKSAILDWPKRLNIIMG----------VARG 479
C + Y + P+K F+ D L + + + + G
Sbjct: 60 VC--------MTYAFHTPDKLC--FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILG 109
Query: 480 LLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYM 539
L ++H V ++RD+K +NILLD +ISD GLA F S+ + H GT GYM
Sbjct: 110 LEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYM 162
Query: 540 APEYAIRGF-LSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEE 593
APE +G +D FS G +L +++ G + + + E+ ++ + E
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVE 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 56/169 (33%), Positives = 80/169 (47%), Gaps = 20/169 (11%)
Query: 476 VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGT 535
VARG+ +L + + IHRD+ A NILL KI DFGLA+ + + R
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 536 FGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDR-QLEAENQELLKLARRLEEE 593
+MAPE + +SDV+SFGVLL EI S G Y Q+ E +RL++
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDG 293
Query: 594 GRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
R+ PE +I L C + ++RPT SA + +L +
Sbjct: 294 TRMRA---------PENATPEIYRIMLACWQGDPKERPTFSALVEILGD 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 19/231 (8%)
Query: 375 MLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFEN---EVRVLLKMQHRNLVQLF 430
+LG+G FG V R + G+ A+K L + K+E + E RVL +H L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL- 60
Query: 431 GCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
Q +R+ V EY L F S+ + + + L YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALGYLHSCD-- 115
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL 549
+++RD+K N++LD KI+DFGL K GT Y+APE
Sbjct: 116 -VVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 550 SVKSDVFSFGVLLLEIISGR-----KNYDRQLEAENQELLKLARRLEEEGR 595
D + GV++ E++ GR +++++ E E ++ R L E +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAK 223
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 376 LGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKE-EFENEVRVLLKMQHRNLVQLFGCC 433
LG G + TV+KGR + +A+K++ +G EV +L ++H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 434 VQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIM-GVARGLLYLHRDSVLRII 492
ER LV+EYL + L ++L L + I M + RGL Y H+ +I+
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KIL 125
Query: 493 HRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGF-LSV 551
HRD+K N+L++ + + K++DFGLA+ ++ ++++ T Y P+ + S
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 552 KSDVFSFGVLLLEIISGR 569
D++ G +L E+ +GR
Sbjct: 184 PIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 375 MLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFEN---EVRVL-LKMQHRNLVQL 429
+LG+G FG V L+ G AVK L + + ++ E E RVL L ++ L L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 430 FGCCVQERERIL-VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488
+ C Q +E + V E+L L + DK + D + + GL +LH
Sbjct: 62 Y-CTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKG- 116
Query: 489 LRIIHRDIKASNILLDHQMKPKISDFGLAK--LFHDEQSRHRTHQIAGTFGYMAPEYAIR 546
II+RD+K N++LD KI+DFG+ K +F D +R GT Y+APE
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD----NRASTFCGTPDYIAPEILQG 170
Query: 547 GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE 579
+ D +SFGVLL E++ G+ + E E
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 54/205 (26%), Positives = 104/205 (50%), Gaps = 10/205 (4%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKL--ATNSMQGKEEFENEVRVLLKMQHR 424
+ F ++G G +G V K R ++ +EI A+KK + + + KE E+++L ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLH 484
N+V+L + + LV+EY+ K++ + L + + K + I + + + + H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYV-EKNMLELLEEMPNGVPPE--KVRSYIYQLIKAIHWCH 117
Query: 485 RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYA 544
++ I+HRDIK N+L+ H K+ DFG A+ + + + T +A T Y +PE
Sbjct: 118 KND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA-TRWYRSPELL 173
Query: 545 IRGFLSVKSDVFSFGVLLLEIISGR 569
+ D++S G +L E+ G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 37/219 (16%)
Query: 368 DNFSTKNMLGRGGFGTVYKG-RLQDGREIAVKKLAT--NSMQGKEEFENEVRVLLKMQHR 424
+ + + +G G +G+V + G +AVKKL+ S+ + E+R+L M+H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDKF--------LFDKSKSAILDWPKRLN----- 471
N++ L + P +SL++F L + I+ K +
Sbjct: 77 NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 124
Query: 472 IIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQ 531
+I + RGL Y+H IIHRD+K SN+ ++ + KI DFGLA+ DE + +
Sbjct: 125 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---- 177
Query: 532 IAGTFGYMAPEYAIRGF-LSVKSDVFSFGVLLLEIISGR 569
T Y APE + + D++S G ++ E+++GR
Sbjct: 178 -VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 414 EVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNII 473
E +L + H +++++ V +V LP+ S D + + +S L + L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 474 MGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIA 533
+ GL YLH RIIHRD+K NI ++ + I D G A+ + +A
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA---FLGLA 217
Query: 534 GTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEE 593
GT APE R + K+D++S G++L E+++ + +E +K
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCH----- 272
Query: 594 GRLMELVDV--RIGTYPEE 610
L+ + + +PEE
Sbjct: 273 ---SHLLKIISTLKVHPEE 288
|
Length = 357 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 56/198 (28%), Positives = 101/198 (51%), Gaps = 14/198 (7%)
Query: 376 LGRGGFGTVYKGRLQD-GREIAVKKL--ATNSMQGKEEFENEVRVLLKMQHRNLVQLFGC 432
+G G +G V+K R ++ G+ +A+KK + + K+ E+R+L +++H NLV L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 433 CVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRII 492
++R+ LV+EY + L++ +K+ + II + + + H+ + I
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNEL--EKNPRG-VPEHLIKKIIWQTLQAVNFCHKHNC---I 122
Query: 493 HRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVK 552
HRD+K NIL+ Q + K+ DFG A++ T +A T Y APE + G
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARIL-TGPGDDYTDYVA-TRWYRAPELLV-GDTQYG 179
Query: 553 S--DVFSFGVLLLEIISG 568
DV++ G + E+++G
Sbjct: 180 PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 55/169 (32%), Positives = 76/169 (44%), Gaps = 20/169 (11%)
Query: 476 VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGT 535
VA+G+ +L + + IHRD+ A NILL KI DFGLA+ + + R
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 536 FGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNY-DRQLEAENQELLKLARRLEEE 593
+MAPE +++SDV+SFGVLL EI S G Y +++ E RRL+E
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEG 298
Query: 594 GRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
R+ P+ Q L C RPT S + L N
Sbjct: 299 TRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 370 FSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFE---NEVRVLLKMQHRN 425
F +G+GG+G V+ + +D EI A+K++ + + E E +L +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 426 LVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPK-RLNII-MGVARGLLY 482
LV+L Q+ E + L EY+P L + +L R + M A +
Sbjct: 63 LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFEA--VDA 116
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
LH L IHRD+K N L+D K++DFGL+K + + G+ YMAPE
Sbjct: 117 LHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPE 168
Query: 543 YAIRGF-LSVKSDVFSFGVLLLEIISG 568
+RG D +S G +L E + G
Sbjct: 169 -VLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 35/214 (16%)
Query: 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHR 424
+F LG G FG V + + G A+K L M+ + E +L+++ H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 425 NLVQLFGCCVQERERI-LVYEYLPN-------KSLDKFLFDKSK--SAILDWPKRLNIIM 474
+V + C Q+ R+ + E++ + +F D +K A +++
Sbjct: 79 FIVNMM-CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA--------ELVL 129
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAG 534
YLH II+RD+K N+LLD++ K++DFG AK + RT + G
Sbjct: 130 AFE----YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCG 177
Query: 535 TFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISG 568
T Y+APE D ++ GVLL E I+G
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 65/225 (28%), Positives = 112/225 (49%), Gaps = 26/225 (11%)
Query: 376 LGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFE--NEVRVLLKMQHRNLVQLFGC 432
LG G + TVYKGR + G+ +A+K++ +G F E +L ++H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP-FTAIREASLLKDLKHANIVTLHDI 71
Query: 433 CVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRII 492
++ LV+EYL + L +++ D + RL + + RGL Y H+ R++
Sbjct: 72 IHTKKTLTLVFEYL-DTDLKQYM-DDCGGGLSMHNVRL-FLFQLLRGLAYCHQR---RVL 125
Query: 493 HRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP-------EYAI 545
HRD+K N+L+ + + K++DFGLA+ S+ ++++ T Y P EY
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLARA-KSVPSKTYSNEVV-TLWYRPPDVLLGSTEY-- 181
Query: 546 RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL 590
S D++ G + E+ +GR + + E+Q L K+ R L
Sbjct: 182 ----STSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ-LHKIFRVL 221
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 15/217 (6%)
Query: 369 NFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFEN---EVRVL-LKMQH 423
+F+ +LG+G FG V + E+ A+K L + + ++ E E RVL L +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 424 RNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLY 482
L QL C Q +R+ V EY+ L ++ + P + +A GL +
Sbjct: 61 PFLTQLHSC-FQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFF 116
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
LH II+RD+K N++LD + KI+DFG+ K + T GT Y+APE
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPE 171
Query: 543 YAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE 579
D ++FGVLL E+++G+ ++ + E E
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGR--EIAVKKLATNSMQGKEEFE---NEVRVLLKMQ 422
++F+ LG G FG V ++ +A+K+ + + +++ + +E ++L +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 423 HRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLY 482
H V L+G E LV E++ FL + +P + L++
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR-----FPNDVGCFYAAQIVLIF 144
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
+ S L I++RD+K N+LLD K++DFG AK+ RT+ + GT Y+APE
Sbjct: 145 EYLQS-LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-----RTYTLCGTPEYIAPE 198
Query: 543 YAIRGFLSVKSDVFSFGVLLLEIISG 568
+ +D ++ G+ + EI+ G
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 67/231 (29%), Positives = 102/231 (44%), Gaps = 19/231 (8%)
Query: 375 MLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFEN---EVRVLLKMQHRNLVQLF 430
+LG+G FG V R + GR A+K L + K+E + E RVL +H L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 431 GCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
Q +R+ V EY L F S+ + + + L YLH V
Sbjct: 61 KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHSRDV- 116
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL 549
++RDIK N++LD KI+DFGL K + + +T GT Y+APE
Sbjct: 117 --VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDY 172
Query: 550 SVKSDVFSFGVLLLEIISGR-----KNYDRQLEAENQELLKLARRLEEEGR 595
D + GV++ E++ GR ++++R E E ++ R L E +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 223
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-11
Identities = 51/193 (26%), Positives = 95/193 (49%), Gaps = 20/193 (10%)
Query: 390 QDGREIAVKKLATNSMQGKEE---FENEVRVLLKMQHRNLVQLFGCCVQERERIL-VYEY 445
G E+A+K L T++ + + + F E + ++ H N+V L + V+EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL-- 503
+P ++L + L + L + +++ V L H I+HRD+K NI++
Sbjct: 61 VPGRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQ 114
Query: 504 -DHQMKPKISDFGLAKL---FHD--EQSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVF 556
+ K+ DFG+ L D + RT ++ GT Y APE +RG ++ SD++
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLY 173
Query: 557 SFGVLLLEIISGR 569
++G++ LE ++G+
Sbjct: 174 AWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 69/252 (27%), Positives = 115/252 (45%), Gaps = 25/252 (9%)
Query: 375 MLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFEN---EVRVLLKMQHRNLVQLF 430
+LG+G FG V R + G+ A+K L + K+E + E RVL +H L L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 431 GCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
Q ++R+ V EY+ L F S+ + + + L YLH
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG--- 114
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL 549
+I++RD+K N++LD KI+DFGL K + + +T GT Y+APE
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDNDY 172
Query: 550 SVKSDVFSFGVLLLEIISGR-----KNYDRQLEAENQELLKLARRLEEE------GRLME 598
D + GV++ E++ GR +++++ E E +K R L + G L++
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIK 232
Query: 599 LVDVRIGTYPEE 610
+ R+G P++
Sbjct: 233 DPNKRLGGGPDD 244
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN---EVRVLLK-MQHRNLVQLF 430
+G+G FG V + DG+ AVK L ++ K+E ++ E VLLK ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 431 GCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
Q +++ V +Y+ L F + P+ +A L YLH L
Sbjct: 63 -YSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---L 115
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL 549
II+RD+K NILLD Q ++DFGL K + T GT Y+APE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 550 SVKSDVFSFGVLLLEIISG 568
D + G +L E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 43/228 (18%)
Query: 376 LGRGGFGTV----YKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQ----HRNLV 427
LG+G +G V + +A+KK+ TN K + +R L ++ H+N+
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKI-TNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN------IIMGVARGLL 481
L+ I+ L + L + I+ + L I + GL
Sbjct: 66 CLYDM------DIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLK 119
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD---EQSRHRTHQIAGTFGY 538
Y+H +V +HRD+K N+L++ + KI DFGLA+ F + E + T +A T Y
Sbjct: 120 YIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-TRWY 175
Query: 539 MAPEYAIRGFLSVKS-----DVFSFGVLLLEIISGR-----KNYDRQL 576
APE LS +S DV+S G +L E++ + K+Y QL
Sbjct: 176 RAPEI----MLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQL 219
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 53/208 (25%), Positives = 105/208 (50%), Gaps = 21/208 (10%)
Query: 376 LGRGGFGTVYKGRLQDG---REIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGC 432
+GRG +G VYK + +DG +E A+K++ + E+ +L +++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQKV 66
Query: 433 CVQERER--ILVYEYLPNKSLDKFLFDKSKSA---ILDWPKRL--NIIMGVARGLLYLHR 485
+ +R L+++Y + F ++ A + P+ + +++ + G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 486 DSVLRIIHRDIKASNILL----DHQMKPKISDFGLAKLFHDE-QSRHRTHQIAGTFGYMA 540
+ VL HRD+K +NIL+ + + KI+D G A+LF+ + + TF Y A
Sbjct: 127 NWVL---HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 541 PEYAIRGFLSVKS-DVFSFGVLLLEIIS 567
PE + K+ D+++ G + E+++
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 8e-11
Identities = 56/218 (25%), Positives = 105/218 (48%), Gaps = 13/218 (5%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFE-NEVRVLLKMQHRN 425
D++ LG G + TVYKG+ + +G+ +A+K + +G E +L ++H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIM-GVARGLLYLH 484
+V L + LV+EY+ + L +++ DK + P+ + + + + RGL Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYV-HTDLCQYM-DKHPGGL--HPENVKLFLFQLLRGLSYIH 120
Query: 485 RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYA 544
+ +L HRD+K N+L+ + K++DFGLA+ H T Y P+
Sbjct: 121 QRYIL---HRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPDVL 175
Query: 545 IRGF-LSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQ 581
+ S D++ G + +E+I G + + ++Q
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 8e-11
Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 29/174 (16%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFEN---EVRVLLKMQH 423
D+F + ++GRG FG V + +D I A+KKL + M KE+ + E +L + +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 424 RNLVQLFGCCVQERERI-LVYEYLPNKSL-------DKFLFDKSKSAILDWPKRLNIIMG 475
+V+L+ Q+ + L+ EYLP + D F ++++ I
Sbjct: 61 PWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYI------------ 107
Query: 476 VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRT 529
A +L + L IHRDIK N+LLD + K+SDFGL HRT
Sbjct: 108 -AETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK---KSHRT 157
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 8e-11
Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 49/238 (20%)
Query: 375 MLGRGGFGTVYKGRLQD---GREIAVKK----LATNSMQGKEEFENEVRVLLKMQHRNLV 427
++G+GG G VY D R +A+KK L+ N + K+ F E ++ + H +V
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLL-KKRFLREAKIAADLIHPGIV 65
Query: 428 QLFGCCVQERERILVYEYLPN------KSLDKFLFDKS--------KSAILDWPKRLNII 473
++ C VY +P KSL K ++ K K+++ L+I
Sbjct: 66 PVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV---GAFLSIF 119
Query: 474 MGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK---------LFHDEQ 524
+ + Y+H VL HRD+K NILL + I D+G A L D
Sbjct: 120 HKICATIEYVHSKGVL---HRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 525 SRHRTH-------QIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQ 575
R+ + +I GT YMAPE + S +D+++ GV+L ++++ Y R+
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234
|
Length = 932 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 28/213 (13%)
Query: 376 LGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLF---- 430
LG G G V+ D + +AVKK+ Q + E++++ ++ H N+V+++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 431 --GCCVQERERIL--------VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGL 480
G + E L V EY+ L L + + + RL + + RGL
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL---EQGPLSEEHARL-FMYQLLRGL 127
Query: 481 LYLHRDSVLRIIHRDIKASNILLD-HQMKPKISDFGLAKLFHDEQSRHRTHQIAG--TFG 537
Y+H +VL HRD+K +N+ ++ + KI DFGLA++ D H+ + G T
Sbjct: 128 KYIHSANVL---HRDLKPANVFINTEDLVLKIGDFGLARIV-DPHYSHKGYLSEGLVTKW 183
Query: 538 YMAPEYAIRGFLSVKS-DVFSFGVLLLEIISGR 569
Y +P + K+ D+++ G + E+++G+
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 63/199 (31%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 375 MLGRGGFGTVY-KGRLQDGREIAVKKLATNSMQGKEEFEN---EVRVLLK-MQHRNLVQL 429
++G+G FG V R DG AVK L ++ K+E + E VLLK ++H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
+ V +Y+ L F + + L+ P+ VA + YLH L
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLE-PRARFYAAEVASAIGYLHS---L 115
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL 549
II+RD+K NILLD Q ++DFGL K + + T GT Y+APE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKEPY 173
Query: 550 SVKSDVFSFGVLLLEIISG 568
D + G +L E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 54/227 (23%), Positives = 99/227 (43%), Gaps = 41/227 (18%)
Query: 374 NMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN--------------EVRVL 418
LG G +G V K G+ +A+KK+ + + E++++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 419 LKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR 478
+++H N++ L V+ LV + + L K + K + + I++ +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTE---SQVKCILLQILN 130
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA----------KLFHDEQSRHR 528
GL LH+ +HRD+ +NI ++ + KI+DFGLA L DE + R
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 529 ---THQIAGTFGYMAPEY---AIRGFLSVKSDVFSFGVLLLEIISGR 569
T ++ T Y APE A + +V D++S G + E+++G+
Sbjct: 188 EEMTSKVV-TLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 64/243 (26%), Positives = 108/243 (44%), Gaps = 25/243 (10%)
Query: 341 DANALTNNQGIDMRSFLFNLDVLI-------AATDNFSTKNMLGRGGFGTVYKGRLQDGR 393
D AL N+ ID +FL + ++ +++ ++GRG FG V R + +
Sbjct: 11 DFPALRKNKNID--NFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQ 68
Query: 394 EI-AVKKLATNSMQGKEE---FENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNK 449
++ A+K L+ M + + F E ++ +VQLF ++ +V EY+P
Sbjct: 69 KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGG 128
Query: 450 SLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP 509
L + + D P++ A +L L + +IHRD+K N+LLD
Sbjct: 129 DLVNLMSN------YDVPEKWAKFY-TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHL 181
Query: 510 KISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR----GFLSVKSDVFSFGVLLLEI 565
K++DFG + DE R GT Y++PE G+ + D +S GV L E+
Sbjct: 182 KLADFGTC-MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 240
Query: 566 ISG 568
+ G
Sbjct: 241 LVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 66/238 (27%), Positives = 102/238 (42%), Gaps = 43/238 (18%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEEFEN---EVRVLLKMQH 423
D+F + ++GRG FG V + +D G A+K L M KE+ + E +L++
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL 483
+V++F +R L+ E+LP + L K D +A +L +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK------DTLSEEATQFYIAETVLAI 114
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA----KLFHDEQSRHRTH--------- 530
L IHRDIK N+LLD + K+SDFGL K E R+ TH
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 531 ----------------QIA----GTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISG 568
Q+A GT Y+APE ++ + D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEF---ENEVRVLLKMQHR 424
++F +G G +G VYK R + E+A K+ ++ E+F + E+ ++ +H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI--KLEPGEDFAVVQQEIIMMKDCKHS 66
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR----GL 480
N+V FG ++ + + E+ SL + P + I V+R GL
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH-------VTGPLSESQIAYVSRETLQGL 119
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMA 540
YLH +HRDIK +NILL K++DFG++ ++ ++ GT +MA
Sbjct: 120 YYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMA 174
Query: 541 PEYAI---RGFLSVKSDVFSFGVLLLEI 565
PE A +G + D+++ G+ +E+
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 13/204 (6%)
Query: 375 MLGRGGFGTVYKGRLQDGREI----AVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQL 429
++GRG + V RL+ I VKK N + + + E V + H LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
C E V EY+ L +F + L ++ L YLH
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG-- 116
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL 549
II+RD+K N+LLD + K++D+G+ K + T GT Y+APE
Sbjct: 117 -IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 550 SVKSDVFSFGVLLLEIISGRKNYD 573
D ++ GVL+ E+++GR +D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-10
Identities = 52/196 (26%), Positives = 87/196 (44%), Gaps = 17/196 (8%)
Query: 378 RGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER 437
R G + +G+ + R IA K + + ENE+ L ++ H N+++ ++E
Sbjct: 179 RRGVNSTNQGKPKCERLIA--KRVKAGSRAAIQLENEILALGRLNHENILK-----IEEI 231
Query: 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKR--LNIIMGVARGLL----YLHRDSVLRI 491
R Y+ + D L+ DW R L + + LL Y+H ++
Sbjct: 232 LRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KL 288
Query: 492 IHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSV 551
IHRDIK NI L+ K + DFG A F E+ + GT +PE
Sbjct: 289 IHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCE 347
Query: 552 KSDVFSFGVLLLEIIS 567
+D++S G++LL+++S
Sbjct: 348 ITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 34/213 (15%)
Query: 376 LGRGGFGTVYKG---RLQDGREIAVKKLATNSMQGK-----EEFENEVRVLLKMQHRNLV 427
LG+G F ++KG + D E+ ++ + E F ++ ++ H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAI-LDWPKRLNIIMGVARGLLYLHRD 486
+G CV E I+V EY+ SLD +L K+K+ I + W +L + +A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISW--KLEVAKQLAWALHFLEDK 119
Query: 487 SVLRIIHRDIKASNILL-----DHQMKP---KISDFGLA-KLFHDEQSRHRTHQIAGTFG 537
+ H ++ A N+LL P K+SD G++ + E R
Sbjct: 120 G---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER-------IP 169
Query: 538 YMAPEYAIRG--FLSVKSDVFSFGVLLLEIISG 568
++ PE I LS+ +D +SFG L EI SG
Sbjct: 170 WVPPE-CIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 56/198 (28%), Positives = 87/198 (43%), Gaps = 20/198 (10%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCV 434
+G G +G VYK R L G AVK + + E+ ++ + +H N+V FG +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 435 QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR----GLLYLHRDSVLR 490
+ + EY SL + L I V R GL YLH +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQ-------IAYVCRETLQGLAYLHSKGKM- 128
Query: 491 IIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI---RG 547
HRDIK +NILL K++DFG+A ++ ++ GT +MAPE A G
Sbjct: 129 --HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAVEKNG 184
Query: 548 FLSVKSDVFSFGVLLLEI 565
+ D+++ G+ +E+
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 375 MLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEE---FENEVRVLLK-MQHRNLVQL 429
++G+G FG V R + + + AVK L ++ K+E +E VLLK ++H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
+ V +Y+ L F + + L+ P+ +A L YLH L
Sbjct: 62 HFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLE-PRARFYAAEIASALGYLHS---L 115
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL 549
I++RD+K NILLD Q ++DFGL K + + T GT Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 550 SVKSDVFSFGVLLLEIISG 568
D + G +L E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 36/215 (16%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKL--ATNSMQGKEEFENEVRVLLKMQHRNLVQ---- 428
+G+G +G V R DG++ +KKL S + ++ E E ++L +++H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 429 ----------LFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR 478
+ G C E +Y L + K L + + +++W + +A
Sbjct: 68 WEGEDGLLYIVMGFC----EGGDLYHKLKEQK-GKLLPE---NQVVEW------FVQIAM 113
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY 538
L YLH I+HRD+K N+ L K+ D G+A++ ++ T + GT Y
Sbjct: 114 ALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYY 168
Query: 539 MAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYD 573
M+PE + KSDV++ G + E+ + + ++
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 54/202 (26%), Positives = 102/202 (50%), Gaps = 21/202 (10%)
Query: 376 LGRGGFGTVYKG--RLQDGREIAVKKLATNSMQGKEEFE--NEVRVLLKMQHRNLVQLFG 431
LG G + TVYKG R+ +G+ +A+K ++ + +G F E +L ++H N+V L
Sbjct: 13 LGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHD 70
Query: 432 CCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIM-GVARGLLYLHRDSVL 489
+ +E + V+EY+ + L +++ P + + M + RGL Y+H
Sbjct: 71 I-IHTKETLTFVFEYM-HTDLAQYMIQHPGGL---HPYNVRLFMFQLLRGLAYIHGQ--- 122
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL 549
I+HRD+K N+L+ + + K++DFGLA+ + + + T Y P+ + G
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD-VLLGAT 179
Query: 550 SVKS--DVFSFGVLLLEIISGR 569
S D++ G + +E++ G+
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 376 LGRGGFGTVYKG-RLQDGREIAVKKLA---TNSMQGKEEFENEVRVLLKMQHRN---LVQ 428
+G G +G+V + G ++A+KKL+ + + K + E+ +L MQH N L+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81
Query: 429 LFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488
+F V E Y +P D K L K ++ + GL Y+H
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG- 137
Query: 489 LRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAG---TFGYMAPEYAI 545
IIHRD+K N+ ++ + KI DFGLA RH ++ G T Y APE +
Sbjct: 138 --IIHRDLKPGNLAVNEDCELKILDFGLA--------RHADAEMTGYVVTRWYRAPEVIL 187
Query: 546 RGFLSVKS-DVFSFGVLLLEIISGR-----KNYDRQL 576
++ D++S G ++ E+++G+ K+Y QL
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL 224
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 34/207 (16%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN--EVRVLLKMQ-HRNLVQLF- 430
+G G F V K + + G+ A+K + + E+ N E++ L ++ H N+++L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 431 -------GCC--VQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLL 481
G V E + +YE + + K + + + + + + L
Sbjct: 66 VLFDRKTGRLALVFELMDMNLYELIKGR---KRPLPEKRV--------KSYMYQLLKSLD 114
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP 541
++HR+ I HRDIK NIL+ K++DFG + + + T I+ T Y AP
Sbjct: 115 HMHRNG---IFHRDIKPENILIK-DDILKLADFGSCRGIYSKPP--YTEYIS-TRWYRAP 167
Query: 542 EYAIR-GFLSVKSDVFSFGVLLLEIIS 567
E + G+ K D+++ G + EI+S
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 61/225 (27%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN---------EVRVLLKMQHRN 425
+GRG +G V + + ++A+KK+A F+N E+++L + H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIAN-------AFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 426 LVQLFGCCVQERERI-----LVYEYLPNKSLDKFLFDKSKSAILDWPKRLN------IIM 474
++ + +VYE L D I+ + L+ +
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYE----------LMDTDLHQIIRSSQTLSDDHCQYFLY 115
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAG 534
+ RGL Y+H +VL HRD+K SN+LL+ KI DFGLA+ E+ T +
Sbjct: 116 QLLRGLKYIHSANVL---HRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVV- 170
Query: 535 TFGYMAPEY---------AIRGFLSVKSDVFSFGVLLLEIISGRK 570
T Y APE AI DV+S G + E++ GRK
Sbjct: 171 TRWYRAPELLLNCSEYTTAI--------DVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 7e-10
Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 19/178 (10%)
Query: 415 VRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFD--KSKSAILDWPKRLNI 472
V L+K + N ++L+ + +L+ +Y+ D LFD K + L + I
Sbjct: 61 VHQLMK-DNPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGK-LSEAEVKKI 114
Query: 473 IMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP-KISDFGLAKLFHDEQSRHRTHQ 531
I + L LH+ IIH DIK N+L D + D+GL K+ S +
Sbjct: 115 IRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-SCYD--- 167
Query: 532 IAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARR 589
GT Y +PE V D ++ GVL E+++G+ + E E +L L +R
Sbjct: 168 --GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED-EDEELDLESLLKR 222
|
Length = 267 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 7e-10
Identities = 52/208 (25%), Positives = 104/208 (50%), Gaps = 21/208 (10%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQG---KEEFENEVRVLLKMQHRNLVQLFGC 432
+GRG +G VYK + +DG++ + A ++G E+ +L +++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDD--RDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 433 CVQERER--ILVYEYLPNKSLDKFLFDKSKSA---ILDWPKRL--NIIMGVARGLLYLHR 485
+ +R L+++Y + F ++ A + P+ + +++ + G+ YLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 486 DSVLRIIHRDIKASNILL----DHQMKPKISDFGLAKLFHDE-QSRHRTHQIAGTFGYMA 540
+ VL HRD+K +NIL+ + + KI+D G A+LF+ + + TF Y A
Sbjct: 127 NWVL---HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 541 PEYAIRGFLSVKS-DVFSFGVLLLEIIS 567
PE + K+ D+++ G + E+++
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 45/215 (20%)
Query: 376 LGRGGFGTV-YKGRLQDGREIAVKKLA---TNSMQGKEEFENEVRVLLKMQHRNLVQLFG 431
+G G +GTV + G ++A+KKL + + K + E+R+L M+H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGLLD 81
Query: 432 CCVQERERILVYEYLPNKSLDKF-------------LFDKSKSAILDWPKRLNIIMGVAR 478
+ P+ SLD+F L K L + ++ + +
Sbjct: 82 V------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLK 129
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAG---T 535
GL Y+H IIHRD+K N+ ++ + KI DFGLA R ++ G T
Sbjct: 130 GLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA--------RQTDSEMTGYVVT 178
Query: 536 FGYMAPEYAIRGFLSVKS-DVFSFGVLLLEIISGR 569
Y APE + ++ D++S G ++ E+++G+
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 72/282 (25%), Positives = 123/282 (43%), Gaps = 70/282 (24%)
Query: 376 LGRGGFGTV---YKGRLQDGREIAVKKLAT--NSMQGKEEFENEVRVLLKMQHRNLVQLF 430
+G G +G+V Y RL+ +++AVKKL+ S+ E+R+L M+H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 431 GCCVQERERILVYEYLPNKSLDKF--------LFDKSKSAILDWPKRLN-----IIMGVA 477
+ P S++ F L + I+ K + +I +
Sbjct: 81 DV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128
Query: 478 RGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFG 537
RGL Y+H IIHRD+K SN+ ++ + +I DFGLA+ DE + + T
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY-----VATRW 180
Query: 538 YMAPEYAIRGFLSVKS-DVFSFGVLLLEIISGR-----KNYDRQLEAENQELLKLARRLE 591
Y APE + ++ D++S G ++ E++ G+ +Y QL+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLK-------------- 226
Query: 592 EEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTM 633
R+ME+V GT E+ +I+ +I+ P M
Sbjct: 227 ---RIMEVV----GTPSPEV---LKKISSEHARKYIQSLPHM 258
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 42/129 (32%), Positives = 60/129 (46%), Gaps = 12/129 (9%)
Query: 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNIL 502
Y+ + + L D L L+ VARG+ +L + +HRD+ A N+L
Sbjct: 214 YKGSNDSEVKNLLSDDGSEG-LTTLDLLSFTYQVARGMEFLASKNC---VHRDLAARNVL 269
Query: 503 LDHQMKPKISDFGLAK-LFHDEQSRHRTHQIAGTF---GYMAPEYAIRGFLSVKSDVFSF 558
L KI DFGLA+ + HD + TF +MAPE + SDV+S+
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSK----GSTFLPVKWMAPESIFDNLYTTLSDVWSY 325
Query: 559 GVLLLEIIS 567
G+LL EI S
Sbjct: 326 GILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 41/117 (35%), Positives = 58/117 (49%), Gaps = 4/117 (3%)
Query: 457 DKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGL 516
D S LD L VA+G+ +L + IHRD+ A N+LL KI DFGL
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGL 258
Query: 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNY 572
A+ ++ + +MAPE +V+SDV+S+G+LL EI S G+ Y
Sbjct: 259 ARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 367 TDNFSTKNMLGRGGFGTVYK-GRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-HR 424
+D + +G+G +G V+K ++G + AVK L EE E E +L + H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSDHP 75
Query: 425 NLVQLFGCCVQERERI-----LVYEYLPNKSLDKFLFDKSKSAILDWPKRLN------II 473
N+V+ +G ++ + LV E S+ + L +R+ I+
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGERMEEPIIAYIL 130
Query: 474 MGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIA 533
GL +LH + + IHRD+K +NILL + K+ DFG++ +R R +
Sbjct: 131 HEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRNTSV 185
Query: 534 GTFGYMAPEY-----AIRGFLSVKSDVFSFGVLLLEIISG 568
GT +MAPE + + DV+S G+ +E+ G
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 63/231 (27%), Positives = 103/231 (44%), Gaps = 18/231 (7%)
Query: 375 MLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFEN---EVRVLLKMQHRNLVQLF 430
+LG+G FG V + + GR A+K L + K+E + E RVL +H L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL- 60
Query: 431 GCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
Q +R+ V EY L F S+ + + + L YLH +
Sbjct: 61 KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSEK-- 115
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL 549
+++RD+K N++LD KI+DFGL K + + +T GT Y+APE
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDNDY 173
Query: 550 SVKSDVFSFGVLLLEIISGR-----KNYDRQLEAENQELLKLARRLEEEGR 595
D + GV++ E++ GR +++++ E E ++ R L E +
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAK 224
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 26/202 (12%)
Query: 375 MLGRGGFGT--VYKGRLQDG----REIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQ 428
++G G FG + + D +EI + K ++ E+ E +L KM+H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAV----EDSRKEAVLLAKMKHPNIVA 62
Query: 429 LFGCCVQERERILVYEYLPNKSLDKFLFDK-----SKSAILDWPKRLNIIMGVARGLLYL 483
+ +V EY L + + + + IL W + + G+ ++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHI 116
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEY 543
H R++HRDIK+ NI L K K+ DFG A+L + T+ GT Y+ PE
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY--VGTPYYVPPEI 171
Query: 544 AIRGFLSVKSDVFSFGVLLLEI 565
+ KSD++S G +L E+
Sbjct: 172 WENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 37/109 (33%), Positives = 57/109 (52%), Gaps = 15/109 (13%)
Query: 478 RGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL---FHDEQSRHRTHQIAG 534
RGL Y+H +V IHRD+K SN+L++ + +I DFG+A+ E T +A
Sbjct: 118 RGLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA- 173
Query: 535 TFGYMAPE--YAIRGFLSVKSDVFSFGVLLLEIISGR-----KNYDRQL 576
T Y APE ++ + + D++S G + E++ R KNY QL
Sbjct: 174 TRWYRAPELLLSLPEY-TTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL 221
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 58/199 (29%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 375 MLGRGGFGTVY-KGRLQDGREIAVKKLATNSMQGKEEFEN---EVRVLLK-MQHRNLVQL 429
++G+G FG V R DG+ AVK L + ++E ++ E VLLK ++H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
+ V +++ L F + P+ +A L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---I 115
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL 549
I++RD+K NILLD Q ++DFGL K T GT Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 550 SVKSDVFSFGVLLLEIISG 568
D + G +L E++ G
Sbjct: 174 DNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 30/219 (13%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE---FENEVRVLLKMQH 423
+F K+++GRG FG V R G A+K + + + +E FE E +L
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 424 RNLVQLFGCCVQERERI-LVYEYLPNKSLDKFL------FDKSKSAILDWPKRLNIIMGV 476
+ QL Q+++ + LV EY P L L FD+ + +
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-----------L 108
Query: 477 ARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF 536
A +L +H + +HRDIK N+L+D K++DFG A + + + GT
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTP 167
Query: 537 GYMAPEY------AIRGFLSVKSDVFSFGVLLLEIISGR 569
Y+APE +G V+ D +S GV+ E+I GR
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 38/104 (36%), Positives = 54/104 (51%), Gaps = 3/104 (2%)
Query: 464 LDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523
LD L+ VA+G+ +L + IHRD+ A NILL H KI DFGLA+ ++
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS 567
+ +MAPE + +SDV+S+G+LL EI S
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 63/241 (26%), Positives = 106/241 (43%), Gaps = 21/241 (8%)
Query: 341 DANALTNNQGID-----MRSFLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREI 395
D AL N+ ID + + + L +++ ++GRG FG V R + R++
Sbjct: 11 DFPALRKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV 70
Query: 396 -AVKKLATNSMQGKEE---FENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSL 451
A+K L+ M + + F E ++ +VQLF +R +V EY+P L
Sbjct: 71 YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL 130
Query: 452 DKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKI 511
+ + D P++ A +L L + IHRD+K N+LLD K+
Sbjct: 131 VNLMSN------YDVPEKWARFY-TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKL 183
Query: 512 SDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR----GFLSVKSDVFSFGVLLLEIIS 567
+DFG + +++ R GT Y++PE G+ + D +S GV L E++
Sbjct: 184 ADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242
Query: 568 G 568
G
Sbjct: 243 G 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 4e-09
Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 36/213 (16%)
Query: 376 LGRGGFGTVYKGRLQDGREI-AVKKLA---TNSMQGKEEFENEVRVLLKM-QHRNLVQLF 430
LG+G +G V+K + +E+ A+KK+ N+ + F E+ L ++ H N+V+L
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL 73
Query: 431 GCCVQERER--ILVYEYLPNKSLDKFLFDKSKSAIL-DWPKRLNIIMGVARGLLYLHRDS 487
E ++ LV+EY+ + L ++ IL D KR I+ + + L Y+H
Sbjct: 74 NVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLLKALKYIHSG- 126
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR----THQIAGTFGYMAPEY 543
+IHRD+K SNILL+ + K++DFGLA+ + + T +A T Y APE
Sbjct: 127 --NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA-TRWYRAPE- 182
Query: 544 AIRGFLSVKS-------DVFSFGVLLLEIISGR 569
+ + S D++S G +L E++ G+
Sbjct: 183 -----ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 48/199 (24%), Positives = 85/199 (42%), Gaps = 16/199 (8%)
Query: 398 KKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFD 457
KK+ ++ G + E+ +L + HR ++ L R + V +P D F +
Sbjct: 120 KKVIVKAVTGGKTPGREIDILKTISHRAIINLIHA---YRWKSTVCMVMPKYKCDLFTYV 176
Query: 458 KSKSAILDWPKRLNIIMGVARGLL----YLHRDSVLRIIHRDIKASNILLDHQMKPKISD 513
P L + + R LL YLH IIHRD+K NI LD + D
Sbjct: 177 DRSG-----PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGD 228
Query: 514 FGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEI-ISGRKNY 572
FG A + + +GT +PE K+D++S G++L E+ + +
Sbjct: 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288
Query: 573 DRQLEAENQELLKLARRLE 591
+Q+++ + +L + R ++
Sbjct: 289 GKQVKSSSSQLRSIIRCMQ 307
|
Length = 392 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 376 LGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFEN---EVRVLLKMQHRNLVQLFG 431
+G+G FG V + R +D + I A+K + + + E + E VL ++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 432 CCVQERERI-LVYEYLPNKSLDKFL-----FDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
Q E++ LV ++ L L FD S++ A L L
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFY-----------TAELLCALEN 108
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI 545
+I+RD+K NILLD+Q + DFGL KL + + +T+ GT Y+APE +
Sbjct: 109 LHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLL 166
Query: 546 RGFLSVKSDVFSFGVLLLEIISG 568
+ D ++ GVLL E+++G
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 23/218 (10%)
Query: 375 MLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEE----FENEVRVLLKM-QHRNLVQL 429
++GRG + V L+ R I K+ + +E + E V H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
C E V E++ L +F + L ++ L +LH
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNFLHERG-- 116
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR--HRTHQIAGTFGYMAPEYAIRG 547
II+RD+K N+LLD + K++D+G+ K E R T GT Y+APE +RG
Sbjct: 117 -IIYRDLKLDNVLLDAEGHIKLTDYGMCK----EGIRPGDTTSTFCGTPNYIAPE-ILRG 170
Query: 548 ---FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQE 582
SV D ++ GVL+ E+++GR +D ++N +
Sbjct: 171 EDYGFSV--DWWALGVLMFEMMAGRSPFDIVGMSDNPD 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 50/220 (22%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLK--------------- 420
LGRG +Y G L + + G E E++V+LK
Sbjct: 3 LGRGTRTQIYAGILNYKDD--------DEDDGYSY-EKEIKVILKVLDPSHRDISLAFFE 53
Query: 421 -------MQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNII 473
+ H+++V L+G CV++ E I+V E++ LD LF KS +L P + +
Sbjct: 54 TASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVA 111
Query: 474 MGVARGLLYLHRDSVLRIIHRDIKASNILL-----DHQMKP--KISDFGLAKLFHDEQSR 526
+A L YL ++H ++ NILL D + P K+SD G+ Q
Sbjct: 112 KQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ-- 166
Query: 527 HRTHQIAGTFGYMAPE-YAIRGFLSVKSDVFSFGVLLLEI 565
+I ++APE LS+ +D +SFG L EI
Sbjct: 167 ECVERIP----WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 32/209 (15%)
Query: 376 LGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFEN---EVRVLLKMQHRN---LVQ 428
+G+G FG VY+ R +D R I A+K L+ + K+E + E +L++ +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 429 LFGCCVQERERILVYEYLPNKSL-------DKFLFDKSKSAILDWPKRLNIIMGVARGLL 481
L + + LV +Y+ L +F D++K I + + L
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAE----------LVLALE 110
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP 541
+LH+ I++RD+K NILLD + DFGL+K + T+ GT Y+AP
Sbjct: 111 HLHKYD---IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAP 165
Query: 542 EYAI--RGFLSVKSDVFSFGVLLLEIISG 568
E + +G+ + D +S GVL+ E+ G
Sbjct: 166 EVLLDEKGY-TKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-08
Identities = 49/159 (30%), Positives = 71/159 (44%), Gaps = 16/159 (10%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGK---EEFENEVRVLLKMQH 423
+ F + RG FG VY GR + + + AVK + M K + + E L +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAI---LDWPKRLNIIMGVARGL 480
+V L+ LV EYL + KS I D + I VA L
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDV------KSLLHIYGYFDEEMAVKYISEVALAL 117
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519
YLHR IIHRD+K N+L+ ++ K++DFGL+K+
Sbjct: 118 DYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 61/238 (25%), Positives = 97/238 (40%), Gaps = 43/238 (18%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEE---FENEVRVLLKMQH 423
++F + ++GRG FG V + +D G A+K L M KE+ E +L++
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL 483
+V++F + L+ E+LP + L K D +A +L +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK------DTLTEEETQFYIAETVLAI 114
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA----KLFHDEQSRHRTHQI------- 532
L IHRDIK N+LLD + K+SDFGL K E R+ H +
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 533 ----------------------AGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISG 568
GT Y+APE ++ + D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 53/204 (25%), Positives = 83/204 (40%), Gaps = 13/204 (6%)
Query: 375 MLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEE----FENEVRVLLKMQHRN-LVQL 429
++GRG + V RL+ +I K+ + +E + E V + LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
C LV EY+ L +F + L + L +LH
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHERG-- 116
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL 549
II+RD+K N+LLD K++D+G+ K T GT Y+APE
Sbjct: 117 -IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 550 SVKSDVFSFGVLLLEIISGRKNYD 573
D ++ GVL+ E+++GR +D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 29/78 (37%), Positives = 46/78 (58%)
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL 549
+++HRD+K++NI L K+ DFG +K + D S GT Y+APE R
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 550 SVKSDVFSFGVLLLEIIS 567
S K+D++S GV+L E+++
Sbjct: 249 SKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEE--FENEVRVLLKMQHR 424
++F ++GRG FG V R + +++ A+K L+ M + + F E R + M H
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI--MAHA 100
Query: 425 N---LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLL 481
N +VQL ++ +V EY+P L + + W + V L
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE--KWARFY--TAEVVLALD 156
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP 541
+H + IHRD+K N+LLD K++DFG + D R GT Y++P
Sbjct: 157 AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRCDTAVGTPDYISP 212
Query: 542 EY----AIRGFLSVKSDVFSFGVLLLEIISG 568
E G+ + D +S GV L E++ G
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 57/222 (25%), Positives = 102/222 (45%), Gaps = 31/222 (13%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGRE-IAVKKLATNSMQGKEEFEN---EVRVLLKMQH 423
++F T ++ G +G VY R ++ R+ A+KK+ ++ + + + E +L ++
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAI-LDWPKRLNIIMGVARGLL- 481
+V +F +R +V EY+ L K+ A+ +D + M A +L
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMAR-----MYFAETVLA 113
Query: 482 --YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL-----------FHDEQSRHR 528
YLH I+HRD+K N+L+ K++DFGL+K+ H E+
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 529 --THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISG 568
Q+ GT Y+APE +R D ++ G++L E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 24/165 (14%)
Query: 368 DNFSTKNMLGRGGFGTV-YKGRLQDGREIAVKKLATNSMQGKEEFEN---EVRVLLKMQH 423
++F T ++G+G FG V + G+ A+K L + M K++ + E VL +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSL-------DKFLFDKSKSAILDWPKRLNIIMGV 476
+V L+ + L+ E+LP L D F D ++ + + ++ +
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAE------CVLAI 114
Query: 477 ARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521
+H+ L IHRDIK NIL+D K+SDFGL+ FH
Sbjct: 115 EA----VHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 48/206 (23%), Positives = 84/206 (40%), Gaps = 28/206 (13%)
Query: 379 GGFGTVYKGRLQDGREIAVKKLATNSMQGKEEF---ENEVRVLLKMQHRNLVQLFGCCVQ 435
+ K + +AVKK+ +S KE+ + E+ ++QH N++ +
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSCS-KEDLKLLQQEIITSRQLQHPNILPYVTSFIV 70
Query: 436 ERERILVYEYLPNKS---LDKFLFDK--SKSAILDWPKRLNIIMGVARGLLYLHRDSVLR 490
+ E +V + S L K F + + AI I+ V L Y+H
Sbjct: 71 DSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIA------FILKDVLNALDYIHS---KG 121
Query: 491 IIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR-----THQIAGTFGYMAPEY-- 543
IHR +KAS+ILL K +S + R R +++PE
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181
Query: 544 -AIRGFLSVKSDVFSFGVLLLEIISG 568
++G+ + KSD++S G+ E+ +G
Sbjct: 182 QNLQGY-NEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 54/203 (26%)
Query: 392 GREIAVKKLA---TNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPN 448
G+ +A+KKL+ N K + E+ ++ + H+N++ L + P
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLNV------------FTPQ 87
Query: 449 KSLDKF--------LFDKSKSAI----LDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDI 496
KSL++F L D + + LD + ++ + G+ +LH IIHRD+
Sbjct: 88 KSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 144
Query: 497 KASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGF-------- 548
K SNI++ KI DFGLA RT AGT M P R +
Sbjct: 145 KPSNIVVKSDCTLKILDFGLA----------RT---AGTSFMMTPYVVTRYYRAPEVILG 191
Query: 549 --LSVKSDVFSFGVLLLEIISGR 569
D++S G ++ E+I G
Sbjct: 192 MGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 59/254 (23%), Positives = 100/254 (39%), Gaps = 57/254 (22%)
Query: 376 LGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEE---FENEVRVLLKMQHRNLVQLFG 431
+G G FG V R D + A+K L + + + + E +L + + +V+L+
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 432 CCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLN--IIMGVARGLLYLHRDSV 488
Q+++ + V +Y+P + L + + L I + + +H+
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGI-----FEEDLARFYIAELTCAIESVHK--- 119
Query: 489 LRIIHRDIKASNILLDHQMKPKISDFGLAKLF---HD----------------------- 522
+ IHRDIK NIL+D K++DFGL F HD
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 523 ---------------EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS 567
+ R H + GT Y+APE +R + D +S GV+L E++
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239
Query: 568 GRKNYDRQLEAENQ 581
G+ + AE Q
Sbjct: 240 GQPPFLADTPAETQ 253
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 58/222 (26%), Positives = 109/222 (49%), Gaps = 27/222 (12%)
Query: 361 DVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGRE-IAVKKLATNSMQGKEEFENEVRVLL 419
D+ + ++ N++G G FG VY+ D E +A+KK+ +Q + E+ ++
Sbjct: 59 DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMK 114
Query: 420 KMQHRNLVQL----FGCCVQERERIL----VYEYLPNKSLDKFL--FDKSKSAILDWPKR 469
+ H N++ L + C ++ E+ + V E++P +++ K++ + ++ A+ + +
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVK 173
Query: 470 LNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP-KISDFGLAK-LFHDEQSRH 527
L + R L Y+H I HRD+K N+L+D K+ DFG AK L ++S
Sbjct: 174 LYSYQ-LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS-- 227
Query: 528 RTHQIAGTFGYMAPEYAIRGF-LSVKSDVFSFGVLLLEIISG 568
I F Y APE + + D++S G ++ E+I G
Sbjct: 228 -VSYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 36/113 (31%), Positives = 55/113 (48%), Gaps = 11/113 (9%)
Query: 459 SKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518
++S L + + VA G+ +L + +HRD+ A N+L+ KI DFGLA+
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLASKNC---VHRDLAARNVLICEGKLVKICDFGLAR 287
Query: 519 -LFHDEQSRHRTHQIAGTF---GYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS 567
+ D + TF +MAPE + SDV+SFG+LL EI +
Sbjct: 288 DIMRDSNYISK----GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 63/231 (27%), Positives = 92/231 (39%), Gaps = 47/231 (20%)
Query: 376 LGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEEF---ENEVRVLLKMQHRNLVQLFG 431
LG+G G V+ RL+ G+ A+K L M + + E +L + H L L+
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 432 CCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRI 491
E LV +Y P L + L + + + R V L YLH +L I
Sbjct: 69 SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARF-YAAEVLLALEYLH---LLGI 124
Query: 492 IHRDIKASNILLD---HQMKPKISDFGLAKL-----------FHDEQSRHRTHQIA---- 533
++RD+K NILL H M +SDF L+K R + I
Sbjct: 125 VYRDLKPENILLHESGHIM---LSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181
Query: 534 ------------GTFGYMAPEYAIRGF---LSVKSDVFSFGVLLLEIISGR 569
GT Y+APE I G +V D ++ G+LL E++ G
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAV--DWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 43/195 (22%), Positives = 88/195 (45%), Gaps = 20/195 (10%)
Query: 384 VYKGRLQDGREIAV---KKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFG----CCVQE 436
+YKG + +E+ + KK + ENE++ L ++ N+++++G
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 437 RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDI 496
L+ EY L + L DK K L + +L++ + +GL L++ + ++++
Sbjct: 95 PRLSLILEYCTRGYLREVL-DKEKD--LSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNL 149
Query: 497 KASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGF--LSVKSD 554
+ + L+ K KI GL K+ ++ Y + + F ++K D
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPFKN-----VNFMVYFSYKMLNDIFSEYTIKDD 204
Query: 555 VFSFGVLLLEIISGR 569
++S GV+L EI +G+
Sbjct: 205 IYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 38/109 (34%), Positives = 55/109 (50%), Gaps = 13/109 (11%)
Query: 478 RGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL-FHDEQSRHRTHQIAGTF 536
R L Y+H +V HRD+K NIL + K KI DFGLA++ F+D + T
Sbjct: 114 RALKYIHTANVF---HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 537 GYMAPEYAIRGFLSVKS---DVFSFGVLLLEIISGR-----KNYDRQLE 577
Y APE F S + D++S G + E+++G+ KN QL+
Sbjct: 171 WYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 218
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 376 LGRGGFGTVYKGRLQDGREIA---VKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQLFG 431
+G G FG V + +A VK+L N S + + EF + +QH N++Q G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 432 CCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIM-------GVARGLLYLH 484
CV+ +LV+EY L +L + W +R + ++ +A G+ ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMACEIAAGVTHMH 116
Query: 485 RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYA 544
+ +H D+ N L + K+ D+G+ + E ++APE
Sbjct: 117 K---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 545 IR---GFLSVK----SDVFSFGVLLLEI 565
G ++ + S+V++ GV L E+
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEE---FENEVRVLLKMQH 423
D+F ++GRG FG V ++++ ++ A+K L M + E F E VL+
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 424 RNLVQLFGCCVQERERILVYEY--------LPNKSLDKFLFDKSKSAILDWPKRLNIIMG 475
R + L E LV +Y L +K D+ D ++ + + +++
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAE------MVLA 114
Query: 476 VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGT 535
+ +H+ L +HRDIK N+LLD +++DFG + L +++ GT
Sbjct: 115 IDS----VHQ---LGYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGT 166
Query: 536 FGYMAPEY--AI---RGFLSVKSDVFSFGVLLLEIISG 568
Y++PE A+ +G + D +S GV + E++ G
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 55/220 (25%)
Query: 376 LGRGGFGTV---YKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGC 432
+G G G V Y L+ R +A+KKL+ F+N+ K +R LV +
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLS-------RPFQNQTHA--KRAYRELVLM--K 78
Query: 433 CVQERERI-LVYEYLPNKSLDKF--------LFDKSKSAI----LDWPKRLNIIMGVARG 479
CV + I L+ + P KSL++F L D + + LD + ++ + G
Sbjct: 79 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 480 LLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYM 539
+ +LH IIHRD+K SNI++ KI DFGLA+ AGT M
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------------TAGTSFMM 182
Query: 540 APEYAIRGFLSVK----------SDVFSFGVLLLEIISGR 569
P R + + + D++S G ++ E+I G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 55/190 (28%), Positives = 85/190 (44%), Gaps = 30/190 (15%)
Query: 392 GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI-LVYEYLPNKS 450
G +AVKKL+ F+N+ K +R LV L CV + I L+ + P KS
Sbjct: 46 GINVAVKKLS-------RPFQNQTHA--KRAYRELVLL--KCVNHKNIISLLNVFTPQKS 94
Query: 451 LDKF--------LFDKSKSAI----LDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKA 498
L++F L D + + LD + ++ + G+ +LH IIHRD+K
Sbjct: 95 LEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 151
Query: 499 SNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSF 558
SNI++ KI DFGLA+ + T Y APE + D++S
Sbjct: 152 SNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 208
Query: 559 GVLLLEIISG 568
G ++ E++ G
Sbjct: 209 GCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 31/218 (14%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEE---FENEVRVLLKMQH 423
D+F ++GRG FG V +++ I A+K L M + E F E VL+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 424 RNLVQLFGCCVQERERILVYEY--------LPNKSLDKFLFDKSKSAILDWPKRLNIIMG 475
+ + L E LV +Y L +K D+ D ++
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR-------------FY 107
Query: 476 VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGT 535
+A +L +H L +HRDIK N+LLD +++DFG + + + + + GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GT 166
Query: 536 FGYMAPEY--AIR---GFLSVKSDVFSFGVLLLEIISG 568
Y++PE A+ G + D +S GV + E++ G
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-06
Identities = 22/76 (28%), Positives = 36/76 (47%), Gaps = 3/76 (3%)
Query: 173 PNPTTFDQTVNSLTVNLAV-LAGKSGKRFAVAKMKVISSDIYLYGYVECTRDVNGESCTK 231
+TF+ +N+L +L+ A SGK FA + D +YG +C D++ C
Sbjct: 14 TANSTFESNLNALLSSLSSNAASSSGKGFAAGT-SGAAPDT-VYGLAQCRGDLSASDCRS 71
Query: 232 CLLSLRSYMMTCCSGR 247
CL + S + CC +
Sbjct: 72 CLATAVSELRRCCPNK 87
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 44/156 (28%), Positives = 69/156 (44%), Gaps = 14/156 (8%)
Query: 413 NEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNI 472
+E R+L ++ H ++ L V LV LP D + + ++ L +
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQ---- 261
Query: 473 IMGVARGLL----YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528
+ VAR LL Y+H + IIHRDIK N+L++ + DFG A S
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLE 564
+ IAGT APE + D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 59/231 (25%), Positives = 95/231 (41%), Gaps = 60/231 (25%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFEN----------EVRVLLKM---- 421
LG+G +Y GRL+ + + E E+ E+RV+LK+
Sbjct: 3 LGQGTRTNIYDGRLRVEG-------GGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS 55
Query: 422 ------------------QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAI 463
H +L + G CV+ E I+V E++ + LD L +
Sbjct: 56 HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVP 115
Query: 464 LDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ-----MKP--KISDFGL 516
+ W ++ + +A L YL + ++H ++ A NILL P K+SD G+
Sbjct: 116 VAW--KITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV 170
Query: 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGF--LSVKSDVFSFGVLLLEI 565
+ F R +I ++APE + G LS +D +SFG LLEI
Sbjct: 171 S--FTALSREERVERIP----WIAPE-CVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 77/317 (24%), Positives = 129/317 (40%), Gaps = 27/317 (8%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEE---FENEVRVLLKMQH 423
++F ++GRG FG V +L++ ++ A+K L M + E F E VL+ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL 483
+ + L E LV +Y L L D + M +A
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI----- 115
Query: 484 HRDSV--LRIIHRDIKASNILLDHQMKPKISDFG-LAKLFHDEQSRHRTHQIAGTFGYMA 540
DSV L +HRDIK NIL+D +++DFG KL D ++ GT Y++
Sbjct: 116 --DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV--QSSVAVGTPDYIS 171
Query: 541 PEYAI-----RGFLSVKSDVFSFGVLLLEIISGRKN-YDRQLEAENQELLKLARRLEEEG 594
PE +G + D +S GV + E++ G Y L +++ R +
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPA 231
Query: 595 RLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSAT-LSMLSNSSVP-IPSVTE 652
++ ++ + I R ++ EDF + P + + N P IP V+
Sbjct: 232 QVTDVSEDAKDLIRRLICSREHRLGQNGIEDF-KQHPFFTGIDWDNIRNCEAPYIPEVSS 290
Query: 653 SPD--HYEGDDDAGDNA 667
D +++ DDD N+
Sbjct: 291 PTDTSNFDVDDDCLKNS 307
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 375 MLGRGGFGTVYKGRLQDGREI---AVKK-------------LATNSMQGKEEFENEVRVL 418
++G GGFG VY+ + I AV K L N++ ++ +
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH 78
Query: 419 LKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSK--SAILDWPKRL--NIIM 474
+ H + + +GC +R R+ Y ++ L+K + + + I K+L NI+
Sbjct: 79 -NIDHLGIPKYYGCGSFKRCRMY-YRFI---LLEKLVENTKEIFKRIKCKNKKLIKNIMK 133
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF-----HDEQSRHRT 529
+ L Y+H I H DIK NI++D + I D+G+A F H E S+ +
Sbjct: 134 DMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK 190
Query: 530 HQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLE 564
GT Y + ++ + D+ S G +L+
Sbjct: 191 DLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 53/187 (28%), Positives = 86/187 (45%), Gaps = 30/187 (16%)
Query: 393 REIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI-LVYEYLPNKSL 451
R +A+KKL+ F+N+ K +R LV + CV + I L+ + P KSL
Sbjct: 43 RNVAIKKLS-------RPFQNQTHA--KRAYRELVLM--KCVNHKNIISLLNVFTPQKSL 91
Query: 452 DKF--------LFDKSKSAI----LDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKAS 499
++F L D + + LD + ++ + G+ +LH IIHRD+K S
Sbjct: 92 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 148
Query: 500 NILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFG 559
NI++ KI DFGLA+ S T + + Y APE + D++S G
Sbjct: 149 NIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVG 205
Query: 560 VLLLEII 566
++ E++
Sbjct: 206 CIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 37/135 (27%), Positives = 51/135 (37%), Gaps = 45/135 (33%)
Query: 492 IHRDIKASNILLDHQMKPKISDFGLAKLF---HD-------------------------- 522
IHRDIK NIL+D K++DFGL F HD
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 523 ----------------EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEII 566
+ R H + GT Y+APE +R + D +S GV+L E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 567 SGRKNYDRQLEAENQ 581
G+ + Q E Q
Sbjct: 243 VGQPPFLAQTPLETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 60/256 (23%), Positives = 99/256 (38%), Gaps = 57/256 (22%)
Query: 376 LGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFEN---EVRVLLKMQHRNLVQLFG 431
LG G FG V D + A+K L + + + + E +L + + +V+L+
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLY- 67
Query: 432 CCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLR 490
Q+++ + V +Y+P + L +P+ L +A L + +
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMEV-----FPEVLARFY-IAELTLAIESVHKMG 121
Query: 491 IIHRDIKASNILLDHQMKPKISDFGLAKLF---HD------------------------- 522
IHRDIK NIL+D K++DFGL F H+
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 523 -----------EQSRHRTHQ------IAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEI 565
EQ + HQ + GT Y+APE +R + D +S GV+L E+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 566 ISGRKNYDRQLEAENQ 581
+ G+ + E Q
Sbjct: 242 LVGQPPFLAPTPTETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 67/288 (23%), Positives = 114/288 (39%), Gaps = 49/288 (17%)
Query: 365 AATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHR 424
+T F ++LG G FG V + + +E K+ N + + + E++ + K++
Sbjct: 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQA 185
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDK-FLFDKSKSAILDWPKR---------LNIIM 474
+ F +R Y N++ + K +LDW + II
Sbjct: 186 DPADRFPLMKIQR-------YFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIF 238
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILLD----------HQMKP------KISDFGLAK 518
L Y H + L ++H D+K NIL++ ++ P +I D G
Sbjct: 239 QTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC- 295
Query: 519 LFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEA 578
DE RH I T Y +PE + +D++S G ++ E+ +G+ YD
Sbjct: 296 --CDE--RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351
Query: 579 ENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALL--CTE 624
E+ L++ + GRL R GT EE L + L CT+
Sbjct: 352 EHLHLME-----KTLGRLPSEWAGRCGT--EEARLLYNSAGQLRPCTD 392
|
Length = 467 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 25/133 (18%), Positives = 51/133 (38%), Gaps = 14/133 (10%)
Query: 391 DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLV--QLFGCCVQERERILVYEYLPN 448
+ +K S + + E EV +L + + L ++ + L+ E++
Sbjct: 20 KDEDYVLKI--NPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77
Query: 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK 508
++LD+ ++ + +A L LH+ +L + H D+ NIL+D
Sbjct: 78 ETLDEVSEEEKEDIAEQ----------LAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI 127
Query: 509 PKISDFGLAKLFH 521
I D+ A
Sbjct: 128 LGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 36/110 (32%), Positives = 59/110 (53%), Gaps = 18/110 (16%)
Query: 471 NIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTH 530
NI+ G RGL YLH++ IHR+IKAS+IL+ +S GL+ L+ ++ +
Sbjct: 105 NILFGALRGLNYLHQNGY---IHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQK-A 158
Query: 531 QIAGTFG--------YMAPEYAIRGFLS---VKSDVFSFGVLLLEIISGR 569
++ F +++PE +R L VKSD++S G+ E+ +GR
Sbjct: 159 KVVYDFPQFSTSVLPWLSPEL-LRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 9e-05
Identities = 68/266 (25%), Positives = 114/266 (42%), Gaps = 57/266 (21%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFEN-----EVRVLLKMQHRNLVQLF 430
+G G FG V+ + + +E K S +G +E E EV V+ +++H+N+V+
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAI--SYRGLKEREKSQLVIEVNVMRELKHKNIVRYI 78
Query: 431 GCCVQERERIL--VYEYLPNKSLDKF------LFDK-SKSAILDWPKRLNIIMGVARGLL 481
+ + + L + E+ L + +F K + AI+D ++L L
Sbjct: 79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL------LHALA 132
Query: 482 YLHR----DSVLRIIHRDIKASNILLDHQMK-----------------PKISDFGLAKLF 520
Y H + R++HRD+K NI L ++ KI DFGL+K
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSV--KSDVFSFGVLLLEIISGRKNYDR---- 574
E H GT Y +PE + S KSD+++ G ++ E+ SG+ + +
Sbjct: 193 GIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249
Query: 575 -QLEAENQELLKLARRLEEEGRLMEL 599
QL +E LK L +G+ EL
Sbjct: 250 SQLISE----LKRGPDLPIKGKSKEL 271
|
Length = 1021 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 47/181 (25%), Positives = 65/181 (35%), Gaps = 40/181 (22%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLV 427
D+F LG G FG VYK L + + K + E E+ M R
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLK--KATEYGAVEIW----MNERVRR 185
Query: 428 QLFGCCV-------------QERERILVYEYLPNKSLDKFLFDKS-----KSAIL----D 465
C +E E LV+ Y +L + K + +L D
Sbjct: 186 ACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQD 245
Query: 466 WPK---RLNIIMG-VARGLLY----LHRDSVLRIIHRDIKASNILLDHQMKP-KISDFGL 516
PK R N I+ + R +L+ LH I+HRD+K NI+ KI D G
Sbjct: 246 LPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGA 302
Query: 517 A 517
A
Sbjct: 303 A 303
|
Length = 566 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 686 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.43 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.24 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.17 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.13 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.09 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.07 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.04 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.95 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.84 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.77 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.6 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.6 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.55 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.52 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.5 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.31 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.25 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.18 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.11 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.09 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.09 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.07 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.91 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.89 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.83 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.77 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.66 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.64 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.61 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.59 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.55 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.55 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.48 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.25 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.16 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.12 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.08 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.07 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.98 | |
| PLN02236 | 344 | choline kinase | 96.66 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.64 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.44 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.34 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.28 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 96.15 | |
| PF04478 | 154 | Mid2: Mid2 like cell wall stress sensor; InterPro: | 95.95 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.93 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.88 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.83 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.76 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.7 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.65 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.5 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.48 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.34 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.32 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.86 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.69 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-54 Score=457.75 Aligned_cols=287 Identities=49% Similarity=0.793 Sum_probs=255.4
Q ss_pred ccccCHHHHHHhhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEE
Q 005649 355 SFLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCV 434 (686)
Q Consensus 355 ~~~~~~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 434 (686)
...|++++|..||++|...++||+|+||.||+|.+++|+.||||++.........+|.+|+.++.+++|||+|+|+|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 55699999999999999999999999999999999999999999887655431455999999999999999999999999
Q ss_pred ecC-ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 005649 435 QER-ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISD 513 (686)
Q Consensus 435 ~~~-~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 513 (686)
+.+ +.+||||||++|+|.++|+..... .++|.+|++|+.++|+||+|||+...++|+||||||+|||||+++++||+|
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 998 599999999999999999876554 799999999999999999999999888999999999999999999999999
Q ss_pred cCCccccCCcCcccccccc-ccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHh
Q 005649 514 FGLAKLFHDEQSRHRTHQI-AGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEE 592 (686)
Q Consensus 514 fgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 592 (686)
||+++........ .... .||.+|+|||+...+..+.|+|||||||+|+||+||+.+.+.........++.|.+..+.
T Consensus 221 FGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999755431111 1112 899999999999999999999999999999999999999987654555568999999999
Q ss_pred cCccccccccccC--CCCH-HHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 593 EGRLMELVDVRIG--TYPE-EIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 593 ~~~~~~~~d~~l~--~~~~-~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
++.+.+++|+.+. .++. ....++..++.+|++.+|.+||+|.||+++|+.+.
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 9999999999984 5554 68888999999999999999999999999995543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=399.46 Aligned_cols=255 Identities=35% Similarity=0.561 Sum_probs=226.9
Q ss_pred CCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCC
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
.+...+.||+|-||.||.|.++....||+|.++.... ..++|.+|+++|++|+|+|||+++|+|..++..+||||||++
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 3456789999999999999998777999999987643 357889999999999999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
|+|.+||.. ..+..++..+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+...++... .
T Consensus 286 GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~-~ 360 (468)
T KOG0197|consen 286 GSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT-A 360 (468)
T ss_pred CcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee-e
Confidence 999999976 34456999999999999999999999987 999999999999999999999999999965544432 3
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCC
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTY 607 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 607 (686)
.....-+..|.|||.+..++++.|||||||||+||||+| |+.||.+....+....++.+.++..
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~--------------- 425 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR--------------- 425 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---------------
Confidence 344566889999999999999999999999999999999 9999999988888777776666654
Q ss_pred CHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 608 PEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 608 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
|+.++..+.+||..||+.+|++|||+..+...|+.+.
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 7789999999999999999999999999999998753
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=411.32 Aligned_cols=266 Identities=29% Similarity=0.480 Sum_probs=234.8
Q ss_pred HHHHHhhCCCcccccccccCcEEEEEEEec------CCCEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCCcccEEEEE
Q 005649 361 DVLIAATDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNSMQ-GKEEFENEVRVLLKMQHRNLVQLFGCC 433 (686)
Q Consensus 361 ~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~ 433 (686)
+..+..+.+.+..+.||+|.||+||+|+.. +.+.||||.++..... ...+|++|++++..++|||||+|+|+|
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 334456778888999999999999999854 3567999999887665 778999999999999999999999999
Q ss_pred EecCceEEEEeecCCCChhHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 005649 434 VQERERILVYEYLPNKSLDKFLFDKSK-----------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNIL 502 (686)
Q Consensus 434 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 502 (686)
.+++..++|+|||..|+|.+||..... ..+|+..+.+.|+.|||.||.||-++. +|||||..+|+|
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCL 635 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCL 635 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhce
Confidence 999999999999999999999965321 223899999999999999999999987 999999999999
Q ss_pred EcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHH
Q 005649 503 LDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQ 581 (686)
Q Consensus 503 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~ 581 (686)
|.++..|||+||||+|.....+......+..-+.+|||||.++.++||.+||||||||+|||+++ |+.||.+...+|..
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 99999999999999998887777666656677899999999999999999999999999999999 99999998888876
Q ss_pred HHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 582 ELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
+.+....-+ ..|++++.++++||+.||+.+|.+||+++||-..|+.-.
T Consensus 716 e~i~~g~lL---------------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 716 ECIRAGQLL---------------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred HHHHcCCcc---------------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 665543322 348899999999999999999999999999999998643
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=387.94 Aligned_cols=258 Identities=31% Similarity=0.531 Sum_probs=213.9
Q ss_pred CCcccccccccCcEEEEEEEecCCCEEEEEEecccCccc--HHHHHHHHHHHHhcCCCCcccEEEEEEecC-ceEEEEee
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQG--KEEFENEVRVLLKMQHRNLVQLFGCCVQER-ERILVYEY 445 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~Ey 445 (686)
++...+.||+|+||+||+|.++....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..+|||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 334456699999999999999744449999997654332 569999999999999999999999999988 79999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-CeEEEecCCccccCCcC
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM-KPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~ 524 (686)
+++|+|.++++.. ....+++..++.++.|||+||.|||+++. ||||||||+||||+.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999875 44569999999999999999999999873 99999999999999997 99999999998765432
Q ss_pred ccccccccccCCCcCchhhhh--cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAI--RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
.......||..|||||++. ...++.|+||||||++||||+||+.||.......... .....+...
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~------~v~~~~~Rp----- 265 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVAS------AVVVGGLRP----- 265 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHH------HHHhcCCCC-----
Confidence 1233368999999999999 6699999999999999999999999998765522211 111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCC
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSV 645 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 645 (686)
..+..++..+..++.+||+.||+.||++.+++.+|+.+..
T Consensus 266 ---~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 266 ---PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred ---CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 2345578889999999999999999999999999986543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=378.91 Aligned_cols=249 Identities=27% Similarity=0.452 Sum_probs=218.7
Q ss_pred CCCcccccccccCcEEEEEEEe-cCCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRL-QDGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
.+|...++||+|||+.+|.++. ..|+.||+|++.+.. ....+...+|+++.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5789999999999999999997 789999999997643 234577899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
|+|++++|..++. .++.+++.++..++.||+.||.|||+.+ |+|||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999885 4466999999999999999999999987 999999999999999999999999999988754
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
.. +....+||+.|+|||++.....+..+||||+|||||-|+.|++||+...-.+....+....-
T Consensus 172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y-------------- 235 (592)
T KOG0575|consen 172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY-------------- 235 (592)
T ss_pred cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc--------------
Confidence 33 33457999999999999999999999999999999999999999997766655443332211
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
..|...+....+||..+|++||.+|||+++|+..=
T Consensus 236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred --ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 12556778889999999999999999999998643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=360.47 Aligned_cols=207 Identities=29% Similarity=0.524 Sum_probs=186.3
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
.++|...+.||+|.||.||+|+++ ++..||||.+... .....+.+..|+.+|+.++|||||.+++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 468888899999999999999976 6899999999766 4455677899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC------CCeEEEecCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ------MKPKISDFGLA 517 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~Dfgla 517 (686)
|||++|+|.+|++.++ .+++.....++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999997654 4999999999999999999999998 9999999999999764 46899999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHH
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQE 582 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~ 582 (686)
+.+.... .....+|++-|||||+++..+|+.|.|+||+|++||++++|+.||+.....|...
T Consensus 163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~ 224 (429)
T KOG0595|consen 163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL 224 (429)
T ss_pred hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 9987433 3456799999999999999999999999999999999999999999777666554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=360.66 Aligned_cols=251 Identities=32% Similarity=0.451 Sum_probs=211.3
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecC-ceEEEEe
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER-ERILVYE 444 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E 444 (686)
++.+..+.||+|..|+|||++++ +++.+|+|.+... .....+++.+|++++++.+||+||+++|.|.++. ...|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 34566789999999999999987 6888999999544 3344678999999999999999999999999998 5999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
||++|+|++++... +.+++...-+|+.++++||.|||++ ..|+||||||+||||+..|.+||+|||.+..+.+.
T Consensus 159 YMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred hcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999999654 4599999999999999999999974 24999999999999999999999999999987654
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccch--HhHHHHHHHHHHHHhcCcccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLE--AENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
......||..|||||.+.+..|+.++||||||++++|+.+|+.||..... ....+++.+ +++.
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~------------Iv~~ 297 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA------------IVDE 297 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH------------HhcC
Confidence 33456899999999999999999999999999999999999999986511 122222222 2221
Q ss_pred ccCCCCHH-HHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 603 RIGTYPEE-IALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 603 ~l~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.-...|.+ .+.++.+++..||++||.+||++.|+++.
T Consensus 298 ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 298 PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11233444 78889999999999999999999999865
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=387.43 Aligned_cols=255 Identities=26% Similarity=0.472 Sum_probs=223.7
Q ss_pred CCCcccccccccCcEEEEEEEec-C---CCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-D---GREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~---g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
....+.++||.|.||.|++|+++ . ...||||.++.... ..+.+|+.|..||.+++||||++|.|+.......+||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 45677899999999999999986 2 45699999987643 4467899999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
+|||+||+|+.||..+. +++++.++..++++||.||.||.+-+ +|||||..+||||+.+..+|++||||+|.+.+
T Consensus 709 TEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999997643 55999999999999999999999866 99999999999999999999999999998765
Q ss_pred cCccc-cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 523 EQSRH-RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 523 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
+.... .+....-+.+|.|||.+...+++.+|||||||++|||.++ |.+||..+...+....++...+++.
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp-------- 855 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP-------- 855 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC--------
Confidence 44221 2223445789999999999999999999999999999999 9999998887777666665555543
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
|++++..|.+||+.|||+|-.+||.+.||+.+|.+
T Consensus 856 -------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 856 -------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred -------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 78899999999999999999999999999999976
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=353.06 Aligned_cols=254 Identities=25% Similarity=0.341 Sum_probs=207.8
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc-------cHHHHHHHHHHHHhcCCCCcccEEEEEEecCc
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ-------GKEEFENEVRVLLKMQHRNLVQLFGCCVQERE 438 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 438 (686)
.+.|...+.||+|+||.|-+|..+ +|+.||||++.+.... ......+|+++|++|+|||||++++++.+.+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 466888899999999999999865 7999999999764222 12345799999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC---CCeEEEecC
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ---MKPKISDFG 515 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg 515 (686)
.|+|+||+++|.|.+++..+ +.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999999654 34777788889999999999999998 9999999999999765 679999999
Q ss_pred CccccCCcCccccccccccCCCcCchhhhhcCC---CChhHHHHHHHHHHHHHHcCCCCCcccchHh-HHHHHHHHHHHH
Q 005649 516 LAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGF---LSVKSDVFSFGVLLLEIISGRKNYDRQLEAE-NQELLKLARRLE 591 (686)
Q Consensus 516 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~ 591 (686)
+|+...... .....+||+.|.|||++.+.. +..|.|+||+||+||-+++|.+||.....+. ..+.+..++-..
T Consensus 325 lAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f 401 (475)
T KOG0615|consen 325 LAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF 401 (475)
T ss_pred hhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc
Confidence 999876332 345679999999999997653 4458899999999999999999998655443 222222211110
Q ss_pred hcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 592 EEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 592 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
. .......+++..++|.+||..||++|||+.|+++.-.
T Consensus 402 ~------------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 402 G------------PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred c------------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 0 0123467889999999999999999999999987543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=339.82 Aligned_cols=257 Identities=25% Similarity=0.429 Sum_probs=211.4
Q ss_pred CCCcccccccccCcEEEEEEEe-cCCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEE-EecCc-eEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRL-QDGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCC-VQERE-RILV 442 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~-~~lv 442 (686)
.+|++.++||+|.||+|||++. .+|..+|.|.+... +....++...|+.+|++|+|||||+++++- .++.+ ..||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 5678889999999999999984 58999999999754 334567889999999999999999999844 33444 7899
Q ss_pred EeecCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 443 YEYLPNKSLDKFLFDK-SKSAILDWPKRLNIIMGVARGLLYLHRDSVLR--IIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
|||+..|+|...+... .....+++..+|+++.|+++||.++|.+- ++ |.||||||.||+|+.+|.|||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999653 34456999999999999999999999843 34 99999999999999999999999999998
Q ss_pred cCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 520 FHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 520 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
+..... .....+||+.||+||.+.+..|+.||||||+||++|||+.-++||.+.+-.+. ..++.+ +..
T Consensus 178 l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L------~~KI~q-gd~--- 245 (375)
T KOG0591|consen 178 LSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSL------CKKIEQ-GDY--- 245 (375)
T ss_pred hcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHH------HHHHHc-CCC---
Confidence 865433 34457899999999999999999999999999999999999999987633322 222222 211
Q ss_pred cccccCCCC-HHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 600 VDVRIGTYP-EEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 600 ~d~~l~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
...| ...+.++..|+..|+..||+.||+...+++.+..
T Consensus 246 -----~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 -----PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -----CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1124 5678999999999999999999996555555543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=390.54 Aligned_cols=261 Identities=33% Similarity=0.504 Sum_probs=223.7
Q ss_pred hhCCCcccccccccCcEEEEEEEec--CCC----EEEEEEeccc-CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCc
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ--DGR----EIAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERE 438 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~--~g~----~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 438 (686)
..++.+..+.||+|.||.||.|... +|. .||||.++.. +.+...+|.+|..+|++++|||||+++|+|.+...
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 3566777889999999999999865 343 3899999765 45667899999999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEec
Q 005649 439 RILVYEYLPNKSLDKFLFDKS----KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDF 514 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 514 (686)
.+|++|||++|+|..||.+.+ ....|+....+.++.|||+|+.||++++ +|||||..+|+||+....|||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEccc
Confidence 999999999999999997652 1345999999999999999999999987 999999999999999999999999
Q ss_pred CCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhc
Q 005649 515 GLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEE 593 (686)
Q Consensus 515 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 593 (686)
|||+.+.+.+.........-+..|||||.++.+.++.|+|||||||+||||+| |..||......+....+.. .
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~------g 920 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE------G 920 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh------C
Confidence 99997666555544444456789999999999999999999999999999999 9999997776665442222 2
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 594 GRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 594 ~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
+++ ..|..+++.+++||+.||+.+|++||++..|++.+..+.
T Consensus 921 gRL---------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 921 GRL---------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred Ccc---------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 222 137789999999999999999999999999999887653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=341.02 Aligned_cols=243 Identities=26% Similarity=0.356 Sum_probs=207.6
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
..++|+..++||+|+||+|+.++.+ .++.+|+|++++... .+.+...+|..+|.+++||.||+++..|.+.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3578999999999999999999866 688999999976533 345678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
|+||+.||.|..+|.++ ..+++..+.-++.+|+.||.|||+.+ ||||||||+|||||.+|+++|+|||+++..-
T Consensus 103 Vld~~~GGeLf~hL~~e---g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQRE---GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHHhc---CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999999644 44999999999999999999999998 9999999999999999999999999999654
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
.... .+...+||+.|||||++.+..++..+|+||+|+++|||++|.+||...+..+..+.+....
T Consensus 177 ~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k------------- 241 (357)
T KOG0598|consen 177 KDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK------------- 241 (357)
T ss_pred cCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-------------
Confidence 3322 2344799999999999999999999999999999999999999998766554433322211
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCC
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRP 631 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RP 631 (686)
+...+.-.+....+++...++.||++|-
T Consensus 242 --~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 --LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred --CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1122444677889999999999999996
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=353.52 Aligned_cols=267 Identities=24% Similarity=0.410 Sum_probs=224.0
Q ss_pred HhhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 365 AATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQ-GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 365 ~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
-+.+...++++||+|-||.|.++....+..||||+++..... ..++|..|+++|.+++||||++++|+|..++..++|+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 356677888999999999999999988899999999877554 4589999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
|||++|+|.+|+..+.-.. +.-...++|+.||+.||+||.+-+ +|||||.++|+|+|.++++||+|||++|-+...
T Consensus 615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999997653322 556677889999999999999865 999999999999999999999999999977766
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc--CCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS--GRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
+.........-+.+|||||.+..++++.++|||+||++|||+++ .+.||....++... +....+.+.+.....
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv---en~~~~~~~~~~~~~-- 765 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV---ENAGEFFRDQGRQVV-- 765 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---HhhhhhcCCCCccee--
Confidence 66655556677899999999999999999999999999999976 88999866554432 222233322221111
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
...|.-++..+++++++||..|-++||++++|...|++.
T Consensus 766 ---l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 ---LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 133566788899999999999999999999999988754
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=353.71 Aligned_cols=273 Identities=28% Similarity=0.440 Sum_probs=219.3
Q ss_pred cCHHHHHHhhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEe
Q 005649 358 FNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQ 435 (686)
Q Consensus 358 ~~~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 435 (686)
.+.++.++..+.+.+.+.||+|.||+||+|++. .+||||++..... ...+.|++|+..+++-+|.||+-++|+|..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 344566667777888899999999999999997 4799999976533 346789999999999999999999999998
Q ss_pred cCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecC
Q 005649 436 ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFG 515 (686)
Q Consensus 436 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 515 (686)
... .||+.+|++.+|+.+++... ..++..+.+.|+.||++|+.|||.++ |+|||||.+|||+.++++|||+|||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccc
Confidence 877 99999999999999998654 44899999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCcCccccccccccCCCcCchhhhhc---CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHh
Q 005649 516 LAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR---GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEE 592 (686)
Q Consensus 516 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 592 (686)
++..-..-..........|...|||||++.. .+|+..+||||||+++|||++|..||.....+.....+..+
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG----- 608 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG----- 608 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc-----
Confidence 9875443222222334567889999999864 47999999999999999999999999843332221111111
Q ss_pred cCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCCCC
Q 005649 593 EGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPS 649 (686)
Q Consensus 593 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~ 649 (686)
. +-+++.....+++.++.+|+..||..++++||.+.+|+.+|+..-..+|.
T Consensus 609 --~----l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pk 659 (678)
T KOG0193|consen 609 --Y----LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPK 659 (678)
T ss_pred --c----cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccc
Confidence 0 01112122346788899999999999999999999999988876543433
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=353.18 Aligned_cols=261 Identities=31% Similarity=0.482 Sum_probs=207.5
Q ss_pred hhCCCcccccccccCcEEEEEEEe------cCCCEEEEEEecccCc-ccHHHHHHHHHHHHhc-CCCCcccEEEEEEecC
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRL------QDGREIAVKKLATNSM-QGKEEFENEVRVLLKM-QHRNLVQLFGCCVQER 437 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 437 (686)
+.++|++.++||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.++.++ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 457899999999999999999974 2356799999975432 3346789999999999 8999999999987654
Q ss_pred -ceEEEEeecCCCChhHHHhhcCC--------------------------------------------------------
Q 005649 438 -ERILVYEYLPNKSLDKFLFDKSK-------------------------------------------------------- 460 (686)
Q Consensus 438 -~~~lv~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 460 (686)
..+++|||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999965321
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCC
Q 005649 461 ---SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFG 537 (686)
Q Consensus 461 ---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 537 (686)
...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 134888999999999999999999987 99999999999999999999999999986543322222223456788
Q ss_pred cCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHH
Q 005649 538 YMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFM 616 (686)
Q Consensus 538 y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~ 616 (686)
|+|||.+.+..++.++||||||+++|||++ |+.||......+.. . .. ...+... ..+...+..+.
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~--~---~~-~~~~~~~--------~~~~~~~~~l~ 307 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF--C---QR-LKDGTRM--------RAPENATPEIY 307 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH--H---HH-HhcCCCC--------CCCCCCCHHHH
Confidence 999999999999999999999999999997 99999764432211 0 11 1111110 11334556789
Q ss_pred HHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 617 QIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 617 ~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
+++.+||+.||++|||+.||+++|++.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=338.53 Aligned_cols=259 Identities=30% Similarity=0.460 Sum_probs=210.3
Q ss_pred hCCCcccccccccCcEEEEEEEecC-CCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecC--ceEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER--ERILVY 443 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 443 (686)
..++...+.||+|.||.||++...+ |...|||.....+....+.+++|+.+|.+++|||||+.+|...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3567778999999999999999764 8999999997664444677999999999999999999999865544 588999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCCeEEEecCCccccCC
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH-QMKPKISDFGLAKLFHD 522 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~ 522 (686)
||+++|+|.+++...+. .+++..+..+..||++||.|||+++ |+||||||+||||+. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999976543 5999999999999999999999988 999999999999999 79999999999987664
Q ss_pred -cCccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 523 -EQSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 523 -~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
...........||+.|||||++.++ ....++|||||||++.||+||++||... .+. ..+........
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~----~~~~~~ig~~~------ 239 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEE----AEALLLIGRED------ 239 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cch----HHHHHHHhccC------
Confidence 1111223457899999999999864 3445999999999999999999999753 111 11111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
....+|...+....+++.+|++.||++|||+.++++..-..
T Consensus 240 --~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 240 --SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred --CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 11244667888899999999999999999999999877543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=335.30 Aligned_cols=270 Identities=30% Similarity=0.413 Sum_probs=205.9
Q ss_pred CCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHh--cCCCCcccEEEEEEecC----ceEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLK--MQHRNLVQLFGCCVQER----ERIL 441 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~l 441 (686)
+..+..++||+|+||.||||+++ ++.||||++.. ..++.|++|-.+.+. ++|+||+++++.-...+ +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 44556788999999999999996 59999999954 446678888777665 58999999999876554 8899
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCcEEEcCCCCeEEEecC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS------VLRIIHRDIKASNILLDHQMKPKISDFG 515 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 515 (686)
|+||.++|+|.+||.. ..++|....+|+..+++||+|||+.- +++|+|||||++||||..|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 9999999999999954 55999999999999999999999754 4789999999999999999999999999
Q ss_pred CccccCCcCccccccccccCCCcCchhhhhcCC-CC-----hhHHHHHHHHHHHHHHcCCCCCc--------ccchHhHH
Q 005649 516 LAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGF-LS-----VKSDVFSFGVLLLEIISGRKNYD--------RQLEAENQ 581 (686)
Q Consensus 516 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~ksDv~s~Gvvl~elltG~~p~~--------~~~~~~~~ 581 (686)
+|..+............+||.+|||||++.+.. +. .+.||||+|.|||||++...-++ ...+.+..
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 999988777666677789999999999997742 22 36899999999999998643332 11111111
Q ss_pred H--HHHHHHHH-HhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCCC
Q 005649 582 E--LLKLARRL-EEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIP 648 (686)
Q Consensus 582 ~--~~~~~~~~-~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 648 (686)
. .++..+.. ..+...-.+-|...+ ...+..+.+.+..||..||+.|.|+.=+-+.+.+.....+
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 0 01111111 111111111111121 2456778999999999999999999988888877654443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=339.97 Aligned_cols=265 Identities=25% Similarity=0.418 Sum_probs=208.2
Q ss_pred hCCCcccccccccCcEEEEEEEecC-----------------CCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCccc
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQD-----------------GREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQ 428 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 428 (686)
.++|+..++||+|+||.||++.+++ +..||+|.+.... .....+|.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3678889999999999999998642 3369999987543 233567999999999999999999
Q ss_pred EEEEEEecCceEEEEeecCCCChhHHHhhcC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 005649 429 LFGCCVQERERILVYEYLPNKSLDKFLFDKS----------------KSAILDWPKRLNIIMGVARGLLYLHRDSVLRII 492 (686)
Q Consensus 429 l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 492 (686)
+++++.+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999986432 1134788999999999999999999987 99
Q ss_pred ecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc--CCC
Q 005649 493 HRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS--GRK 570 (686)
Q Consensus 493 H~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt--G~~ 570 (686)
||||||+|||+++++.+||+|||+++...............++..|+|||.+..+.++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999986654333223334456789999999999999999999999999999987 567
Q ss_pred CCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 571 NYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 571 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
||......+... ........... ... ...+..++..+.+++.+||+.+|++|||+.||.+.|++
T Consensus 241 p~~~~~~~~~~~---~~~~~~~~~~~-~~~----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDEQVIE---NAGEFFRDQGR-QVY----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHHHHHH---HHHHHhhhccc-ccc----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 777554333222 11111111100 000 01123455678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=310.89 Aligned_cols=274 Identities=23% Similarity=0.362 Sum_probs=219.6
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCccc--HHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQG--KEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
++|...++||+|.||.||+|+.. +|+.||||+++.....+ .....+|++.|+.++|+||+.+++++.+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46778899999999999999864 79999999997653321 3457899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|| ..+|...+.++ ...++...+..++.++++||+|||++. |+||||||.|+|++++|.+||+|||+++.+....
T Consensus 82 fm-~tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ec-cccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 99 45898888653 456999999999999999999999987 9999999999999999999999999999987654
Q ss_pred ccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccc---c
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMEL---V 600 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 600 (686)
... ....-|.+|+|||.+.+. +|....||||.|||+.||+-|.+-|.+.++-+....+-..-....+..|.++ -
T Consensus 156 ~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 156 RIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred ccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 332 223778999999998874 7999999999999999999999988877665544444333322222222221 1
Q ss_pred c---------cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCCCC
Q 005649 601 D---------VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPS 649 (686)
Q Consensus 601 d---------~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~ 649 (686)
| +.+...-...+.+..+++..++..||.+|+|++|.+++=--.+.+.|+
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt 291 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT 291 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence 1 111223334567779999999999999999999999876555544444
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.24 Aligned_cols=257 Identities=25% Similarity=0.341 Sum_probs=214.3
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 440 (686)
..++|.+.+.||+|.|++|++++.. .++.+|||++.+.- ....+-...|-..|.+| +||.|++|+-.|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3578999999999999999999865 68999999996542 12234466788899999 8999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+|+||+++|+|.++++.. +.+++.....++.+|+.||+|||+.| ||||||||+|||||+|+++||+|||-|+.+
T Consensus 151 FvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999765 44999999999999999999999998 999999999999999999999999999988
Q ss_pred CCcCcc---------cc--ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHH
Q 005649 521 HDEQSR---------HR--THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARR 589 (686)
Q Consensus 521 ~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 589 (686)
...... .. ....+||..|.+||++..+..+..+|+|+||||||+|+.|++||...++--....+...
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l-- 302 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL-- 302 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh--
Confidence 643221 11 13478999999999999999999999999999999999999999866543222111111
Q ss_pred HHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 590 LEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 590 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
|. .+++..++...+|+.+.|..||.+|+|.+||-+..-...
T Consensus 303 -----------~y---~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 303 -----------DY---EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred -----------cc---cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 11 235566688899999999999999999999988764333
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=339.58 Aligned_cols=267 Identities=25% Similarity=0.340 Sum_probs=212.7
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEec--CceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQE--RERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 441 (686)
.+.|+..++||+|.||.||+++.. +|+.||+|++..... ....-..+|+.+|++|+||||++|.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 356777889999999999999854 799999999976542 2344567899999999999999999999886 68999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
|+|||++ +|.-++.. ..-.+++.++..++.|++.||.|+|+++ |+|||||.+|||||.+|.+||+|||||+++.
T Consensus 196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999976 56666643 2345999999999999999999999998 9999999999999999999999999999887
Q ss_pred CcCccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccc--c
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM--E 598 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 598 (686)
...... .+..+-|.+|+|||++.+. .|+.+.|+||.||||.||+.|++.|.+..+-+..+.+-....-..+..|. .
T Consensus 270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 554433 4566789999999999875 79999999999999999999999999888776665554333222222222 1
Q ss_pred cc-----c------cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 599 LV-----D------VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 599 ~~-----d------~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
+- - ..+.+--...+....+|+..+|..||.+|.|+.++++.=
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~se 401 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSE 401 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCc
Confidence 10 0 011111123456678999999999999999999987643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=318.59 Aligned_cols=262 Identities=21% Similarity=0.335 Sum_probs=206.6
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
+.|+...++|+|+||.|||++.+ .|+.||||++..... .-++-.++|+++|++++|+|+|.++.+|..+...+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45777889999999999999987 699999999965432 234567899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|++..-|.+.-.. ...++...+.+++.|+++|+.|+|+++ ++||||||+||||+.++.+||+|||+|+.+....
T Consensus 82 ~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 9987666554432 233889999999999999999999998 9999999999999999999999999999887421
Q ss_pred ccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH--------HHHhcCc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR--------RLEEEGR 595 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 595 (686)
...+....|.+|+|||.+.+ -+|....|||++||++.||++|.+-|.+.++-+....+...- .+.....
T Consensus 156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 23445577999999999988 689999999999999999999999998877655443332211 1111111
Q ss_pred -cccccccccC-------CCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 596 -LMELVDVRIG-------TYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 596 -~~~~~d~~l~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
+.-+.-|... .+ +....-+++++..|++.||.+|++-+|++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111111111 11 234556889999999999999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=343.90 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=218.2
Q ss_pred hCCCcccccccccCcEEEEEEEe-cCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRL-QDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
...|...++||+|+.|.||.++. .+++.||||++.......++-+.+|+.+|+..+|+|||++++.+..+++.+.||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 45688889999999999999975 47899999999888777788899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
|++|+|.+.+.. ..+++.++..|+.++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 352 m~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999998843 34999999999999999999999998 99999999999999999999999999988876554
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......||+.|||||+.....|.+|.||||||+|++||+-|++||-... .+...+.+...+... +
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~------PlrAlyLIa~ng~P~------l- 489 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN------PLRALYLIATNGTPK------L- 489 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC------hHHHHHHHhhcCCCC------c-
Confidence 3445789999999999999999999999999999999999999997422 233333333333321 1
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
..++..+..+.+++.+||+.|+++||+++|+|+.
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 2256678889999999999999999999999874
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.24 Aligned_cols=264 Identities=24% Similarity=0.357 Sum_probs=213.5
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHH--HHHHHHHHhcC-CCCcccEEEEEEecC-ceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEF--ENEVRVLLKMQ-HRNLVQLFGCCVQER-ERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~--~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~l 441 (686)
-++|...++||.|.||.||+|+.. +|..||||+++..-.. .++. .+|++.|++|+ ||||+++..++.+.+ .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 367888999999999999999965 7899999999765333 3332 57999999998 999999999999988 8999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||| ..+|++.+.++ +..+++..+..|+.||++||+|+|++| +.|||+||+|||+..+..+||+|||+||.+.
T Consensus 88 VfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 99999 56899999765 567999999999999999999999998 9999999999999999999999999999876
Q ss_pred CcCccccccccccCCCcCchhhhh-cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccc--
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAI-RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME-- 598 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 598 (686)
.... .+....|.+|+|||++. .+.|+.+.|||++|||++||.+-++.|.+.++-+....+..+-....+..+.+
T Consensus 162 SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 SKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred cCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 5443 44557899999999775 57899999999999999999999999998776554443332221111111111
Q ss_pred ----ccccc--------cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 599 ----LVDVR--------IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 599 ----~~d~~--------l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
.+..+ +...-...+.++.+++.+|+..||.+|||+.|.+++-
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 11111 1112234788899999999999999999999999865
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=333.33 Aligned_cols=250 Identities=34% Similarity=0.587 Sum_probs=199.3
Q ss_pred ccccccccCcEEEEEEEec-----CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 372 TKNMLGRGGFGTVYKGRLQ-----DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 372 ~~~~LG~G~fG~Vy~~~~~-----~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
..+.||.|.||.||+|.+. .+..|+||.++.... ...+.|.+|++.+.+++||||++++|++.+.+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999986 356799999965433 3468899999999999999999999999988889999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++|+|.++|... ....+++..++.|+.||++||.|||+++ ++|+||+++||++++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999775 2345899999999999999999999987 99999999999999999999999999987743332
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
............|+|||.+....++.++||||||+++|||++ |+.||......+... .. .++...
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~------~~-~~~~~~------- 224 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIE------KL-KQGQRL------- 224 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHH------HH-HTTEET-------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------cc-cccccc-------
Confidence 223334557789999999999999999999999999999999 789987664433222 11 111111
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
..+..++..+.+++..||..+|++|||+.++++.|
T Consensus 225 -~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 -PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11334567788999999999999999999999976
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=334.34 Aligned_cols=244 Identities=20% Similarity=0.345 Sum_probs=201.1
Q ss_pred ccccccCcEEEEEEEecCCCEEEEEEecccCccc---HHHHHHHHHHHHhcCCCCcccEEEEEEe----cCceEEEEeec
Q 005649 374 NMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQG---KEEFENEVRVLLKMQHRNLVQLFGCCVQ----ERERILVYEYL 446 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~Ey~ 446 (686)
..||+|++|.||+|.+ +|+.||||++....... .+.|.+|+.++.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 68999999997654333 4678899999999999999999999977 34678999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD-SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
++|+|.+++... ..+++...+.++.|++.||.|||+. + ++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999999653 3589999999999999999999985 4 7799999999999999999999999998654322
Q ss_pred cccccccccCCCcCchhhhhc--CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAIR--GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+ ...+.. +
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i------~~~~~~-----~- 241 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI------INKNNS-----L- 241 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HhcCCC-----C-
Confidence 12357889999999976 68999999999999999999999999865443322211 111100 0
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+...+..+.+++.+||+.||++|||++|+++.|+..
T Consensus 242 --~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 242 --KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred --CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 12334567799999999999999999999999999764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=349.82 Aligned_cols=260 Identities=33% Similarity=0.484 Sum_probs=213.7
Q ss_pred hhCCCcccccccccCcEEEEEEEecC--C--CE-EEEEEeccc---CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecC
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQD--G--RE-IAVKKLATN---SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER 437 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~--g--~~-vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 437 (686)
..++....++||+|+||.||+|++.. + .. ||||..+.. ......+|++|.++|.+++|||||+++|++..+.
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34566667999999999999999763 2 23 899998753 3445678999999999999999999999999999
Q ss_pred ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCc
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 517 (686)
..+||||++.||+|.++|....+ .++..+++.++.+.|.||+|||+++ ++||||..+|+|++.++.+||+|||++
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccc
Confidence 99999999999999999976543 5999999999999999999999987 999999999999999999999999998
Q ss_pred cccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcc
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRL 596 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (686)
+.-.. .........-+..|+|||.+..+.++.++|||||||++||+++ |..||.+....+....+ ...+..
T Consensus 310 ~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI------~~~~~r 381 (474)
T KOG0194|consen 310 RAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI------VKNGYR 381 (474)
T ss_pred cCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH------HhcCcc
Confidence 86431 1111112256789999999999999999999999999999999 99999977665443222 111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCC
Q 005649 597 MELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVP 646 (686)
Q Consensus 597 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 646 (686)
+ ..+...+..+..++.+||..+|++||+|.++.+.|+.....
T Consensus 382 ~--------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 382 M--------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred C--------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 1 12345667788899999999999999999999999876543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=323.54 Aligned_cols=260 Identities=23% Similarity=0.363 Sum_probs=210.8
Q ss_pred hCCCcccccccccCcEEEEEEEe-cCCCEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRL-QDGREIAVKKLATNSMQ-GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.++|+..+.||.|.-+.||+|+. +.+..||||++...... ..+.+.+|+..++.++||||++++..|..+..+++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 47899999999999999999985 46799999999765443 35889999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
||.+|++.+.+...-..+ +++..+..|++++++||.|||.+| .+|||||+.||||+++|.|||+|||.+-.+.+..
T Consensus 105 fMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999997754433 999999999999999999999998 8999999999999999999999999987665433
Q ss_pred cccc--ccccccCCCcCchhhhhc--CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcc-ccc
Q 005649 525 SRHR--THQIAGTFGYMAPEYAIR--GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL-MEL 599 (686)
Q Consensus 525 ~~~~--~~~~~gt~~y~aPE~~~~--~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 599 (686)
.... .....|++.|||||+++. ..|+.|+||||||++..||.+|+.||.......... ...+.... .+.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl------~tLqn~pp~~~t 254 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL------LTLQNDPPTLLT 254 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH------HHhcCCCCCccc
Confidence 2222 245689999999999655 479999999999999999999999998654432211 11111111 000
Q ss_pred cccccC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 600 VDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 600 ~d~~l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
-.+. +........+.+++-.|++.||.+|||++++++
T Consensus 255 --~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 --SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred --ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0000 112334567899999999999999999999975
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.85 Aligned_cols=257 Identities=31% Similarity=0.530 Sum_probs=211.4
Q ss_pred CCCcccccccccCcEEEEEEEecC------CCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQD------GREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
++|+..+.||+|+||.||+|.... ...|++|.+..... .....|.+|+..+.+++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 478889999999999999998643 25789999865432 33467899999999999999999999999989999
Q ss_pred EEEeecCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 005649 441 LVYEYLPNKSLDKFLFDKSK-------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM 507 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 507 (686)
++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999975421 145889999999999999999999987 99999999999999999
Q ss_pred CeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHH
Q 005649 508 KPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKL 586 (686)
Q Consensus 508 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 586 (686)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||......+....+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~- 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR- 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 999999999986644333223334456788999999998999999999999999999998 999997655443322111
Q ss_pred HHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 587 ARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 587 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
.+.. ...+...+..+.+|+.+||+.+|++||++.||++.|++
T Consensus 241 ------~~~~--------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 241 ------SRQL--------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ------cCCc--------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111 12245567889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.15 Aligned_cols=261 Identities=28% Similarity=0.430 Sum_probs=226.2
Q ss_pred HHHHHhhCCCcccccccccCcEEEEEEEecC-CCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCce
Q 005649 361 DVLIAATDNFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERER 439 (686)
Q Consensus 361 ~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 439 (686)
++++-.+.++...++||-|.||.||.|.|+. .-.||||.++.+. -..++|+.|..+|+.++|||+|+|+|+|..+...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4444456677788999999999999999974 5679999997654 3578999999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
|||+|||.+|+|.+||.+.. +..++-..++.++.||++||+||..++ ++||||..+|+|+.++..|||+||||+++
T Consensus 339 YIiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 99999999999999997653 345788888999999999999999987 99999999999999999999999999998
Q ss_pred cCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 520 FHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 520 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
+..+... ......-+..|.|||.+....++.|+|||+|||+||||.| |..||.+.+-.....+++...++..
T Consensus 415 MtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~------ 487 (1157)
T KOG4278|consen 415 MTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDG------ 487 (1157)
T ss_pred hcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccC------
Confidence 8754332 2223345788999999999999999999999999999999 9999998877777776666555533
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
|+.++..+++||+.||+.+|.+||++.|+-+.++.
T Consensus 488 ---------PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 488 ---------PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred ---------CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 78899999999999999999999999999887753
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=345.22 Aligned_cols=260 Identities=30% Similarity=0.453 Sum_probs=207.6
Q ss_pred hhCCCcccccccccCcEEEEEEEe------cCCCEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecC
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRL------QDGREIAVKKLATNS-MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQER 437 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 437 (686)
..++|+..+.||+|+||.||+++. +++..||||+++... ....+.+.+|+.++..+ +||||+++++++.+.+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 356899999999999999999963 245689999996543 33456788999999999 8999999999999999
Q ss_pred ceEEEEeecCCCChhHHHhhcCC---------------------------------------------------------
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSK--------------------------------------------------------- 460 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 460 (686)
..++||||+++|+|.+++.....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999999965321
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 461 ---------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 461 ---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
...+++..++.++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 124789999999999999999999987 99999999999999999999999999987654332
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
........++..|+|||.+.+..++.++||||||+++|||++ |..||........ .... ...+...
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~~----~~~~~~~------- 336 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYKM----IKEGYRM------- 336 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHHH----HHhCccC-------
Confidence 222222345678999999999999999999999999999998 8899875433221 1111 1111100
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+...+.++.+++.+||+.||++||++.||+++|++
T Consensus 337 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 -LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0122335678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.21 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=207.1
Q ss_pred hCCCcccccccccCcEEEEEEEec----CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ----DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
.++|++.+.||+|+||.||+|.++ .+..|++|.++.... .....|.+|+..+.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 467888999999999999999864 356899999976533 334678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999999653 235899999999999999999999987 9999999999999999999999999876543
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
..... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||......+....+ ..+..
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~-------~~~~~---- 226 (266)
T cd05064 159 SEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-------EDGFR---- 226 (266)
T ss_pred ccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-------HCCCC----
Confidence 22111 1112345678999999999999999999999999999886 99999765443322111 11110
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
...+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 227 ----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 ----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 01234456778999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=323.75 Aligned_cols=252 Identities=29% Similarity=0.495 Sum_probs=206.5
Q ss_pred CCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecC
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLP 447 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 447 (686)
++|+..+.||+|+||.||+++++++..+++|.+.... ...++|.+|+.++++++||||+++++++.+++..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 5688889999999999999999888899999886433 335678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc
Q 005649 448 NKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH 527 (686)
Q Consensus 448 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 527 (686)
+|+|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 999999986532 35899999999999999999999987 999999999999999999999999998865432221
Q ss_pred cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCC
Q 005649 528 RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 606 (686)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. ..... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~------~~~~~---------~ 221 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS------RGFRL---------Y 221 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH------CCCCC---------C
Confidence 1112245668999999998899999999999999999999 999997654433222111 11110 0
Q ss_pred CCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
.+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 12223467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=335.74 Aligned_cols=249 Identities=23% Similarity=0.356 Sum_probs=208.1
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc----Cc-ccHHHHHHHHHHHHhcC-CCCcccEEEEEEecCc
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN----SM-QGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQERE 438 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 438 (686)
..++|...+.||+|.||.|+.|+.. +++.||+|++... .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4578999999999999999999865 7899999977553 11 23456678999999998 9999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CCeEEEecCCc
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ-MKPKISDFGLA 517 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla 517 (686)
.++||||+.+|+|.+++.+ .+.+.+.+...++.|+++|++|+|+.+ |+||||||+|||+|.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999976 345888999999999999999999998 9999999999999999 99999999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhcCC-CC-hhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCc
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRGF-LS-VKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGR 595 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 595 (686)
..... ........+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.......... ...+.
T Consensus 169 ~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k-------i~~~~ 239 (370)
T KOG0583|consen 169 AISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK-------IRKGE 239 (370)
T ss_pred cccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-------HhcCC
Confidence 97741 122345579999999999999876 75 789999999999999999999986433222211 11111
Q ss_pred cccccccccCCCCHHH-HHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 596 LMELVDVRIGTYPEEI-ALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 596 ~~~~~d~~l~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
+ .+|... +..+..++.+|++.||.+|+|+.++++
T Consensus 240 ~---------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 240 F---------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred c---------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1 234444 888999999999999999999999994
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.57 Aligned_cols=261 Identities=27% Similarity=0.466 Sum_probs=214.3
Q ss_pred CCCcccccccccCcEEEEEEEec------CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
++|...+.||+|+||.||+++.. ++..+++|.+........+.+.+|+..+++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 56788899999999999999743 345689999876665556789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC
Q 005649 442 VYEYLPNKSLDKFLFDKS-------------KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK 508 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 508 (686)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999997542 1235899999999999999999999987 999999999999999999
Q ss_pred eEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHH
Q 005649 509 PKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLA 587 (686)
Q Consensus 509 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 587 (686)
+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~---- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC---- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----
Confidence 99999999986554332222334456788999999999999999999999999999999 9999876554332211
Q ss_pred HHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCC
Q 005649 588 RRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVP 646 (686)
Q Consensus 588 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 646 (686)
...+...+ .+...+..+.+++.+||+.+|++||++.+|+++|+++..+
T Consensus 238 ---~~~~~~~~--------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 238 ---ITQGRVLE--------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred ---HhCCCCCC--------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11121111 1233456789999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=324.59 Aligned_cols=255 Identities=29% Similarity=0.500 Sum_probs=210.2
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
.++|+..++||+|+||.||+|...+++.|++|.+.... ...+.+.+|+.++++++|+||+++++.+.+.+..++++||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 46789999999999999999998888899999986543 23578999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++++|.+++... ....+++..++.++.|+++||.|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999999654 2345899999999999999999999987 999999999999999999999999999876543221
Q ss_pred ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......++..|+|||++....++.++||||||+++|||++ |+.||......+....+. .+... +
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-------~~~~~----~--- 224 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-------RGYRM----P--- 224 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH-------cCCCC----C---
Confidence 1222345678999999998899999999999999999998 999997654333221111 11000 0
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
.....+..+.+++.+|++.+|++||++++++++|++
T Consensus 225 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 -RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 112345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=328.44 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=204.9
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.|+..+.||+|+||.||++... +|+.||+|++..... .....+.+|+.++.+++|+||+++++.+.+++..++|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677899999999999999865 789999999865432 223467899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999998886532 235899999999999999999999987 9999999999999999999999999998654322
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
. .....|+..|+|||.+.+..++.++|||||||++|||++|+.||...........+.. ......
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---~~~~~~--------- 221 (285)
T cd05631 157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR---RVKEDQ--------- 221 (285)
T ss_pred e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH---Hhhccc---------
Confidence 1 2234689999999999999999999999999999999999999986544322211111 011000
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCC-----HHHHHHH
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPT-----MSATLSM 639 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 639 (686)
..++...+..+.+|+.+||+.||++||+ +.++++.
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1223445677899999999999999997 7888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.76 Aligned_cols=257 Identities=30% Similarity=0.518 Sum_probs=215.2
Q ss_pred hhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
+..+|+..++||+|+||.||+|...+++.+++|.+........+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45678899999999999999999988999999999877665677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999997643 345899999999999999999999987 99999999999999999999999999986643321
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
. .....++..|++||.+.+..++.++||||||+++++|++ |+.||......+....+. ...+.
T Consensus 160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~------~~~~~-------- 223 (261)
T cd05148 160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT------AGYRM-------- 223 (261)
T ss_pred c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH------hCCcC--------
Confidence 1 123345678999999998899999999999999999998 899997655433222111 11000
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+..++..+.+++.+||+.+|++|||++++++.|++.
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 -PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11334567788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=327.72 Aligned_cols=258 Identities=28% Similarity=0.490 Sum_probs=211.1
Q ss_pred hCCCcccccccccCcEEEEEEEecC------CCEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCCcccEEEEEEecCce
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQD------GREIAVKKLATNSMQ-GKEEFENEVRVLLKMQHRNLVQLFGCCVQERER 439 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 439 (686)
.++|.+.+.||+|+||.||+|...+ ++.|++|++...... ..+.+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4568888999999999999998643 478999999765444 457899999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC
Q 005649 440 ILVYEYLPNKSLDKFLFDKS-----------KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK 508 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 508 (686)
+++|||+++++|.+++.... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999997542 2345889999999999999999999987 999999999999999999
Q ss_pred eEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHH
Q 005649 509 PKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLA 587 (686)
Q Consensus 509 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 587 (686)
+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-- 238 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-- 238 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--
Confidence 99999999986543322222223345788999999999999999999999999999998 999997654433222111
Q ss_pred HHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 588 RRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 588 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
.+... ..+...+..+.+++.+||+.||++||++.||++.|++
T Consensus 239 -----~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 -----QGRLL--------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -----cCCcC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11111 1133456778999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=340.57 Aligned_cols=248 Identities=30% Similarity=0.454 Sum_probs=207.7
Q ss_pred CCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecC
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLP 447 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 447 (686)
+.+...+-||.|+.|.||+|+++ ++.||||+++.-. +.+++-|++|+||||+.+.|+|.....++||||||.
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred HHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 33455688999999999999996 6889999885322 457888999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc
Q 005649 448 NKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH 527 (686)
Q Consensus 448 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 527 (686)
.|-|...|... ..++......|.++||.|+.|||.+. |+|||||+=||||.-+..+||+|||-++.+.+..+
T Consensus 196 ~GqL~~VLka~---~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST-- 267 (904)
T KOG4721|consen 196 QGQLYEVLKAG---RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKST-- 267 (904)
T ss_pred cccHHHHHhcc---CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhh--
Confidence 99999999654 44888999999999999999999986 99999999999999999999999999998765432
Q ss_pred cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC-C
Q 005649 528 RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG-T 606 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~ 606 (686)
.....||..|||||++.+.+.++|.||||||||||||+||..||....... +.| .-|. -.|. .
T Consensus 268 -kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIw-----GVGs------NsL~Lp 331 (904)
T KOG4721|consen 268 -KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIW-----GVGS------NSLHLP 331 (904)
T ss_pred -hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEE-----eccC------Cccccc
Confidence 233689999999999999999999999999999999999999997433221 111 1110 0111 2
Q ss_pred CCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCC
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPI 647 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 647 (686)
.|..+++-+.-|+++||+..|.+||++++++..|+-...++
T Consensus 332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 36678888999999999999999999999999998765544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=334.55 Aligned_cols=247 Identities=27% Similarity=0.404 Sum_probs=211.0
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+... .+.+.+.+|++++++++||||+.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46778889999999999999976 678899999966533 345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+.+ +|..+|.... .+++..+..++.|+..||.|||+.+ |.|||+||.|||++.++.+|++|||+|+....
T Consensus 82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-- 152 (808)
T ss_pred hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc--
Confidence 9976 9999996544 4999999999999999999999987 99999999999999999999999999997654
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
.......+.||+-|||||...+..|+..+|+||+||++||+++|++||..... ..+++ .+..+ +.
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si---~~Lv~---~I~~d-~v-------- 217 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI---TQLVK---SILKD-PV-------- 217 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH---HHHHH---HHhcC-CC--------
Confidence 23345678999999999999999999999999999999999999999974322 22222 22111 11
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
..|...+..+.+++...+++||.+|.|..+++..
T Consensus 218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1255778889999999999999999999998764
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=327.30 Aligned_cols=259 Identities=24% Similarity=0.429 Sum_probs=208.7
Q ss_pred hhCCCcccccccccCcEEEEEEEec------CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCc
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERE 438 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 438 (686)
.+++|+..+.||+|+||.||+|... .+..||+|++.... .....+|.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999753 34679999986432 2345678999999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEE
Q 005649 439 RILVYEYLPNKSLDKFLFDKSK-------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKI 511 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 511 (686)
.++|+||+++|+|.+++..... ...+++..++.++.|+++||.|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999865322 234688999999999999999999987 999999999999999999999
Q ss_pred EecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHH
Q 005649 512 SDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRL 590 (686)
Q Consensus 512 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 590 (686)
+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |..||......+....+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~------ 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV------ 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------
Confidence 99999986654333222223345778999999999999999999999999999999 78898765443322111
Q ss_pred HhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 591 EEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 591 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+.. ...+...+..+.+++.+||+.+|++|||+.|++++|++
T Consensus 235 -~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 -MEGGL--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -HcCCc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111 11133445678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=307.88 Aligned_cols=236 Identities=29% Similarity=0.409 Sum_probs=205.4
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc---cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ---GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|+..+.||.|+||+|.+.+.+ +|.-+|+|++.+.... ..+...+|..+|+.+.||.++++.+.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 67888999999999999999977 6888999999776443 3456788999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||.++|-|..+|+.. +.+++.....++.||+.||+|||+.+ |++|||||+|||||.+|.+||.|||+|+.+..
T Consensus 124 eyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred eccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 999999999999654 45999999999999999999999987 99999999999999999999999999997754
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
.+...+||+.|+|||.+....+....|.|+|||++|||+.|.+||...+.....+.+- ++.+
T Consensus 197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~-------~~~v------- 258 (355)
T KOG0616|consen 197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL-------EGKV------- 258 (355)
T ss_pred ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH-------hCcc-------
Confidence 3556899999999999999999999999999999999999999998665533322211 1111
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCC
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDR 630 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~R 630 (686)
.+|.-....+.+|+...++.|-.+|
T Consensus 259 --~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 --KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2466677889999999999999999
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=323.34 Aligned_cols=256 Identities=30% Similarity=0.490 Sum_probs=210.6
Q ss_pred hhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
..++|+..+.||+|++|.||+|...+++.|++|.++... ...+++.+|+.++++++|+||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 456789999999999999999998888899999986543 3456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999996543 345899999999999999999999987 99999999999999999999999999987653221
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
. .......+..|+|||++.+..++.++||||||+++|||++ |+.||......+....+. .....
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~------~~~~~-------- 223 (261)
T cd05068 159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD------QGYRM-------- 223 (261)
T ss_pred c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH------cCCCC--------
Confidence 1 1111223467999999999999999999999999999999 999997654333221111 10000
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+...+..+.+++.+|++.+|++||++.++++.|++
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1133456778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.16 Aligned_cols=260 Identities=30% Similarity=0.460 Sum_probs=206.6
Q ss_pred hhCCCcccccccccCcEEEEEEEec------CCCEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecC
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNS-MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQER 437 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 437 (686)
..++|+..+.||+|+||.||+++.. ++..||+|++.... ....+.+.+|+.+++.+ +|+||+++++++.+.+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3467899999999999999998742 34579999997543 23346788999999999 8999999999999999
Q ss_pred ceEEEEeecCCCChhHHHhhcCC---------------------------------------------------------
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSK--------------------------------------------------------- 460 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 460 (686)
..++||||+++|+|.+++.....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999999864211
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccccc
Q 005649 461 ----------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTH 530 (686)
Q Consensus 461 ----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 530 (686)
...+++.++++++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 124788999999999999999999987 9999999999999999999999999998654332222222
Q ss_pred ccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCH
Q 005649 531 QIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPE 609 (686)
Q Consensus 531 ~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 609 (686)
...++..|+|||++.+..++.++||||||+++|||++ |+.||......... . .....+. .+ ..+.
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~--~----~~~~~~~-----~~---~~~~ 338 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF--Y----KMVKRGY-----QM---SRPD 338 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH--H----HHHHccc-----Cc---cCCC
Confidence 3345678999999999999999999999999999997 99999754332211 1 1111110 00 0122
Q ss_pred HHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 610 EIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 610 ~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+..+.+++.+||+.||++|||+.+|+++|++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 235678999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=330.49 Aligned_cols=246 Identities=26% Similarity=0.348 Sum_probs=205.2
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|+..+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47888999999999999999976 68999999986532 223466889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++... ..+++.....++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 999999999999653 34899999999999999999999987 999999999999999999999999999865432
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+. . +..
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~------~-~~~------- 215 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL------A-GKL------- 215 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------h-CCc-------
Confidence 123468999999999999899999999999999999999999998655433222111 1 110
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCC-----HHHHHHHh
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPT-----MSATLSML 640 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~L 640 (686)
.++......+.+++.+||+.||.+||+ +.|+++.-
T Consensus 216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 123344567889999999999999995 88887664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=323.27 Aligned_cols=256 Identities=28% Similarity=0.489 Sum_probs=208.8
Q ss_pred hCCCcccccccccCcEEEEEEEecC----CCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQD----GREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
.++|+..+.||+|+||.||+|++.. ...|++|.+.... .....+|.+|+.++++++||||+++++++.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3678999999999999999998752 4578999986543 3335678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
+|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999999996533 36899999999999999999999987 9999999999999999999999999998775
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
............++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+. .+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~~--- 227 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-------DGYRL--- 227 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-------cCCCC---
Confidence 3222222223345678999999999999999999999999999998 999997544333221111 11000
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+...+..+.+++.+||+.+|++||++.||++.|++
T Consensus 228 -----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 228 -----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1123445678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=379.56 Aligned_cols=259 Identities=26% Similarity=0.479 Sum_probs=212.7
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
..+...++||+|+||.||+|+.. +++.||||++...... ...|++.+++++||||++++|++.+++..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 45778889999999999999974 7899999998643322 235688999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++|+|.++++. ++|..+..++.|+++||+|||....++|+||||||+||+++.++..++. ||........
T Consensus 766 ~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 766 EGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 99999999942 8999999999999999999997655679999999999999999888875 6655433211
Q ss_pred ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC-
Q 005649 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG- 605 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~- 605 (686)
....++..|+|||++.+..++.|+|||||||++|||+||+.||+.... .......|.+.........+.+|+.+.
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccC
Confidence 123678999999999999999999999999999999999999964322 223445555555444555667777663
Q ss_pred --CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 606 --TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 606 --~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
..+.+...++.+++.+||+.+|++||||.||++.|++..
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 334567778999999999999999999999999998764
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=327.72 Aligned_cols=260 Identities=28% Similarity=0.478 Sum_probs=211.3
Q ss_pred hCCCcccccccccCcEEEEEEEec------CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
.++|.+.+.||+|+||.||++... ++..+++|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 467889999999999999999852 34568999887665555678999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeE
Q 005649 441 LVYEYLPNKSLDKFLFDKS----------KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPK 510 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 510 (686)
+++||+++++|.+++.... ....+++..++.++.|++.+|.|||+++ ++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999996532 1234899999999999999999999987 99999999999999999999
Q ss_pred EEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHH
Q 005649 511 ISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARR 589 (686)
Q Consensus 511 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 589 (686)
|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i----- 235 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI----- 235 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----
Confidence 999999986643332222233445778999999999999999999999999999998 99998765443321111
Q ss_pred HHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 590 LEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 590 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
..+... ..+...+..+.+++.+||+.+|.+|||+.++++.|++..
T Consensus 236 --~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 236 --TQGRVL--------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred --HcCCcC--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 111111 012224456899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=325.56 Aligned_cols=257 Identities=30% Similarity=0.476 Sum_probs=208.0
Q ss_pred CCCcccccccccCcEEEEEEEe-----cCCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRL-----QDGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
++|+..+.||+|+||.||+|.. .+++.+++|.+.... ......+.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5688889999999999999984 246789999997533 2334678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 005649 442 VYEYLPNKSLDKFLFDKSK--------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM 507 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 507 (686)
+|||+++++|.+++..... ...+++...+.++.|++.||.|||+++ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999864321 234889999999999999999999987 99999999999999999
Q ss_pred CeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHH
Q 005649 508 KPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKL 586 (686)
Q Consensus 508 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 586 (686)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||......+....+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~- 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR- 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 999999999987644332222333445778999999998899999999999999999999 999997544332222111
Q ss_pred HHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 587 ARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 587 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..... ..+...+..+.+++.+||+.+|++||++.+|++.|..
T Consensus 241 ------~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 ------KRQLL--------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ------cCCcC--------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111 1133455678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=332.38 Aligned_cols=255 Identities=27% Similarity=0.465 Sum_probs=205.2
Q ss_pred CCCcccccccccCcEEEEEEEec-CCC----EEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGR----EIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
.+|+..+.||+|+||.||+|++. +++ .||+|++.... ....+++.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 57899999999999999999864 343 38999986543 33456789999999999999999999999764 5779
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
++||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 999999999999996532 34889999999999999999999987 9999999999999999999999999998765
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
............++..|++||.+.+..++.++||||||+++|||++ |+.||......+...... ....+
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~------~~~~~---- 230 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE------KGERL---- 230 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh------CCCCC----
Confidence 4332222222344678999999999999999999999999999998 999997654433221111 11110
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+..+...+.+++.+||+.+|++||++.+++..|...
T Consensus 231 -----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 231 -----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11223456788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=327.61 Aligned_cols=265 Identities=26% Similarity=0.356 Sum_probs=208.2
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.++|+..+.||+|+||.||+++.. ++..+|+|.+..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999976 678899998865432 334679999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++|+|.+++... ..+++..+..++.|++.||.|||+++ .|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 99999999999653 34899999999999999999999853 39999999999999999999999999987654322
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCc---------
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGR--------- 595 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 595 (686)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||......+....+.........+.
T Consensus 159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 2334689999999999999999999999999999999999999976554433221110000000000
Q ss_pred ------------------ccccccccc----CC-CCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 596 ------------------LMELVDVRI----GT-YPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 596 ------------------~~~~~d~~l----~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
..+..+... .. .....+.++.+++.+||+.||++|||+.|+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000000000 00 0113456799999999999999999999998765
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=324.96 Aligned_cols=263 Identities=22% Similarity=0.267 Sum_probs=212.6
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc---cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ---GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
..++|+.+..||+|+||.||+++-+ .|..+|+|++++.... ..+....|-.+|...++|.||+|+..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4689999999999999999999976 6899999999876543 34567789999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||++||++-.+|.. .+.|++.....++.+++.|+..||+.| ++||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL~~---~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR---KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHh---cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 9999999999999954 456999999999999999999999988 9999999999999999999999999985321
Q ss_pred C----------------------cCccc----c-------------------ccccccCCCcCchhhhhcCCCChhHHHH
Q 005649 522 D----------------------EQSRH----R-------------------THQIAGTFGYMAPEYAIRGFLSVKSDVF 556 (686)
Q Consensus 522 ~----------------------~~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~s~ksDv~ 556 (686)
. .+... . .....|||.|||||++.+..|...+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 00000 0 1124799999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCC---H
Q 005649 557 SFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPT---M 633 (686)
Q Consensus 557 s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt---~ 633 (686)
|+|||+|||+.|-+||......+....+...+..+.. ........+..++|.+|+. ||++|-. +
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f------------P~~~~~s~eA~DLI~rll~-d~~~RLG~~G~ 439 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF------------PEEVDLSDEAKDLITRLLC-DPENRLGSKGA 439 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC------------CCcCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence 9999999999999999987776655433322222210 0122345778899999999 9999975 6
Q ss_pred HHHHHHhcCCCCCC
Q 005649 634 SATLSMLSNSSVPI 647 (686)
Q Consensus 634 ~evl~~L~~~~~~~ 647 (686)
.||-+.--...++|
T Consensus 440 ~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 440 EEIKKHPFFKGVDW 453 (550)
T ss_pred HHHhcCCccccCCc
Confidence 66666553334443
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=320.08 Aligned_cols=252 Identities=31% Similarity=0.515 Sum_probs=206.4
Q ss_pred CCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecC
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLP 447 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 447 (686)
++|+..+.||+|+||.||+++..++..+++|.+.... ...+.|.+|+.++.+++||||+++++++.+.+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4678889999999999999998877789999987543 335679999999999999999999999998888999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc
Q 005649 448 NKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH 527 (686)
Q Consensus 448 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 527 (686)
+|+|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 999999986533 25899999999999999999999987 999999999999999999999999998866443221
Q ss_pred cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCC
Q 005649 528 RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 606 (686)
......++..|++||.+.+..++.++||||||+++|||++ |+.||......+....+ ....+. .
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~------~~~~~~---------~ 221 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV------SQGLRL---------Y 221 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH------hcCCCC---------C
Confidence 1112345678999999998889999999999999999999 99999755443322111 111000 0
Q ss_pred CCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
.+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 12234577899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=348.09 Aligned_cols=252 Identities=21% Similarity=0.284 Sum_probs=207.4
Q ss_pred CCcccccccccCcEEEEEEEec-C-CCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-D-GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~-g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
.|...+.||+|+||.||++... + ++.|++|.+..........+.+|+.+++.++||||+++++++..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999865 3 6778888876555555567888999999999999999999999999999999999
Q ss_pred CCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 447 PNKSLDKFLFDK-SKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 447 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
++|+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988653 23446899999999999999999999987 99999999999999999999999999987654333
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... ... +.. .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~------~~~-~~~--------~ 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ------VLY-GKY--------D 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHh-CCC--------C
Confidence 2233445789999999999999999999999999999999999999976544332111 111 111 1
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
..+...+..+.+++.+||+.+|++||++.++++
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 123345567899999999999999999999864
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=332.65 Aligned_cols=254 Identities=21% Similarity=0.286 Sum_probs=208.2
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999986 58899999997542 233467889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 999999999999543 35899999999999999999999987 99999999999999999999999999986543
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
......|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+........ .+.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------~~~ 221 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ--------RPV 221 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc--------CCC
Confidence 22345789999999999999999999999999999999999999986654443222211100000 000
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
........+..+.+++.+||+.+|++||++.++++.-
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 0000123467788999999999999999999999764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.59 Aligned_cols=249 Identities=30% Similarity=0.429 Sum_probs=200.8
Q ss_pred ccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCCh
Q 005649 374 NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSL 451 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL 451 (686)
+.||+|+||.||+|+.. +++.+++|.+.... ......+.+|++++++++||||+++++++..+...++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999975 78899999876432 33456799999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccc
Q 005649 452 DKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQ 531 (686)
Q Consensus 452 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 531 (686)
.+++... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++.............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998643 235899999999999999999999987 99999999999999999999999999876543221111112
Q ss_pred cccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHH
Q 005649 532 IAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEE 610 (686)
Q Consensus 532 ~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 610 (686)
...+..|+|||.+.++.++.++||||||+++|||++ |..||......+....+. .... ...+..
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~------~~~~---------~~~~~~ 220 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE------QGVR---------LPCPEL 220 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH------cCCC---------CCCccc
Confidence 233567999999999999999999999999999998 889987544332211111 1000 012334
Q ss_pred HHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 611 IALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 611 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
.+..+.+++.+|++.+|++|||+.+|+++|+.
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 56788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=330.48 Aligned_cols=242 Identities=24% Similarity=0.282 Sum_probs=199.6
Q ss_pred ccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCC
Q 005649 374 NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNK 449 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~g 449 (686)
+.||+|+||.||+++.. +|+.+|+|++.... ......+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 78999999997542 223456788999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccc
Q 005649 450 SLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRT 529 (686)
Q Consensus 450 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 529 (686)
+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~ 152 (323)
T cd05571 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cc
Confidence 999988643 35899999999999999999999987 99999999999999999999999999875432211 22
Q ss_pred cccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCH
Q 005649 530 HQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPE 609 (686)
Q Consensus 530 ~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 609 (686)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||...........+ .. +.. .++.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~------~~-~~~---------~~p~ 216 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LM-EEI---------RFPR 216 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH------Hc-CCC---------CCCC
Confidence 3457899999999999999999999999999999999999999765433322111 11 110 1234
Q ss_pred HHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 005649 610 EIALRFMQIALLCTEDFIEDRP-----TMSATLSM 639 (686)
Q Consensus 610 ~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 639 (686)
..+..+.+++.+||+.||++|| ++.++++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 4567788999999999999999 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.56 Aligned_cols=256 Identities=29% Similarity=0.436 Sum_probs=209.1
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
..+|+..+.||+|+||.||+|..+ .++.+++|++... ....+++.+|++.+.+++|+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 356888899999999999999876 5888999998654 33456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++.... ...+++..++.++.|+++||.|||+++ ++||||||+||++++++.+||+|||+++.......
T Consensus 84 ~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 99999999986533 345899999999999999999999987 99999999999999999999999999987654322
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
. ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+ .. +. .
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~------~~-~~-~------- 223 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL------EK-GY-R------- 223 (263)
T ss_pred e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------HC-CC-C-------
Confidence 1 1112234668999999999999999999999999999998 99999765433321111 11 10 0
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
...+...+..+.+++.+||+.+|++||++.+++++|++.
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 012334567799999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=334.34 Aligned_cols=245 Identities=24% Similarity=0.336 Sum_probs=204.1
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|+..+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 67889999999999999999976 68899999986542 233467889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999999653 34889999999999999999999987 999999999999999999999999999866432
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
. ....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+... .. ..+..
T Consensus 172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~------~i-~~~~~------- 232 (329)
T PTZ00263 172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE------KI-LAGRL------- 232 (329)
T ss_pred c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH------HH-hcCCc-------
Confidence 2 23468999999999999999999999999999999999999997554332211 11 11111
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCC-----HHHHHHH
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPT-----MSATLSM 639 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 639 (686)
..+...+..+.+++.+||+.||++||+ +.++++.
T Consensus 233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112334567889999999999999997 6777754
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=338.07 Aligned_cols=261 Identities=27% Similarity=0.412 Sum_probs=208.8
Q ss_pred hhCCCcccccccccCcEEEEEEEec------CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcC-CCCcccEEEEEEecC
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQER 437 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 437 (686)
..++|++.++||+|+||.||+|+.. .+..||||++..... ...+.+.+|+.+++++. ||||+++++++.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 4678899999999999999999853 234699999965433 33467999999999996 999999999999999
Q ss_pred ceEEEEeecCCCChhHHHhhcCC---------------------------------------------------------
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSK--------------------------------------------------------- 460 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 460 (686)
..+|||||+++|+|.++++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999999865311
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 005649 461 ------------------------------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD 504 (686)
Q Consensus 461 ------------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 504 (686)
...+++..++.++.||++||.|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 124788899999999999999999987 99999999999999
Q ss_pred CCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHH
Q 005649 505 HQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQEL 583 (686)
Q Consensus 505 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~ 583 (686)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..........
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~- 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY- 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH-
Confidence 999999999999987644332222223456788999999999999999999999999999997 999987543322110
Q ss_pred HHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 584 LKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 584 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
.....+... ..+...+..+.+++.+||+.+|++||++.+|.++|+..
T Consensus 351 -----~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 351 -----NKIKSGYRM--------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred -----HHHhcCCCC--------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 111111000 11334567789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.77 Aligned_cols=252 Identities=31% Similarity=0.505 Sum_probs=205.7
Q ss_pred CCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecC
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLP 447 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 447 (686)
.+|++.+.||+|+||.||+++.+++..+++|++.... ...+.|.+|+.++++++|+||+++++++.+.+..++|+||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4578889999999999999998877889999986433 234678899999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc
Q 005649 448 NKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH 527 (686)
Q Consensus 448 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 527 (686)
+++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++...+....
T Consensus 83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 999999996533 35899999999999999999999987 999999999999999999999999999865432211
Q ss_pred cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCC
Q 005649 528 RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 606 (686)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. . +. .. .
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------~-~~-----~~---~ 221 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS------A-GY-----RL---Y 221 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH------c-CC-----cC---C
Confidence 1112234567999999999999999999999999999999 899997654433221111 1 10 00 1
Q ss_pred CCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
.+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 12335677999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.52 Aligned_cols=258 Identities=26% Similarity=0.448 Sum_probs=209.1
Q ss_pred hCCCcccccccccCcEEEEEEEec------CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
.+++...++||+|+||.||++... ++..+++|.+........+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 357788899999999999999742 35678999887666666778999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC
Q 005649 441 LVYEYLPNKSLDKFLFDKSK------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK 508 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 508 (686)
+++||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999999975421 134899999999999999999999987 999999999999999999
Q ss_pred eEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHH
Q 005649 509 PKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLA 587 (686)
Q Consensus 509 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 587 (686)
+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+......
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-- 238 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT-- 238 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH--
Confidence 99999999876543322222223345678999999999999999999999999999998 999987544433221111
Q ss_pred HHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 588 RRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 588 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..... ..+...+..+.+++.+||+.+|++||++.||++.|+.
T Consensus 239 ----~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 239 ----QGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ----cCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 10000 1122345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.48 Aligned_cols=259 Identities=31% Similarity=0.481 Sum_probs=207.7
Q ss_pred hhCCCcccccccccCcEEEEEEEecC------CCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCc
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQD------GREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERE 438 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 438 (686)
++++|...+.||+|++|.||+|.+.+ +..|++|.+.... ......|.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45789999999999999999998753 5678888886443 2334678999999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC---CeEE
Q 005649 439 RILVYEYLPNKSLDKFLFDKSK----SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM---KPKI 511 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 511 (686)
.++++||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976432 235899999999999999999999987 99999999999998755 5999
Q ss_pred EecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHH
Q 005649 512 SDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRL 590 (686)
Q Consensus 512 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 590 (686)
+|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||......+....+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~----- 235 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT----- 235 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----
Confidence 99999987643322222222334568999999999999999999999999999997 999998655443222111
Q ss_pred HhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 591 EEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 591 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..... ..+...+..+.+++.+|++.+|++||++.+|++.|++
T Consensus 236 -~~~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 236 -GGGRL---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred -cCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 11111 1233445678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=322.20 Aligned_cols=256 Identities=27% Similarity=0.411 Sum_probs=203.9
Q ss_pred CCCcccccccccCcEEEEEEEec-CCC----EEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGR----EIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
++|+..+.||+|+||.||+|.+. +++ .+++|.+..... ....++..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 57788899999999999999874 344 477777754322 23457788888999999999999999875 456789
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
++||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 999999999999996532 35899999999999999999999987 9999999999999999999999999998764
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
............++..|++||.+.++.++.++||||||+++|||++ |+.||......+....+. .+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~~-- 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-------KGERLA-- 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CCCcCC--
Confidence 4332222334567788999999999999999999999999999998 999997655443322221 111100
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
.+......+.+++.+||..+|++|||+.|+++.|....
T Consensus 232 ------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 232 ------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11223456788999999999999999999999997744
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=323.27 Aligned_cols=261 Identities=25% Similarity=0.396 Sum_probs=211.1
Q ss_pred hhCCCcccccccccCcEEEEEEEecC-----CCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEe-cCc
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQD-----GREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ-ERE 438 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 438 (686)
..++|+..++||+|+||.||+|...+ +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999999765 6889999886542 3345678899999999999999999999876 467
Q ss_pred eEEEEeecCCCChhHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKS-----AILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISD 513 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 513 (686)
.++++||+++++|.+++...... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999999664322 46899999999999999999999987 99999999999999999999999
Q ss_pred cCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHh
Q 005649 514 FGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEE 592 (686)
Q Consensus 514 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 592 (686)
||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||......+.. .+ ...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~---~~~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA---AY---LKD 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH---HH---HHc
Confidence 999986654433222233456778999999998899999999999999999999 99999754432221 11 111
Q ss_pred cCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 593 EGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 593 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
...+. .+...+..+.+++.+||+.+|++|||+.++++.|+...
T Consensus 235 ~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 GYRLA---------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CCCCC---------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11110 12234567899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=324.11 Aligned_cols=257 Identities=26% Similarity=0.458 Sum_probs=207.8
Q ss_pred CCCcccccccccCcEEEEEEEec------CCCEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNSMQ-GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
.+|+..+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 35677889999999999999864 2478999999754432 2467889999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 005649 441 LVYEYLPNKSLDKFLFDKS-------------KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM 507 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 507 (686)
+++||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985321 1234889999999999999999999987 99999999999999999
Q ss_pred CeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHH
Q 005649 508 KPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKL 586 (686)
Q Consensus 508 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 586 (686)
.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..||......+....+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~- 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR- 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 999999999886644332222334456789999999998899999999999999999998 888987654433221111
Q ss_pred HHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 587 ARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 587 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
.+. ....+.+.+..+.+++..||+.+|++||++++|++.|+.
T Consensus 241 ------~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 ------NRQ--------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ------cCC--------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111 112234566778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=321.33 Aligned_cols=264 Identities=22% Similarity=0.309 Sum_probs=204.3
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
++|++.+.||+|+||.||+++.+ +++.+|+|++.... ....+.+.+|+.++.+++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47889999999999999999986 67889999986542 2335678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|++++.+..+... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 9998877655422 245899999999999999999999987 9999999999999999999999999998764322
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH--------HH-HhcCc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR--------RL-EEEGR 595 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~-~~~~~ 595 (686)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.||......+....+.... .. .....
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 NA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred cc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 11 2233568999999999999899999999999999999999999998654433221111100 00 00000
Q ss_pred cccccccccC-------CCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 596 LMELVDVRIG-------TYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 596 ~~~~~d~~l~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
......+... .+....+..+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 111224567999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=322.61 Aligned_cols=263 Identities=23% Similarity=0.320 Sum_probs=203.5
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
++|+..++||+|+||.||+|+.+ +++.||+|++..... .....+.+|+.++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 67899999999999999999876 688999999865432 2345678999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
++ |+|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LD-SDLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CC-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 97 5898888543 234789999999999999999999987 99999999999999999999999999876543221
Q ss_pred cccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccc------
Q 005649 526 RHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME------ 598 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 598 (686)
......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......+....+...........+..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 1233467899999998875 5689999999999999999999999987655443332221110000000100
Q ss_pred ---ccccccC-----CCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 599 ---LVDVRIG-----TYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 599 ---~~d~~l~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
...+... .........+.+++.+|++.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0111100 001123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=327.80 Aligned_cols=242 Identities=24% Similarity=0.295 Sum_probs=198.7
Q ss_pred ccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCC
Q 005649 374 NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNK 449 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~g 449 (686)
+.||+|+||.||+++.. +|+.||+|++.... ......+.+|++++++++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999875 68999999997542 223456788999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccc
Q 005649 450 SLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRT 529 (686)
Q Consensus 450 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 529 (686)
+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~ 152 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cc
Confidence 999888543 35899999999999999999999987 99999999999999999999999999875332211 12
Q ss_pred cccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCH
Q 005649 530 HQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPE 609 (686)
Q Consensus 530 ~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 609 (686)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+....+. . +.. ..+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~------~-~~~---------~~p~ 216 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------M-EEI---------RFPR 216 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh------c-CCC---------CCCC
Confidence 33568999999999999999999999999999999999999997654433221111 0 000 1233
Q ss_pred HHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 005649 610 EIALRFMQIALLCTEDFIEDRP-----TMSATLSM 639 (686)
Q Consensus 610 ~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 639 (686)
..+..+.+++.+||+.||++|| ++.++++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 4566788999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=322.91 Aligned_cols=257 Identities=30% Similarity=0.451 Sum_probs=206.3
Q ss_pred CCcccccccccCcEEEEEEEec------CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
+|+..+.||+|+||.||+|+.. ....+++|.+..... ...+++.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 235688888865432 335678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 005649 442 VYEYLPNKSLDKFLFDKS---------------------KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASN 500 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 500 (686)
++||+.+|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999986421 1234889999999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHh
Q 005649 501 ILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAE 579 (686)
Q Consensus 501 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~ 579 (686)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986643332222223345678999999988899999999999999999999 999997654433
Q ss_pred HHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 580 NQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..... ..+... ..+...+..+.+++.+||+.+|++||++.++++.|++.
T Consensus 238 ~~~~~-------~~~~~~--------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 238 LFNLL-------KTGYRM--------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred HHHHH-------hCCCCC--------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 22211 111000 11233456788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=318.01 Aligned_cols=254 Identities=26% Similarity=0.431 Sum_probs=200.3
Q ss_pred cccccccccCcEEEEEEEecCC-C--EEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEec------Cce
Q 005649 371 STKNMLGRGGFGTVYKGRLQDG-R--EIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE------RER 439 (686)
Q Consensus 371 ~~~~~LG~G~fG~Vy~~~~~~g-~--~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 439 (686)
.+.++||+|+||.||+|++.+. . .+|+|.++.. .....+.+.+|+.++++++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4568899999999999997643 3 5899988654 233456789999999999999999999988542 246
Q ss_pred EEEEeecCCCChhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCC
Q 005649 440 ILVYEYLPNKSLDKFLFDKS---KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGL 516 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 516 (686)
++++||+++|+|.+++.... ....+++...+.++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999999885322 2345899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCc
Q 005649 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGR 595 (686)
Q Consensus 517 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 595 (686)
++...............++..|++||.+.+..++.++||||||+++|||++ |+.||......+... . .. .+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~---~---~~-~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD---Y---LR-QGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---H---HH-cCC
Confidence 987654332211223345678999999999999999999999999999999 889997544332211 1 11 111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 596 LMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 596 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
.. ..+...+..+.+++.+||+.+|++|||+.+|++.|++
T Consensus 232 ~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 232 RL--------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 10 1122345668999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=321.41 Aligned_cols=265 Identities=23% Similarity=0.377 Sum_probs=206.4
Q ss_pred hCCCcccccccccCcEEEEEEEecC---------------CCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQD---------------GREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLF 430 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~---------------g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~ 430 (686)
.++|++.+.||+|+||.||+++..+ ...|++|.+.... ....+.|.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4678999999999999999987642 1248999986542 33456799999999999999999999
Q ss_pred EEEEecCceEEEEeecCCCChhHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcE
Q 005649 431 GCCVQERERILVYEYLPNKSLDKFLFDKSK---------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNI 501 (686)
Q Consensus 431 ~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 501 (686)
+++......++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999965321 124789999999999999999999987 99999999999
Q ss_pred EEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc--CCCCCcccchHh
Q 005649 502 LLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS--GRKNYDRQLEAE 579 (686)
Q Consensus 502 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt--G~~p~~~~~~~~ 579 (686)
++++++.+||+|||++................++..|+|||.+.++.++.++||||||++++||++ |..||......+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999986543322222223345778999999999999999999999999999998 667877554433
Q ss_pred HHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 580 NQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
...... ........... ...+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 241 ~~~~~~---~~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 VIENTG---EFFRNQGRQIY-----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHH---Hhhhhcccccc-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 222111 11110000000 01122345689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=346.39 Aligned_cols=260 Identities=26% Similarity=0.338 Sum_probs=210.1
Q ss_pred HHHHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecC-
Q 005649 362 VLIAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER- 437 (686)
Q Consensus 362 ~l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~- 437 (686)
+.....++|.+.++||+|+||.||+++.. +|+.||||++.... ......+.+|+..+..++|+|++++++.+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 33445689999999999999999999865 78999999986543 334467889999999999999999988775432
Q ss_pred -------ceEEEEeecCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCe
Q 005649 438 -------ERILVYEYLPNKSLDKFLFDKS-KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP 509 (686)
Q Consensus 438 -------~~~lv~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 509 (686)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 3579999999999999997543 2346899999999999999999999987 9999999999999999999
Q ss_pred EEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHH
Q 005649 510 KISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARR 589 (686)
Q Consensus 510 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 589 (686)
||+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||......+....
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~------ 256 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK------ 256 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH------
Confidence 99999999876543322233446799999999999999999999999999999999999999986544332111
Q ss_pred HHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 590 LEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 590 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.. .+.. ...+...+..+.+++.+||+.+|++||++.++++.
T Consensus 257 ~~-~~~~--------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TL-AGRY--------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred Hh-cCCC--------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 1111 11234456778999999999999999999999864
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.90 Aligned_cols=252 Identities=30% Similarity=0.450 Sum_probs=217.0
Q ss_pred CCcccccccccCcEEEEEEEec--CCC--EEEEEEecccCcc-cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ--DGR--EIAVKKLATNSMQ-GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~--~g~--~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
+....++||+|.||.|++|.|+ +|+ .||||.+...... ...+|.+|+.+|.+|+|+|+++|+|+..+ ....+|+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3455689999999999999986 344 5799999876555 67899999999999999999999999888 6788999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
|.++.|+|.+.|+. .....|-......++.|||.||.||.++. +|||||..+|+||-....+||+||||.+.+...
T Consensus 190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999987 45567888999999999999999999987 999999999999999999999999999988754
Q ss_pred Cccc-cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 524 QSRH-RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 524 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
+... ......-+..|+|||.+...+++.++|||+|||+||||+| |+.||.+.......+.++...++.
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLp---------- 335 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLP---------- 335 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCC----------
Confidence 4332 3344566788999999999999999999999999999999 999999877766655555333332
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
-++.++++++++++.||..+|++|||+..|++.+
T Consensus 336 -----RPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 336 -----RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred -----CCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 2778999999999999999999999999997443
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=325.68 Aligned_cols=265 Identities=25% Similarity=0.356 Sum_probs=205.2
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.++|+..++||+|+||.||+++.. ++..+++|++.... ....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999987 67888999886542 2334678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++|+|.+++... ..+++.....++.|++.||.|||+.+ +|+|+||||+|||+++++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 99999999999643 34889999999999999999999753 39999999999999999999999999987653321
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhc-----------
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEE----------- 593 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----------- 593 (686)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+..............
T Consensus 159 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred ----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 22346889999999999889999999999999999999999999765443222111100000000
Q ss_pred --------------CccccccccccC----CCC-HHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 594 --------------GRLMELVDVRIG----TYP-EEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 594 --------------~~~~~~~d~~l~----~~~-~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
.....+.+.... ..+ ...+.++.+++.+||+.||++|||+.|+++.-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~ 300 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA 300 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence 000000000000 000 11345688999999999999999999997643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=329.23 Aligned_cols=242 Identities=24% Similarity=0.288 Sum_probs=199.7
Q ss_pred ccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCC
Q 005649 374 NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNK 449 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~g 449 (686)
+.||+|+||.||+++.. +|+.||+|++.... ......+.+|+.+++.++||||+++.+++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999875 68999999997542 233467889999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccc
Q 005649 450 SLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRT 529 (686)
Q Consensus 450 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 529 (686)
+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~ 152 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TM 152 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cc
Confidence 999888543 35899999999999999999999987 99999999999999999999999999875432211 22
Q ss_pred cccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCH
Q 005649 530 HQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPE 609 (686)
Q Consensus 530 ~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 609 (686)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+....+. . +. . .++.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~------~-~~------~---~~p~ 216 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------M-ED------I---KFPR 216 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc------c-CC------c---cCCC
Confidence 34578999999999999999999999999999999999999997654433221111 0 00 0 1234
Q ss_pred HHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 005649 610 EIALRFMQIALLCTEDFIEDRP-----TMSATLSM 639 (686)
Q Consensus 610 ~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 639 (686)
..+..+.+++.+||+.||++|| ++.|+++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 4566788999999999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.86 Aligned_cols=262 Identities=29% Similarity=0.442 Sum_probs=211.5
Q ss_pred HHhhCCCcccccccccCcEEEEEEEecC------CCEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCCcccEEEEEEe
Q 005649 364 IAATDNFSTKNMLGRGGFGTVYKGRLQD------GREIAVKKLATNS-MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQ 435 (686)
Q Consensus 364 ~~at~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 435 (686)
....++|+..+.||+|+||.||++...+ ...+++|.+.... .....++.+|+.++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3455788999999999999999998642 3578999887542 23345788999999999 89999999999999
Q ss_pred cCceEEEEeecCCCChhHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 005649 436 ERERILVYEYLPNKSLDKFLFDK-------------SKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNIL 502 (686)
Q Consensus 436 ~~~~~lv~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 502 (686)
++..+++|||+++|+|..++... .....+++..++.++.|++.||.|||+.+ |+||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence 99999999999999999999643 22356899999999999999999999987 999999999999
Q ss_pred EcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHH
Q 005649 503 LDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQ 581 (686)
Q Consensus 503 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~ 581 (686)
+++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||......+..
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 99999999999999987654333222333445678999999999999999999999999999998 99998765443322
Q ss_pred HHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 582 ELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+. .+.. ...+......+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 245 ~~~~-------~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 245 KLLK-------EGYR--------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHH-------cCCc--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 2111 1110 011334466788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=314.93 Aligned_cols=254 Identities=31% Similarity=0.529 Sum_probs=207.0
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
.++|++.++||+|+||.||+|+..++..|++|++..... ..+.|.+|++++.+++|+||+++++++. +...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 467899999999999999999987777899999975332 3567899999999999999999999874 45679999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++|+|.+++.... ...+++..++.++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||.++........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999996532 345799999999999999999999987 999999999999999999999999999866533221
Q ss_pred ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......++..|+|||+..+..++.++||||||+++|||++ |+.||......+.... .......
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~------~~~~~~~--------- 222 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ------VERGYRM--------- 222 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH------HhcCCCC---------
Confidence 1223456778999999998999999999999999999999 8889876543332211 1111000
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+.+.+..+.+++.+|++.+|++||++.+++++|+.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1133456778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=320.05 Aligned_cols=258 Identities=25% Similarity=0.451 Sum_probs=210.4
Q ss_pred hCCCcccccccccCcEEEEEEEecC------CCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCce
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQD------GREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERER 439 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 439 (686)
.++|+..+.||+|+||.||+|...+ +..+++|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4678889999999999999998652 3679999986543 23356788999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEE
Q 005649 440 ILVYEYLPNKSLDKFLFDKSK-------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKIS 512 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 512 (686)
++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999965322 234789999999999999999999987 9999999999999999999999
Q ss_pred ecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHH
Q 005649 513 DFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLE 591 (686)
Q Consensus 513 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 591 (686)
|||+++...............++..|+|||.+.++.++.++||||||+++||+++ |+.||......+....+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~------ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI------ 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh------
Confidence 9999986654332222333456789999999998899999999999999999998 999997554433222111
Q ss_pred hcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 592 EEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 592 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
.+... ..+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 236 -~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 -DGGHL--------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred -cCCCC--------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11111 1233346788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=329.93 Aligned_cols=260 Identities=32% Similarity=0.480 Sum_probs=206.3
Q ss_pred hhCCCcccccccccCcEEEEEEEec------CCCEEEEEEecccCc-ccHHHHHHHHHHHHhc-CCCCcccEEEEEEec-
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNSM-QGKEEFENEVRVLLKM-QHRNLVQLFGCCVQE- 436 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 436 (686)
+.++|++.+.||+|+||.||+|+.. .++.||+|++..... ...+.+..|+.++.++ +|+||+++++++...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 4568999999999999999999642 347899999865432 2345678899999999 899999999988754
Q ss_pred CceEEEEeecCCCChhHHHhhcCC--------------------------------------------------------
Q 005649 437 RERILVYEYLPNKSLDKFLFDKSK-------------------------------------------------------- 460 (686)
Q Consensus 437 ~~~~lv~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 460 (686)
...++++||+++++|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 567899999999999999864321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCCc
Q 005649 461 --SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY 538 (686)
Q Consensus 461 --~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y 538 (686)
...++|..+..++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++.+.............++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 126899999999999999999999987 999999999999999999999999999876443322223334567789
Q ss_pred CchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHH
Q 005649 539 MAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQ 617 (686)
Q Consensus 539 ~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~ 617 (686)
+|||++.+..++.++|||||||++|||++ |+.||......+.. . .....+... ..+......+.+
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~--~----~~~~~~~~~--------~~~~~~~~~~~~ 307 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF--C----RRLKEGTRM--------RAPEYATPEIYS 307 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH--H----HHHhccCCC--------CCCccCCHHHHH
Confidence 99999999999999999999999999998 99999754332211 0 111111110 112334567899
Q ss_pred HHHHcccccccCCCCHHHHHHHhcC
Q 005649 618 IALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 618 li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
++.+||+.+|++||++.||+++|++
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHH
Confidence 9999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=331.58 Aligned_cols=249 Identities=26% Similarity=0.362 Sum_probs=212.6
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
+-|+..+.||.|+-|.|-+|+.- .|+.+|||++.+.. ......+++|+.+|+.+.|||+++++++++++.++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 56788899999999999999865 79999999996652 223456789999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|-|.+++..+ +.+.+.+..++++||+.|+.|+|..+ |+||||||+|+|||.++++||+|||+|-.-..+
T Consensus 92 Eyv~gGELFdylv~k---G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK---GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999999654 45999999999999999999999987 999999999999999999999999999864332
Q ss_pred CccccccccccCCCcCchhhhhcCCC-ChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFL-SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
......+|.+.|.+||++.+.+| ..++||||.|||||.|+||+.||+..+... ++..+.+ |.+
T Consensus 166 ---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~---LLlKV~~----G~f------ 229 (786)
T KOG0588|consen 166 ---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV---LLLKVQR----GVF------ 229 (786)
T ss_pred ---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH---HHHHHHc----Ccc------
Confidence 23455689999999999999877 568999999999999999999999544333 3333222 111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
+.|.+++.++.+|+.+|+..||+.|.|++||++..-
T Consensus 230 ---~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 230 ---EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred ---cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 347788899999999999999999999999998753
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=295.88 Aligned_cols=249 Identities=26% Similarity=0.399 Sum_probs=214.3
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
-++|++.+.||+|.||.||.|+.+ ++-.||+|++.+... .-.+++.+|+++-+.|+||||+++++++.++...||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 478999999999999999999976 677899999966532 2346789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
+||..+|.|...|.+. ....+++...+.++.|+|.||.|+|..+ ++||||||+|+|++.++.+||+|||-+..-.
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999999753 3456899999999999999999999976 9999999999999999999999999987533
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
..+....+||..|.+||...+...+.+.|+|++|++.||++.|.+||+....++....+.....
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~------------- 239 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL------------- 239 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc-------------
Confidence 2234557899999999999999999999999999999999999999987765554433332211
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+|...+....++|.+|+..+|.+|.+..|++..
T Consensus 240 ---~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 ---KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ---cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2356677889999999999999999999999864
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.40 Aligned_cols=240 Identities=24% Similarity=0.300 Sum_probs=195.7
Q ss_pred ccccCcEEEEEEEec-CCCEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCCh
Q 005649 376 LGRGGFGTVYKGRLQ-DGREIAVKKLATN---SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSL 451 (686)
Q Consensus 376 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL 451 (686)
||+|+||.||+++.. +++.||+|++... .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999976 5889999998643 223346788999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccc
Q 005649 452 DKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQ 531 (686)
Q Consensus 452 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 531 (686)
.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 152 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNT 152 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccc
Confidence 9999653 34899999999999999999999987 99999999999999999999999999885432221 2234
Q ss_pred cccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHH
Q 005649 532 IAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEI 611 (686)
Q Consensus 532 ~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 611 (686)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||......+... .... +.. .++...
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~------~~~~-~~~---------~~~~~~ 216 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYR------KILQ-EPL---------RFPDGF 216 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHH------HHHc-CCC---------CCCCcC
Confidence 578999999999999999999999999999999999999997654332211 1111 110 123445
Q ss_pred HHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 612 ALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 612 ~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
+..+.+++.+||+.||++||+..++.+.
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~ 244 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEI 244 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence 6778899999999999999865433333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=320.29 Aligned_cols=259 Identities=27% Similarity=0.494 Sum_probs=208.5
Q ss_pred hhCCCcccccccccCcEEEEEEEec------CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCc
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERE 438 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 438 (686)
..++|+..+.||+|+||.||+++.+ ++..+++|++.... ....+++.+|+.++++++||||+++++++.+++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3578999999999999999999863 46789999986543 2345678999999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 005649 439 RILVYEYLPNKSLDKFLFDKS-------------------KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKAS 499 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 499 (686)
.++++||+++|+|.+++.... ....+++..++.++.|++.||.|||+++ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999996432 1134788999999999999999999987 999999999
Q ss_pred cEEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchH
Q 005649 500 NILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEA 578 (686)
Q Consensus 500 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~ 578 (686)
||++++++.+||+|||+++................+..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876543322212222344677999999998999999999999999999998 88888654433
Q ss_pred hHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 579 ENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
+... .. ..+... ..+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 240 ~~~~------~~-~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 EVIY------YV-RDGNVL--------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHH------HH-hcCCCC--------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 3211 11 111111 1133456779999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=320.86 Aligned_cols=261 Identities=24% Similarity=0.428 Sum_probs=209.0
Q ss_pred HhhCCCcccccccccCcEEEEEEEec------CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecC
Q 005649 365 AATDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER 437 (686)
Q Consensus 365 ~at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 437 (686)
..+++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+..+++++||||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999999754 24579999886443 223456889999999999999999999999999
Q ss_pred ceEEEEeecCCCChhHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeE
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSK-------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPK 510 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 510 (686)
..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+++ |+||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 99999999999999999965321 234678889999999999999999987 99999999999999999999
Q ss_pred EEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHH
Q 005649 511 ISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARR 589 (686)
Q Consensus 511 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 589 (686)
|+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.||......+....
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~------ 233 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------ 233 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------
Confidence 999999986544332222223345678999999999999999999999999999999 7889875444332211
Q ss_pred HHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 590 LEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 590 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
....+. ...+...+..+.+++.+|++.+|++|||+.++++.|.+.
T Consensus 234 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 VMDGGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111111 111334457899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=314.09 Aligned_cols=254 Identities=33% Similarity=0.556 Sum_probs=207.2
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
.++|++.++||+|+||.||++..+++..+++|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 467888999999999999999988888999999875443 3567999999999999999999999875 45688999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999998653 2345899999999999999999999987 999999999999999999999999999866432211
Q ss_pred ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......++..|+|||.+.+..++.++|+||||+++|||++ |+.||......+... . .......
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~---~---~~~~~~~--------- 222 (260)
T cd05070 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLE---Q---VERGYRM--------- 222 (260)
T ss_pred -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH---H---HHcCCCC---------
Confidence 1122345678999999988899999999999999999999 899997544332221 1 1111000
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+...+..+.+++.+|++.+|++|||+.++++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1233456779999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=316.96 Aligned_cols=256 Identities=26% Similarity=0.425 Sum_probs=204.9
Q ss_pred CcccccccccCcEEEEEEEecC----CCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCc-----
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQD----GREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERE----- 438 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 438 (686)
|.+.+.||+|+||.||+|.... +..+|+|+++.... ...+.+.+|++.++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998752 36799999875432 334678999999999999999999999876554
Q ss_pred -eEEEEeecCCCChhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEec
Q 005649 439 -RILVYEYLPNKSLDKFLFDKS---KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDF 514 (686)
Q Consensus 439 -~~lv~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 514 (686)
.++++||+++|+|..++.... ....+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999986532 2346899999999999999999999987 999999999999999999999999
Q ss_pred CCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhc
Q 005649 515 GLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEE 593 (686)
Q Consensus 515 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 593 (686)
|+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+.. ... ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~---~~~---~~- 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY---DYL---RH- 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH---Hc-
Confidence 99987654332222222345678999999988899999999999999999999 88998754433221 111 11
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 594 GRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 594 ~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
+.. ...+...+..+.+++.+||+.||++|||+.|+++.|++.
T Consensus 231 ~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNR--------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCC--------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 112344567899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=329.84 Aligned_cols=247 Identities=21% Similarity=0.284 Sum_probs=204.4
Q ss_pred hCCCcccccccccCcEEEEEEEecC--CCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQD--GREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
.++|+..+.||+|+||.||+|+.++ +..||+|++.... ....+.+.+|+.++..++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3678999999999999999998653 3689999986432 2334678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999999653 34899999999999999999999987 9999999999999999999999999998654
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||........... .. .+..
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~------i~-~~~~----- 245 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK------IL-EGII----- 245 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH------Hh-cCCC-----
Confidence 32 1235789999999999998899999999999999999999999986543322111 11 1110
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCC-----CHHHHHHHh
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRP-----TMSATLSML 640 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~L 640 (686)
.++...+..+.+++.+|++.+|++|+ +++++++.-
T Consensus 246 ----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 246 ----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 12334456688999999999999995 899988763
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=318.30 Aligned_cols=263 Identities=24% Similarity=0.371 Sum_probs=198.2
Q ss_pred CCCcccccccccCcEEEEEEEec--CCCEEEEEEecccCc--ccHHHHHHHHHHHHhc---CCCCcccEEEEEEe-----
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ--DGREIAVKKLATNSM--QGKEEFENEVRVLLKM---QHRNLVQLFGCCVQ----- 435 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----- 435 (686)
++|+..+.||+|+||.||+++.. +++.||+|++..... .....+.+|+.+++++ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 46888999999999999999863 467899999865432 2234566777777665 69999999999863
Q ss_pred cCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecC
Q 005649 436 ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFG 515 (686)
Q Consensus 436 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 515 (686)
....++|+||++ ++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346889999996 68998886533 234899999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCc
Q 005649 516 LAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGR 595 (686)
Q Consensus 516 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 595 (686)
+++...... ......|+..|+|||.+.+..++.++||||||+++|||++|++||......+....+...........
T Consensus 156 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 156 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred ceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 998654331 23345689999999999988999999999999999999999999987655433222211100000000
Q ss_pred cc-------cccccc----cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 596 LM-------ELVDVR----IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 596 ~~-------~~~d~~----l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
+. ..+.+. +.......+..+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 000000 00111234566789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=319.19 Aligned_cols=265 Identities=25% Similarity=0.406 Sum_probs=209.3
Q ss_pred hCCCcccccccccCcEEEEEEEecC-----------------CCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCccc
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQD-----------------GREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQ 428 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 428 (686)
.++|+..+.||+|+||.||++...+ +..|++|++.... ....+.+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678999999999999999998642 2458999987543 334578899999999999999999
Q ss_pred EEEEEEecCceEEEEeecCCCChhHHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 005649 429 LFGCCVQERERILVYEYLPNKSLDKFLFDKS--------KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASN 500 (686)
Q Consensus 429 l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 500 (686)
+++++..++..++++||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999996543 1235899999999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc--CCCCCcccchH
Q 005649 501 ILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS--GRKNYDRQLEA 578 (686)
Q Consensus 501 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt--G~~p~~~~~~~ 578 (686)
|++++++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999986544332222334456788999999998899999999999999999998 67788654432
Q ss_pred hHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 579 ENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
+. +............... ...+...+.++.+++.+|++.+|++|||+.||++.|++
T Consensus 241 ~~---~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 QV---IENAGHFFRDDGRQIY-----LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HH---HHHHHhcccccccccc-----CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 22 2222211111110000 01123345679999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=313.11 Aligned_cols=246 Identities=30% Similarity=0.456 Sum_probs=198.9
Q ss_pred cccccCcEEEEEEEec---CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCC
Q 005649 375 MLGRGGFGTVYKGRLQ---DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNK 449 (686)
Q Consensus 375 ~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~g 449 (686)
.||+|+||.||+|.++ +++.+++|+++.... ...+++.+|+.++++++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 578899999865432 23567899999999999999999999875 45678999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc-c
Q 005649 450 SLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH-R 528 (686)
Q Consensus 450 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~ 528 (686)
+|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++......... .
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 999998543 34899999999999999999999987 9999999999999999999999999998765433211 1
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCC
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTY 607 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 607 (686)
.....++..|+|||.+....++.++|+||||+++|||++ |+.||......+....+. .+... ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-------~~~~~--------~~ 219 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-------SGERM--------EC 219 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------CCCCC--------CC
Confidence 122334578999999988889999999999999999998 999998654433322211 11110 12
Q ss_pred CHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 608 PEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 608 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
+...+..+.+++.+||+.||++||++.+|++.|++
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 33456778899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=326.15 Aligned_cols=264 Identities=19% Similarity=0.305 Sum_probs=198.5
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecC-----ceE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER-----ERI 440 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 440 (686)
+|+..++||+|+||.||+|+.. +++.||||++... .......+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999965 6899999998643 2233457889999999999999999999886432 479
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+||||++ ++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 6888888543 34899999999999999999999987 999999999999999999999999999865
Q ss_pred CCcCc-cccccccccCCCcCchhhhhc--CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH--------H
Q 005649 521 HDEQS-RHRTHQIAGTFGYMAPEYAIR--GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR--------R 589 (686)
Q Consensus 521 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~ 589 (686)
..... ........|+..|+|||++.+ ..++.++|||||||++|||++|+.||...........+.... .
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 43221 112234578999999999876 678999999999999999999999997654322211111000 0
Q ss_pred HHhcCccccccc---ccc----CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 590 LEEEGRLMELVD---VRI----GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 590 ~~~~~~~~~~~d---~~l----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
........+.++ ... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000 000 00001234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=330.82 Aligned_cols=242 Identities=29% Similarity=0.411 Sum_probs=210.0
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 441 (686)
-++|...++||+|.||+|+++..+ +++.+|||.+++... .+.+..+.|.+++... +||.+++++..+..+++.+.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 478999999999999999999987 678899999988743 3456778898888877 59999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||+.||++..+. ..+.+++..+..++..|+.||.|||+++ |++||||.+|||||.+|.+||+|||+++.--
T Consensus 447 vmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999943333 3456999999999999999999999998 9999999999999999999999999998643
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
.. ...+...+||+.|||||++.+..|+...|.|+|||+||||+.|+.||.+.++++..+.+....
T Consensus 520 ~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~------------- 584 (694)
T KOG0694|consen 520 GQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE------------- 584 (694)
T ss_pred CC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-------------
Confidence 11 124566899999999999999999999999999999999999999999988887655433211
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCCH
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTM 633 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 633 (686)
..||...+.+.++|+.+++.++|++|..+
T Consensus 585 ---~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 ---VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 13577788999999999999999999987
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.93 Aligned_cols=265 Identities=21% Similarity=0.386 Sum_probs=207.0
Q ss_pred hCCCcccccccccCcEEEEEEEec-----------------CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCccc
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-----------------DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQ 428 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-----------------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 428 (686)
.++|++.++||+|+||.||+++.. ++..+++|++.... ....++|.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 467899999999999999998542 23468999987543 334568999999999999999999
Q ss_pred EEEEEEecCceEEEEeecCCCChhHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 005649 429 LFGCCVQERERILVYEYLPNKSLDKFLFDKSK--------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASN 500 (686)
Q Consensus 429 l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 500 (686)
+++++..++..+++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999975321 134788999999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc--CCCCCcccchH
Q 005649 501 ILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS--GRKNYDRQLEA 578 (686)
Q Consensus 501 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt--G~~p~~~~~~~ 578 (686)
|++++++.++|+|||+++.+.............++..|++||....+.++.++||||||+++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999986543322222222344678999999988899999999999999999998 77888755443
Q ss_pred hHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 579 ENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
+.... ......... ..... ..+..++..+.+++.+||+.||++||++.+|++.|++
T Consensus 241 ~~~~~---~~~~~~~~~-~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QVIEN---TGEFFRDQG-RQVYL----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHH---HHHHHhhcc-ccccC----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 32211 111111110 00000 1122345778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.73 Aligned_cols=260 Identities=20% Similarity=0.367 Sum_probs=210.2
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|++.+.||+|+||.||+|+.. +++.|+||.+.... ......+.+|++++++++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999975 78999999885432 233457889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 444 EYLPNKSLDKFLFDKS-KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
||+++|+|.+++.... +...+++..++.++.|+++||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885432 2345889999999999999999999987 99999999999999999999999999887653
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
... ......++..|+|||.+.+..++.++|+||||+++|||++|+.||....... .... ......+. +
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~---~~~~~~~~------~ 226 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLC---QKIEQCDY------P 226 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHH---HHHhcCCC------C
Confidence 321 1223467889999999998889999999999999999999999986432211 1111 11111110 0
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
. ......+..+.+++.+||+.+|++||++.+|++.|++.+
T Consensus 227 ~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 P--LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred C--CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0 112345677999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=322.90 Aligned_cols=260 Identities=27% Similarity=0.440 Sum_probs=209.7
Q ss_pred hhCCCcccccccccCcEEEEEEEec--------CCCEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCCcccEEEEEEe
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ--------DGREIAVKKLATNS-MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQ 435 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 435 (686)
..++|.+.+.||+|+||.||+++.. ++..+++|.+.... ....+.+.+|+.++..+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3567888999999999999999741 24578999886542 33456789999999999 89999999999999
Q ss_pred cCceEEEEeecCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 005649 436 ERERILVYEYLPNKSLDKFLFDKSK-------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNIL 502 (686)
Q Consensus 436 ~~~~~lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 502 (686)
....+++|||+++|+|.+++..... ...+++..++.++.||++||.|||+++ ++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 9999999999999999999976421 235889999999999999999999987 999999999999
Q ss_pred EcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHH
Q 005649 503 LDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQ 581 (686)
Q Consensus 503 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~ 581 (686)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 99999999999999987654333222333455678999999998899999999999999999998 88888755433322
Q ss_pred HHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 582 ELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+ ..+... ..+...+..+.+++.+||+.+|++||++.|+++.|.++
T Consensus 250 ~~~-------~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 250 KLL-------KEGHRM--------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred HHH-------HcCCcC--------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 211 111110 11234567788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=323.40 Aligned_cols=259 Identities=29% Similarity=0.444 Sum_probs=207.9
Q ss_pred hCCCcccccccccCcEEEEEEEec--------CCCEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCCcccEEEEEEec
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ--------DGREIAVKKLATNS-MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQE 436 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 436 (686)
.++|.+.+.||+|+||.||+++.. ++..+|+|.+.... .....++.+|+.++.++ +|+||+++++++..+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 468999999999999999999753 23569999987542 23456788999999999 799999999999999
Q ss_pred CceEEEEeecCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 005649 437 RERILVYEYLPNKSLDKFLFDKSK-------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL 503 (686)
Q Consensus 437 ~~~~lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 503 (686)
+..++|+||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999975422 235899999999999999999999987 9999999999999
Q ss_pred cCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHH
Q 005649 504 DHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQE 582 (686)
Q Consensus 504 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~ 582 (686)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 9999999999999876543222111222234568999999999999999999999999999998 889987544333222
Q ss_pred HHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 583 LLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
.+. .+... ..+...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 254 ~~~-------~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 254 LLK-------EGHRM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred HHH-------cCCCC--------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111 11110 12334567888999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=329.92 Aligned_cols=249 Identities=25% Similarity=0.369 Sum_probs=197.6
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
++|+..++||+|+||.||+++.. +++.||||++..... ...+.+.+|++++++++|+||+++++++.+++..++|+||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45667789999999999999876 689999999865432 3346789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++|+|.... ..++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986432 3567788899999999999999987 99999999999999999999999999987643221
Q ss_pred cccccccccCCCcCchhhhhc-----CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAIR-----GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
......|+..|+|||.+.. ...+.++|||||||++|||++|+.||......+......... ....
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~---~~~~----- 293 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC---MSQP----- 293 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---ccCC-----
Confidence 1233578999999998743 234568999999999999999999997433322222111110 0000
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
...+......+.+++.+||+.||++|||+.|+++.-
T Consensus 294 ----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 294 ----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred ----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 112334567789999999999999999999999863
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=321.68 Aligned_cols=241 Identities=27% Similarity=0.346 Sum_probs=194.1
Q ss_pred ccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEEeecCC
Q 005649 374 NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
+.||+|+||.||+++.. +++.||+|+++... ....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 57889999997542 22344556677777654 899999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 9999988643 34899999999999999999999987 9999999999999999999999999998653322 12
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCC
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYP 608 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 608 (686)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ .. .. ..++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~-~~---------~~~~ 216 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI------LN-DR---------PHFP 216 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hc-CC---------CCCC
Confidence 33457899999999999999999999999999999999999999865543322111 11 10 1123
Q ss_pred HHHHHHHHHHHHHcccccccCCCCHH-HHHH
Q 005649 609 EEIALRFMQIALLCTEDFIEDRPTMS-ATLS 638 (686)
Q Consensus 609 ~~~~~~l~~li~~cl~~~p~~RPt~~-evl~ 638 (686)
...+..+.+++.+||+.+|++||++. ++++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 34566788999999999999999976 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=324.42 Aligned_cols=245 Identities=28% Similarity=0.387 Sum_probs=197.6
Q ss_pred CcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHH---HhcCCCCcccEEEEEEecCceEEE
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVL---LKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
|++.+.||+|+||.||+++.. +++.||||+++... ....+.+.+|.+++ ..++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999876 68999999997542 22345566676655 456899999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+++|+|..++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999888743 35999999999999999999999987 99999999999999999999999999875432
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
.. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ .. +..
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i------~~-~~~------ 218 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI------VN-DEV------ 218 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hh-CCC------
Confidence 21 1223457899999999999999999999999999999999999999865543322211 11 100
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRP-----TMSATLSM 639 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 639 (686)
.++...+..+.+++.+||+.||++|| ++.++++.
T Consensus 219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 ---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 12334567788999999999999999 56666664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=314.52 Aligned_cols=256 Identities=27% Similarity=0.502 Sum_probs=206.1
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCC---EEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGR---EIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~---~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
.++|+..+.||+|+||.||+|+.. +++ .+++|++.... ....+.+.+|++++.+++|+|++++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888999999999999999975 333 68999886542 3345678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999998653 245899999999999999999999987 9999999999999999999999999988664
Q ss_pred CcCccccc-cccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 522 DEQSRHRT-HQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 522 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
........ .....+..|+|||++....++.++||||||+++|||++ |+.||......+....+. .....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~------~~~~~--- 229 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN------DGFRL--- 229 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh------cCCCC---
Confidence 33221111 11223457999999998899999999999999999998 999997554332211111 10000
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+.+.+..+.+++.+||+.+|++||++.+|++.|.+
T Consensus 230 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 230 ------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1122345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=317.90 Aligned_cols=270 Identities=28% Similarity=0.397 Sum_probs=204.1
Q ss_pred CCCcccccccccCcEEEEEEEec-----CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEec--CceE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-----DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE--RERI 440 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 440 (686)
.+|++.+.||+|+||.||++..+ +++.|++|++........+.|.+|++++.+++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57888999999999999999742 5788999999776666667899999999999999999999987543 4678
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+|+||+++|+|.+++... ...+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999999643 235899999999999999999999987 999999999999999999999999999876
Q ss_pred CCcCccc-cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHH-HhcCcccc
Q 005649 521 HDEQSRH-RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL-EEEGRLME 598 (686)
Q Consensus 521 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 598 (686)
....... ......++..|+|||.+.+..++.++||||||+++|||++|..++.......... ....... .....+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRM-MGNDKQGQMIVYHLIE 237 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhh-cccccccccchHHHHH
Confidence 5432211 1112233456999999998899999999999999999999877654322110000 0000000 00000000
Q ss_pred ccccccC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 599 LVDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 599 ~~d~~l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
.+..... ..+...+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000000 11234456799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=315.27 Aligned_cols=255 Identities=27% Similarity=0.349 Sum_probs=205.3
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--------------ccHHHHHHHHHHHHhcCCCCcccEE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--------------QGKEEFENEVRVLLKMQHRNLVQLF 430 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~l~ 430 (686)
.-+.|++.+.||+|.||.|-+|+.. +++.||||++.+... ...+...+|+.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3478999999999999999999965 789999999965311 1235788999999999999999999
Q ss_pred EEEEe--cCceEEEEeecCCCChhHHHhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 005649 431 GCCVQ--ERERILVYEYLPNKSLDKFLFDKSKSAI-LDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM 507 (686)
Q Consensus 431 ~~~~~--~~~~~lv~Ey~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 507 (686)
.+.-+ .+..|||+||+..|.+...- .... +++.+.++++.++..||+|||.++ |+||||||+|+||+++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 99865 46889999999988875322 2333 999999999999999999999998 99999999999999999
Q ss_pred CeEEEecCCccccCCcC---ccccccccccCCCcCchhhhhcCC----CChhHHHHHHHHHHHHHHcCCCCCcccchHhH
Q 005649 508 KPKISDFGLAKLFHDEQ---SRHRTHQIAGTFGYMAPEYAIRGF----LSVKSDVFSFGVLLLEIISGRKNYDRQLEAEN 580 (686)
Q Consensus 508 ~~kl~Dfgla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~ 580 (686)
.+||+|||.+....... .........||+.|+|||...++. .+.+.||||+||+||.|+.|+.||-....-+.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 99999999998763321 122234478999999999887742 46789999999999999999999976544333
Q ss_pred HHHHHHHHHHHhcCccccccccccC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 581 QELLKLARRLEEEGRLMELVDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
.+. ++...|. ...+++.+.+.+||+++|++||++|.+..+|.....-
T Consensus 328 ~~K---------------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 328 FDK---------------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred HHH---------------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 221 1122221 1123578889999999999999999999999877753
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=340.71 Aligned_cols=252 Identities=29% Similarity=0.456 Sum_probs=221.0
Q ss_pred CcccccccccCcEEEEEEEec-CCC----EEEEEEeccc-CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQ-DGR----EIAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
.+..++||+|+||+||+|.+- +|+ +||+|++... ..+..+++..|...|.+++|||+++|+|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 345689999999999999863 443 5799988655 3445688999999999999999999999998876 88999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
+||+.|+|.+|++.++ ..+-.+..+.|..|||+||.|||++. +|||||..+||||..-..+||.|||+++.+..+
T Consensus 777 q~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999997744 45888999999999999999999987 999999999999999999999999999988766
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
..........-++.|||-|.+....++.++|||||||++|||+| |..||++...++..++++...++..
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsq---------- 921 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQ---------- 921 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCC----------
Confidence 55545555666889999999999999999999999999999999 9999999999888887776665433
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
|+.++.+++.++.+||..|++.||+++++...+.+
T Consensus 922 -----PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 922 -----PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred -----CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 78899999999999999999999999999887754
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.51 Aligned_cols=250 Identities=35% Similarity=0.549 Sum_probs=207.9
Q ss_pred ccccccCcEEEEEEEecC----CCEEEEEEecccCccc-HHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCC
Q 005649 374 NMLGRGGFGTVYKGRLQD----GREIAVKKLATNSMQG-KEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
+.||+|+||.||++...+ +..+++|.+....... .+.+.+|++.+..++|+|++++++++.++...++++||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999764 7889999997654433 67899999999999999999999999999999999999999
Q ss_pred CChhHHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 449 KSLDKFLFDKSK------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 449 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
++|.+++..... ...+++..++.++.|+++||.|||+++ ++|+||+|+||++++++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999976421 356999999999999999999999987 99999999999999999999999999987765
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
...........++..|+|||.+....++.++||||||++++||++ |..||......+....+. . +..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------~-~~~----- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR------K-GYR----- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH------c-CCC-----
Confidence 432223334567889999999998899999999999999999999 699998664333221111 1 100
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
...+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ---LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1224455778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=313.51 Aligned_cols=265 Identities=25% Similarity=0.357 Sum_probs=232.0
Q ss_pred HHHHHHhhCCCcccccccccCcEEEEEEEec------CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEE
Q 005649 360 LDVLIAATDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGC 432 (686)
Q Consensus 360 ~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~ 432 (686)
..++.....+++...++.+|.||.||+|.+. +.+.|.+|.++.... .....+..|--++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4456666788999999999999999999654 345677888765533 334678888888888999999999999
Q ss_pred EEec-CceEEEEeecCCCChhHHHh-----hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC
Q 005649 433 CVQE-RERILVYEYLPNKSLDKFLF-----DKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ 506 (686)
Q Consensus 433 ~~~~-~~~~lv~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 506 (686)
+.++ ..++.+|.++.-|+|+.||. +....+.++..+...++.|++.|++|||+++ ++|.||..+|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 9765 57899999999999999998 4455566888999999999999999999998 9999999999999999
Q ss_pred CCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHH
Q 005649 507 MKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLK 585 (686)
Q Consensus 507 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~ 585 (686)
.++||+|-.++|.+...+..+..++...+..||+||.+.+..|+..+|||||||+||||+| |+.||...+..|....+.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk 512 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK 512 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence 9999999999999999999888888889999999999999999999999999999999999 999999888777766666
Q ss_pred HHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 586 LARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 586 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
.+.++.+ |.+++.+|..++.-||...|++||+++|++..|++
T Consensus 513 dGyRlaQ---------------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 513 DGYRLAQ---------------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ccceecC---------------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 5554433 77899999999999999999999999999999975
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=314.26 Aligned_cols=252 Identities=27% Similarity=0.375 Sum_probs=205.1
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
+|+..++||+|+||.||++... +++.||+|++..... .....+.+|+.++++++||||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999975 689999999965432 223457889999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998886532 345899999999999999999999987 9999999999999999999999999998654322
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
. .....|+..|+|||.+.+..++.++||||||+++|||++|+.||...........+.. .. ... .
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~--~~-~~~---------~ 221 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER--RV-KED---------Q 221 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH--Hh-hhc---------c
Confidence 1 1234688999999999988999999999999999999999999986543322211111 11 100 0
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRP-----TMSATLSM 639 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 639 (686)
..++...+..+.+++.+||+.||++|| ++.++++.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 122445677789999999999999999 88888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=312.25 Aligned_cols=255 Identities=31% Similarity=0.519 Sum_probs=208.3
Q ss_pred hhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
..++|+..++||+|+||.||++..++++.+++|.+..... ..+++.+|+.++++++|+|++++++++ ..+..++++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence 3577899999999999999999998899999999875433 457899999999999999999999986 45578999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++.... ...+++.+++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999986543 346899999999999999999999987 99999999999999999999999999987653222
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
. ......++..|+|||.+....++.++||||||+++|||++ |+.||......+....+. .+...
T Consensus 158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~~------- 222 (260)
T cd05067 158 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-------RGYRM------- 222 (260)
T ss_pred c-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-------cCCCC-------
Confidence 1 1122345678999999998899999999999999999999 999997554333221111 11000
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+...+..+.+++.+|++.+|++||+++++++.|++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 -PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1123345679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=308.63 Aligned_cols=247 Identities=31% Similarity=0.470 Sum_probs=201.3
Q ss_pred ccccccCcEEEEEEEecCCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCChh
Q 005649 374 NMLGRGGFGTVYKGRLQDGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLD 452 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 452 (686)
++||+|+||.||+|...+++.+++|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988899999999865433 23457889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccccccc
Q 005649 453 KFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQI 532 (686)
Q Consensus 453 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 532 (686)
+++... ...+++..++.++.|++.+|.|||+++ ++||||||+||++++++.+||+|||++......... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 998643 235899999999999999999999987 999999999999999999999999998754332211 11122
Q ss_pred ccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHH
Q 005649 533 AGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEI 611 (686)
Q Consensus 533 ~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 611 (686)
.++..|+|||++..+.++.++||||||+++||+++ |..||...........+ .. +... ..+...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~------~~-~~~~--------~~~~~~ 219 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV------EK-GYRM--------SCPQKC 219 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH------Hc-CCCC--------CCCCCC
Confidence 44677999999998999999999999999999999 99999765433322111 11 1000 112345
Q ss_pred HHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 612 ALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 612 ~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=314.86 Aligned_cols=255 Identities=26% Similarity=0.486 Sum_probs=204.8
Q ss_pred CCCcccccccccCcEEEEEEEec-CC---CEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DG---REIAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g---~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
.+|+..+.||+|+||.||+|+.. ++ ..|++|.+... .....++|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45778899999999999999975 33 35999998654 333457899999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
+||+++++|.+++... ...+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998653 245899999999999999999999987 99999999999999999999999999886643
Q ss_pred cCcccccc-ccc--cCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 523 EQSRHRTH-QIA--GTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 523 ~~~~~~~~-~~~--gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
........ ... .+..|+|||.+.+..++.++||||||+++||+++ |+.||......+... +.. ....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~---~i~---~~~~~-- 230 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN---AIE---QDYRL-- 230 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHH---HHH---cCCcC--
Confidence 32211111 111 2457999999999999999999999999999997 999997654332221 111 11000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+.+.+..+.+++.+||+.+|++||++.+|+++|++
T Consensus 231 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 231 -------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred -------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 1123445678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.94 Aligned_cols=251 Identities=32% Similarity=0.482 Sum_probs=209.4
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
.++|+..+.||.|+||.||++... |+.|++|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 467888999999999999999875 78999999976544 5678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999965432 35899999999999999999999987 99999999999999999999999999987633221
Q ss_pred ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
....+..|+|||.+..+.++.++||||||+++||+++ |..||......+....+. .+...
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~~-------- 218 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-------KGYRM-------- 218 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-------cCCCC--------
Confidence 2334678999999998899999999999999999998 999997654433221111 11000
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+...+..+.+++.+|++.+|++||++.|++++|+++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11234467789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.42 Aligned_cols=254 Identities=31% Similarity=0.526 Sum_probs=206.3
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
.++|+..+.||+|++|.||++..+++..+++|++.... ...+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 35688889999999999999998877789999886543 23567899999999999999999999875 45688999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999999653 2345899999999999999999999987 999999999999999999999999999866432211
Q ss_pred ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......++..|+|||...+..++.++||||||+++|||++ |+.||......+... + .......
T Consensus 159 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~---~~~~~~~--------- 222 (260)
T cd05069 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE---Q---VERGYRM--------- 222 (260)
T ss_pred -ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---H---HHcCCCC---------
Confidence 1122345678999999998999999999999999999999 899997654333211 1 1111000
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1233456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=328.78 Aligned_cols=254 Identities=23% Similarity=0.308 Sum_probs=199.2
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.|+..+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999875 68899999996543 2234578899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 99999999998653 34889999999999999999999987 9999999999999999999999999976432100
Q ss_pred c---------------------------------------------cccccccccCCCcCchhhhhcCCCChhHHHHHHH
Q 005649 525 S---------------------------------------------RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFG 559 (686)
Q Consensus 525 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~G 559 (686)
. ........||+.|+|||.+.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001224699999999999988999999999999
Q ss_pred HHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHH--cccccccCCCCHHHHH
Q 005649 560 VLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALL--CTEDFIEDRPTMSATL 637 (686)
Q Consensus 560 vvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~--cl~~~p~~RPt~~evl 637 (686)
|++|||++|+.||......+....+. .+ .... .. ......+..+.+++.+ |+..+|..||++.|++
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~----~~-~~~~------~~-~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVI----NW-ENTL------HI-PPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHH----cc-cccc------CC-CCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 99999999999998655433221110 00 0000 00 0011234567777866 5666777799999998
Q ss_pred HHh
Q 005649 638 SML 640 (686)
Q Consensus 638 ~~L 640 (686)
+.-
T Consensus 304 ~hp 306 (381)
T cd05626 304 AHP 306 (381)
T ss_pred cCc
Confidence 753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=318.91 Aligned_cols=247 Identities=27% Similarity=0.417 Sum_probs=211.0
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
..|+..+.||+|.||.||+|... .++.||+|++... .....+++++|+.+|.+++++||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45777789999999999999975 6889999999654 344568899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+.+|++.+.|.. ...+++..+.-++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+-.+.....
T Consensus 93 ~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 999999999843 233588888899999999999999997 89999999999999999999999999987765443
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
. .....||+.|||||++....|+.|+||||||++.+||.+|.+|+..... .++.-++...-.
T Consensus 167 r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----------------mrvlflIpk~~P 228 (467)
T KOG0201|consen 167 R--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----------------MRVLFLIPKSAP 228 (467)
T ss_pred c--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----------------ceEEEeccCCCC
Confidence 3 3567999999999999988999999999999999999999999975433 233333333322
Q ss_pred -CCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 606 -TYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 606 -~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
.+....+..+.+++..|+++||+.||++.++++
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 334467788999999999999999999999875
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=326.43 Aligned_cols=253 Identities=24% Similarity=0.323 Sum_probs=203.8
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|+..+.||+|+||.||+++.. +|+.+|+|++..... ...+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47889999999999999999876 688999999975422 23456889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999999654 235899999999999999999999987 999999999999999999999999999876543
Q ss_pred CccccccccccCCCcCchhhhh------cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAI------RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
... ......|++.|+|||++. ...++.++||||||+++|||++|+.||......+... .........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------~i~~~~~~~ 228 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN------NIMNFQRFL 228 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH------HHHcCCCcc
Confidence 221 223356899999999986 4567899999999999999999999997654433211 111111100
Q ss_pred cccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 598 ~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
. . ......+..+.+++..|++ +|.+||++.++++.
T Consensus 229 ~-----~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 229 K-----F-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred C-----C-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 0 0012345678899999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.40 Aligned_cols=257 Identities=28% Similarity=0.449 Sum_probs=205.8
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCC----EEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGR----EIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
.++|+..++||+|+||.||+|++. +|+ .||+|++..... ...+.+.+|..++..++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 467888999999999999999854 444 479999865433 335678899999999999999999999875 4578
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+++||+++|+|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998653 235899999999999999999999987 999999999999999999999999999876
Q ss_pred CCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
.............++..|+|||...+..++.++||||||+++|||++ |+.||......+....+. .+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~-- 230 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-------KGERL-- 230 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CCCcC--
Confidence 54332222222345678999999998899999999999999999998 999997544333222111 11100
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
..+...+..+.+++.+||+.||++||++.++++.|.+..
T Consensus 231 ------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 231 ------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred ------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 112335567889999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=310.82 Aligned_cols=256 Identities=33% Similarity=0.536 Sum_probs=210.0
Q ss_pred hhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
..++|++.+.||+|+||.||++..++++.++||.+.... ...+++.+|+.++++++|+||+++++++..+...++++||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 357899999999999999999998888899999987543 3457799999999999999999999999988899999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999996542 345899999999999999999999987 99999999999999999999999999887653221
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
.......++..|+|||.+.+..++.++|+||||++++|+++ |+.||......+... .. ......
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~---~~---~~~~~~-------- 223 (261)
T cd05034 159 -TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLE---QV---ERGYRM-------- 223 (261)
T ss_pred -hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HH---HcCCCC--------
Confidence 11122334578999999998899999999999999999999 999997554332211 11 110000
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+...+..+.+++.+|++.+|++||+++++++.|++
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 -PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1122335678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.86 Aligned_cols=250 Identities=28% Similarity=0.425 Sum_probs=207.3
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
+|+..+.||+|++|.||++..+ +++.+++|.+... .....+.+.+|++++++++|||++++++++.+++..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999976 6899999998643 234457789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999999764 2346899999999999999999999987 99999999999999999999999999887654322
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......++..|+|||+..+..++.++|+||||+++|||++|+.||......+.. . ... .+. ..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~---~~~-~~~--------~~ 219 (256)
T cd08529 157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI---L---KII-RGV--------FP 219 (256)
T ss_pred --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH---H---HHH-cCC--------CC
Confidence 122346788999999999999999999999999999999999999765532211 1 111 111 11
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
..+...+..+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1233556779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=326.04 Aligned_cols=260 Identities=23% Similarity=0.275 Sum_probs=197.9
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.++|+..+.||+|+||.||++... +++.||+|... .+.+.+|++++++++||||+++++++..+...++++|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999875 68899999753 24568999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+. ++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 165 YK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred CC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 84 7888888543 34899999999999999999999987 9999999999999999999999999997543221
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccch-----HhHHHHHHHHHHH---HhcC---
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLE-----AENQELLKLARRL---EEEG--- 594 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~-----~~~~~~~~~~~~~---~~~~--- 594 (686)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+..... .....+....... ..+.
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 1122345799999999999999999999999999999999999987643211 0000000000000 0000
Q ss_pred ---cccccc---------ccccC---CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 595 ---RLMELV---------DVRIG---TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 595 ---~~~~~~---------d~~l~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
...+.. .+... ......+..+.+++.+||+.||++|||+.|+++.-
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 000000 00000 00113456789999999999999999999998644
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=315.74 Aligned_cols=263 Identities=23% Similarity=0.336 Sum_probs=200.4
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.++|+..+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.++++++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 578999999999999999999976 688999999865432 233567889999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|++ ++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 6787777543 245889999999999999999999987 9999999999999999999999999987543222
Q ss_pred ccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhc---Ccccc--
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEE---GRLME-- 598 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~-- 598 (686)
.......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ..+......... ..+..
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchh
Confidence 12233567899999998865 468999999999999999999999998643321 111111111000 00000
Q ss_pred ---cccc-ccC-CCCH---------HHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 599 ---LVDV-RIG-TYPE---------EIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 599 ---~~d~-~l~-~~~~---------~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
..++ ... ..+. .....+.+++.+|++.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0000 000 0000 123467899999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=324.52 Aligned_cols=242 Identities=26% Similarity=0.382 Sum_probs=197.8
Q ss_pred ccccccCcEEEEEEEe----cCCCEEEEEEecccC----cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 374 NMLGRGGFGTVYKGRL----QDGREIAVKKLATNS----MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
+.||+|+||.||+++. .+++.||+|++.... ......+.+|+.++++++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 357889999986532 22345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++... ..+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 9999999998543 34788899999999999999999987 99999999999999999999999999875432221
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......|++.|+|||++.+..++.++||||||+++|||++|+.||.......... .... +..
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~------~~~~-~~~--------- 217 (323)
T cd05584 156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID------KILK-GKL--------- 217 (323)
T ss_pred --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH------HHHc-CCC---------
Confidence 2233578999999999999889999999999999999999999998654332211 1111 110
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRP-----TMSATLSM 639 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 639 (686)
..+...+..+.+++.+||+.+|++|| ++.++++.
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 12334566788999999999999999 78888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.15 Aligned_cols=258 Identities=22% Similarity=0.395 Sum_probs=209.0
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|+..+.||+|+||.||+++.. +++.++||.+.... .....++.+|+.+++.++|+||+++++++.+++..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 56888899999999999999964 78999999886532 223467889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 444 EYLPNKSLDKFLFDKS-KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999986432 3456899999999999999999999987 99999999999999999999999999886643
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
... ......++..|+|||.+.+..++.++|+||||+++|||++|+.||.....+. ..... .... ...+
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~---~~~~------~~~~ 226 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCK---KIEQ------CDYP 226 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhh---hhhc------CCCC
Confidence 221 1223467889999999998899999999999999999999999996433221 11111 1110 0011
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
.+ .....+..+.+++.+||+.+|++||||.+|++++++
T Consensus 227 ~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 227 PL--PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CC--CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 11 123456789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=300.29 Aligned_cols=274 Identities=22% Similarity=0.309 Sum_probs=212.0
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCccc--HHHHHHHHHHHHhcCCCCcccEEEEEEe--cCceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQG--KEEFENEVRVLLKMQHRNLVQLFGCCVQ--ERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 441 (686)
.++|+..+.|++|.||.||+|+.+ +++.||+|+++...... .-.-.+|+.+|.+.+|||||.+-.+... -+..||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 367888999999999999999976 78899999997653221 1345789999999999999999888764 357999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||++. +|...+.... +.+...+...+..|+++|++|||.+. |+|||||++|+|++..|.+||+|||+||.+.
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999976 7888886654 46899999999999999999999987 9999999999999999999999999999987
Q ss_pred CcCccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
... ...+...-|.+|+|||.+.+. .|+...|+||+|||+.|++++++.|.+..+-+..+.+-..-....+.-|...-
T Consensus 229 sp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 SPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred CCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 652 345567889999999998875 69999999999999999999999998876655444333222111111111111
Q ss_pred ccc------cCC---------CCHH-HHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCCC
Q 005649 601 DVR------IGT---------YPEE-IALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIP 648 (686)
Q Consensus 601 d~~------l~~---------~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 648 (686)
+.. ... ++.. .++.-.+++...+..||.+|-|+.|-++.=--...+.|
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP 370 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence 100 001 1111 44677899999999999999999998765433333333
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.23 Aligned_cols=256 Identities=30% Similarity=0.436 Sum_probs=203.8
Q ss_pred CCCcccccccccCcEEEEEEEecC-CC--EEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQD-GR--EIAVKKLATN-SMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 442 (686)
++|++.+.||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 678899999999999999998753 33 4688888643 233456789999999999 799999999999999999999
Q ss_pred EeecCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCe
Q 005649 443 YEYLPNKSLDKFLFDKS-------------KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP 509 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 509 (686)
+||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996532 1135889999999999999999999987 9999999999999999999
Q ss_pred EEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHH
Q 005649 510 KISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLAR 588 (686)
Q Consensus 510 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 588 (686)
||+|||++....... .......+..|+|||.+....++.++||||||+++|||++ |+.||......+...
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~------ 229 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE------ 229 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH------
Confidence 999999986432111 1111223557999999998899999999999999999998 999997654433211
Q ss_pred HHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 589 RLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 589 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
.... +.. ...+...+..+.+++.+||+.+|.+||++.++++.|++..
T Consensus 230 ~~~~-~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 230 KLPQ-GYR--------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred HHhc-CCC--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 100 0113345567889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=329.27 Aligned_cols=254 Identities=26% Similarity=0.347 Sum_probs=207.0
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|+..+.||+|+||.||+++.. +|+.||+|++.... ......+..|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47889999999999999999976 68999999996542 233467889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999654 45899999999999999999999987 999999999999999999999999999866543
Q ss_pred C---------------------------ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccc
Q 005649 524 Q---------------------------SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQL 576 (686)
Q Consensus 524 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~ 576 (686)
. .........||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0012234568999999999999999999999999999999999999998655
Q ss_pred hHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCC-HHHHHHHh
Q 005649 577 EAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPT-MSATLSML 640 (686)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~~L 640 (686)
..+....+.. +. ... .+.. ....+..+.+++..|++ +|++||+ +.++++..
T Consensus 235 ~~~~~~~i~~----~~-~~~------~~p~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 235 LQETYNKIIN----WK-ESL------RFPP-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HHHHHHHHhc----cC-Ccc------cCCC-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 3332211110 00 000 0000 11146778899999997 9999999 99999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=321.45 Aligned_cols=261 Identities=29% Similarity=0.453 Sum_probs=208.9
Q ss_pred hhCCCcccccccccCcEEEEEEEec--------CCCEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCCcccEEEEEEe
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ--------DGREIAVKKLATNS-MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQ 435 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 435 (686)
..++|.+.+.||+|+||.||+++.. ....+++|++.... ......+.+|+.+++++ +||||+++++++.+
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3467889999999999999999742 24568999887543 23356788999999999 69999999999999
Q ss_pred cCceEEEEeecCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 005649 436 ERERILVYEYLPNKSLDKFLFDKSK-------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNIL 502 (686)
Q Consensus 436 ~~~~~lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 502 (686)
+...++++||+++|+|.+++..... ...+++..+..++.|++.||.|||+++ ++||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 9999999999999999999965321 245899999999999999999999987 999999999999
Q ss_pred EcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHH
Q 005649 503 LDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQ 581 (686)
Q Consensus 503 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~ 581 (686)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+..
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999986653322222222334567999999999999999999999999999999 89999765443322
Q ss_pred HHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 582 ELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
..+. .+... ..+...+..+.+++.+||+.+|++|||+.|+++.|++..
T Consensus 247 ~~~~-------~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 247 KLLR-------EGHRM--------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHHH-------cCCCC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 2111 11111 113344567889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=317.98 Aligned_cols=240 Identities=29% Similarity=0.353 Sum_probs=194.2
Q ss_pred ccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEEeecCC
Q 005649 374 NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
+.||+|+||.||+++.+ +|+.||+|+++... ....+.+..|..++... +||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 68899999997542 22345567788887765 899999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
|+|..++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 9999988643 34899999999999999999999987 9999999999999999999999999987432211 12
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCC
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYP 608 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 608 (686)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+....+ . .+. ..++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~---~----~~~---------~~~~ 216 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI---R----VDT---------PHYP 216 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH---H----hCC---------CCCC
Confidence 23457899999999999999999999999999999999999999765443322111 1 010 1123
Q ss_pred HHHHHHHHHHHHHcccccccCCCCHH-HHH
Q 005649 609 EEIALRFMQIALLCTEDFIEDRPTMS-ATL 637 (686)
Q Consensus 609 ~~~~~~l~~li~~cl~~~p~~RPt~~-evl 637 (686)
......+.+++.+||+.||++||++. +++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 33556788999999999999999985 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=322.49 Aligned_cols=260 Identities=29% Similarity=0.438 Sum_probs=207.8
Q ss_pred hCCCcccccccccCcEEEEEEEec--------CCCEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCCcccEEEEEEec
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ--------DGREIAVKKLATNS-MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQE 436 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 436 (686)
..+|++.+.||+|+||.||+++.. .+..+++|.+.... ....+++.+|+.++.++ +||||+++++++.++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 356888999999999999999742 12368999886543 23356889999999999 899999999999999
Q ss_pred CceEEEEeecCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 005649 437 RERILVYEYLPNKSLDKFLFDKS-------------KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL 503 (686)
Q Consensus 437 ~~~~lv~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 503 (686)
+..++++||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 99999999999999999996532 1235889999999999999999999987 9999999999999
Q ss_pred cCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHH
Q 005649 504 DHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQE 582 (686)
Q Consensus 504 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~ 582 (686)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999999986644322222222344567999999999999999999999999999998 889987654433222
Q ss_pred HHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 583 LLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
.+. .+... ..+...+..+.+++.+||+.+|++||++.|+++.|..+.
T Consensus 248 ~~~-------~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 248 LLK-------EGHRM--------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHH-------cCCCC--------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 111 11100 112334567889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=309.46 Aligned_cols=248 Identities=27% Similarity=0.432 Sum_probs=198.5
Q ss_pred cccccCcEEEEEEEec---CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCC
Q 005649 375 MLGRGGFGTVYKGRLQ---DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKS 450 (686)
Q Consensus 375 ~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gs 450 (686)
.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++|+||+++++++. .+..++|+||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999764 355699999865533 23467899999999999999999999875 457899999999999
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc-cc
Q 005649 451 LDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH-RT 529 (686)
Q Consensus 451 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~ 529 (686)
|.+++... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++......... ..
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99998643 345899999999999999999999987 9999999999999999999999999998654332211 11
Q ss_pred cccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCC
Q 005649 530 HQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYP 608 (686)
Q Consensus 530 ~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 608 (686)
....++..|+|||.+....++.++||||||+++||+++ |+.||......+....+. .+.. ...+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~--------~~~~ 220 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-------QGKR--------LDCP 220 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-------CCCC--------CCCC
Confidence 12234578999999988889999999999999999997 999997654433221111 1110 0123
Q ss_pred HHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 609 EEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 609 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
...+..+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 44567888999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=325.85 Aligned_cols=242 Identities=24% Similarity=0.286 Sum_probs=198.2
Q ss_pred ccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCC
Q 005649 374 NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNK 449 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~g 449 (686)
+.||+|+||.||+++.. +|+.||+|++.... ......+.+|++++..++||||+++.+++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999865 78999999997542 223456788999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 450 SLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR-DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 450 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
+|..++... ..+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (325)
T cd05594 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T 152 (325)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence 999888543 358999999999999999999997 55 99999999999999999999999999875432211 1
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCC
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYP 608 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 608 (686)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+....+. . +.. .++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~------~-~~~---------~~p 216 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------M-EEI---------RFP 216 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh------c-CCC---------CCC
Confidence 233568999999999999999999999999999999999999997654433222111 0 000 123
Q ss_pred HHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 005649 609 EEIALRFMQIALLCTEDFIEDRP-----TMSATLSM 639 (686)
Q Consensus 609 ~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 639 (686)
...+..+.+++.+||+.||++|+ ++.++++.
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 34556788999999999999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=323.78 Aligned_cols=252 Identities=24% Similarity=0.364 Sum_probs=217.0
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCc-eEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERE-RILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 443 (686)
++|...+++|+|+||.++..+.+ +++.+++|++.... ....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999876 67899999986543 3344577899999999999999999999999998 99999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
+|++||+|.+.+.... ...++++.++.++.|++.|+.|||++. |+|||||+.|||++.+..+||+|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999997654 566999999999999999999999876 999999999999999999999999999988765
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
.. ......||+.||.||.+.+.+|..|+|+|||||++|||++-+++|...+..+....+... .
T Consensus 160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~---------------~ 222 (426)
T KOG0589|consen 160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG---------------L 222 (426)
T ss_pred hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc---------------c
Confidence 42 334578999999999999999999999999999999999999999876554443222211 1
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
....+..++..+..++..|++.+|+.||++.+++.+.
T Consensus 223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 1234667888999999999999999999999998763
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=308.98 Aligned_cols=248 Identities=34% Similarity=0.494 Sum_probs=199.6
Q ss_pred ccccccCcEEEEEEEec--C--CCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCC
Q 005649 374 NMLGRGGFGTVYKGRLQ--D--GREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~--~--g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
++||+|+||.||+|+.. + +..+++|.+..... ...+++.+|++++++++|+||+++++++. .+..++++||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999754 2 26899999876544 34567899999999999999999999875 4568999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc-
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH- 527 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 527 (686)
|+|.+++.... .+++..++.++.|++.+|.|||+.+ ++|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999996543 5899999999999999999999987 9999999999999999999999999998664332211
Q ss_pred cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCC
Q 005649 528 RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 606 (686)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. ..... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-------~~~~~--------~ 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-------SGERL--------P 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-------cCCcC--------C
Confidence 1112234568999999999999999999999999999998 999997654433222111 11100 1
Q ss_pred CCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
.+...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1334556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=313.47 Aligned_cols=247 Identities=29% Similarity=0.397 Sum_probs=198.9
Q ss_pred ccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCCh
Q 005649 376 LGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSL 451 (686)
Q Consensus 376 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL 451 (686)
||+|+||.||++... +++.+|+|++..... ...+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 788999999865432 2335678899999999999999999999999999999999999999
Q ss_pred hHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccccc
Q 005649 452 DKFLFDKS-KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTH 530 (686)
Q Consensus 452 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 530 (686)
..++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 98886432 3456999999999999999999999987 99999999999999999999999999986644322 123
Q ss_pred ccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHH
Q 005649 531 QIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEE 610 (686)
Q Consensus 531 ~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 610 (686)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||.......... ........ .. ..++..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~---------~~-~~~~~~ 223 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRILN---------DS-VTYPDK 223 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHHHhhcc---------cC-CCCccc
Confidence 3578999999999999999999999999999999999999997543321111 00011100 00 122345
Q ss_pred HHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 005649 611 IALRFMQIALLCTEDFIEDRP-----TMSATLSM 639 (686)
Q Consensus 611 ~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 639 (686)
.+..+.+++.+||+.||++|| ++.++++.
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 667789999999999999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=308.36 Aligned_cols=249 Identities=29% Similarity=0.471 Sum_probs=203.3
Q ss_pred ccccccCcEEEEEEEecC--CC--EEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCC
Q 005649 374 NMLGRGGFGTVYKGRLQD--GR--EIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~--g~--~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
+.||+|++|.||+|.+.+ ++ .+++|.+..... ...+.+.+|+..+++++||||+++++++.+ ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998753 33 589999977665 556789999999999999999999999988 889999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc-c
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR-H 527 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~ 527 (686)
++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999976433 46899999999999999999999987 999999999999999999999999999876543221 1
Q ss_pred cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCC
Q 005649 528 RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 606 (686)
......++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+. . ... .+ .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---~---~~~-------~~-~ 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID---K---EGE-------RL-E 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---h---cCC-------cC-C
Confidence 1123456788999999999899999999999999999999 999997554433222111 0 000 00 1
Q ss_pred CCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
.+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 12345677899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=311.90 Aligned_cols=255 Identities=27% Similarity=0.480 Sum_probs=205.4
Q ss_pred CCCcccccccccCcEEEEEEEec-C---CCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-D---GREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~---g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
++|++.+.||+|+||.||+|+.. + +..+++|.+.... ....+.|.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57888999999999999999864 2 3368999886543 23356889999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+++++|.+++.... ..+++.+++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999996532 45899999999999999999999987 99999999999999999999999999987654
Q ss_pred cCcccc-ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 523 EQSRHR-THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 523 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
...... .....++..|++||.+.+..++.++|+||||+++||+++ |+.||......+....+ ......
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~------~~~~~~---- 228 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI------EEGYRL---- 228 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH------hCCCcC----
Confidence 322111 112233568999999999899999999999999999987 99999755433221111 110000
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+...+..+.+++.+|++.+|++||+|.++++.|++
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 229 -----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0122345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.33 Aligned_cols=252 Identities=27% Similarity=0.341 Sum_probs=200.3
Q ss_pred CCcccccccccCcEEEEEEEe----cCCCEEEEEEecccC----cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCce
Q 005649 369 NFSTKNMLGRGGFGTVYKGRL----QDGREIAVKKLATNS----MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERER 439 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 439 (686)
+|++.+.||+|+||.||+++. .+++.+|+|++.... ....+.+..|+.++.++ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 578899999999999999875 357899999986432 22345678899999999 599999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999998653 34899999999999999999999987 99999999999999999999999999986
Q ss_pred cCCcCccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 520 FHDEQSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 520 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
....... ......||..|+|||.+.+. .++.++|||||||++|||++|+.||...........+. ......
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~~~----- 226 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--RRILKC----- 226 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--HHHhcC-----
Confidence 5432221 22345789999999998765 47889999999999999999999997443222111111 111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRP-----TMSATLSM 639 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 639 (686)
++ ..+...+..+.+++.+||+.||++|| +++++++.
T Consensus 227 --~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 --DP---PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --CC---CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 11 12334566788999999999999999 67787764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=322.60 Aligned_cols=243 Identities=26% Similarity=0.333 Sum_probs=197.9
Q ss_pred ccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEEeecCC
Q 005649 374 NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
++||+|+||.||+|+.. +++.||+|++.... ....+.+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 57899999997542 23345677888888876 899999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T 152 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence 9999888643 34899999999999999999999987 99999999999999999999999999875432221 1
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCC
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYP 608 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 608 (686)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||......+.... ..... . ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~------i~~~~-~---------~~p 216 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES------ILHDD-V---------LYP 216 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH------HHcCC-C---------CCC
Confidence 2335689999999999999999999999999999999999999986654432211 11111 0 112
Q ss_pred HHHHHHHHHHHHHcccccccCCC-------CHHHHHHHh
Q 005649 609 EEIALRFMQIALLCTEDFIEDRP-------TMSATLSML 640 (686)
Q Consensus 609 ~~~~~~l~~li~~cl~~~p~~RP-------t~~evl~~L 640 (686)
...+..+.+++..||+.||++|| ++.++++.-
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 33456788999999999999999 788887653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=318.44 Aligned_cols=256 Identities=28% Similarity=0.481 Sum_probs=203.2
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCC----EEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGR----EIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
.++|+..+.||+|+||.||+|++. +|. .+++|.+..... ....++.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 467788899999999999999864 444 468888865432 2234788999999999999999999998754 467
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+++||+++|+|.+++... ...+++..++.++.|++.||.|||+++ |+|+||||+||++++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 999999999999998653 234899999999999999999999987 999999999999999999999999999876
Q ss_pred CCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
.............++..|++||.+.+..++.++||||||+++|||++ |+.||......+....+. .+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~--- 229 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-------KGER--- 229 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------CCCC---
Confidence 54332222223345678999999999999999999999999999998 999997654333222211 1100
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
+ ..+...+..+.+++..||..+|++||++.++++.|...
T Consensus 230 ----~-~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 230 ----L-PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ----C-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 01223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=308.56 Aligned_cols=252 Identities=30% Similarity=0.532 Sum_probs=205.6
Q ss_pred CCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecC
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLP 447 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 447 (686)
.+|+..+.||+|+||.||++.+.+++.+++|++..... ...+|.+|++++++++|||++++++++......++++||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 57788899999999999999987788999999865433 35678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc
Q 005649 448 NKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH 527 (686)
Q Consensus 448 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 527 (686)
+++|.+++.... ..+++..++.++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 999999986432 34889999999999999999999987 999999999999999999999999998865433221
Q ss_pred cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCC
Q 005649 528 RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 606 (686)
......++..|+|||.+.++.++.++||||||+++|||++ |+.||......+....+ .++. ...+
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~--~~~~----- 222 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI-------NAGF--RLYK----- 222 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH-------hCCC--CCCC-----
Confidence 1112234678999999998999999999999999999998 99999755433322111 1110 0001
Q ss_pred CCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 223 -~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 -PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1223567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.03 Aligned_cols=262 Identities=26% Similarity=0.420 Sum_probs=207.8
Q ss_pred HHhhCCCcccccccccCcEEEEEEEec------CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcC-CCCcccEEEEEEe
Q 005649 364 IAATDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQ 435 (686)
Q Consensus 364 ~~at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 435 (686)
....++|.+.++||+|+||.||+|++. .++.||+|++..... ...+.+.+|++++.++. ||||+++++++..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 344567888899999999999999864 346799999975432 23457899999999997 9999999999999
Q ss_pred cCceEEEEeecCCCChhHHHhhcCC-------------------------------------------------------
Q 005649 436 ERERILVYEYLPNKSLDKFLFDKSK------------------------------------------------------- 460 (686)
Q Consensus 436 ~~~~~lv~Ey~~~gsL~~~l~~~~~------------------------------------------------------- 460 (686)
.+..++|+||+++|+|.++++....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 9999999999999999999965321
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 005649 461 ----------------------------------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASN 500 (686)
Q Consensus 461 ----------------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 500 (686)
...+++..++.++.||+.||.|||+.+ ++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcce
Confidence 124778889999999999999999976 9999999999
Q ss_pred EEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHh
Q 005649 501 ILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAE 579 (686)
Q Consensus 501 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~ 579 (686)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986543222111222356788999999998899999999999999999998 899987543322
Q ss_pred HHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 580 NQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
... .....+.. + ..+...+..+.+++.+||+.+|++||+++||++.|++
T Consensus 350 ~~~------~~~~~~~~-------~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 350 QFY------NAIKRGYR-------M-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred HHH------HHHHcCCC-------C-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 110 11111100 0 1133456778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.08 Aligned_cols=266 Identities=28% Similarity=0.416 Sum_probs=203.8
Q ss_pred CcccccccccCcEEEEEEEe-----cCCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEec--CceEE
Q 005649 370 FSTKNMLGRGGFGTVYKGRL-----QDGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQE--RERIL 441 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 441 (686)
|+..+.||+|+||.||++.. .+++.||+|.+..... .....|.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988653 3578899999875432 3456788999999999999999999998764 35789
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
+|||+++++|.+++.. ..+++..++.++.|++.||.|||+++ |+||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999854 24899999999999999999999987 9999999999999999999999999998765
Q ss_pred CcCccc-cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 522 DEQSRH-RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 522 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ...............+.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhh
Confidence 432211 1122345667999999998899999999999999999999999986433211 11111111000011111111
Q ss_pred ccccC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 601 DVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 601 d~~l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
+.... ..+...+..+.+++.+||+.+|++|||+++|+++|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111 22334567899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=306.87 Aligned_cols=248 Identities=31% Similarity=0.458 Sum_probs=202.5
Q ss_pred ccccccCcEEEEEEEecCCCEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCChh
Q 005649 374 NMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQ-GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLD 452 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 452 (686)
++||+|+||.||++...+++.|++|++...... ....+.+|++++++++|+||+++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765443 4568999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccccccc
Q 005649 453 KFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQI 532 (686)
Q Consensus 453 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 532 (686)
+++.... ..+++..++.++.+++.+|.|||+++ ++||||+|+||+++.++.+||+|||+++..............
T Consensus 81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9986532 35889999999999999999999987 999999999999999999999999998865422211111222
Q ss_pred ccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHH
Q 005649 533 AGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEI 611 (686)
Q Consensus 533 ~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 611 (686)
.++..|+|||.+.++.++.++|+||||+++|||++ |..||...........+. .... + ..+...
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~------~~~~--------~-~~~~~~ 220 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE------SGYR--------M-PAPQLC 220 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh------cCCC--------C-CCCccC
Confidence 34567999999998899999999999999999999 888887554333222111 0000 0 113345
Q ss_pred HHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 612 ALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 612 ~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
+..+.+++.+|++.+|++|||+.||++.|+
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 668999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.79 Aligned_cols=236 Identities=28% Similarity=0.380 Sum_probs=193.6
Q ss_pred ccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEEeecCC
Q 005649 374 NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
+.||+|+||.||+++.+ +++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999976 68899999986532 23345677888888876 799999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 9999888543 34899999999999999999999987 9999999999999999999999999987543221 12
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCC
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYP 608 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 608 (686)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ .. +.. ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i------~~-~~~---------~~~ 216 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI------LN-DEV---------VYP 216 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------hc-CCC---------CCC
Confidence 23457899999999999999999999999999999999999999865543322111 11 110 123
Q ss_pred HHHHHHHHHHHHHcccccccCCCCH
Q 005649 609 EEIALRFMQIALLCTEDFIEDRPTM 633 (686)
Q Consensus 609 ~~~~~~l~~li~~cl~~~p~~RPt~ 633 (686)
...+..+.+++.+||+.||++||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 3356678899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=307.52 Aligned_cols=258 Identities=23% Similarity=0.407 Sum_probs=210.4
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|+..+.||+|+||.||+|... +|+.+++|.++... ....+.+.+|++++++++|+|++++++.+.+.+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 67899999999999999999987 78999999886432 233567899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 444 EYLPNKSLDKFLFDKS-KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
||+++++|.+++.... ....+++..++.++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999986532 2345899999999999999999999987 99999999999999999999999999886543
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
.... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||...... .... ..... .+..
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~---~~~~~-~~~~------ 225 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSL---CKKIE-KCDY------ 225 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHH---Hhhhh-cCCC------
Confidence 2211 12345788999999999889999999999999999999999998643311 1111 11111 1111
Q ss_pred ccCCCCH-HHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 603 RIGTYPE-EIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 603 ~l~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
...+. ..+..+.+++.+||+.+|++|||+.+|+++|++.
T Consensus 226 --~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 226 --PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred --CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11122 4566789999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=321.82 Aligned_cols=246 Identities=27% Similarity=0.337 Sum_probs=199.2
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCC-CcccEEEEEEecCceEEEE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHR-NLVQLFGCCVQERERILVY 443 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 443 (686)
+|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.+++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5788899999999999999876 57889999997542 23456778899999999765 5888999999899999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999999988543 34899999999999999999999987 999999999999999999999999998753221
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.||......+....+ .. ..
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i------~~-~~-------- 217 (324)
T cd05587 155 GK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI------ME-HN-------- 217 (324)
T ss_pred CC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------Hc-CC--------
Confidence 11 123356899999999999999999999999999999999999999865543322111 11 10
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCH-----HHHHH
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTM-----SATLS 638 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~ 638 (686)
..++...+..+.+++.+||+.||++||+. .++++
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 01233456678899999999999999986 56554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=318.53 Aligned_cols=241 Identities=28% Similarity=0.372 Sum_probs=194.9
Q ss_pred ccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEEeecCC
Q 005649 374 NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999976 57889999997542 22345567778888764 999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--K 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--c
Confidence 9999998543 34899999999999999999999987 99999999999999999999999999875322111 2
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCC
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYP 608 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 608 (686)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+....+. . .. + .++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~------~-~~------~---~~~ 216 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR------M-DN------P---CYP 216 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH------h-CC------C---CCC
Confidence 234568999999999999999999999999999999999999998655433222111 0 00 0 123
Q ss_pred HHHHHHHHHHHHHcccccccCCCCHH-HHHH
Q 005649 609 EEIALRFMQIALLCTEDFIEDRPTMS-ATLS 638 (686)
Q Consensus 609 ~~~~~~l~~li~~cl~~~p~~RPt~~-evl~ 638 (686)
......+.+++.+||+.+|++||++. ++.+
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 33556788999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=316.55 Aligned_cols=258 Identities=29% Similarity=0.450 Sum_probs=207.4
Q ss_pred hCCCcccccccccCcEEEEEEEec------CCCEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCc
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNS-MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERE 438 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 438 (686)
.++|...+.||+|+||.||++... .+..+|+|+++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 467999999999999999999742 34579999887543 23356789999999999 79999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.++++||+++|+|.+++.... ...+++.+++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999996533 234899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 519 LFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 519 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+... . ....+...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~--~----~~~~~~~~ 263 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY--K----LIKEGYRM 263 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH--H----HHHcCCcC
Confidence 6644322112223345778999999999999999999999999999998 999987554332211 1 11111000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 598 ~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+...+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 264 --------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 264 --------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 1122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=324.88 Aligned_cols=254 Identities=22% Similarity=0.318 Sum_probs=197.8
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|+..+.||+|+||.||+++.. +++.+|+|++.... ......+.+|+.++.+++|+||+++++.+.++...++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999875 68899999996532 223356788999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 999999999999653 45899999999999999999999987 999999999999999999999999998765321
Q ss_pred Ccc---------------------------------ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCC
Q 005649 524 QSR---------------------------------HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRK 570 (686)
Q Consensus 524 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~ 570 (686)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123479999999999999999999999999999999999999
Q ss_pred CCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHccc--ccccCCCCHHHHHHH
Q 005649 571 NYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTE--DFIEDRPTMSATLSM 639 (686)
Q Consensus 571 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~--~~p~~RPt~~evl~~ 639 (686)
||......+....+... . ... .+.+. ......+.+++.+++. .++..||++.||++.
T Consensus 235 Pf~~~~~~~~~~~i~~~----~-~~~--~~p~~-----~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETPQETYKKVMNW----K-ETL--IFPPE-----VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCHHHHHHHHHcC----c-Ccc--cCCCc-----CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 99865543322211100 0 000 01110 1123456666665433 344567999999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.51 Aligned_cols=251 Identities=32% Similarity=0.527 Sum_probs=201.6
Q ss_pred ccccccCcEEEEEEEecC-------CCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 374 NMLGRGGFGTVYKGRLQD-------GREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~-------g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
+.||+|+||.||+|+..+ ++.+++|.+.... ......+.+|+.+++.++||||+++++++...+..++++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999998653 2578999886543 23456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-----CeEEEecCC
Q 005649 446 LPNKSLDKFLFDKS----KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM-----KPKISDFGL 516 (686)
Q Consensus 446 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~Dfgl 516 (686)
+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 2234889999999999999999999987 99999999999999877 899999999
Q ss_pred ccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCc
Q 005649 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGR 595 (686)
Q Consensus 517 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 595 (686)
++...............++..|+|||.+.++.++.++||||||+++|||++ |+.||......+....+ .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~------~~~~~ 231 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV------TAGGR 231 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH------hcCCc
Confidence 986644332222223345678999999999999999999999999999998 99999754433221111 11111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 596 LMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 596 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
. ..+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus 232 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 232 L---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred c---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 1233456788999999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=308.62 Aligned_cols=259 Identities=25% Similarity=0.361 Sum_probs=206.3
Q ss_pred HHHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 363 LIAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 363 l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
++.+++++.....||+|+||.||+|+.. +++.|++|.+........+.+.+|+.++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3456778888889999999999999865 678899999877666667789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCCeEEEecCCcccc
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH-QMKPKISDFGLAKLF 520 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~ 520 (686)
++||+++++|.+++.........++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 9999999999999975432222388889999999999999999987 999999999999986 678999999998765
Q ss_pred CCcCccccccccccCCCcCchhhhhcCC--CChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGF--LSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
..... ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||......... .+......
T Consensus 160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~~------ 228 (268)
T cd06624 160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMFK------ 228 (268)
T ss_pred ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhhc------
Confidence 43221 122345788999999986643 789999999999999999999999643221111 11100000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.....+......+.+++.+||+.+|++|||+.|+++.
T Consensus 229 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 ----IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ----cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0012244556778999999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=320.19 Aligned_cols=237 Identities=25% Similarity=0.319 Sum_probs=190.7
Q ss_pred ccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHH-HHHhcCCCCcccEEEEEEecCceEEEEeecCC
Q 005649 374 NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVR-VLLKMQHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
+.||+|+||.||+++.. +|+.||+|++..... .....+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999976 789999999965321 22344555544 56778999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 9999988543 35899999999999999999999987 9999999999999999999999999987543221 12
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCC
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYP 608 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 608 (686)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+... .... +.. ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~------~i~~-~~~---------~~~ 216 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD------NILN-KPL---------RLK 216 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH------HHHc-CCC---------CCC
Confidence 234568999999999999999999999999999999999999997654333211 1111 110 112
Q ss_pred HHHHHHHHHHHHHcccccccCCCCHH
Q 005649 609 EEIALRFMQIALLCTEDFIEDRPTMS 634 (686)
Q Consensus 609 ~~~~~~l~~li~~cl~~~p~~RPt~~ 634 (686)
...+..+.+++.+|++.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 33467788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=321.07 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=197.1
Q ss_pred ccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEEeecCC
Q 005649 374 NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
++||+|+||.||+++.. +++.||+|+++... ....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999976 68899999997542 22345678899999988 799999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 9999888543 35999999999999999999999987 9999999999999999999999999987432211 12
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHh--HHHHHHHHHHHHhcCccccccccccCC
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE--NQELLKLARRLEEEGRLMELVDVRIGT 606 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~ 606 (686)
.....|+..|+|||++.+..++.++|+|||||++|||++|+.||+.....+ ......+.......+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 223 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---------R 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC---------C
Confidence 234578999999999999999999999999999999999999996422111 11111111111111111 1
Q ss_pred CCHHHHHHHHHHHHHcccccccCCCC------HHHHHHH
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRPT------MSATLSM 639 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RPt------~~evl~~ 639 (686)
.+...+..+.+++.+||+.||++||+ +.++++.
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 23345667899999999999999997 6677653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=309.66 Aligned_cols=266 Identities=23% Similarity=0.338 Sum_probs=200.7
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHh--cCCCCcccEEEEEEecC----ceE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLK--MQHRNLVQLFGCCVQER----ERI 440 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~ 440 (686)
.......+.||+|.||.||+|+++ |+.||||++...+ .+.+.+|.++... |+|+||+.+++.-..++ +++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 357888899999999999999997 8999999996543 4466777777666 49999999998876543 578
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCCCCCcEEEcCCCCeEEEecC
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR-----DSVLRIIHRDIKASNILLDHQMKPKISDFG 515 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-----~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 515 (686)
||++|.++|||.|||.. ..++....++++..+|.||+|||. +|+|.|.|||||++||||..++.+.|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 99999999999999954 459999999999999999999995 567899999999999999999999999999
Q ss_pred CccccCCcC--ccccccccccCCCcCchhhhhcCC------CChhHHHHHHHHHHHHHHcC----------CCCCcccch
Q 005649 516 LAKLFHDEQ--SRHRTHQIAGTFGYMAPEYAIRGF------LSVKSDVFSFGVLLLEIISG----------RKNYDRQLE 577 (686)
Q Consensus 516 la~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~------~s~ksDv~s~Gvvl~elltG----------~~p~~~~~~ 577 (686)
||....... .........||.+|||||++.... --..+||||||.|+||+... +.||.....
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 998665432 222345578999999999987642 12358999999999999742 356643222
Q ss_pred HhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 578 AENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
.+... +..++..=..++...++.+ ....+....+.++|..||..||.-|-|+--+-+.|.+..
T Consensus 442 ~DPs~--eeMrkVVCv~~~RP~ipnr--W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 442 SDPSF--EEMRKVVCVQKLRPNIPNR--WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCCCH--HHHhcceeecccCCCCCcc--cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 11100 0000000001111111111 224567888999999999999999999998888886643
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=328.52 Aligned_cols=253 Identities=23% Similarity=0.305 Sum_probs=201.7
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|+..+.||+|+||.||+++.. +|+.||||++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999976 68999999996542 223456788999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 999999999999653 34899999999999999999999987 999999999999999999999999998754321
Q ss_pred Cccc------------------------------------cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc
Q 005649 524 QSRH------------------------------------RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS 567 (686)
Q Consensus 524 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt 567 (686)
.... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112358999999999999999999999999999999999
Q ss_pred CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCC---HHHHHHH
Q 005649 568 GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPT---MSATLSM 639 (686)
Q Consensus 568 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl~~ 639 (686)
|+.||......+....+ ....... ... .....+..+.+++.+|+. +|.+|++ +.|+++.
T Consensus 235 G~~Pf~~~~~~~~~~~i------~~~~~~~-----~~~-~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQETYRKI------INWKETL-----QFP-DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHHHHHHHH------HcCCCcc-----CCC-CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99999865543321111 1000000 000 011235567889999996 9999998 8888774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.53 Aligned_cols=256 Identities=30% Similarity=0.467 Sum_probs=203.0
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCC--EEEEEEecccC-cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGR--EIAVKKLATNS-MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~--~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 441 (686)
.++|++.+.||+|+||.||+|+++ ++. .+++|.+.... ......+.+|+.++.++ +|+||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 468889999999999999999975 454 35777765432 33456788999999999 89999999999999999999
Q ss_pred EEeecCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC
Q 005649 442 VYEYLPNKSLDKFLFDKS-------------KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK 508 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 508 (686)
++||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999997542 1235899999999999999999999987 999999999999999999
Q ss_pred eEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHH
Q 005649 509 PKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLA 587 (686)
Q Consensus 509 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 587 (686)
+||+|||+++...... ......++..|+|||++.+..++.++||||||+++|||+| |..||......+...
T Consensus 163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----- 234 (303)
T cd05088 163 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----- 234 (303)
T ss_pred EEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH-----
Confidence 9999999986432111 1111234567999999988889999999999999999998 999997554333211
Q ss_pred HHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 588 RRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 588 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
........ ..+...+..+.+++.+||+.+|++||++.++++.|.+.
T Consensus 235 -~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 235 -KLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred -HHhcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11110000 11223455688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=319.57 Aligned_cols=242 Identities=28% Similarity=0.348 Sum_probs=197.9
Q ss_pred ccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEEeecCC
Q 005649 374 NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
+.||+|+||.||+++.. +++.+|+|++.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 57899999997542 23345677888888888 799999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--T 152 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--c
Confidence 9999888543 35899999999999999999999987 99999999999999999999999999875322211 1
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCC
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYP 608 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 608 (686)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+....+ .. ... .++
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i------~~-~~~---------~~~ 216 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI------LE-DEV---------RYP 216 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH------Hc-CCC---------CCC
Confidence 22346899999999999999999999999999999999999999765443322111 11 110 123
Q ss_pred HHHHHHHHHHHHHcccccccCCCCH-----HHHHHH
Q 005649 609 EEIALRFMQIALLCTEDFIEDRPTM-----SATLSM 639 (686)
Q Consensus 609 ~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~~ 639 (686)
...+..+.+++.+||+.||++||++ .++++.
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 3456778999999999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=303.75 Aligned_cols=266 Identities=23% Similarity=0.324 Sum_probs=210.2
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCC-cccEEEEEEecC------
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ--GKEEFENEVRVLLKMQHRN-LVQLFGCCVQER------ 437 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------ 437 (686)
..|+..++||+|+||.||+|+.+ +|+.||+|++...... ......+|+.++++++|+| |+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 45667788999999999999976 7899999999765432 3355689999999999999 999999998877
Q ss_pred ceEEEEeecCCCChhHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCC
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSKS-AILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGL 516 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 516 (686)
..++|+||+ .-+|..++...... ..++...+..++.||++||+|||+++ |+||||||+||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 788999999 56899999765432 34777889999999999999999998 99999999999999999999999999
Q ss_pred ccccCCcCccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCc
Q 005649 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGR 595 (686)
Q Consensus 517 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 595 (686)
|+...-+.. ......+|..|.|||++.+. .|+...||||+||++.||++++.-|.+..+.+....+-.......+..
T Consensus 167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 996653221 24556789999999999886 799999999999999999999999998777444333333222232333
Q ss_pred ccccc---cccc--C------CCC---HHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 596 LMELV---DVRI--G------TYP---EEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 596 ~~~~~---d~~l--~------~~~---~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
|..+. |... . .+. +.......+++.+|++.+|.+|.|++..+++
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 32222 1111 0 001 1112478899999999999999999999987
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=320.99 Aligned_cols=246 Identities=26% Similarity=0.350 Sum_probs=199.4
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 443 (686)
+|+..+.||+|+||.||+++.. +++.+|+|++..... ...+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788899999999999999876 578999999875422 2234567788888777 5899999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 999999999888543 34899999999999999999999987 999999999999999999999999998754322
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
.. ......|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+. . ...
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~------~-~~~------- 218 (323)
T cd05616 155 GV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------E-HNV------- 218 (323)
T ss_pred CC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH------h-CCC-------
Confidence 11 2234578999999999999999999999999999999999999998655433222111 1 110
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCH-----HHHHH
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTM-----SATLS 638 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~ 638 (686)
.++...+..+.+++.+|++.+|++|++. .++.+
T Consensus 219 --~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 219 --AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred --CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 1244556778999999999999999985 56543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.96 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=215.5
Q ss_pred HhhCCCcccccccccCcEEEEEEEecC---CC--EEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCc
Q 005649 365 AATDNFSTKNMLGRGGFGTVYKGRLQD---GR--EIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERE 438 (686)
Q Consensus 365 ~at~~f~~~~~LG~G~fG~Vy~~~~~~---g~--~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 438 (686)
.+++..+..++||.|-||.||+|...+ |. .||||..+.+. ....+.|+.|..+|++++||||++++|+|.+. .
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence 345566677899999999999998642 33 48999998753 44578899999999999999999999999864 6
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.+||||.++.|-|..||..+ ...|+......++.||..+|.|||+.. +|||||..+|||+...--|||+|||++|
T Consensus 465 ~WivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence 78999999999999999654 345899999999999999999999976 9999999999999999999999999999
Q ss_pred ccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 519 LFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 519 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
.+.++...... ...-+..|||||.+.-..++.++|||.|||.+|||+. |..||.+....+....++.+.++
T Consensus 540 ~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl------- 611 (974)
T KOG4257|consen 540 YLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL------- 611 (974)
T ss_pred hccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCC-------
Confidence 98876554333 4566889999999999999999999999999999998 99999876554433222222211
Q ss_pred cccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 598 ~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..|+.++..|+.|+.+||..+|.+||++.++...|+.
T Consensus 612 --------P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 612 --------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred --------CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 3478899999999999999999999999999888764
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=323.24 Aligned_cols=263 Identities=23% Similarity=0.315 Sum_probs=200.7
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecC-----ceE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER-----ERI 440 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 440 (686)
+|+..++||+|+||.||++... +|+.||+|++... .....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999965 7899999998653 2234467889999999999999999999998766 789
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+|+||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 577777743 345899999999999999999999987 999999999999999999999999999865
Q ss_pred CCcCccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHH------------
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLA------------ 587 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~------------ 587 (686)
...... ......++..|+|||.+.+. .++.++|||||||++|||++|+.||......+....+...
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 433221 12234678899999998774 5799999999999999999999999866543322221110
Q ss_pred ----HHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 588 ----RRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 588 ----~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
................+..........+.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000000000001112235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=315.19 Aligned_cols=265 Identities=22% Similarity=0.340 Sum_probs=203.4
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
++|...+.||+|+||.||+|+.+ +++.+|+|++..... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 67889999999999999999876 678899999865432 2345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++ +|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 788877543 235889999999999999999999987 99999999999999999999999999876533221
Q ss_pred cccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccc------c
Q 005649 526 RHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM------E 598 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 598 (686)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+...........+. +
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1223467889999998865 468999999999999999999999998665544333222111000000000 0
Q ss_pred ccccccC--------CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 599 LVDVRIG--------TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 599 ~~d~~l~--------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
..+.... ......+..+.+++.+|++.||++|||+.|+++.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 0000000 00123456788999999999999999999998743
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=307.75 Aligned_cols=253 Identities=29% Similarity=0.474 Sum_probs=202.8
Q ss_pred CcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHH--HHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKE--EFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~--~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
|+..+.||+|+||.||+++.. +++.+|+|++......... ....|+.++.+++||||+++++++.++...+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567889999999999999987 4668999999776544332 3456999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++++|.+++. ....+++..++.++.|+++||.+||+.+ ++|+||||+||+++.++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence 9999999997 2345899999999999999999999987 99999999999999999999999999876421 12
Q ss_pred ccccccccCCCcCchhhhh-cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 527 HRTHQIAGTFGYMAPEYAI-RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
.......++..|+|||.+. +...+.++||||+|+++|+|++|..||......+................ .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~- 223 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS--------S- 223 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH--------T-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc--------c-
Confidence 2334567889999999998 88999999999999999999999999987632222222221111000000 0
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.........+.+++.+||+.||++||++.++++.
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001113789999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=292.15 Aligned_cols=264 Identities=25% Similarity=0.342 Sum_probs=214.2
Q ss_pred HhhCCCcccccccccCcEEEEEEE-ecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecC-----c
Q 005649 365 AATDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER-----E 438 (686)
Q Consensus 365 ~at~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~ 438 (686)
+..++|++.+.||+|||.-||+++ ..+++.+|+|++......+.+..++|++..++++|||+++++++...+. .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 346789999999999999999998 5578999999998888778888999999999999999999999886543 4
Q ss_pred eEEEEeecCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCc
Q 005649 439 RILVYEYLPNKSLDKFLFDKS-KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 517 (686)
.||+++|...|+|.+.+.... ++..+++.+.+.|+.+|++||++||+.. +++.||||||.|||+.+++.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 899999999999999997644 3447999999999999999999999987 68999999999999999999999999998
Q ss_pred cccCCcC---cc-c---cccccccCCCcCchhhhh---cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHH
Q 005649 518 KLFHDEQ---SR-H---RTHQIAGTFGYMAPEYAI---RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLA 587 (686)
Q Consensus 518 ~~~~~~~---~~-~---~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 587 (686)
....-.- .. . .-....-|..|+|||.+. +...++++|||||||+||+|+.|..||+...+
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------- 246 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------- 246 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh----------
Confidence 7653110 00 0 111235688999999874 45689999999999999999999999974322
Q ss_pred HHHHhcCcc-ccccccccC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 588 RRLEEEGRL-MELVDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 588 ~~~~~~~~~-~~~~d~~l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+.+ ..+..+.+. .-....++.+.+++.+|++.||.+||+..+++..++..
T Consensus 247 ----~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 ----QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11111 122222332 11234788999999999999999999999999988753
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=307.84 Aligned_cols=255 Identities=23% Similarity=0.319 Sum_probs=204.1
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.++|+..+.||+|+||.||+|+.. +++.+++|++..........+.+|+.++.+++||||+++++.+..++..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 467999999999999999999974 7889999999765545556788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++... ..+++..+..++.|+++||.|||+.+ |+||||+|+||+++.++.+||+|||++........
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999999988643 35899999999999999999999987 99999999999999999999999999986643221
Q ss_pred cccccccccCCCcCchhhhh---cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAI---RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
......++..|+|||.+. ...++.++||||||+++|||++|+.||......+... .. ..... ..+
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~-~~~~~---~~~ 229 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LM-SKSNF---QPP 229 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------ee-ecCCC---CCC
Confidence 122346788999999874 3457889999999999999999999986433211110 00 00000 001
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
... .....+..+.+++.+||+.+|++|||++++++.|
T Consensus 230 ~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLK-DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCc-cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 111 1123457789999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.33 Aligned_cols=249 Identities=23% Similarity=0.318 Sum_probs=196.0
Q ss_pred ccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEEeecCC
Q 005649 374 NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
+.||+|+||.||+++.. +++.+|+|++.... ....+.+..|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 67899999997542 22345677888888877 899999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~ 152 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--T 152 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--c
Confidence 9999888543 35899999999999999999999987 99999999999999999999999999875432211 1
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHh--HHHHHHHHHHHHhcCccccccccccCC
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE--NQELLKLARRLEEEGRLMELVDVRIGT 606 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~ 606 (686)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||....... ......+.......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------~ 223 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------R 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC---------C
Confidence 234578999999999999999999999999999999999999996321111 01111111111111111 1
Q ss_pred CCHHHHHHHHHHHHHcccccccCCCC------HHHHHHH
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRPT------MSATLSM 639 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RPt------~~evl~~ 639 (686)
.+...+..+.+++.+||+.||++||+ +.++++.
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 24455677889999999999999998 4666543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=324.81 Aligned_cols=238 Identities=26% Similarity=0.364 Sum_probs=195.7
Q ss_pred ccccccCcEEEEEEEe----cCCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecC
Q 005649 374 NMLGRGGFGTVYKGRL----QDGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLP 447 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 447 (686)
+.||+|+||.||+++. .+|+.+|+|++..... .....+.+|++++.+++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 3578999999975432 234567889999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc
Q 005649 448 NKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH 527 (686)
Q Consensus 448 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 527 (686)
+|+|.+++... ..+++..++.++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 99999998543 35899999999999999999999987 99999999999999999999999999886543321
Q ss_pred cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCC
Q 005649 528 RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTY 607 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 607 (686)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+.... ... ... ..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~------i~~-~~~---------~~ 217 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM------ILK-AKL---------GM 217 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHH------HHc-CCC---------CC
Confidence 22345789999999999988899999999999999999999999986543332211 111 110 12
Q ss_pred CHHHHHHHHHHHHHcccccccCCCCHHH
Q 005649 608 PEEIALRFMQIALLCTEDFIEDRPTMSA 635 (686)
Q Consensus 608 ~~~~~~~l~~li~~cl~~~p~~RPt~~e 635 (686)
+...+..+.+++.+||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 3445667889999999999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.31 Aligned_cols=240 Identities=25% Similarity=0.296 Sum_probs=191.6
Q ss_pred ccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHH-HHHhcCCCCcccEEEEEEecCceEEEEeecCC
Q 005649 374 NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVR-VLLKMQHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
+.||+|+||.||+++.. +|+.+|+|++.... ......+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999875 78999999996542 223345555654 46778999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 152 (325)
T cd05604 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--T 152 (325)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--C
Confidence 9999888543 45899999999999999999999987 99999999999999999999999999875422111 2
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCC
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYP 608 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 608 (686)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+... .... +. + ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~------~~~~-~~--------~-~~~ 216 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD------NILH-KP--------L-VLR 216 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH------HHHc-CC--------c-cCC
Confidence 234578999999999999999999999999999999999999997654333211 1111 10 0 012
Q ss_pred HHHHHHHHHHHHHcccccccCCCCHHHHH
Q 005649 609 EEIALRFMQIALLCTEDFIEDRPTMSATL 637 (686)
Q Consensus 609 ~~~~~~l~~li~~cl~~~p~~RPt~~evl 637 (686)
...+..+.+++.+|++.+|++||++.+.+
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 23456788999999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=316.41 Aligned_cols=241 Identities=27% Similarity=0.374 Sum_probs=196.0
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcC-CCCcccEEEEEEecCceEEEE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 443 (686)
+|+..+.||+|+||.||+++.. +|+.||+|++.... ....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999875 68899999997542 223456778888888885 577888999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++... ..+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 999999999988543 34899999999999999999999987 999999999999999999999999998754322
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
.. ......|+..|+|||++.+..++.++||||||+++|||++|+.||........... ... ...
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~------i~~-~~~------- 218 (323)
T cd05615 155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS------IME-HNV------- 218 (323)
T ss_pred Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH------HHh-CCC-------
Confidence 11 12335689999999999999999999999999999999999999986544332211 111 110
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCH
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTM 633 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 633 (686)
.++...+..+.+++.+|++.+|.+|++.
T Consensus 219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 --SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1234456678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=331.74 Aligned_cols=257 Identities=21% Similarity=0.318 Sum_probs=210.9
Q ss_pred hhCCCcccccccccCcEEEEEEEecCC-CEEEEEEecccCcccHHHHHHHHHHHHhcC-CCCcccEEE-EEEe------c
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQDG-REIAVKKLATNSMQGKEEFENEVRVLLKMQ-HRNLVQLFG-CCVQ------E 436 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~-~~~~------~ 436 (686)
...+.++.+.|.+|||+.||.+++..+ ..+|+|++-..+....+...+|+.+|++|+ |+|||.+++ .... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 346678889999999999999998866 999999998888888899999999999996 999999999 3322 1
Q ss_pred CceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCC
Q 005649 437 RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGL 516 (686)
Q Consensus 437 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 516 (686)
-+.+|.||||++|.|-+++..+.... |++.++++|+.|+++|+.+||... ++|+|||||-+||||+.+++.||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 36789999999999999997654444 999999999999999999999976 7899999999999999999999999999
Q ss_pred ccccCCcCcc-ccc----c--ccccCCCcCchhhhh---cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHH
Q 005649 517 AKLFHDEQSR-HRT----H--QIAGTFGYMAPEYAI---RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKL 586 (686)
Q Consensus 517 a~~~~~~~~~-~~~----~--~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 586 (686)
+......... ... . ...-|+.|++||.+. +...++|+|||+|||+||-|+....||+....
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--------- 263 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--------- 263 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---------
Confidence 8754322211 000 0 124589999999874 56899999999999999999999999984321
Q ss_pred HHHHHhcCccccccccccC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 587 ARRLEEEGRLMELVDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 587 ~~~~~~~~~~~~~~d~~l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..|++.... .-...++.++.+||..||+.||++||++.||+..+...
T Consensus 264 ----------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 264 ----------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred ----------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 112222221 11257899999999999999999999999999988654
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=307.84 Aligned_cols=254 Identities=30% Similarity=0.500 Sum_probs=207.3
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
.++|+..++||+|+||.||++...++..+++|.+.... ...+.+.+|++++++++|+||+++.+++.+ ...++++||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 47889999999999999999998778889999886542 245678999999999999999999999887 7789999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999999653 2345899999999999999999999987 999999999999999999999999999865432211
Q ss_pred ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......++..|+|||++....++.++|+||||++++|+++ |+.||...........+. .+...
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-------~~~~~-------- 222 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-------RGYRM-------- 222 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-------CCCCC--------
Confidence 1222345678999999998899999999999999999999 999997654332221111 11000
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+...+..+.+++.+|++.+|++||++.+++++|++
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1123445678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=313.73 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=207.4
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
..+|+..+.||+|+||.||+|+.. +++.+++|.+........+.+.+|+.+++.++|+|++++++.+..+...++|+||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 357888999999999999999864 6899999999776666667899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++.. ..+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999999853 34899999999999999999999987 99999999999999999999999999876543221
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......+++.|+|||.+.+..++.++|||||||++|||++|+.||......+.. .. ....+. +.+
T Consensus 172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~----~~~~~~------~~~- 236 (296)
T cd06654 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YL----IATNGT------PEL- 236 (296)
T ss_pred --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HH----HhcCCC------CCC-
Confidence 122346788999999999888999999999999999999999999754432211 11 111110 001
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
..+......+.+++.+||+.+|++||++.++++.
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1234456778899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=326.76 Aligned_cols=254 Identities=22% Similarity=0.292 Sum_probs=199.2
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|+..++||+|+||.||+++.. +++.||||++.... ....+.+.+|++++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999999865 78999999986432 223457889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999998643 34889999999999999999999987 999999999999999999999999998643211
Q ss_pred Ccc------------c---------------------------------cccccccCCCcCchhhhhcCCCChhHHHHHH
Q 005649 524 QSR------------H---------------------------------RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSF 558 (686)
Q Consensus 524 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~ 558 (686)
... . ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0 0012468999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCC---CCHHH
Q 005649 559 GVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDR---PTMSA 635 (686)
Q Consensus 559 Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~e 635 (686)
||++|||++|+.||......+....+.. +. ..+ .+.. ....+..+.+++.+|++ +|.+| |++.|
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~----~~-~~~------~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYRKIIN----WR-ETL------YFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHHHHHc----cC-Ccc------CCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 9999999999999976544332211110 00 000 0000 11235567889999997 66665 59999
Q ss_pred HHHHh
Q 005649 636 TLSML 640 (686)
Q Consensus 636 vl~~L 640 (686)
+++.-
T Consensus 302 ~l~hp 306 (377)
T cd05629 302 IKSHP 306 (377)
T ss_pred HhcCC
Confidence 88764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=310.45 Aligned_cols=264 Identities=23% Similarity=0.333 Sum_probs=201.8
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
+|+..+.||+|++|.||+|+.. +++.|++|++.... ....+.+.+|+.++.+++||||+++++++.+++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5788899999999999999976 68999999986543 22346788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
++ ++|.+++........+++..++.++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 689888865544467999999999999999999999987 99999999999999999999999999876543211
Q ss_pred cccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHH-HHHH----HHHHhcC----c
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQEL-LKLA----RRLEEEG----R 595 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~-~~~~----~~~~~~~----~ 595 (686)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+.... .... ...+... .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 12233568899999988654 578999999999999999999999976543221111 0000 0000000 0
Q ss_pred cccc----cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 596 LMEL----VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 596 ~~~~----~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
.... ....+.......+.++.+++.+||+.||++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 000010111224567789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=310.54 Aligned_cols=239 Identities=24% Similarity=0.365 Sum_probs=189.8
Q ss_pred cccccCcEEEEEEEecC-------------------------CCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccE
Q 005649 375 MLGRGGFGTVYKGRLQD-------------------------GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQL 429 (686)
Q Consensus 375 ~LG~G~fG~Vy~~~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l 429 (686)
+||+|+||.||+|.+.. ...|++|++..........|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13478888865544445678899999999999999999
Q ss_pred EEEEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC--
Q 005649 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM-- 507 (686)
Q Consensus 430 ~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 507 (686)
++++.++...++||||+++|+|..++... ...+++..++.++.||++||.|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999988643 345899999999999999999999987 99999999999997644
Q ss_pred -----CeEEEecCCccccCCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHH-cCCCCCcccchHhH
Q 005649 508 -----KPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEII-SGRKNYDRQLEAEN 580 (686)
Q Consensus 508 -----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~ell-tG~~p~~~~~~~~~ 580 (686)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+.
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999987644221 12356788999998865 56899999999999999995 69999975543332
Q ss_pred HHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 581 QELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
..... ... ..+......+.+++.+||+.+|++|||+.+|++.|+
T Consensus 231 ~~~~~------~~~-----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ERFYE------KKH-----------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHH------hcc-----------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 21111 000 012222356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=306.64 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=204.5
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-----ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-----QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
++|+..+.||+|++|.||++... +++.+++|.+..... ...+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999865 689999999864322 123568899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
++||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999998643 34889999999999999999999987 9999999999999999999999999987654
Q ss_pred CcCcccc-ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 522 DEQSRHR-THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 522 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+.. . .......
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~---~~~~~~~----- 224 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---F---KIATQPT----- 224 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---H---HHhccCC-----
Confidence 3211111 12345778999999999988999999999999999999999999754322211 1 1111000
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
....+......+.+++.+||+.+|++|||+.|+++.
T Consensus 225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 ---NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 012244556778999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=306.04 Aligned_cols=248 Identities=30% Similarity=0.444 Sum_probs=202.5
Q ss_pred CCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEe-cCceEEEEeec
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ-ERERILVYEYL 446 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~Ey~ 446 (686)
++|+..+.||+|+||.||++... |+.+++|.+.... ..+.+.+|+.++++++|+|++++++++.. ++..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 57888899999999999999875 7889999986433 35678999999999999999999998654 45789999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++++|.+++.... ...+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999986543 345899999999999999999999987 9999999999999999999999999987543322
Q ss_pred ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
....++..|+|||++.+..++.++||||||+++|||++ |+.||......+... .. .. +...
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~---~~---~~-~~~~-------- 218 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP---RV---EK-GYKM-------- 218 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HH---hc-CCCC--------
Confidence 12344568999999998899999999999999999998 999987543322211 11 11 1000
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+...+..+.+++.+|++.+|++|||+.++++.|++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1123456778899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=307.90 Aligned_cols=249 Identities=22% Similarity=0.389 Sum_probs=211.1
Q ss_pred hCCCcccccccccCcEEEEEEEe-cCCCEEEEEEecccCcccH---HHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRL-QDGREIAVKKLATNSMQGK---EEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
..+|++.+.||+|.||.|-++.. ..|+.||||.+++...... -.+.+|+++|+.|+||||+.++.+|+..+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35788889999999999999986 5899999999987655444 3567899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||..+|.|++|+.+. +.|++.+...+++||.+|+.|+|++. ++|||||.+|||+|+|+++||+|||++.++.+
T Consensus 132 MEYaS~GeLYDYiSer---~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISER---GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHHh---ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999999654 45999999999999999999999987 99999999999999999999999999988765
Q ss_pred cCccccccccccCCCcCchhhhhcCCC-ChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFL-SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
.. ..+..+|.+-|.+||++.+.+| .+..|-|||||+||-|+.|..||++.+.......+. .|.+.
T Consensus 206 ~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs-------~GaYr---- 271 (668)
T KOG0611|consen 206 KK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQIS-------RGAYR---- 271 (668)
T ss_pred cc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhh-------ccccc----
Confidence 54 3455789999999999998876 578999999999999999999999765433222111 22221
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
.++.+....-||.|||..||++|-|+.+|...-.
T Consensus 272 ------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 272 ------EPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 2234455667999999999999999999987653
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=308.72 Aligned_cols=249 Identities=31% Similarity=0.473 Sum_probs=196.9
Q ss_pred ccccccCcEEEEEEEecC-CC--EEEEEEecccC-cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEEeecCC
Q 005649 374 NMLGRGGFGTVYKGRLQD-GR--EIAVKKLATNS-MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~-g~--~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
+.||+|+||.||+|++++ +. .+++|.++... ....+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999863 43 46888886432 33456789999999999 899999999999999999999999999
Q ss_pred CChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecC
Q 005649 449 KSLDKFLFDKS-------------KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFG 515 (686)
Q Consensus 449 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 515 (686)
|+|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999996532 1234889999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcC
Q 005649 516 LAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEG 594 (686)
Q Consensus 516 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 594 (686)
++....... .......+..|+|||++....++.++||||||+++|||++ |+.||......+... ......
T Consensus 158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~------~~~~~~ 228 (270)
T cd05047 158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE------KLPQGY 228 (270)
T ss_pred Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHH------HHhCCC
Confidence 986322111 1111233567999999988899999999999999999997 999997544332211 111100
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 595 RLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 595 ~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
.. ..+...+..+.+++.+||+.+|.+|||+.++++.|.++
T Consensus 229 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 229 RL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00 11223456788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=308.91 Aligned_cols=251 Identities=24% Similarity=0.400 Sum_probs=200.5
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
++|+..++||+|+||.||+++.. +++.+++|++.... ....+.+.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 46788899999999999999864 78899999986542 33346789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 9999997552 3788889999999999999999987 9999999999999999999999999987654321
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHH-HHHHHHHHHHhcCcccccccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQ-ELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||......+.. ........... .. .+.+
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~-----~~~~ 220 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-ED-----PPVL 220 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-cC-----CCCC
Confidence 22346889999999999989999999999999999999999999753322111 01111111110 00 0111
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
. ....+..+.+++.+|++.+|++||++.|+++..
T Consensus 221 ~--~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 221 P--VGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred C--CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 1 122455688999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=305.74 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=205.5
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
+|+..+.||+|+||.||+++.. +++.+++|.+... .....+.+.+|+.++++++|+||+++++.+.+++..++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5778899999999999999876 6889999998643 3334577889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++++|.+++... ....+++...+.++.|++.||.|||+++ ++|+||||+||++++++.++|+|||+++.......
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999999988643 3345889999999999999999999987 99999999999999999999999999886643221
Q ss_pred ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCC
Q 005649 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 606 (686)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......... .... +... .
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~------~~~~-~~~~--------~ 219 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL------KVCQ-GSYK--------P 219 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH------HHhc-CCCC--------C
Confidence 1223568889999999999899999999999999999999999997543322211 1111 1111 1
Q ss_pred CCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+...+..+.+++.+||+.||++||++.+++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 233455678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=318.58 Aligned_cols=237 Identities=24% Similarity=0.310 Sum_probs=189.9
Q ss_pred ccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHH-HHHhcCCCCcccEEEEEEecCceEEEEeecCC
Q 005649 374 NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVR-VLLKMQHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
++||+|+||.||+++.. +++.+|+|++..... .....+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 688999999865322 22344555554 57888999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
|+|..++... ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (321)
T cd05603 81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--T 152 (321)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--c
Confidence 9998888543 34888999999999999999999987 99999999999999999999999999875432221 2
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCC
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYP 608 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 608 (686)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+... .... +.. ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~------~i~~-~~~---------~~~ 216 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD------NILH-KPL---------QLP 216 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH------HHhc-CCC---------CCC
Confidence 234568999999999999899999999999999999999999997654332211 1111 110 123
Q ss_pred HHHHHHHHHHHHHcccccccCCCCHH
Q 005649 609 EEIALRFMQIALLCTEDFIEDRPTMS 634 (686)
Q Consensus 609 ~~~~~~l~~li~~cl~~~p~~RPt~~ 634 (686)
......+.+++.+|++.+|.+||+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 34566788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=307.19 Aligned_cols=254 Identities=26% Similarity=0.386 Sum_probs=195.7
Q ss_pred ccccccCcEEEEEEEecC---CCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCC
Q 005649 374 NMLGRGGFGTVYKGRLQD---GREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNK 449 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~---g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~g 449 (686)
+.||+|+||.||+|...+ +..+++|.+..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998653 45789998865432 33457889999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc
Q 005649 450 SLDKFLFDKSK--SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH 527 (686)
Q Consensus 450 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 527 (686)
+|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975432 234678888899999999999999987 9999999999999999999999999987544333222
Q ss_pred cccccccCCCcCchhhhhcC-------CCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 528 RTHQIAGTFGYMAPEYAIRG-------FLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~~~~-------~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
......++..|+|||++.+. .++.++|+||||+++|||++ |+.||......+... ... . +.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~~~---~-~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---YTV---R-EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---HHh---h-cccCCC
Confidence 22334577889999988642 35789999999999999997 999997554333211 111 1 111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
.++.+. ......+.+++..|+ .+|++|||+.||+..|+
T Consensus 231 ~~~~~~---~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLK---LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccC---CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 222221 123455778999999 58999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=306.49 Aligned_cols=254 Identities=25% Similarity=0.365 Sum_probs=193.7
Q ss_pred ccccccCcEEEEEEEecC---CCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCC
Q 005649 374 NMLGRGGFGTVYKGRLQD---GREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNK 449 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~---g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~g 449 (686)
+.||+|+||.||+|...+ ...+++|.+.... ......|.+|+..++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 358999999999997543 3468888775443 233467889999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc
Q 005649 450 SLDKFLFDKSK--SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH 527 (686)
Q Consensus 450 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 527 (686)
+|.+++..... ....++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 233578888999999999999999987 9999999999999999999999999987543322221
Q ss_pred cccccccCCCcCchhhhhc-------CCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 528 RTHQIAGTFGYMAPEYAIR-------GFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~~~-------~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
......++..|+|||+... ..++.++||||||+++|||++ |..||......+.. . ...... ...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~---~---~~~~~~-~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL---K---QVVREQ-DIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH---H---HHhhcc-CccC
Confidence 2233456778999998743 357889999999999999999 78888755433211 1 111111 1111
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
.++. .+...+..+.+++..|+ .||++|||+++|+++|+
T Consensus 231 ~~~~---~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQ---LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCc---ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1121 13345566778888998 59999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=306.31 Aligned_cols=240 Identities=25% Similarity=0.404 Sum_probs=191.2
Q ss_pred ccccccCcEEEEEEEecC-------------CCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 374 NMLGRGGFGTVYKGRLQD-------------GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
+.||+|+||.||+|...+ ...|++|.+..........|.+|+.++..++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998542 2258889886655555567889999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC-------eEEEe
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK-------PKISD 513 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl~D 513 (686)
+++||+++|+|..++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999888543 245899999999999999999999987 999999999999987664 89999
Q ss_pred cCCccccCCcCccccccccccCCCcCchhhhh-cCCCChhHHHHHHHHHHHHHH-cCCCCCcccchHhHHHHHHHHHHHH
Q 005649 514 FGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI-RGFLSVKSDVFSFGVLLLEII-SGRKNYDRQLEAENQELLKLARRLE 591 (686)
Q Consensus 514 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~s~Gvvl~ell-tG~~p~~~~~~~~~~~~~~~~~~~~ 591 (686)
||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|+......+... ..
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-------~~ 222 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-------FY 222 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-------HH
Confidence 9998755322 1235678899999886 467899999999999999998 5888886543322211 11
Q ss_pred hcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 592 EEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 592 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
. +.. . . .......+.+++.+||+.||++||++.+|++.|.
T Consensus 223 ~-~~~-~-----~---~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 E-GQC-M-----L---VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred h-cCc-c-----C---CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1 100 0 0 1112456889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.54 Aligned_cols=256 Identities=21% Similarity=0.264 Sum_probs=204.2
Q ss_pred HhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 365 AATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 365 ~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
...++|+..++||+|+||.||+++.. +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34578999999999999999999976 68899999996432 223456788999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+||||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999988542 3788889999999999999999987 999999999999999999999999999865
Q ss_pred CCcCccccccccccCCCcCchhhhhcC----CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRG----FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL 596 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (686)
..... .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||......+.... .......
T Consensus 193 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~------i~~~~~~ 265 (370)
T cd05596 193 DANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK------IMDHKNS 265 (370)
T ss_pred cCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH------HHcCCCc
Confidence 43221 112345789999999988653 488999999999999999999999986544322111 1110000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHcccccccC--CCCHHHHHHHh
Q 005649 597 MELVDVRIGTYPEEIALRFMQIALLCTEDFIED--RPTMSATLSML 640 (686)
Q Consensus 597 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~L 640 (686)
.. .. .....+..+.+++.+|++.+|.+ ||++.|+++.-
T Consensus 266 ~~-----~~-~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 266 LT-----FP-DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred CC-----CC-CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 00 00 01134677889999999999987 99999998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=310.59 Aligned_cols=256 Identities=28% Similarity=0.469 Sum_probs=206.6
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCC----EEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGR----EIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
.++|+..+.||+|+||.||+|..+ +|+ .+++|.+..... ....++.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 367888899999999999999865 333 589998865543 334678999999999999999999999987 7889
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+++||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 9999999999999996532 34899999999999999999999977 999999999999999999999999999876
Q ss_pred CCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
.............++..|+|||.+....++.++|+||||+++||+++ |+.||......+....+. .+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~--- 229 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-------KGER--- 229 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-------CCCC---
Confidence 54332222222334578999999988899999999999999999999 999998655433222111 1100
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
...+......+.+++.+||..+|++||++.++++.|++.
T Consensus 230 -----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 230 -----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 011223446788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=321.00 Aligned_cols=260 Identities=31% Similarity=0.467 Sum_probs=203.5
Q ss_pred hCCCcccccccccCcEEEEEEEe------cCCCEEEEEEecccCc-ccHHHHHHHHHHHHhc-CCCCcccEEEEEEec-C
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRL------QDGREIAVKKLATNSM-QGKEEFENEVRVLLKM-QHRNLVQLFGCCVQE-R 437 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~ 437 (686)
.++|++.+.||+|+||.||+|+. .+++.||||+++.... .....+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46899999999999999999973 3578899999975432 2345788999999999 789999999988764 4
Q ss_pred ceEEEEeecCCCChhHHHhhcCC---------------------------------------------------------
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSK--------------------------------------------------------- 460 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 460 (686)
..++++||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999999864321
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccccc
Q 005649 461 -------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIA 533 (686)
Q Consensus 461 -------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 533 (686)
...+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124788899999999999999999987 9999999999999999999999999998654332222222334
Q ss_pred cCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHH
Q 005649 534 GTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIA 612 (686)
Q Consensus 534 gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 612 (686)
++..|+|||.+.+..++.++||||||+++|||++ |..||......+.. .. . ...+... ..+....
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~~---~-~~~~~~~--------~~~~~~~ 308 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CR---R-LKEGTRM--------RAPDYTT 308 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH--HH---H-HhccCCC--------CCCCCCC
Confidence 5678999999999999999999999999999997 99998754322111 11 1 1111110 0112234
Q ss_pred HHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 613 LRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 613 ~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+.+++..||+.+|++|||+.||++.|+..
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 5688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=309.52 Aligned_cols=256 Identities=25% Similarity=0.373 Sum_probs=205.9
Q ss_pred hCCCcccccccccCcEEEEEEEecC----CCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQD----GREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
.++|...+.||+|+||.||+|...+ ...+++|...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568888999999999999998653 2468999886654 3455789999999999999999999998875 45789
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 999999999999996532 34899999999999999999999987 9999999999999999999999999998765
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
...... .....++..|+|||.+....++.++||||||+++||+++ |+.||......+....+ ....+.
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~------~~~~~~---- 227 (270)
T cd05056 159 DESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI------ENGERL---- 227 (270)
T ss_pred ccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------HcCCcC----
Confidence 432211 122334568999999988889999999999999999996 99999765543322111 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
..+...+..+.+++.+|+..+|++|||+.++++.|++..
T Consensus 228 -----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 228 -----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 113345677999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=304.67 Aligned_cols=250 Identities=26% Similarity=0.421 Sum_probs=206.8
Q ss_pred hCCCcccccccccCcEEEEEEEecC-CCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.++|+..+.||+|+||.||+++..+ ++.+++|.+..... .+++.+|++++++++|+||+++++++.++...++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3688999999999999999999874 78999999865433 67899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 9999999998543 345899999999999999999999987 99999999999999999999999999887654321
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......++..|+|||++.+..++.++||||||+++|||++|+.||......+....+ .... .+.+
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~-----~~~~- 219 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-------PNKP-----PPTL- 219 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-------ccCC-----CCCC-
Confidence 122345788999999999999999999999999999999999999754332211100 0000 0001
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
..+......+.+++.+||+.+|++|||+.||++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 123345677899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.29 Aligned_cols=248 Identities=28% Similarity=0.368 Sum_probs=196.7
Q ss_pred ccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCCh
Q 005649 376 LGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSL 451 (686)
Q Consensus 376 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL 451 (686)
||+|+||.||+++.+ +|+.+|+|++..... .....+..|++++.+++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 689999999864322 2234556799999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccc
Q 005649 452 DKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQ 531 (686)
Q Consensus 452 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 531 (686)
.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+||++++++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 98886543 334899999999999999999999987 9999999999999999999999999988664322 1223
Q ss_pred cccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHH
Q 005649 532 IAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEI 611 (686)
Q Consensus 532 ~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 611 (686)
..|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ........ . .........
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~-~--------~~~~~~~~~ 222 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELKRRTLE-D--------EVKFEHQNF 222 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH--HHHHHhhc-c--------ccccccccC
Confidence 468899999999999899999999999999999999999997543321111 11111111 0 010011234
Q ss_pred HHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 612 ALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 612 ~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
+..+.+++.+||+.||++||+++|+++.+.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 567899999999999999999987765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=340.23 Aligned_cols=259 Identities=22% Similarity=0.297 Sum_probs=204.1
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|+..++||+|+||.||+|+.. +|+.||+|++..... ...++|.+|++++++++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999976 689999999965422 23467899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecC
Q 005649 444 EYLPNKSLDKFLFDKS--------KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFG 515 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 515 (686)
||+++|+|.+++.... ....+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999986421 1234677888999999999999999987 9999999999999999999999999
Q ss_pred CccccCCcCc----------------cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHh
Q 005649 516 LAKLFHDEQS----------------RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE 579 (686)
Q Consensus 516 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~ 579 (686)
+++....... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......+
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 001123468999999999999999999999999999999999999997533221
Q ss_pred HHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCC-CHHHHHHHhcC
Q 005649 580 NQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRP-TMSATLSMLSN 642 (686)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~ 642 (686)
... .... .++.-.....+.+..+.+++.+|++.||++|| +++++++.|+.
T Consensus 239 i~~----~~~i---------~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 ISY----RDVI---------LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred hhh----hhhc---------cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 110 0000 00000000123456688999999999999995 66777777654
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=327.10 Aligned_cols=253 Identities=25% Similarity=0.317 Sum_probs=199.1
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|++++.+++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47899999999999999999975 68899999986532 223456889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999999643 35888999999999999999999987 999999999999999999999999997533100
Q ss_pred C-----------------------------------------ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHH
Q 005649 524 Q-----------------------------------------SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLL 562 (686)
Q Consensus 524 ~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl 562 (686)
. .........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 00001124689999999999999999999999999999
Q ss_pred HHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCC---CHHHHHHH
Q 005649 563 LEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRP---TMSATLSM 639 (686)
Q Consensus 563 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~evl~~ 639 (686)
|||++|+.||......+....+.. +. .... . ......+..+.+++.+|+ .+|++|+ ++.|+++.
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~----~~--~~~~-----~-~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVIN----WE--TTLH-----I-PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhc----cC--cccc-----C-CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999999986654433221110 00 0000 0 001123455677787765 5999999 88888876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=306.24 Aligned_cols=250 Identities=29% Similarity=0.440 Sum_probs=194.7
Q ss_pred ccccccCcEEEEEEEec----CCCEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCCcccEEEEEEe-cCceEEEEeecC
Q 005649 374 NMLGRGGFGTVYKGRLQ----DGREIAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ-ERERILVYEYLP 447 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~Ey~~ 447 (686)
+.||+|+||.||+|.+. ++..+++|++... .....+.+.+|+.+++.++||||+++++++.. ++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999864 2357899988543 33345688899999999999999999998764 556889999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc
Q 005649 448 NKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH 527 (686)
Q Consensus 448 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 527 (686)
+|+|.+++.... ..+++..++.++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999996532 34678888999999999999999987 9999999999999999999999999998654322111
Q ss_pred --cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcC-CCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 528 --RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISG-RKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 528 --~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
......++..|+|||.+.+..++.++||||||+++|||++| ..||......+ .... .......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~---~~~~~~~-------- 221 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVY---LLQGRRL-------- 221 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH---HhcCCCC--------
Confidence 11223457789999999989999999999999999999995 56665433222 1111 1111110
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+...+..+.+++.+||+.+|++||++.||++.|++.
T Consensus 222 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 222 -LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11223456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=317.45 Aligned_cols=249 Identities=22% Similarity=0.295 Sum_probs=197.0
Q ss_pred ccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEEeecCC
Q 005649 374 NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
+.||+|+||.||+++.. +++.+|+|++..... ...+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 678999999975422 2345678899999888 699999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--T 152 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--c
Confidence 9999888543 35999999999999999999999987 99999999999999999999999999875322111 1
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCC
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYP 608 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 608 (686)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||........................ ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~p 223 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI---------RIP 223 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC---------CCC
Confidence 23457899999999999999999999999999999999999999643322211111112222211111 123
Q ss_pred HHHHHHHHHHHHHcccccccCCCCH------HHHHHH
Q 005649 609 EEIALRFMQIALLCTEDFIEDRPTM------SATLSM 639 (686)
Q Consensus 609 ~~~~~~l~~li~~cl~~~p~~RPt~------~evl~~ 639 (686)
...+..+.+++.+||+.||++||++ .++++.
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 4456678899999999999999985 466543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=305.93 Aligned_cols=251 Identities=25% Similarity=0.421 Sum_probs=203.1
Q ss_pred CCcccccccccCcEEEEEEEecCCCEEEEEEecccCc------ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSM------QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
+|+..+.||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999988899999999864321 1235688999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999999543 34889999999999999999999987 99999999999999999999999999876532
Q ss_pred cCc----cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 523 EQS----RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 523 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
... ........++..|+|||.+.+..++.++||||||+++|||++|+.||......+....+. ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~-- 227 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-----AHRGLM-- 227 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh-----hccCCC--
Confidence 111 111223468899999999998889999999999999999999999997543322211110 000100
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
...+...+..+.+++.+||+.+|++||++.|+++
T Consensus 228 ------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 ------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1123345677899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=308.13 Aligned_cols=253 Identities=26% Similarity=0.424 Sum_probs=201.5
Q ss_pred HhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEec------
Q 005649 365 AATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQE------ 436 (686)
Q Consensus 365 ~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------ 436 (686)
.+++.|+..+.||+|+||.||+|... +++.+++|++.... .....+.+|+.++.++ +|+|++++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678899999999999999999876 67889999986543 3456788999999998 799999999998753
Q ss_pred CceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCC
Q 005649 437 RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGL 516 (686)
Q Consensus 437 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 516 (686)
...++++||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 3578999999999999998653 2345899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCcCccccccccccCCCcCchhhhh-----cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHH
Q 005649 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAI-----RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLE 591 (686)
Q Consensus 517 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 591 (686)
+........ ......|+..|+|||++. +..++.++|||||||++|||++|+.||........... ..
T Consensus 158 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~------~~ 229 (272)
T cd06637 158 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------IP 229 (272)
T ss_pred ceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH------Hh
Confidence 886543221 223356889999999886 34688899999999999999999999965433221111 11
Q ss_pred hcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 592 EEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 592 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
. ... +.+ .+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 230 ~-~~~-----~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 R-NPA-----PRL--KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred c-CCC-----CCC--CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1 110 111 11234567889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.56 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=202.6
Q ss_pred CcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc---cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ---GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
|+..+.||+|+||+||++... +++.+|+|.+...... ....+.+|++++.+++|+|++++.+.+..++..++++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999875 6889999998654322 234578899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 99999998886543 345999999999999999999999987 9999999999999999999999999987654322
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......|+..|+|||.+.+..++.++|+||||+++|||++|+.||...........+. ..... .. .
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~~~~~-~~---------~ 222 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--RRVLE-TE---------E 222 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhhhc-cc---------c
Confidence 1223468999999999998999999999999999999999999998654433222111 11111 00 0
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCC-----HHHHHHH
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPT-----MSATLSM 639 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 639 (686)
.++...+..+.+++..|++.||++||+ +.++++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 123344566789999999999999999 6677664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.90 Aligned_cols=249 Identities=28% Similarity=0.463 Sum_probs=202.3
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCccc---------HHHHHHHHHHHHhcCCCCcccEEEEEEecCc
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQG---------KEEFENEVRVLLKMQHRNLVQLFGCCVQERE 438 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 438 (686)
+|.....||+|++|.||+|... +++.+++|.+....... .+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999865 68899999886543221 2568899999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.++++||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999999543 34889999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCcCcc----ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcC
Q 005649 519 LFHDEQSR----HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEG 594 (686)
Q Consensus 519 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 594 (686)
........ .......|+..|+|||.+.+..++.++|+||||+++|||++|+.||......... . .... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~---~~~~-~ 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI---F---KIGE-N 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH---H---HHhc-c
Confidence 76532111 1112245788999999999989999999999999999999999999754332211 0 1100 0
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 595 RLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 595 ~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
.. ...+...+..+.+++.+||+.+|++||++.|+++
T Consensus 228 -----~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 -----AS---PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----CC---CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00 1223445677899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=308.45 Aligned_cols=263 Identities=29% Similarity=0.443 Sum_probs=206.9
Q ss_pred CCCcccccccccCcEEEEEEEec-----CCCEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCCcccEEEEEEe--cCce
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-----DGREIAVKKLATNSMQ-GKEEFENEVRVLLKMQHRNLVQLFGCCVQ--ERER 439 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 439 (686)
++|+..+.||+|+||.||+++++ +++.+|||++...... ..+.|.+|++++++++|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46777899999999999999864 3678999999765443 46789999999999999999999999887 5578
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++++||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999996543 24999999999999999999999987 99999999999999999999999999987
Q ss_pred cCCcCcc-ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHH--------HHHHHHHHH
Q 005649 520 FHDEQSR-HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQ--------ELLKLARRL 590 (686)
Q Consensus 520 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~--------~~~~~~~~~ 590 (686)
....... .......++..|++||.+.+..++.++||||||+++|||++|+.|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 7533221 1112234566799999999889999999999999999999999998643322110 000000011
Q ss_pred HhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 591 EEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 591 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
...+. .. ..+..++..+.+++.+||+.+|++|||+.||+++|+++
T Consensus 239 ~~~~~-------~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGE-------RL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCC-------cC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11000 00 11233457799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=307.55 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=205.2
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
++|+..+.||.|++|.||+|+.. +++.+++|++.... ......+.+|+++++.++|+|++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999976 68899999986543 33456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++... .+++..++.++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999998542 6899999999999999999999987 99999999999999999999999999987654321
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......++..|+|||++.+..++.++||||||+++|||++|+.||......+... .... +. .+.+
T Consensus 154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~------~~~~-~~-----~~~~- 218 (274)
T cd06609 154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF------LIPK-NN-----PPSL- 218 (274)
T ss_pred --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH------Hhhh-cC-----CCCC-
Confidence 2233467889999999999889999999999999999999999997544222111 1111 10 1111
Q ss_pred CCCHH-HHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 606 TYPEE-IALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 606 ~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
+.. .+..+.+++.+||..+|++|||++++++.
T Consensus 219 --~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 219 --EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred --cccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111 55678899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=325.98 Aligned_cols=252 Identities=24% Similarity=0.313 Sum_probs=196.5
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
+|+..++||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999875 68889999986542 2234578899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999998653 34888999999999999999999987 9999999999999999999999999975331100
Q ss_pred c---------------------------------------------cccccccccCCCcCchhhhhcCCCChhHHHHHHH
Q 005649 525 S---------------------------------------------RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFG 559 (686)
Q Consensus 525 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~G 559 (686)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 0001124689999999999999999999999999
Q ss_pred HHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCC---HHHH
Q 005649 560 VLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPT---MSAT 636 (686)
Q Consensus 560 vvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~ev 636 (686)
|++|||++|+.||......+....+. ...... .. ......+..+.+++.+++ .+|++|++ +.++
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~------~~~~~~-----~~-p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVI------NWQTSL-----HI-PPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHH------ccCCCc-----CC-CCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 99999999999998655433221111 000000 00 001223455667777765 59999997 7777
Q ss_pred HHH
Q 005649 637 LSM 639 (686)
Q Consensus 637 l~~ 639 (686)
++.
T Consensus 303 ~~h 305 (382)
T cd05625 303 KAH 305 (382)
T ss_pred hcC
Confidence 653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=322.51 Aligned_cols=259 Identities=21% Similarity=0.279 Sum_probs=203.6
Q ss_pred HHHHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecC
Q 005649 362 VLIAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN---SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER 437 (686)
Q Consensus 362 ~l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 437 (686)
.+....++|+..+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 33445678999999999999999999976 5788999998643 2223456789999999999999999999999999
Q ss_pred ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCc
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 517 (686)
..++||||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence 999999999999999998532 4788999999999999999999987 999999999999999999999999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhcC----CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhc
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRG----FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEE 593 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 593 (686)
........ .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+... .....
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~------~i~~~ 262 (370)
T cd05621 190 MKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS------KIMDH 262 (370)
T ss_pred eecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHH------HHHhC
Confidence 87643221 122345799999999998754 37899999999999999999999998654433221 11111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHcccccccC--CCCHHHHHHHh
Q 005649 594 GRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIED--RPTMSATLSML 640 (686)
Q Consensus 594 ~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~L 640 (686)
..... . ......+..+.+++..|++.++.+ ||++.|+++.-
T Consensus 263 ~~~~~-----~-p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 263 KNSLN-----F-PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred CcccC-----C-CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 00000 0 001234666788899999755543 89999998873
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.73 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=207.5
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
.+|+..+.||.|++|.||+|... +++.|++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46899999999999999999864 78999999997665556678899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++++|..++.. ..+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 99999998843 34899999999999999999999987 99999999999999999999999999886543321
Q ss_pred ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCC
Q 005649 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 606 (686)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||......+....+ ..... . .+ .
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~------~~~~~-~-----~~-~ 236 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGT-P-----EL-Q 236 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhcCC-c-----cc-C
Confidence 122346788999999999888999999999999999999999999765443322111 10000 0 00 1
Q ss_pred CCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
.+...+..+.+++.+||+.+|++||++.++++.=
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 1334556788999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.49 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=202.3
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc---cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ---GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.|+..+.||+|+||.||++... +++.+|+|.+...... ....+.+|+.++++++|+|++++++.+.+++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999876 6889999998654322 23457789999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++++|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999999886533 235899999999999999999999987 9999999999999999999999999987654322
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
. .....|+..|+|||.+.+..++.++||||||+++|||++|+.||....................
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~------------ 221 (285)
T cd05630 157 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ------------ 221 (285)
T ss_pred c---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh------------
Confidence 1 1234689999999999999999999999999999999999999975433221111111100000
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCC-----HHHHHHH
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPT-----MSATLSM 639 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 639 (686)
..++......+.+++..||+.||++||| +.|+++.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 0112334566889999999999999999 8888873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=310.31 Aligned_cols=266 Identities=25% Similarity=0.348 Sum_probs=205.0
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
++|+..+.||+|+||.||+++.. ++..+++|.+..... ...+++.+|++++.+++||||+++++.+.+++..++++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47899999999999999999876 578888888865422 2345688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++... ..+++..+..++.|+++||.|||+.. +++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 9999999999643 45899999999999999999999742 39999999999999999999999999987653322
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcC-----------
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEG----------- 594 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 594 (686)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.||......................
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 223467889999999988889999999999999999999999997544322221111100000000
Q ss_pred ------ccccccccccC----CCC-HHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 595 ------RLMELVDVRIG----TYP-EEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 595 ------~~~~~~d~~l~----~~~-~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
...+..+.... ..+ ...+..+.+++.+||+.+|++|||+.||++..--
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 00000000000 001 1245668999999999999999999999987543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.83 Aligned_cols=251 Identities=26% Similarity=0.369 Sum_probs=202.4
Q ss_pred CcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCC
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
|++.+.||+|+||.||+++.. ++..+++|.+........+.+.+|+++++.++|||++++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788999999999999976 5778899988766655667899999999999999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
++|..++... ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~ 159 (282)
T cd06643 87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 159 (282)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence 9999887642 345899999999999999999999987 9999999999999999999999999987653321 12
Q ss_pred ccccccCCCcCchhhhh-----cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 529 THQIAGTFGYMAPEYAI-----RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
.....++..|+|||.+. +..++.++|||||||++|||++|+.||......+... .. ... ... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--~~----~~~-~~~-----~ 227 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLL--KI----AKS-EPP-----T 227 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHH--HH----hhc-CCC-----C
Confidence 23346889999999874 3457889999999999999999999997544322111 11 000 000 0
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
+ ..+...+..+.+++.+||+.+|++||++.++++.-
T Consensus 228 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 228 L-AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred C-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 0 11334567789999999999999999999987654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.03 Aligned_cols=257 Identities=27% Similarity=0.416 Sum_probs=206.6
Q ss_pred CCCcccccccccCcEEEEEEEec------CCCEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNSMQ-GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
++|+..+.||+|+||.||+++.+ +.+.+++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 67888999999999999999864 3467899988654433 3567999999999999999999999999989999
Q ss_pred EEEeecCCCChhHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEec
Q 005649 441 LVYEYLPNKSLDKFLFDKSKS------AILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDF 514 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 514 (686)
+||||+++|+|.+++...... ..+++..+..++.|++.+|.|||+++ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999754422 25899999999999999999999987 999999999999999999999999
Q ss_pred CCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhc
Q 005649 515 GLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEE 593 (686)
Q Consensus 515 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 593 (686)
|++........ .......++..|+|||.+.+...+.++||||||+++|||++ |..||.......... . ...
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~---~----~~~ 233 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN---R----LQA 233 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHH---H----HHc
Confidence 99875433221 12223456778999999988889999999999999999999 888986543322111 1 111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 594 GRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 594 ~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
+.... ..+...+..+.+++.+||+.+|++||++.|+++.|++
T Consensus 234 ~~~~~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 234 GKLEL-------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCcCC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 11110 1122345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=326.39 Aligned_cols=264 Identities=20% Similarity=0.282 Sum_probs=196.1
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEec--------
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE-------- 436 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 436 (686)
..++|+..++||+|+||.||+|+.. +++.||||++.... ....+|+.++++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4578999999999999999999875 68899999885432 2345799999999999999999987532
Q ss_pred CceEEEEeecCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-CeEEEec
Q 005649 437 RERILVYEYLPNKSLDKFLFDK-SKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM-KPKISDF 514 (686)
Q Consensus 437 ~~~~lv~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Df 514 (686)
...++||||+++ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999974 676666432 23456899999999999999999999987 99999999999999665 6999999
Q ss_pred CCccccCCcCccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHH----
Q 005649 515 GLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARR---- 589 (686)
Q Consensus 515 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~---- 589 (686)
|+++.+..... .....|++.|+|||++.+. .++.++|||||||++|||++|.+||......+....+.....
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99986643221 2234678999999988764 689999999999999999999999986554332211111000
Q ss_pred -HHh--cCccccc-----cccccC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 590 -LEE--EGRLMEL-----VDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 590 -~~~--~~~~~~~-----~d~~l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
... ...+.++ ....+. .++...+.++.+++.+||+.||.+|||+.|+++.-
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 000 0000000 000010 12223456789999999999999999999998553
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=301.27 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=208.2
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.++|+..+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++++.++...+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 468899999999999999999975 5788999999776655678899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999988653 245899999999999999999999987 99999999999999999999999999876543221
Q ss_pred cccccccccCCCcCchhhhhcC---CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRG---FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
......++..|+|||.+.+. .++.++|+||||+++|||++|+.||......+...... ..+ . ..+
T Consensus 157 --~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~------~~~-~---~~~ 224 (262)
T cd06613 157 --KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS------KSN-F---PPP 224 (262)
T ss_pred --ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hcc-C---CCc
Confidence 12234678889999998776 88999999999999999999999997654332211111 000 0 000
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
.+ ..+...+..+.+++.+||+.+|++|||+.+|+.
T Consensus 225 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KL-KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cc-cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11 113345678999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=302.27 Aligned_cols=251 Identities=22% Similarity=0.374 Sum_probs=207.2
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
+|+..+.||+|+||.||.++.. +++.+++|++... .....+++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5788999999999999999865 6889999998654 234456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999986542 345899999999999999999999987 99999999999999999999999999986644332
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......++..|+|||.+.+..++.++||||||+++|||++|+.||......+... ... .+.+.
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~------~~~-~~~~~-------- 219 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV------KIV-QGNYT-------- 219 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHH-cCCCC--------
Confidence 2233568899999999988889999999999999999999999997544332211 111 11111
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
..+...+..+.+++.+||+.+|++||++.++++.+
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11234567788999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.19 Aligned_cols=254 Identities=27% Similarity=0.404 Sum_probs=204.6
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
++|+..+.||+|+||.||+++.. +++.+++|.+... .......+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999986 7899999988654 233356789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|..++........+++..+..++.|++.||.|||++. +|+|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999999865433446999999999999999999999742 39999999999999999999999999987653322
Q ss_pred cccccccccCCCcCchhhhhcC------CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRG------FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~------~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
.....++..|+|||.+.+. .++.++|+|||||++|||++|+.||...........+ ..... +
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~-~----- 225 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL---SAIVD-G----- 225 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH---HHHhh-c-----
Confidence 2234578899999988554 3588999999999999999999999754332221111 11111 1
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.....+...+..+.+++.+||+.+|++||++.++++.
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 226 ---DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1112244567888999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.64 Aligned_cols=267 Identities=21% Similarity=0.308 Sum_probs=206.5
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEec--ccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEe-----cCc
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLA--TNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ-----ERE 438 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~ 438 (686)
...|...+.||+|+||.|..+... +|+.||||++. .......++-.+|+++|+.++|+||+.+.+.+.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 456666789999999999999876 78999999997 3455556788999999999999999999999865 347
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.|+|+|+| ..+|...++. ++.|+......++.||++||.|+|+.+ |+||||||+|++++.+..+||+|||+|+
T Consensus 101 vYiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 89999999 6688888843 234999999999999999999999987 9999999999999999999999999999
Q ss_pred ccCCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 519 LFHDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 519 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
...........+.-..|.+|.|||++.. ..|+...||||.|||+.||++|++-|.+.+.-+...++...-....+..+.
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 8864422223345677999999998765 589999999999999999999999998766543333322111111000000
Q ss_pred cccc-------cccC--------CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 598 ELVD-------VRIG--------TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 598 ~~~d-------~~l~--------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
.+-. ..+. ..-+......++++.+||..||.+|+|++|.++.-
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 0000 0000 00124456688999999999999999999998653
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=301.82 Aligned_cols=251 Identities=36% Similarity=0.574 Sum_probs=204.7
Q ss_pred CcccccccccCcEEEEEEEecC-----CCEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQD-----GREIAVKKLATNSMQ-GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
|++.+.||.|+||.||+++..+ +..+++|++...... ..+.+.+|+..+.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999763 378999999765443 5678999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++++|.+++..... ..+++..+..++.|++.+|.|||+.+ ++|+||||+||++++++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999965332 22899999999999999999999987 999999999999999999999999999876544
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
...... ...++..|+|||.+.+..++.++||||+|++++||++ |+.||...........+. . +...
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~------~-~~~~----- 223 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK------K-GYRL----- 223 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh------c-CCCC-----
Confidence 222111 2346789999999988899999999999999999999 888887543333222111 1 1110
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
..+...+..+.+++.+|++.+|++|||+.|+++.|
T Consensus 224 ---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11233567789999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=310.20 Aligned_cols=263 Identities=26% Similarity=0.418 Sum_probs=203.6
Q ss_pred CCCcccccccccCcEEEEEEEe-----cCCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEec--Cce
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRL-----QDGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE--RER 439 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 439 (686)
..|++.+.||+|+||.||+++. .++..|++|.+.... ....+.+.+|+.++++++|||++++.+++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3567889999999999999974 257889999986543 33346799999999999999999999998875 567
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 89999999999999985432 35899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCcCcc-ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHh--------HHHHHHHHHHH
Q 005649 520 FHDEQSR-HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE--------NQELLKLARRL 590 (686)
Q Consensus 520 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~--------~~~~~~~~~~~ 590 (686)
+...... .......++..|+|||.+.+..++.++||||||+++|||++++.|........ ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6533221 11223456778999999998899999999999999999999876643211100 00000111111
Q ss_pred HhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 591 EEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 591 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
...+... ..+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 239 ~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKRL--------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCccC--------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111110 11234567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=303.20 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=203.1
Q ss_pred CCcccccccccCcEEEEEEEecC--CCEEEEEEecccC----------cccHHHHHHHHHHHHh-cCCCCcccEEEEEEe
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQD--GREIAVKKLATNS----------MQGKEEFENEVRVLLK-MQHRNLVQLFGCCVQ 435 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~~--g~~vavK~l~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 435 (686)
+|+..+.||+|+||.||++.... ++.+++|.+.... .....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999864 6789999885321 1223457788888875 799999999999999
Q ss_pred cCceEEEEeecCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEec
Q 005649 436 ERERILVYEYLPNKSLDKFLFDK-SKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDF 514 (686)
Q Consensus 436 ~~~~~lv~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 514 (686)
++..+++|||+++++|.+++... .....+++..++.++.|++.+|.|||+.. +++|+||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988542 23346899999999999999999999632 3999999999999999999999999
Q ss_pred CCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcC
Q 005649 515 GLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEG 594 (686)
Q Consensus 515 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 594 (686)
|++....... ......++..|++||.+.+..++.++||||||+++|||++|+.||.......... ... .+
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~------~~~-~~ 228 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT------KIV-EA 228 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH------HHh-hc
Confidence 9998755432 2334568889999999999899999999999999999999999997543322211 111 11
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 595 RLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 595 ~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..... .....+..+.+++.+||+.||++||++.|+..++++
T Consensus 229 ~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 229 VYEPL-------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred cCCcC-------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 11100 011345678899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=308.99 Aligned_cols=264 Identities=22% Similarity=0.320 Sum_probs=202.7
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
++|+..+.||+|+||.||+|+.+ +++.||+|.+.... ......+.+|+.++++++||||+++++++.+++..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 67889999999999999999876 67899999986543 23345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
++ ++|.+++... ...+++..+..++.||++||.|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 96 6898888653 235889999999999999999999987 99999999999999999999999999876433221
Q ss_pred cccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc---
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD--- 601 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--- 601 (686)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+....+...........+..+++
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 12234568899999988654 588999999999999999999999986654333221111100000011111100
Q ss_pred ---cccC--------CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 602 ---VRIG--------TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 602 ---~~l~--------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.... ......+..+.+++.+|++.||.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 0112345568899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=316.96 Aligned_cols=240 Identities=24% Similarity=0.297 Sum_probs=191.2
Q ss_pred ccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHH-HHHhcCCCCcccEEEEEEecCceEEEEeecCC
Q 005649 374 NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVR-VLLKMQHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
+.||+|+||.||+++.. +++.+|+|++..... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 678899999865321 22234444443 56778999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
|+|.+++... ..+++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~ 152 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--T 152 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--C
Confidence 9999998643 34788888999999999999999987 99999999999999999999999999875432221 2
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCC
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYP 608 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 608 (686)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||......+.... ... ... ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~------i~~-~~~---------~~~ 216 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN------ILN-KPL---------QLK 216 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHH------HHh-CCc---------CCC
Confidence 2345789999999999999999999999999999999999999986544332211 111 110 112
Q ss_pred HHHHHHHHHHHHHcccccccCCCCHHHHH
Q 005649 609 EEIALRFMQIALLCTEDFIEDRPTMSATL 637 (686)
Q Consensus 609 ~~~~~~l~~li~~cl~~~p~~RPt~~evl 637 (686)
...+..+.+++.+|++.+|.+||+..+.+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 34566788999999999999999987443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.54 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=202.0
Q ss_pred CcccccccccCcEEEEEEEec----CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecC------
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQ----DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER------ 437 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 437 (686)
|.+.+.||+|+||.||+|.+. +++.++||++.... ....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999864 36889999986542 334567899999999999999999999986542
Q ss_pred ceEEEEeecCCCChhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEec
Q 005649 438 ERILVYEYLPNKSLDKFLFDKS---KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDF 514 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 514 (686)
..++++||+++|+|.+++.... +...+++...+.++.|++.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875432 2234889999999999999999999987 999999999999999999999999
Q ss_pred CCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhc
Q 005649 515 GLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEE 593 (686)
Q Consensus 515 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 593 (686)
|+++...............++..|++||.+.+..++.++||||||+++|||++ |+.||......+... +.. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~---~~~---~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN---YLI---KG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHH---HHH---cC
Confidence 99986644332222223345678999999999999999999999999999999 889987554332211 111 11
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 594 GRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 594 ~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
... ..+...+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 232 ~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRL---------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 01223456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=302.59 Aligned_cols=238 Identities=27% Similarity=0.448 Sum_probs=191.5
Q ss_pred ccccccCcEEEEEEEecCCC-----------EEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 374 NMLGRGGFGTVYKGRLQDGR-----------EIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
+.||+|+||.||+|.+.+.. .+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999986433 4777877554333 6788999999999999999999999988 788999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-------CeEEEecC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM-------KPKISDFG 515 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~Dfg 515 (686)
+||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999965432 5899999999999999999999987 99999999999999888 79999999
Q ss_pred CccccCCcCccccccccccCCCcCchhhhhcC--CCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHh
Q 005649 516 LAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG--FLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEE 592 (686)
Q Consensus 516 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 592 (686)
++..... .....++..|+|||++... .++.++||||||+++|||++ |..|+......+...... .
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~------~ 221 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ------D 221 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh------c
Confidence 9886543 1123466789999998876 78999999999999999999 577776543222111110 0
Q ss_pred cCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 593 EGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 593 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
... .+......+.+++.+||+.+|++|||+.+|++.|+
T Consensus 222 ~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QHR-----------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCC-----------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 01111277889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=306.12 Aligned_cols=240 Identities=25% Similarity=0.398 Sum_probs=191.3
Q ss_pred ccccccCcEEEEEEEecC--------CCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 374 NMLGRGGFGTVYKGRLQD--------GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
+.||+|+||.||+|.... ...+++|.+........+.+.+|..+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 468999999999998642 234788887655545557889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC--------eEEEecCCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK--------PKISDFGLA 517 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~Dfgla 517 (686)
+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999996543 35899999999999999999999987 999999999999987765 699999988
Q ss_pred cccCCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCC-CCCcccchHhHHHHHHHHHHHHhcCc
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGR-KNYDRQLEAENQELLKLARRLEEEGR 595 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 595 (686)
...... ....++..|+|||.+.+ ..++.++||||||+++|||++|. .|+............ ....
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~------~~~~- 222 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY------EDRH- 222 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH------Hccc-
Confidence 654321 22457788999999876 45899999999999999999985 565533322211110 0000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 596 LMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 596 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
..+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 223 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 ----------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 112233467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=308.26 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=206.5
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.++|++.+.||.|+||.||++... +++.+++|.+........+.|..|++++++++|+|++++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 567899999999999999999975 6889999999776666667899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999999986532 35899999999999999999999987 99999999999999999999999999876533221
Q ss_pred cccccccccCCCcCchhhhh-----cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAI-----RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
......++..|++||.+. ...++.++|+||||+++|||++|+.||......+... .... +..
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~-~~~---- 225 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL------KILK-SEP---- 225 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH------HHhc-CCC----
Confidence 123356888999999875 3457889999999999999999999997554322211 1111 100
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
+.+ ..+...+..+.+++.+||+.+|++||++.++++.
T Consensus 226 -~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 -PTL-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -CCc-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 001 1123455678899999999999999999999775
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=308.09 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=204.7
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.+.|++.++||+|+||.||+|+.. +++.+++|.+........+.+.+|+.++++++|+|++++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 367889999999999999999976 5889999999776666677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|..++.... ..+++..++.++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 91 CPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 99999988875432 34899999999999999999999987 9999999999999999999999999987543221
Q ss_pred cccccccccCCCcCchhhhh-----cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAI-----RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
.......++..|+|||++. ...++.++||||||+++|||++|+.||......+.. ........
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~~----- 232 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIAKSEP----- 232 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH------HHHhcCCC-----
Confidence 1123346788999999874 345788999999999999999999999754332211 11111000
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
+.+ ..+...+..+.+++.+||+.+|++||++.++++.
T Consensus 233 -~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 233 -PTL-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -ccC-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 1133455678899999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=303.95 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=207.5
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.++|+..+.||+|+||.||+++.. +|+.+++|++.... ....+.+.+|++++..++||||+++++++...+..++|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 367888899999999999999875 68889999886543 2345788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++++|.+++... +.+++.....++.+++.+|.|||+.. .++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 84 FMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred cCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999988543 35899999999999999999999742 39999999999999999999999999987543221
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHh-----HHHHHHHHHHHHhcCccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE-----NQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 599 (686)
.....|+..|+|||.+.+..++.++|+|||||++|||++|+.||......+ ...............
T Consensus 159 ----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd06620 159 ----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----- 229 (284)
T ss_pred ----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence 223568899999999988899999999999999999999999998544321 111122222221111
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
.+.+. ....+..+.+++.+|++.||++|||+.|++++..-
T Consensus 230 -~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 230 -PPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred -CCCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 01110 12255678999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.26 Aligned_cols=256 Identities=20% Similarity=0.260 Sum_probs=198.8
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN---SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999976 6889999998642 2223456889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999999542 235899999999999999999999987 999999999999999999999999998765432
Q ss_pred CccccccccccCCCcCchhhhhc-----CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIR-----GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||......+... ..........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~------~i~~~~~~~~ 228 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHKEHFQ 228 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH------HHHcCCCccc
Confidence 221 1223468999999999863 457889999999999999999999997554332221 1111110000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccc--cccCCCCHHHHHHHh
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTED--FIEDRPTMSATLSML 640 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~--~p~~RPt~~evl~~L 640 (686)
+.......+..+.+++.+|+.. ++..||++.++++.-
T Consensus 229 -----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 229 -----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred -----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 1111122456677888876654 444488999998874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=300.41 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=203.6
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEec-CceEEEEe
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE-RERILVYE 444 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E 444 (686)
+|+..+.||+|++|.||+++.+ +++.+++|++.... ....+.+.+|++++++++|+|++++++.+... ...++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999976 57889999986542 23456789999999999999999999987644 45789999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++++|.+++... ....+++.+++.++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999999653 2345899999999999999999999987 9999999999999999999999999998664322
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
. ......+++.|+|||.+.+..++.++||||||++++||++|+.||......... ..... +..
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~------~~~~~-~~~-------- 219 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV------YRIIE-GKL-------- 219 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH------HHHHh-cCC--------
Confidence 1 223356788999999999999999999999999999999999999754432211 11111 111
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
...+...+..+.+++.+|++.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11234566789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=302.79 Aligned_cols=247 Identities=30% Similarity=0.486 Sum_probs=201.6
Q ss_pred CCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecC
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLP 447 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 447 (686)
++|++.+.||+|+||.||++.. +++.+++|.+.... ..+.+.+|+.++.+++|||++++++++..+ ..++++||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5688899999999999999986 57889999986532 346789999999999999999999998654 5799999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc
Q 005649 448 NKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH 527 (686)
Q Consensus 448 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 527 (686)
+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999996543 235899999999999999999999987 9999999999999999999999999987543221
Q ss_pred cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCC
Q 005649 528 RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 606 (686)
.....+..|+|||.+.++.++.++|+||||+++|||++ |+.||......+....+. .+... .
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~~--------~ 217 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-------KGYRM--------E 217 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-------CCCCC--------C
Confidence 12234567999999998899999999999999999998 999997654433221111 11100 1
Q ss_pred CCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
.+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 123345778899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=307.98 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=202.5
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
.|+..+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|++++++++||||+++++++..++..++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4666788999999999999865 57889999886443 334567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++++|.+++.. ..+++..+..++.|+++||.|||+++ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 99999998843 35899999999999999999999987 99999999999999999999999999886643221
Q ss_pred ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCC
Q 005649 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 606 (686)
......++..|+|||++.+..++.++||||||+++|||++|+.|+......+... .. ..+. .+ .
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~~-~~~~-----~~---~ 220 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF------LI-PKNS-----PP---T 220 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh------hh-hcCC-----CC---C
Confidence 1223467889999999999899999999999999999999999987443222111 01 1010 11 1
Q ss_pred CCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+...+..+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 233456778899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.92 Aligned_cols=254 Identities=22% Similarity=0.337 Sum_probs=203.1
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.++|+..+.||+|+||.||+++.. +++.+++|.++.........+.+|+.+++.++||||+++++.+..++..++++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888899999999999999875 6889999998766555556788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++... ..+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 88 CGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 9999999998543 35899999999999999999999987 9999999999999999999999999987654321
Q ss_pred cccccccccCCCcCchhhhh---cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAI---RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
.......|+..|+|||.+. ...++.++|+|||||++|||++|+.||............ .. .... .+
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~------~~-~~~~---~~ 229 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM------TK-SNFQ---PP 229 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh------hc-cCCC---CC
Confidence 1223356889999999874 456889999999999999999999998644322211100 00 0000 00
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.... ....+..+.+++.+|++.+|++||++.+|++.
T Consensus 230 ~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 230 KLKD-KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cccc-cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0100 11234568899999999999999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.33 Aligned_cols=262 Identities=24% Similarity=0.340 Sum_probs=196.3
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhc---CCCCcccEEEEEEec-----C
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKM---QHRNLVQLFGCCVQE-----R 437 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~-----~ 437 (686)
+|+..+.||+|+||.||+++.. +++.||+|.+..... .....+.+|+.+++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999876 688999999865322 1234556677776665 799999999998652 3
Q ss_pred ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCc
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 517 (686)
..++++||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 5789999997 58888885432 345899999999999999999999987 999999999999999999999999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
+...... ......++..|+|||.+.+..++.++|||||||++|||++|++||......+....+...........+.
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 8664322 1223467899999999999999999999999999999999999997654433221111100000000000
Q ss_pred c-------ccccc----cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 598 E-------LVDVR----IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 598 ~-------~~d~~----l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
. ...+. +..........+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00000 00111234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=304.99 Aligned_cols=264 Identities=22% Similarity=0.330 Sum_probs=203.2
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
++|+..+.||+|++|.||+++.. +|+.|++|++.... ....+.+.+|+.++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999986 68999999986442 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++++|..++... ..+++..++.++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 99999888776432 34899999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH--------HHHhcCc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR--------RLEEEGR 595 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 595 (686)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.... .......
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1223457789999999876 568899999999999999999999998655433222111100 0000000
Q ss_pred c-ccccccccC------CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 596 L-MELVDVRIG------TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 596 ~-~~~~d~~l~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
+ .....+... ......+..+.+++.+||+.+|++||++.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 000000000 0011235678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=313.93 Aligned_cols=255 Identities=20% Similarity=0.249 Sum_probs=199.2
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN---SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|+..+.||+|+||.||+++.. +++.||+|++... .......+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57899999999999999999976 6788999998643 2223455788999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999653 235899999999999999999999987 999999999999999999999999999866433
Q ss_pred CccccccccccCCCcCchhhhhc-----CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIR-----GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
... ......|++.|+|||++.+ +.++.++||||||+++|||++|+.||......+... ........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~~~-- 226 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHEER-- 226 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH------HHHcCCCc--
Confidence 221 1223568999999999875 568899999999999999999999997554332211 11111000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccccccC--CCCHHHHHHH
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIED--RPTMSATLSM 639 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~ 639 (686)
..+.....+.+..+.+++.+|+...+.+ |+++.++++.
T Consensus 227 ---~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 ---FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ---ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0011111234567888999988865543 4678888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=316.37 Aligned_cols=262 Identities=21% Similarity=0.248 Sum_probs=198.8
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecC------
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER------ 437 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 437 (686)
.++|+..+.||+|+||.||+++.. +|+.||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 478999999999999999999875 6899999999653 2233567889999999999999999999986543
Q ss_pred ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCc
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 517 (686)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 46899999965 56555532 3788999999999999999999987 999999999999999999999999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHH-------------
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELL------------- 584 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~------------- 584 (686)
+...... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+....+
T Consensus 171 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 171 RTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred cccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 7643321 123356889999999999999999999999999999999999999765432211100
Q ss_pred ---HHHHHHHhcC-c-----cccccc----cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 585 ---KLARRLEEEG-R-----LMELVD----VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 585 ---~~~~~~~~~~-~-----~~~~~d----~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
.......... . +.+... +.....+......+.+++.+||+.||++|||+.|+++.-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0000000000 0 000000 000011122356688999999999999999999998854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.09 Aligned_cols=251 Identities=27% Similarity=0.408 Sum_probs=206.6
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.++|+..+.||+|+||.||++... +++.|++|.+........+.+.+|+.+++.++|+|++++++++..++..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 367899999999999999999964 7899999999766655667889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++.. ..+++.++..++.|++.+|.|||+.+ ++||||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999999843 34889999999999999999999987 99999999999999999999999999876543221
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......+++.|+|||.+.+..++.++|+||||+++|++++|+.||.......... . ....+. +. .
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--~----~~~~~~------~~-~ 235 (297)
T cd06656 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--L----IATNGT------PE-L 235 (297)
T ss_pred --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--e----eccCCC------CC-C
Confidence 1223467889999999999899999999999999999999999997543221100 0 000000 00 0
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
..+...+..+.+++.+||+.+|++||++.++++.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1233456678899999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=320.14 Aligned_cols=265 Identities=20% Similarity=0.248 Sum_probs=203.0
Q ss_pred hCCCcccccccccCcEEEEEEEec---CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ---DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
..+|++.+.||+|+||.||++... .++.|++|.+... +.+.+|++++++++||||+++++++......+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 467999999999999999999754 3577899988543 24568999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
|++. ++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9985 68888883 2345999999999999999999999987 999999999999999999999999999876544
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccc------
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM------ 597 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 597 (686)
..........||..|+|||++.+..++.++|||||||++|||++|+.||...........+....+........
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 33333344679999999999999999999999999999999999999997544322111111111111000000
Q ss_pred ----c---ccccccC---CCC-----HHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 598 ----E---LVDVRIG---TYP-----EEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 598 ----~---~~d~~l~---~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
. .+..... ..+ ......+.+++.+||+.||++|||+.|++..---.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~ 379 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFT 379 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhh
Confidence 0 0000000 000 12345678899999999999999999999875443
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.80 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=202.5
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecC
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLP 447 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 447 (686)
.|.....||+|+||.||++... +++.|+||++........+.+.+|+..+.+++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444567999999999999875 688999999876655566789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc
Q 005649 448 NKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH 527 (686)
Q Consensus 448 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 527 (686)
+++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence 9999998843 34899999999999999999999987 99999999999999999999999999876543221
Q ss_pred cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCC
Q 005649 528 RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTY 607 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 607 (686)
......++..|+|||.+.+..++.++||||||+++|||++|+.||......+.... ... .+.+.+. .
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~---------~~~~~~~-~ 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---IRD---------NLPPRVK-D 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHh---------cCCCccc-c
Confidence 12234678899999999888899999999999999999999999975443222111 110 0111111 1
Q ss_pred CHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 608 PEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 608 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.......+.+++.+|++.+|++|||+.|+++.
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 12345578899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=319.71 Aligned_cols=261 Identities=22% Similarity=0.280 Sum_probs=205.2
Q ss_pred HHHHHHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEe
Q 005649 360 LDVLIAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ 435 (686)
Q Consensus 360 ~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 435 (686)
+.++....++|+..+.||+|+||.||+++.. +++.+|+|++.... ......+.+|..+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4445556789999999999999999999976 67889999986422 2234567889999999999999999999999
Q ss_pred cCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecC
Q 005649 436 ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFG 515 (686)
Q Consensus 436 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 515 (686)
++..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999999854 23788889999999999999999987 9999999999999999999999999
Q ss_pred CccccCCcCccccccccccCCCcCchhhhhcC----CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHH
Q 005649 516 LAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG----FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLE 591 (686)
Q Consensus 516 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 591 (686)
+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... ...
T Consensus 188 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~------~i~ 260 (371)
T cd05622 188 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS------KIM 260 (371)
T ss_pred ceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHH------HHH
Confidence 9987643221 122345799999999998754 37899999999999999999999998654432211 111
Q ss_pred hcCccccccccccCCCCHHHHHHHHHHHHHcccccccC--CCCHHHHHHHh
Q 005649 592 EEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIED--RPTMSATLSML 640 (686)
Q Consensus 592 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~L 640 (686)
........ ......+..+.+++.+|++.++.+ ||++.|+++..
T Consensus 261 ~~~~~~~~------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 261 NHKNSLTF------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cCCCcccC------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11100000 011245667889999999844433 78999998865
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=303.37 Aligned_cols=249 Identities=26% Similarity=0.391 Sum_probs=205.7
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
..|+..+.||.|+||.||+|... +++.|++|.+.... ....+.+.+|+.++++++|+||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35677889999999999999975 58899999986543 34456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++.. ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998843 34889999999999999999999987 99999999999999999999999999976643321
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||...........+ .. +. ..
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------~~-~~--------~~ 219 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI------PK-NN--------PP 219 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh------hc-CC--------CC
Confidence 122345788899999999889999999999999999999999999754432221111 00 10 01
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
..+...+..+.+++.+||+.+|++||++.++++.-
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 23456778899999999999999999999998763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=321.24 Aligned_cols=261 Identities=21% Similarity=0.219 Sum_probs=197.2
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
..+|.+.+.||+|+||.||+++.. .++.|+||... ...+.+|++++++++|+||+++++++..++..++|+|+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346999999999999999999976 57889999642 23467899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+ .++|.+++... ...++|..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~-~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 Y-RSDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 9 47888888543 235999999999999999999999987 99999999999999999999999999987644322
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccc--------hHhHHHHHHHHHHHHhcCc--
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQL--------EAENQELLKLARRLEEEGR-- 595 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~--------~~~~~~~~~~~~~~~~~~~-- 595 (686)
........||..|+|||++.+..++.++|||||||+||||++|..++-... .......+........+-.
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 222234579999999999999999999999999999999999876543211 1112222221111000000
Q ss_pred -cccccc-----------ccc-C-CCC--HHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 596 -LMELVD-----------VRI-G-TYP--EEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 596 -~~~~~d-----------~~l-~-~~~--~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
...+.. +.. . ... ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000 000 0 000 0123468899999999999999999999975
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=299.18 Aligned_cols=247 Identities=28% Similarity=0.437 Sum_probs=202.5
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-----ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-----QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
+|+..+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|+.++++++|+||+++++++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999987 789999999865431 2346789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
+||+++++|.+++... ..+++..++.++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998643 34899999999999999999999987 99999999999999999999999999886543
Q ss_pred cCccccccccccCCCcCchhhhhcCC-CChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGF-LSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
.. ......++..|++||.+.... ++.++|+||||+++|+|++|+.||......+.. .. ......
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~--~~----~~~~~~------ 219 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV--FK----IGRSKE------ 219 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH--HH----HHhccc------
Confidence 32 123356788999999987776 899999999999999999999999754321111 11 111000
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
....+......+.+++.+||+.+|++||++.++++
T Consensus 220 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 --LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11123345677889999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.41 Aligned_cols=264 Identities=26% Similarity=0.370 Sum_probs=205.9
Q ss_pred cCHHHHHHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEe
Q 005649 358 FNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQ 435 (686)
Q Consensus 358 ~~~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 435 (686)
+.++.+..+.++|+..+.||+|+||.||++... +++.+++|++.... ....++.+|+.++.++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 334556677899999999999999999999875 67899999875432 2246788999999999 79999999998853
Q ss_pred -----cCceEEEEeecCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCe
Q 005649 436 -----ERERILVYEYLPNKSLDKFLFDK-SKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP 509 (686)
Q Consensus 436 -----~~~~~lv~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 509 (686)
++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 35689999999999999988643 23346899999999999999999999987 9999999999999999999
Q ss_pred EEEecCCccccCCcCccccccccccCCCcCchhhhhc-----CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHH
Q 005649 510 KISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR-----GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELL 584 (686)
Q Consensus 510 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~ 584 (686)
||+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.||......... .
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~ 239 (286)
T cd06638 164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--F 239 (286)
T ss_pred EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--h
Confidence 9999999886643221 1223468899999998753 45789999999999999999999999754322111 0
Q ss_pred HHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 585 KLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 585 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
. .. ....... ..+......+.+++.+||+.+|++|||+.|+++.+
T Consensus 240 ~----~~-~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 240 K----IP-RNPPPTL------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred h----cc-ccCCCcc------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 00 0000010 01222345688999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=301.06 Aligned_cols=254 Identities=21% Similarity=0.339 Sum_probs=192.7
Q ss_pred ccccccCcEEEEEEEecCCC---EEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCC
Q 005649 374 NMLGRGGFGTVYKGRLQDGR---EIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNK 449 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~g~---~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~g 449 (686)
+.||+|+||.||+|+..++. .+++|.+.... ....+.|.+|+..+..++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999865433 45677665443 334578999999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 450 SLDKFLFDKSK-SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 450 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
+|.+++..... ...+++..++.++.||++||.|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999976432 234677788899999999999999987 99999999999999999999999999864322221112
Q ss_pred ccccccCCCcCchhhhhc-------CCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 529 THQIAGTFGYMAPEYAIR-------GFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~-------~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||......+.... ...+ ......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~------~~~~-~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNH------VIKD-QQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------HHhh-cccccC
Confidence 233567889999998753 245789999999999999997 6778865443322211 1111 112223
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
++.+. ......+.+++..|| .+|++||++++|++.|.
T Consensus 231 ~~~~~---~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLE---LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccC---CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33332 224566788999999 57999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=300.39 Aligned_cols=250 Identities=22% Similarity=0.359 Sum_probs=205.1
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
+|+..+.||+|+||.+|+++.. +|+.+++|++... .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5788999999999999999865 6899999998653 233456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999886432 235789999999999999999999987 99999999999999999999999999986643221
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......|+..|+|||.+.+..++.++|+||||++++||++|+.||......+... .... +.. .
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~------~~~~-~~~--------~ 219 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL------KIIR-GSY--------P 219 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHH------HHhc-CCC--------C
Confidence 1223457889999999999899999999999999999999999997543322211 1111 110 1
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
..+......+.+++.+||+.+|++||++.+|++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1234456778999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=304.25 Aligned_cols=264 Identities=23% Similarity=0.316 Sum_probs=202.8
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc-----cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ-----GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
+|+..+.||+|++|.||+|... +|+.|++|++...... ....+.+|++++++++|+||+++++++.+++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999975 6899999999765432 234577899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+ +++|.+++.... ..+++..++.++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999986533 35999999999999999999999987 99999999999999999999999999987654
Q ss_pred cCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH-----HHHh-cCc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR-----RLEE-EGR 595 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~-----~~~~-~~~ 595 (686)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|..+|......+....+.... ..+. ...
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence 321 1222356778999998865 467899999999999999999988887544332211111000 0000 000
Q ss_pred cccccc------cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 596 LMELVD------VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 596 ~~~~~d------~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
...... ..+..........+.+++.+||+.+|++|||+.|+++.=
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~ 283 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHP 283 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCc
Confidence 000000 000111233467889999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=287.10 Aligned_cols=252 Identities=26% Similarity=0.372 Sum_probs=204.6
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc----cc----HHHHHHHHHHHHhc-CCCCcccEEEEEEec
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM----QG----KEEFENEVRVLLKM-QHRNLVQLFGCCVQE 436 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~----~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 436 (686)
-.+|...++||.|..+.|-+...+ .|++.|+|++..... .. .+.-..|+.+|+++ .||+|+++.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 467888899999999999888765 788999999854211 11 23456799999998 799999999999999
Q ss_pred CceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCC
Q 005649 437 RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGL 516 (686)
Q Consensus 437 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 516 (686)
...++|+|.|+.|-|.++|.... .++++...+|++|+.+|+.|||.++ ||||||||+|||+|++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 99999999999999999996543 4999999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCcCccccccccccCCCcCchhhhhc------CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHH
Q 005649 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIR------GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL 590 (686)
Q Consensus 517 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 590 (686)
+..+.... +....+||++|+|||.+.- ..|+...|+|+.||+||-|+.|.+||.-...-- ..++
T Consensus 170 a~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml-------MLR~ 239 (411)
T KOG0599|consen 170 ACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML-------MLRM 239 (411)
T ss_pred eeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH-------HHHH
Confidence 98776543 3456799999999998742 468999999999999999999999997332211 1122
Q ss_pred HhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 591 EEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 591 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.-+|+..-- ...-.+.+....+++.+|++.||.+|.|.+|.++.
T Consensus 240 ImeGkyqF~-----speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 240 IMEGKYQFR-----SPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHhcccccC-----CcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 223322110 01123567889999999999999999999998753
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=313.51 Aligned_cols=262 Identities=21% Similarity=0.227 Sum_probs=199.5
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEec------C
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE------R 437 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 437 (686)
.++|+..+.||+|+||.||+++.. .++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 478999999999999999999865 68899999996542 23346788999999999999999999987643 3
Q ss_pred ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCc
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 517 (686)
..++||||+++ +|.+++.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 57999999965 67666632 3788999999999999999999987 999999999999999999999999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHH----------
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLA---------- 587 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~---------- 587 (686)
+...... ......++..|+|||.+.+..++.++|||||||++|||++|+.||......+....+...
T Consensus 174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 174 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred cccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 8654322 123346899999999999999999999999999999999999999765543322111000
Q ss_pred ------HHHHhc-Ccc-----cccccccc----CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 588 ------RRLEEE-GRL-----MELVDVRI----GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 588 ------~~~~~~-~~~-----~~~~d~~l----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
...... ... .+.....+ ..........+.+++.+|++.||.+|||+.|+++.-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 000000 000 00000000 011112345788999999999999999999998863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=306.94 Aligned_cols=254 Identities=24% Similarity=0.286 Sum_probs=204.6
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc---cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ---GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|+..+.||+|++|.||++... +++.+++|.+...... ..+.+.+|++.+..++|+||+++++.+.+....+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888999999999999999976 5899999999765332 4467889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+.+++|.+++... ....+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999998643 3356899999999999999999999987 999999999999999999999999998765322
Q ss_pred Cccc---------------------------cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccc
Q 005649 524 QSRH---------------------------RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQL 576 (686)
Q Consensus 524 ~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~ 576 (686)
.... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1100 1112357889999999999899999999999999999999999997654
Q ss_pred hHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCC----HHHHHHH
Q 005649 577 EAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPT----MSATLSM 639 (686)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt----~~evl~~ 639 (686)
..+... .... ... ... .....+..+.+++.+||+.+|++||+ +.|+++.
T Consensus 237 ~~~~~~------~~~~-~~~------~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RDETFS------NILK-KEV------TFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hHHHHH------HHhc-CCc------cCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 432211 0111 000 000 11125778999999999999999999 7777663
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=319.76 Aligned_cols=253 Identities=24% Similarity=0.318 Sum_probs=198.5
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|+..+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++.+++|+||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999876 68899999996432 223457888999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 999999999998643 34899999999999999999999987 999999999999999999999999998754321
Q ss_pred Ccc---------------------------------ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCC
Q 005649 524 QSR---------------------------------HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRK 570 (686)
Q Consensus 524 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~ 570 (686)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00112468999999999999999999999999999999999999
Q ss_pred CCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCC---HHHHHHH
Q 005649 571 NYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPT---MSATLSM 639 (686)
Q Consensus 571 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl~~ 639 (686)
||......+....+. .... ...+.+ ....+..+.+++.+++ .+|++|++ +.|+++.
T Consensus 235 Pf~~~~~~~~~~~i~------~~~~-~~~~p~-----~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQETYRKVM------NWKE-TLVFPP-----EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHHHHHHHHH------cCCC-ceecCC-----CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 998655433221111 0000 000000 0123456778888866 49999996 5565554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=305.52 Aligned_cols=264 Identities=28% Similarity=0.389 Sum_probs=208.2
Q ss_pred ccCHHHHHHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEE
Q 005649 357 LFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCV 434 (686)
Q Consensus 357 ~~~~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 434 (686)
+++.+.+..++++|+..+.||+|+||.||++... +++.+++|++.... .....+.+|+.++.++ +|||++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 4566677778899999999999999999999875 68899999986432 2246678899999999 8999999999987
Q ss_pred ec-----CceEEEEeecCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC
Q 005649 435 QE-----RERILVYEYLPNKSLDKFLFDK-SKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK 508 (686)
Q Consensus 435 ~~-----~~~~lv~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 508 (686)
.. ...++|+||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 54 3579999999999999988642 23346899999999999999999999987 999999999999999999
Q ss_pred eEEEecCCccccCCcCccccccccccCCCcCchhhhhcC-----CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHH
Q 005649 509 PKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG-----FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQEL 583 (686)
Q Consensus 509 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~ 583 (686)
+||+|||+++........ .....++..|+|||.+... .++.++||||||+++|||++|+.||......+..
T Consensus 167 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~-- 242 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL-- 242 (291)
T ss_pred EEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH--
Confidence 999999998865432211 1234678899999987643 3689999999999999999999999754332221
Q ss_pred HHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 584 LKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 584 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.. ... +....+ ..+......+.+++.+||+.+|++||++.|+++.
T Consensus 243 ~~----~~~-~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 FK----IPR-NPPPTL------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HH----Hhc-CCCCCC------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 111 111111 1123345678999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.42 Aligned_cols=255 Identities=19% Similarity=0.251 Sum_probs=198.5
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|+..++||+|+||.||+++.+ +++.+|+|++.... ......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999976 57789999986422 223345888999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999653 235899999999999999999999987 999999999999999999999999998765432
Q ss_pred CccccccccccCCCcCchhhhh-----cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAI-----RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||......+... .........
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~~~~- 227 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHKERF- 227 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH------HHhCCCccc-
Confidence 21 1223357899999999986 3468899999999999999999999997654333221 111111000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccccc--cCCCCHHHHHHH
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTEDFI--EDRPTMSATLSM 639 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~~p--~~RPt~~evl~~ 639 (686)
.........+..+.+++.+|+..++ ..||++.|+++.
T Consensus 228 ----~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 ----QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0111112345677888888775543 447899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=314.32 Aligned_cols=262 Identities=20% Similarity=0.230 Sum_probs=199.3
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEec------
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE------ 436 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 436 (686)
..++|+..+.||+|+||.||++... .++.+|||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3578999999999999999999865 68899999996542 23346788999999999999999999998653
Q ss_pred CceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCC
Q 005649 437 RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGL 516 (686)
Q Consensus 437 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 516 (686)
...++||||+++ +|.+.+.. .+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 246899999965 56666532 3889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHH-HH---------
Q 005649 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELL-KL--------- 586 (686)
Q Consensus 517 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~-~~--------- 586 (686)
++...... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||......+..... ..
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98654322 123356899999999999999999999999999999999999999765432221110 00
Q ss_pred ------HHHHHhc-Cccccccccc-----c----CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 587 ------ARRLEEE-GRLMELVDVR-----I----GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 587 ------~~~~~~~-~~~~~~~d~~-----l----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
....... ........+. + ...+......+.+++.+|++.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 0000000000 0 01112235678899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=310.44 Aligned_cols=251 Identities=29% Similarity=0.377 Sum_probs=214.9
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc---cHHHHHHHHHHHHhcC-CCCcccEEEEEEecCceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ---GKEEFENEVRVLLKMQ-HRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 441 (686)
.+.|++.+.||+|.||.||+++.+ +|+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+.+.+++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 467888899999999999999987 4999999999776543 3468999999999998 9999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC----CCCeEEEecCCc
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH----QMKPKISDFGLA 517 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Dfgla 517 (686)
|||++.+|.|.+.+... .+++.....++.|++.++.|||+.+ |+||||||+|+|+.. ++.+|++|||++
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999999765 2999999999999999999999987 999999999999953 357999999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
..... ........||+.|+|||.+....++...||||+||++|.|++|..||......+....+. .+.+
T Consensus 187 ~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~-------~~~~- 255 (382)
T KOG0032|consen 187 KFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL-------RGDF- 255 (382)
T ss_pred eEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH-------cCCC-
Confidence 98765 335667899999999999999999999999999999999999999999777655443221 1111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 598 ~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
+.. ...-+..+..+.+++..++..||..|+|+.++++.
T Consensus 256 ---~f~-~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ---DFT-SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ---CCC-CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 000 12234568889999999999999999999999994
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=304.07 Aligned_cols=263 Identities=24% Similarity=0.364 Sum_probs=202.2
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ--GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
++|+..++||+|+||.||++..+ +++.+++|++...... ..+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999986 5889999998654322 34678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++++|..+.... ..+++..++.++.||+++|.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 99999998876432 34899999999999999999999987 9999999999999999999999999988654432
Q ss_pred ccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHH-HHHH-------HhcCc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKL-ARRL-------EEEGR 595 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~-------~~~~~ 595 (686)
. ......++..|+|||++.+ ..++.++||||||+++|||++|++||......+....+.. .... .....
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 1 2223457889999999875 4578899999999999999999999975543222111111 0000 00000
Q ss_pred c-ccccccccC------CCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 596 L-MELVDVRIG------TYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 596 ~-~~~~d~~l~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
. .....+... ...+..+..+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 000000000 011234677999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=306.82 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=202.2
Q ss_pred CcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCC
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
|+....||+|+||.||++... +++.|++|.+........+.+.+|+.++..++|||++++++++..++..++++||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334557999999999999875 6899999999765555567889999999999999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
++|..++.. ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ .
T Consensus 103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 173 (297)
T cd06659 103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 173 (297)
T ss_pred CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence 999987743 34899999999999999999999987 99999999999999999999999999875543221 1
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCC
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYP 608 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 608 (686)
.....++..|+|||++.+..++.++||||||+++|||++|+.||......+.... ... ... +.. ...
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~------~~~-~~~-----~~~-~~~ 240 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR------LRD-SPP-----PKL-KNA 240 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------Hhc-cCC-----CCc-ccc
Confidence 2234688999999999988999999999999999999999999975443322111 111 000 000 011
Q ss_pred HHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 609 EEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 609 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
......+.+++.+||+.+|++||++.++++.-
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 22345688999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=308.48 Aligned_cols=264 Identities=19% Similarity=0.243 Sum_probs=196.0
Q ss_pred cccccccc--CcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 372 TKNMLGRG--GFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 372 ~~~~LG~G--~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
..++||+| +|++||+++.+ +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78999999875 789999999965432 23456788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+++.||+...........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999986532 234899999999999999999999987 999999999999999999999999875443211110
Q ss_pred -----ccccccccCCCcCchhhhhc--CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH--H------HH
Q 005649 527 -----HRTHQIAGTFGYMAPEYAIR--GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR--R------LE 591 (686)
Q Consensus 527 -----~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--~------~~ 591 (686)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||................ . ..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 01122346778999999876 468999999999999999999999997543322111000000 0 00
Q ss_pred hcC----ccccccccc------------------cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 592 EEG----RLMELVDVR------------------IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 592 ~~~----~~~~~~d~~------------------l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+. ......+.. ...........+.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 000 000000000 001122345678999999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=298.93 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=197.0
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-----ccHHHHHHHHHHHHhcCCCCcccEEEEEEec--Cce
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-----QGKEEFENEVRVLLKMQHRNLVQLFGCCVQE--RER 439 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 439 (686)
.+|+..+.||+|+||.||++... +++.+++|++..... ...+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999999999999875 688999998864321 2345688999999999999999999988763 567
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++++||+++++|.+++... ..+++...+.++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999999643 34899999999999999999999987 99999999999999999999999999876
Q ss_pred cCCcCc-cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 520 FHDEQS-RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 520 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||......+... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~------~~~~~~---- 225 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF------KIATQP---- 225 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH------HHhcCC----
Confidence 543211 111223457889999999998889999999999999999999999997543221110 111000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
.. ...+......+.+++ +||..+|++||+++||++
T Consensus 226 -~~---~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 -TN---PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CC---CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 01 122344455666776 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=298.84 Aligned_cols=256 Identities=27% Similarity=0.400 Sum_probs=207.8
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
++|++.+.||.|+||.||+|... ++..+++|++.... ....+.+.+|++.++.++|+|++++++.+..++..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999965 67889999986543 23457889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++........+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976444456899999999999999999999987 99999999999999999999999999887654332
Q ss_pred cc--cccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 526 RH--RTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 526 ~~--~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
.. ......|+..|++||++... .++.++|+||||+++|||++|+.||......+.. .. ..... ++
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~--~~----~~~~~------~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL--ML----TLQND------PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH--HH----HhcCC------CC
Confidence 21 22334688899999998877 7899999999999999999999999754332211 11 11110 01
Q ss_pred ccCCC--CHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 603 RIGTY--PEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 603 ~l~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
.+... ....+..+.+++.+||+.||++||++.+|++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11110 1245677899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=306.37 Aligned_cols=256 Identities=21% Similarity=0.287 Sum_probs=203.2
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|+..+.||+|+||.||+++.. .++.|++|.+..... ...+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47888999999999999999976 578999999865432 23457889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999999543 35899999999999999999999987 999999999999999999999999998742111
Q ss_pred Cc-------------cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHH
Q 005649 524 QS-------------RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL 590 (686)
Q Consensus 524 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 590 (686)
.. ........++..|+|||.+.+..++.++|+||||+++|||++|+.||......+... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~------~~ 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------QV 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HH
Confidence 00 001112457889999999998899999999999999999999999997544332211 11
Q ss_pred HhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 591 EEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 591 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
.... . ..+. .+...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 229 ~~~~-~---~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ISDD-I---EWPE---GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred Hhcc-c---CCCC---ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1100 0 0000 011345668899999999999999997777776655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=335.91 Aligned_cols=255 Identities=21% Similarity=0.333 Sum_probs=199.7
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEec--CceE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE--RERI 440 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 440 (686)
..++|++.+.||+|+||.||+++.. ++..+++|.+.... ......|..|+.++.+++||||+++++++.+. ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3578999999999999999999976 56788999886542 23356789999999999999999999988654 4689
Q ss_pred EEEeecCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCcEEEcC----------
Q 005649 441 LVYEYLPNKSLDKFLFDKS-KSAILDWPKRLNIIMGVARGLLYLHRDSV----LRIIHRDIKASNILLDH---------- 505 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~----~~ivH~Dlkp~NIll~~---------- 505 (686)
|||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999996532 23469999999999999999999998542 34999999999999964
Q ss_pred -------CCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhc--CCCChhHHHHHHHHHHHHHHcCCCCCcccc
Q 005649 506 -------QMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR--GFLSVKSDVFSFGVLLLEIISGRKNYDRQL 576 (686)
Q Consensus 506 -------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~s~Gvvl~elltG~~p~~~~~ 576 (686)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3348999999998664322 1233578999999999864 458999999999999999999999997543
Q ss_pred hHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 577 EAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
... .++.. + ..+. .+. ....+..+.+||..||+.+|++||++.|+++
T Consensus 248 ~~~--qli~~---l-k~~p-------~lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 NFS--QLISE---L-KRGP-------DLP--IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cHH--HHHHH---H-hcCC-------CCC--cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 221 11111 1 1110 010 1123567889999999999999999999983
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=299.82 Aligned_cols=260 Identities=22% Similarity=0.329 Sum_probs=197.8
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecC-----ceEEE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER-----ERILV 442 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv 442 (686)
.|+..+++|.|.||.||+|.+. +++.||||+.-.+... -.+|+++|.+++|||||+++.++.... ...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4566789999999999999976 5789999998654332 146899999999999999999987532 23589
Q ss_pred EeecCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CCeEEEecCCcccc
Q 005649 443 YEYLPNKSLDKFLFDK-SKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ-MKPKISDFGLAKLF 520 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~ 520 (686)
||||+. +|.+.++.. ..+..++...+.-+..||.+||.|||+.+ |+||||||+|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999965 788888642 22345777788889999999999999977 9999999999999966 89999999999988
Q ss_pred CCcCccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcC-----
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEG----- 594 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----- 594 (686)
...+.... -.-+..|+|||.+.+. .|+.+.||||.||++.||+-|++-|.+.+..+....+-..-.....+
T Consensus 177 ~~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 65543321 1346689999998875 79999999999999999999999999866544333332221111111
Q ss_pred --ccccccccccC------CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 595 --RLMELVDVRIG------TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 595 --~~~~~~d~~l~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
...+...+.+. -.....+.+..+++.++++.+|.+|.+..|++..
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11122223332 1234567789999999999999999999998764
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.77 Aligned_cols=245 Identities=29% Similarity=0.434 Sum_probs=204.9
Q ss_pred cccccCcEEEEEEEecC-CCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCChhH
Q 005649 375 MLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDK 453 (686)
Q Consensus 375 ~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~ 453 (686)
+||+|.||+||.|+..+ ...+|||.+...+....+-+..|+.+.++|+|.|||+++|.+.+++..-|.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999764 56789999988777777788999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-CCCCeEEEecCCccccCCcCcccccc
Q 005649 454 FLFDKSKSAIL--DWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD-HQMKPKISDFGLAKLFHDEQSRHRTH 530 (686)
Q Consensus 454 ~l~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~ 530 (686)
.|.. +-+++ ++..+-.+.+||++||.|||++. |||||||-+||||+ -.|.+||+|||-++.+..-+ ..+.
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TE 734 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTE 734 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC--cccc
Confidence 9954 33445 78888899999999999999987 99999999999997 57889999999988764322 2345
Q ss_pred ccccCCCcCchhhhhcC--CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCC
Q 005649 531 QIAGTFGYMAPEYAIRG--FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYP 608 (686)
Q Consensus 531 ~~~gt~~y~aPE~~~~~--~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 608 (686)
...||..|||||++..+ .|...+|||||||++.||.||++||.........- .+-|-.. +- ...|
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM--------FkVGmyK--vH---P~iP 801 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM--------FKVGMYK--VH---PPIP 801 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh--------hhhccee--cC---CCCc
Confidence 57899999999999876 58999999999999999999999997544332111 1111000 00 1458
Q ss_pred HHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 609 EEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 609 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
++.+.+...+|++|+.++|.+||+++++++-
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 8999999999999999999999999999874
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=297.16 Aligned_cols=249 Identities=24% Similarity=0.430 Sum_probs=203.3
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
+|+..+.||+|++|.||++... +++.+++|++.... ....+.+.+|++++++++|||++++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788899999999999999875 68889999986542 23456889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-CeEEEecCCccccCCcC
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM-KPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~ 524 (686)
+++++|.+++.... ...+++..+..++.|++++|.|||+++ ++|+||+|+||+++++. .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999996532 345899999999999999999999987 99999999999998654 58999999998764332
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......... .. ... +..
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~---~~---~~~-~~~-------- 218 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV---LK---IMS-GTF-------- 218 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH---HH---HHh-cCC--------
Confidence 1 22346788999999999888999999999999999999999999755432221 11 111 000
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
...+...+..+.+++.+||+.+|++|||+.|+++.
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01133456678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=306.59 Aligned_cols=198 Identities=25% Similarity=0.451 Sum_probs=161.7
Q ss_pred cccccccCcEEEEEEEec---CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEe--cCceEEEEeecC
Q 005649 373 KNMLGRGGFGTVYKGRLQ---DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ--ERERILVYEYLP 447 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~Ey~~ 447 (686)
.++||+|+||.||+|+.. +++.+|+|.+.... ....+.+|+.++++++||||+++++++.. +...++++||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999865 46789999986543 23457889999999999999999999865 346789999985
Q ss_pred CCChhHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE----cCCCCeEEEecCCc
Q 005649 448 NKSLDKFLFDKS------KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL----DHQMKPKISDFGLA 517 (686)
Q Consensus 448 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla 517 (686)
++|.+++.... +...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 57877774321 2235889999999999999999999987 9999999999999 45678999999999
Q ss_pred cccCCcCcc-ccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccc
Q 005649 518 KLFHDEQSR-HRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQL 576 (686)
Q Consensus 518 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~ 576 (686)
+........ .......||+.|+|||++.+ ..++.++||||+||++|||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876543211 12234578999999999877 468999999999999999999999996443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=296.29 Aligned_cols=252 Identities=28% Similarity=0.431 Sum_probs=209.7
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
++|+..+.||+|++|.||+++.. +++.+++|++..... ...+.+.+|+..+.+++|+|++++++++......++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999987 589999999876544 4467899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR-DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
+++++|.+++... ..+++..++.++.|++++|.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999654 458999999999999999999999 77 9999999999999999999999999998765433
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
.. .....++..|+|||.+.+..++.++|+||||+++|||++|+.||................ . ...
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~---------~~~ 220 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---D---------GPP 220 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---c---------CCC
Confidence 22 123467889999999999999999999999999999999999997654322222222211 1 111
Q ss_pred CCCCHH-HHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 605 GTYPEE-IALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 605 ~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
...+.. .+..+.+++.+|++.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 112333 66789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=297.42 Aligned_cols=253 Identities=28% Similarity=0.426 Sum_probs=205.2
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
++|+..+.||+|++|.||++..+ +++.+++|++..... ...+++.+|++++++++||||+++++.+..+...++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46788899999999999999986 688999999876532 3456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR-DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
+++++|.+++.... ..+++..+..++.|++++|.|||+ .+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999986542 458999999999999999999999 66 9999999999999999999999999987653322
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
. ....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... .............. .
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~---------~ 221 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEP---------P 221 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCC---------C
Confidence 1 12567889999999999999999999999999999999999997542211 11111111111111 0
Q ss_pred CCCCHH-HHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 605 GTYPEE-IALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 605 ~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
...+.. .+..+.+++.+||..+|++|||+.+++..
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111222 56778999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=301.70 Aligned_cols=264 Identities=21% Similarity=0.299 Sum_probs=204.1
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
+|++.+.||+|++|.||+|+.. +|+.|++|++.... ....+.+.+|+.++++++||||+++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999975 78999999997654 23356789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+ +++|.+++.... ..+++.+++.++.||+++|.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999986543 45999999999999999999999987 99999999999999999999999999987654321
Q ss_pred cccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH-----HHHhc----Cc
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR-----RLEEE----GR 595 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~-----~~~~~----~~ 595 (686)
.......++..|+|||.+.+. .++.++||||+|++++||++|+++|......+....+.... ..+.+ ..
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 122335688899999988654 46899999999999999999988887554432221111000 00000 00
Q ss_pred cccccccc-----cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 596 LMELVDVR-----IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 596 ~~~~~d~~-----l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
+..+..+. +.....+....+.+++.+|++.+|++||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 001112345788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.78 Aligned_cols=259 Identities=22% Similarity=0.282 Sum_probs=192.9
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
...+|++.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++|+||+++++++.+....++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4568999999999999999999976 5678999975432 23568999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+ .++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 138 ~~-~~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 138 HY-SSDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred cc-CCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 99 56888888543 345899999999999999999999987 9999999999999999999999999987543221
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCC-CcccchH--h-----HHHHHHHHHHHH--hcC
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKN-YDRQLEA--E-----NQELLKLARRLE--EEG 594 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p-~~~~~~~--~-----~~~~~~~~~~~~--~~~ 594 (686)
......||..|+|||++.+..++.++|||||||++|||+++..+ |...... . ...+........ .+.
T Consensus 212 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 288 (357)
T PHA03209 212 ---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288 (357)
T ss_pred ---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence 12235689999999999999999999999999999999995544 4322111 0 011111111000 000
Q ss_pred cc--------ccccccc-cC-----CC----CHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 595 RL--------MELVDVR-IG-----TY----PEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 595 ~~--------~~~~d~~-l~-----~~----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.. ...++.. .. .+ ....+..+.+++.+||+.||++|||+.|+++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 00 0000000 00 00 01224456679999999999999999999864
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.06 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=204.5
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEe--cCceEEEE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ--ERERILVY 443 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 443 (686)
+|+..+.||.|+||.||++... +++.+++|++.... ....+.+.+|++++++++|+||+++++++.. +...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999865 68899999986543 2334678899999999999999999998865 34578999
Q ss_pred eecCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 444 EYLPNKSLDKFLFDK-SKSAILDWPKRLNIIMGVARGLLYLHRDS--VLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
||+++++|.+++... .....+++..++.++.||+.||.|||..+ ..+++|+||+|+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999653 22456999999999999999999999332 234999999999999999999999999999876
Q ss_pred CCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
...... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+.. .. ...+.
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~----~~~~~----- 226 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA---SK----IKEGK----- 226 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHH---HH----HhcCC-----
Confidence 543321 22346889999999999988999999999999999999999999865432211 11 11111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
....+...+..+.+++.+|++.+|++||++.+|++.
T Consensus 227 ---~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 ---FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 112344567789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.93 Aligned_cols=255 Identities=26% Similarity=0.389 Sum_probs=200.6
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc----------cHHHHHHHHHHHHhcCCCCcccEEEEEEecC
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ----------GKEEFENEVRVLLKMQHRNLVQLFGCCVQER 437 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~----------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 437 (686)
+|...+.||+|+||.||+|... +|+.+++|.++..... ..+.+.+|+.++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999865 6899999988542110 1246788999999999999999999999999
Q ss_pred ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCc
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 517 (686)
..++|+||+++++|.+++... ..+++..+..++.||+.||.|||+++ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998654 45899999999999999999999987 999999999999999999999999998
Q ss_pred cccCCcCccccccccccCCCcCchhhhhcCC--CChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCc
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRGF--LSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGR 595 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 595 (686)
+...............++..|+|||.+.... ++.++|+||||+++||+++|+.||......+.. .. ... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~----~~~-~~ 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM--FK----LGN-KR 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH--HH----hhc-cc
Confidence 8654322222223356788999999987654 899999999999999999999999643322111 11 110 00
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 596 LMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 596 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
....++. ......+..+.+++.+||+.+|++||++.+|++.
T Consensus 229 ~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPIPP---DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcCCc---cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111111 1122356788999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=324.34 Aligned_cols=263 Identities=19% Similarity=0.242 Sum_probs=195.3
Q ss_pred HHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCC------CCcccEEEEEEec
Q 005649 364 IAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQH------RNLVQLFGCCVQE 436 (686)
Q Consensus 364 ~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~~ 436 (686)
...+++|++.++||+|+||.||++... .++.||||+++... ....++..|+.++..++| .+++++++++..+
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 345689999999999999999999875 57889999986432 223455677777777654 4588898888765
Q ss_pred -CceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCC-------
Q 005649 437 -RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD-SVLRIIHRDIKASNILLDHQM------- 507 (686)
Q Consensus 437 -~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dlkp~NIll~~~~------- 507 (686)
.+.++|||++ +++|.+++... ..+++..+..++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence 4788999988 77888888543 3599999999999999999999984 5 99999999999998765
Q ss_pred ---------CeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchH
Q 005649 508 ---------KPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEA 578 (686)
Q Consensus 508 ---------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~ 578 (686)
.+||+|||++..... ......||..|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 499999998764322 123457899999999999999999999999999999999999999876554
Q ss_pred hHHHHHHHHHH-----------------HHh-cCccccccccc----c-C---CCCHHHHHHHHHHHHHcccccccCCCC
Q 005649 579 ENQELLKLARR-----------------LEE-EGRLMELVDVR----I-G---TYPEEIALRFMQIALLCTEDFIEDRPT 632 (686)
Q Consensus 579 ~~~~~~~~~~~-----------------~~~-~~~~~~~~d~~----l-~---~~~~~~~~~l~~li~~cl~~~p~~RPt 632 (686)
+....+..... ... .+.+....++. + . .........+.+|+.+||+.||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 43332221100 000 00000000000 0 0 000012356789999999999999999
Q ss_pred HHHHHHH
Q 005649 633 MSATLSM 639 (686)
Q Consensus 633 ~~evl~~ 639 (686)
+.|+++.
T Consensus 432 a~e~L~H 438 (467)
T PTZ00284 432 ARQMTTH 438 (467)
T ss_pred HHHHhcC
Confidence 9999973
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=296.69 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=199.6
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-----cccHHHHHHHHHHHHhcCCCCcccEEEEEEec--Cce
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-----MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE--RER 439 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 439 (686)
++|+..++||+|+||.||+++.. +++.|++|.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57889999999999999999975 58999999885322 12245788999999999999999999988764 457
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++++||+++++|.+++... ..+++...+.++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999998643 34788999999999999999999987 99999999999999999999999999886
Q ss_pred cCCcCc-cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 520 FHDEQS-RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 520 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||......... . .... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~---~~~~-~~--- 225 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI---F---KIAT-QP--- 225 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH---H---HHhc-CC---
Confidence 543211 11122346888999999998888999999999999999999999999754222211 0 1110 00
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.....+......+.+++.+|+. +|++||+++||++.
T Consensus 226 ----~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 ----TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ----CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0112355667778899999995 89999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.76 Aligned_cols=240 Identities=23% Similarity=0.284 Sum_probs=188.1
Q ss_pred ccccCcEEEEEEEec-CCCEEEEEEecccCcc---cHHHHHHHHHHHHhc---CCCCcccEEEEEEecCceEEEEeecCC
Q 005649 376 LGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ---GKEEFENEVRVLLKM---QHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 376 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
||+|+||.||+++.. +++.||+|++...... ....+..|..++... +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999876 6899999998643221 223445566666655 699999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
|+|.+++... ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~ 152 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--T 152 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--C
Confidence 9999888543 45899999999999999999999987 99999999999999999999999999875432221 1
Q ss_pred ccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCC
Q 005649 529 THQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTY 607 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 607 (686)
.....|+..|+|||.+.+. .++.++|||||||++|||++|+.||......+....+ ..+.. .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i-------~~~~~------~~~-- 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI-------AFGKV------RFP-- 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH-------HcCCC------CCC--
Confidence 2345789999999998764 4899999999999999999999999765443322111 11110 010
Q ss_pred CHHHHHHHHHHHHHcccccccCCC----CHHHHHH
Q 005649 608 PEEIALRFMQIALLCTEDFIEDRP----TMSATLS 638 (686)
Q Consensus 608 ~~~~~~~l~~li~~cl~~~p~~RP----t~~evl~ 638 (686)
....+..+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 112456778999999999999998 4666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.46 Aligned_cols=262 Identities=23% Similarity=0.283 Sum_probs=205.6
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcC-C-----CCcccEEEEEEecCceEE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-H-----RNLVQLFGCCVQERERIL 441 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 441 (686)
+|++.+.||+|.||.|.++... +++.||||+++....- ..+-..|+.+|..|+ | -|+|++++++...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 8899999999999999999865 6999999999765432 345578999999996 4 389999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC--CeEEEecCCccc
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM--KPKISDFGLAKL 519 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~Dfgla~~ 519 (686)
|+|.+ .-+|.++++.+.-. .++...+..++.||+.+|.+||+.+ |||+||||+||||.+.. .+||+|||.+..
T Consensus 266 VfELL-~~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99998 66999999876544 4999999999999999999999877 99999999999997543 699999999987
Q ss_pred cCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHH---------
Q 005649 520 FHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL--------- 590 (686)
Q Consensus 520 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~--------- 590 (686)
....-. .-..+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.++.+....+......
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 654322 224467899999999999999999999999999999999999888776544433221110
Q ss_pred ------Hhc--Cccc-----c----------------ccc----c-c---cC-CCCHHHHHHHHHHHHHcccccccCCCC
Q 005649 591 ------EEE--GRLM-----E----------------LVD----V-R---IG-TYPEEIALRFMQIALLCTEDFIEDRPT 632 (686)
Q Consensus 591 ------~~~--~~~~-----~----------------~~d----~-~---l~-~~~~~~~~~l~~li~~cl~~~p~~RPt 632 (686)
... +.+. + ..+ | . +. ..+......+++++++|+..||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 000 0000 0 000 0 0 00 111234566899999999999999999
Q ss_pred HHHHHHHhc
Q 005649 633 MSATLSMLS 641 (686)
Q Consensus 633 ~~evl~~L~ 641 (686)
..|.++.--
T Consensus 496 p~qal~Hpf 504 (586)
T KOG0667|consen 496 PAQALNHPF 504 (586)
T ss_pred HHHHhcCcc
Confidence 999987653
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=301.87 Aligned_cols=265 Identities=24% Similarity=0.362 Sum_probs=204.9
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
++|+..+.||+|++|.||++..+ +++.|++|++.... ....+.+.+|++++++++|+||+++++++.+++..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46888999999999999999976 58899999986532 3345788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|++++.+..+... ...+++..++.++.||+.||.|||+++ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998777665532 234899999999999999999999987 9999999999999999999999999988765433
Q ss_pred ccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH--------HHHh-cC
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR--------RLEE-EG 594 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~-~~ 594 (686)
. .......++..|+|||++.+. .++.++||||||+++|||++|+.||......+......... .... ..
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 2 122334678889999999888 88999999999999999999999997654432221111100 0000 00
Q ss_pred cc-----ccccccc-cC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 595 RL-----MELVDVR-IG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 595 ~~-----~~~~d~~-l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.. .+..++. +. .++...+..+.+++.+||+.+|++||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 0000000 00 1223347889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.45 Aligned_cols=264 Identities=22% Similarity=0.325 Sum_probs=203.5
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ-GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
+|+..+.||+|++|.||+|+.. +|+.|+||++...... ..+.+.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999986 6889999998765433 3467788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++ +|.+++........+++..+..++.|+++||.|||+.+ ++||||||+||++++++.++|+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 74 88888866554456999999999999999999999987 99999999999999999999999999976543211
Q ss_pred ccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH--------HHHh-cCcc
Q 005649 527 HRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR--------RLEE-EGRL 596 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~-~~~~ 596 (686)
......++..|++||.+.+. .++.++||||||+++|||++|+.||......+....+.... .... ...+
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 11234567889999988664 57899999999999999999999998655433222111100 0000 0000
Q ss_pred cc----ccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 597 ME----LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 597 ~~----~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
.. ..+.......+..+..+.+++.+|++.+|++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0000001111234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.97 Aligned_cols=255 Identities=28% Similarity=0.422 Sum_probs=203.9
Q ss_pred HhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecC-----
Q 005649 365 AATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQER----- 437 (686)
Q Consensus 365 ~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~----- 437 (686)
.++++|+..+.||+|++|.||+|... +++.+++|++..... ..+++.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45789999999999999999999986 678899998865443 356789999999999 7999999999997654
Q ss_pred -ceEEEEeecCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecC
Q 005649 438 -ERILVYEYLPNKSLDKFLFDKS-KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFG 515 (686)
Q Consensus 438 -~~~lv~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 515 (686)
..+++|||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4799999999999999986532 2456899999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCcCccccccccccCCCcCchhhhhc-----CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHH
Q 005649 516 LAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR-----GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL 590 (686)
Q Consensus 516 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 590 (686)
++........ ......++..|+|||.+.. ..++.++||||||++++||++|+.||.......... . .
T Consensus 159 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~----~ 230 (275)
T cd06608 159 VSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF--K----I 230 (275)
T ss_pred cceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH--H----h
Confidence 9876543221 2233568889999998753 357889999999999999999999997443222111 1 1
Q ss_pred HhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 591 EEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 591 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
.. +.. +.+ ..+...+..+.+++.+||..||++|||+.|+++
T Consensus 231 ~~-~~~-----~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PR-NPP-----PTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hc-cCC-----CCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 110 111 112345678899999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.30 Aligned_cols=245 Identities=28% Similarity=0.385 Sum_probs=203.4
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|+..+.||+|+||.||++... +++.+++|.+.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47888999999999999999976 68999999986532 233467889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998654 45899999999999999999999987 999999999999999999999999998876443
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||......+.... .. .+..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~-~~~~------- 215 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK------IL-EGKV------- 215 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------Hh-cCCc-------
Confidence 2234688999999999888899999999999999999999999975542221111 11 1111
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRP-----TMSATLSM 639 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 639 (686)
..+......+.+++.+||+.+|.+|| +.+|+++.
T Consensus 216 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 216 --RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred --cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 12334467888999999999999999 67777644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=303.78 Aligned_cols=259 Identities=21% Similarity=0.326 Sum_probs=188.0
Q ss_pred ccccccCcEEEEEEEec---CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEe--cCceEEEEeecCC
Q 005649 374 NMLGRGGFGTVYKGRLQ---DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ--ERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~Ey~~~ 448 (686)
.+||+|+||.||+|+.. ++..+|+|.+.... ....+.+|+.++++++||||+++++++.. +...++++||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999865 35789999886543 23467899999999999999999999864 4567899999864
Q ss_pred CChhHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE----cCCCCeEEEecCCcc
Q 005649 449 KSLDKFLFDK------SKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL----DHQMKPKISDFGLAK 518 (686)
Q Consensus 449 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla~ 518 (686)
+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 777776422 12235889999999999999999999987 9999999999999 566789999999998
Q ss_pred ccCCcCcc-ccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHH-------HHHHHH--
Q 005649 519 LFHDEQSR-HRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQ-------ELLKLA-- 587 (686)
Q Consensus 519 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~-------~~~~~~-- 587 (686)
........ .......++..|+|||.+.+ ..++.++||||||+++|||+||+.||....++... ......
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 76543221 12234568899999999876 45899999999999999999999999754322110 000000
Q ss_pred --------HHHHh-cCccccccc---------cc----cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 588 --------RRLEE-EGRLMELVD---------VR----IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 588 --------~~~~~-~~~~~~~~d---------~~----l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
|.... ......... .. +..........+.+++.+|++.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 000000000 00 00001112345888999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=297.53 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=202.3
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
-|+..+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|+..+.+++||||+++++++..++..++|+||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667789999999999999865 68899999886443 233467889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++++|.+++.. ..+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999998843 35899999999999999999999987 99999999999999999999999999876643221
Q ss_pred ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCC
Q 005649 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 606 (686)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... .... +.. ..
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~-~~~--------~~ 220 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF------LIPK-NNP--------PT 220 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH------HHhc-CCC--------CC
Confidence 1223467889999999988889999999999999999999999997543322111 1111 110 11
Q ss_pred CCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+...+..+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 233456778899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=301.08 Aligned_cols=259 Identities=25% Similarity=0.411 Sum_probs=204.1
Q ss_pred CHHHHHHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEe-
Q 005649 359 NLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQ- 435 (686)
Q Consensus 359 ~~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~- 435 (686)
++.++..+.+.|+..+.||+|+||.||+|+.. +++.+++|++.... ....++..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44555567789999999999999999999975 68889999885543 3346788999999998 79999999999863
Q ss_pred -----cCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeE
Q 005649 436 -----ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPK 510 (686)
Q Consensus 436 -----~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 510 (686)
....+++|||+++|+|.+++.... ...+++..++.++.||++||.|||+.+ |+|+||+|+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 356799999999999999886533 345888999999999999999999987 99999999999999999999
Q ss_pred EEecCCccccCCcCccccccccccCCCcCchhhhh-----cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHH
Q 005649 511 ISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI-----RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLK 585 (686)
Q Consensus 511 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~ 585 (686)
|+|||++........ ......|+..|+|||.+. +..++.++||||||+++|||++|+.||......+....
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-- 237 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-- 237 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh--
Confidence 999999876532211 122356888999999875 34688899999999999999999999965432221110
Q ss_pred HHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 586 LARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 586 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
..... .+.+ .....+..+.+++.+||+.||.+||++.|+++
T Consensus 238 ----~~~~~------~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 ----IPRNP------PPKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ----HhhCC------CCCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00000 0111 12235667999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=295.04 Aligned_cols=253 Identities=25% Similarity=0.451 Sum_probs=203.2
Q ss_pred CCcccccccccCcEEEEEEEe-cCCCEEEEEEecccCc------ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRL-QDGREIAVKKLATNSM------QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
+|+..+.||+|++|.||++.. .+++.+++|.+..... ...+.+.+|++.+++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999986 4789999999864321 124678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-CeEEEecCCcccc
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM-KPKISDFGLAKLF 520 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~ 520 (686)
|+||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999998643 35899999999999999999999987 99999999999998776 5999999998876
Q ss_pred CCcCcc--ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 521 HDEQSR--HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 521 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
...... .......++..|+|||.+.+..++.++||||+|+++++|++|+.||............. .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~--- 228 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF---KIASATT--- 228 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH---HHhccCC---
Confidence 543211 11223467889999999988889999999999999999999999996443222111111 1100000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
....+......+.+++.+|++.+|++||++.++++
T Consensus 229 -----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 -----APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -----CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 01234566788999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=296.74 Aligned_cols=260 Identities=28% Similarity=0.336 Sum_probs=204.0
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEec--CceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQE--RERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 443 (686)
++|+..+.||.|++|.||++... +++.+++|.+..... .....+.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999985 678899999875433 3456789999999999999999999998654 3689999
Q ss_pred eecCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 444 EYLPNKSLDKFLFDK-SKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
||+++++|.+++... .....+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987542 23455899999999999999999999987 99999999999999999999999999876543
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccch--HhHHHHHHHHHHHHhcCcccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLE--AENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
... ....++..|++||.+.+..++.++||||||+++|||++|+.||..... ........+... .....+
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~- 228 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPEL- 228 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhh-
Confidence 221 234578889999999999999999999999999999999999975532 111122222111 010000
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
+... ......+..+.+++.+||+.+|++|||+.|+++.-
T Consensus 229 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 229 KDEP-GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred ccCC-CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 0000 00123467789999999999999999999998843
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.11 Aligned_cols=257 Identities=23% Similarity=0.312 Sum_probs=196.8
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEec------
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE------ 436 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 436 (686)
..++|+..+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999865 67899999986542 22345678999999999999999999987643
Q ss_pred CceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCC
Q 005649 437 RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGL 516 (686)
Q Consensus 437 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 516 (686)
...++++|++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3568999988 7889887742 34999999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCc
Q 005649 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGR 595 (686)
Q Consensus 517 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 595 (686)
++..... .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+. .... ..
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~---~~~~-~~ 235 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIM---EVVG-TP 235 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH---HHhC-CC
Confidence 9865432 223468899999999877 578999999999999999999999997544322111110 0000 00
Q ss_pred ccccc-----------ccccCCCC--------HHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 596 LMELV-----------DVRIGTYP--------EEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 596 ~~~~~-----------d~~l~~~~--------~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
..+.. ...+...+ ......+.+++.+|++.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00000001 1123457899999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=299.05 Aligned_cols=254 Identities=29% Similarity=0.462 Sum_probs=208.7
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.++.|+..+.||+|++|.||++..+ +++.+++|++..... ..+.+.+|++.+.+++|+|++++++.+...+..++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4677888999999999999999987 688999999976544 56778999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999997643 36999999999999999999999987 9999999999999999999999999987554322
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
. ......++..|++||.+.+..++.++|+||||+++|+|++|+.||........... ....+ ... +
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~------~~~~~-~~~-----~ 236 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL------ITTKG-IPP-----L 236 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhcC-CCC-----C
Confidence 1 12234577899999999888899999999999999999999999975443322111 11100 000 0
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
..+...+..+.+++.+||+.+|.+||++.++++..
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 237 -KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred -cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 11223567789999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=298.21 Aligned_cols=262 Identities=23% Similarity=0.374 Sum_probs=199.6
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
+|+..+.||+|++|.||+|+.. +|+.|+||++..... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999875 689999999865432 2335788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+. ++|..++.... ...+++..++.++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 68988886533 345899999999999999999999987 99999999999999999999999999876543221
Q ss_pred cccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhc-----------
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEE----------- 593 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----------- 593 (686)
......++..|+|||.+.+. .++.++||||||+++|||+||+.||......+.. ..........
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL--FRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCChhhhhhhhHH
Confidence 12233567889999987664 4688999999999999999999999755432211 1111100000
Q ss_pred ----CccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 594 ----GRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 594 ----~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
..........+..........+.+++.+|++.||++|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000001111234567899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=298.85 Aligned_cols=249 Identities=25% Similarity=0.389 Sum_probs=202.8
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecC
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLP 447 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 447 (686)
.|...+.||+|++|.||++... +++.+++|++........+.+.+|+.++..++|+|++++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4555679999999999999864 788999999866555556678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc
Q 005649 448 NKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH 527 (686)
Q Consensus 448 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 527 (686)
+++|.+++.. ..+++..+..++.|++.+|.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 9999999854 34899999999999999999999987 99999999999999999999999998875543221
Q ss_pred cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCC
Q 005649 528 RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTY 607 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 607 (686)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+... ...... .+.+ ..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~------~~~~~~------~~~~-~~ 237 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK------RIRDNL------PPKL-KN 237 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH------HHHhcC------CCCC-cc
Confidence 1223458889999999988889999999999999999999999997543322211 111110 0111 11
Q ss_pred CHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 608 PEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 608 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
+...+..+.+++.+||+.+|++||++.++++.
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 22245679999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=294.53 Aligned_cols=252 Identities=29% Similarity=0.441 Sum_probs=202.8
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ--GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
+|...+.||+|+||.||+|... +++.+++|.+...... ..+.+.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999875 6889999998765443 567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999998643 34889999999999999999999987 99999999999999999999999999887654322
Q ss_pred ccc--ccccccCCCcCchhhhhcCC---CChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 526 RHR--THQIAGTFGYMAPEYAIRGF---LSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 526 ~~~--~~~~~gt~~y~aPE~~~~~~---~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
... .....++..|+|||.+.... .+.++||||||+++||+++|+.||......... ...... +.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~-----~~~~~~-~~----- 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI-----MFHVGA-GH----- 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH-----HHHHhc-CC-----
Confidence 111 12356788999999998766 899999999999999999999999754321111 001100 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
.+.+.. .......+.+++.+||+.+|++||++.|++.
T Consensus 224 ~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 KPPIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111111 1123667889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=285.20 Aligned_cols=252 Identities=26% Similarity=0.355 Sum_probs=205.9
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++.|++.+.||+|.|+.|++.... .|+.+++|++... .....+++.+|+++-..|+||||+++.+...++...+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 467888899999999999998754 7899999988533 3346788999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCCeEEEecCCcccc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH---QMKPKISDFGLAKLF 520 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~~~ 520 (686)
|+|++++|..-+..+ ...++...-..+.||+++|.|.|.++ |||||+||+|+++.. ..-+||+|||++..+
T Consensus 90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999997666443 44788888899999999999999998 999999999999953 335899999999988
Q ss_pred CCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
.... ......||++|||||++...+|+..+|||+.||+||-|+.|..||.+.......+.+.... .. +
T Consensus 164 ~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~-------yd--~ 231 (355)
T KOG0033|consen 164 NDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA-------YD--Y 231 (355)
T ss_pred CCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc-------cC--C
Confidence 7332 3345689999999999999999999999999999999999999998755544433222111 10 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
++ .+-...++...+|+.+||..||.+|.|+.|.++.
T Consensus 232 ~~---~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 232 PS---PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CC---cccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 00 1123457778899999999999999999887653
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=289.97 Aligned_cols=250 Identities=31% Similarity=0.491 Sum_probs=206.8
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecC
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLP 447 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 447 (686)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4777899999999999999986 688999999977665566789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc
Q 005649 448 NKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH 527 (686)
Q Consensus 448 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 527 (686)
+++|.+++.... ..+++..+..++.|++++|.+||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999986532 45899999999999999999999977 99999999999999999999999999887654331
Q ss_pred cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCC
Q 005649 528 RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTY 607 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 607 (686)
.....++..|++||.+.+..++.++||||||+++++|++|+.||......+...... . ...... ..
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~----~~~~~~------~~ 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA---T----NGPPGL------RN 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---h----cCCCCc------Cc
Confidence 234567889999999998889999999999999999999999997553322211111 0 000000 01
Q ss_pred CHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 608 PEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 608 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
+...+..+.+++.+||+.+|++|||+.|+++.
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11235678999999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=301.41 Aligned_cols=267 Identities=22% Similarity=0.360 Sum_probs=198.5
Q ss_pred CCcccccccccCcEEEEEEEecC---CCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEec--CceE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQD---GREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE--RERI 440 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~~---g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 440 (686)
+|+..++||+|+||.||+|...+ ++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788999999999999999754 7899999997643 33346778899999999999999999999988 7899
Q ss_pred EEEeecCCCChhHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC----CCCeEEEec
Q 005649 441 LVYEYLPNKSLDKFLFDKS--KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH----QMKPKISDF 514 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df 514 (686)
+||||+++ +|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 6666664322 2236899999999999999999999987 999999999999999 999999999
Q ss_pred CCccccCCcCc-cccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhH-------HHHHH
Q 005649 515 GLAKLFHDEQS-RHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAEN-------QELLK 585 (686)
Q Consensus 515 gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~-------~~~~~ 585 (686)
|++........ ........++..|+|||.+.+. .++.++||||||++++||++|+.||........ ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 1122345678899999988764 589999999999999999999999975543320 00000
Q ss_pred HHHHHH-----------hcCccccccc-cccCCCC-----------HHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 586 LARRLE-----------EEGRLMELVD-VRIGTYP-----------EEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 586 ~~~~~~-----------~~~~~~~~~d-~~l~~~~-----------~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
....+. .........+ .....++ ......+.+++.+|++.||++|||+.|+++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 0000000000 0000011 0334578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.39 Aligned_cols=251 Identities=28% Similarity=0.436 Sum_probs=206.4
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.++|+..+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++|||++++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 368889999999999999999864 6889999998765555567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999999853 24789999999999999999999987 99999999999999999999999999876543322
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......++..|++||.+.+..++.++|+||||+++||+++|+.||......+.... ....+.. ..
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~~~------~~- 235 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGTP------EL- 235 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCCCC------CC-
Confidence 12234678899999999888899999999999999999999999975433221110 0000000 00
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
..+...+..+.+++.+||+.+|++||++.+++..
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1123455678899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=307.00 Aligned_cols=266 Identities=21% Similarity=0.323 Sum_probs=200.5
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecC-----ce
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER-----ER 439 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~ 439 (686)
+++|++.++||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 578999999999999999999865 78999999986432 233466889999999999999999999876543 57
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++++||++ ++|.+++.. ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 99999996 477777632 35899999999999999999999987 99999999999999999999999999886
Q ss_pred cCCcCcc-ccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhc---C
Q 005649 520 FHDEQSR-HRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEE---G 594 (686)
Q Consensus 520 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~ 594 (686)
....... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+ ...... +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~---~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI---LGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHcCCCCHH
Confidence 5432211 11233567899999998755 56899999999999999999999999754332211111 000000 0
Q ss_pred ccccccccc-------------cC--CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH--hcCC
Q 005649 595 RLMELVDVR-------------IG--TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM--LSNS 643 (686)
Q Consensus 595 ~~~~~~d~~-------------l~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~ 643 (686)
.+..+.+.. .. ......+..+.+++.+||+.+|++|||+.|+++. ++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 000000000 00 0011235678899999999999999999999987 5544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=299.26 Aligned_cols=261 Identities=22% Similarity=0.342 Sum_probs=198.2
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ-GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
++|+..+.||+|++|.||+|+.+ +++.|++|.+...... ....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67889999999999999999976 6899999998654322 234577899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
++ ++|.+++.... ..+++.....++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~-~~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LD-TDLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CC-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 97 48999886532 35899999999999999999999987 99999999999999999999999999875432211
Q ss_pred cccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhc---Ccccc---
Q 005649 526 RHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEE---GRLME--- 598 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~--- 598 (686)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ .+......... ..+..
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhhh
Confidence 1122346788999998875 4689999999999999999999999975442111 11111111000 00000
Q ss_pred ---ccc--------cccCCCCHHH--HHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 599 ---LVD--------VRIGTYPEEI--ALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 599 ---~~d--------~~l~~~~~~~--~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
... ..+....... ...+.+++.+|++.+|++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 0000000011 267789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=298.94 Aligned_cols=263 Identities=23% Similarity=0.312 Sum_probs=201.7
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCCcccEEEEEEec--CceEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ--GKEEFENEVRVLLKMQHRNLVQLFGCCVQE--RERILV 442 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 442 (686)
++|+..+.||+|+||.||+|..+ +++.+++|.++..... ....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888999999999999999986 6889999999654322 234577899999999999999999999877 789999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
+||++ ++|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 58988886532 35899999999999999999999987 99999999999999999999999999987654
Q ss_pred cCccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHH--------HHHHhc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLA--------RRLEEE 593 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~ 593 (686)
... ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||......+....+... |.....
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 321 12234568899999988764 4689999999999999999999999865543322211110 000000
Q ss_pred ------CccccccccccC-CCCHH-HHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 594 ------GRLMELVDVRIG-TYPEE-IALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 594 ------~~~~~~~d~~l~-~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
..+.......+. .++.. ....+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000001111 11222 4677889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=289.62 Aligned_cols=251 Identities=29% Similarity=0.437 Sum_probs=207.6
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEec--CceEEEE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQE--RERILVY 443 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 443 (686)
+|...+.||+|++|.||+|... +++.+++|++..... ...+.+.+|+..+++++|+||+++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999987 789999999866543 4467889999999999999999999999988 8899999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++++|.+++.... .+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999986543 6999999999999999999999987 999999999999999999999999999877654
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
..........++..|++||.+.+...+.++||||||+++++|++|+.||....... ...+...... .
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~--------~ 221 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALYKIGSSG--------E 221 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHhccccC--------C
Confidence 32111234567889999999998889999999999999999999999997654111 1111111000 1
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
....+...+..+.+++.+|++.+|++||++.|+++
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11234455788999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=297.71 Aligned_cols=266 Identities=21% Similarity=0.277 Sum_probs=198.6
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCc-----
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERE----- 438 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~----- 438 (686)
++|+..+.||+|+||.||+|... +++.|++|++..... .....+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47889999999999999999976 689999998865432 2346788999999999 46999999999987665
Q ss_pred eEEEEeecCCCChhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCCeEEEecC
Q 005649 439 RILVYEYLPNKSLDKFLFDKSK--SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH-QMKPKISDFG 515 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg 515 (686)
.+++|||+++ +|.+++..... ...+++..++.++.||++||.|||+.+ |+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 78888865432 346899999999999999999999987 999999999999998 8899999999
Q ss_pred CccccCCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcC
Q 005649 516 LAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEG 594 (686)
Q Consensus 516 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 594 (686)
+++.+..... ......+++.|+|||.+.+ ..++.++|+||||+++|||++|+.||......+....+..........
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9886543211 1222356788999998865 457999999999999999999999997654332211110000000000
Q ss_pred ccccccc------------cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 595 RLMELVD------------VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 595 ~~~~~~d------------~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+....+ ..+....+..+..+.+++.+||+.+|++||++.|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000 00001112356778999999999999999999998753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=297.47 Aligned_cols=262 Identities=19% Similarity=0.291 Sum_probs=197.0
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
+|+..+.||+|+||.||+++.. +|+.+++|++..... .....+.+|+.++++++|+||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999976 689999999865422 2235678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
++ ++|.+++... ...+++..++.++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 96 5788877543 245899999999999999999999987 99999999999999999999999999886543221
Q ss_pred cccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccch-HhHHHHHHHHHHHHhcC---cccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLE-AENQELLKLARRLEEEG---RLMELV 600 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~ 600 (686)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+..... .+....+.......... ...+..
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 12234568899999988765 479999999999999999999888643222 21111110000000000 000000
Q ss_pred ccc--------c--CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 601 DVR--------I--GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 601 d~~--------l--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
+.. . .......+..+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 0 0111234577889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=299.35 Aligned_cols=249 Identities=27% Similarity=0.368 Sum_probs=210.4
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
-+.|+.-++||+|+||.|+-++.. +|+.+|.|++.+... .+...-++|-++|.+++.+.||.+-..++..+.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 467888999999999999999876 699999999865432 3344568899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
+..|+||+|.-+|++.++ ..+++..++.++.+|+.||++||++. ||.|||||+|||+|+.|+++|+|.|||..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999987765 56999999999999999999999987 99999999999999999999999999998866
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
.+.. ....||.+|||||++.++.|+...|.||+||+||||+.|+.||....+......++..-....
T Consensus 340 g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~---------- 406 (591)
T KOG0986|consen 340 GKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP---------- 406 (591)
T ss_pred CCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch----------
Confidence 5432 234899999999999999999999999999999999999999986655443322221111100
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMS 634 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 634 (686)
..+++..++++.++....|++||++|..-.
T Consensus 407 --~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 407 --EEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred --hhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 145677888999999999999999996544
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=298.08 Aligned_cols=252 Identities=29% Similarity=0.436 Sum_probs=195.8
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHH-HHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRV-LLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
++|++.+.||+|+||.||+++.. +|+.||+|++..... .....+..|+.. ++.++|||++++++++..+...++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47889999999999999999976 689999999865432 233455666665 566799999999999999999999999
Q ss_pred ecCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 445 YLPNKSLDKFLFDK-SKSAILDWPKRLNIIMGVARGLLYLHRD-SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 445 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|++ |+|.+++... .....+++..++.++.||+.||.|||++ + ++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 7888887542 2345699999999999999999999986 5 99999999999999999999999999886543
Q ss_pred cCccccccccccCCCcCchhhhhc----CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIR----GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
... .....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...... ..... .......
T Consensus 157 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~----~~~~~~~--- 225 (283)
T cd06617 157 SVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLK----QVVEEPS--- 225 (283)
T ss_pred ccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHH----HHHhcCC---
Confidence 221 122467889999998865 45688999999999999999999999643211 11111 1111100
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
+.+. ....+..+.+++.+||+.+|++||++.++++.
T Consensus 226 ---~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 226 ---PQLP--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred ---CCCC--ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1110 12345678999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=297.46 Aligned_cols=263 Identities=22% Similarity=0.338 Sum_probs=199.3
Q ss_pred CcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
|+..+.||.|++|.||+|... +|+.|++|++..... ...+.+.+|++.+++++|||++++++++.+++..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999875 799999999865432 23467889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
+ ++|.+++..... ..+++..++.++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 4 689998865432 45899999999999999999999987 99999999999999999999999999976543211
Q ss_pred ccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHH-HHHHHH-------HHHH-hc-C-
Q 005649 527 HRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQ-ELLKLA-------RRLE-EE-G- 594 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~-~~~~~~-------~~~~-~~-~- 594 (686)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||......... ...... +... .. +
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 11223567889999987664 5789999999999999999999999765432211 111100 0000 00 0
Q ss_pred --ccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 595 --RLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 595 --~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.........+.......+..+.+++.+|++.+|++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000001111122345678899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=330.11 Aligned_cols=263 Identities=31% Similarity=0.463 Sum_probs=215.7
Q ss_pred HHHHhhCCCcccccccccCcEEEEEEEec----C----CCEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCCcccEEE
Q 005649 362 VLIAATDNFSTKNMLGRGGFGTVYKGRLQ----D----GREIAVKKLATNS-MQGKEEFENEVRVLLKM-QHRNLVQLFG 431 (686)
Q Consensus 362 ~l~~at~~f~~~~~LG~G~fG~Vy~~~~~----~----g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~ 431 (686)
.++...++..+.+.||+|.||.|++|... . ...||||.++... ....+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 44555666667779999999999999753 1 4568999997653 34668899999999999 6999999999
Q ss_pred EEEecCceEEEEeecCCCChhHHHhhcC-------C----C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 005649 432 CCVQERERILVYEYLPNKSLDKFLFDKS-------K----S--AILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKA 498 (686)
Q Consensus 432 ~~~~~~~~~lv~Ey~~~gsL~~~l~~~~-------~----~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp 498 (686)
.|.+++..++|.||++.|+|.++|...+ . . ..++....+.++.|||.|++||++.. ++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999998765 0 0 24899999999999999999999976 99999999
Q ss_pred CcEEEcCCCCeEEEecCCccccCCcCccc-cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccc
Q 005649 499 SNILLDHQMKPKISDFGLAKLFHDEQSRH-RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQL 576 (686)
Q Consensus 499 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~ 576 (686)
+|||+.++..+||+|||+++...+..... ......-+..|||||.+....|+.|+|||||||+||||+| |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999765544332 1111114677999999999999999999999999999999 999998633
Q ss_pred -hHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 577 -EAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 577 -~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+. .+ ..++|..++ .|..+..+++++|+.||+.+|++||++.++++.++.
T Consensus 527 ~~~~l---~~----~l~~G~r~~--------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 527 PTEEL---LE----FLKEGNRME--------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred cHHHH---HH----HHhcCCCCC--------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 2222 11 223333222 266778999999999999999999999999999987
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=296.95 Aligned_cols=248 Identities=25% Similarity=0.439 Sum_probs=200.7
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEeccc-CcccHHHHHHHHHHHHhcC---CCCcccEEEEEEecCceEEEE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN-SMQGKEEFENEVRVLLKMQ---HRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 443 (686)
.|+..+.||+|+||.||+|... +++.+++|.+... .....+++.+|+.++++++ |||++++++++.++...+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4677889999999999999974 7899999998654 2334567889999999996 999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++++|.+++.. ..+++...+.++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998843 25899999999999999999999987 999999999999999999999999999876543
Q ss_pred CccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
.. ......|+..|+|||.+.++ .++.++|+||||+++|+|++|+.||........... . . ....+
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~------~-~-----~~~~~ 220 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML------I-P-----KSKPP 220 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc------c-c-----cCCCC
Confidence 32 12334688899999988754 578999999999999999999999975432221110 0 0 00011
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+. ....+..+.+++.+||+.+|++||++.|+++.
T Consensus 221 ~~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 RLE--DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCC--cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 111 11245678899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=295.70 Aligned_cols=247 Identities=28% Similarity=0.339 Sum_probs=204.2
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
+|+..+.||.|+||.||+++.. +++.+++|.+..... ...+.+.+|++++++++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999976 689999999965432 345788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998543 45899999999999999999999987 9999999999999999999999999988654332
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||............... ... .
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~~---------~ 218 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ----ETA---------D 218 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh----ccc---------c
Confidence 123356788999999999888999999999999999999999999865542221111111 000 0
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCH--HHHH
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTM--SATL 637 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~--~evl 637 (686)
...+...+..+.+++.+||+.+|.+||+. +|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 12244456889999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=293.08 Aligned_cols=250 Identities=23% Similarity=0.395 Sum_probs=202.9
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
+|+..+.||+|+||.||++..+ +|..+++|.+.... ....+.+.+|++++++++|+|++++++.+.+....++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999976 68899999986542 23456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-CeEEEecCCccccCCcC
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM-KPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~ 524 (686)
+++++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999986532 235899999999999999999999987 99999999999999886 46999999988664322
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
. ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||......+.. ..... +. +
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-~~--------~ 219 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV------LKICQ-GY--------F 219 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH------HHHhc-cc--------C
Confidence 1 122346788999999998889999999999999999999999999754332211 11111 11 1
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.......+..+.+++.+|++.+|++|||+.|+++.
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11122345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=289.57 Aligned_cols=261 Identities=21% Similarity=0.256 Sum_probs=212.1
Q ss_pred CCCcccccccccCcEEEEEEEecC-CCEEEEEEecccCcc---cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQ---GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|+..+.||.|.-|+||++++++ +..+|+|++.+.... ...+.+.|-+||+.++||.++.|+..++.+.-.+|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 567778999999999999999874 588999999765433 3456778999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
|||+||+|...++. +....+++..+..++.+++-||+|||..| ||.|||||+||||.++|++-|+||.|+......
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999988754 45567999999999999999999999987 999999999999999999999999997543210
Q ss_pred ---------------------------------Ccc---------------------ccccccccCCCcCchhhhhcCCC
Q 005649 524 ---------------------------------QSR---------------------HRTHQIAGTFGYMAPEYAIRGFL 549 (686)
Q Consensus 524 ---------------------------------~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~ 549 (686)
... .+....+||-.|+|||++.+..-
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 01122468999999999999999
Q ss_pred ChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC-CCCHHHHHHHHHHHHHccccccc
Q 005649 550 SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG-TYPEEIALRFMQIALLCTEDFIE 628 (686)
Q Consensus 550 s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~l~~li~~cl~~~p~ 628 (686)
+.+.|+|+|||+||||+.|..||.+.+..+....+ +-..+. ......+..+.+||.+.|.+||.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI---------------v~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI---------------VGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH---------------hcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 99999999999999999999999988776653222 112221 11236778899999999999999
Q ss_pred CCCC----HHHHHHHh--cCCCCCC
Q 005649 629 DRPT----MSATLSML--SNSSVPI 647 (686)
Q Consensus 629 ~RPt----~~evl~~L--~~~~~~~ 647 (686)
+|.. +.||-+.- +.+++++
T Consensus 378 kRlg~~rGA~eIK~HpFF~gVnWaL 402 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRHPFFEGVNWAL 402 (459)
T ss_pred hhhccccchHHhhcCccccCCChhh
Confidence 9998 77775543 4555543
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=295.11 Aligned_cols=263 Identities=21% Similarity=0.299 Sum_probs=198.9
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++++|...+.||+|+||.||+|... +|+.+++|++..... .....+.+|+.+++.++|+||+++.+++.+++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4688999999999999999999865 688999999865433 23356789999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+. ++|.+++... ...+.+..+..++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9995 6777776543 234788889999999999999999987 999999999999999999999999998764332
Q ss_pred CccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhc---------
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEE--------- 593 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------- 593 (686)
.. ......++..|+|||.+.+. .++.++||||||+++|||++|+.||+....... .+...+.....
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChhhhhhh
Confidence 21 12234568899999988764 578999999999999999999999975543211 11111111000
Q ss_pred ---Ccc-ccccc----cccCCC--CHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 594 ---GRL-MELVD----VRIGTY--PEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 594 ---~~~-~~~~d----~~l~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
... .+... ..+... .......+.+++.+|++.||++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000 00000 000000 0012456789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=290.93 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=206.7
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
+|++.+.||+|++|.||+++.. +++.+++|++.... ......+.+|++++++++|+||+++++++.++...++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999865 68899999986543 23356788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 446 LPNKSLDKFLFDKS-KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 446 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999986532 2356899999999999999999999987 9999999999999999999999999998765441
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
.....++..|++||.+.+..++.++|+||||+++|||++|+.||......+....+ ..+..
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~-------~~~~~-------- 218 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV-------QRGKY-------- 218 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------hcCCC--------
Confidence 22245788999999999999999999999999999999999999765443221111 11111
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
...+......+.+++.+|++.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 12234567789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=296.06 Aligned_cols=245 Identities=24% Similarity=0.374 Sum_probs=199.7
Q ss_pred cccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCCh
Q 005649 373 KNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSL 451 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL 451 (686)
..+||+|+||.||++..+ +++.+++|++........+.+.+|+.+++.++|+|++++++.+...+..+++|||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 467999999999999875 7899999998665555567799999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccc
Q 005649 452 DKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQ 531 (686)
Q Consensus 452 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 531 (686)
.+++.. ..+++.....++.|++.+|.|||+.+ ++||||+|+||+++.++.++|+|||++........ ....
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~ 175 (292)
T cd06657 105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS 175 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence 988743 24899999999999999999999987 99999999999999999999999999876543221 1223
Q ss_pred cccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHH
Q 005649 532 IAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEI 611 (686)
Q Consensus 532 ~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 611 (686)
..++..|++||.+.+..++.++|+||||+++|||++|+.||......+....+. ... .+.+.. ....
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~---~~~---------~~~~~~-~~~~ 242 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---DNL---------PPKLKN-LHKV 242 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hhC---------CcccCC-cccC
Confidence 467889999999988889999999999999999999999997544332221111 100 011111 1234
Q ss_pred HHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 612 ALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 612 ~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
+..+.+++.+||+.+|.+||++.++++.
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 5567899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=298.73 Aligned_cols=248 Identities=28% Similarity=0.397 Sum_probs=199.5
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
.+.|+..+.||+|+||.||+|+.. +++.|++|++..... ...+++.+|+++++.++|||++++.+++.+++..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888899999999999999875 689999999864432 2235688999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
+||++ |+|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99996 6777776433 235899999999999999999999987 99999999999999999999999999875532
Q ss_pred cCccccccccccCCCcCchhhhh---cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAI---RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
. ....++..|+|||.+. .+.++.++||||||+++|||++|+.||...........+ .....
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~------~~~~~---- 231 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------AQNDS---- 231 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH------hcCCC----
Confidence 2 1235778999999874 456889999999999999999999999755433221111 00000
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
+. ..+...+..+.+++.+||+.+|++||++.+|+...
T Consensus 232 --~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 232 --PT--LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred --CC--CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 01 11234567799999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=295.92 Aligned_cols=265 Identities=24% Similarity=0.312 Sum_probs=198.6
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
++|+..+.||+|++|.||+|+.. +|+.|++|++..... ...+.+.+|++++++++|+||+++++++.++...++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999976 688999999865432 234678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCCeEEEecCCccccCCc
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH-QMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~ 523 (686)
|++ ++|.+++.... ...+++.....++.||+.||.|||+++ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 995 57877775432 234688888999999999999999987 999999999999985 557999999999765432
Q ss_pred CccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccc---
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMEL--- 599 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 599 (686)
.. ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+.............+..+...
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 11 12234568899999988764 5789999999999999999999999765433221111000000000000000
Q ss_pred ----------cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 600 ----------VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 600 ----------~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
....+.......+..+.+++.+|++.+|++||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000001112345668899999999999999999999873
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=293.80 Aligned_cols=263 Identities=24% Similarity=0.324 Sum_probs=201.0
Q ss_pred CcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEec--CceEEEEe
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE--RERILVYE 444 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~E 444 (686)
|+..+.||+|++|.||+|+.. +++.+++|++.... ....+.+.+|++++++++|+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999976 58899999997653 33346788999999999999999999999988 78999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++ +|.+++.... ..+++..++.++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9974 8888885432 45899999999999999999999987 9999999999999999999999999998765433
Q ss_pred ccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccc-----
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME----- 598 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 598 (686)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+...........+..
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 21 1223456788999997765 4689999999999999999999999986554332222111100000000000
Q ss_pred ---------ccccccC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 599 ---------LVDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 599 ---------~~d~~l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.....+. .+...++..+.+++.+||+.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000 0111136778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.82 Aligned_cols=260 Identities=20% Similarity=0.269 Sum_probs=195.6
Q ss_pred CcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcC-CCCcccEEEEEEec--CceEEEEe
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQE--RERILVYE 444 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~E 444 (686)
|+..+.||+|+||.||++... +++.+++|+++.... .......+|+..+.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999865 688999999865422 22234457888888885 99999999999987 88999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|++ ++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||+|+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 996 58888775432 45899999999999999999999987 999999999999999 999999999998664332
Q ss_pred ccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHH--------HHHHhcCc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLA--------RRLEEEGR 595 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 595 (686)
. .....++..|+|||.+.. +.++.++|||||||++|||++|+.||......+........ ........
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 2 122457889999997654 56789999999999999999999999765543322111100 00000000
Q ss_pred cccccccc-----cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 596 LMELVDVR-----IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 596 ~~~~~d~~-----l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
......+. +.......+..+.+++.+||+.+|++||++.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000 001112457889999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.73 Aligned_cols=274 Identities=24% Similarity=0.321 Sum_probs=204.6
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCCcccEEEEEEec--CceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ--GKEEFENEVRVLLKMQHRNLVQLFGCCVQE--RERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 441 (686)
.++|+..+.||+|+||.||+|... +|+.||+|++...... ....+.+|+.++.+++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 478999999999999999999975 6899999998644322 234567899999999999999999998765 46799
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
|+||++ ++|.+++.... ..+++..++.++.||++||.|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 47888875432 45899999999999999999999987 9999999999999999999999999998765
Q ss_pred CcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccc--
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME-- 598 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 598 (686)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+...........+..
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 4321 1222345778999998865 4679999999999999999999999986554433222221100000000000
Q ss_pred ------ccc---cccCC---CCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCCC
Q 005649 599 ------LVD---VRIGT---YPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIP 648 (686)
Q Consensus 599 ------~~d---~~l~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 648 (686)
... ..+.. .....+..+.+++.+|++.||++|||+.|+++.---....+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 000 00000 001235667899999999999999999999976554444444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=294.02 Aligned_cols=262 Identities=21% Similarity=0.315 Sum_probs=202.9
Q ss_pred CcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ--GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
|+..+.||+|++|.||++... +++.+++|++...... ....+.+|++++++++|+||+++++++.+++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566788999999999999875 7889999998654332 3567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++ +|.+++.... ..+++..++.++.|+++||.|||+.+ |+|+||+|+||++++++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 75 8888875532 45899999999999999999999987 9999999999999999999999999988765433
Q ss_pred ccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc----
Q 005649 527 HRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD---- 601 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d---- 601 (686)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....+...........+....+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 112234577889999998876 789999999999999999999999976554332211110000000000000000
Q ss_pred ----------cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 602 ----------VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 602 ----------~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
..+.......+..+.+++.+||+.||.+||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00011123457789999999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=295.08 Aligned_cols=250 Identities=21% Similarity=0.382 Sum_probs=212.2
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ--GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.-|...+.||+|.|..|-+++.- .|..||||++.+.... ....++.|++-|+.++|||||+++.+.-.+...|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 34666788999999999999865 8999999999765433 45678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE-cCCCCeEEEecCCccccCCc
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL-DHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Dfgla~~~~~~ 523 (686)
.-++|+|.+|+-.+..+ +.+....+++.||+.|+.|+|+-. +|||||||+||.+ ..-|-|||.|||++..+...
T Consensus 98 LGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999999765443 899999999999999999999976 9999999999876 67788999999998876544
Q ss_pred CccccccccccCCCcCchhhhhcCCCC-hhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLS-VKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
. .....+|...|-|||++.+..|+ ++.||||||||||.|++|+.||+..++.|....+ +|.
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---------------mDC 234 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---------------MDC 234 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh---------------hcc
Confidence 3 33456899999999999998765 6799999999999999999999987776654322 232
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
.. ..|...+.++.+||..||+.||.+|.+.+||+..-.
T Consensus 235 KY-tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 235 KY-TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred cc-cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 22 236788999999999999999999999999986543
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=293.72 Aligned_cols=255 Identities=26% Similarity=0.404 Sum_probs=196.9
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcC-CCCcccEEEEEEecCceEEEEe
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 444 (686)
++|+..+.||+|+||.||+++.. +++.+++|++.... ......+.+|+.++.++. |+||+++++++..+...++++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 45667789999999999999875 68999999986543 234567889999999996 9999999999999999999999
Q ss_pred ecCCCChhHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 445 YLPNKSLDKFLFD--KSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 445 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|++. ++.++... ......+++..+..++.|++.||.|||++. +++||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 55443321 112356899999999999999999999752 399999999999999999999999999976543
Q ss_pred cCccccccccccCCCcCchhhhhcC---CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRG---FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
... .....|+..|+|||.+.+. .++.++||||||+++|||++|+.||..... ............
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~----- 227 (288)
T cd06616 161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKGD----- 227 (288)
T ss_pred CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcCCC-----
Confidence 221 1223578899999998776 689999999999999999999999975431 111111111100
Q ss_pred cccccC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 600 VDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 600 ~d~~l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+.+. ..+...+..+.+++.+||+.+|++|||+.+|++.
T Consensus 228 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 -PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111 1123456789999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=291.68 Aligned_cols=244 Identities=27% Similarity=0.388 Sum_probs=195.6
Q ss_pred ccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCCh
Q 005649 376 LGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSL 451 (686)
Q Consensus 376 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL 451 (686)
||+|+||+||++... +|+.+++|.+.... ......+.+|++++++++|||++++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 68999999986532 22345678899999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccc
Q 005649 452 DKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQ 531 (686)
Q Consensus 452 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 531 (686)
.+++..... ..+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++....... ....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 999975433 45899999999999999999999987 9999999999999999999999999987654321 1223
Q ss_pred cccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHH
Q 005649 532 IAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEI 611 (686)
Q Consensus 532 ~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 611 (686)
..++..|++||.+.+..++.++||||||+++++|++|+.||...........+... . . ......+...
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~-----~-----~~~~~~~~~~ 221 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR--T-----L-----EMAVEYPDKF 221 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc--c-----c-----cccccCCccC
Confidence 45778999999998888999999999999999999999999754432111111100 0 0 0001223445
Q ss_pred HHHHHHHHHHcccccccCCC-----CHHHHHH
Q 005649 612 ALRFMQIALLCTEDFIEDRP-----TMSATLS 638 (686)
Q Consensus 612 ~~~l~~li~~cl~~~p~~RP-----t~~evl~ 638 (686)
+..+.+++.+||+.+|++|| +..++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 67789999999999999999 6666765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=288.08 Aligned_cols=251 Identities=24% Similarity=0.428 Sum_probs=208.2
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
+|+..+.||+|++|.||++... +++.+++|++..... ...+.+.+|++.+++++|+|++++.+.+..++..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5778899999999999999976 688999999976533 4567789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 446 LPNKSLDKFLFDKS-KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 446 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
+++++|.+++.... ....+++..++.++.++++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999996542 2356999999999999999999999987 9999999999999999999999999998765433
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
.......|++.|+|||...+..++.++|+||+|+++++|++|+.||......+... .... .. .
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~------~~~~-~~--------~ 220 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL------KILK-GQ--------Y 220 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHH------HHhc-CC--------C
Confidence 12233467889999999998899999999999999999999999997554322111 1111 11 1
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
...+......+.+++.+||..+|++|||+.++++.
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 12233456778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=295.94 Aligned_cols=266 Identities=22% Similarity=0.309 Sum_probs=198.1
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecC-------
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQER------- 437 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------- 437 (686)
++|+..+.||+|+||.||+++.. +++.||||++..... .....+.+|+.++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 67999999999999999999976 689999999864432 22345678999999999999999999987654
Q ss_pred -ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCC
Q 005649 438 -ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGL 516 (686)
Q Consensus 438 -~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 516 (686)
..++|+||+. ++|.+++... ...+++.+++.++.||++||.|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 3499999996 4787777542 235899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCcCcc--ccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhc
Q 005649 517 AKLFHDEQSR--HRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEE 593 (686)
Q Consensus 517 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 593 (686)
+......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+.........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9866433221 112234577889999988764 4788999999999999999999999765544333332222110000
Q ss_pred Cccc-----ccccc-ccC-CC---------CHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 594 GRLM-----ELVDV-RIG-TY---------PEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 594 ~~~~-----~~~d~-~l~-~~---------~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
+.+. +..+. .+. .. +......+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000 00000 000 00 00123456799999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=291.30 Aligned_cols=245 Identities=26% Similarity=0.386 Sum_probs=200.0
Q ss_pred ccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCCh
Q 005649 376 LGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSL 451 (686)
Q Consensus 376 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL 451 (686)
||+|+||.||+++.. +|+.+++|.+..... ...+.+.+|++++++++|+||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 489999999865433 3456789999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc------
Q 005649 452 DKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS------ 525 (686)
Q Consensus 452 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~------ 525 (686)
.+++.... .+++..++.++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99996533 5899999999999999999999987 99999999999999999999999999876543211
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
........++..|++||.......+.++||||||+++|||++|+.||......+....+. . +..
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~------~-~~~--------- 218 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL------N-GKI--------- 218 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh------c-CCc---------
Confidence 112233567889999999988889999999999999999999999997655433221111 0 110
Q ss_pred CCCHH--HHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 606 TYPEE--IALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 606 ~~~~~--~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+.. .+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 01122 26778999999999999999999777777654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=291.33 Aligned_cols=257 Identities=19% Similarity=0.268 Sum_probs=186.1
Q ss_pred hCCCcccccccccCcEEEEEEEecCC----CEEEEEEecccCcccH-----------HHHHHHHHHHHhcCCCCcccEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDG----REIAVKKLATNSMQGK-----------EEFENEVRVLLKMQHRNLVQLFG 431 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g----~~vavK~l~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l~~ 431 (686)
.++|++.++||+|+||.||+|+..++ ..+++|+......... .....++..+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46899999999999999999997643 4556665432221110 11223344555678999999999
Q ss_pred EEEecC----ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 005649 432 CCVQER----ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM 507 (686)
Q Consensus 432 ~~~~~~----~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 507 (686)
++.... ..++++|++. .++.+.+... ...++..+..++.|+++||.|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876544 3367778763 3566555332 23578889999999999999999987 99999999999999999
Q ss_pred CeEEEecCCccccCCcCcc-----ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchH-hHH
Q 005649 508 KPKISDFGLAKLFHDEQSR-----HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEA-ENQ 581 (686)
Q Consensus 508 ~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~-~~~ 581 (686)
.++|+|||+++.+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +..
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999999876432111 1112346999999999999999999999999999999999999999866322 211
Q ss_pred HHH--HHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 582 ELL--KLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 582 ~~~--~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
... +...+... +. +. ....+..+.+++..|++.+|++||++.++++.|+
T Consensus 244 ~~~~~~~~~~~~~-~~--------~~--~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFIKRLHE-GK--------IK--IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHHHHhhh-hh--------hc--cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111 11111111 10 00 1233577889999999999999999999998874
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=286.53 Aligned_cols=247 Identities=28% Similarity=0.444 Sum_probs=204.7
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
+|+..+.||+|++|.||+++.. +++.+++|.+..... ...+.+.+|++++.+++|+|++++++++.++...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999876 678999999976654 3457899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++... ..+++..++.++.|++.+|.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998643 45899999999999999999999987 99999999999999999999999999987654332
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
. .....++..|+|||...+...+.++|||++|+++|+|++|+.||......... +...... . .
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~------~~~~~~~-~--------~ 217 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL------FRIVQDD-H--------P 217 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH------HHHhccC-C--------C
Confidence 1 22346788999999998888999999999999999999999999754321111 1111100 0 1
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
..+...+..+.+++.+||+.+|++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 123344677889999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=288.12 Aligned_cols=242 Identities=27% Similarity=0.375 Sum_probs=197.4
Q ss_pred ccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCCh
Q 005649 376 LGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSL 451 (686)
Q Consensus 376 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL 451 (686)
||.|++|.||+++.. +++.+++|++..... ...+.+.+|++++++++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999986 488999999865432 2346789999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccc
Q 005649 452 DKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQ 531 (686)
Q Consensus 452 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 531 (686)
.+++... ..+++..+..++.|+++||.|||+++ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 9999653 34899999999999999999999987 9999999999999999999999999998765432 1223
Q ss_pred cccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHH
Q 005649 532 IAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEI 611 (686)
Q Consensus 532 ~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 611 (686)
..++..|++||.+.+..++.++|+||||+++|||++|+.||.....+.. .... .... + .....++...
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~---~~~~-~-------~~~~~~~~~~ 219 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-EIYN---DILK-G-------NGKLEFPNYI 219 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-HHHH---HHhc-c-------CCCCCCCccc
Confidence 4678899999999888899999999999999999999999976543111 1111 1110 0 0001233444
Q ss_pred HHHHHHHHHHcccccccCCCC-----HHHHHH
Q 005649 612 ALRFMQIALLCTEDFIEDRPT-----MSATLS 638 (686)
Q Consensus 612 ~~~l~~li~~cl~~~p~~RPt-----~~evl~ 638 (686)
+..+.+++.+||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 678999999999999999999 677665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.30 Aligned_cols=268 Identities=25% Similarity=0.334 Sum_probs=200.9
Q ss_pred HhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecC----
Q 005649 365 AATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQER---- 437 (686)
Q Consensus 365 ~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 437 (686)
...++|++.+.||+|+||.||+|..+ +|+.|++|++..... .....+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34678999999999999999999986 688999999965432 23356788999999999999999999987654
Q ss_pred ------ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEE
Q 005649 438 ------ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKI 511 (686)
Q Consensus 438 ------~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 511 (686)
..++++||+++ ++..++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999976 676766443 335899999999999999999999987 999999999999999999999
Q ss_pred EecCCccccCCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHH
Q 005649 512 SDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL 590 (686)
Q Consensus 512 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 590 (686)
+|||++........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+......
T Consensus 158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999986654322 11122345778999998765 45789999999999999999999999754433222222111100
Q ss_pred HhcCccccc--------ccc------ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 591 EEEGRLMEL--------VDV------RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 591 ~~~~~~~~~--------~d~------~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.....+..+ .++ .+.......+..+.+++.+||+.+|++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000000 000 0000011235678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.37 Aligned_cols=265 Identities=22% Similarity=0.323 Sum_probs=199.9
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhc-CCCCcccEEEEEEec--CceE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQE--RERI 440 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~~ 440 (686)
.++|+..+.||+|+||.||+|... +++.+++|++... .......+..|+.++.++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 468889999999999999999976 6889999988543 233345678899999999 999999999998654 3679
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+|+||++ ++|..++... .+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999996 5898888432 5899999999999999999999987 999999999999999999999999999866
Q ss_pred CCcCcc---ccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH--------
Q 005649 521 HDEQSR---HRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR-------- 588 (686)
Q Consensus 521 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~-------- 588 (686)
...... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 433221 12233467889999998765 467899999999999999999999997554332211111100
Q ss_pred HHHhcCccccccc----c---ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 589 RLEEEGRLMELVD----V---RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 589 ~~~~~~~~~~~~d----~---~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.........++++ . .+.......+..+.+++.+||+.+|++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000111 0 0001111246778999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=290.27 Aligned_cols=243 Identities=24% Similarity=0.365 Sum_probs=190.0
Q ss_pred cccccCcEEEEEEEec-CCCEEEEEEecccCcc---cHHHHHHHHHHHH---hcCCCCcccEEEEEEecCceEEEEeecC
Q 005649 375 MLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ---GKEEFENEVRVLL---KMQHRNLVQLFGCCVQERERILVYEYLP 447 (686)
Q Consensus 375 ~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~e~~~l~---~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 447 (686)
+||+|+||.||++... +++.+|+|.+...... ....+.+|..++. ..+|||++.+.+.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 6889999988654221 1233444444333 3479999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc
Q 005649 448 NKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH 527 (686)
Q Consensus 448 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 527 (686)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 99999988643 35999999999999999999999987 9999999999999999999999999987554322
Q ss_pred cccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCC
Q 005649 528 RTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 606 (686)
.....|+..|+|||.+.+ ..++.++|+||||++++||++|+.||............. .... .+. .
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~~------~~~---~ 217 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLT------VNV---E 217 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH----Hhhc------CCc---C
Confidence 123468999999998864 568999999999999999999999997543322211111 0000 001 2
Q ss_pred CCHHHHHHHHHHHHHcccccccCCC-----CHHHHHHHh
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRP-----TMSATLSML 640 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~L 640 (686)
.+...+..+.+++.+||+.||++|| +++++++..
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 2445667889999999999999999 699998864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.27 Aligned_cols=264 Identities=20% Similarity=0.294 Sum_probs=200.4
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEec-----Cc
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE-----RE 438 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 438 (686)
.++|...+.||+|+||.||+++.. +++.|+||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467899999999999999999865 6899999998653 223345678899999999999999999988654 34
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.++++||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999995 6888888542 45999999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHH--------
Q 005649 519 LFHDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARR-------- 589 (686)
Q Consensus 519 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~-------- 589 (686)
...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||......+....+.....
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 664332 11223457889999998865 4689999999999999999999999976543222211111000
Q ss_pred HHhcCccccc-------cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 590 LEEEGRLMEL-------VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 590 ~~~~~~~~~~-------~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
........+. .++.........+..+.+++.+||+.+|++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000000 0011111112356778999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=294.78 Aligned_cols=250 Identities=28% Similarity=0.394 Sum_probs=199.4
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.|+..+.||+|+||.||+++.. ++..+++|++..... .....+.+|++++++++|+|++++++++.+++..++|+|
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3677889999999999999975 688999999864422 223578899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|++ |+|.+.+... ...+++.++..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 996 5777777543 245899999999999999999999987 999999999999999999999999998754322
Q ss_pred ccccccccccCCCcCchhhhh---cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAI---RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
....++..|+|||.+. .+.++.++||||||+++|||++|+.||......+.... ....+..
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~------~~~~~~~----- 242 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------IAQNESP----- 242 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH------HHhccCC-----
Confidence 2346788999999874 45789999999999999999999999875432222111 1111100
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
.......+..+.+++.+||+.+|++||++.++++.+-...
T Consensus 243 ---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 243 ---TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ---CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0112234567899999999999999999999998765433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=299.09 Aligned_cols=262 Identities=22% Similarity=0.255 Sum_probs=200.2
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEec------C
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE------R 437 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 437 (686)
.++|+..+.||+|+||.||+++.. +|+.||+|++... .....+.+.+|+.++++++|+||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 478999999999999999999975 7899999998643 223345678899999999999999999998643 3
Q ss_pred ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCc
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 517 (686)
..++|+||+. ++|.+.+... +++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 5699999995 5888777431 889999999999999999999987 999999999999999999999999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHH-----------
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKL----------- 586 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~----------- 586 (686)
+....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+..
T Consensus 166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 166 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred eeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 86543221 2234578899999999999999999999999999999999999975543221111100
Q ss_pred ----H-HHHHhcC------ccccccccccC-----CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 587 ----A-RRLEEEG------RLMELVDVRIG-----TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 587 ----~-~~~~~~~------~~~~~~d~~l~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
. ....... .+.++....+. ..+......+.+++.+||+.||++|||+.|+++.=
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 0 0000000 00111111110 11223466788999999999999999999998753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=286.70 Aligned_cols=245 Identities=22% Similarity=0.265 Sum_probs=192.0
Q ss_pred ccccccCcEEEEEEEec-CCCEEEEEEecccCccc---HHHHHHHHHHH-HhcCCCCcccEEEEEEecCceEEEEeecCC
Q 005649 374 NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQG---KEEFENEVRVL-LKMQHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
+.||+|+||.||++... +|+.||+|.+....... ...+..|..++ ...+|+|++++++++..++..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999875 68899999986543221 23344554443 445899999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 9999998543 34899999999999999999999987 99999999999999999999999999875432
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCC
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYP 608 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 608 (686)
.....++..|++||.+.+..++.++||||||+++|||++|..||......+....+. .+... ... ...
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~~~--~~~---~~~ 217 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL-------SRRIN--WPE---EVK 217 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------hcccC--CCC---ccc
Confidence 123457889999999988889999999999999999999999997654433221111 11100 000 112
Q ss_pred HHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 609 EEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 609 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
...+..+.+++.+||+.+|++||++.++.+.|+-
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 2346778999999999999999988766666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=302.29 Aligned_cols=245 Identities=30% Similarity=0.417 Sum_probs=202.3
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc---cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ---GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.|...+.||.|.||.||-++.. +.+.||||++.....+ ..+++..|+..|.+++|||++.+-|++..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3667789999999999999965 7888999999655443 34678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|| -|+-.+.+.-. .+++.+.++..|..+.+.||+|||+.+ .+|||||..|||+.+.|.|||+|||.+.+....
T Consensus 107 YC-lGSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 107 YC-LGSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HH-hccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 99 56666666332 345899999999999999999999987 899999999999999999999999999876533
Q ss_pred ccccccccccCCCcCchhhhh---cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAI---RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
....||+.|||||++. .+.|+-|.||||||++..||.-.++|+-.++.......+ ..++.+..
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI-----AQNesPtL---- 245 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-----AQNESPTL---- 245 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH-----HhcCCCCC----
Confidence 3468999999999874 589999999999999999999999998765543321111 11111111
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
-..+.+..+.+++..||++-|.+|||..+++..
T Consensus 246 -----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 246 -----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred -----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 145778899999999999999999999988653
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.99 Aligned_cols=255 Identities=24% Similarity=0.356 Sum_probs=204.9
Q ss_pred HhhCCCcccccccccCcEEEEEEEecCCCEEEEEEecc--cCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEE
Q 005649 365 AATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLAT--NSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 365 ~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 441 (686)
.....|++.++||+||.+.||++...+.+.+|+|++.. .+.+...-|.+|+..|.+| .|.+|++|++|-..++..|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 34567999999999999999999998888999998743 3555668899999999999 59999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||- .-+|..+|..... ....| .+..+..|++.++.++|.++ |||.||||.|+|+= .|.+||+|||.|..+.
T Consensus 438 vmE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 99985 6689999966433 33445 67788899999999999998 99999999999984 5789999999999887
Q ss_pred CcCccccccccccCCCcCchhhhhcC-----------CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHH
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRG-----------FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL 590 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 590 (686)
.+.+........||+.||+||.+... +.++++||||+|||||+|+-|+.||... .+.+.
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n~~a----- 580 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----INQIA----- 580 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HHHHH-----
Confidence 76666666778999999999988532 3678999999999999999999999632 11111
Q ss_pred HhcCccccccccccC-CCCHHH-HHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 591 EEEGRLMELVDVRIG-TYPEEI-ALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 591 ~~~~~~~~~~d~~l~-~~~~~~-~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
++..+.||.-. +++.-- ...++++++.||+.||.+||+..+|++.-
T Consensus 581 ----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 581 ----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred ----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 12234444331 222111 11299999999999999999999998753
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=287.26 Aligned_cols=261 Identities=25% Similarity=0.360 Sum_probs=197.6
Q ss_pred CcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc--cHHHHHHHHHHHHhc---CCCCcccEEEEEEecCc-----
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ--GKEEFENEVRVLLKM---QHRNLVQLFGCCVQERE----- 438 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 438 (686)
|++.+.||+|+||.||+|+.+ +++.+++|++...... ....+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999987 5899999999643222 234566787777666 69999999999988776
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.+++|||++ ++|.+++..... ..+++..++.++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999996 588888865332 35899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcc--
Q 005649 519 LFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL-- 596 (686)
Q Consensus 519 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 596 (686)
....... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||......+....+...........+
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 7643321 12234688899999999999999999999999999999999999865544332211100000000000
Q ss_pred ---------ccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 597 ---------MELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 597 ---------~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
..................+.+++.+||+.||++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000001112245677889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=291.03 Aligned_cols=249 Identities=25% Similarity=0.367 Sum_probs=205.0
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcC-CCCcccEEEEEEecCceEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 442 (686)
++|...+.||+|++|.||+++.. +++.+++|++.... ....+.+.+|.+++.+++ |+||+++++++.+++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47888999999999999999976 78999999986532 233467889999999998 99999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999999653 35999999999999999999999987 99999999999999999999999999886654
Q ss_pred cCcc------------------ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHH
Q 005649 523 EQSR------------------HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELL 584 (686)
Q Consensus 523 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~ 584 (686)
.... .......++..|++||......++.++|+||||++++++++|+.||.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--- 231 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF--- 231 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH---
Confidence 3211 1223356788999999998888999999999999999999999999865432211
Q ss_pred HHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCH----HHHHH
Q 005649 585 KLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTM----SATLS 638 (686)
Q Consensus 585 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~----~evl~ 638 (686)
.. ... .. ...+...+..+.+++.+||+.+|++||++ .++++
T Consensus 232 ~~---~~~-~~---------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 QK---ILK-LE---------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HH---HHh-cC---------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11 111 00 02234456778999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=299.55 Aligned_cols=269 Identities=19% Similarity=0.288 Sum_probs=202.6
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEe----cCce
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ----ERER 439 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 439 (686)
.++|+..+.||+|++|.||++... +|+.|++|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999875 68999999986542 2345677889999999999999999998763 3467
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++|+||+. ++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999995 6898888543 34899999999999999999999987 99999999999999999999999999986
Q ss_pred cCCcCccc--cccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHH------
Q 005649 520 FHDEQSRH--RTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL------ 590 (686)
Q Consensus 520 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~------ 590 (686)
........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 64332211 1123468889999998765 46899999999999999999999999765432221111110000
Q ss_pred --HhcCccccccc---cc----cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 591 --EEEGRLMELVD---VR----IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 591 --~~~~~~~~~~d---~~----l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
.......+.++ .. +.......+..+.+++.+||+.+|++||++.++++..--
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 00000000000 00 000112346789999999999999999999999886543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=299.31 Aligned_cols=283 Identities=21% Similarity=0.319 Sum_probs=205.2
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEec---------
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE--------- 436 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------- 436 (686)
..+|+..+.||+|+||.||+|... +|+.|++|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999875 6889999999766666667889999999999999999999776543
Q ss_pred -----CceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-CCCCeE
Q 005649 437 -----RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD-HQMKPK 510 (686)
Q Consensus 437 -----~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k 510 (686)
...++++||++ ++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 588888743 34899999999999999999999987 99999999999997 456789
Q ss_pred EEecCCccccCCcCcc-ccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH
Q 005649 511 ISDFGLAKLFHDEQSR-HRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR 588 (686)
Q Consensus 511 l~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 588 (686)
|+|||+++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+.........
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999865432111 11123457889999998754 568899999999999999999999997654433221111000
Q ss_pred HHHhc---Ccccccc---------ccc--cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH--hcCCCCCCCCCCC
Q 005649 589 RLEEE---GRLMELV---------DVR--IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM--LSNSSVPIPSVTE 652 (686)
Q Consensus 589 ~~~~~---~~~~~~~---------d~~--l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~~~~~~~p~ 652 (686)
..... ......+ ... +..........+.+++.+||+.||++|||+.|+++. ++....+.+. |.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~-~~ 314 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDE-PV 314 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccc-cC
Confidence 00000 0000000 000 000111245678899999999999999999999854 3433333333 45
Q ss_pred CCCCcc
Q 005649 653 SPDHYE 658 (686)
Q Consensus 653 ~p~~~~ 658 (686)
++.+++
T Consensus 315 ~~~~~~ 320 (342)
T cd07854 315 SLHPFH 320 (342)
T ss_pred CCCCcc
Confidence 544443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=284.26 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=199.5
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc-----CcccHHHHHHHHHHHHhcCCCCcccEEEEEEec--Cce
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN-----SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE--RER 439 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 439 (686)
.+|+..+.||+|+||.||+++.. +++.+++|.+... .......+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57889999999999999999875 6899999987532 122345788999999999999999999998764 457
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++++||+++++|.+++... ..+++.....++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999998543 34889999999999999999999987 99999999999999999999999999986
Q ss_pred cCCcCcc-ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 520 FHDEQSR-HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 520 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
....... .......++..|+|||.+.+..++.++|+||||+++|||++|+.||......+.. .. .... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~---~~~~--~~~- 227 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI--FK---IATQ--PTK- 227 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH--HH---HHcC--CCC-
Confidence 5432111 1112345788999999999888999999999999999999999999754322211 11 1100 000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
...+......+.+++.+|++ +|..||+..+++.
T Consensus 228 ------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 ------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 12355667789999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=294.58 Aligned_cols=269 Identities=20% Similarity=0.253 Sum_probs=200.6
Q ss_pred CCCc-ccccccccCcEEEEEEEec-CCCEEEEEEecccCccc--------------HHHHHHHHHHHHhcCCCCcccEEE
Q 005649 368 DNFS-TKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQG--------------KEEFENEVRVLLKMQHRNLVQLFG 431 (686)
Q Consensus 368 ~~f~-~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~~ 431 (686)
++|. ..+.||+|+||.||+++.. +++.||||++....... ...+.+|++++.+++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 3577999999999999965 68999999986543221 125778999999999999999999
Q ss_pred EEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEE
Q 005649 432 CCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKI 511 (686)
Q Consensus 432 ~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 511 (686)
++..++..+++|||++ |+|.+++... ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999996 6898888542 34899999999999999999999987 999999999999999999999
Q ss_pred EecCCccccCCcC------------ccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchH
Q 005649 512 SDFGLAKLFHDEQ------------SRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEA 578 (686)
Q Consensus 512 ~Dfgla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~ 578 (686)
+|||+++...... .........++..|+|||.+.+. .++.++||||||+++|||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999998664111 01111223467889999998764 4799999999999999999999999866543
Q ss_pred hHHHHHHHHHHHHhcCccccc------------cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 579 ENQELLKLARRLEEEGRLMEL------------VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~~~------------~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
+....+...........+... ..+.+.......+..+.+++.+|++.+|++||++.|++..---.
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~ 317 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence 322211111000000000000 00011111123356788999999999999999999999866443
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=291.80 Aligned_cols=263 Identities=22% Similarity=0.304 Sum_probs=195.0
Q ss_pred cccccc--CcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCC
Q 005649 374 NMLGRG--GFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G--~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
..||+| +||+||+++.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 89999999975 78999999986543 22346788999999999999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc-
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH- 527 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 527 (686)
++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999998865432 34899999999999999999999987 9999999999999999999999998654332111100
Q ss_pred ----cccccccCCCcCchhhhhcC--CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHH-HHH-------------H
Q 005649 528 ----RTHQIAGTFGYMAPEYAIRG--FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQEL-LKL-------------A 587 (686)
Q Consensus 528 ----~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~-~~~-------------~ 587 (686)
......++..|++||++.+. .++.++||||||+++|||++|+.||......+.... ... .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 01112345679999998764 578999999999999999999999976543221100 000 0
Q ss_pred HHH-------H---------hcCccccccccccC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 588 RRL-------E---------EEGRLMELVDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 588 ~~~-------~---------~~~~~~~~~d~~l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
... . ..+....+.+..+. ..+......+.+++.+||+.||++|||+.|+++.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 000 0 00000011111121 12345677899999999999999999999998543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=282.95 Aligned_cols=244 Identities=22% Similarity=0.328 Sum_probs=191.8
Q ss_pred hhCCCcccccc--cccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEE
Q 005649 366 ATDNFSTKNML--GRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 366 at~~f~~~~~L--G~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 441 (686)
..++|++.+.+ |+|+||.||+++.+ +++.+++|.+........ |+.....+ +|+|++++++.+...+..++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34667776666 99999999999875 678899998865432211 22222222 79999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-CeEEEecCCcccc
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM-KPKISDFGLAKLF 520 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~ 520 (686)
||||+++++|.+++.... .+++..++.++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 999999999999996542 6999999999999999999999987 99999999999999998 9999999998765
Q ss_pred CCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
.... ...++..|+|||.+.+..++.++||||||+++|||++|+.||......+. ....+.... . .
T Consensus 161 ~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-~-~------ 225 (267)
T PHA03390 161 GTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKRQ-Q-K------ 225 (267)
T ss_pred CCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHhh-c-c------
Confidence 4322 23578899999999998999999999999999999999999985433221 111111111 1 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCC-HHHHHH
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPT-MSATLS 638 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~ 638 (686)
.. ..+...+..+.+++.+||+.+|.+||+ ++|+++
T Consensus 226 --~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 --KL-PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --cC-CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 113356778999999999999999996 688874
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=292.89 Aligned_cols=266 Identities=25% Similarity=0.336 Sum_probs=197.5
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCCcccEEEEEEecC------
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ--GKEEFENEVRVLLKMQHRNLVQLFGCCVQER------ 437 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 437 (686)
.++|+..++||+|+||.||+++.. +++.+++|++...... ....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999976 6889999998654322 2346788999999999999999999876543
Q ss_pred --ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecC
Q 005649 438 --ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFG 515 (686)
Q Consensus 438 --~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 515 (686)
..++|+||++. +|...+... ...+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999965 676666442 345999999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCcCcc---------ccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHH
Q 005649 516 LAKLFHDEQSR---------HRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLK 585 (686)
Q Consensus 516 la~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~ 585 (686)
+++........ .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99865432211 111234567889999987654 58999999999999999999999998655543322221
Q ss_pred HHHHHHhcC------ccccccc--------cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 586 LARRLEEEG------RLMELVD--------VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 586 ~~~~~~~~~------~~~~~~d--------~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
......... ......+ +.+..........+.+++.+|++.+|++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111000000 0000000 0000000122356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=290.81 Aligned_cols=252 Identities=29% Similarity=0.389 Sum_probs=199.9
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN---SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
.+.|+..+.||+|+||.||+|+.. +++.+++|.+... .....+++.+|+++++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 345777789999999999999975 6788999988643 222345788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
+||+. |+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 94 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 99996 6887777543 234899999999999999999999987 99999999999999999999999999876543
Q ss_pred cCccccccccccCCCcCchhhhh---cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAI---RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
. ....++..|+|||.+. .+.++.++||||||+++|||++|+.||......+.... ......
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------~~~~~~---- 231 (308)
T cd06634 168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------IAQNES---- 231 (308)
T ss_pred c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH------HhhcCC----
Confidence 2 2245788999999875 35688899999999999999999999865433222111 111000
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
+. ......+..+.+++.+||+.+|++||++.++++......
T Consensus 232 --~~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 232 --PA--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred --CC--cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 00 012245667889999999999999999999998765544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=287.58 Aligned_cols=256 Identities=27% Similarity=0.365 Sum_probs=201.5
Q ss_pred CCcccccccccCcEEEEEEEec----CCCEEEEEEecccC----cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCce
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ----DGREIAVKKLATNS----MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERER 439 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 439 (686)
+|+..+.||+|++|.||+++.. +++.++||.++... ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999999742 57889999986432 22345688999999999 699999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++||||+++|+|.+++... ..+++..+..++.|++++|.|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999998543 35899999999999999999999987 99999999999999999999999999886
Q ss_pred cCCcCccccccccccCCCcCchhhhhcCC--CChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 520 FHDEQSRHRTHQIAGTFGYMAPEYAIRGF--LSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 520 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
....... ......|+..|++||.+.+.. .+.++||||||+++|||++|+.||.......... ..........
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~--- 228 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS--EISRRILKSK--- 228 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHH--HHHHHHHccC---
Confidence 5443221 122345788999999987665 7889999999999999999999996432211111 1111111100
Q ss_pred cccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 598 ~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
...+......+.+++.+||+.+|++|||+.++.+.|.-.
T Consensus 229 -------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 -------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 112333456788999999999999999999888877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=280.46 Aligned_cols=248 Identities=26% Similarity=0.384 Sum_probs=208.8
Q ss_pred CcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCC
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
|.++++||+|.||.||++.++ .|+.+|||.+... ...+++..|+.++.+.+.|++|+++|.+.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 667889999999999999876 7999999998644 3467888999999999999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
|+..+.+..+ +++|++.++..++...++||+|||.- +-+|||||..|||++-+|.+||+|||.+..+.+... .
T Consensus 113 GSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--K 185 (502)
T KOG0574|consen 113 GSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--K 185 (502)
T ss_pred CcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH--h
Confidence 9999999653 45699999999999999999999984 479999999999999999999999999988765433 3
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCC
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYP 608 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 608 (686)
.....||+.|||||++..-.|..++||||||++..||.-|++||......... ... +.. .|.--.-|
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI------FMI-PT~------PPPTF~KP 252 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI------FMI-PTK------PPPTFKKP 252 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee------Eec-cCC------CCCCCCCh
Confidence 34578999999999999999999999999999999999999999743321110 000 000 00011236
Q ss_pred HHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 609 EEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 609 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
+..+..+-++++.||-++|++|-|+.++++.
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 7788999999999999999999999988764
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=289.48 Aligned_cols=261 Identities=21% Similarity=0.234 Sum_probs=195.5
Q ss_pred cccccccCcEEEEEEEecCCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCC
Q 005649 373 KNMLGRGGFGTVYKGRLQDGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKS 450 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gs 450 (686)
.+.+|.|+++.|+++.. +++.||||++... .....+.+..|++++++++|+||+++++++.+++..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455556666666555 6899999998754 33445789999999999999999999999999999999999999999
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc-----
Q 005649 451 LDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS----- 525 (686)
Q Consensus 451 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~----- 525 (686)
|.+++..... ..+++.....++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999975432 34889999999999999999999987 99999999999999999999999999875532211
Q ss_pred cccccccccCCCcCchhhhhcC--CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHH-----------Hh
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRG--FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL-----------EE 592 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-----------~~ 592 (686)
........++..|+|||.+... .++.++||||||+++|||++|+.||........ ..+..... ..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhh
Confidence 1112234567889999998763 588999999999999999999999975433221 11111000 00
Q ss_pred cCcccc----cccccc-----CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 593 EGRLME----LVDVRI-----GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 593 ~~~~~~----~~d~~l-----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
...... ..++.. ..........+.+++.+||+.||++|||++++++.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 000000 000000 122345567889999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=284.84 Aligned_cols=262 Identities=24% Similarity=0.315 Sum_probs=198.9
Q ss_pred CcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcC-CCCcccEEEEEEecCceEEEEeec
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
|++.+.||+|++|.||+|+.. +++.++||++..... .......+|+..+.+++ |+|++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999986 578899999865432 22334567899999998 999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
+|+|.+++.... ...+++..++.++.|++++|.|||+++ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 889998886543 245899999999999999999999987 99999999999999999999999999986543221
Q ss_pred ccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHH----------HHHHHHhcCc
Q 005649 527 HRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLK----------LARRLEEEGR 595 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~----------~~~~~~~~~~ 595 (686)
.....++..|+|||.+.+ ..++.++|+||||++++||++|+.||......+...... |.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 223457889999998754 568999999999999999999999997654433221111 0000100111
Q ss_pred cccccccc----cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 596 LMELVDVR----IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 596 ~~~~~d~~----l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
+...+... +..........+.+++.+||+.+|++|||+.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 11111000 111111225679999999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=310.15 Aligned_cols=268 Identities=22% Similarity=0.314 Sum_probs=189.0
Q ss_pred hCCCcccccccccCcEEEEEEEecC--CCEEEEEE--------------ecc---cCcccHHHHHHHHHHHHhcCCCCcc
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQD--GREIAVKK--------------LAT---NSMQGKEEFENEVRVLLKMQHRNLV 427 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vavK~--------------l~~---~~~~~~~~~~~e~~~l~~l~h~niv 427 (686)
.++|++.+.||+|+||.||++..+. +...++|. +.+ ........+.+|+.++.+++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4789999999999999999987642 22222221 100 1112245688999999999999999
Q ss_pred cEEEEEEecCceEEEEeecCCCChhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC
Q 005649 428 QLFGCCVQERERILVYEYLPNKSLDKFLFDKSK--SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH 505 (686)
Q Consensus 428 ~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 505 (686)
++++++.+.+..++++|++. ++|.+++..... ...........++.||+.||.|||+++ |+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 99999999999999999984 577777754321 122345667789999999999999987 999999999999999
Q ss_pred CCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCC-CCcccchHhHHHHH
Q 005649 506 QMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRK-NYDRQLEAENQELL 584 (686)
Q Consensus 506 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~-p~~~~~~~~~~~~~ 584 (686)
++.+||+|||+++.+...... ......|+..|+|||++.+..++.++|||||||++|||++|+. |+..........+.
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999999876543221 1223578999999999999999999999999999999999875 44332222222222
Q ss_pred HHHHHHH--hcC------cccccccc-ccC----CCC-----HHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 585 KLARRLE--EEG------RLMELVDV-RIG----TYP-----EEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 585 ~~~~~~~--~~~------~~~~~~d~-~l~----~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
....... .++ .+.+.++. .+. ..+ .....++.+++.+||+.||.+|||+.|+++.
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111100 000 00000000 000 000 0123456788999999999999999999875
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=296.25 Aligned_cols=264 Identities=20% Similarity=0.301 Sum_probs=204.5
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecC-----ceE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER-----ERI 440 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 440 (686)
+|++.+.||+|++|.||+++.. +++.+++|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999976 58999999987643 334567899999999999999999999998765 789
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+++||++ ++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 5888888543 36999999999999999999999987 999999999999999999999999999876
Q ss_pred CCcCc-cccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHh------
Q 005649 521 HDEQS-RHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEE------ 592 (686)
Q Consensus 521 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~------ 592 (686)
..... ........++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 54321 0112334678899999999887 899999999999999999999999986654433222111100000
Q ss_pred --cCccccccc-------cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 593 --EGRLMELVD-------VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 593 --~~~~~~~~d-------~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.....+.+. ..+.......+..+.+++.+||+.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000000 00001112246678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=296.04 Aligned_cols=264 Identities=22% Similarity=0.322 Sum_probs=196.7
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecC------
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER------ 437 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 437 (686)
.++|...+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999965 68999999986532 223456889999999999999999999987543
Q ss_pred ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCc
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 517 (686)
..++|+||+.. +|..++ ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 45899999964 676654 124899999999999999999999987 999999999999999999999999998
Q ss_pred cccCCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH--------
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR-------- 588 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~-------- 588 (686)
+..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+....
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 764321 123456888999999876 468999999999999999999999998654322211111100
Q ss_pred HHHhcCccccccc-------cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH--hcCCC
Q 005649 589 RLEEEGRLMELVD-------VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM--LSNSS 644 (686)
Q Consensus 589 ~~~~~~~~~~~~d-------~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~ 644 (686)
...........++ ..+..........+.+++.+||+.||++||++.+++.. ++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000000000000 00000001234568899999999999999999999854 55443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=293.98 Aligned_cols=268 Identities=22% Similarity=0.299 Sum_probs=201.1
Q ss_pred HHHHHHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEec
Q 005649 360 LDVLIAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE 436 (686)
Q Consensus 360 ~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 436 (686)
..++...+++|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++.+++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3455667899999999999999999999864 78899999996532 22346788899999999999999999988643
Q ss_pred ------CceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeE
Q 005649 437 ------RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPK 510 (686)
Q Consensus 437 ------~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 510 (686)
...+++++++ +++|.+++.. ..+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3467888876 7899887743 34899999999999999999999987 99999999999999999999
Q ss_pred EEecCCccccCCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHH
Q 005649 511 ISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARR 589 (686)
Q Consensus 511 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 589 (686)
|+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.....
T Consensus 161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999998864322 223467889999998876 5688999999999999999999999975443322211111000
Q ss_pred HHhcCccccc-----------ccc----ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 590 LEEEGRLMEL-----------VDV----RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 590 ~~~~~~~~~~-----------~d~----~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
.........+ ++. ............+.+++.+|++.+|++||++.++++.-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0000000000 000 00000011345688999999999999999999998765
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=288.58 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=195.8
Q ss_pred hCCCcccccccccCcEEEEEEEecC-CCEEEEEEecccCc-ccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSM-QGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 443 (686)
.++|+..+.||+|++|.||+++.++ ++.++||++..... .....+..|+.++.+. .|+||+++++++.++...+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3678889999999999999999874 89999999975432 2345667777777666 4999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||++ ++|.+++.... ..+++..+..++.|+++||.|||+.. +|+||||+|+||++++++.+||+|||++..+...
T Consensus 94 e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9985 57777664422 36899999999999999999999742 3999999999999999999999999998765433
Q ss_pred CccccccccccCCCcCchhhhhcCC----CChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGF----LSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... .... .......
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~---~~~~~~~---- 236 (296)
T cd06618 169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--EVLT---KILQEEP---- 236 (296)
T ss_pred Ccc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH--HHHH---HHhcCCC----
Confidence 221 2235778999999987553 7899999999999999999999997432211 1111 1111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
+.+. .....+..+.+++.+||+.+|++||++.++++..
T Consensus 237 --~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 237 --PSLP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred --CCCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0010 0112456789999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=285.83 Aligned_cols=261 Identities=25% Similarity=0.347 Sum_probs=200.8
Q ss_pred CcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
|+..+.||+|++|.||+|+.. +++.+++|++.... ....+.+..|+.++++++|+|++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999976 58999999997653 333467889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
+ ++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 7 58999996542 35999999999999999999999987 99999999999999999999999999886643321
Q ss_pred ccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccc---c--c
Q 005649 527 HRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME---L--V 600 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~--~ 600 (686)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+....+........+..+.. + .
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12223456789999998776 889999999999999999999999976544322211110000000000000 0 0
Q ss_pred ccccC--------CCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 601 DVRIG--------TYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 601 d~~l~--------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
+.... .........+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 10110 001123567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=298.19 Aligned_cols=254 Identities=25% Similarity=0.373 Sum_probs=209.3
Q ss_pred hCCCcccccccccCcEEEEEEEecC-CCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.+-|+++..||.|+||.||+++.++ +-..|.|++........++|+-|+++|+..+||+||+|++.+..++.++++.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 3556777889999999999999874 344577888877888889999999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
|.||-.+..+..-. ..|++.++..++.|++.||.|||++. |+|||||..|||+..+|.++|+|||.+-... ..
T Consensus 111 C~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--ST 183 (1187)
T ss_pred cCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hH
Confidence 99999999886643 45999999999999999999999987 9999999999999999999999999975432 22
Q ss_pred cccccccccCCCcCchhhhh-----cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAI-----RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
....+...||+.|||||+.+ ..+|+.++||||||++|.||..+.+|....+.... ++. +...++
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV--llK----iaKSeP----- 252 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLK----IAKSEP----- 252 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH--HHH----HhhcCC-----
Confidence 23445678999999999864 46899999999999999999999999874433221 111 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
|-| ..|...+..+.+++.+||.+||..||++.++++.-
T Consensus 253 -PTL-lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 253 -PTL-LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred -Ccc-cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 111 12567788899999999999999999999998754
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.73 Aligned_cols=246 Identities=24% Similarity=0.406 Sum_probs=193.8
Q ss_pred cccccccccCcEEEEEEEec-CCCEEEEEEecc----cCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCc--eEEEE
Q 005649 371 STKNMLGRGGFGTVYKGRLQ-DGREIAVKKLAT----NSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERE--RILVY 443 (686)
Q Consensus 371 ~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~ 443 (686)
+...+||+|.|-+||+|.+. +|-.||=-.++. .+....++|..|+.+|+.|+||||++++..+.+... .-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45678999999999999875 466664322221 123345889999999999999999999999988655 67999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCCeEEEecCCccccCC
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH-QMKPKISDFGLAKLFHD 522 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~ 522 (686)
|.+..|+|..|+...++ ++.+.+..|++||++||.|||++. |||+|||||-+||||+. -|.|||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999976544 889999999999999999999987 89999999999999975 57899999999998754
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
... ....|||.|||||... ..|.+..||||||+.++||+|+..||..- .+..+..++... |. ...
T Consensus 199 s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-----~n~AQIYKKV~S-Gi----KP~ 263 (632)
T KOG0584|consen 199 SHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-----TNPAQIYKKVTS-GI----KPA 263 (632)
T ss_pred ccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-----CCHHHHHHHHHc-CC----CHH
Confidence 432 2378999999999776 78999999999999999999999999632 222222222222 11 111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+. .-....+.++|.+|+.. .++|||+.|+|+-
T Consensus 264 sl~---kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 264 ALS---KVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred Hhh---ccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 111 11134578999999998 9999999999864
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=285.09 Aligned_cols=252 Identities=27% Similarity=0.375 Sum_probs=198.4
Q ss_pred CCcccccccccCcEEEEEEEe----cCCCEEEEEEecccCc----ccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCce
Q 005649 369 NFSTKNMLGRGGFGTVYKGRL----QDGREIAVKKLATNSM----QGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERER 439 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 439 (686)
+|+..+.||+|+||.||+++. .+|+.||+|++..... ...+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 3688999999865322 2346788999999999 699999999999998899
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++|+||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||+|+|||+++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999998643 34889999999999999999999987 99999999999999999999999999986
Q ss_pred cCCcCccccccccccCCCcCchhhhhcC--CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 520 FHDEQSRHRTHQIAGTFGYMAPEYAIRG--FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 520 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
....... ......|+..|+|||.+... .++.++||||||+++|+|++|+.||......... ...........
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~--- 228 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSE--- 228 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--HHHHHHhhccC---
Confidence 5432211 12234678899999998753 4688999999999999999999999643221111 11111111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 005649 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRP-----TMSATLSM 639 (686)
Q Consensus 598 ~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 639 (686)
..++......+.+++.+||+.+|++|| +..+++..
T Consensus 229 -------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 -------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 112334566788999999999999997 67777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=297.58 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=209.0
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ--GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
...|.+...||+|.|+.|.+++.. .+..||||.+.+.... ....+.+|+++|+.++|||||+++.+.+.+..+++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 467888999999999999999976 7999999999765333 3356899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+.+|.+.+++..... ..+.....++.|+.++++|||+++ |||||||++||||+.+.++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence 99999999999976543 666888899999999999999998 999999999999999999999999999987633
Q ss_pred CccccccccccCCCcCchhhhhcCCC-ChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFL-SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
. ..+..+|++.|.|||++.+.++ .++.|+||+|++||-|+.|..||++..-.+....+-... +
T Consensus 209 ~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk-------~------ 272 (596)
T KOG0586|consen 209 L---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK-------Y------ 272 (596)
T ss_pred c---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee-------e------
Confidence 2 3455789999999999988754 678999999999999999999999665444322111100 0
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
..+.-...++.+++.+++..+|.+|++++++.+--
T Consensus 273 ---rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 273 ---RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred ---cccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 12444567788999999999999999999997643
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=282.86 Aligned_cols=249 Identities=25% Similarity=0.351 Sum_probs=197.0
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-----cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-----MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
+|.+.+.||+|+||.||+++.. .+..+++|.++... .....++..|+.++++++||||+++++++.+.+..+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999875 34455566554321 22334577899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 443 YEYLPNKSLDKFLFDK-SKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
+||+++++|.+++... .....+++..++.++.|+++||.|||+.+ ++|+||+|+||++++ +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988653 23456999999999999999999999987 999999999999976 569999999987664
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+.. ..... +.
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~------~~~~~-~~------ 221 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV------LRIVE-GP------ 221 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH------HHHHc-CC------
Confidence 3322 122346788999999998888999999999999999999999999643322211 11111 10
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
....+...+..+.+++.+||+.+|++||++.|+++
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 --TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11224456778899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=283.39 Aligned_cols=243 Identities=24% Similarity=0.361 Sum_probs=189.7
Q ss_pred cccccCcEEEEEEEec-CCCEEEEEEecccCcc---cHHHHHHHHH---HHHhcCCCCcccEEEEEEecCceEEEEeecC
Q 005649 375 MLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ---GKEEFENEVR---VLLKMQHRNLVQLFGCCVQERERILVYEYLP 447 (686)
Q Consensus 375 ~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 447 (686)
.||+|+||.||+++.. +++.||+|.+...... ....+..|.. .+...+||||+++.+++.+.+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999865 6889999998654322 1222344433 3444579999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc
Q 005649 448 NKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH 527 (686)
Q Consensus 448 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 527 (686)
+|+|..++.. ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 9999988854 345999999999999999999999987 9999999999999999999999999987654322
Q ss_pred cccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCC
Q 005649 528 RTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 606 (686)
.....|+..|+|||.+.++ .++.++|+||+|+++|||++|+.||........... . ...... +. .
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~---~~~~~~------~~---~ 217 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-D---RMTLTM------AV---E 217 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-H---HHhhcc------CC---C
Confidence 1234688999999998754 689999999999999999999999975432221111 1 010000 01 1
Q ss_pred CCHHHHHHHHHHHHHcccccccCCC-----CHHHHHHHh
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRP-----TMSATLSML 640 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~L 640 (686)
.+...+..+.+++.+|++.+|++|| ++.++++.-
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 2334467899999999999999999 999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=286.65 Aligned_cols=244 Identities=28% Similarity=0.407 Sum_probs=194.2
Q ss_pred CcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
|...+.||+|+||.||+|+.. +++.+++|++..... ...+.+.+|++++++++|||++++++++.++...++|+||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999875 688999999865432 2235688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+. |+|.+++... ...+++..++.++.||+.+|.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 95 6777777543 245899999999999999999999987 99999999999999999999999999864322
Q ss_pred cccccccccCCCcCchhhhh---cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAI---RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
.....|+..|+|||.+. ...++.++||||||+++|||++|..||........... ...... +
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~------~~~~~~------~ 238 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------IAQNDS------P 238 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH------HHhcCC------C
Confidence 12346788999999874 46788999999999999999999999875433222111 111110 0
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.. .....+..+.+++.+||+.+|++||++.++++.
T Consensus 239 ~~--~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 TL--QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 112334568899999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=289.92 Aligned_cols=261 Identities=22% Similarity=0.310 Sum_probs=197.6
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecC-----
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER----- 437 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 437 (686)
..++|+..+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999865 78999999985432 223456889999999999999999999987653
Q ss_pred -ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCC
Q 005649 438 -ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGL 516 (686)
Q Consensus 438 -~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 516 (686)
..++|+||+ +++|.+++.. ..+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 358999998 7789888743 35899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHH-HHH-------
Q 005649 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELL-KLA------- 587 (686)
Q Consensus 517 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~-~~~------- 587 (686)
+...... .....++..|++||.+.+ ..++.++|+||||+++|+|++|+.||...........+ ...
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 165 ARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred ccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 8865332 123456889999998876 46899999999999999999999999755432211110 000
Q ss_pred HHHHhcCcccc-------ccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 588 RRLEEEGRLME-------LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 588 ~~~~~~~~~~~-------~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
........... .....+..........+.+++.+|++.||++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 00000001112345568899999999999999999999843
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=299.50 Aligned_cols=257 Identities=27% Similarity=0.375 Sum_probs=199.4
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCCcccEEEEEEec------CceE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE------RERI 440 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~ 440 (686)
.+...+.||+|+||.||+|+.+ .|+.||||.+... .....+...+|+++|++++|+|||++++.-.+. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3455678999999999999955 7999999999764 344567889999999999999999999987654 3678
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE--cCCC--CeEEEecCC
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL--DHQM--KPKISDFGL 516 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~Dfgl 516 (686)
++||||.+|+|...|....+...|++.+.+.++.++..||.|||+++ |+||||||.||++ ..+| ..||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999998888888999999999999999999999987 9999999999998 3334 479999999
Q ss_pred ccccCCcCccccccccccCCCcCchhhhh-cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCc
Q 005649 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAI-RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGR 595 (686)
Q Consensus 517 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 595 (686)
|+.+.+.. ......||..|++||... .+.|+...|.|||||++|+.+||..||...........+.|.....+...
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99887654 456689999999999988 48999999999999999999999999975544321111222211111111
Q ss_pred ccccccccc-------------CCCCHHHHHHHHHHHHHcccccccCCC
Q 005649 596 LMELVDVRI-------------GTYPEEIALRFMQIALLCTEDFIEDRP 631 (686)
Q Consensus 596 ~~~~~d~~l-------------~~~~~~~~~~l~~li~~cl~~~p~~RP 631 (686)
.--..++.. .........++-..+..++..+|++|-
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 111111110 122334555666777777888888887
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=290.60 Aligned_cols=264 Identities=19% Similarity=0.258 Sum_probs=193.7
Q ss_pred CCcccccccccCcEEEEEEEec-C--CCEEEEEEecccC--cccHHHHHHHHHHHHhc-CCCCcccEEEEEEec----Cc
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-D--GREIAVKKLATNS--MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQE----RE 438 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~--g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~ 438 (686)
+|+..+.||+|+||.||+++.. . +..+|+|++.... ....+.+.+|+.++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999976 3 7789999986432 22346788999999999 599999999976533 35
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.++++||++ ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678889885 688888853 345899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCcCcc--ccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH-------
Q 005649 519 LFHDEQSR--HRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR------- 588 (686)
Q Consensus 519 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~------- 588 (686)
........ .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......+....+....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 66432211 11233568899999998766 468999999999999999999999997654322111100000
Q ss_pred -HHHhcCccccc---c----ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 589 -RLEEEGRLMEL---V----DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 589 -~~~~~~~~~~~---~----d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
........... . ...+..........+.+++.+|++.+|++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000 0 000000011235678899999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=290.87 Aligned_cols=264 Identities=22% Similarity=0.320 Sum_probs=199.8
Q ss_pred HHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEe-cCce
Q 005649 364 IAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ-ERER 439 (686)
Q Consensus 364 ~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 439 (686)
...+++|+..+.||+|+||.||+++.. +++.+++|++.... ....+.+.+|++++.+++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346789999999999999999999865 78999999886432 2234678899999999999999999999876 5578
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++++||+ +++|.+++.. ..+++.....++.|+++||.|||+.+ |+||||+|+||++++++.+||+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999998 5688888743 34788888999999999999999987 99999999999999999999999999875
Q ss_pred cCCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHH--------HHH
Q 005649 520 FHDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLA--------RRL 590 (686)
Q Consensus 520 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~ 590 (686)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+... ...
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 4321 122356788999998766 57899999999999999999999999755432221111100 000
Q ss_pred HhcCcccccccc-ccC-CCC-----HHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 591 EEEGRLMELVDV-RIG-TYP-----EEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 591 ~~~~~~~~~~d~-~l~-~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
...+...+.+.. ... ..+ ...+..+.+++.+|++.+|++||++.+++..=
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 000000000000 000 111 12357789999999999999999999997763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=270.88 Aligned_cols=286 Identities=22% Similarity=0.317 Sum_probs=210.0
Q ss_pred hCCCcccccccccCcEEEEEEEecC-----CCEEEEEEecccCcc-c-HHHHHHHHHHHHhcCCCCcccEEEEEEe-cCc
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQD-----GREIAVKKLATNSMQ-G-KEEFENEVRVLLKMQHRNLVQLFGCCVQ-ERE 438 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~~~-~-~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 438 (686)
-..|+....||+|.||.||++.-.+ .+.+|||+++..... + -....+|+.+++.++|||++.+..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3568888999999999999996432 236899999765322 1 2456789999999999999999999987 778
Q ss_pred eEEEEeecCCCChhHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC----CCeEEE
Q 005649 439 RILVYEYLPNKSLDKFLFDK--SKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ----MKPKIS 512 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~ 512 (686)
.+|++||.+. +|...++.+ .+...++...+..|++||+.|+.|||++- |+||||||.||||..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 8999999977 666666543 33457899999999999999999999986 9999999999999877 899999
Q ss_pred ecCCccccCCcCccc-cccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHH----HHHH
Q 005649 513 DFGLAKLFHDEQSRH-RTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQE----LLKL 586 (686)
Q Consensus 513 Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~----~~~~ 586 (686)
|+|++|.+.+.-..- ..+...-|..|+|||.+.+. .|+.+.|||++|||..||+|-++-|.+..++.... .-+.
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999887643322 34557789999999999875 69999999999999999999988886544321111 1111
Q ss_pred HHHHHhcCccccccccccCCCC---------------H-----------HHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 587 ARRLEEEGRLMELVDVRIGTYP---------------E-----------EIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 587 ~~~~~~~~~~~~~~d~~l~~~~---------------~-----------~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
.+.+.--|...+..=|.+..+| . .-+....+|+.++|+.||-+|.|..+.++..
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 1111111111100001111000 0 0122367899999999999999999999877
Q ss_pred cCCCCCCCCCCCCCCC
Q 005649 641 SNSSVPIPSVTESPDH 656 (686)
Q Consensus 641 ~~~~~~~~~~p~~p~~ 656 (686)
=....++|+.|.+.-+
T Consensus 339 yF~~d~lpp~pt~~~v 354 (438)
T KOG0666|consen 339 YFTEDPLPPLPTSDNV 354 (438)
T ss_pred ccccCCCCCCccccee
Confidence 6666667665555444
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.25 Aligned_cols=261 Identities=23% Similarity=0.303 Sum_probs=198.3
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCc----
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERE---- 438 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 438 (686)
..++|+..+.||+|++|.||+|+.. +++.+++|++.... ....+.+.+|+.++++++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3678999999999999999999986 67899999986532 2234567889999999999999999988766554
Q ss_pred --eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCC
Q 005649 439 --RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGL 516 (686)
Q Consensus 439 --~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 516 (686)
.++|+||+ +++|.+++.. ..+++..++.++.|+++||.|||+.+ |+||||+|+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 6799888853 35899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHH-----H
Q 005649 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARR-----L 590 (686)
Q Consensus 517 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~-----~ 590 (686)
+...... .....++..|+|||.+.+ ..++.++||||||+++||+++|+.||......+....+..... .
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 9865432 223357888999998865 4688999999999999999999999975443222111100000 0
Q ss_pred ---HhcCccccccc-------cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 591 ---EEEGRLMELVD-------VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 591 ---~~~~~~~~~~d-------~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.........+. +.+.......+..+.+++.+|++.+|++|||+.+|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000000 00000011236779999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=276.32 Aligned_cols=236 Identities=29% Similarity=0.365 Sum_probs=194.7
Q ss_pred ccccCcEEEEEEEec-CCCEEEEEEecccCcc---cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCCh
Q 005649 376 LGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ---GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSL 451 (686)
Q Consensus 376 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL 451 (686)
||+|+||.||++... +++.+++|.+...... ....+.+|+.++++++|+||+++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999976 5889999998665332 346789999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccc
Q 005649 452 DKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQ 531 (686)
Q Consensus 452 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 531 (686)
.+++... ..+++..++.++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 9999643 24899999999999999999999987 9999999999999999999999999988664332 12234
Q ss_pred cccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHH
Q 005649 532 IAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEI 611 (686)
Q Consensus 532 ~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 611 (686)
..++..|++||...+...+.++|+||||+++||+++|+.||......+.. .. ... +.. ..+...
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~---~~---~~~-~~~---------~~~~~~ 216 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY---EK---ILK-DPL---------RFPEFL 216 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH---HH---Hhc-CCC---------CCCCCC
Confidence 56788999999998888999999999999999999999999755432211 11 111 100 123334
Q ss_pred HHHHHHHHHHcccccccCCCCHHH
Q 005649 612 ALRFMQIALLCTEDFIEDRPTMSA 635 (686)
Q Consensus 612 ~~~l~~li~~cl~~~p~~RPt~~e 635 (686)
+..+.+++.+||..||++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 677889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=266.06 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=198.4
Q ss_pred CcccccccccCcEEEEEEEec-CCCEEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEEeec
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN-SMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
.+.+..||.|.-|.||+.+.+ .|..+|||.+... +..+.+++...+.++.+- ++|.||+-+|+|..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 345568999999999999976 5889999999654 445567788888877766 4899999999999999999999998
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
...++..+... .+++++.-+-++...+.+||.||.++. .|+|||+||+|||+|+.|++||+|||.+-.+.++..
T Consensus 174 -s~C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA- 247 (391)
T KOG0983|consen 174 -STCAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA- 247 (391)
T ss_pred -HHHHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc-
Confidence 44566666432 345888888899999999999999876 499999999999999999999999999987765443
Q ss_pred ccccccccCCCcCchhhhhc---CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 527 HRTHQIAGTFGYMAPEYAIR---GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
.....|-+.|||||.+.- .+|+.++||||||++|+||.||+.||..-..+- +.+. +..+++ .|.
T Consensus 248 --htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~lt---kvln~e------PP~ 314 (391)
T KOG0983|consen 248 --HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EVLT---KVLNEE------PPL 314 (391)
T ss_pred --cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HHHH---HHHhcC------CCC
Confidence 334578899999999864 479999999999999999999999998643321 1111 111111 133
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
|.. ....+..+.+++..||++|+.+||.+.++++.
T Consensus 315 L~~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 315 LPG-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCc-ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 321 22367889999999999999999999999874
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=272.98 Aligned_cols=241 Identities=26% Similarity=0.314 Sum_probs=204.5
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHH---HHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEE---FENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~---~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
-++|+..++||+|.||.|.+++-+ .|+.+|+|++++.....+++ -..|-++|+.-+||.+..+...+...+..++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 368999999999999999999976 78999999998875554443 45688899999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||..+|.|..+|... ..+++.....+-..|..||.|||+++ ||.||||.+|.|+|.+|++||.|||+++.-..
T Consensus 247 MeyanGGeLf~HLsre---r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE---RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhhh---hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999999888543 44888888888999999999999987 99999999999999999999999999985322
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
. .......+||+.|+|||++....|....|.|.+||++|||++|+.||...+.+....++-....
T Consensus 321 ~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~------------- 385 (516)
T KOG0690|consen 321 Y--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL------------- 385 (516)
T ss_pred c--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc-------------
Confidence 1 1234567999999999999999999999999999999999999999987766655554443221
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCC
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRP 631 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RP 631 (686)
.+|...+.+...|+...+.+||.+|.
T Consensus 386 ---kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 ---KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ---cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 23566677788899999999999995
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=307.26 Aligned_cols=145 Identities=32% Similarity=0.468 Sum_probs=130.8
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|.+.++||+|+||.||+|+.. +++.||||++..... .....+..|+.++..++|+||+++++.+......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67899999999999999999986 689999999965432 22467889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
||+++++|.+++... ..+++..++.++.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998643 34889999999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=309.06 Aligned_cols=253 Identities=28% Similarity=0.441 Sum_probs=188.8
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEe---------
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ--------- 435 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------- 435 (686)
..+|+..++||+||||.|||++.+ ||+.+|||++.... ........+|+..+++|+|||+|+++..+.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 468899999999999999999988 99999999997653 3334568899999999999999998742210
Q ss_pred --------------------------------------------------------------------------------
Q 005649 436 -------------------------------------------------------------------------------- 435 (686)
Q Consensus 436 -------------------------------------------------------------------------------- 435 (686)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ----------------------c--------CceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 005649 436 ----------------------E--------RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485 (686)
Q Consensus 436 ----------------------~--------~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~ 485 (686)
+ ...||=||||+...|++++..+.-.. .....|+++.+|++||.|+|+
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh
Confidence 0 01357788898888887775432211 466789999999999999999
Q ss_pred CCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC--------------C--cCccccccccccCCCcCchhhhhcC--
Q 005649 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH--------------D--EQSRHRTHQIAGTFGYMAPEYAIRG-- 547 (686)
Q Consensus 486 ~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~--------------~--~~~~~~~~~~~gt~~y~aPE~~~~~-- 547 (686)
++ |+||||||.||++|++..|||+|||++.... . .......+...||.-|+|||.+.+.
T Consensus 716 ~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 QG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred Cc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 98 9999999999999999999999999998721 0 0111123456899999999998764
Q ss_pred -CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHccccc
Q 005649 548 -FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDF 626 (686)
Q Consensus 548 -~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~ 626 (686)
+|+.|+|+||+|+|++||+. ||....+ -...+...+ .+.+..- ..+..+....-..+|++++++|
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra~iL~~LR----~g~iP~~-----~~f~~~~~~~e~slI~~Ll~hd 858 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSME--RASILTNLR----KGSIPEP-----ADFFDPEHPEEASLIRWLLSHD 858 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHH--HHHHHHhcc----cCCCCCC-----cccccccchHHHHHHHHHhcCC
Confidence 59999999999999999995 5553222 111122111 2221111 1123334445568999999999
Q ss_pred ccCCCCHHHHHH
Q 005649 627 IEDRPTMSATLS 638 (686)
Q Consensus 627 p~~RPt~~evl~ 638 (686)
|.+|||+.|+++
T Consensus 859 P~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 859 PSKRPTATELLN 870 (1351)
T ss_pred CccCCCHHHHhh
Confidence 999999999985
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-33 Score=318.31 Aligned_cols=253 Identities=28% Similarity=0.366 Sum_probs=203.4
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ--GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
-++....+||.|.||.||.+... +|...|+|.++..... ..+...+|+.++..++|||+|+++|+-.+.+..+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 35677789999999999999854 6888899988654333 34567899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
||++|+|.+.+...+ ..++.....+..|++.|+.|||++| ||||||||.||+|+.+|.+|++|||.|..+....
T Consensus 1315 yC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 999999999985432 2566666678899999999999998 9999999999999999999999999999876542
Q ss_pred --ccccccccccCCCcCchhhhhcCC---CChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 525 --SRHRTHQIAGTFGYMAPEYAIRGF---LSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 525 --~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
.....+...||+.|||||.+.+.+ -..+.||||+|||+.||+||++||...+.+=. +.+ .. ..|.
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a---IMy--~V-~~gh---- 1458 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA---IMY--HV-AAGH---- 1458 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH---HHh--HH-hccC----
Confidence 122344578999999999997643 45689999999999999999999974432110 000 00 0111
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
....|+..+..=.+++..|++.||..|.++.|+++.=
T Consensus 1459 ----~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1459 ----KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred ----CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 1234667788888999999999999999988887653
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-33 Score=268.87 Aligned_cols=260 Identities=23% Similarity=0.342 Sum_probs=203.8
Q ss_pred CHHHHHHhhCCCcccccccccCcEEEEEEE-ecCCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEec
Q 005649 359 NLDVLIAATDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQE 436 (686)
Q Consensus 359 ~~~~l~~at~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 436 (686)
+++++.+-| .++||+|+|+.|-.+. +.+|.++|||++.+.......+..+|++++.+. .|+||++++.+|+++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 455555555 4689999999999887 568999999999887666778899999999998 699999999999999
Q ss_pred CceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC---eEEEe
Q 005649 437 RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK---PKISD 513 (686)
Q Consensus 437 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~D 513 (686)
...|||||-|.+|+|..++.++ ..+++.+.-.++++|+.||.|||.++ |.||||||+|||-.+... +||+|
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR---KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeec
Confidence 9999999999999999999653 45999999999999999999999998 999999999999965543 79999
Q ss_pred cCCccccCC--c---CccccccccccCCCcCchhhhh-----cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHH--
Q 005649 514 FGLAKLFHD--E---QSRHRTHQIAGTFGYMAPEYAI-----RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQ-- 581 (686)
Q Consensus 514 fgla~~~~~--~---~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~-- 581 (686)
|.+..-... + ..........|...|||||+.. ...|+.++|.||||||||-|++|-+||.+.-.++..
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 998754321 1 1111223467888999999763 246899999999999999999999999765432211
Q ss_pred ------HHHHHHHHHHhcCccccccccccCCCCH----HHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 582 ------ELLKLARRLEEEGRLMELVDVRIGTYPE----EIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 582 ------~~~~~~~~~~~~~~~~~~~d~~l~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
.-.+....-.++|.. ++|+ .++....+++...+..++.+|-++.++++
T Consensus 303 rGe~Cr~CQ~~LFesIQEGkY---------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEGKY---------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCCccHHHHHHHHHHHhccCC---------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 001111111223322 2232 45677888999999999999999999887
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-33 Score=267.80 Aligned_cols=255 Identities=26% Similarity=0.363 Sum_probs=197.4
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEEe
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 444 (686)
++.+....||.|.||+|+|-..+ .|+..|||++..... .+.+++..|.+...+- ++||||+++|.+..++..++.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 34445678999999999999876 799999999976654 5667888888865554 79999999999999999999999
Q ss_pred ecCCCChhHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 445 YLPNKSLDKFLFD--KSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 445 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
.| ..||+.+... ..+...+++.-+-.|......||.||.++- +|+|||+||+|||||..|.+||+|||.+-.+.+
T Consensus 144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 99 5566554422 123345888888889889999999999864 699999999999999999999999999887654
Q ss_pred cCccccccccccCCCcCchhhhhcC--CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRG--FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
+-. .+.-.|-..|||||.+... .|+.+|||||||++|+|+.||+.||..... . .+..........
T Consensus 221 SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--v---feql~~Vv~gdp----- 287 (361)
T KOG1006|consen 221 SIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--V---FEQLCQVVIGDP----- 287 (361)
T ss_pred HHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--H---HHHHHHHHcCCC-----
Confidence 322 2334677889999988653 489999999999999999999999986543 1 111222211111
Q ss_pred ccccC--CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 601 DVRIG--TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 601 d~~l~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
|.|. ....+....+..++..|+.+|..+||.+.++.++
T Consensus 288 -p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 288 -PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1111 1112467789999999999999999999998764
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=281.68 Aligned_cols=244 Identities=25% Similarity=0.389 Sum_probs=199.8
Q ss_pred cccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCC
Q 005649 373 KNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNK 449 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~g 449 (686)
.+.||+|.||+||-|+.+ +|+.||||++.+.. .....++.+|+.+|.+++||.||.+...|+..+..+.|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 478999999999999865 89999999996543 334467899999999999999999999999999999999999 56
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC---CCeEEEecCCccccCCcCcc
Q 005649 450 SLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ---MKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 450 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~~~~~~~ 526 (686)
+..+.+.... .+.|++..-..++.||+.||.|||.++ |+|+||||+|||+.+. .++||+|||+||++......
T Consensus 648 DMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 648 DMLEMILSSE-KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 6666554433 345898888899999999999999987 9999999999999654 36999999999998765543
Q ss_pred ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCC
Q 005649 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 606 (686)
....||+.|+|||++.++.|...-|+||.|||+|--++|..||... ++..+.++.+.-+.+..+|.
T Consensus 724 ---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~--------- 789 (888)
T KOG4236|consen 724 ---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWS--------- 789 (888)
T ss_pred ---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchh---------
Confidence 3468999999999999999999999999999999999999999732 33344444444444444443
Q ss_pred CCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
+.+...+++|...||..-++|-+..+-+.
T Consensus 790 ---eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 790 ---EISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred ---hcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 34566778888889888888888776543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=303.44 Aligned_cols=269 Identities=22% Similarity=0.260 Sum_probs=217.2
Q ss_pred ccCHHHHHHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEE
Q 005649 357 LFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGC 432 (686)
Q Consensus 357 ~~~~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~ 432 (686)
+....++.-..++|+++++||+|+||.|..++.+ .++.+|.|++.+.. .....-|..|-.+|..-+.+=|++++..
T Consensus 64 v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA 143 (1317)
T KOG0612|consen 64 VKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA 143 (1317)
T ss_pred HHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH
Confidence 3445556667899999999999999999999986 57889999997642 3344568889999998899999999999
Q ss_pred EEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEE
Q 005649 433 CVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKIS 512 (686)
Q Consensus 433 ~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 512 (686)
|.++..+|+|||||+||+|...+.... .+++.....++..|.-||.-||+-| +|||||||+|||||..|++||+
T Consensus 144 FQD~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLA 217 (1317)
T KOG0612|consen 144 FQDERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLA 217 (1317)
T ss_pred hcCccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeec
Confidence 999999999999999999999995543 5999999999999999999999976 9999999999999999999999
Q ss_pred ecCCccccCCcCccccccccccCCCcCchhhhhc-----CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHH
Q 005649 513 DFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR-----GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLA 587 (686)
Q Consensus 513 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 587 (686)
|||.+-.+..+ ........+|||.|++||++.. +.|.+.+|+||+||++|||+.|..||....-.+....+...
T Consensus 218 DFGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h 296 (1317)
T KOG0612|consen 218 DFGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH 296 (1317)
T ss_pred cchhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch
Confidence 99998776532 3344566799999999999852 67999999999999999999999999865544443322211
Q ss_pred HHHHhcCccccccccccCCCC--HHHHHHHHHHHHHcccccccCCCC---HHHHHHHhcCCCCCC
Q 005649 588 RRLEEEGRLMELVDVRIGTYP--EEIALRFMQIALLCTEDFIEDRPT---MSATLSMLSNSSVPI 647 (686)
Q Consensus 588 ~~~~~~~~~~~~~d~~l~~~~--~~~~~~l~~li~~cl~~~p~~RPt---~~evl~~L~~~~~~~ 647 (686)
... + .+| .+.++...+||.+.+. +|+.|-. +.++-...-....+|
T Consensus 297 k~~-------------l-~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 297 KES-------------L-SFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred hhh-------------c-CCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 111 1 123 3477888899988886 6888877 899887765444444
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=264.13 Aligned_cols=238 Identities=29% Similarity=0.393 Sum_probs=195.2
Q ss_pred CcEEEEEEEec-CCCEEEEEEecccCccc-HHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCChhHHHhh
Q 005649 380 GFGTVYKGRLQ-DGREIAVKKLATNSMQG-KEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFD 457 (686)
Q Consensus 380 ~fG~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~ 457 (686)
+||.||+++.. +|+.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48999999997765554 68899999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCC
Q 005649 458 KSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFG 537 (686)
Q Consensus 458 ~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 537 (686)
... +++..++.++.++++++.+||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 332 899999999999999999999987 9999999999999999999999999998765432 2234567889
Q ss_pred cCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHH
Q 005649 538 YMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQ 617 (686)
Q Consensus 538 y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~ 617 (686)
|++||.+....++.++|||+||+++++|++|..||......+ ....... .+.... .......+..+.+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~~~~----~~~~~~------~~~~~~~~~~~~~ 219 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFKKIG----KPKPPF------PPPEWKISPEAKD 219 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHh----ccCCCC------ccccccCCHHHHH
Confidence 999999998889999999999999999999999997532211 1111111 111000 0000015578899
Q ss_pred HHHHcccccccCCCCHHHHHH
Q 005649 618 IALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 618 li~~cl~~~p~~RPt~~evl~ 638 (686)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=283.90 Aligned_cols=241 Identities=22% Similarity=0.283 Sum_probs=195.4
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 444 (686)
++.|+....+|.|.|+.|-.+... +++..++|++.... .+-.+|+.++... +||||+++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 567888888999999999998865 68889999997652 2234566555555 89999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE-cCCCCeEEEecCCccccCCc
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL-DHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Dfgla~~~~~~ 523 (686)
.+.++-+.+-+..... .. .++..|+.+|+.++.|||+++ +|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999887776643321 33 777789999999999999998 9999999999999 69999999999999876544
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
....+-|..|.|||++....+++++|+||||++||+|++|+.||.....+. ++.. ....+
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~--ei~~----~i~~~--------- 529 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI--EIHT----RIQMP--------- 529 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--HHHH----hhcCC---------
Confidence 223466889999999999999999999999999999999999998655441 1111 11111
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
.+....+....+|+.+||+.||.+||+|.++...=
T Consensus 530 --~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 530 --KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred --ccccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence 12356788899999999999999999999997654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=263.91 Aligned_cols=219 Identities=20% Similarity=0.155 Sum_probs=177.4
Q ss_pred cCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCChhHHHhh
Q 005649 379 GGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFD 457 (686)
Q Consensus 379 G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~ 457 (686)
|.+|.||+++.. +++.+|+|++.... .+..|...+....||||+++++++.+.+..+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999975 78899999996543 234455556666899999999999999999999999999999999865
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCC
Q 005649 458 KSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFG 537 (686)
Q Consensus 458 ~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 537 (686)
. ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++++|||.+....... ....++..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 3 24899999999999999999999987 9999999999999999999999999876554321 12345677
Q ss_pred cCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHH
Q 005649 538 YMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQ 617 (686)
Q Consensus 538 y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~ 617 (686)
|+|||...+..++.++|+||+|+++|||++|+.|+....... .. .... ..+...+..+.+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~-----~~~~---~~~~~~~~~~~~ 207 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT-----HTTL---NIPEWVSEEARS 207 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc-----cccc---CCcccCCHHHHH
Confidence 999999988889999999999999999999998875321100 00 0000 123345677899
Q ss_pred HHHHcccccccCCCCH
Q 005649 618 IALLCTEDFIEDRPTM 633 (686)
Q Consensus 618 li~~cl~~~p~~RPt~ 633 (686)
++.+|++.||++||++
T Consensus 208 li~~~l~~dp~~R~~~ 223 (237)
T cd05576 208 LLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHccCCHHHhcCC
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=268.55 Aligned_cols=242 Identities=27% Similarity=0.352 Sum_probs=201.1
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccH---HHHHHHHHHHHhc-CCCCcccEEEEEEecCceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGK---EEFENEVRVLLKM-QHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~---~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 441 (686)
..+|..+.+||+|.||.|-++..+ ..+.+|||++++.-.... +--+.|-++|+.. +-|.+++++.++..-+.+++
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 357899999999999999999876 466799999987643322 2235677777766 56789999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||+.+|+|--++.+-+ .+.+.....++.+||-||-+||+++ |+.||||.+|||+|.+|.+||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999977775543 3888899999999999999999998 9999999999999999999999999987532
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
-+. ..+...+||+.|+|||++...+|....|.|||||+||||+.|++||++.++++....+....
T Consensus 502 ~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn------------- 566 (683)
T KOG0696|consen 502 FDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN------------- 566 (683)
T ss_pred cCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc-------------
Confidence 111 23445799999999999999999999999999999999999999999888777644332111
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCC
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPT 632 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt 632 (686)
..||...+.+...+....+.+.|.+|..
T Consensus 567 ---vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 567 ---VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ---CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 1467888889999999999999999853
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=236.10 Aligned_cols=263 Identities=22% Similarity=0.333 Sum_probs=202.0
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
+|...++||+|.||+||+|+.. .++.||+|++...+. .-.....+|+-+++.++|+|||+++++...+...-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556689999999999999966 578899999865433 2246678999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+ ..+|..|... -++.++......++.|+++||.|.|+++ +.||||||.|.+|+.+|.+|++|||+++.+.-+.
T Consensus 83 c-dqdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv- 155 (292)
T KOG0662|consen 83 C-DQDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV- 155 (292)
T ss_pred h-hHHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence 9 4577777643 3345899999999999999999999987 9999999999999999999999999999875432
Q ss_pred cccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccc---cc
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLME---LV 600 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 600 (686)
.......-|..|.+|+++.+. -|+...|+||-||++.|+.. |++.|.+.+.++....+-+......+..|.. +-
T Consensus 156 -rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred -EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 123345678999999998875 58999999999999999998 8888887666554444444333333333322 11
Q ss_pred cccc-CCCC---------HHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 601 DVRI-GTYP---------EEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 601 d~~l-~~~~---------~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
|... ..++ +.....=.++++..+.-+|.+|.++++.++.
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111 1111 2223334577888888899999999887753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=279.90 Aligned_cols=262 Identities=21% Similarity=0.233 Sum_probs=184.5
Q ss_pred hCCCcccccccccCcEEEEEEEe-----------------cCCCEEEEEEecccCcccHHHH--------------HHHH
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRL-----------------QDGREIAVKKLATNSMQGKEEF--------------ENEV 415 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~~~--------------~~e~ 415 (686)
.++|++.++||+|+||.||+|.. .+++.||||++........++| ..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 57899999999999999999964 2456899999865443323333 3467
Q ss_pred HHHHhcCCCCc-----ccEEEEEEe--------cCceEEEEeecCCCChhHHHhhcCC---------------------C
Q 005649 416 RVLLKMQHRNL-----VQLFGCCVQ--------ERERILVYEYLPNKSLDKFLFDKSK---------------------S 461 (686)
Q Consensus 416 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~Ey~~~gsL~~~l~~~~~---------------------~ 461 (686)
..+.+++|.++ ++++++|.. ++..+|||||+++++|.++++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777776654 677888753 3568999999999999999975321 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCch
Q 005649 462 AILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP 541 (686)
Q Consensus 462 ~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aP 541 (686)
..++|..+..++.|++++|.|||+.+ |+||||||+|||++.++.+||+|||+++........ ......+++.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence 23577889999999999999999987 999999999999999999999999999765432211 11123347899999
Q ss_pred hhhhcCC----------------------CChhHHHHHHHHHHHHHHcCCC-CCcccchHh--HH--HHHHHHHHHHhcC
Q 005649 542 EYAIRGF----------------------LSVKSDVFSFGVLLLEIISGRK-NYDRQLEAE--NQ--ELLKLARRLEEEG 594 (686)
Q Consensus 542 E~~~~~~----------------------~s~ksDv~s~Gvvl~elltG~~-p~~~~~~~~--~~--~~~~~~~~~~~~~ 594 (686)
|.+.... ...+.||||+||+++||++|.. |+....... .. ......|+.....
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9875432 1234799999999999999875 665322111 00 0011112222211
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHcccccc---cCCCCHHHHHHH
Q 005649 595 RLMELVDVRIGTYPEEIALRFMQIALLCTEDFI---EDRPTMSATLSM 639 (686)
Q Consensus 595 ~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p---~~RPt~~evl~~ 639 (686)
.+ +.. ..........+++.+++..+| .+|+|++|+++.
T Consensus 460 ~~----~~~---~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 KY----DFS---LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CC----Ccc---cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11 111 122346778899999998765 689999999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=252.64 Aligned_cols=273 Identities=21% Similarity=0.322 Sum_probs=205.2
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEec--------
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQE-------- 436 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 436 (686)
+.|+...+||+|.||.||+++.+ .|+.|++|+....+. .-...-.+|+++|..++|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 55677789999999999999976 577788887643222 2234567899999999999999999888542
Q ss_pred CceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCC
Q 005649 437 RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGL 516 (686)
Q Consensus 437 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 516 (686)
...+|||++++. +|.-.|.+. ...++..++.+++.++.+||.|+|... |+|||+|+.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 347899999965 566666432 245899999999999999999999976 99999999999999999999999999
Q ss_pred ccccCCcCc--cccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhc
Q 005649 517 AKLFHDEQS--RHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEE 593 (686)
Q Consensus 517 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 593 (686)
++.+..... ....++..-|..|++||.+.+ ..++++.|||.-||++.||+||.+-+.+..+.....++.....-...
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 987754322 223456677999999998877 57999999999999999999999999887766665555543322222
Q ss_pred Cccccccccc---------cCC--C--CHHH------HHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCC
Q 005649 594 GRLMELVDVR---------IGT--Y--PEEI------ALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVP 646 (686)
Q Consensus 594 ~~~~~~~d~~---------l~~--~--~~~~------~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 646 (686)
+.|.++..-. +.. + -++. .....+++..++..||.+||+..+++..--.-+.+
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 2222211110 110 0 0111 23567899999999999999999998765444433
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=254.57 Aligned_cols=250 Identities=20% Similarity=0.256 Sum_probs=195.7
Q ss_pred hCCCccc-ccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEe----cCce
Q 005649 367 TDNFSTK-NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQ----ERER 439 (686)
Q Consensus 367 t~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~ 439 (686)
+++|++. ++||-|-.|.|-.+..+ .++.+|+|++... ....+|+++.-.. .|||||.+++++.+ ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 5666554 68999999999998865 7889999998543 2335677665444 79999999999875 3457
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCCeEEEecCC
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH---QMKPKISDFGL 516 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgl 516 (686)
++|||.|+||.|...+.++ ..+.+++.+...|+.||..|+.|||+.+ |.||||||+|+|... |..+||+|||+
T Consensus 135 LiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred EeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 8999999999999888664 3456999999999999999999999976 999999999999964 55699999999
Q ss_pred ccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcc
Q 005649 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL 596 (686)
Q Consensus 517 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (686)
|+.-.. .......+-|+.|.|||++...+|+..+|+||+||++|-|++|-+||........ .--.++....+..
T Consensus 211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---spgMk~rI~~gqy 284 (400)
T KOG0604|consen 211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKRRIRTGQY 284 (400)
T ss_pred ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---ChhHHhHhhccCc
Confidence 986543 2233446779999999999999999999999999999999999999975543110 0001111111111
Q ss_pred ccccccccCCCC----HHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 597 MELVDVRIGTYP----EEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 597 ~~~~d~~l~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
++| ...++...++|+.+|..+|.+|.|+.+++..-
T Consensus 285 ---------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 285 ---------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred ---------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 122 35688899999999999999999999998754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=284.81 Aligned_cols=259 Identities=23% Similarity=0.234 Sum_probs=170.6
Q ss_pred hhCCCcccccccccCcEEEEEEEec-C----CCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEE------EE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-D----GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGC------CV 434 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~----g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~ 434 (686)
..++|+..+.||+|+||.||+|++. + +..||+|++..... .+.+.+| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999976 4 68999998854321 1222221 1122222222222211 23
Q ss_pred ecCceEEEEeecCCCChhHHHhhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 005649 435 QERERILVYEYLPNKSLDKFLFDKSKS-----------------AILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIK 497 (686)
Q Consensus 435 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk 497 (686)
.+...+||+||+++++|.+++...... .......+..++.||+.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 456789999999999999998643210 01123445679999999999999987 9999999
Q ss_pred CCcEEEcC-CCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcC----------------------CCChhHH
Q 005649 498 ASNILLDH-QMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG----------------------FLSVKSD 554 (686)
Q Consensus 498 p~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksD 554 (686)
|+|||+++ ++.+||+|||+++.+...... ......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 579999999999865432221 22345788999999965322 2445679
Q ss_pred HHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcC----ccccccccccC-------CCCHHHHHHHHHHHHHcc
Q 005649 555 VFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEG----RLMELVDVRIG-------TYPEEIALRFMQIALLCT 623 (686)
Q Consensus 555 v~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~d~~l~-------~~~~~~~~~l~~li~~cl 623 (686)
||||||+||||+++..+++..... ....+...+ .+...+++... ...........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~-------~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQ-------FNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHH-------HHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 999999999999987765422111 001100000 01111111100 000111234568999999
Q ss_pred cccccCCCCHHHHHHH
Q 005649 624 EDFIEDRPTMSATLSM 639 (686)
Q Consensus 624 ~~~p~~RPt~~evl~~ 639 (686)
+.||++|||+.|+++.
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999985
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=279.60 Aligned_cols=262 Identities=26% Similarity=0.405 Sum_probs=214.4
Q ss_pred cCHHHHHHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEe
Q 005649 358 FNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQ 435 (686)
Q Consensus 358 ~~~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 435 (686)
..++.+--.++.|++.+.||.|.+|.||+++.. +++.+|+|++... ....++.+.|..+++.. +|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 345555566889999999999999999999854 7888999988543 34457788899999988 79999999999975
Q ss_pred -----cCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeE
Q 005649 436 -----ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPK 510 (686)
Q Consensus 436 -----~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 510 (686)
++.++||||||.+|+..+++++.. ...+.|..+..|+..++.||.+||.+. ++|||||=.|||++.++.||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 468899999999999999997765 677999999999999999999999986 99999999999999999999
Q ss_pred EEecCCccccCCcCccccccccccCCCcCchhhhhc-----CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHH
Q 005649 511 ISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR-----GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLK 585 (686)
Q Consensus 511 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~ 585 (686)
|.|||++..++.. ..+.....||+.|||||++.- ..|+.++|+||||++..||--|.+|+..+.......
T Consensus 164 LvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF--- 238 (953)
T KOG0587|consen 164 LVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF--- 238 (953)
T ss_pred Eeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc---
Confidence 9999999877543 334455789999999998853 357889999999999999999999987554322111
Q ss_pred HHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 586 LARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 586 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
...+.. .|.| ..+.....++.++|..|+.+|-++||++.++++.
T Consensus 239 ---~IpRNP------PPkL-krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 239 ---LIPRNP------PPKL-KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---cCCCCC------Cccc-cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111110 0111 2367788999999999999999999999998764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=265.74 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=213.9
Q ss_pred CCCcccccccccCcEEEEEEEecCCC-EEEEEEeccc---CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQDGR-EIAVKKLATN---SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~g~-~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
.+++.+..||-|+||.|-+.+.++.. .+|+|++++. +....+...+|-.+|...+.|.||+++.-+.++...|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666778999999999999886433 3788888654 3344567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
|-|-+|.|...|.+ ++.++......++..+.+|++|||+++ |+.|||||+|.|+|.+|-+||.|||+|+.+...
T Consensus 500 EaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999955 445899999999999999999999998 999999999999999999999999999988654
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
. ++...+||+.|.|||++.+...+...|.|+||+++|||++|.+||...+.....+++-..-..+
T Consensus 574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i------------ 638 (732)
T KOG0614|consen 574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI------------ 638 (732)
T ss_pred C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh------------
Confidence 3 4566899999999999999999999999999999999999999999888777766665544333
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCC-----HHHHHHHhc
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPT-----MSATLSMLS 641 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~L~ 641 (686)
++|........+++++....+|.+|.. ..||-+.-.
T Consensus 639 --~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 639 --EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred --hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 246777888899999999999999976 556655443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=261.38 Aligned_cols=257 Identities=29% Similarity=0.407 Sum_probs=197.7
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--cc-----HHHHHHHHHHHHhcCCCCcccEEEEEEe-cC
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QG-----KEEFENEVRVLLKMQHRNLVQLFGCCVQ-ER 437 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~ 437 (686)
.++|-..++||+|||+.||++..- ..+-||||+-..+.. .+ .+...+|.++.+.|+||.||++++++.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 356777899999999999999854 567788887643321 11 1345789999999999999999999965 56
Q ss_pred ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc---CCCCeEEEec
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD---HQMKPKISDF 514 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Df 514 (686)
..|-|+||+++.+|+.||..+ ..+++++...|+.||..+|.||.+.. ++|+|-||||.|||+- .-|.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 788999999999999999654 45999999999999999999999875 8899999999999994 4567999999
Q ss_pred CCccccCCcCcc-----ccccccccCCCcCchhhhhc----CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHH
Q 005649 515 GLAKLFHDEQSR-----HRTHQIAGTFGYMAPEYAIR----GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLK 585 (686)
Q Consensus 515 gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~ 585 (686)
|+++++.++... ..+....||.+|++||.+.- .+.+.|.||||.|||+|..+-|+.||...... +++++
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdILq 695 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDILQ 695 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHHh
Confidence 999998765433 23456789999999998753 36889999999999999999999999743322 22222
Q ss_pred HHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHH
Q 005649 586 LARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATL 637 (686)
Q Consensus 586 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl 637 (686)
.. .+...-.-... -.+..+.....+|++||+.--++|....++.
T Consensus 696 eN-------TIlkAtEVqFP-~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 EN-------TILKATEVQFP-PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hh-------chhcceeccCC-CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11 11111111111 1234566788999999999999998777664
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=258.26 Aligned_cols=262 Identities=23% Similarity=0.276 Sum_probs=200.3
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcC-C-C----CcccEEEEEEecCce
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-H-R----NLVQLFGCCVQERER 439 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h-~----niv~l~~~~~~~~~~ 439 (686)
+++|.++..+|+|.||.|-.+... .+..||||+++.-.. -.+.-+.|+++|.++. + | -++.+.+++.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 689999999999999999999765 468899999865432 2355678999999993 2 2 367777888889999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc---------------
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD--------------- 504 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--------------- 504 (686)
+||+|.+ +-|+.++|..+ +-.+++...+..|+.|+++++.|||+.. ++|-||||+|||+-
T Consensus 167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999998 66999999654 3345889999999999999999999976 99999999999982
Q ss_pred -----CCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHh
Q 005649 505 -----HQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE 579 (686)
Q Consensus 505 -----~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~ 579 (686)
.+..+||+|||.|..-.... ..+..|-.|.|||++.+-.++..+||||+||||.|+.||...|....+.|
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 13458999999998654332 44677899999999999999999999999999999999999998766444
Q ss_pred HHHHHHHH--------------HHHHhcCcc-----------ccccccc--c---CCCCHHHHHHHHHHHHHcccccccC
Q 005649 580 NQELLKLA--------------RRLEEEGRL-----------MELVDVR--I---GTYPEEIALRFMQIALLCTEDFIED 629 (686)
Q Consensus 580 ~~~~~~~~--------------~~~~~~~~~-----------~~~~d~~--l---~~~~~~~~~~l~~li~~cl~~~p~~ 629 (686)
.....+.. .+....+++ ..+.++. | ......+..+|.+|+..||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 22221111 111111110 0111110 0 0123456778999999999999999
Q ss_pred CCCHHHHHHH
Q 005649 630 RPTMSATLSM 639 (686)
Q Consensus 630 RPt~~evl~~ 639 (686)
|+|+.|+++.
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999998863
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-30 Score=234.15 Aligned_cols=207 Identities=30% Similarity=0.454 Sum_probs=172.1
Q ss_pred HHHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCce
Q 005649 363 LIAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN-SMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERER 439 (686)
Q Consensus 363 l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 439 (686)
++...++......||+|++|.|-+-++. +|+..|+|++... +.+..++..+|+.+..+- .+|.+|.++|....+...
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 4445566667788999999999888865 8999999999654 445567788888876554 799999999999999999
Q ss_pred EEEEeecCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 440 ILVYEYLPNKSLDKFLFDK-SKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
++.||.| ..||+.+..+. .+++.+++..+-+|+..+.+||.|||++ +.++|||+||+||||+.+|++|++|||.+-
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999 56787776543 3455689999999999999999999997 469999999999999999999999999998
Q ss_pred ccCCcCccccccccccCCCcCchhhhhc----CCCChhHHHHHHHHHHHHHHcCCCCCccc
Q 005649 519 LFHDEQSRHRTHQIAGTFGYMAPEYAIR----GFLSVKSDVFSFGVLLLEIISGRKNYDRQ 575 (686)
Q Consensus 519 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDv~s~Gvvl~elltG~~p~~~~ 575 (686)
.+.++-.. +...|-..|||||.+.. ..|+-|+||||||+++.||.+++.||+..
T Consensus 198 ~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 198 YLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred eehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 87654321 22356778999998754 36999999999999999999999999854
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=274.48 Aligned_cols=246 Identities=26% Similarity=0.403 Sum_probs=187.5
Q ss_pred CcccccccccCcEE-EEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEEeecC
Q 005649 370 FSTKNMLGRGGFGT-VYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYEYLP 447 (686)
Q Consensus 370 f~~~~~LG~G~fG~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~ 447 (686)
|...+++|.|..|+ ||+|.. +|+.||||++-... .....+|+..|..- +|||||++++.-.++...||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 55567899998876 699999 48999999985432 23457899998887 6999999999988889999999999
Q ss_pred CCChhHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---C--CCeEEEecCCccccC
Q 005649 448 NKSLDKFLFDKSKS-AILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH---Q--MKPKISDFGLAKLFH 521 (686)
Q Consensus 448 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~Dfgla~~~~ 521 (686)
.-+|++++...... ........+.+..|+++||++||+-+ ||||||||.||||+. + ..++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 66999999663111 11222455778899999999999955 999999999999975 3 468999999999886
Q ss_pred CcCc-cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 522 DEQS-RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 522 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
.+.. -.......||.+|+|||.+....-+...||||+||++|+.++ |++||......+.. .+-....+.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N-------Il~~~~~L~-- 733 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN-------ILTGNYTLV-- 733 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh-------hhcCcccee--
Confidence 5432 223456789999999999999888889999999999999999 69999754332211 111100000
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
.|.. ..++ ...+||.+|++++|..||++.+|+.
T Consensus 734 ---~L~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 ---HLEP-LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ---eecc-CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0111 1112 6789999999999999999999964
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=241.32 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=197.5
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 441 (686)
-.+|...++||+|.|.+|..++++ ..+.+|+|++++.. ....+..+.|..+..+- +||.+|.++.++..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 468999999999999999999976 56788999987642 33345566677777666 79999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
|.||+++|+|-.++... ..++++....+..+|.-+|.|||++| |+.||||.+|+|+|.+|.+||.|+|+++.--
T Consensus 329 vieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999997666443 44899999999999999999999998 9999999999999999999999999988533
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHh-HHHHHHHHHHHHhcCcccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE-NQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 600 (686)
.+. ..+...+||+.|+|||++.+..|....|.|++||+++||+.|+.||+....+. ..+..++..+..-+..+
T Consensus 403 ~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi---- 476 (593)
T KOG0695|consen 403 GPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI---- 476 (593)
T ss_pred CCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc----
Confidence 221 23456799999999999999999999999999999999999999997433211 11111222222211111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCC
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPT 632 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt 632 (686)
..|...+.+...+++.-+++||.+|..
T Consensus 477 -----riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 477 -----RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred -----cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 125556677788999999999999853
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=229.91 Aligned_cols=211 Identities=38% Similarity=0.609 Sum_probs=183.8
Q ss_pred ccccCcEEEEEEEecC-CCEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCChhH
Q 005649 376 LGRGGFGTVYKGRLQD-GREIAVKKLATNSMQ-GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDK 453 (686)
Q Consensus 376 LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~ 453 (686)
||+|.+|.||+++..+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 899999999765432 35679999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCCeEEEecCCccccCCcCcccccccc
Q 005649 454 FLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH-QMKPKISDFGLAKLFHDEQSRHRTHQI 532 (686)
Q Consensus 454 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~ 532 (686)
++.... ..+++..++.++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 986532 35899999999999999999999987 999999999999999 89999999999986654321 12334
Q ss_pred ccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHH
Q 005649 533 AGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEI 611 (686)
Q Consensus 533 ~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 611 (686)
.+...|++||..... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 577889999998887 889999999999999999
Q ss_pred HHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 612 ALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 612 ~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
..+.+++..|++.+|++||++.++++.+
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3466899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-29 Score=240.16 Aligned_cols=265 Identities=22% Similarity=0.324 Sum_probs=198.2
Q ss_pred CcccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEec-----CceEE
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE-----RERIL 441 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~l 441 (686)
.+..+-||.|+||.||..... +|+.|++|++..- +....+.+.+|+++|...+|.|++..++..... .+.|.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 344678999999999999876 8999999998643 344557889999999999999999998876543 25678
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
++|.| ..+|...+.. .+.++...+.-+..||++||.|||+.+ |.||||||.|.|++.|..+||+|||+++...
T Consensus 135 ~TELm-QSDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHH-Hhhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 88888 5567766643 345888888889999999999999987 9999999999999999999999999999876
Q ss_pred CcCccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH--------HHHh
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR--------RLEE 592 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~ 592 (686)
.++....+. ..-|-.|.|||++++. .|+...||||.||++.||+..+..|.....-+..+++.... +..=
T Consensus 208 ~d~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 208 QRDRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhhhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 655544443 4568899999999985 79999999999999999999988887655544333322110 0000
Q ss_pred cCcccccc-----ccccC-----CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 593 EGRLMELV-----DVRIG-----TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 593 ~~~~~~~~-----d~~l~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
+|.-.-++ .|.+. .-+........++..+++..||++|.+..+.+..+-.
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 11000011 01110 1122334456678889999999999999998877643
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=254.54 Aligned_cols=207 Identities=27% Similarity=0.395 Sum_probs=174.2
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCccc---HHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQG---KEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
-|..++.||-|+||.|.+++.. ....+|.|.+.+.+.-. ....+.|-.||..-+.+=||+|+..|.+++.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 4777889999999999999754 45668999997765433 3456789999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc----
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF---- 520 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~---- 520 (686)
|+++|++-.+|... +.+.+.....++.++..|+++.|+-| ++||||||+|||||.+|.+||.||||+.=+
T Consensus 710 YIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 99999999999654 45888888889999999999999976 999999999999999999999999998422
Q ss_pred -----CCcC----------------c---------------cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHH
Q 005649 521 -----HDEQ----------------S---------------RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLE 564 (686)
Q Consensus 521 -----~~~~----------------~---------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~e 564 (686)
...+ . ........||+.|+|||++....++..+|.||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 1100 0 001123579999999999999999999999999999999
Q ss_pred HHcCCCCCcccchHhHH
Q 005649 565 IISGRKNYDRQLEAENQ 581 (686)
Q Consensus 565 lltG~~p~~~~~~~~~~ 581 (686)
|+.|+.||......+.+
T Consensus 864 m~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQ 880 (1034)
T ss_pred HhhCCCCccCCCCCcce
Confidence 99999999876665554
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=224.12 Aligned_cols=257 Identities=19% Similarity=0.363 Sum_probs=194.0
Q ss_pred hhCCCcccccccccCcEEEEEEEe-cCCCEEEEEEecccCcccHHHHHHHHHHHHhcC-CCCcccEEEEEEec--CceEE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRL-QDGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQE--RERIL 441 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~l 441 (686)
..++|++.+++|+|.++.||.|.. .+.+.++||+++.- .++.+.+|+++|..|. ||||+++++...+. ..+.|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 357899999999999999999984 57889999999653 3567889999999996 99999999998774 46789
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCCeEEEecCCcccc
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH-QMKPKISDFGLAKLF 520 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~ 520 (686)
|+||+++.+..... ..++...+...+.++++||.|+|+.| |.|||+||.|+|||. ...++|+|||+|.++
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998887655 23888889999999999999999988 999999999999995 457999999999987
Q ss_pred CCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhc------
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEE------ 593 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------ 593 (686)
...... .....+..|.-||.+.. ..|+..-|+|||||++.+|+..+.||-...+. ..+++..+..+-.+
T Consensus 184 Hp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 184 HPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred CCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHHHHH
Confidence 654432 22345566889998865 56888999999999999999999998532221 12222222211000
Q ss_pred CccccccccccC-----------------CCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 594 GRLMELVDVRIG-----------------TYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 594 ~~~~~~~d~~l~-----------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
.+..-.+|+... +-..-...+.++++...+..|-.+|||++|.+.
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 011111222221 000112466889999999999999999999765
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=226.22 Aligned_cols=199 Identities=33% Similarity=0.514 Sum_probs=173.0
Q ss_pred CcccccccccCcEEEEEEEecC-CCEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecC
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQ-GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLP 447 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 447 (686)
|...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999875 889999999766554 56789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc
Q 005649 448 NKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH 527 (686)
Q Consensus 448 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 527 (686)
+++|.+++...... +++..++.++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 99999998653321 889999999999999999999986 999999999999999999999999999876543211
Q ss_pred cccccccCCCcCchhhh-hcCCCChhHHHHHHHHHHHHHHcCCCCCcc
Q 005649 528 RTHQIAGTFGYMAPEYA-IRGFLSVKSDVFSFGVLLLEIISGRKNYDR 574 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~-~~~~~s~ksDv~s~Gvvl~elltG~~p~~~ 574 (686)
......++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12334677889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=246.69 Aligned_cols=197 Identities=25% Similarity=0.366 Sum_probs=168.4
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCccc--------HHHHHHHHHHHHhcC---CCCcccEEEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQG--------KEEFENEVRVLLKMQ---HRNLVQLFGCCV 434 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~--------~~~~~~e~~~l~~l~---h~niv~l~~~~~ 434 (686)
-.+|...+.||+|+||.|+.+..+ +...|+||.+.+...-. .-..-.|+++|+.++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346889999999999999999987 56788999886643211 112457999999997 999999999999
Q ss_pred ecCceEEEEeecC-CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 005649 435 QERERILVYEYLP-NKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISD 513 (686)
Q Consensus 435 ~~~~~~lv~Ey~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 513 (686)
+++.++|++|-.. +-+|.+++..+ ..+++.+...|++||+-|+++||+++ |||||||-+|+.+|.+|-+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 9999999999774 45888888443 44999999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCcCccccccccccCCCcCchhhhhcCCCC-hhHHHHHHHHHHHHHHcCCCCCc
Q 005649 514 FGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLS-VKSDVFSFGVLLLEIISGRKNYD 573 (686)
Q Consensus 514 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDv~s~Gvvl~elltG~~p~~ 573 (686)
||.+-+.... ..+..+||..|.|||++.+.+|- ..-|||++|++||-++-...||.
T Consensus 714 fgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999876543 35567899999999999998765 45899999999999999888875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-27 Score=241.84 Aligned_cols=265 Identities=22% Similarity=0.275 Sum_probs=207.1
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcC------CCCcccEEEEEEecCc
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQ------HRNLVQLFGCCVQERE 438 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~~~ 438 (686)
.-++|.+....|+|-|++|.+|... -|+.||||++..+..- .+.=+.|+++|++|+ -.|+++++.+|...++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 3578999999999999999999876 5889999999765332 334468999999995 3589999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-CeEEEecCCc
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM-KPKISDFGLA 517 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla 517 (686)
+|||+|-+ .-+|.+.|...+.+..|....+..++.|+.-||..|..-+ |+|.||||.||||++.. .+||||||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 99999987 6799999988888888999999999999999999999877 99999999999998765 5799999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH-----HHHh
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR-----RLEE 592 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~-----~~~~ 592 (686)
......+.. ...-.-.|.|||++.+-.|+...|+||.||+||||.||+..|.+........+..-.. ++..
T Consensus 585 ~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR 660 (752)
T KOG0670|consen 585 SFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR 660 (752)
T ss_pred ccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence 877654322 2233457999999999999999999999999999999999998766544332221111 1122
Q ss_pred cCccc-ccccc--------------------------------------ccCCCCHHHHHHHHHHHHHcccccccCCCCH
Q 005649 593 EGRLM-ELVDV--------------------------------------RIGTYPEEIALRFMQIALLCTEDFIEDRPTM 633 (686)
Q Consensus 593 ~~~~~-~~~d~--------------------------------------~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 633 (686)
.+.+. +-+|. .+..........+.+|+..|+..||++|.|.
T Consensus 661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~ 740 (752)
T KOG0670|consen 661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV 740 (752)
T ss_pred hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence 22111 11111 1111223456678899999999999999999
Q ss_pred HHHHHH
Q 005649 634 SATLSM 639 (686)
Q Consensus 634 ~evl~~ 639 (686)
.+.|+.
T Consensus 741 nqAL~H 746 (752)
T KOG0670|consen 741 NQALKH 746 (752)
T ss_pred HHHhcC
Confidence 998753
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=224.04 Aligned_cols=255 Identities=23% Similarity=0.267 Sum_probs=192.7
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEec------Cc
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE------RE 438 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 438 (686)
.+|...+.+|.|.- .|-.+... .++.|++|++... .....++-.+|+..+..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778888887 55555433 6899999998544 334456778999999999999999999999643 36
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.++|||+| ..+|...+.. .++-..+..|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+++
T Consensus 96 ~y~v~e~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 79999999 6688887753 2677788899999999999999988 9999999999999999999999999998
Q ss_pred ccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcc--
Q 005649 519 LFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL-- 596 (686)
Q Consensus 519 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 596 (686)
.-... -..+....+..|.|||++.+-.+.++.||||.||++.||++|+.-|.+...-+ +|.+....-|..
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~id-----Q~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHID-----QWNKIIEQLGTPDP 238 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHH-----HHHHHHHHhcCCCH
Confidence 54332 23445677889999999998889999999999999999999998887443211 111111111110
Q ss_pred -------------------------cccccccc----CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 597 -------------------------MELVDVRI----GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 597 -------------------------~~~~d~~l----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
.+.+.-.+ .+.+.-....+.+++.+||..+|++|.+.+++++.-
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 00110000 112223455677999999999999999999998864
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-25 Score=226.39 Aligned_cols=132 Identities=28% Similarity=0.395 Sum_probs=110.0
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcC-----C---CCcccEEEEEEe--
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-----H---RNLVQLFGCCVQ-- 435 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~-- 435 (686)
..+|...++||-|.|++||++... +.+.||+|+.+... .-.+.-+.|+++|++++ | .+||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 468899999999999999999865 67789999986432 22456688999999983 3 479999999975
Q ss_pred --cCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 005649 436 --ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL 503 (686)
Q Consensus 436 --~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 503 (686)
+.+.++|+|++ +.+|..++.... -..++...+.+|+.||+.||.|||.+. .|+|-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 45899999999 678888776543 334899999999999999999999987 59999999999999
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-26 Score=245.99 Aligned_cols=254 Identities=24% Similarity=0.317 Sum_probs=205.9
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
..++|+....+|.|.+|.|||++.. .++..|+|.++........-.+.|+-+++.-+|+||+.++|.+...+..+++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3578999999999999999999975 788999999988777777778889999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+.+|+|++..+- .+++++.++..+.+..++||.|||+.+ =+|||||=.||++++.+.+|++|||.+-.+...-
T Consensus 93 ycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred ecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence 9999999998753 456999999999999999999999998 5899999999999999999999999987665322
Q ss_pred ccccccccccCCCcCchhhh---hcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYA---IRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~---~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
.+.....||+.|||||+. ..+.|..++|+|+.|+...|+---++|.-....... -.+....... .
T Consensus 167 --~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~-------l~LmTkS~~q---p 234 (829)
T KOG0576|consen 167 --AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA-------LFLMTKSGFQ---P 234 (829)
T ss_pred --hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH-------HHHhhccCCC---C
Confidence 234457899999999975 456899999999999999999876666432221111 1111111110 1
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
+.++ .+....+.+.++++.|+.++|.+||+...+++
T Consensus 235 p~lk-Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred Cccc-CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2222 13456778899999999999999999987654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=215.68 Aligned_cols=254 Identities=17% Similarity=0.298 Sum_probs=188.9
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEE-EecCceEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCC-VQERERILVY 443 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~-~~~~~~~lv~ 443 (686)
.+.|.+.+.||+|.||.+-+++++ ..+.+++|-+...- ....+|.+|..---.| .|.||+.-+++. ...+.+.+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 467899999999999999999987 56788888876543 3467899998765555 689999877654 4456778999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE-c-CCCCeEEEecCCccccC
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL-D-HQMKPKISDFGLAKLFH 521 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll-~-~~~~~kl~Dfgla~~~~ 521 (686)
||++.|+|...+.. ..+-+.....++.|+++|+.|+|+++ +||||||.+|||| + +..++||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999887733 33777888899999999999999987 9999999999999 3 34479999999988654
Q ss_pred CcCccccccccccCCCcCchhhhhcC-----CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRG-----FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL 596 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (686)
.. .....-+..|.+||..... +..+.+|+|.||++++.++||+.||+.....+. .-|.|..|..+..
T Consensus 175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~---~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK---PYWEWEQWLKRKN 246 (378)
T ss_pred ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc---hHHHHHHHhcccC
Confidence 32 2223445679999976532 456789999999999999999999985443322 2233333332222
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 597 MELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 597 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
. ++...-...++++.++.++-+.+++++|=...++-++-.
T Consensus 247 ~-----~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 247 P-----ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred c-----cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 1 222112345677888999999999999966555555543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=221.20 Aligned_cols=263 Identities=25% Similarity=0.378 Sum_probs=196.8
Q ss_pred hCCCcccccccccCcEEEEEEEec----CCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ----DGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 441 (686)
.+.|..+++||+|.|++||++.+. ..+.||+|.+...+ ......+|++.|..+ .+.||+++.+++..++...+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i 112 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI 112 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence 467899999999999999999754 36789999985443 345688999999999 69999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCCeEEEecCCcccc
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH-QMKPKISDFGLAKLF 520 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~ 520 (686)
|+||++.....+++.. ++...+...++.+..||.++|++| ||||||||+|+|.+. -+.-.|.|||+|...
T Consensus 113 vlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred EecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHH
Confidence 9999999999998843 778899999999999999999998 999999999999974 456789999999722
Q ss_pred CCc------------------------------------------CccccccccccCCCcCchhhhhc-CCCChhHHHHH
Q 005649 521 HDE------------------------------------------QSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFS 557 (686)
Q Consensus 521 ~~~------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s 557 (686)
... ..........||++|.|||++.. ...+++.||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 100 00001123579999999999876 46789999999
Q ss_pred HHHHHHHHHcCCCCCcccchHh--HHHHH---HHHH---HHHhcCc--ccc---------------ccc-ccc-C-----
Q 005649 558 FGVLLLEIISGRKNYDRQLEAE--NQELL---KLAR---RLEEEGR--LME---------------LVD-VRI-G----- 605 (686)
Q Consensus 558 ~Gvvl~elltG~~p~~~~~~~~--~~~~~---~~~~---~~~~~~~--~~~---------------~~d-~~l-~----- 605 (686)
-|||++-+++++.||-...++- ..++. .+.. -..-.|+ +.+ .++ +.+ +
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 9999999999999996443321 11111 1000 0000111 111 010 000 0
Q ss_pred ----CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 606 ----TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 606 ----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
...+..+..+++++.+|+..||.+|.|+++.|+.-
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 11122345789999999999999999999998654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-25 Score=258.52 Aligned_cols=197 Identities=17% Similarity=0.191 Sum_probs=138.9
Q ss_pred hcCC-CCcccEEEEE-------EecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 005649 420 KMQH-RNLVQLFGCC-------VQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRI 491 (686)
Q Consensus 420 ~l~h-~niv~l~~~~-------~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 491 (686)
.++| +||+++++.+ .+.+..++++||+ +++|.++|... ...+++.+++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3455 5778888876 2234567788987 66999999643 345999999999999999999999987 9
Q ss_pred EecCCCCCcEEEcC-------------------CCCeEEEecCCccccCCcCc--------------cccccccccCCCc
Q 005649 492 IHRDIKASNILLDH-------------------QMKPKISDFGLAKLFHDEQS--------------RHRTHQIAGTFGY 538 (686)
Q Consensus 492 vH~Dlkp~NIll~~-------------------~~~~kl~Dfgla~~~~~~~~--------------~~~~~~~~gt~~y 538 (686)
+||||||+||||+. ++.+|++|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965 44556666666653211000 0001113578889
Q ss_pred CchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHH
Q 005649 539 MAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQI 618 (686)
Q Consensus 539 ~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l 618 (686)
||||++.+..++.++|||||||+||||++|..|+..... ... ...... +++.. ........++
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~--~~~~~~---------~~~~~----~~~~~~~~~~ 244 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMS--SLRHRV---------LPPQI----LLNWPKEASF 244 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHH--HHHHhh---------cChhh----hhcCHHHHHH
Confidence 999999999999999999999999999999888653211 100 000000 01110 1112345688
Q ss_pred HHHcccccccCCCCHHHHHHH
Q 005649 619 ALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 619 i~~cl~~~p~~RPt~~evl~~ 639 (686)
+.+||+++|.+||+|.|+++.
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc
Confidence 899999999999999999863
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=203.48 Aligned_cols=166 Identities=23% Similarity=0.255 Sum_probs=125.8
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
|+|.+++... ...+++..++.++.||++||.|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 7899999643 345999999999999999999999864 999999999999999 99988654322
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCC
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYP 608 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 608 (686)
..|++.|+|||++.+..++.++|||||||++|||++|+.||........ ........... . ++.-...+
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~-~------~~~~~~~~ 132 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGMPA-D------DPRDRSNL 132 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHhcc-C------CccccccH
Confidence 2578999999999999999999999999999999999999965432111 11111111110 0 00000112
Q ss_pred HHHHH--HHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 609 EEIAL--RFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 609 ~~~~~--~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..... .+.+++.+||+.+|++||++.|+++.+..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 23333 68999999999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=207.66 Aligned_cols=246 Identities=22% Similarity=0.368 Sum_probs=192.7
Q ss_pred cccccccCcEEEEEEEecCCCEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCC
Q 005649 373 KNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQ--GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKS 450 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gs 450 (686)
..+|.+...|..|+|+++ |.++++|++...... ..++|..|.-.|+.+.||||+.++|.|....++.++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 457888899999999996 678888988654333 23679999999999999999999999999999999999999999
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccccc
Q 005649 451 LDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTH 530 (686)
Q Consensus 451 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 530 (686)
|...|++. .....+-.+..+++.+|++|++|||+-. +-|.---|.++.++||++.+++|+- +-+++..+..
T Consensus 274 lynvlhe~-t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kfsfqe~------ 344 (448)
T KOG0195|consen 274 LYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQEV------ 344 (448)
T ss_pred HHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccceeeeecc------
Confidence 99999864 3456788899999999999999999976 2233346899999999999988752 2222222111
Q ss_pred ccccCCCcCchhhhhcCC---CChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCC
Q 005649 531 QIAGTFGYMAPEYAIRGF---LSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTY 607 (686)
Q Consensus 531 ~~~gt~~y~aPE~~~~~~---~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 607 (686)
...-.+.||+||.++..+ .-..+|+|||+++||||.|...||......|..-.+. -+|.. ...
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia------leglr--------v~i 410 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA------LEGLR--------VHI 410 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh------hcccc--------ccC
Confidence 122357899999998764 3457999999999999999999998766555432111 11110 144
Q ss_pred CHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 608 PEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 608 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
|+..+.-+.+++.-|+..||.+||.+..|+-.|+.
T Consensus 411 ppgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 411 PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 77788889999999999999999999999988875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-22 Score=211.16 Aligned_cols=259 Identities=21% Similarity=0.258 Sum_probs=195.7
Q ss_pred CCcccccccccCcEEEEEEEecCC--CEEEEEEecccCcccHHHHHHHHHHHHhcCC----CCcccEEEEE-EecCceEE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQDG--REIAVKKLATNSMQGKEEFENEVRVLLKMQH----RNLVQLFGCC-VQERERIL 441 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~~g--~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l 441 (686)
+|.+.++||+|+||.||++...+. ..+|+|............+..|..++..+.+ +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999997653 4788887765433333377889999888863 6899999998 46778899
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-----CCeEEEecCC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ-----MKPKISDFGL 516 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Dfgl 516 (686)
||+.+ +.+|.++..... ...++..+.+.|+.|++.+|.+||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 889999775544 567999999999999999999999988 9999999999999865 4699999999
Q ss_pred cc--ccCCcCcc----cc--ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH
Q 005649 517 AK--LFHDEQSR----HR--THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR 588 (686)
Q Consensus 517 a~--~~~~~~~~----~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 588 (686)
++ .+...... .. .....||..|.+++.+.+...+++.|+||++.++.|++.|..||................
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98 33222211 11 123569999999999999999999999999999999999999997554332221111111
Q ss_pred HHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 589 RLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 589 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
.... .. . . ....+..+.++...+-..+..++|.+..+...|+..
T Consensus 254 ~~~~---~~----~-~---~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 254 RKLL---TD----R-F---GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred hhhc---cc----c-c---cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 1110 00 0 1 112234455556666668999999999999998664
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-23 Score=180.46 Aligned_cols=100 Identities=31% Similarity=0.665 Sum_probs=76.1
Q ss_pred cccCC-C-CCcc-CCCChHHHHHHHHHHHhhhhcCC---CCcceeeecCCCCCCcEEEEEeccCCCChhhhHHHHHHHHH
Q 005649 53 IKVCD-S-STNN-TLDSAFSSNLGIALKTLQNNTAQ---TGFSFTTISASNSSQPVTALALCRATITQSECQECMDSAVL 126 (686)
Q Consensus 53 ~~~C~-~-~~~~-~~~s~~~~nl~~l~~~l~~~~~~---~~f~~~~~~~~~~~~~vyg~~~Cr~d~~~~~C~~Cl~~a~~ 126 (686)
|+.|+ + .++| +++++|++||+.||..|.++++. .+|+++.. |.+++++||++||++|+++.+|..||+.|+.
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~--~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~ 78 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSA--GSGPDTVYGLAQCRGDLSPSDCRACLADAVA 78 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE----ST---EEEEEEE-TTS-HHHHHHHHHHHHC
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeec--CCCCCeEEEEEEcCCCCChhhhHHHHHHHHH
Confidence 67898 4 4567 67888999999999999999743 47887775 4599999999999999999999999999999
Q ss_pred HHHhhCCCCcceEEEcceEEEEEcCCcc
Q 005649 127 SIRRVCPDQTTAQIWHTYCMIRYSSRKF 154 (686)
Q Consensus 127 ~~~~~C~~~~~a~i~~~~C~~ry~~~~f 154 (686)
.+...|+++++|+||++.|+||||+++|
T Consensus 79 ~~~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 79 NISSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp CHHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHHHhCCCCceEEEECCCEEEEEECCCC
Confidence 9999999999999999999999999998
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=211.53 Aligned_cols=166 Identities=22% Similarity=0.261 Sum_probs=129.7
Q ss_pred HhhCCCcccccccccCcEEEEEEEec--CCCEEEEEEecccC-----cccHHHHHHHHHHHHhcCCCCcccEEEEEEecC
Q 005649 365 AATDNFSTKNMLGRGGFGTVYKGRLQ--DGREIAVKKLATNS-----MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER 437 (686)
Q Consensus 365 ~at~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 437 (686)
...++|+..+.||+|+||.||+|+.+ +++.+|||++.... ....+.|.+|++++++++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34578999999999999999999875 57778999875331 1234568999999999999999853322 24
Q ss_pred ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCcEEEcCCCCeEEEecCC
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDI-KASNILLDHQMKPKISDFGL 516 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfgl 516 (686)
..+|||||+++++|... . .. . ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~~--~--~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA--R--PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHHh--C--cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 68999999999999632 1 11 1 1467889999999999987 999999 99999999999999999999
Q ss_pred ccccCCcCcccc------ccccccCCCcCchhhhhc
Q 005649 517 AKLFHDEQSRHR------THQIAGTFGYMAPEYAIR 546 (686)
Q Consensus 517 a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 546 (686)
++.+........ .....+++.|++||++..
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 997754321111 235678889999998864
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-22 Score=174.64 Aligned_cols=101 Identities=26% Similarity=0.466 Sum_probs=77.4
Q ss_pred ccccc---ccCC-CCcchHHHHHHHHHHHHHHHhccC-CCccccceeeeccCCceeEEEEeeeccCCccChhhHHHHHHh
Q 005649 164 FSLFD---QREV-PNPTTFDQTVNSLTVNLAVLAGKS-GKRFAVAKMKVISSDIYLYGYVECTRDVNGESCTKCLLSLRS 238 (686)
Q Consensus 164 ~~~~~---~~~~-~~~~~f~~~~~~ll~~l~~~a~~~-~~~fa~~~~~~~~~~~~vyglaQC~~Dls~~dC~~CL~~a~~ 238 (686)
|..|+ .+++ ++++.|.++++.+|..|+..|+.+ +.+|++++.+ .+..+||||+||++||++.||+.||+.++.
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~--~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~ 78 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAG--SGPDTVYGLAQCRGDLSPSDCRACLADAVA 78 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE----ST---EEEEEEE-TTS-HHHHHHHHHHHHC
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeecC--CCCCeEEEEEEcCCCCChhhhHHHHHHHHH
Confidence 45676 3444 566779999999999999998764 5799999863 577789999999999999999999999999
Q ss_pred hhhccCCCCcceEEeccccceeeccCCC
Q 005649 239 YMMTCCSGRWAIWVGAPTCSVQVNLDPV 266 (686)
Q Consensus 239 ~~~~~c~~~~g~~v~~~~C~lRy~~~~f 266 (686)
+++.+|+++.||+|++++|+||||+|+|
T Consensus 79 ~~~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 79 NISSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp CHHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHHHhCCCCceEEEECCCEEEEEECCCC
Confidence 9999999999999999999999999998
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.7e-21 Score=187.27 Aligned_cols=257 Identities=19% Similarity=0.280 Sum_probs=194.3
Q ss_pred CCCcccccccccCcEEEEEEEe-cCCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEEee
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRL-QDGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
-.|.+.++||+|.||.++.|+. -+++.||||.-...+ ...++..|.+..+.| ..++|..++.|..++.+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 3688899999999999999984 489999999764433 345677888888888 579999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-----CeEEEecCCcccc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM-----KPKISDFGLAKLF 520 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~Dfgla~~~ 520 (686)
+ +-||+++..--. ..++.+.++.++.|++.-++|+|++. +|.|||||+|+||...+ .+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 668888774433 34999999999999999999999987 99999999999996433 5899999999988
Q ss_pred CCcCccc-----cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCc
Q 005649 521 HDEQSRH-----RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGR 595 (686)
Q Consensus 521 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 595 (686)
.+..+.. ......||.+||+-....+...+.+.|+-++|-|+++.+-|..||.+...+......+... +.+
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG----e~K 255 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG----ETK 255 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc----ccc
Confidence 7655432 2345679999999999999999999999999999999999999998776544332222111 111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 596 LMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 596 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
-..-++.. -...++++..-+.-.-..+-++-|.+.-+...+
T Consensus 256 r~T~i~~L----c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf 296 (449)
T KOG1165|consen 256 RSTPIEVL----CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLF 296 (449)
T ss_pred ccCCHHHH----HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 11111111 122344455555555556677777776554443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.1e-20 Score=193.11 Aligned_cols=261 Identities=32% Similarity=0.468 Sum_probs=199.4
Q ss_pred CcccccccccCcEEEEEEEecCCCEEEEEEecccCcc---cHHHHHHHHHHHHhcCCC-CcccEEEEEEecCceEEEEee
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQ---GKEEFENEVRVLLKMQHR-NLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~Ey 445 (686)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|..++..+.|+ +++++.+++......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 567788999999999999987 78899999765433 367899999999999988 799999999777778999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-CeEEEecCCccccCCcC
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM-KPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~ 524 (686)
+.++++.+++........+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .+++.|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999976644321125889999999999999999999988 99999999999999988 79999999998665433
Q ss_pred ccc----cccccccCCCcCchhhhhc---CCCChhHHHHHHHHHHHHHHcCCCCCcccchH-hHHHHHHHHHHHHhcCcc
Q 005649 525 SRH----RTHQIAGTFGYMAPEYAIR---GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEA-ENQELLKLARRLEEEGRL 596 (686)
Q Consensus 525 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 596 (686)
... ......|+..|++||.+.+ ...+...|+|++|++++++++|..|+...... ............... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence 221 2356789999999999987 68899999999999999999999997655431 011111111111100 00
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 597 MELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 597 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
...... .........+.+++..++..+|..|.++.+....
T Consensus 236 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSP---SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCc---cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000 0002224578899999999999999999987764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=178.21 Aligned_cols=258 Identities=21% Similarity=0.314 Sum_probs=194.4
Q ss_pred hCCCcccccccccCcEEEEEEE-ecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCC-CCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQH-RNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E 444 (686)
.++|..+++||.|.||.+|.|. ..+|..||||.-..... ..++.-|.++...|++ ..|+.+..+..++..-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4789999999999999999998 45899999998754432 3456778888888865 788888888889999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC---CCeEEEecCCccccC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ---MKPKISDFGLAKLFH 521 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~~ 521 (686)
.+ +-+|.+...--.+ .++..+.+-++.|++.-++|+|.++ ++||||||+|+|..-+ .++.++|||+++.+.
T Consensus 92 LL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 98 6788887754333 3888999999999999999999998 9999999999999644 358999999999876
Q ss_pred CcCcc-----ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcc
Q 005649 522 DEQSR-----HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL 596 (686)
Q Consensus 522 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (686)
+..+. ....+..||.+|.+-..+.+...+.+.|+-|+|.+|.+.--|..||.+..........+.. .+.+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI----~EkK~ 241 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI----SEKKM 241 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH----HHhhc
Confidence 53322 2234578999999999888888899999999999999999999999977654433222211 11111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 597 MELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 597 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
.-.+...-..+ +.++.-.+.-|-..--++-|...-+.++.
T Consensus 242 s~~ie~LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF 281 (341)
T KOG1163|consen 242 STPIEVLCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLF 281 (341)
T ss_pred CCCHHHHhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence 11111111133 34455566677777777777776655544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-21 Score=214.91 Aligned_cols=254 Identities=19% Similarity=0.213 Sum_probs=188.3
Q ss_pred CCcccccccccCcEEEEEEEecCCCEEEEEEecccC-cccHHHHHHHHHH--HHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNS-MQGKEEFENEVRV--LLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
++..++.||.+.|=+|.+++.++|. |+||++-+.. ....+.|.++++. ...++|||.+++...-..+...+||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6778899999999999999998887 8999986543 4445556555444 4445899999998887778888999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC-cC
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD-EQ 524 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~-~~ 524 (686)
..+ +|.|.+ ..+.-+...+...|+.|++.||.-+|+.+ |+|||||.+||||+.-.-+.|+||.--+...- .+
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 844 677776 34556888899999999999999999988 99999999999999998999999987654321 11
Q ss_pred ccc----cccccccCCCcCchhhhhcC-----------CCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHH
Q 005649 525 SRH----RTHQIAGTFGYMAPEYAIRG-----------FLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLAR 588 (686)
Q Consensus 525 ~~~----~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 588 (686)
... ..+....-.+|+|||.+... ..+++.||||+||++.||++ |+++|.- .++..+..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aYr~ 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAYRS 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhHhc
Confidence 111 12233445689999987541 26889999999999999999 8999862 23333222
Q ss_pred HHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCC
Q 005649 589 RLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSV 645 (686)
Q Consensus 589 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 645 (686)
.. .......|. .-+...+.++++.|++.||++|-++++.++.-.....
T Consensus 250 ~~------~~~~e~~Le---~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F 297 (1431)
T KOG1240|consen 250 GN------ADDPEQLLE---KIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF 297 (1431)
T ss_pred cC------ccCHHHHHH---hCcCccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence 10 000000111 1122367899999999999999999999998766543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.5e-20 Score=182.69 Aligned_cols=170 Identities=14% Similarity=0.186 Sum_probs=134.5
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHH---H------HHHHHHHHHhcCCCCcccEEEEEEec-
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKE---E------FENEVRVLLKMQHRNLVQLFGCCVQE- 436 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~---~------~~~e~~~l~~l~h~niv~l~~~~~~~- 436 (686)
.++|+..++||.|+||.||.... ++..+|||.+......... . +.+|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 68999999999999999999766 5778999999754333222 2 68899999999999999999987643
Q ss_pred -------CceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCe
Q 005649 437 -------RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP 509 (686)
Q Consensus 437 -------~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 509 (686)
...+|+|||++|.+|.++.. ++. ....+++.+|..+|+.+ ++|||+||+||+++.++ +
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 35789999999999987741 222 24568999999999988 99999999999999988 9
Q ss_pred EEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHH
Q 005649 510 KISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEII 566 (686)
Q Consensus 510 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ell 566 (686)
+|+|||........... ..+.....+..++|+|+||+++..+.
T Consensus 174 ~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999988755322111 11445555667999999999987664
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3e-20 Score=199.04 Aligned_cols=216 Identities=27% Similarity=0.436 Sum_probs=165.3
Q ss_pred HhcCCCCcccEEEEEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 005649 419 LKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKA 498 (686)
Q Consensus 419 ~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp 498 (686)
+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....++|.....++++|+.||.|||+.. . -+|+.|++
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~s 77 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALKS 77 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeecc
Confidence 567999999999999999999999999999999999976 3455999999999999999999999865 2 29999999
Q ss_pred CcEEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcC-------CCChhHHHHHHHHHHHHHHcCCCC
Q 005649 499 SNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG-------FLSVKSDVFSFGVLLLEIISGRKN 571 (686)
Q Consensus 499 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDv~s~Gvvl~elltG~~p 571 (686)
+|+++|..+.+||+|||+.................-..-|.|||.+... ..+.+.|+||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998776431111111222334569999988763 257789999999999999999999
Q ss_pred CcccchHhH-HHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 572 YDRQLEAEN-QELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 572 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
|+.....+. .+++..... .....+-|.+.... +....+..++..||..+|++||++.+|-..++...
T Consensus 158 ~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred cccccccCChHHHHHHHHh-----cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 986443322 233333222 11112222222111 44457999999999999999999999999887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=176.02 Aligned_cols=141 Identities=19% Similarity=0.216 Sum_probs=109.7
Q ss_pred cccccccCcEEEEEEEecCCCEEEEEEecccCcc--c-------HH-----------------HHHHHHHHHHhcCCCCc
Q 005649 373 KNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQ--G-------KE-----------------EFENEVRVLLKMQHRNL 426 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--~-------~~-----------------~~~~e~~~l~~l~h~ni 426 (686)
...||+|+||.||+|...+|+.||||+++..... . .. ....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999999654211 1 11 22359999999988877
Q ss_pred ccEEEEEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCcEEEcC
Q 005649 427 VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL-HRDSVLRIIHRDIKASNILLDH 505 (686)
Q Consensus 427 v~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dlkp~NIll~~ 505 (686)
.....+.. ...+|||||++++++...... ...+++.....++.|++.+|.++ |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 54433322 234899999998877654322 23588999999999999999999 6776 99999999999998
Q ss_pred CCCeEEEecCCccccCC
Q 005649 506 QMKPKISDFGLAKLFHD 522 (686)
Q Consensus 506 ~~~~kl~Dfgla~~~~~ 522 (686)
++.++|+|||++.....
T Consensus 153 ~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred CCcEEEEEccccccCCC
Confidence 47899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.8e-21 Score=214.22 Aligned_cols=253 Identities=22% Similarity=0.273 Sum_probs=187.6
Q ss_pred cccccccccCcEEEEEEEec-CCCEEEEEEecc---cCcccH---HHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 371 STKNMLGRGGFGTVYKGRLQ-DGREIAVKKLAT---NSMQGK---EEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 371 ~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~---~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
...+++|.|.+|.|+..... .......|.... ...... ..+..|+.+-..++|+|++..+....+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999977777643 333333333321 111111 12556777778889999988877777766666669
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++ +|..++... ..++..++..++.|+..|+.|+|+.| |.|||||++|+++..++.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 999888543 34888899999999999999999988 999999999999999999999999998866543
Q ss_pred Ccc--ccccccccCCCcCchhhhhcCCCChh-HHHHHHHHHHHHHHcCCCCCcccchHhHHH--HHHHHHHHHhcCcccc
Q 005649 524 QSR--HRTHQIAGTFGYMAPEYAIRGFLSVK-SDVFSFGVLLLEIISGRKNYDRQLEAENQE--LLKLARRLEEEGRLME 598 (686)
Q Consensus 524 ~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k-sDv~s~Gvvl~elltG~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 598 (686)
... .......|...|+|||.+.+..|.+. .||||.|+++..|++|+.||......+... .....+.....+
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~---- 549 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEG---- 549 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccC----
Confidence 333 45566889999999999999888765 899999999999999999998665543321 000000000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.......++.....++.++++.+|.+|.|+.+|++.
T Consensus 550 -----~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 550 -----PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred -----hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 011234567778899999999999999999999875
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-18 Score=169.40 Aligned_cols=141 Identities=22% Similarity=0.271 Sum_probs=112.0
Q ss_pred cccccccCcEEEEEEEecCCCEEEEEEecccCcc---------------------c-----HHHHHHHHHHHHhcCCCCc
Q 005649 373 KNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQ---------------------G-----KEEFENEVRVLLKMQHRNL 426 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~ni 426 (686)
...||+|++|.||+|+..+|+.||||++...... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999888999999998754211 0 1234678999999999988
Q ss_pred ccEEEEEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcC
Q 005649 427 VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR-DSVLRIIHRDIKASNILLDH 505 (686)
Q Consensus 427 v~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~ 505 (686)
.....+... ..+|||||++++++...... ...++......++.|++.++.++|+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 555544333 34899999998865443222 2347888999999999999999999 77 99999999999999
Q ss_pred CCCeEEEecCCccccCC
Q 005649 506 QMKPKISDFGLAKLFHD 522 (686)
Q Consensus 506 ~~~~kl~Dfgla~~~~~ 522 (686)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.4e-18 Score=164.01 Aligned_cols=188 Identities=19% Similarity=0.133 Sum_probs=142.1
Q ss_pred cccccccccCcEEEEEEEecCCCEEEEEEecccCccc----HHHHHHHHHHHHhcC-CCCcccEEEEEEecCceEEEEee
Q 005649 371 STKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQG----KEEFENEVRVLLKMQ-HRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 371 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~----~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.....|++|+||+||.+.. ++..++.+.+....... ...+.+|+++|++++ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997766 67888888886554321 235889999999995 5889999886 457999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDI-KASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
+++.+|...+.. ....++.|++++|.++|+++ |+|||| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999988654311 11357789999999999998 999999 7999999999999999999998654322
Q ss_pred cc----cc-------ccccccCCCcCchhhhhc--CCCChhHHHHHHHHHHHHHHcCCCCCcccc
Q 005649 525 SR----HR-------THQIAGTFGYMAPEYAIR--GFLSVKSDVFSFGVLLLEIISGRKNYDRQL 576 (686)
Q Consensus 525 ~~----~~-------~~~~~gt~~y~aPE~~~~--~~~s~ksDv~s~Gvvl~elltG~~p~~~~~ 576 (686)
.. .. ......++.|++|+...- ..--...+.++-|..+|.++|+..+.....
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 10 00 112346788888885432 333367888999999999999988765443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=174.25 Aligned_cols=233 Identities=18% Similarity=0.262 Sum_probs=152.3
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcC----------CCCcccEEEEEE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQ----------HRNLVQLFGCCV 434 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~----------h~niv~l~~~~~ 434 (686)
.....+.||.|+++.||.++.. .|++++||+..... ....+++++|......+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3455688999999999999987 58999999985433 223566777665554432 212222222221
Q ss_pred ---------ec---C-----ceEEEEeecCCCChhHHHhh---cCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 005649 435 ---------QE---R-----ERILVYEYLPNKSLDKFLFD---KSK-SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIH 493 (686)
Q Consensus 435 ---------~~---~-----~~~lv~Ey~~~gsL~~~l~~---~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 493 (686)
.. . ..+++|+-+ .++|.+++.. ... ...+....++.+..|+++.+++||+.+ +||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 11 1 236788877 6788877632 211 223455667788899999999999998 999
Q ss_pred cCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhc--------CCCChhHHHHHHHHHHHHH
Q 005649 494 RDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR--------GFLSVKSDVFSFGVLLLEI 565 (686)
Q Consensus 494 ~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDv~s~Gvvl~el 565 (686)
+||+|+|++++.+|.++|+||+.....+.... ....+..|.+||.... -.++.+.|.|++|+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999988775443211 1244578999997644 2589999999999999999
Q ss_pred HcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCC
Q 005649 566 ISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDR 630 (686)
Q Consensus 566 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~R 630 (686)
.+|..||.....+.... .....+. +.++.+..+|..+|+.||++|
T Consensus 244 WC~~lPf~~~~~~~~~~-------------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPE-------------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSG-------------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCcccccc-------------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999998543322110 0233455 788999999999999999998
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-18 Score=198.37 Aligned_cols=196 Identities=20% Similarity=0.247 Sum_probs=159.6
Q ss_pred hhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcC---CCCcccEEEEEEecCceEEE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQ---HRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv 442 (686)
..+.|.+.+.||+|+||.||+|...+|+.||+|+-+..+..+ |..-.+++.+|+ -+.|..+...+.-.+..+||
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 455788889999999999999999889999999987765542 333344444454 23445555555667888999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-------CCCCeEEEecC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD-------HQMKPKISDFG 515 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-------~~~~~kl~Dfg 515 (686)
+||.+.|+|.+++. ..+.++|.....++.|+++.+.+||..+ ||||||||+|.||. +...++|+|||
T Consensus 773 ~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecc
Confidence 99999999999996 4456999999999999999999999987 99999999999994 23458999999
Q ss_pred CccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCC
Q 005649 516 LAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRK 570 (686)
Q Consensus 516 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~ 570 (686)
.+..+..-.........++|-.+--+|...+..++...|.|.|+-+++-|+.|+.
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9876543222234556788899999999999999999999999999999999986
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.5e-19 Score=188.45 Aligned_cols=225 Identities=25% Similarity=0.320 Sum_probs=179.5
Q ss_pred cccccCcEEEEEEE----ecCCCEEEEEEecccCccc--HHHHHHHHHHHHhcC-CCCcccEEEEEEecCceEEEEeecC
Q 005649 375 MLGRGGFGTVYKGR----LQDGREIAVKKLATNSMQG--KEEFENEVRVLLKMQ-HRNLVQLFGCCVQERERILVYEYLP 447 (686)
Q Consensus 375 ~LG~G~fG~Vy~~~----~~~g~~vavK~l~~~~~~~--~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~Ey~~ 447 (686)
.+|+|.||.|++.+ .+.|..++.|.+++..... +.....|-.++...+ ||.++++...+..+...+++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999998765 3356778888886543221 124556777888886 9999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc
Q 005649 448 NKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH 527 (686)
Q Consensus 448 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 527 (686)
+|.|...+.+. ..+++.........++-++.++|+.+ |+|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 81 gg~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccccC---CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 99998777443 33666677777888999999999987 999999999999999999999999999876443322
Q ss_pred cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCC
Q 005649 528 RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTY 607 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 607 (686)
+||..|||||++. ......|.||||++++||+||..||.. +. ..++...+ ...
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~------~~~Il~~~----------~~~ 206 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DT------MKRILKAE----------LEM 206 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HH------HHHHhhhc----------cCC
Confidence 8899999999988 557789999999999999999999985 11 11222111 134
Q ss_pred CHHHHHHHHHHHHHcccccccCCCCH
Q 005649 608 PEEIALRFMQIALLCTEDFIEDRPTM 633 (686)
Q Consensus 608 ~~~~~~~l~~li~~cl~~~p~~RPt~ 633 (686)
|.+......+++..++..+|.+|--.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 77888888999999999999999766
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=4e-17 Score=159.73 Aligned_cols=136 Identities=17% Similarity=0.278 Sum_probs=106.5
Q ss_pred cccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhc-----CCCCcccEEEEEEecC---c-eEE
Q 005649 371 STKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKM-----QHRNLVQLFGCCVQER---E-RIL 441 (686)
Q Consensus 371 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~-~~l 441 (686)
...+.||+|+||.||. .++....+||++........+.+.+|+.++.++ +||||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 443333479988765555567899999999999 5799999999998864 3 337
Q ss_pred EEee--cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCcEEEcC----CCCeEEEec
Q 005649 442 VYEY--LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGL-LYLHRDSVLRIIHRDIKASNILLDH----QMKPKISDF 514 (686)
Q Consensus 442 v~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df 514 (686)
|+|| +.+|+|.+++.+. .+++. ..++.+++.++ .|||+++ |+||||||+|||++. +..++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 5579999999542 25555 35677888777 8999988 999999999999974 347999995
Q ss_pred CCc
Q 005649 515 GLA 517 (686)
Q Consensus 515 gla 517 (686)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.3e-16 Score=156.18 Aligned_cols=134 Identities=24% Similarity=0.377 Sum_probs=114.4
Q ss_pred ccccccCcEEEEEEEecCCCEEEEEEecccCcc--------cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 374 NMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQ--------GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
+.||+|++|.||+|+. +|..+++|+....... ....+.+|+.++..+.|++++....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 6788999987543221 124578899999999999998888888888889999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
+++++|.+++... .+ .+..++.+++.+|.++|+.+ ++|+|++|+|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988532 22 78899999999999999987 99999999999999 78999999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.5e-16 Score=151.96 Aligned_cols=130 Identities=25% Similarity=0.425 Sum_probs=107.9
Q ss_pred cccccCcEEEEEEEecCCCEEEEEEecccCcc--------cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 375 MLGRGGFGTVYKGRLQDGREIAVKKLATNSMQ--------GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 375 ~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
.||+|+||.||+|.+ +|..+++|+....... ...++.+|++++..++|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 5788999986543211 1356788999999999988766666666777789999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++++|.+++..... .++.+++.+|.+||+.+ ++|||++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988743210 78999999999999987 99999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.6e-16 Score=152.42 Aligned_cols=146 Identities=19% Similarity=0.190 Sum_probs=113.7
Q ss_pred HHHHHhhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcc----------------------cHHHHHHHHHHH
Q 005649 361 DVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQ----------------------GKEEFENEVRVL 418 (686)
Q Consensus 361 ~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~----------------------~~~~~~~e~~~l 418 (686)
.++......|...+.||+|+||.||++..++|+.|+||++...... ....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444444457888999999999999999888999999987543210 112367788899
Q ss_pred HhcCCC--CcccEEEEEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 005649 419 LKMQHR--NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDI 496 (686)
Q Consensus 419 ~~l~h~--niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 496 (686)
.++.|+ .+++.++ ....+++|||+++++|...... .....++.+++.++.++|+.+ ++||||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 999877 4455544 2456899999999998765420 234678899999999999987 999999
Q ss_pred CCCcEEEcCCCCeEEEecCCccccCC
Q 005649 497 KASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 497 kp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
||+||++++++.++|+|||++.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.3e-16 Score=156.18 Aligned_cols=149 Identities=19% Similarity=0.226 Sum_probs=114.4
Q ss_pred HHHhhCCCcccccccccCcEEEEEEE--ecCCCEEEEEEecccCcc------------------------cHHHHHHHHH
Q 005649 363 LIAATDNFSTKNMLGRGGFGTVYKGR--LQDGREIAVKKLATNSMQ------------------------GKEEFENEVR 416 (686)
Q Consensus 363 l~~at~~f~~~~~LG~G~fG~Vy~~~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~e~~ 416 (686)
+..-...|.+.+.||+|++|.||+|. ..+|+.||+|++...... ....+..|+.
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 33344468889999999999999998 568999999998653210 0123578999
Q ss_pred HHHhcCCC--CcccEEEEEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 005649 417 VLLKMQHR--NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHR 494 (686)
Q Consensus 417 ~l~~l~h~--niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 494 (686)
.+.++.+. .+++++++ ...++||||+++++|...... ...+.......++.||+.++.+||+.+ .++||
T Consensus 103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~ 173 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHG 173 (237)
T ss_pred HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeC
Confidence 99999753 34445543 245899999999888765422 223566677889999999999999975 39999
Q ss_pred CCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 495 DIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 495 Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||+||+++ ++.++|+|||.+....
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999999 8899999999987543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.2e-17 Score=173.59 Aligned_cols=173 Identities=23% Similarity=0.361 Sum_probs=131.1
Q ss_pred ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCc
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 517 (686)
..++.|++++..+|.+||.........++...+.++.|++.++.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999877777778999999999999999999 44 899999999999999999999999998
Q ss_pred cccCCcC----ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHh
Q 005649 518 KLFHDEQ----SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEE 592 (686)
Q Consensus 518 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 592 (686)
....... .........||..||+||.+.+..|+.|+|||+||++|+||+. =..+++ ... .....+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------r~~----t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------RIA----TLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------HHH----hhhhhh
Confidence 7665433 1223455789999999999999999999999999999999997 222221 000 001111
Q ss_pred cCcccccccccc-CCCCHHHHHHHHHHHHHcccccccCCCCHHH
Q 005649 593 EGRLMELVDVRI-GTYPEEIALRFMQIALLCTEDFIEDRPTMSA 635 (686)
Q Consensus 593 ~~~~~~~~d~~l-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e 635 (686)
.+ ++++.. .++|. -..++++++.+.|.+||+..+
T Consensus 474 ~g----~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 474 DG----IIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred cC----CCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHH
Confidence 11 111111 12222 347899999999999994433
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.1e-16 Score=173.90 Aligned_cols=138 Identities=22% Similarity=0.332 Sum_probs=113.1
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEe-ccc-Cc------ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCc
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKL-ATN-SM------QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERE 438 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l-~~~-~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 438 (686)
...|...+.||+|+||.||+|.+.+. .+++|+. ... .. ...+.+.+|++++.+++|++++....++.+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 44556789999999999999988644 4444443 221 11 123568899999999999999988888888778
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ +++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999999884 35678999999999999987 9999999999999 67799999999987
Q ss_pred cc
Q 005649 519 LF 520 (686)
Q Consensus 519 ~~ 520 (686)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 53
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.6e-16 Score=155.90 Aligned_cols=198 Identities=19% Similarity=0.281 Sum_probs=141.5
Q ss_pred CCCCcccEEEEEEe---------------------------cCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHH
Q 005649 422 QHRNLVQLFGCCVQ---------------------------ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIM 474 (686)
Q Consensus 422 ~h~niv~l~~~~~~---------------------------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 474 (686)
+|||||++.++|.+ ....|+||.-. .-+|..++... ..+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC----CCchHHHHHHHH
Confidence 59999999887743 22457888766 45788888543 356667777899
Q ss_pred HHHHHHHHHHhCCCCCeEecCCCCCcEEEc--CCC--CeEEEecCCccccCCcC----ccccccccccCCCcCchhhhhc
Q 005649 475 GVARGLLYLHRDSVLRIIHRDIKASNILLD--HQM--KPKISDFGLAKLFHDEQ----SRHRTHQIAGTFGYMAPEYAIR 546 (686)
Q Consensus 475 ~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~Dfgla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~ 546 (686)
|+++|+.|||+++ |.|||+|++||||. +|. .+.|+|||.+-.-.... .........|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 99999999999983 333 57999999975433211 1111223457788999998764
Q ss_pred CC------CChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHH
Q 005649 547 GF------LSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIAL 620 (686)
Q Consensus 547 ~~------~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~ 620 (686)
.+ .-.|.|.|+.|.+.||+++...||....+.-. +...+ . ..+|...++.++..+.+++.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~~r~Y----------q---e~qLPalp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-DTRTY----------Q---ESQLPALPSRVPPVARQLVF 491 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-chhhh----------h---hhhCCCCcccCChHHHHHHH
Confidence 32 23589999999999999999999986332111 11111 1 11233446677888899999
Q ss_pred HcccccccCCCCHHHHHHHhc
Q 005649 621 LCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 621 ~cl~~~p~~RPt~~evl~~L~ 641 (686)
..++.||.+||+..=..+.|.
T Consensus 492 ~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHhcCCccccCCccHHHhHHH
Confidence 999999999999775555553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.5e-16 Score=176.55 Aligned_cols=212 Identities=22% Similarity=0.244 Sum_probs=149.2
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.++|+.++.|-.|++|.||..+++ .-+.+|+|+-+.+. . .+. ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-i-----lRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-I-----LRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch-h-----hhc--cccccCCccee------------------
Confidence 478999999999999999999876 35667774332211 1 000 22222333333
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC-
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ- 524 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~- 524 (686)
|+=...+... +.+.... +.+++|||+.+ |+|||+||+|.+|..-|.+|+.|||+.+......
T Consensus 136 ---gDc~tllk~~---g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLKNI---GPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcccC---CCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 2322333221 2233222 67899999987 9999999999999999999999999987542111
Q ss_pred -----------cccc-ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHh
Q 005649 525 -----------SRHR-THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEE 592 (686)
Q Consensus 525 -----------~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 592 (686)
.+.. ....+||+.|+|||++....|....|+|++|+++||.+.|+.||.+...++....+-.....|.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 278 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence 1111 2346899999999999999999999999999999999999999998877776554444444444
Q ss_pred cCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHH
Q 005649 593 EGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMS 634 (686)
Q Consensus 593 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 634 (686)
++ .+....+..+++.+.|+.+|.+|--..
T Consensus 279 E~-------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 279 EE-------------DEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred cc-------------CcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 33 233456677899999999999996443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.4e-14 Score=132.96 Aligned_cols=135 Identities=21% Similarity=0.263 Sum_probs=114.6
Q ss_pred ccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCC--CCcccEEEEEEecCceEEEEeecCCC
Q 005649 372 TKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQH--RNLVQLFGCCVQERERILVYEYLPNK 449 (686)
Q Consensus 372 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~Ey~~~g 449 (686)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| .++++++++...++..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999864 7899999865443 5678999999999976 58999999888888899999999887
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 450 SLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 450 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
.+..+ +......++.+++++|.+||......++|+|++|+||++++++.+++.|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76543 5566778899999999999986445699999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.2e-14 Score=139.13 Aligned_cols=138 Identities=22% Similarity=0.249 Sum_probs=99.3
Q ss_pred cccccccCcEEEEEEEecCCCEEEEEEecccCccc--HHH----------------------HHHHHHHHHhcCCCC--c
Q 005649 373 KNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQG--KEE----------------------FENEVRVLLKMQHRN--L 426 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~--~~~----------------------~~~e~~~l~~l~h~n--i 426 (686)
.+.||+|+||.||++...+|+.||||++....... ... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999986532211 111 135666666664433 4
Q ss_pred ccEEEEEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcC
Q 005649 427 VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR-DSVLRIIHRDIKASNILLDH 505 (686)
Q Consensus 427 v~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~ 505 (686)
.+.++. ...+++|||++++.+......... .. .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 455443 346899999998543221111100 11 5677899999999999999 66 99999999999999
Q ss_pred CCCeEEEecCCccccCC
Q 005649 506 QMKPKISDFGLAKLFHD 522 (686)
Q Consensus 506 ~~~~kl~Dfgla~~~~~ 522 (686)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 89999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=1e-13 Score=139.38 Aligned_cols=135 Identities=21% Similarity=0.256 Sum_probs=105.3
Q ss_pred ccccc-ccCcEEEEEEEecCCCEEEEEEecccC-------------cccHHHHHHHHHHHHhcCCCCc--ccEEEEEEec
Q 005649 373 KNMLG-RGGFGTVYKGRLQDGREIAVKKLATNS-------------MQGKEEFENEVRVLLKMQHRNL--VQLFGCCVQE 436 (686)
Q Consensus 373 ~~~LG-~G~fG~Vy~~~~~~g~~vavK~l~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~ 436 (686)
...|| .|+.|+||..... +..++||++.... ......+.+|+.++.+++|+++ ++.+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8889999999885 7789999885421 1223567889999999998875 7777775543
Q ss_pred C----ceEEEEeecCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEE
Q 005649 437 R----ERILVYEYLPN-KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKI 511 (686)
Q Consensus 437 ~----~~~lv~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 511 (686)
. ..++|+|++++ .+|.+++.. ..++.. .+.+|+.+|.+||+.+ |+|+||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 689888743 224443 3568999999999998 999999999999999899999
Q ss_pred EecCCccc
Q 005649 512 SDFGLAKL 519 (686)
Q Consensus 512 ~Dfgla~~ 519 (686)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=8.7e-15 Score=164.63 Aligned_cols=256 Identities=21% Similarity=0.279 Sum_probs=187.4
Q ss_pred CCCcccccccccCcEEEEEEEecC--CCEEEEEEecccC--cccHHHHHHHHHHHHhcC-CCCcccEEEEEEecCceEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQD--GREIAVKKLATNS--MQGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 442 (686)
..|...+.||+|.|+.|-...... ...+++|.+.... ....+....|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456677789999999998887643 3345556554433 222233444777777776 99999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCcEEEcCCC-CeEEEecCCcccc
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLH-RDSVLRIIHRDIKASNILLDHQM-KPKISDFGLAKLF 520 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~ 520 (686)
.||..++++.+.+... .....+....-..+.|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999988777311 1113556667778999999999999 766 99999999999999999 9999999999887
Q ss_pred CC-cCcccccccccc-CCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 521 HD-EQSRHRTHQIAG-TFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 521 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
.. ...........| ++.|+|||...+ ....+..|+||.|+++.-+++|..|++........ ...|... +
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~-----~-- 247 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSN-----K-- 247 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeeccc-----c--
Confidence 76 444444555678 999999999887 45677899999999999999999999865543311 0111100 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 598 ~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
+..-............++..+++..+|..|.+.+++-.
T Consensus 248 ---~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 ---GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ---cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00000112334556778888999999999999887743
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.6e-12 Score=141.92 Aligned_cols=142 Identities=23% Similarity=0.294 Sum_probs=100.5
Q ss_pred cccccccCcEEEEEEEecCCCEEEEEEecccCcccH----------------------------------------HHHH
Q 005649 373 KNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGK----------------------------------------EEFE 412 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~----------------------------------------~~~~ 412 (686)
.+.||.|++|.||+|++++|+.||||+......... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999865421100 0244
Q ss_pred HHHHHHHhc----CCCCcccEEEEEE-ecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 005649 413 NEVRVLLKM----QHRNLVQLFGCCV-QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR-GLLYLHRD 486 (686)
Q Consensus 413 ~e~~~l~~l----~h~niv~l~~~~~-~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~~ 486 (686)
+|...+.++ +|.+-+.+-.++. .....+|||||+++++|.++....... . .+..++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhC
Confidence 555555555 2333233323332 244679999999999998876432111 2 23456666665 46788988
Q ss_pred CCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 487 SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 487 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
+ ++|+|+||.||+++.++.++++|||++..+..
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7 99999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.4e-13 Score=132.85 Aligned_cols=205 Identities=22% Similarity=0.214 Sum_probs=142.8
Q ss_pred HHHHHhcCCCCcccEEEEEEec-----CceEEEEeecCCCChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 005649 415 VRVLLKMQHRNLVQLFGCCVQE-----RERILVYEYLPNKSLDKFLFDKSK-SAILDWPKRLNIIMGVARGLLYLHRDSV 488 (686)
Q Consensus 415 ~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~ 488 (686)
+..|-++.|.|||+++.|+.+. ....++.|||+.|++..+|.+..+ ...+......+|+.||..||.|||+-.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 3445567899999999988653 457899999999999999987543 344777788899999999999999975
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc---CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHH
Q 005649 489 LRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE---QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEI 565 (686)
Q Consensus 489 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~el 565 (686)
++|+|+++.-+-|++..++-+|++- +-....... ........-.+.++|.+||+-..-+.+..+|||+||...+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 8899999999999999999888743 111111100 001112223567899999988777888899999999999999
Q ss_pred HcCCCC-CcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 566 ISGRKN-YDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 566 ltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
.-|..- -......+....+...-.... ...-..++..|++.+|..||+|++++...
T Consensus 276 ailEiq~tnseS~~~~ee~ia~~i~~le-------------------n~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIANVIIGLE-------------------NGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHheeccCCCcceeehhhhhhhheeecc-------------------CccccCcCcccccCCCCCCcchhhhhcCc
Confidence 876643 222222122111111111111 01112578899999999999999886543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.2e-11 Score=114.73 Aligned_cols=130 Identities=18% Similarity=0.154 Sum_probs=97.3
Q ss_pred cccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCc-ccEEEEEEecCceEEEEeecCCCCh
Q 005649 373 KNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL-VQLFGCCVQERERILVYEYLPNKSL 451 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~Ey~~~gsL 451 (686)
.+.|+.|.++.||+.+.. ++.+++|....... ....+..|+..+..+.+.++ ++++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 457899999999999875 78899998754432 23356789999998865554 4555443 3346899999999887
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 452 DKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS--VLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 452 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.... . ....+..+++++|..||+.+ ...++|+|++|+||+++ ++.++++|||.+.
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 5420 1 11345678999999999976 23469999999999999 6689999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.5e-10 Score=125.82 Aligned_cols=166 Identities=17% Similarity=0.221 Sum_probs=127.5
Q ss_pred ecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHH
Q 005649 389 LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPK 468 (686)
Q Consensus 389 ~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~ 468 (686)
..++.+|.|...+.......+...+-++.|+.++||||++++.....++..|||+|-+. .|..++.+ +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 34788888888876655334556778899999999999999999999999999999874 46666644 33556
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCC
Q 005649 469 RLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGF 548 (686)
Q Consensus 469 ~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 548 (686)
....+.||+.||.|||+.+ .++|++|..+.|+|+..|..||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 6677899999999999876 499999999999999999999999998765443221 111112223466777554333
Q ss_pred CChhHHHHHHHHHHHHHHcC
Q 005649 549 LSVKSDVFSFGVLLLEIISG 568 (686)
Q Consensus 549 ~s~ksDv~s~Gvvl~elltG 568 (686)
-..|.|.||++++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=6.8e-12 Score=135.08 Aligned_cols=249 Identities=22% Similarity=0.227 Sum_probs=179.5
Q ss_pred CCcccccccc--cCcEEEEEEEe--c-CCCEEEEEEecccCcc--cHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceE
Q 005649 369 NFSTKNMLGR--GGFGTVYKGRL--Q-DGREIAVKKLATNSMQ--GKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 369 ~f~~~~~LG~--G~fG~Vy~~~~--~-~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 440 (686)
.|...+.+|. |.+|.||.+.. . ++..+++|+-+..... ....=.+|+...+++ .|+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566778999 99999999987 3 6888999985444332 222224566666666 5999999888888999999
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCcEEEcCC-CCeEEEecC
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR----GLLYLHRDSVLRIIHRDIKASNILLDHQ-MKPKISDFG 515 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg 515 (686)
+-+|++ +.+|..+.+... ..+.....+....+..+ ||.++|+.. ++|-|+||.||++..+ ...+++|||
T Consensus 195 iqtE~~-~~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeccc-cchhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 999988 478888775432 33677778888888888 999999987 9999999999999999 889999999
Q ss_pred CccccCCcCcccc---ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHh
Q 005649 516 LAKLFHDEQSRHR---THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEE 592 (686)
Q Consensus 516 la~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 592 (686)
+...+........ .....|...|++||... +.++.++|+|++|.+..+-.+|.......... . |...+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~--W~~~r 339 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS------S--WSQLR 339 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC------C--ccccc
Confidence 9998876543222 22346788999999654 56788999999999999999977655422100 0 00000
Q ss_pred cCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 593 EGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 593 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+. +-+ ++-..-..++...+..+++.+|-.|++.+.+...
T Consensus 340 ~~~---ip~----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 340 QGY---IPL----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ccc---Cch----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 000 000 1112224445558999999999999988877554
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.4e-10 Score=128.19 Aligned_cols=144 Identities=19% Similarity=0.286 Sum_probs=95.3
Q ss_pred CCCcccccccccCcEEEEEEEecC-CCEEEEEEecccCccc----------------------------------HH---
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQG----------------------------------KE--- 409 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~----------------------------------~~--- 409 (686)
.+|+. +.||.|++|.||+|++++ |+.||||++....... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999987 9999999997542110 01
Q ss_pred ---HHHHHHHHHHhcC----CCCcccEEEEEEe-cCceEEEEeecCCCChhHHHhhcCCC---CCCCHHHHHHHHHHHHH
Q 005649 410 ---EFENEVRVLLKMQ----HRNLVQLFGCCVQ-ERERILVYEYLPNKSLDKFLFDKSKS---AILDWPKRLNIIMGVAR 478 (686)
Q Consensus 410 ---~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~Ey~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia~ 478 (686)
+|.+|...+.++. +.+.+.+-.++.+ .....|||||++|+.+.++..-...+ ..+.......++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 2344554444442 3433443344433 45678999999999998753211111 112222233333333
Q ss_pred HHHHHHhCCCCCeEecCCCCCcEEEcCCC----CeEEEecCCccccCC
Q 005649 479 GLLYLHRDSVLRIIHRDIKASNILLDHQM----KPKISDFGLAKLFHD 522 (686)
Q Consensus 479 ~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgla~~~~~ 522 (686)
+..| ++|+|+||.||+++.++ ++++.|||+...++.
T Consensus 277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3455 99999999999999888 999999999987754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.2e-09 Score=105.19 Aligned_cols=138 Identities=18% Similarity=0.167 Sum_probs=99.7
Q ss_pred ccccccCcEEEEEEEecC-------CCEEEEEEecccCc----------------------ccHHHH----HHHHHHHHh
Q 005649 374 NMLGRGGFGTVYKGRLQD-------GREIAVKKLATNSM----------------------QGKEEF----ENEVRVLLK 420 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~-------g~~vavK~l~~~~~----------------------~~~~~~----~~e~~~l~~ 420 (686)
..||.|-=+.||.|...+ +..+|||+.+.... ...+.+ +.|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 47999998753210 001223 379999999
Q ss_pred cCC--CCcccEEEEEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCC
Q 005649 421 MQH--RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL-HRDSVLRIIHRDIK 497 (686)
Q Consensus 421 l~h--~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dlk 497 (686)
+.. -++++++++ ...+|||||+.++.+..... +...++..+...+..+++.+|..| |+.+ |+||||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 853 466777764 56789999997654422111 112245556677889999999999 7776 9999999
Q ss_pred CCcEEEcCCCCeEEEecCCccccCC
Q 005649 498 ASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 498 p~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
+.|||++ ++.+.|+|||.+.....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCCC
Confidence 9999997 46899999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.09 E-value=5e-09 Score=110.60 Aligned_cols=168 Identities=22% Similarity=0.368 Sum_probs=129.9
Q ss_pred EEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEe----cCceEEEEeecCC-CChhHHH
Q 005649 382 GTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ----ERERILVYEYLPN-KSLDKFL 455 (686)
Q Consensus 382 G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~Ey~~~-gsL~~~l 455 (686)
.+.||+... ||..+++|++.............-+++++++.|.|+|++..++.. +...++||+|.++ ++|.+..
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 567888765 899999999955544444344566889999999999999998863 4578899999986 5777766
Q ss_pred hhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 456 FDKS------------KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 456 ~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
.... .+....+..+|.++.|+..||.++|+.| +.-+-|.+++|+++.+.+++|+..|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 5421 1234778899999999999999999998 777999999999999999999998887665443
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCC
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKN 571 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p 571 (686)
.. |-+.. -.+-|.=-||.+++.|.||...
T Consensus 447 ~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 31 11111 2367888999999999999653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.1e-09 Score=109.06 Aligned_cols=142 Identities=20% Similarity=0.281 Sum_probs=110.0
Q ss_pred ccccccCcEEEEEEEecCCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCC--CCcccEEEEEEecC---ceEEEEeecC
Q 005649 374 NMLGRGGFGTVYKGRLQDGREIAVKKLATNSM-QGKEEFENEVRVLLKMQH--RNLVQLFGCCVQER---ERILVYEYLP 447 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~Ey~~ 447 (686)
+.|+.|..+.+|++...+|+.+++|....... .....+..|.+++..+.+ .++++++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778999999765432 235678899999999976 44677888776543 5689999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 005649 448 NKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS---------------------------------------- 487 (686)
Q Consensus 448 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------------------------- 487 (686)
+.++.+.+.. ..++...+..++.++++.|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888765421 23677777788888888888888521
Q ss_pred -------------CCCeEecCCCCCcEEEcC--CCCeEEEecCCccc
Q 005649 488 -------------VLRIIHRDIKASNILLDH--QMKPKISDFGLAKL 519 (686)
Q Consensus 488 -------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~ 519 (686)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 135899999999999998 56689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.8e-09 Score=99.02 Aligned_cols=132 Identities=24% Similarity=0.364 Sum_probs=103.6
Q ss_pred ccccccCcEEEEEEEecCCCEEEEEEecccCcc--------cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 374 NMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQ--------GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
..+++|+-+.+|.+.+. |..+++|.-...... ..++-.+|.+++.+++--.|.-..=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999875 445666654332211 124567899999998776766666667788889999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+++..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+...
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999998543 2567788888899999998 99999999999998765 999999998753
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=5.9e-09 Score=96.31 Aligned_cols=144 Identities=19% Similarity=0.296 Sum_probs=109.9
Q ss_pred ccccccccCcEEEEEEEecCCCEEEEEEecccC--------cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 372 TKNMLGRGGFGTVYKGRLQDGREIAVKKLATNS--------MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 372 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
....+-+|+-+.|+++.+. |+..+||.-.... .-...+..+|.+.+.++.--.|.-..=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678899999999999985 7777777553321 112456788999999987666666666677888889999
Q ss_pred eecCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC---CeEEEecCCccc
Q 005649 444 EYLPN-KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM---KPKISDFGLAKL 519 (686)
Q Consensus 444 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~~ 519 (686)
||+++ .++.+++...-... ........++..|-+.+.-||.+. |+||||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 47888887644332 233333788999999999999987 99999999999997655 358999999875
Q ss_pred c
Q 005649 520 F 520 (686)
Q Consensus 520 ~ 520 (686)
.
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 4
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.95 E-value=6.8e-10 Score=119.86 Aligned_cols=248 Identities=19% Similarity=0.163 Sum_probs=177.4
Q ss_pred hhCCCcccccccccCcEEEEEEEec--CCCEEEEEEecccCcccHHHH--HHHHHHHHhc-CCCCcccEEEEEEecCceE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ--DGREIAVKKLATNSMQGKEEF--ENEVRVLLKM-QHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vavK~l~~~~~~~~~~~--~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 440 (686)
-+.+|..+..||.|.|+.|++...+ ++..+++|.+.+.......+. ..|+.+...+ .|.+.+.....+...+..+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3568999999999999999998754 678889998876544333322 3566666665 5888888877777777888
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CCeEEEecCCccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ-MKPKISDFGLAKL 519 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~ 519 (686)
+--||++++++...+ .....++...++.+..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+.-
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 999999999887666 23344788889999999999999999866 9999999999999876 7889999999863
Q ss_pred cCCcCccccccccccCCCcC--chhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 520 FHDEQSRHRTHQIAGTFGYM--APEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 520 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
+.-.. .......++. +++......+-.+.|+++||..+.|.++|..--.... . +.
T Consensus 417 ~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~----------~~ 473 (524)
T KOG0601|consen 417 LAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------Q----------SL 473 (524)
T ss_pred cceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------c----------ce
Confidence 22111 0112223344 5555566778899999999999999999875322110 0 11
Q ss_pred cccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 598 ~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
.+.-..+...+... ..+..+...+..+++..||...++..+...+
T Consensus 474 ~i~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 474 TIRSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred eeecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 11111111112223 6777888899999999999999887766544
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.6e-08 Score=95.54 Aligned_cols=126 Identities=26% Similarity=0.349 Sum_probs=83.8
Q ss_pred EEEEEEecCCCEEEEEEecccCcc--------------------------cHHHHHHHHHHHHhcCCC--CcccEEEEEE
Q 005649 383 TVYKGRLQDGREIAVKKLATNSMQ--------------------------GKEEFENEVRVLLKMQHR--NLVQLFGCCV 434 (686)
Q Consensus 383 ~Vy~~~~~~g~~vavK~l~~~~~~--------------------------~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 434 (686)
.||.|...+|..+|||+.+..... ......+|.+.|.++..- ++++++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 489999999999999987542100 013467899999999765 56777655
Q ss_pred ecCceEEEEeecC--CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEecCCCCCcEEEcCCCCeEE
Q 005649 435 QERERILVYEYLP--NKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLY-LHRDSVLRIIHRDIKASNILLDHQMKPKI 511 (686)
Q Consensus 435 ~~~~~~lv~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 511 (686)
....|||||++ +..+..+.... ++......++.+++..+.. +|..+ |+||||++.||+++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24579999998 55554433211 1134456677788886655 56766 9999999999999988 9999
Q ss_pred EecCCccccC
Q 005649 512 SDFGLAKLFH 521 (686)
Q Consensus 512 ~Dfgla~~~~ 521 (686)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999987554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=6.1e-08 Score=98.67 Aligned_cols=139 Identities=18% Similarity=0.146 Sum_probs=101.0
Q ss_pred ccccCcEEEEEEEecCCCEEEEEEecccCcc-----------cHHHHHHHHHHHHhcCCCC--cccEEEEEEec-----C
Q 005649 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQ-----------GKEEFENEVRVLLKMQHRN--LVQLFGCCVQE-----R 437 (686)
Q Consensus 376 LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~-----------~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~-----~ 437 (686)
+-+.....|.+..+ +|+.+.||+....... ....+.+|...+.++...+ .++++.+.+.. .
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333445777766 5789999977443311 1124788999988885433 34556666542 3
Q ss_pred ceEEEEeecCCC-ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-------CCCe
Q 005649 438 ERILVYEYLPNK-SLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH-------QMKP 509 (686)
Q Consensus 438 ~~~lv~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------~~~~ 509 (686)
..+||+|++++. +|.+++.+.. ....+...+..++.+++..+.-||..+ |+|+|++++|||++. +..+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 578999999886 8988885321 223566677889999999999999998 999999999999975 4689
Q ss_pred EEEecCCccc
Q 005649 510 KISDFGLAKL 519 (686)
Q Consensus 510 kl~Dfgla~~ 519 (686)
.|+||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998753
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.1e-07 Score=98.20 Aligned_cols=272 Identities=16% Similarity=0.161 Sum_probs=165.0
Q ss_pred cccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEE------EEecC-ceEEE
Q 005649 371 STKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGC------CVQER-ERILV 442 (686)
Q Consensus 371 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~------~~~~~-~~~lv 442 (686)
...+-||+|+-+.+|---. -...+.|+..........+.. ..|.+. .||-+-.=+-+ .-++. ...+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4457799999999986432 234567888665544333322 223332 45533220111 01122 25577
Q ss_pred EeecCCC-ChhHHHhh---cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 443 YEYLPNK-SLDKFLFD---KSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 443 ~Ey~~~g-sL~~~l~~---~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
|..+.+. -...++.- .+.-...+|...+++++.++.+.+.||+.| .+-||++++|+|+.+++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 7777654 23333321 122245889999999999999999999998 8899999999999999999999865433
Q ss_pred ccCCcCccccccccccCCCcCchhhhh-----cCCCChhHHHHHHHHHHHHHHcC-CCCCcccchHhHH-HHHHHHHHHH
Q 005649 519 LFHDEQSRHRTHQIAGTFGYMAPEYAI-----RGFLSVKSDVFSFGVLLLEIISG-RKNYDRQLEAENQ-ELLKLARRLE 591 (686)
Q Consensus 519 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG-~~p~~~~~~~~~~-~~~~~~~~~~ 591 (686)
...+ ........|...|.+||... +..-+...|-|.+||++++++.| ++||.+....... ...+ ..+
T Consensus 166 i~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~I 239 (637)
T COG4248 166 INAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDI 239 (637)
T ss_pred eccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhh
Confidence 3211 12234467888999999754 33456789999999999999985 9999754321100 0000 000
Q ss_pred hcCccccccccccC------CCC-HHHHHHHHHHHHHcccc--cccCCCCHHHHHHHhcCCCCCCCCCCCCCCC
Q 005649 592 EEGRLMELVDVRIG------TYP-EEIALRFMQIALLCTED--FIEDRPTMSATLSMLSNSSVPIPSVTESPDH 656 (686)
Q Consensus 592 ~~~~~~~~~d~~l~------~~~-~~~~~~l~~li~~cl~~--~p~~RPt~~evl~~L~~~~~~~~~~p~~p~~ 656 (686)
..+.+-..-|...+ ..| ...+..+..+..+|+.. ++.-|||.+..+..|.....++-++.-+..|
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H 313 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMH 313 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccc
Confidence 11111111111110 111 23456677788888865 3568999999988887655444433333333
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=9.9e-10 Score=124.42 Aligned_cols=250 Identities=20% Similarity=0.214 Sum_probs=163.8
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCccc---HHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQG---KEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
..+.|.+.+-+.+|.++.++...-. .|...++|......... .+....+-.++-..+||-++....-+.-.....|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3466777778888999988876532 23222333332211111 1111122122222233444433333334567889
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
+++|..+++|...|+... ..+.......+..+...+++||... +.|+|++|.|+++..++..++.|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999999887543 3454445556667888999999864 8999999999999999999999998433221
Q ss_pred C------c-------------------Cc----cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCC
Q 005649 522 D------E-------------------QS----RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNY 572 (686)
Q Consensus 522 ~------~-------------------~~----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~ 572 (686)
. . .. ........||+.|.+||.+.+.......|.|+.|++++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0 00 01123367899999999999999999999999999999999999999
Q ss_pred cccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHH
Q 005649 573 DRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMS 634 (686)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 634 (686)
...........+-.. |......+........+++...+..+|.+|-.+.
T Consensus 1036 na~tpq~~f~ni~~~-------------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNR-------------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccC-------------CCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 865443322111100 1111233555667778889999999999998776
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.4e-06 Score=84.28 Aligned_cols=138 Identities=16% Similarity=0.167 Sum_probs=104.2
Q ss_pred cccCcEEEEEEEecCCCEEEEEEecccC------cccHHHHHHHHHHHHhcCC--CCcccEEEEEEec----CceEEEEe
Q 005649 377 GRGGFGTVYKGRLQDGREIAVKKLATNS------MQGKEEFENEVRVLLKMQH--RNLVQLFGCCVQE----RERILVYE 444 (686)
Q Consensus 377 G~G~fG~Vy~~~~~~g~~vavK~l~~~~------~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~----~~~~lv~E 444 (686)
|+||.+.|++-.+. |+.+-+|+-.... ..+...|.+|+..+.++.. -++++++...... ...+||+|
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 67899999998774 5579999876321 2356789999999999853 2355555222221 24689999
Q ss_pred ecCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC--eEEEecCCccc
Q 005649 445 YLPN-KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK--PKISDFGLAKL 519 (686)
Q Consensus 445 y~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~~ 519 (686)
-+++ -+|.+++.+.. ....+...+..++.+++..+.-||..+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 106 ~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 8864 58888875432 234677888899999999999999998 999999999999986667 99999977654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=3.9e-07 Score=89.97 Aligned_cols=137 Identities=20% Similarity=0.228 Sum_probs=97.9
Q ss_pred CcccccccccCcEEEEEEEecCCCEEEEEEecccCc----------------------ccHHHHHHHHHHHHhcCCC--C
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSM----------------------QGKEEFENEVRVLLKMQHR--N 425 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~----------------------~~~~~~~~e~~~l~~l~h~--n 425 (686)
..+.++||.|--+.||.|..++|.+++||.=+.... ......++|.+.|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345688999999999999999999999996432110 0122357899999998654 6
Q ss_pred cccEEEEEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC
Q 005649 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH 505 (686)
Q Consensus 426 iv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 505 (686)
+++.+++ +...+||||+++-.|...- ++....-.++..|++-+..+-..| |||||+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 7776654 4567999999886664332 123333344555555555555555 999999999999999
Q ss_pred CCCeEEEecCCccccC
Q 005649 506 QMKPKISDFGLAKLFH 521 (686)
Q Consensus 506 ~~~~kl~Dfgla~~~~ 521 (686)
+|.+.++||-.+....
T Consensus 238 dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 238 DGDIVVIDWPQAVPIS 253 (304)
T ss_pred CCCEEEEeCcccccCC
Confidence 9999999997665443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.55 E-value=9.7e-07 Score=86.81 Aligned_cols=124 Identities=23% Similarity=0.282 Sum_probs=92.7
Q ss_pred CCCEEEEEEecccCc-------ccHHHHHHHHHHHHhcCC--CCcccEEEEEEecC----ceEEEEeecCCC-ChhHHHh
Q 005649 391 DGREIAVKKLATNSM-------QGKEEFENEVRVLLKMQH--RNLVQLFGCCVQER----ERILVYEYLPNK-SLDKFLF 456 (686)
Q Consensus 391 ~g~~vavK~l~~~~~-------~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~Ey~~~g-sL~~~l~ 456 (686)
.++.+.+|.+..... .......+|...+..+.. -..++.+++.+... ..+||+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 355666665432211 234567888888888753 34567777776633 458999999884 7999886
Q ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC---CeEEEecCCcccc
Q 005649 457 DKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM---KPKISDFGLAKLF 520 (686)
Q Consensus 457 ~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~~~ 520 (686)
.... ++......++.++++.+.-||..+ |+|+|++++|||++.+. .+.++||+-++..
T Consensus 111 ~~~~---~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQ---LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcc---cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 5322 566678889999999999999998 99999999999999887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.7e-08 Score=110.59 Aligned_cols=154 Identities=21% Similarity=0.310 Sum_probs=109.2
Q ss_pred HHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc-------cccccccccCCCcCchhhhhc
Q 005649 474 MGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS-------RHRTHQIAGTFGYMAPEYAIR 546 (686)
Q Consensus 474 ~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~ 546 (686)
.+++.||.|+|... ++||++|.|++|.++.++..||+.|+.+........ .....-......|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34559999999875 699999999999999999999999998765443111 011111234567999999999
Q ss_pred CCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccc
Q 005649 547 GFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTED 625 (686)
Q Consensus 547 ~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~ 625 (686)
...+.++|+||+|+++|-+.. |+.-+............. ...+.....+..+.+.++.+-+.+++..
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~------------~~~~~~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR------------NLLNAGAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh------------cccccccccccccCcHHHHHHHHHHhcC
Confidence 889999999999999999995 655554332222211111 0111112234566778888899999999
Q ss_pred cccCCCCHHHHHHHhc
Q 005649 626 FIEDRPTMSATLSMLS 641 (686)
Q Consensus 626 ~p~~RPt~~evl~~L~ 641 (686)
++.-||++.++....-
T Consensus 252 ~~~~rp~~~~l~~~~f 267 (700)
T KOG2137|consen 252 DSAVRPTLDLLLSIPF 267 (700)
T ss_pred CcccCcchhhhhcccc
Confidence 9999998888765543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=5.9e-07 Score=99.02 Aligned_cols=141 Identities=19% Similarity=0.263 Sum_probs=92.6
Q ss_pred ccccccCcEEEEEEEecCCCEEEEEEecccCcccH------------------------------H----------HHHH
Q 005649 374 NMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGK------------------------------E----------EFEN 413 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~------------------------------~----------~~~~ 413 (686)
+-|+.++-|.||+|++++|+.||||+...+-.... + +|..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67899999999999999999999999875421110 0 1334
Q ss_pred HHHHHHhc----C-CCCcccEEEEEE-ecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 005649 414 EVRVLLKM----Q-HRNLVQLFGCCV-QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487 (686)
Q Consensus 414 e~~~l~~l----~-h~niv~l~~~~~-~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ 487 (686)
|...+.++ + .++ +++=.++. -.....|+|||++|-.+.+....+. ..++.+.+.....++.- ..+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f~--~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAFL--RQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHHH--HHHHhcC
Confidence 44444444 1 233 22223333 2467789999999999988853322 22454443333322221 1122233
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 488 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
++|.|.+|.||+++.++++.+.|||+...+..
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999887654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.1e-05 Score=80.36 Aligned_cols=139 Identities=17% Similarity=0.201 Sum_probs=85.5
Q ss_pred ccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCC--cccEEEEEEecCceEEEEeecCCCC-
Q 005649 374 NMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN--LVQLFGCCVQERERILVYEYLPNKS- 450 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~Ey~~~gs- 450 (686)
..||+|..+.||+. .|..+++|...... ......+|.+++..+..-+ +++.+++..+.+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999983 25567888875432 3456788999999986443 4778888877777889999998863
Q ss_pred hhHHHh--------------h-----cC-CCCCCCHHHHHHHH-H----------HHHH-HHHHHHh-CCCCCeEecCCC
Q 005649 451 LDKFLF--------------D-----KS-KSAILDWPKRLNII-M----------GVAR-GLLYLHR-DSVLRIIHRDIK 497 (686)
Q Consensus 451 L~~~l~--------------~-----~~-~~~~l~~~~~~~i~-~----------~ia~-~L~~LH~-~~~~~ivH~Dlk 497 (686)
+...+. . +. ............-. . .+.+ ...+|.. .....++|+|++
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 221110 0 00 00001111110000 0 0111 1122221 112457999999
Q ss_pred CCcEEEcCCCCeEEEecCCcc
Q 005649 498 ASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 498 p~NIll~~~~~~kl~Dfgla~ 518 (686)
|.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.4e-05 Score=77.69 Aligned_cols=138 Identities=14% Similarity=0.220 Sum_probs=92.5
Q ss_pred hhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHH---------HHHHHHHHhcC---CCCcccEEEEE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEF---------ENEVRVLLKMQ---HRNLVQLFGCC 433 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~---------~~e~~~l~~l~---h~niv~l~~~~ 433 (686)
...+|...+++-......|.+-.. +|+.+++|..........+.| .+.+..+.+++ ...+..++-..
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 357788888888877777777666 578999998866543333222 23344444443 23333333332
Q ss_pred Ee-----cCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC
Q 005649 434 VQ-----ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK 508 (686)
Q Consensus 434 ~~-----~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 508 (686)
.. ....+|+|||++|..|.++.. ++. .+...+.+.+.-||+.| ++|||.+|.|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 22 234568999999988765531 222 24456778899999998 99999999999998654
Q ss_pred eEEEecCCccc
Q 005649 509 PKISDFGLAKL 519 (686)
Q Consensus 509 ~kl~Dfgla~~ 519 (686)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.18 E-value=1e-05 Score=88.91 Aligned_cols=140 Identities=16% Similarity=0.247 Sum_probs=91.3
Q ss_pred ccccccCcEEEEEEEecCCCEEEEEEecccCccc---------------------------HH----------HHHHHHH
Q 005649 374 NMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQG---------------------------KE----------EFENEVR 416 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~---------------------------~~----------~~~~e~~ 416 (686)
+-||.-..|.||++++++|+.||||+.+..-... .+ +|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5789999999999999999999999986532111 00 1334444
Q ss_pred HHHhc----CCCC------cccEEEEEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 005649 417 VLLKM----QHRN------LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD 486 (686)
Q Consensus 417 ~l~~l----~h~n------iv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~ 486 (686)
-..+. .|-+ |++++.. -.....|+||||+|..+.+...-.. ..++...+..-+.+...-+-+-|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~~l~~~~~~qIf~~-- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDK--RGISPHDILNKLVEAYLEQIFKT-- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHH--cCCCHHHHHHHHHHHHHHHHHhc--
Confidence 33332 3544 3333322 2347789999999987766543222 22555555544444433333333
Q ss_pred CCCCeEecCCCCCcEEEcC----CCCeEEEecCCccccCC
Q 005649 487 SVLRIIHRDIKASNILLDH----QMKPKISDFGLAKLFHD 522 (686)
Q Consensus 487 ~~~~ivH~Dlkp~NIll~~----~~~~kl~Dfgla~~~~~ 522 (686)
| ++|+|-+|.||+++. ++.+.+-|||+...+..
T Consensus 321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3 899999999999984 66899999999876653
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.11 E-value=4.3e-05 Score=77.27 Aligned_cols=139 Identities=17% Similarity=0.150 Sum_probs=85.6
Q ss_pred ccccCc-EEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcC-CCCcccEEEEEEecCceEEEEeecCCCChhH
Q 005649 376 LGRGGF-GTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQERERILVYEYLPNKSLDK 453 (686)
Q Consensus 376 LG~G~f-G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~ 453 (686)
|..|.. ..||+.... +..+++|+..... ...+..|++++..+. +--+++++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 344444 778998764 4778888875443 345678888888883 4556788888777777899999999888764
Q ss_pred HHh-------------------hcCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----CC
Q 005649 454 FLF-------------------DKSK-SAILD--WPKRLNIIM--------------------GVARGLLYLHR----DS 487 (686)
Q Consensus 454 ~l~-------------------~~~~-~~~l~--~~~~~~i~~--------------------~ia~~L~~LH~----~~ 487 (686)
... .... ...+. ....+.... .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 421 0000 00111 001110000 01111222211 12
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 488 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2559999999999999998778899998765
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.09 E-value=4.5e-05 Score=76.16 Aligned_cols=143 Identities=21% Similarity=0.210 Sum_probs=85.5
Q ss_pred cccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCC--CcccEEEEEEec---CceEEEEeecC
Q 005649 373 KNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHR--NLVQLFGCCVQE---RERILVYEYLP 447 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~Ey~~ 447 (686)
++.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+++++.+.... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678999999999999977 69999997554 4456778888888888433 456777755433 34689999999
Q ss_pred CCChhH----------------HH---hhc-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 005649 448 NKSLDK----------------FL---FDK-SKSAILDWPK---------RLNI------------IMGVAR-GLLYLHR 485 (686)
Q Consensus 448 ~gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-~L~~LH~ 485 (686)
+..+.. .+ +.. .....+.+.. .... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 111 0111111110 0000 111222 2333332
Q ss_pred ----CCCCCeEecCCCCCcEEEc-CCCCeEEEecCCcc
Q 005649 486 ----DSVLRIIHRDIKASNILLD-HQMKPKISDFGLAK 518 (686)
Q Consensus 486 ----~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~ 518 (686)
.....++|+|+.|+|||++ +++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2335699999999999999 66666899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.09 E-value=4.7e-05 Score=74.74 Aligned_cols=153 Identities=22% Similarity=0.266 Sum_probs=99.1
Q ss_pred CHHHHHHhhCCCccccc---ccccCcEEEEEEEecCCCEEEEEEecccCcccH---------H---------------HH
Q 005649 359 NLDVLIAATDNFSTKNM---LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGK---------E---------------EF 411 (686)
Q Consensus 359 ~~~~l~~at~~f~~~~~---LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~---------~---------------~~ 411 (686)
+++.|....++..+... |..|.-+.||+|...++..+|||+++....... . .-
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 34445555555555444 556777889999988899999999865322111 1 12
Q ss_pred HHHHHHHHhcC--CCCcccEEEEEEecCceEEEEeecCCCCh-hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 005649 412 ENEVRVLLKMQ--HRNLVQLFGCCVQERERILVYEYLPNKSL-DKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488 (686)
Q Consensus 412 ~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~Ey~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~ 488 (686)
..|+.-|.++. +=.+++.+.+. +-.|||||+...-+ .-.| +...+...+...+..++++.+.-|-...
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a- 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA- 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence 45777777763 33445555442 34699999965411 1111 1112233356666777888888877733
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 489 LRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 489 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
.+||+||+.-|||+. ++.+.|+|++.+....+
T Consensus 187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred -CcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 399999999999999 88999999999876543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.9e-05 Score=76.17 Aligned_cols=105 Identities=22% Similarity=0.237 Sum_probs=83.0
Q ss_pred HHHHHHHHhcCC-CCcccEEEEEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 005649 412 ENEVRVLLKMQH-RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLR 490 (686)
Q Consensus 412 ~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 490 (686)
.+|..++..+++ +++++++|.| ..+++.||...+++......-..-...+|..+.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888876 6999999999 34789999987765421000001123689999999999999999999866556
Q ss_pred eEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 491 IIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 491 ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+...|++++|+-+++++++|+.|.+.+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999887644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00013 Score=86.94 Aligned_cols=79 Identities=18% Similarity=0.400 Sum_probs=59.1
Q ss_pred cccccccCcEEEEEEEecCC---CEEEEEEecccC-cccHHHHHHHHHHHHhcC-CCCc--ccEEEEEEec---CceEEE
Q 005649 373 KNMLGRGGFGTVYKGRLQDG---REIAVKKLATNS-MQGKEEFENEVRVLLKMQ-HRNL--VQLFGCCVQE---RERILV 442 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 442 (686)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|.++++.+. |.++ ++++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999887654 467888765432 223457889999999995 6655 8888888764 467999
Q ss_pred EeecCCCCh
Q 005649 443 YEYLPNKSL 451 (686)
Q Consensus 443 ~Ey~~~gsL 451 (686)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987653
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00027 Score=73.57 Aligned_cols=80 Identities=13% Similarity=0.162 Sum_probs=59.9
Q ss_pred CCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCC---CCcccEEEEEEec---CceEEE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQH---RNLVQLFGCCVQE---RERILV 442 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~---~~~~lv 442 (686)
.....+.||.|..+.||+-...++ .+++|..+. ......|..|.+.|+.+.- -.++++++++..+ +..+||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 445567899999999999887655 466676432 1134688999999998843 4688999888653 568999
Q ss_pred EeecCCCCh
Q 005649 443 YEYLPNKSL 451 (686)
Q Consensus 443 ~Ey~~~gsL 451 (686)
||+++++++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00029 Score=68.31 Aligned_cols=129 Identities=17% Similarity=0.298 Sum_probs=89.8
Q ss_pred ccccccccCcEEEEEEEecCCCEEEEEEecccC----------------cccHHHHHHHHHHHHhcC------CCCcccE
Q 005649 372 TKNMLGRGGFGTVYKGRLQDGREIAVKKLATNS----------------MQGKEEFENEVRVLLKMQ------HRNLVQL 429 (686)
Q Consensus 372 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~l 429 (686)
....||+|+.-.||. ++++....||+..... ....++..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346799999999986 4455677888886654 222456667776666655 8899999
Q ss_pred EEEEEecCceEEEEeecCC--C----ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 005649 430 FGCCVQERERILVYEYLPN--K----SLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL 503 (686)
Q Consensus 430 ~~~~~~~~~~~lv~Ey~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 503 (686)
+|+..++....+|+|.+.+ | +|.+++.+ ..++. .....+.++ ..||-++. |+.+|++|+||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEEE
Confidence 9999999999999998743 3 47777733 33555 444444444 44555554 9999999999999
Q ss_pred cCCC----CeEEEe
Q 005649 504 DHQM----KPKISD 513 (686)
Q Consensus 504 ~~~~----~~kl~D 513 (686)
..+. .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 5332 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00023 Score=71.56 Aligned_cols=73 Identities=15% Similarity=0.229 Sum_probs=46.7
Q ss_pred ccccccCcEE-EEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCC---CcccEEEEEEecC---ceEEEEeec
Q 005649 374 NMLGRGGFGT-VYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHR---NLVQLFGCCVQER---ERILVYEYL 446 (686)
Q Consensus 374 ~~LG~G~fG~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~---~~~lv~Ey~ 446 (686)
+.|+.|+... ||+. +..+++|.... ......+..|.+.+..+... .+.++++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 4577777664 8875 23577776543 22345788999999888532 3455555443322 348899999
Q ss_pred CCCChh
Q 005649 447 PNKSLD 452 (686)
Q Consensus 447 ~~gsL~ 452 (686)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00057 Score=63.67 Aligned_cols=128 Identities=23% Similarity=0.372 Sum_probs=88.7
Q ss_pred cccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCc-ccEEEEEEecCceEEEEeecCCC
Q 005649 371 STKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL-VQLFGCCVQERERILVYEYLPNK 449 (686)
Q Consensus 371 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~Ey~~~g 449 (686)
...+.|++|++|.||+|.+. |..+|+|+-..++ ....++.|.++|..+.-.++ .+++.+..+ ++.|||+.+-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence 34578999999999999996 5688999876544 45678999999999876554 445554333 4559999888
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC-C-CcEEEcCCCCeEEEecCCccc
Q 005649 450 SLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIK-A-SNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 450 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk-p-~NIll~~~~~~kl~Dfgla~~ 519 (686)
.|.+.-... +-.. +..+++.-.-|-..| |-|+.|+ | +||++. +..+.|+||.-|..
T Consensus 98 ~L~~~~~~~------~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~-~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG------DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVN-DRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc------cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEec-CCcEEEEEccchhh
Confidence 887765321 2222 334445544455544 8899887 4 455554 45999999998874
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00063 Score=68.27 Aligned_cols=75 Identities=16% Similarity=0.264 Sum_probs=48.7
Q ss_pred cccccccCcEEEEEEEecC--CCEEEEEEecccCcccHHHHHHHHHHHHhcCCCC-cccEEEEEEecCceEEEEeecCCC
Q 005649 373 KNMLGRGGFGTVYKGRLQD--GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN-LVQLFGCCVQERERILVYEYLPNK 449 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~Ey~~~g 449 (686)
.+.|..|-...+|+....+ ++.+++|+....... ..+-.+|+.++..+...+ .+++++... ..++|||+++.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3567778888999988764 678889977543221 123357888888885433 345544322 24899999987
Q ss_pred Chh
Q 005649 450 SLD 452 (686)
Q Consensus 450 sL~ 452 (686)
++.
T Consensus 78 ~l~ 80 (235)
T cd05157 78 TLE 80 (235)
T ss_pred cCC
Confidence 763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.61 E-value=6.7e-06 Score=89.56 Aligned_cols=190 Identities=17% Similarity=0.104 Sum_probs=132.5
Q ss_pred hhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCC-cccEEEEEEecCceEEEEe
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN-LVQLFGCCVQERERILVYE 444 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E 444 (686)
.+.-+..-+-+++|+++.++|.+-...+....+.+... ....-++++|.+++||| .+..++-+..++...+.++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 34445555678899999999987544444444544322 34456889999999999 5666666666677889999
Q ss_pred ecCCC-ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 445 YLPNK-SLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 445 y~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
++..+ +-..-.. .....+...+...+...-.+++++||+.- =+|+| ||+..+ ...|..||+....+...
T Consensus 315 i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 315 ICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 98776 2111110 01111334445566667788999999853 38888 776655 67899999998877654
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYD 573 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~ 573 (686)
. ......+++.++|||....+.+..+-|+|+.|+--.++--|-+|-.
T Consensus 385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 3 2334578999999999999999999999999987777776766643
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.0013 Score=70.57 Aligned_cols=76 Identities=16% Similarity=0.215 Sum_probs=55.0
Q ss_pred cccccccCcEEEEEEEecCC-CEEEEEEeccc-----C--cccHHHHHHHHHHHHhcC---CCCcccEEEEEEecCceEE
Q 005649 373 KNMLGRGGFGTVYKGRLQDG-REIAVKKLATN-----S--MQGKEEFENEVRVLLKMQ---HRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~g-~~vavK~l~~~-----~--~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~l 441 (686)
.+.||.|.+..||+....+| +.++||.-... . .-..+++..|.+.|..+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35789999999999999877 48999985321 1 123466777888887762 3467777776 4466889
Q ss_pred EEeecCCCC
Q 005649 442 VYEYLPNKS 450 (686)
Q Consensus 442 v~Ey~~~gs 450 (686)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00056 Score=69.69 Aligned_cols=138 Identities=16% Similarity=0.114 Sum_probs=79.3
Q ss_pred ccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCc-ccEEEEEEecCceEEEEeecCCCChhHH
Q 005649 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL-VQLFGCCVQERERILVYEYLPNKSLDKF 454 (686)
Q Consensus 376 LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~Ey~~~gsL~~~ 454 (686)
+..|-...+|+... +++.+++|........-.-+..+|.++++.+....+ ++++.... ..+|+||+++..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677788998874 567888887654322211235778888888854333 45554432 3689999998765421
Q ss_pred -----------------HhhcC-CCCCCCHHHHH-HHHH---------HHHHHHHHHHhC-----CCCCeEecCCCCCcE
Q 005649 455 -----------------LFDKS-KSAILDWPKRL-NIIM---------GVARGLLYLHRD-----SVLRIIHRDIKASNI 501 (686)
Q Consensus 455 -----------------l~~~~-~~~~l~~~~~~-~i~~---------~ia~~L~~LH~~-----~~~~ivH~Dlkp~NI 501 (686)
+|... ....++....+ .... .+...+..+... ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11111 11112222111 1111 111222222221 123589999999999
Q ss_pred EEcCCCCeEEEecCCccc
Q 005649 502 LLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 502 ll~~~~~~kl~Dfgla~~ 519 (686)
++++++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 78999988763
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.001 Score=63.98 Aligned_cols=125 Identities=27% Similarity=0.434 Sum_probs=89.7
Q ss_pred CCCcccccccccCc-EEEEEEEecCCCEEEEEEeccc---C-------c-----------ccHHHHHHHHHHHHhcC---
Q 005649 368 DNFSTKNMLGRGGF-GTVYKGRLQDGREIAVKKLATN---S-------M-----------QGKEEFENEVRVLLKMQ--- 422 (686)
Q Consensus 368 ~~f~~~~~LG~G~f-G~Vy~~~~~~g~~vavK~l~~~---~-------~-----------~~~~~~~~e~~~l~~l~--- 422 (686)
.+++..+.||.|.. |.||+.++. |+.+|+|.+... . . .-..-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78888999999999 999999994 789999994221 0 0 01134788999888874
Q ss_pred CCCc--ccEEEEEEec------------------CceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 005649 423 HRNL--VQLFGCCVQE------------------RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLY 482 (686)
Q Consensus 423 h~ni--v~l~~~~~~~------------------~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~ 482 (686)
+.++ |+.+||..-. ....||.||.+... .++ ..-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 4566 8888887322 12357788775433 112 2345667788889
Q ss_pred HHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCc
Q 005649 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517 (686)
Q Consensus 483 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 517 (686)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99987 999999999975 3489999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0011 Score=77.65 Aligned_cols=198 Identities=21% Similarity=0.171 Sum_probs=135.3
Q ss_pred HHHHHHHHHhcCCCCcccEEEEEEecCceE----EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 005649 411 FENEVRVLLKMQHRNLVQLFGCCVQERERI----LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD 486 (686)
Q Consensus 411 ~~~e~~~l~~l~h~niv~l~~~~~~~~~~~----lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~ 486 (686)
.+-|+..+.++.|+|++.++.+..++.... +..|++..-++...+... ..++......+..++.+||.|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v---~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV---GSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc---cccCHHHHHHHHHHHhhhHHHHHHh
Confidence 456777888889999999999987754332 445777777777666433 3477888888899999999999997
Q ss_pred CCCCeEecCCCCC---cEEEcCCCCeEEE--ecCCccccCCcCccccccccccCCCcCchhhhhcCCC--ChhHHHHHHH
Q 005649 487 SVLRIIHRDIKAS---NILLDHQMKPKIS--DFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL--SVKSDVFSFG 559 (686)
Q Consensus 487 ~~~~ivH~Dlkp~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--s~ksDv~s~G 559 (686)
. ..|.-|..+ +.-++.++.+.++ ||+..+.+.+.... .....+..+.+||....... +...|+|.+|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHH
Confidence 5 455544444 5555667777777 88888766543221 11233456778887766544 4458999999
Q ss_pred HHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 560 VLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 560 vvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
..+..+..|..+-....... .. + +......+.+....|+..++++|++..+++..
T Consensus 380 ll~~~~~~~~~i~~~~~~~~---------~~-------------l---~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAVPV---------SL-------------L---DVLSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHHhhhhhcCcccccccchh---------hh-------------h---ccccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 99999999876532110000 00 0 11111256678899999999999999999987
Q ss_pred hcC
Q 005649 640 LSN 642 (686)
Q Consensus 640 L~~ 642 (686)
...
T Consensus 435 ~f~ 437 (1351)
T KOG1035|consen 435 PFL 437 (1351)
T ss_pred hhc
Confidence 743
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0048 Score=64.26 Aligned_cols=143 Identities=17% Similarity=0.131 Sum_probs=86.4
Q ss_pred ccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCC--cccEEEE------EEecCceEEEE
Q 005649 372 TKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN--LVQLFGC------CVQERERILVY 443 (686)
Q Consensus 372 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~ 443 (686)
..+.|..|....+|+....+ ..+++|+... ...+....|+.++..+.+.+ +++++.. ....+..++++
T Consensus 18 ~i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 18 SFEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred heecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 35667778778999987754 4788888754 23456677888887774332 4454432 12345668999
Q ss_pred eecCCCChhH----HH----------hhcCC--------CCCCCHHHHH----------HHHHHHHHHHHHHHhC----C
Q 005649 444 EYLPNKSLDK----FL----------FDKSK--------SAILDWPKRL----------NIIMGVARGLLYLHRD----S 487 (686)
Q Consensus 444 Ey~~~gsL~~----~l----------~~~~~--------~~~l~~~~~~----------~i~~~ia~~L~~LH~~----~ 487 (686)
||++|..+.. .. |.... .....|.... .....+...+.++.+. .
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9998876532 11 11000 0112222211 0111233444555431 1
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 488 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
...++|+|++|.||+++++....|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 2359999999999999998777899998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.003 Score=66.08 Aligned_cols=140 Identities=23% Similarity=0.305 Sum_probs=82.1
Q ss_pred ccccccCcEEEEEEEecC-------CCEEEEEEecccCcccHHHHHHHHHHHHhcCCCC-cccEEEEEEecCceEEEEee
Q 005649 374 NMLGRGGFGTVYKGRLQD-------GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN-LVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~Ey 445 (686)
+.|..|--..+|+....+ ++.+++|+..... ....+..+|.+++..+...+ .+++++++. -.+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 345556666888887655 5788899875433 22234577888888874333 345665553 2368999
Q ss_pred cCCCChhHHH-----------------hhcCCCC------CCC--HHHHHH--------------------------HHH
Q 005649 446 LPNKSLDKFL-----------------FDKSKSA------ILD--WPKRLN--------------------------IIM 474 (686)
Q Consensus 446 ~~~gsL~~~l-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~ 474 (686)
++|..+.... |...... ... |..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9887764321 1111000 000 111111 111
Q ss_pred HHHHHHHHHHh------CCCCCeEecCCCCCcEEEcCC----CCeEEEecCCcc
Q 005649 475 GVARGLLYLHR------DSVLRIIHRDIKASNILLDHQ----MKPKISDFGLAK 518 (686)
Q Consensus 475 ~ia~~L~~LH~------~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~ 518 (686)
.+..-+..|.. .....++|+|+.+.|||++++ +.++++||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22223334432 134579999999999999985 889999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0033 Score=64.82 Aligned_cols=76 Identities=18% Similarity=0.292 Sum_probs=50.2
Q ss_pred CcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhc---CCCCcccEEEEEEecCceEEEEeec
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKM---QHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
.+..+.++-|....+|+.. .+++.+.||.-. ......|..|..-|+.| .--.+++++++...++..+|++||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 4556678889999999987 568899999876 23345788888888888 3456889999998888889999999
Q ss_pred CCC
Q 005649 447 PNK 449 (686)
Q Consensus 447 ~~g 449 (686)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0055 Score=63.60 Aligned_cols=147 Identities=16% Similarity=0.252 Sum_probs=83.3
Q ss_pred cccccccccCcEEEEEEEecCCCEEEEEEec--ccCcccHHHHHHHHHHHHhcCC--CCcccEEEEEEecC--ceEEEEe
Q 005649 371 STKNMLGRGGFGTVYKGRLQDGREIAVKKLA--TNSMQGKEEFENEVRVLLKMQH--RNLVQLFGCCVQER--ERILVYE 444 (686)
Q Consensus 371 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~--~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~E 444 (686)
...+.+..|---.+|..... ++.++++ .. ...........+|+++++.+.- --....++.|.++. ..+.||+
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred ceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 33444433333334444333 7788888 33 1233345566788888888743 34456677777766 7799999
Q ss_pred ecCCCChhHHHhhcC-----------------------------------CCCCCCHHHHHHHH--------HHHHHHHH
Q 005649 445 YLPNKSLDKFLFDKS-----------------------------------KSAILDWPKRLNII--------MGVARGLL 481 (686)
Q Consensus 445 y~~~gsL~~~l~~~~-----------------------------------~~~~l~~~~~~~i~--------~~ia~~L~ 481 (686)
|+++..+.+.+.... .++.-.|...+..+ -....-..
T Consensus 106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~ 185 (321)
T COG3173 106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK 185 (321)
T ss_pred EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence 998743322211000 00111122222100 01122233
Q ss_pred HHHhCC-----CCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 482 YLHRDS-----VLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 482 ~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
+|+.+- ...++|||+++.|++++++.-+-|.||+++..
T Consensus 186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 443332 25699999999999999988899999999874
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0097 Score=62.72 Aligned_cols=142 Identities=15% Similarity=0.142 Sum_probs=77.4
Q ss_pred cccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCC--CcccEEE------EEEecCceEEEEe
Q 005649 373 KNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHR--NLVQLFG------CCVQERERILVYE 444 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~------~~~~~~~~~lv~E 444 (686)
.+.|+.|....+|+....+| .+++|+... ...+....|...+..|... .+++++. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 35566777778999887655 688898752 1233444455555555322 2344442 1223456789999
Q ss_pred ecCCCChh-----------HHH---hhcCCC--------CCC-CHHHHHHH------------HHH-HHHHHHHHHhC--
Q 005649 445 YLPNKSLD-----------KFL---FDKSKS--------AIL-DWPKRLNI------------IMG-VARGLLYLHRD-- 486 (686)
Q Consensus 445 y~~~gsL~-----------~~l---~~~~~~--------~~l-~~~~~~~i------------~~~-ia~~L~~LH~~-- 486 (686)
|++|..+. ..| |..... ..+ .|.....- +.+ +...+..+.+.
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 99887542 111 111100 011 12221111 111 11122233211
Q ss_pred --CCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 487 --SVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 487 --~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
-...++|+|+++.||+++++...-|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 12359999999999999976556899999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.015 Score=60.92 Aligned_cols=143 Identities=16% Similarity=0.178 Sum_probs=81.9
Q ss_pred cccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCC--CcccEEEEE------EecCceEEEEe
Q 005649 373 KNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHR--NLVQLFGCC------VQERERILVYE 444 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~------~~~~~~~lv~E 444 (686)
.+.++.|....+|+....+| .+++|+..... ..+....|.+++..|... .+++++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45667777788999877555 57788765422 234455666777666322 244544421 22456789999
Q ss_pred ecCCCChhH----H----------HhhcCCC---------CCCCHHHHHH------------HHHHHHHHHHHHHh----
Q 005649 445 YLPNKSLDK----F----------LFDKSKS---------AILDWPKRLN------------IIMGVARGLLYLHR---- 485 (686)
Q Consensus 445 y~~~gsL~~----~----------l~~~~~~---------~~l~~~~~~~------------i~~~ia~~L~~LH~---- 485 (686)
|++|..+.. . +|..... ..-.|..... ....+.+.+.++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 998855321 1 1111110 0011211110 01123344555543
Q ss_pred CCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 486 ~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.....++|+|+++.||++++++...|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123569999999999999988777899998864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.017 Score=61.42 Aligned_cols=140 Identities=19% Similarity=0.267 Sum_probs=79.4
Q ss_pred cccccCcEEEEEEEecC-----CCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCc-ccEEEEEEecCceEEEEeecCC
Q 005649 375 MLGRGGFGTVYKGRLQD-----GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL-VQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 375 ~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
.|-.|-.-.+|+....+ ++.+++|+.......-.+ -.+|..++..+...++ +++++.+... .|.||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 44446667788877532 367888887554322222 2678888888854444 4566655332 58999987
Q ss_pred CChhHH-----------------HhhcC--CCC-CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-C
Q 005649 449 KSLDKF-----------------LFDKS--KSA-ILDWPKRLNIIMGV-----------------ARGLLYL----HR-D 486 (686)
Q Consensus 449 gsL~~~-----------------l~~~~--~~~-~l~~~~~~~i~~~i-----------------a~~L~~L----H~-~ 486 (686)
.+|... +|... ... ..-|..+.++..++ ...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 776422 11111 001 11122222222111 1112222 22 2
Q ss_pred CCCCeEecCCCCCcEEEcC-CCCeEEEecCCccc
Q 005649 487 SVLRIIHRDIKASNILLDH-QMKPKISDFGLAKL 519 (686)
Q Consensus 487 ~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~ 519 (686)
....++|+|+++.|||+++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2346899999999999986 46899999988764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.016 Score=59.62 Aligned_cols=31 Identities=26% Similarity=0.519 Sum_probs=25.8
Q ss_pred CCeEecCCCCCcEEEcCCCC-eEEEecCCccc
Q 005649 489 LRIIHRDIKASNILLDHQMK-PKISDFGLAKL 519 (686)
Q Consensus 489 ~~ivH~Dlkp~NIll~~~~~-~kl~Dfgla~~ 519 (686)
+.++|+|+++.|||++++++ .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998763
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.02 Score=59.57 Aligned_cols=173 Identities=24% Similarity=0.295 Sum_probs=109.0
Q ss_pred CccccccccccccccccccCHHHHHHhhCCC-cccccccccCcEEEEEEEecCCCEEEEEEecccCcc---------c--
Q 005649 340 DDANALTNNQGIDMRSFLFNLDVLIAATDNF-STKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQ---------G-- 407 (686)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~l~~at~~f-~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~---------~-- 407 (686)
+..+..+-.+-++++...+-+..+ +.+-+ ++...|..|--+.||.+.-.+|..+|||+++..... +
T Consensus 117 DKaDRATvEqVLDPRTrmvLfrll--~RG~i~~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEf 194 (520)
T KOG2270|consen 117 DKADRATVEQVLDPRTRMVLFRLL--NRGVIVEINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEF 194 (520)
T ss_pred cchhhhhHHHhcChHHHHHHHHHH--hcCeeeecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhcccee
Confidence 334444445555555544333322 12222 333567789999999999999999999998643110 0
Q ss_pred ---------------HHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHH
Q 005649 408 ---------------KEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNI 472 (686)
Q Consensus 408 ---------------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i 472 (686)
.-..+.|++-|++|+.-.|+-.--... ....|||+|+.... |-...-+...++...+..+
T Consensus 195 RFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~ 269 (520)
T KOG2270|consen 195 RFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKAREL 269 (520)
T ss_pred eeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCCCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHH
Confidence 012356788888886554432221111 13468999985321 1111123344777777777
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 473 IMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 473 ~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
-.+++.-+.-|-+.+ ++||.||+--|+|+ .+|.+.|+|-+.+.....
T Consensus 270 Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-hdG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 270 YQQCVRIMRRLYQKC--RLVHADLSEFNLLY-HDGKLYIIDVSQSVEHDH 316 (520)
T ss_pred HHHHHHHHHHHHHHh--ceeccchhhhhheE-ECCEEEEEEccccccCCC
Confidence 788888888888776 59999999999988 457899999887765443
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.0066 Score=61.95 Aligned_cols=134 Identities=16% Similarity=0.185 Sum_probs=92.5
Q ss_pred CcccccccccCcEEEEEEEecCCCEEEEEEeccc-----Cccc-----------------HHHHHHHHHHHHhcCC--CC
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATN-----SMQG-----------------KEEFENEVRVLLKMQH--RN 425 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~-----~~~~-----------------~~~~~~e~~~l~~l~h--~n 425 (686)
+...++||-|.-+.||.+-..+|++.++|.=... +... .-....|+..|+.|.. -.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 5678999999999999999999999988853211 0001 1123567778888743 34
Q ss_pred cccEEEEEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC
Q 005649 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH 505 (686)
Q Consensus 426 iv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 505 (686)
+++.+++ +..++|||++.+-.|...-+ ..+...+. ..+..-+.-|..+| +||+|..-=||+|++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly---~~lm~~Iv~la~~G---lIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLY---DDLMGLIVRLANHG---LIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeee------cCChHHHH---HHHHHHHHHHHHcC---ceecccchheeEEec
Confidence 5555544 45689999998877754331 12333333 33444456677777 999999999999999
Q ss_pred CCCeEEEecCCccc
Q 005649 506 QMKPKISDFGLAKL 519 (686)
Q Consensus 506 ~~~~kl~Dfgla~~ 519 (686)
+..++++||-....
T Consensus 238 d~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 238 DDKIVVIDFPQMVS 251 (465)
T ss_pred CCCEEEeechHhhc
Confidence 99999999965443
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.073 Score=57.25 Aligned_cols=81 Identities=17% Similarity=0.123 Sum_probs=53.1
Q ss_pred ccccccccCcEEEEEEEecCCCEEEEEEecccCc-------ccHHHHHHHHHHHHhcC---CCCcccEEEEEEecCceEE
Q 005649 372 TKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSM-------QGKEEFENEVRVLLKMQ---HRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 372 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~-------~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~l 441 (686)
..+.||-|....||+.... ++.++||+-..... -...+-..|...|..+. ..++++++.++. +..++
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 3567899999999998874 56789997652111 12233344556665553 357888888876 45788
Q ss_pred EEeecCC--CChhHHH
Q 005649 442 VYEYLPN--KSLDKFL 455 (686)
Q Consensus 442 v~Ey~~~--gsL~~~l 455 (686)
+|||+++ ..+.+.+
T Consensus 113 vME~L~~~~~ilr~~L 128 (418)
T PLN02756 113 GMRYLEPPHIILRKGL 128 (418)
T ss_pred EEeecCCcceehhhhh
Confidence 8999976 3455444
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.0056 Score=44.16 Aligned_cols=42 Identities=17% Similarity=0.476 Sum_probs=32.6
Q ss_pred CCCCCCCCCCCCCccCCCCCCCCCCCC----CcccccceeeccccCC
Q 005649 644 SVPIPSVTESPDHYEGDDDAGDNAGRR----EQFTRNSITFSLQDGR 686 (686)
Q Consensus 644 ~~~~~~~p~~p~~~~~~~~~~~~~~~~----~~~s~~~~~~~~~~~~ 686 (686)
...+|. |++|+|+.........++.+ ...|.|++|+|-+++|
T Consensus 3 ~~~LP~-PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQ-PKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCC-CCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 457888 99999998887654444433 3468899999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.012 Score=52.85 Aligned_cols=39 Identities=28% Similarity=0.592 Sum_probs=22.8
Q ss_pred eeeeeeeecchhhHHHHhheeeeEeeeecCCCccccCCcc
Q 005649 303 YLKIGAVAGVGGAVMTIIVVVLIAVLTRKGRSMRFVGDDA 342 (686)
Q Consensus 303 ~~~i~~v~~~~~~v~~l~~~~l~~~~~rr~~~~~~~~~~~ 342 (686)
.++||+|+|+++.++++++++++++++|+|| ..+...+.
T Consensus 49 nIVIGvVVGVGg~ill~il~lvf~~c~r~kk-tdfidSdG 87 (154)
T PF04478_consen 49 NIVIGVVVGVGGPILLGILALVFIFCIRRKK-TDFIDSDG 87 (154)
T ss_pred cEEEEEEecccHHHHHHHHHhheeEEEeccc-CccccCCC
Confidence 4567999888877766655555444444443 44544443
|
The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway []. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.032 Score=54.03 Aligned_cols=153 Identities=18% Similarity=0.183 Sum_probs=95.0
Q ss_pred cCcEEEEEEEecCCCEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCChhHHHhh
Q 005649 379 GGFGTVYKGRLQDGREIAVKKLATNSMQ-GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFD 457 (686)
Q Consensus 379 G~fG~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~ 457 (686)
++..+.-+++.+- .+..+|++..-... ...-|.++.+++++++ .|+++..- +.....++.|+|..-..
T Consensus 73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 3445555555443 34566766554433 4567788999998875 45666522 33456799998832110
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCC
Q 005649 458 KSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFG 537 (686)
Q Consensus 458 ~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 537 (686)
. -..++.-=++.|.-.|+.. ...+|||-.|+|||-|..|.+||.|-+..-. .+..
T Consensus 142 ------~----~~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~ 196 (308)
T PF07387_consen 142 ------N----FSNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVN 196 (308)
T ss_pred ------c----hhHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--------------heee
Confidence 0 0112222246777889654 4699999999999999999999999765321 0111
Q ss_pred cCchhhhhcCCCChhHHHHHHHHHHHHHHcCCC
Q 005649 538 YMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRK 570 (686)
Q Consensus 538 y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~ 570 (686)
|.--| ....++++.+-+|=.-++++...++
T Consensus 197 ~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 197 MVNIE---YESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred EEeee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence 22211 2345778888888888888876443
|
The function of this family is unknown. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.094 Score=55.43 Aligned_cols=80 Identities=20% Similarity=0.194 Sum_probs=50.2
Q ss_pred cccccCcEEEEEEEecCC-CEEEEEEeccc-------CcccHHHHHHHHHHHHhcC--CC-CcccEEEEEEecCceEEEE
Q 005649 375 MLGRGGFGTVYKGRLQDG-REIAVKKLATN-------SMQGKEEFENEVRVLLKMQ--HR-NLVQLFGCCVQERERILVY 443 (686)
Q Consensus 375 ~LG~G~fG~Vy~~~~~~g-~~vavK~l~~~-------~~~~~~~~~~e~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 443 (686)
.||-|....||++..++| +.|+||.-... -.-..++..-|...|.... .| .+++++. .+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 478999999999998754 58999975321 1122344456666666552 34 4555554 3556677999
Q ss_pred eecCCC-ChhHHHh
Q 005649 444 EYLPNK-SLDKFLF 456 (686)
Q Consensus 444 Ey~~~g-sL~~~l~ 456 (686)
|+++.. .|.+.|.
T Consensus 80 EdL~~~~ilR~~Li 93 (370)
T TIGR01767 80 EDLSHHKIARKGLI 93 (370)
T ss_pred hhCccchHHHHHHH
Confidence 999653 3445553
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.23 Score=52.01 Aligned_cols=29 Identities=28% Similarity=0.357 Sum_probs=25.2
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 489 LRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 489 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
..++|||+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45899999999999987 678999998754
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.026 Score=55.62 Aligned_cols=31 Identities=32% Similarity=0.515 Sum_probs=21.9
Q ss_pred CCeEecCCCCCcEEE-cCCCCeEEEecCCccc
Q 005649 489 LRIIHRDIKASNILL-DHQMKPKISDFGLAKL 519 (686)
Q Consensus 489 ~~ivH~Dlkp~NIll-~~~~~~kl~Dfgla~~ 519 (686)
..++|+||.+.|||+ +.++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 458999999999999 8899999999988763
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.48 Score=50.82 Aligned_cols=81 Identities=16% Similarity=0.142 Sum_probs=51.9
Q ss_pred cccccccCcEEEEEEEecC-CCEEEEEEeccc------CcccHHHHHHHHHHHHhcC--CC-CcccEEEEEEecCceEEE
Q 005649 373 KNMLGRGGFGTVYKGRLQD-GREIAVKKLATN------SMQGKEEFENEVRVLLKMQ--HR-NLVQLFGCCVQERERILV 442 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~------~~~~~~~~~~e~~~l~~l~--h~-niv~l~~~~~~~~~~~lv 442 (686)
.+.||-|.-..||++...+ ++.|+||.-... -.-..++..-|.+.|+... .| .+++++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4578999999999999853 568999865321 1223455566667776652 34 45556644 55567788
Q ss_pred EeecCC-CChhHHH
Q 005649 443 YEYLPN-KSLDKFL 455 (686)
Q Consensus 443 ~Ey~~~-gsL~~~l 455 (686)
||+++. ..|.+.|
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 999854 3344444
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.1 Score=55.29 Aligned_cols=140 Identities=13% Similarity=0.200 Sum_probs=77.4
Q ss_pred cccccCcEEEEEEEecC----CCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCc-ccEEEEEEecCceEEEEeecCCC
Q 005649 375 MLGRGGFGTVYKGRLQD----GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL-VQLFGCCVQERERILVYEYLPNK 449 (686)
Q Consensus 375 ~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~Ey~~~g 449 (686)
.|..|-.-.+|+....+ +..+++|+....... .-+-.+|..+++.+..-++ +++++++. . .+|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~---G~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-N---GMIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-C---cEeehhhcCC
Confidence 34446666788876543 237888887554322 2223678888888865444 46666652 2 2589999776
Q ss_pred ChhHH-------H----------hhcC--CCCCC-CHHHHHHHHHHH----------------------HHHHHH----H
Q 005649 450 SLDKF-------L----------FDKS--KSAIL-DWPKRLNIIMGV----------------------ARGLLY----L 483 (686)
Q Consensus 450 sL~~~-------l----------~~~~--~~~~l-~~~~~~~i~~~i----------------------a~~L~~----L 483 (686)
.|..- + |... ..... -|..+.++..++ .+-+.. +
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 65321 1 1110 00101 122222222111 111111 1
Q ss_pred Hh-CCCCCeEecCCCCCcEEEcC-CCCeEEEecCCccc
Q 005649 484 HR-DSVLRIIHRDIKASNILLDH-QMKPKISDFGLAKL 519 (686)
Q Consensus 484 H~-~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~ 519 (686)
.. .....++|+|+.+.|||+++ ++.++++||..+-.
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11 11235899999999999974 57899999988764
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.03 Score=60.59 Aligned_cols=49 Identities=24% Similarity=0.284 Sum_probs=38.9
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEecC-ceEEEEeecCCCChhHHHhh
Q 005649 408 KEEFENEVRVLLKMQHRNLVQLFGCCVQER-ERILVYEYLPNKSLDKFLFD 457 (686)
Q Consensus 408 ~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~Ey~~~gsL~~~l~~ 457 (686)
..+.....++++.+.|+|+...+++..... ...+|+|++ +.||++.+..
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 345667788999999999999999876644 467899998 7788888854
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.26 Score=48.24 Aligned_cols=75 Identities=20% Similarity=0.239 Sum_probs=51.4
Q ss_pred ccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhc---CCCCcccEEEEEEecCceEEEEeecCCCC
Q 005649 374 NMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKM---QHRNLVQLFGCCVQERERILVYEYLPNKS 450 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~Ey~~~gs 450 (686)
+.+.-|..-.-|.... +..++.||+-... ....|..|+.-|..| +.-++.+++.+..+.++.+||+||++-|.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3444444444454443 4567888875332 234677777666665 45678899999999999999999999877
Q ss_pred hh
Q 005649 451 LD 452 (686)
Q Consensus 451 L~ 452 (686)
++
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 65
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.002 Score=77.20 Aligned_cols=161 Identities=12% Similarity=-0.064 Sum_probs=111.6
Q ss_pred HHHHHHHHHhcCCCCcccEEEEEEe--cCceEEEEeecCCCChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 005649 411 FENEVRVLLKMQHRNLVQLFGCCVQ--ERERILVYEYLPNKSLDKFLFDKSK-SAILDWPKRLNIIMGVARGLLYLHRDS 487 (686)
Q Consensus 411 ~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~ 487 (686)
...|...++...|+++.....-... ..+.+..++|+..|.+.+.+....+ ...++.......-.+......-.|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3344445555678877654433322 3466889999999999988865433 233444333333333344444444433
Q ss_pred --CCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHH
Q 005649 488 --VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEI 565 (686)
Q Consensus 488 --~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~el 565 (686)
...-+|++||+-|.+|..+.++|+.++|+.+...... .......+++-|+.|+....-+++.++|+|..|+-+|++
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 2457999999999999999999999999998433211 123345677889999998888999999999999999999
Q ss_pred HcCCCCCc
Q 005649 566 ISGRKNYD 573 (686)
Q Consensus 566 ltG~~p~~ 573 (686)
--|..+|.
T Consensus 1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred hcccHHHH
Confidence 88877664
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.24 Score=51.84 Aligned_cols=30 Identities=20% Similarity=0.277 Sum_probs=27.3
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 489 LRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 489 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
..++|+|+.++||++++++.+.++||..+.
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 459999999999999999999999998775
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.67 Score=48.96 Aligned_cols=71 Identities=15% Similarity=0.166 Sum_probs=44.0
Q ss_pred cCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCC--CcccEE---E--EEEecCceEEEEeecCCCC
Q 005649 379 GGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHR--NLVQLF---G--CCVQERERILVYEYLPNKS 450 (686)
Q Consensus 379 G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~---~--~~~~~~~~~lv~Ey~~~gs 450 (686)
+.-..||+....+|+.+++|+.... .....+...|++.+..|... .++..+ | ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 3445799998888888999987532 23456667777777766321 122211 1 1222456778999998764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.12 Score=53.88 Aligned_cols=71 Identities=20% Similarity=0.240 Sum_probs=56.6
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.+++|++. ++++... ....|.+.+.++++.+..+.-+..+- +.-|||+.-.||||+ +|++.|+||-++|
T Consensus 301 ~yl~~kdh-gt~is~i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 301 LYLHFKDH-GTPISII-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred EEEEEecC-Cceeeee-------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeee
Confidence 45667765 4454321 22578899999999998888888764 699999999999999 9999999999999
Q ss_pred cc
Q 005649 519 LF 520 (686)
Q Consensus 519 ~~ 520 (686)
.-
T Consensus 370 l~ 371 (488)
T COG5072 370 LS 371 (488)
T ss_pred cc
Confidence 53
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 686 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-59 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-58 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-44 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-44 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-36 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-26 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-25 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-25 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-25 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-25 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-25 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-25 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-25 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-25 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-25 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-25 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-25 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-25 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-25 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-25 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-25 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-25 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-25 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-25 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-25 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-24 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-24 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-24 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-24 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-24 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-24 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-24 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-24 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-24 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-24 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-24 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-24 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-24 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-24 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-23 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-22 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-22 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-22 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-22 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-22 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-21 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-21 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-21 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-21 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-21 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-21 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-21 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-18 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-18 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-18 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-17 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-06 | ||
| 3a2e_A | 108 | Crystal Structure Of Ginkbilobin-2, The Novel Antif | 2e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3A2E|A Chain A, Crystal Structure Of Ginkbilobin-2, The Novel Antifungal Protein From Ginkgo Biloba Seeds Length = 108 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 426 bits (1098), Expect = e-146
Identities = 134/294 (45%), Positives = 186/294 (63%), Gaps = 6/294 (2%)
Query: 358 FNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKE-EFENEVR 416
F+L L A+DNFS KN+LGRGGFG VYKGRL DG +AVK+L QG E +F+ EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 417 VLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAI-LDWPKRLNIIMG 475
++ HRNL++L G C+ ER+LVY Y+ N S+ L ++ +S LDWPKR I +G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 476 VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGT 535
ARGL YLH +IIHRD+KA+NILLD + + + DFGLAKL + + H T + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGT 198
Query: 536 FGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYD--RQLEAENQELLKLARRLEEE 593
G++APEY G S K+DVF +GV+LLE+I+G++ +D R ++ LL + L +E
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 594 GRLMELVDVRI-GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVP 646
+L LVDV + G Y +E + +Q+ALLCT+ +RP MS + ML +
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 420 bits (1081), Expect = e-143
Identities = 108/304 (35%), Positives = 154/304 (50%), Gaps = 18/304 (5%)
Query: 349 QGIDMRSFLFNLDVLIAATDNFSTK------NMLGRGGFGTVYKGRLQDGREIAVKKLAT 402
+ D R F+ L T+NF + N +G GGFG VYKG + + +AVKKLA
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 403 ----NSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDK 458
+ + K++F+ E++V+ K QH NLV+L G + LVY Y+PN SL L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 459 SKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518
+ L W R I G A G+ +LH + IHRDIK++NILLD KISDFGLA+
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 519 LFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEA 578
T +I GT YMAPE +RG ++ KSD++SFGV+LLEII+G D E
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
Query: 579 ENQELLKLARR-LEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATL 637
+ LL + +EE + + +D ++ +A C + RP +
Sbjct: 241 QL--LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 638 SMLS 641
+L
Sbjct: 299 QLLQ 302
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 400 bits (1031), Expect = e-136
Identities = 117/304 (38%), Positives = 170/304 (55%), Gaps = 5/304 (1%)
Query: 339 GDDANALTNNQGIDMRSFLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVK 398
+AL+++ + S+ L L AT+NF K ++G G FG VYKG L+DG ++A+K
Sbjct: 10 NSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK 69
Query: 399 KLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDK 458
+ S QG EEFE E+ L +H +LV L G C + E IL+Y+Y+ N +L + L+
Sbjct: 70 RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129
Query: 459 SKSAI-LDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517
+ + W +RL I +G ARGL YLH + IIHRD+K+ NILLD PKI+DFG++
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186
Query: 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLE 577
K + H + + GT GY+ PEY I+G L+ KSDV+SFGV+L E++ R + L
Sbjct: 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246
Query: 578 AENQELLKLARRLEEEGRLMELVDVRI-GTYPEEIALRFMQIALLCTEDFIEDRPTMSAT 636
E L + A G+L ++VD + E +F A+ C EDRP+M
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306
Query: 637 LSML 640
L L
Sbjct: 307 LWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 2e-87
Identities = 74/308 (24%), Positives = 126/308 (40%), Gaps = 29/308 (9%)
Query: 358 FNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRV 417
+ L + + RG FG V+K +L +AVK Q + E EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 418 LLKMQHRNLVQLFGCCVQ----ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNII 473
L M+H N++Q G + + + L+ + SL FL K+ ++ W + +I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 474 MGVARGLLYLHRDSV-------LRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526
+ARGL YLH D I HRDIK+ N+LL + + I+DFGLA F +S
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 527 HRTHQIAGTFGYMAPEYA-----IRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQ 581
TH GT YMAPE + ++ D+++ G++L E+ S D ++
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 582 ELLKLARRLEEEGRLMELVDVRIG------TYPEEIALRFM-QIALLCTEDFIEDRPTMS 634
+ + + E+V + + + + + + C + E R +
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 635 ATLSMLSN 642
++
Sbjct: 308 CVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 2e-69
Identities = 79/335 (23%), Positives = 128/335 (38%), Gaps = 56/335 (16%)
Query: 366 ATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRV--LLKMQH 423
DN ++GRG +G VYKG L D R +AVK S ++ F NE + + M+H
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRVPLMEH 66
Query: 424 RNLVQLFGCCV-----QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR 478
N+ + E +LV EY PN SL K+L + DW + V R
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTR 122
Query: 479 GLLYLHRD------SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH------DEQSR 526
GL YLH + I HRD+ + N+L+ + ISDFGL+ +
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 527 HRTHQIAGTFGYMAPEYAIRGFLSV--------KSDVFSFGVLLLEIISGRKNYDRQLEA 578
+ GT YMAPE + G +++ + D+++ G++ EI +
Sbjct: 183 NAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241
Query: 579 EN-----QELLKLARRLEEEGRLMELVDVRIGTYPE--------EIALRFM-QIALLCTE 624
Q + E+ M+++ R P+ +A+R + + C +
Sbjct: 242 PEYQMAFQTEVGNHPTFED----MQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297
Query: 625 DFIEDRPTMSATLSMLSN--SSVPIPSVTESPDHY 657
E R T ++ H+
Sbjct: 298 QDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 8e-63
Identities = 82/283 (28%), Positives = 137/283 (48%), Gaps = 25/283 (8%)
Query: 373 KNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGK--EEFENEVRVLLKMQHRNLVQLF 430
K +G G FGTV++ G ++AVK L + EF EV ++ +++H N+V
Sbjct: 42 KEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 431 GCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLR 490
G Q +V EYL SL + L LD +RL++ VA+G+ YLH +
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-P 159
Query: 491 IIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL- 549
I+HR++K+ N+L+D + K+ DFGL++L + AGT +MAPE +R
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPE-VLRDEPS 216
Query: 550 SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPE 609
+ KSDV+SFGV+L E+ + ++ + N ++ + + + +E+ P
Sbjct: 217 NEKSDVYSFGVILWELATLQQPW------GNLNPAQVVAAVGFKCKRLEI--------PR 262
Query: 610 EIALRFMQIALLCTEDFIEDRPTMS---ATLSMLSNSSVPIPS 649
+ + I C + RP+ + L L S+VP P+
Sbjct: 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 4e-61
Identities = 79/281 (28%), Positives = 133/281 (47%), Gaps = 37/281 (13%)
Query: 373 KNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQ----GKEEFENEVRVLLKMQHRNLVQ 428
+ ++G GGFG VY+ G E+AVK + + E E ++ ++H N++
Sbjct: 12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 429 LFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488
L G C++E LV E+ L++ L K + +N + +ARG+ YLH +++
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAI 126
Query: 489 LRIIHRDIKASNILLDHQMKP--------KISDFGLAKLFHDEQSRHRTHQIAGTFGYMA 540
+ IIHRD+K+SNIL+ +++ KI+DFGLA+ +H AG + +MA
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA----AGAYAWMA 182
Query: 541 PEYAIRGFL-SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599
PE IR + S SDV+S+GVLL E+++G + + L +A + + +
Sbjct: 183 PE-VIRASMFSKGSDVWSYGVLLWELLTGEVPF------RGIDGLAVAYGVAMNKLALPI 235
Query: 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640
P F ++ C RP+ + L L
Sbjct: 236 --------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 8e-61
Identities = 72/303 (23%), Positives = 121/303 (39%), Gaps = 33/303 (10%)
Query: 373 KNMLGRGGFGTVYKGRL-QDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFG 431
+LG+G FG K + G + +K+L + + F EV+V+ ++H N+++ G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 432 CCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRI 491
+++ + EY+ +L + KS + W +R++ +A G+ YLH + I
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNI 129
Query: 492 IHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS------------RHRTHQIAGTFGYM 539
IHRD+ + N L+ ++DFGLA+L DE++ R + + + G +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 540 APEYAIRGFL-SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME 598
APE I G K DVFSFG++L EII +
Sbjct: 190 APE-MINGRSYDEKVDVFSFGIVLCEIIGRVNADPD-YLPRTMDFGL----NVRGFLDRY 243
Query: 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPSVTESPDHYE 658
P F I + C + E RP+ L + + E
Sbjct: 244 C--------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLE 295
Query: 659 GDD 661
D
Sbjct: 296 QLD 298
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 3e-60
Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 13/208 (6%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLV 427
+ ++GRG FG V K + + +++A+K++ + S ++ F E+R L ++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
+L+G C+ LV EY SL L ++ + ++G+ YLH
Sbjct: 65 KLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 488 VLRIIHRDIKASNILLDHQMK-PKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR 546
+IHRD+K N+LL KI DFG A + + G+ +MAPE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-----KGSAAWMAPE-VFE 176
Query: 547 GFL-SVKSDVFSFGVLLLEIISGRKNYD 573
G S K DVFS+G++L E+I+ RK +D
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFD 204
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 6e-59
Identities = 81/271 (29%), Positives = 132/271 (48%), Gaps = 25/271 (9%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGK--EEFENEVRVLLKMQHRNLVQLFGCC 433
+G G FGTVYKG+ ++AVK L + + + F+NEV VL K +H N++ G
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 434 VQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIH 493
+ I V ++ SL L + + K ++I ARG+ YLH IIH
Sbjct: 90 TAPQLAI-VTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHA---KSIIH 143
Query: 494 RDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL---- 549
RD+K++NI L KI DFGLA H+ Q++G+ +MAPE IR
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSNPY 202
Query: 550 SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPE 609
S +SDV++FG++L E+++G+ Y + +Q + + R +L VR P+
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIEMVGR----GSLSPDLSKVRSNC-PK 256
Query: 610 EIALRFMQIALLCTEDFIEDRPTMSATLSML 640
+ ++ C + ++RP+ L+ +
Sbjct: 257 RMK----RLMAECLKKKRDERPSFPRILAEI 283
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 6e-57
Identities = 54/276 (19%), Positives = 108/276 (39%), Gaps = 33/276 (11%)
Query: 373 KNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGK--EEFENEVRVLLKMQHRNLVQLF 430
L G ++KGR Q G +I VK L + +F E L H N++ +
Sbjct: 15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 431 GCCVQERERIL--VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488
G C + ++P SL L + + ++D + + + +ARG+ +LH
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLEP 132
Query: 489 LRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG- 547
L I + + ++++D M +IS + F ++APE A++
Sbjct: 133 L-IPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------MYAPAWVAPE-ALQKK 183
Query: 548 ---FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604
+D++SF VLL E+++ + + +++ ++ EG +
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPF------ADLSNMEIGMKVALEGLRPTI----- 232
Query: 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640
P I+ ++ +C + RP + +L
Sbjct: 233 ---PPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 9e-57
Identities = 77/288 (26%), Positives = 133/288 (46%), Gaps = 37/288 (12%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGK-------EEFENEVRVLL 419
+ + +G+GGFG V+KGRL D +A+K L +G+ +EF+ EV ++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 420 KMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARG 479
+ H N+V+L+G +V E++P L L DK+ + W +L +++ +A G
Sbjct: 79 NLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALG 134
Query: 480 LLYLHRDSVLRIIHRDIKASNILLDHQ-----MKPKISDFGLAKLFHDEQSRHRTHQIAG 534
+ Y+ + I+HRD+++ NI L + K++DFGL++ S + G
Sbjct: 135 IEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSG-----LLG 188
Query: 535 TFGYMAPE-YAIRGFL-SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEE 592
F +MAPE + K+D +SF ++L I++G +D E ++ + EE
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD---EYSYGKIKFINMIREE 245
Query: 593 EGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640
R T PE+ R + LC + RP S + L
Sbjct: 246 GLRP---------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-56
Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 42/299 (14%)
Query: 373 KNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGK--EEFENEVRVLLKMQHRNLVQLF 430
++G+G FG VY GR E+A++ + + F+ EV + +H N+V
Sbjct: 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 431 GCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLR 490
G C+ ++ ++L + + +LD K I + +G+ YLH
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KG 150
Query: 491 IIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQI---AGTFGYMAPEYAIRG 547
I+H+D+K+ N+ D+ K I+DFGL + Q+ R ++ G ++APE IR
Sbjct: 151 ILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI-IRQ 208
Query: 548 FL----------SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM 597
S SDVF+ G + E+ + + + Q + ++ G
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF------KTQPAEAIIWQM-GTGMKP 261
Query: 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPSVTESPDH 656
L + + +EI+ I L C E+RPT + + ML +P H
Sbjct: 262 NLSQIGM---GKEIS----DILLFCWAFEQEERPTFTKLMDMLEK----LPKRNRRLSH 309
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-51
Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 25/213 (11%)
Query: 374 NMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCC 433
+G+G +G V+ G+ + G ++AVK T E E+ + M+H N++
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIAAD 100
Query: 434 VQERERI----LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
++ L+ +Y N SL +L KS LD L + GL +LH +
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 490 R-----IIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH--RTHQIAGTFGYMAPE 542
I HRD+K+ NIL+ I+D GLA F + + + GT YM PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 543 YAIRGFLSV-------KSDVFSFGVLLLEIISG 568
+ L+ +D++SFG++L E+
Sbjct: 217 -VLDESLNRNHFQSYIMADMYSFGLILWEVARR 248
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 4e-51
Identities = 55/224 (24%), Positives = 100/224 (44%), Gaps = 25/224 (11%)
Query: 374 NMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCC 433
+G+G +G V++G Q G +AVK ++ + E E+ + ++H N++
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK-SWFRETELYNTVMLRHENILGFIASD 71
Query: 434 VQERERI----LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
+ R L+ Y SL +L + LD L I++ +A GL +LH +
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 490 R-----IIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRT--HQIAGTFGYMAPE 542
I HRD+K+ NIL+ + I+D GLA + ++ + GT YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 543 YAIRGFLSV-------KSDVFSFGVLLLEIISGRKNYDRQLEAE 579
+ + V + D+++FG++L E+ + + +
Sbjct: 188 -VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 5e-50
Identities = 80/280 (28%), Positives = 118/280 (42%), Gaps = 27/280 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRN 425
++ +GRG FG V+ GRL+ D +AVK K +F E R+L + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+V+L G C Q++ +V E + FL +++ A L L ++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY--MAPEY 543
IHRD+ A N L+ + KISDFG+++ D + APE
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV--YAASGGLRQVPVKWTAPEA 286
Query: 544 AIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602
G S +SDV+SFG+LL E S G Y NQ+ +E+ GRL
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNL---SNQQTR---EFVEKGGRLPC---- 336
Query: 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
PE ++ C RP+ S L +
Sbjct: 337 -----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 8e-50
Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 25/213 (11%)
Query: 374 NMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCC 433
+G+G FG V++G+ + G E+AVK ++ + E E+ + ++H N++
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAAD 105
Query: 434 VQERERI----LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
++ LV +Y + SL +L + + + + A GL +LH + V
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 490 R-----IIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQI--AGTFGYMAPE 542
I HRD+K+ NIL+ I+D GLA GT YMAPE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 543 YAIRGFLSV-------KSDVFSFGVLLLEIISG 568
+ +++ ++D+++ G++ EI
Sbjct: 222 -VLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 9e-48
Identities = 73/241 (30%), Positives = 113/241 (46%), Gaps = 28/241 (11%)
Query: 376 LGRGGFGTVYKGRL-----QDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLF 430
LG+G FG+V R G +AVK+L + + +F+ E+++L + +V+
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 431 GCCVQERER--ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488
G + LV EYLP+ L FL + A LD + L + +G+ YL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS--- 145
Query: 489 LRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGT-FGYMAPEYAIRG 547
R +HRD+ A NIL++ + KI+DFGLAKL ++ + + + + APE
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 548 FLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAE-----------NQELLKLARRLEEEGR 595
S +SDV+SFGV+L E+ + K+ E LL+L LEE R
Sbjct: 206 IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL---LEEGQR 262
Query: 596 L 596
L
Sbjct: 263 L 263
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 4e-47
Identities = 77/278 (27%), Positives = 127/278 (45%), Gaps = 27/278 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLV 427
+ +G G FG V+ G + ++A+K + +M +E+F E V++K+ H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLV 66
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
QL+G C+++ LV E++ + L +L +++ + L + + V G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY--MAPEYAI 545
+IHRD+ A N L+ K+SDFG+ + D+Q T F +PE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG---TKFPVKWASPEVFS 178
Query: 546 RGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604
S KSDV+SFGVL+ E+ S G+ Y+ + N E+++ G +
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDI----STGFRLYK----- 226
Query: 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
P + QI C + EDRP S L L+
Sbjct: 227 ---PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 5e-47
Identities = 78/277 (28%), Positives = 121/277 (43%), Gaps = 29/277 (10%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLV 427
+G+G FG V G + G ++AVK + ++ + F E V+ +++H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249
Query: 428 QLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD 486
QL G V+E+ + +V EY+ SL +L + +S L L + V + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG- 307
Query: 487 SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR 546
+HRD+ A N+L+ K+SDFGL K + S T ++ + APE
Sbjct: 308 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLP--VKWTAPEALRE 360
Query: 547 GFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605
S KSDV+SFG+LL EI S GR Y R ++++ E+G M+
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRV----EKGYKMDA------ 407
Query: 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
P+ + C RPT L +
Sbjct: 408 --PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 6e-47
Identities = 76/243 (31%), Positives = 115/243 (47%), Gaps = 31/243 (12%)
Query: 376 LGRGGFGTVYKGRL-----QDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLF 430
LG+G FG+V R G +AVKKL ++ + +FE E+ +L +QH N+V+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 431 GCCVQERER--ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488
G C R L+ EYLP SL +L + +D K L + +G+ YL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT--- 132
Query: 489 LRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF--GYMAPEYAIR 546
R IHRD+ NIL++++ + KI DFGL K+ ++ + + G + APE
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE-PGESPIFWYAPESLTE 191
Query: 547 GFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAE------------NQELLKLARRLEEE 593
SV SDV+SFGV+L E+ + K+ E L++L L+
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL---LKNN 248
Query: 594 GRL 596
GRL
Sbjct: 249 GRL 251
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 9e-47
Identities = 79/278 (28%), Positives = 126/278 (45%), Gaps = 27/278 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLV 427
+ + LG G FG V G+ + ++AVK + SM ++EF E + ++K+ H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLV 66
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
+ +G C +E +V EY+ N L +L +S L+ + L + V G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY--MAPEYAI 545
+ IHRD+ A N L+D + K+SDFG+ + D+Q + F APE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAPEVFH 178
Query: 546 RGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604
S KSDV++FG+L+ E+ S G+ YD N E++ +G +
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLY---TNSEVVLKV----SQGHRLYR----- 226
Query: 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
P + QI C + E RPT LS +
Sbjct: 227 ---PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEP 261
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-46
Identities = 74/278 (26%), Positives = 126/278 (45%), Gaps = 27/278 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLV 427
+ + LG G FG V G+ + ++A+K + SM ++EF E +V++ + H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLV 82
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
QL+G C ++R ++ EY+ N L +L + + L + V + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY--MAPEYAI 545
+ +HRD+ A N L++ Q K+SDFGL++ D++ F PE +
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG---SKFPVRWSPPEVLM 194
Query: 546 RGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604
S KSD+++FGVL+ EI S G+ Y+R N E + +G +
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERF---TNSETAEHI----AQGLRLYR----- 242
Query: 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
P + + I C + ++RPT LS + +
Sbjct: 243 ---PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 76/243 (31%), Positives = 116/243 (47%), Gaps = 31/243 (12%)
Query: 376 LGRGGFGTVYKGRL-----QDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLF 430
LG+G FG+V R G +AVKKL ++ + +FE E+ +L +QH N+V+
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 431 GCCVQERER--ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488
G C R L+ EYLP SL +L + +D K L + +G+ YL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT--- 163
Query: 489 LRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF--GYMAPEYAIR 546
R IHRD+ NIL++++ + KI DFGL K+ ++ ++ + G + APE
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE-PGESPIFWYAPESLTE 222
Query: 547 GFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAE------------NQELLKLARRLEEE 593
SV SDV+SFGV+L E+ + K+ E L++L L+
Sbjct: 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL---LKNN 279
Query: 594 GRL 596
GRL
Sbjct: 280 GRL 282
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-46
Identities = 89/278 (32%), Positives = 132/278 (47%), Gaps = 27/278 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLV 427
+ LG G FG V+ G ++AVK L SM + F E ++ ++QH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
+L+ QE I + EY+ N SL FL L K L++ +A G+ ++
Sbjct: 72 RLYAVVTQEPIYI-ITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE-- 127
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY--MAPEYAI 545
IHRD++A+NIL+ + KI+DFGLA+L D + R F APE
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG---AKFPIKWTAPEAIN 183
Query: 546 RGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604
G ++KSDV+SFG+LL EI++ GR Y N E+++ LE R M
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQ---NLERGYR-MVR----- 231
Query: 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
P+ Q+ LC ++ EDRPT S+L +
Sbjct: 232 ---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 5e-46
Identities = 60/243 (24%), Positives = 107/243 (44%), Gaps = 31/243 (12%)
Query: 376 LGRGGFGTVYKGRL-----QDGREIAVKKL-ATNSMQGKEEFENEVRVLLKMQHRNLVQL 429
LG G FG V R G ++AVK L + + + E+ +L + H N+V+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 430 FGCCVQERER--ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
G C ++ L+ E+LP+ SL ++L ++ ++L + + +G+ YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS-- 144
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF--GYMAPEYAI 545
+ +HRD+ A N+L++ + + KI DFGL K ++ + + APE +
Sbjct: 145 -RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD-DRDSPVFWYAPECLM 202
Query: 546 RGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAE-----------NQELLKLARRLEEE 593
+ + SDV+SFGV L E+++ + L+ L+E
Sbjct: 203 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT---LKEG 259
Query: 594 GRL 596
RL
Sbjct: 260 KRL 262
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 5e-46
Identities = 69/229 (30%), Positives = 117/229 (51%), Gaps = 20/229 (8%)
Query: 376 LGRGGFGTVYKGRLQ--DGREI--AVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLF 430
+G G G V GRL+ R++ A+K L + + +F +E ++ + H N+++L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 431 GCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLR 490
G + R ++V EY+ N SLD FL ++ + + ++ GV G+ YL S L
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 491 IIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY--MAPEYAIRGF 548
+HRD+ A N+L+D + K+SDFGL+++ D+ T G APE
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-GGKIPIRWTAPEAIAFRT 230
Query: 549 LSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRL 596
S SDV+SFGV++ E+++ G + Y N++++ +EE RL
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNM---TNRDVIS---SVEEGYRL 273
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-45
Identities = 85/270 (31%), Positives = 127/270 (47%), Gaps = 27/270 (10%)
Query: 376 LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ 435
LG G FG V+ ++AVK + SM E F E V+ +QH LV+L +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 436 ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRD 495
E I + E++ SL FL S PK ++ +A G+ ++ + IHRD
Sbjct: 255 EPIYI-ITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIEQ---RNYIHRD 309
Query: 496 IKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY--MAPEYAIRGFLSVKS 553
++A+NIL+ + KI+DFGLA++ D + R F APE G ++KS
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNEYTAREG---AKFPIKWTAPEAINFGSFTIKS 366
Query: 554 DVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIA 612
DV+SFG+LL+EI++ GR Y N E++ R LE R M PE
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPGM---SNPEVI---RALERGYR-MPR--------PENCP 411
Query: 613 LRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
I + C ++ E+RPT S+L +
Sbjct: 412 EELYNIMMRCWKNRPEERPTFEYIQSVLDD 441
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 2e-45
Identities = 65/236 (27%), Positives = 113/236 (47%), Gaps = 19/236 (8%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGRE-----IAVKKLATNSMQG-KEEFENEVRVLLKM 421
F +LG G FGTVYKG E +A+K+L + +E +E V+ +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 422 QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLL 481
+ ++ +L G C+ ++ + + +P L ++ + + LN + +A+G+
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMN 131
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP 541
YL R++HRD+ A N+L+ KI+DFGLAKL E+ + +MA
Sbjct: 132 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 542 EYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRL 596
E + + +SDV+S+GV + E+++ G K YD E+ + LE+ RL
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSI---LEKGERL 238
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-45
Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 27/279 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGR-EIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL 426
+ + K+ LG G +G VY+G + +AVK L ++M+ EEF E V+ +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 71
Query: 427 VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD 486
VQL G C +E ++ E++ +L +L + ++ + L + ++ + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL--- 127
Query: 487 SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY--MAPEYA 544
IHRD+ A N L+ K++DFGL++L + F APE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG---AKFPIKWTAPESL 184
Query: 545 IRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603
S+KSDV++FGVLL EI + G Y + ++ +L E+ ME
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELL----EKDYRMER---- 233
Query: 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
PE + ++ C + DRP+ +
Sbjct: 234 ----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-45
Identities = 65/238 (27%), Positives = 119/238 (50%), Gaps = 21/238 (8%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGRE-----IAVKKLATNSM-QGKEEFENEVRVLLKM 421
+ + ++G G FG VYKG L+ +A+K L + + +F E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 422 QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLL 481
H N+++L G + + +++ EY+ N +LDKFL + K + + ++ G+A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY--M 539
YL + +HRD+ A NIL++ + K+SDFGL+++ D+ T G
Sbjct: 162 YLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-GGKIPIRWT 217
Query: 540 APEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRL 596
APE + SDV+SFG+++ E+++ G + Y N E++K + + RL
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL---SNHEVMK---AINDGFRL 269
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-45
Identities = 71/231 (30%), Positives = 113/231 (48%), Gaps = 20/231 (8%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLV 427
+G+G FG V G + G ++AVK + ++ + F E V+ +++H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLV 77
Query: 428 QLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD 486
QL G V+E+ + +V EY+ SL +L + +S L L + V + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL--- 133
Query: 487 SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR 546
+HRD+ A N+L+ K+SDFGL K + S T ++ + APE
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLP--VKWTAPEALRE 188
Query: 547 GFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRL 596
S KSDV+SFG+LL EI S GR Y R ++++ R+E+ ++
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVP---RVEKGYKM 233
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 6e-45
Identities = 71/243 (29%), Positives = 101/243 (41%), Gaps = 33/243 (13%)
Query: 376 LGRGGFGTVYKGRL---QDGREI--AVKKL-ATNSMQGKEEFENEVRVLLKMQHRNLVQL 429
LG G FG V DG AVK L A Q + ++ E+ +L + H ++++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 430 FGCCVQERER--ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
GCC LV EY+P SL +L S + + L + G+ YLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHA-- 152
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF--GYMAPEYAI 545
IHRD+ A N+LLD+ KI DFGLAK + +R + G + APE
Sbjct: 153 -QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE-DGDSPVFWYAPECLK 210
Query: 546 RGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAE-----------NQELLKLARRLEEE 593
SDV+SFGV L E+++ + + L +L LE
Sbjct: 211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL---LERG 267
Query: 594 GRL 596
RL
Sbjct: 268 ERL 270
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 7e-45
Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 29/293 (9%)
Query: 373 KNMLGRGGFGTVYKGRLQDGRE---IAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQ 428
LG G FG+V +G + ++ +A+K L + EE E +++ ++ + +V+
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 429 LFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488
L G C E + V E L KFL K + ++ V+ G+ YL
Sbjct: 75 LIGVCQAEALML-VMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 128
Query: 489 LRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF--GYMAPEYAIR 546
+HRD+ A N+LL ++ KISDFGL+K + S + AG + + APE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-AGKWPLKWYAPECINF 187
Query: 547 GFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605
S +SDV+S+GV + E +S G+K Y + + E++ +E+ R+
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPYK---KMKGPEVMA---FIEQGKRMEC------- 234
Query: 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPSVTESPDHYE 658
P E + C EDRP + + S E H+
Sbjct: 235 --PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHHH 285
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-44
Identities = 85/278 (30%), Positives = 131/278 (47%), Gaps = 27/278 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLV 427
++ + LG+G FG V+ G +A+K L +M E F E +V+ K++H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 325
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
QL+ +E I V EY+ SL FL L P+ +++ +A G+ Y+ R
Sbjct: 326 QLYAVVSEEPIYI-VTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER-- 381
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY--MAPEYAI 545
+ +HRD++A+NIL+ + K++DFGLA+L D + R F APE A+
Sbjct: 382 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG---AKFPIKWTAPEAAL 437
Query: 546 RGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604
G ++KSDV+SFG+LL E+ + GR Y N+E+L E G M
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV----ERGYRMPC----- 485
Query: 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
P E + C E+RPT + L +
Sbjct: 486 ---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-44
Identities = 60/254 (23%), Positives = 103/254 (40%), Gaps = 49/254 (19%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGR--------EIAVKKLATNSMQGKEEFENEVRVLL 419
++ LG+G F ++KG ++ E+ +K L E F ++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 420 KMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARG 479
K+ H++LV +G CV E ILV E++ SLD +L K ++ +L + +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 480 LLYLHRDSVLRIIHRDIKASNILLDHQMKP--------KISDFGLAKLFHDEQSRHRTHQ 531
+ +L +IH ++ A NILL + K+SD G++ +
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 532 IAGTFGY------MAPEYAI--RGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQE 582
+ PE I L++ +D +SFG L EI S G K ++Q
Sbjct: 176 -----ILQERIPWVPPE-CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL---DSQR 226
Query: 583 LLKLARRLEEEGRL 596
L + E+ +L
Sbjct: 227 KL---QFYEDRHQL 237
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-44
Identities = 72/237 (30%), Positives = 123/237 (51%), Gaps = 20/237 (8%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQ--DGREI--AVKKLATNSM-QGKEEFENEVRVLLKMQ 422
N S ++G G FG V GRL+ +EI A+K L + + +F E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 423 HRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLY 482
H N+++L G + + ++V EY+ N SLD FL + A + + ++ G+A G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY--MA 540
L S + +HRD+ A NIL++ + K+SDFGL ++ D+ T + G +
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR-GGKIPIRWTS 218
Query: 541 PEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRL 596
PE + SDV+S+G++L E++S G + Y E NQ+++K ++E RL
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW---EMSNQDVIK---AVDEGYRL 269
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 1e-44
Identities = 73/279 (26%), Positives = 126/279 (45%), Gaps = 27/279 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL 426
+ + K+ LG G +G VY+G + +AVK L ++M+ EEF E V+ +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 278
Query: 427 VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD 486
VQL G C +E ++ E++ +L +L + ++ + L + ++ + YL +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEK- 336
Query: 487 SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY--MAPEYA 544
IHR++ A N L+ K++DFGL++L + F APE
Sbjct: 337 --KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG---AKFPIKWTAPESL 391
Query: 545 IRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603
S+KSDV++FGVLL EI + G Y + ++ +L E+ ME
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELL----EKDYRMER---- 440
Query: 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
PE + ++ C + DRP+ +
Sbjct: 441 ----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 475
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-44
Identities = 84/276 (30%), Positives = 131/276 (47%), Gaps = 23/276 (8%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLV 427
++ + LG+G FG V+ G +A+K L +M E F E +V+ K++H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 242
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
QL+ +E I V EY+ SL FL L P+ +++ +A G+ Y+ R
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER-- 298
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG 547
+ +HRD++A+NIL+ + K++DFGLA+L D + R + APE A+ G
Sbjct: 299 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356
Query: 548 FLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606
++KSDV+SFG+LL E+ + GR Y N+E+L E G M
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV----ERGYRMPC------- 402
Query: 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
P E + C E+RPT + L +
Sbjct: 403 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 80/289 (27%), Positives = 124/289 (42%), Gaps = 31/289 (10%)
Query: 376 LGRGGFGTVYKGRLQDGR---EIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLF 430
LG G FGTV KG Q + +AVK L + K+E E V+ ++ + +V++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 431 GCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLR 490
G C E + V E L+K+L + + ++ V+ G+ YL
Sbjct: 85 GICEAESWML-VMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYL---EESN 137
Query: 491 IIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF--GYMAPEYAIRGF 548
+HRD+ A N+LL Q KISDFGL+K +++ ++ G + + APE
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-HGKWPVKWYAPECINYYK 196
Query: 549 LSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTY 607
S KSDV+SFGVL+ E S G+K Y + E+ LE+ R+
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTA---MLEKGERMGC--------- 241
Query: 608 PEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPSVTESPDH 656
P + LC +E+RP +A L N + + H
Sbjct: 242 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHH 290
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-43
Identities = 70/298 (23%), Positives = 129/298 (43%), Gaps = 48/298 (16%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGRE------IAVKKLATNSMQGKEEFENEVRVLLKM 421
+ K LG G FG V+ + +AVK L ++ +++F+ E +L +
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 422 QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFL-------------FDKSKSAILDWPK 468
QH ++V+ +G C I+V+EY+ + L+KFL + L +
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 469 RLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528
L+I +A G++YL + +HRD+ N L+ + KI DFG+++ + +R
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY-YR 190
Query: 529 THQIAGTFG-----YMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQE 582
G +M PE + + +SDV+SFGV+L EI + G++ + + N E
Sbjct: 191 ----VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL---SNTE 243
Query: 583 LLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640
+++ +GR++E P + L C + + R + +L
Sbjct: 244 VIECIT----QGRVLE--------RPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKIL 289
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-43
Identities = 73/283 (25%), Positives = 115/283 (40%), Gaps = 29/283 (10%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQ--DGREI--AVKKL---ATNSMQGKEEFENEVRVLLK 420
+ LG G FG V +G G+ + AVK L + + ++F EV +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 421 MQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGL 480
+ HRNL++L+G + ++ V E P SL L + + VA G+
Sbjct: 78 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGM 134
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGT-FGYM 539
YL R IHRD+ A N+LL + KI DFGL + + + F +
Sbjct: 135 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 540 APEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLME 598
APE S SD + FGV L E+ + G++ + ++L ++++EG +
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI---GLNGSQILH---KIDKEGERLP 245
Query: 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641
PE+ + + C EDRPT A L
Sbjct: 246 R--------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 65/236 (27%), Positives = 113/236 (47%), Gaps = 19/236 (8%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGRE-----IAVKKLATNSMQG-KEEFENEVRVLLKM 421
F +LG G FGTVYKG E +A+K+L + +E +E V+ +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 422 QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLL 481
+ ++ +L G C+ ++ + + +P L ++ + + LN + +A+G+
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMN 131
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP 541
YL R++HRD+ A N+L+ KI+DFGLAKL E+ + +MA
Sbjct: 132 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 542 EYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRL 596
E + + +SDV+S+GV + E+++ G K YD E+ + LE+ RL
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSI---LEKGERL 238
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 70/292 (23%), Positives = 126/292 (43%), Gaps = 37/292 (12%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGRE------IAVKKLATNSMQGKEEFENEVRVLLKM 421
+ K LG G FG V+ + +AVK L S +++F+ E +L +
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 422 QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFL------------FDKSKSAILDWPKR 469
QH+++V+ FG C + R ++V+EY+ + L++FL + L +
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 470 LNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRT 529
L + VA G++YL + L +HRD+ N L+ + KI DFG+++ +
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 530 HQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLAR 588
+ +M PE + + +SDV+SFGV+L EI + G++ + + N E +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY---QLSNTEAIDCIT 274
Query: 589 RLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640
+GR +E P I C + + R ++ + L
Sbjct: 275 ----QGRELE--------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-42
Identities = 65/283 (22%), Positives = 108/283 (38%), Gaps = 32/283 (11%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQ--DGREI--AVKKLATNSM-QGKEEFENEVRVLLKMQ 422
+ +G G FG V++G + + A+K + +E+F E + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 423 HRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLY 482
H ++V+L G + I + E L FL + + LD + ++ L Y
Sbjct: 75 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF--GYMA 540
L R +HRDI A N+L+ K+ DFGL++ D + G +MA
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK---GKLPIKWMA 185
Query: 541 PEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599
PE + SDV+ FGV + EI+ G K + +N +++ R+E RL
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ---GVKNNDVIG---RIENGERLPM- 238
Query: 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
P + C RP + + LS
Sbjct: 239 --------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-42
Identities = 67/283 (23%), Positives = 119/283 (42%), Gaps = 32/283 (11%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQ--DGREI--AVKKLATNSM-QGKEEFENEVRVLLKMQ 422
++ +LG G FG VY+G G +I AVK + KE+F +E ++ +
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 423 HRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLY 482
H ++V+L G +E I + E P L +L + L + + + + + Y
Sbjct: 72 HPHIVKLIGIIEEEPTWI-IMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF--GYMA 540
L + +HRDI NIL+ K+ DFGL++ DE + +M+
Sbjct: 129 LES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV---TRLPIKWMS 182
Query: 541 PEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599
PE + SDV+ F V + EI+S G++ + EN++++ + E+G +
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFF---WLENKDVIGVL----EKGDRLPK 235
Query: 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
P+ + C + DRP + + LS+
Sbjct: 236 --------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-42
Identities = 60/236 (25%), Positives = 108/236 (45%), Gaps = 19/236 (8%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGRE-----IAVKKL-ATNSMQGKEEFENEVRVLLKM 421
+LG G FGTV+KG E + +K + + Q + + + + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 422 QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLL 481
H ++V+L G C ++ V +YLP SL + + L LN + +A+G+
Sbjct: 73 DHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMY 129
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP 541
YL ++HR++ A N+LL + +++DFG+A L + + + +MA
Sbjct: 130 YLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 542 EYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRL 596
E G + +SDV+S+GV + E+++ G + Y E+ L LE+ RL
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA---GLRLAEVPDL---LEKGERL 236
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-42
Identities = 70/279 (25%), Positives = 114/279 (40%), Gaps = 29/279 (10%)
Query: 373 KNMLGRGGFGTVYKGRLQDGRE----IAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLV 427
++G+G FG VY G D + A+K L+ MQ E F E ++ + H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 428 QLFGCCVQERERIL-VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD 486
L G + + Y+ + L +F+ +S ++ + VARG+ YL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYL--- 140
Query: 487 SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF--GYMAPEYA 544
+ + +HRD+ A N +LD K++DFGLA+ D + + A E
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 545 IRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603
+ KSDV+SFGVLL E+++ G Y + +L +GR +
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYR---HIDPFDLTHFL----AQGRRLP----- 248
Query: 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
PE Q+ C E RPT + +
Sbjct: 249 ---QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 69/293 (23%), Positives = 129/293 (44%), Gaps = 49/293 (16%)
Query: 376 LGRGGFGTVYKGRLQDGRE------IAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQ 428
LG FG VYKG L +A+K L + +EEF +E + ++QH N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 429 LFGCCVQERERILVYEYLPNKSLDKFL-------------FDKSKSAILDWPKRLNIIMG 475
L G +++ +++ Y + L +FL D++ + L+ P ++++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 476 VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGT 535
+A G+ YL S ++H+D+ N+L+ ++ KISD GL + + +
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD-----YYKLLG 188
Query: 536 FG-----YMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARR 589
+MAPE + G S+ SD++S+GV+L E+ S G + Y NQ+++++
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC---GYSNQDVVEMI-- 243
Query: 590 LEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
+++ P++ + + C +F RP S L
Sbjct: 244 --RNRQVLP--------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 286
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 73/278 (26%), Positives = 124/278 (44%), Gaps = 29/278 (10%)
Query: 374 NMLGRGGFGTVYKGRLQDGRE----IAVKKL-ATNSMQGKEEFENEVRVLLKMQHRNLVQ 428
++GRG FG VY G L D AVK L + +F E ++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 429 LFGCCVQERERIL-VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
L G C++ L V Y+ + L F+ ++++ + + VA+G+ YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL---A 145
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF--GYMAPEYAI 545
+ +HRD+ A N +LD + K++DFGLA+ +D++ ++ +MA E
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 546 RGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604
+ KSDV+SFGVLL E+++ G Y + ++ +GR +
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAPPYP---DVNTFDITVYL----LQGRRLLQ----- 253
Query: 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
PE ++ L C E RP+ S +S +S
Sbjct: 254 ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 3e-41
Identities = 64/243 (26%), Positives = 112/243 (46%), Gaps = 20/243 (8%)
Query: 361 DVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGRE---IAVKKLATNSM-QGKEEFENEVR 416
+ + + LG G FG+V +G + ++ +A+K L + EE E +
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 388
Query: 417 VLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGV 476
++ ++ + +V+L G C E + V E L KFL K + ++ V
Sbjct: 389 IMHQLDNPYIVRLIGVCQAEALML-VMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQV 445
Query: 477 ARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF 536
+ G+ YL +HR++ A N+LL ++ KISDFGL+K + S + AG +
Sbjct: 446 SMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-AGKW 501
Query: 537 GY--MAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEE 593
APE S +SDV+S+GV + E +S G+K Y + + E++ +E+
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---KGPEVMA---FIEQG 555
Query: 594 GRL 596
R+
Sbjct: 556 KRM 558
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 4e-41
Identities = 54/229 (23%), Positives = 100/229 (43%), Gaps = 39/229 (17%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQ-GKEEFENEVRVLLKMQHRN 425
+F LGRGGFG V++ + D A+K++ + + +E+ EV+ L K++H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 426 LVQLFGCCVQE---------RERILVY---EYLPNKSLDKFLFDKSKSAILDWPKRLNII 473
+V+ F +++ ++ +Y + ++L ++ + + L+I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 474 MGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIA 533
+ +A + +LH ++HRD+K SNI K+ DFGL ++
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 534 ----------GTFGYMAPE------YAIRGFLSVKSDVFSFGVLLLEII 566
GT YM+PE Y S K D+FS G++L E++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSY------SHKVDIFSLGLILFELL 224
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-41
Identities = 74/298 (24%), Positives = 123/298 (41%), Gaps = 64/298 (21%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL 426
+F ++G GGFG V+K + DG+ +K++ N E+ E EV+ L K+ H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNI 66
Query: 427 VQLFGCCVQERERI----------------LVYEYLPNKSLDKFLFDKSKSAILDWPKRL 470
V GC + E+ +L++++ +K + LD L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 471 NIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTH 530
+ + +G+ Y+H ++I+RD+K SNI L + KI DFGL ++ R R+
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS- 181
Query: 531 QIAGTFGYMAPE------YAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELL 584
GT YM+PE Y + D+++ G++L ELL
Sbjct: 182 --KGTLRYMSPEQISSQDY------GKEVDLYALGLIL---------A---------ELL 215
Query: 585 KLARRLEEEGRLMELVDVRIGTYPEEIALRFMQI--ALLCTEDFIEDRPTMSATLSML 640
+ E + D+R G + + + LL + EDRP S L L
Sbjct: 216 HVCDTAFETSKFFT--DLRDGIISDIFDKKEKTLLQKLLSKKP--EDRPNTSEILRTL 269
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 9e-41
Identities = 85/320 (26%), Positives = 128/320 (40%), Gaps = 52/320 (16%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGR------EIAVKKL-ATNSMQGKEEFENEVRVLLK 420
N + LG G FG VY+G++ ++AVK L S Q + +F E ++ K
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 421 MQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFL----FDKSKSAILDWPKRLNIIMGV 476
H+N+V+ G +Q R ++ E + L FL S+ + L L++ +
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 477 ARGLLYLHRDSVLRIIHRDIKASNILLDHQ---MKPKISDFGLAKLFHDEQSRHRTHQIA 533
A G YL IHRDI A N LL KI DFG+A+ + +
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK----- 201
Query: 534 GTFGY-----MAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLA 587
G M PE + G + K+D +SFGVLL EI S G Y NQE+L+
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY---PSKSNQEVLEFV 258
Query: 588 RRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML------- 640
G M+ P+ +I C + EDRP + L +
Sbjct: 259 T----SGGRMD--------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306
Query: 641 --SNSSVPIPSVTESPDHYE 658
N+++PI + +
Sbjct: 307 DVINTALPIEYGPLVEEEEK 326
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 73/303 (24%), Positives = 123/303 (40%), Gaps = 43/303 (14%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGRE----IAVK--KLATNSMQGKEEFENEVRVLLKM 421
+ +LG G FG+V +G L+ +AVK KL +S + EEF +E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 422 QHRNLVQLFGCCVQERERI-----LVYEYLPNKSLDKFL---FDKSKSAILDWPKRLNII 473
H N+++L G C++ + ++ ++ L +L ++ + L +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 474 MGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIA 533
+ +A G+ YL S +HRD+ A N +L M ++DFGL+K + +R
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY-YR----Q 205
Query: 534 GTFG-----YMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLA 587
G ++A E + KSDV++FGV + EI + G Y +N E+
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYP---GVQNHEMYDYL 262
Query: 588 RRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPI 647
G ++ PE+ +I C DRPT S L +
Sbjct: 263 ----LHGHRLKQ--------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310
Query: 648 PSV 650
P V
Sbjct: 311 PDV 313
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 67/295 (22%), Positives = 126/295 (42%), Gaps = 43/295 (14%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGRE------IAVKKL-ATNSMQGKEEFENEVRVLLK 420
+ + LG+G FG VY+G + + +A+K + SM+ + EF NE V+ +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 421 MQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFL-------FDKSKSAILDWPKRLNII 473
++V+L G Q + +++ E + L +L + A K + +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 474 MGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIA 533
+A G+ YL + + +HRD+ A N ++ KI DFG+ + ++ +
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-----YYRK 196
Query: 534 GTFGY-----MAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLA 587
G G M+PE G + SDV+SFGV+L EI + + Y N+++L+
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---GLSNEQVLRFV 253
Query: 588 RRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
EG L++ P+ ++ +C + + RP+ +S +
Sbjct: 254 M----EGGLLDK--------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 296
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 70/322 (21%), Positives = 127/322 (39%), Gaps = 46/322 (14%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGRE----IAVK--KLATNSMQGKEEFENEVRVLLKM 421
F+ MLG+G FG+V + +L+ +AVK K + EEF E + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 422 QHRNLVQLFGCCVQERERI------LVYEYLPNKSLDKFLFD---KSKSAILDWPKRLNI 472
H ++ +L G ++ R + ++ ++ + L FL L +
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 473 IMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQI 532
++ +A G+ YL S IHRD+ A N +L M ++DFGL++ + +R
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY-YR---- 194
Query: 533 AGTFG-----YMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKL 586
G ++A E +V SDV++FGV + EI++ G+ Y EN E+
Sbjct: 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY---AGIENAEIYNY 251
Query: 587 ARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN--SS 644
G ++ P E + C + RP+ + L N
Sbjct: 252 L----IGGNRLKQ--------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299
Query: 645 VPIPSVTESPDHYEGDDDAGDN 666
+ + S ++ P + + +
Sbjct: 300 LSVLSTSQDPLYINIERAHHHH 321
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-40
Identities = 82/293 (27%), Positives = 120/293 (40%), Gaps = 43/293 (14%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGR------EIAVKKL-ATNSMQGKEEFENEVRVLLK 420
N + LG G FG VY+G++ ++AVK L S Q + +F E ++ K
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 421 MQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFL----FDKSKSAILDWPKRLNIIMGV 476
H+N+V+ G +Q R ++ E + L FL S+ + L L++ +
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 477 ARGLLYLHRDSVLRIIHRDIKASNILLDHQ---MKPKISDFGLAKLFHDEQSRHRTHQIA 533
A G YL IHRDI A N LL KI DFG+A+ + +
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK----- 242
Query: 534 GTFGY-----MAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLA 587
G M PE + G + K+D +SFGVLL EI S G Y NQE+L+
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP---SKSNQEVLEFV 299
Query: 588 RRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640
G M+ P+ +I C + EDRP + L +
Sbjct: 300 T----SGGRMD--------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-40
Identities = 75/281 (26%), Positives = 127/281 (45%), Gaps = 35/281 (12%)
Query: 374 NMLGRGGFGTVYKGRLQ--DGREI--AVKKL-ATNSMQGKEEFENEVRVLLKMQHRNLVQ 428
++GRG FG VY G L DG++I AVK L + +F E ++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 429 LFGCCVQERERIL-VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
L G C++ L V Y+ + L F+ ++++ + + VA+G+ +L +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL---A 209
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFG-----YMAPE 542
+ +HRD+ A N +LD + K++DFGLA+ +D++ T +MA E
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF---DSVHNKTGAKLPVKWMALE 266
Query: 543 YAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601
+ KSDV+SFGVLL E+++ G Y + ++ +GR +
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP---DVNTFDITVYL----LQGRRLLQ-- 317
Query: 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
PE ++ L C E RP+ S +S +S
Sbjct: 318 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-39
Identities = 64/275 (23%), Positives = 106/275 (38%), Gaps = 32/275 (11%)
Query: 376 LGRGGFGTVYKGRLQ--DGREI--AVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLF 430
+G G FG V++G + + A+K + +E+F E + + H ++V+L
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 431 GCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLR 490
G + I + E L FL + + LD + ++ L YL R
Sbjct: 458 GVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESKR 511
Query: 491 IIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF--GYMAPEYAIRGF 548
+HRDI A N+L+ K+ DFGL++ D + G +MAPE
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK---GKLPIKWMAPESINFRR 568
Query: 549 LSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTY 607
+ SDV+ FGV + EI+ G K + +N +++ +E RL
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQGV---KNNDVIGR---IENGERLPM--------- 613
Query: 608 PEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
P + C RP + + LS
Sbjct: 614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 59/241 (24%), Positives = 100/241 (41%), Gaps = 25/241 (10%)
Query: 369 NFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLV 427
++ LG GGF V L DG A+K++ + Q +EE + E + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 428 QLFGCCVQERER----ILVYEYLPNKSLDKFLFD-KSKSAILDWPKRLNIIMGVARGLLY 482
+L C++ER L+ + +L + K K L + L +++G+ RGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIA-------GT 535
+H HRD+K +NILL + +P + D G R T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 536 FGYMAPE------YAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARR 589
Y APE + + ++DV+S G +L ++ G YD + + L + +
Sbjct: 207 ISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263
Query: 590 L 590
L
Sbjct: 264 L 264
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVK--KLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGC 432
+GRG F TVYKG + E+A + + ++ F+ E +L +QH N+V+ +
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 433 CV---QERERILVY-EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488
+ ++ I++ E + + +L +L + ++ + + +GL +LH +
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 489 LRIIHRDIKASNILLDHQM-KPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG 547
IIHRD+K NI + KI D GLA L + GT +MAPE
Sbjct: 151 -PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYEEK 205
Query: 548 FLSVKSDVFSFGVLLLEIISGRKNY 572
+ DV++FG+ +LE+ + Y
Sbjct: 206 Y-DESVDVYAFGMCMLEMATSEYPY 229
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 49/216 (22%), Positives = 93/216 (43%), Gaps = 23/216 (10%)
Query: 369 NFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGK--EEFENEVRVLLKMQHRNL 426
+S +G GG V++ + + A+K + + + + NE+ L K+Q +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 427 --VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLH 484
++L+ + ++ +V E N L+ +L K +D +R + + + +H
Sbjct: 89 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIH 144
Query: 485 RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE-- 542
+ I+H D+K +N L+ M K+ DFG+A + + GT YM PE
Sbjct: 145 Q---HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 543 ---------YAIRGFLSVKSDVFSFGVLLLEIISGR 569
+ +S KSDV+S G +L + G+
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 8e-39
Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 369 NFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLV 427
+F K++LG G GT+ + D R++AVK++ + EV++L + +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVI 81
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
+ F + + + E +L +++ + K + + ++ GL +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 488 VLRIIHRDIKASNILL-----DHQMKPKISDFGLAK-LFHDEQSRHRTHQIAGTFGYMAP 541
L I+HRD+K NIL+ ++K ISDFGL K L S R + GT G++AP
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 542 EY---AIRGFLSVKSDVFSFGVLLLEIISGRK-----NYDRQL 576
E + + D+FS G + +IS + RQ
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA 238
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-38
Identities = 72/304 (23%), Positives = 123/304 (40%), Gaps = 52/304 (17%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGRE--------IAVKKLATNSMQG-KEEFENEVRVL 418
D + LG G FG V + +AVK L ++ + + +E+ ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 419 LKM-QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFL-------------FDKSKSAIL 464
+ +H+N++ L G C Q+ ++ EY +L ++L ++ +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 465 DWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524
+ ++ +ARG+ YL + + IHRD+ A N+L+ KI+DFGLA+ ++
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 525 SRHRTHQIAGTFG-----YMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEA 578
+ T G +MAPE + +SDV+SFGVL+ EI + G Y
Sbjct: 258 -----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--- 309
Query: 579 ENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638
+EL KL + EG M+ P + C RPT +
Sbjct: 310 PVEELFKLLK----EGHRMDK--------PANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357
Query: 639 MLSN 642
L
Sbjct: 358 DLDR 361
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKE--EFENEVRVLLKMQHR 424
+ + +G G FG + +DGR+ +K++ + M KE E EV VL M+H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLH 484
N+VQ + +V +Y L K + + K + + L+ + + L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 485 RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE-- 542
+I+HRDIK+ NI L ++ DFG+A++ + R GT Y++PE
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 543 ----YAIRGFLSVKSDVFSFGVLLLEIISGR 569
Y + KSD+++ G +L E+ + +
Sbjct: 198 ENKPY------NNKSDIWALGCVLYELCTLK 222
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 72/310 (23%), Positives = 123/310 (39%), Gaps = 59/310 (19%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGRE------IAVKKL-ATNSMQGKEEFENEVRVLLK 420
+N +G G FG V++ R +AVK L S + +F+ E ++ +
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 421 MQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKR----------- 469
+ N+V+L G C + L++EY+ L++FL S +
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 470 ----------LNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA-K 518
L I VA G+ YL S + +HRD+ N L+ M KI+DFGL+
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 519 LFHDEQSRHRTHQIAGTFGY-----MAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNY 572
++ + + + M PE + +SDV+++GV+L EI S G + Y
Sbjct: 224 IYSADYYKADGN------DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277
Query: 573 DRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPT 632
++E++ R +G ++ PE L + LC DRP+
Sbjct: 278 ---YGMAHEEVIYYVR----DGNILA--------CPENCPLELYNLMRLCWSKLPADRPS 322
Query: 633 MSATLSMLSN 642
+ +L
Sbjct: 323 FCSIHRILQR 332
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 72/304 (23%), Positives = 123/304 (40%), Gaps = 52/304 (17%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGRE--------IAVKKLATNSMQG-KEEFENEVRVL 418
D + LG G FG V + +AVK L ++ + + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 419 LKM-QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFL-------------FDKSKSAIL 464
+ +H+N++ L G C Q+ ++ EY +L ++L ++ +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 465 DWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524
+ ++ +ARG+ YL + + IHRD+ A N+L+ KI+DFGLA+ ++
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 525 SRHRTHQIAGTFG-----YMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEA 578
+ T G +MAPE + +SDV+SFGVL+ EI + G Y
Sbjct: 212 -----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--- 263
Query: 579 ENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638
+EL KL + EG M+ P + C RPT +
Sbjct: 264 PVEELFKLLK----EGHRMD--------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 639 MLSN 642
L
Sbjct: 312 DLDR 315
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 49/216 (22%), Positives = 93/216 (43%), Gaps = 23/216 (10%)
Query: 369 NFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGK--EEFENEVRVLLKMQHRNL 426
+S +G GG V++ + + A+K + + + + NE+ L K+Q +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 427 --VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLH 484
++L+ + ++ +V E N L+ +L K +D +R + + + +H
Sbjct: 70 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIH 125
Query: 485 RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE-- 542
+ I+H D+K +N L+ M K+ DFG+A + + GT YM PE
Sbjct: 126 Q---HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 543 ---------YAIRGFLSVKSDVFSFGVLLLEIISGR 569
+ +S KSDV+S G +L + G+
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 87/329 (26%), Positives = 137/329 (41%), Gaps = 54/329 (16%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRL-QDGREI--AVKKLATNSMQG-KEEFENEVRVLLKM-Q 422
++ ++++G G FG V K R+ +DG + A+K++ + + +F E+ VL K+
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 423 HRNLVQLFGCCVQERERILVYEYLPNKSLDKFL-------------FDKSKSAILDWPKR 469
H N++ L G C L EY P+ +L FL S ++ L +
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 470 LNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRT 529
L+ VARG+ YL S + IHRD+ A NIL+ KI+DFGL SR +
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL--------SRGQE 193
Query: 530 HQIAGTFG-----YMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQEL 583
+ T G +MA E + SDV+S+GVLL EI+S G Y EL
Sbjct: 194 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAEL 250
Query: 584 LKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMS---ATL-SM 639
+ +G +E P + C + +RP+ + +L M
Sbjct: 251 YEKL----PQGYRLE--------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298
Query: 640 LSNSSVPIPSVTESPDHYEGDDDAGDNAG 668
L + + Y G D + + A
Sbjct: 299 LEERKTYVNTTLYEKFTYAGIDCSAEEAA 327
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 37/231 (16%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN 425
+F +LG+G FG V K R D R A+KK+ + +EV +L + H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 426 LVQLFGCCVQERERI-------------LVYEYLPNKSLDKFLFD--KSKSAILDWPKRL 470
+V+ + ++ R + + EY N +L +D S++ +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119
Query: 471 NIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRT- 529
+ + L Y+H IIHRD+K NI +D KI DFGLAK H +
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 530 -----------HQIAGTFGYMAPE-YAIRGFLSVKSDVFSFGVLLLEIISG 568
GT Y+A E G + K D++S G++ E+I
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-38
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 375 MLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCC 433
+LG+G +G VY GR L + IA+K++ + + E+ + ++H+N+VQ G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 434 VQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIH 493
+ + E +P SL L K + + GL YLH + +I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 494 RDIKASNILLD-HQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL--- 549
RDIK N+L++ + KISDFG +K T GT YMAPE I
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPE-IIDKGPRGY 202
Query: 550 SVKSDVFSFGVLLLEIISGR 569
+D++S G ++E+ +G+
Sbjct: 203 GKAADIWSLGCTIIEMATGK 222
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 56/233 (24%), Positives = 107/233 (45%), Gaps = 26/233 (11%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLA-TNSMQGKE--EFENEVRVLLKMQH 423
NF + +GRG F VY+ L DG +A+KK+ + M K + E+ +L ++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFL-FDKSKSAILDWPKRLNIIMGVARGLLY 482
N+++ + +++ E +V E L + + K + ++ + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
+H R++HRDIK +N+ + K+ D GL + F + + + + GT YM+PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 543 ------YAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARR 589
Y + KSD++S G LL E+ + + + + L L ++
Sbjct: 207 RIHENGY------NFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLCKK 249
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 78/303 (25%), Positives = 118/303 (38%), Gaps = 50/303 (16%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQD------GREIAVKKLATNSMQG-KEEFENEVRVLLK 420
D LGRG FG V + R +AVK L + +E+++L+
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 421 M-QHRNLVQLFGCCVQERERILV-YEYLPNKSLDKFL-------------FDKSKSAILD 465
+ H N+V L G C + ++V E+ +L +L + L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 466 WPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525
+ VA+G+ +L + + IHRD+ A NILL + KI DFGLA+ + +
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP- 202
Query: 526 RHRTHQIAGTFG-----YMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAE 579
+ +MAPE +++SDV+SFGVLL EI S G Y
Sbjct: 203 ----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKI 256
Query: 580 NQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639
++E + + EG M P+ Q L C RPT S +
Sbjct: 257 DEEFCRRLK----EGTRMR--------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304
Query: 640 LSN 642
L N
Sbjct: 305 LGN 307
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 30/215 (13%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVK-----KLATNSMQGKEEFENEVRVLLKM 421
+ LG+GGF ++ A K L + K E+ + +
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSL 98
Query: 422 QHRNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLN------IIM 474
H+++V G ++ + + +V E +SL + K K L +
Sbjct: 99 AHQHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRR-----KALTEPEARYYLR 148
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAG 534
+ G YLHR R+IHRD+K N+ L+ ++ KI DFGLA + R + + G
Sbjct: 149 QIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCG 203
Query: 535 TFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
T Y+APE + S + DV+S G ++ ++ G+
Sbjct: 204 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKE--EFENEVRVLLKMQHR 424
+++ +G G +G K R DG+ + K+L SM E +EV +L +++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 425 NLVQLFGCCVQERERIL--VYEYLPNKSLDKFL-FDKSKSAILDWPKRLNIIMGVARGLL 481
N+V+ + + L V EY L + + LD L ++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 482 YLH--RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYM 539
H D ++HRD+K +N+ LD + K+ DFGLA++ + + S +T GT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 540 APE------YAIRGFLSVKSDVFSFGVLLLEIISGR 569
+PE Y + KSD++S G LL E+ +
Sbjct: 184 SPEQMNRMSY------NEKSDIWSLGCLLYELCALM 213
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 80/298 (26%), Positives = 118/298 (39%), Gaps = 47/298 (15%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGRE------IAVKKLATNSMQG-KEEFENEVRVLLK 420
+N LG G FG V + + +AVK L + + KE +E++++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 421 M-QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKR---------- 469
+ QH N+V L G C +++ EY L FL KS+ D
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 470 -LNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528
L+ VA+G+ +L + IHRD+ A N+LL + KI DFGLA+ ++
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS---- 218
Query: 529 THQIAGTFG-----YMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQE 582
+ I +MAPE +V+SDV+S+G+LL EI S G Y N +
Sbjct: 219 -NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY--PGILVNSK 275
Query: 583 LLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640
KL + +G M P I C RPT S L
Sbjct: 276 FYKLVK----DGYQMA--------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 16/208 (7%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFE--NEVRVLLKM-QH 423
+F + LG G +G V+K R +DGR AVK+ + K+ EV K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 424 RNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLY 482
V+L +E + L E SL + ++ A L + + L +
Sbjct: 117 PCCVRLEQA-WEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
LH ++H D+K +NI L + + K+ DFGL G YMAPE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPE 226
Query: 543 YAIRGFLSVKSDVFSFGVLLLEIISGRK 570
++G +DVFS G+ +LE+ +
Sbjct: 227 -LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 30/215 (13%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVK-----KLATNSMQGKEEFENEVRVLLKM 421
+ LG+GGF ++ A K L + K E+ + +
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSL 72
Query: 422 QHRNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLN------IIM 474
H+++V G ++ + + +V E +SL + K K L +
Sbjct: 73 AHQHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRR-----KALTEPEARYYLR 122
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAG 534
+ G YLHR R+IHRD+K N+ L+ ++ KI DFGLA + R + + G
Sbjct: 123 QIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCG 177
Query: 535 TFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
T Y+APE + S + DV+S G ++ ++ G+
Sbjct: 178 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 22/218 (10%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE-FENEVRVLLKMQHRN 425
+ ++LG+G V++GR + G A+K S + E VL K+ H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 426 LVQLFGC--CVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL 483
+V+LF R ++L+ E+ P SL L + S + L + L ++ V G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 484 HRDSVLRIIHRDIKASNILL----DHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYM 539
I+HR+IK NI+ D Q K++DFG A+ D++ + + GT Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYL 182
Query: 540 APEYAIRGFL--------SVKSDVFSFGVLLLEIISGR 569
P+ R L D++S GV +G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 47/216 (21%), Positives = 91/216 (42%), Gaps = 23/216 (10%)
Query: 369 NFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGK--EEFENEVRVLLKMQHRNL 426
+S +G GG V++ + + A+K + + + + NE+ L K+Q +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 427 --VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLH 484
++L+ + ++ +V E N L+ +L K +D +R + + + +H
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIH 172
Query: 485 RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE-- 542
+ I+H D+K +N L+ K+ DFG+A + + G YM PE
Sbjct: 173 Q---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 543 ---------YAIRGFLSVKSDVFSFGVLLLEIISGR 569
+ +S KSDV+S G +L + G+
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 77/307 (25%), Positives = 126/307 (41%), Gaps = 57/307 (18%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGRE------IAVKKLATNSMQG-KEEFENEVRVLLK 420
N LG G FG V K + +AVK L N+ + +E VL +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 421 MQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFL---------------------FDKS 459
+ H ++++L+G C Q+ +L+ EY SL FL D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 460 KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519
L ++ +++G+ YL + ++++HRD+ A NIL+ K KISDFGL++
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 520 FHDEQSRHRTHQIAGTFG-----YMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYD 573
++E + + G +MA E + +SDV+SFGVLL EI++ G Y
Sbjct: 200 VYEED-----SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254
Query: 574 RQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTM 633
+ L L + G ME P+ + ++ L C + + RP
Sbjct: 255 GI---PPERLFNLLK----TGHRMER--------PDNCSEEMYRLMLQCWKQEPDKRPVF 299
Query: 634 SATLSML 640
+ L
Sbjct: 300 ADISKDL 306
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 75/299 (25%), Positives = 115/299 (38%), Gaps = 45/299 (15%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGRE------IAVKKLATNSMQG-KEEFENEVRVLLK 420
+ S LG G FG V + + +AVK L ++ +E +E++VL
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 421 M-QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMG---- 475
+ H N+V L G C +++ EY L FL K S I +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 476 -----------VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524
VA+G+ +L + IHRD+ A NILL H KI DFGLA+ ++
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 525 SRHRTHQIAGTF--GYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQ 581
+ +MAPE + +SDV+S+G+ L E+ S G Y +
Sbjct: 200 NYVVKGN--ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--PGMPVDS 255
Query: 582 ELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640
+ K+ + EG M PE I C + RPT + ++
Sbjct: 256 KFYKMIK----EGFRML--------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-37
Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 25/216 (11%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKL-ATNSMQGKEEFENEVRVLLKM-QHR 424
++ +GRG +G+V K G+ +AVK++ +T + +++ ++ V+++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN------IIMGVAR 478
+VQ +G +E + + E + + S DKF K + I + +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY 538
L +L L+IIHRDIK SNILLD K+ DFG++ D ++ R AG Y
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPY 191
Query: 539 MAPEYAIRGFL-----SVKSDVFSFGVLLLEIISGR 569
MAPE I V+SDV+S G+ L E+ +GR
Sbjct: 192 MAPE-RIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 9e-37
Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 26/216 (12%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKL-ATNSMQGKEEFENEVRVLLKM-QHR 424
D+ LGRG +G V K R + G+ +AVK++ AT + Q ++ ++ + ++
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN------IIMGVAR 478
V +G +E + + E + + SLDKF ++D + + I + + +
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY 538
L +LH S L +IHRD+K SN+L++ + K+ DFG++ D + G Y
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD--DVAKDIDA-GCKPY 175
Query: 539 MAPEYAIRGFL-----SVKSDVFSFGVLLLEIISGR 569
MAPE I L SVKSD++S G+ ++E+ R
Sbjct: 176 MAPE-RINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 75/294 (25%), Positives = 119/294 (40%), Gaps = 52/294 (17%)
Query: 376 LGRGGFGTVYKGRLQD--------GREIAVKKLATNSMQG-KEEFENEVRVLLKM-QHRN 425
LG G FG V ++AVK L +++ + + +E+ ++ + +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFL-------------FDKSKSAILDWPKRLNI 472
++ L G C Q+ ++ EY +L ++L + L ++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 473 IMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQI 532
VARG+ YL + + IHRD+ A N+L+ KI+DFGLA+ H +
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID-----YYK 248
Query: 533 AGTFG-----YMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKL 586
T G +MAPE + +SDV+SFGVLL EI + G Y +EL KL
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---PVEELFKL 305
Query: 587 ARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640
+EG M+ P + C RPT + L
Sbjct: 306 L----KEGHRMD--------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 74/307 (24%), Positives = 114/307 (37%), Gaps = 56/307 (18%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGRE------IAVKKLATNSMQG-KEEFENEVRVLLK 420
+N +LG G FG V + +AVK L + +E +E++++ +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 421 M-QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMG---- 475
+ H N+V L G C L++EY L +L K + D + N
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 476 ----------------VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519
VA+G+ +L +HRD+ A N+L+ H KI DFGLA+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 520 FHDEQSRHRTHQIAGTFG-----YMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYD 573
+ + + +MAPE G ++KSDV+S+G+LL EI S G Y
Sbjct: 222 IMSDS-----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY- 275
Query: 574 RQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTM 633
+ KL + G M+ P I C RP+
Sbjct: 276 -PGIPVDANFYKLIQ----NGFKMD--------QPFYATEEIYIIMQSCWAFDSRKRPSF 322
Query: 634 SATLSML 640
S L
Sbjct: 323 PNLTSFL 329
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 19/231 (8%)
Query: 346 TNNQGIDMRSFLFNLDVLIAATDNFSTK-NMLGRGGFGTVYKGR-LQDGREIAVKKLATN 403
+N+G+ + L +D ++ T +GRG FG V++ + Q G + AVKK+
Sbjct: 35 EDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE 94
Query: 404 SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAI 463
+ E+ + +V L+G + + E L SL + + +
Sbjct: 95 VFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGC 146
Query: 464 LDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ-MKPKISDFGLAKLFHD 522
L + L + GL YLH RI+H D+KA N+LL + + DFG A
Sbjct: 147 LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203
Query: 523 EQ---SRHRTHQIAGTFGYMAPEYAIRGF-LSVKSDVFSFGVLLLEIISGR 569
+ S I GT +MAPE + G K D++S ++L +++G
Sbjct: 204 DGLGKSLLTGDYIPGTETHMAPE-VVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-36
Identities = 61/209 (29%), Positives = 110/209 (52%), Gaps = 17/209 (8%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVK-----KLATNSMQGKEEFENEVRVLLKM 421
++F N+LG+G F VY+ + G E+A+K + M + +NEV++ ++
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR--VQNEVKIHCQL 68
Query: 422 QHRNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGL 480
+H ++++L+ ++ + LV E N ++++L ++ K + + + + G+
Sbjct: 69 KHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKP--FSENEARHFMHQIITGM 125
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMA 540
LYLH I+HRD+ SN+LL M KI+DFGLA +H T + GT Y++
Sbjct: 126 LYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYIS 180
Query: 541 PEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
PE A R ++SDV+S G + ++ GR
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-36
Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 22/218 (10%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE-FENEVRVLLKMQHRN 425
+ ++LG+G V++GR + G A+K S + E VL K+ H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 426 LVQLFGC--CVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL 483
+V+LF R ++L+ E+ P SL L + S + L + L ++ V G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 484 HRDSVLRIIHRDIKASNILL----DHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYM 539
I+HR+IK NI+ D Q K++DFG A+ D++ + + GT Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYL 182
Query: 540 APEYAIRGFL--------SVKSDVFSFGVLLLEIISGR 569
P+ R L D++S GV +G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 12/228 (5%)
Query: 345 LTNNQGIDMRSFLF-NLDVLIAATDNFSTKNMLGRGGFGTVYKGRL-QDGREIAVKKL-A 401
L Q + +FL V D+F + LG G G V+K G +A K +
Sbjct: 9 LDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL 68
Query: 402 TNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKS 461
+ + E++VL + +V +G + E + E++ SLD+ L K+
Sbjct: 69 EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKA 125
Query: 462 AILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521
+ + + V +GL YL +I+HRD+K SNIL++ + + K+ DFG++
Sbjct: 126 GRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183
Query: 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
D S + GT YM+PE SV+SD++S G+ L+E+ GR
Sbjct: 184 D--SMANSF--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 10/203 (4%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN 425
+ +G G G V R GR++AVK + Q +E NEV ++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+V+++ + E ++ E+L +L D L+ + + V + L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI 545
+IHRDIK+ +ILL + K+SDFG + + ++ + GT +MAPE
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVIS 214
Query: 546 RGFLSVKSDVFSFGVLLLEIISG 568
R + + D++S G++++E++ G
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDG 237
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-35
Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 34/228 (14%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNL 426
+ ++ +LG G GTV GR +AVK++ + + E+++L + H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNV 71
Query: 427 VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKS----AILDWPKRLNIIMGVARGLLY 482
++ + +R + E N +L + K+ S + ++++ +A G+ +
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKP-------------KISDFGLAKLFHDEQS--RH 527
LH L+IIHRD+K NIL+ + ISDFGL K QS R
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 528 RTHQIAGTFGYMAPE-------YAIRGFLSVKSDVFSFGVLLLEIISG 568
+ +GT G+ APE + L+ D+FS G + I+S
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN 425
++ +G+G GTVY + G+E+A++++ KE NE+ V+ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+V + E +V EYL SL D +D + + + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI 545
+ ++IHRDIK+ NILL K++DFG EQS+ T + GT +MAPE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189
Query: 546 RGFLSVKSDVFSFGVLLLEIISG 568
R K D++S G++ +E+I G
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVK-----KLATNSMQGKEEFENEVRVLLKM 421
++F LG+G FG VY R Q +A+K +L ++ + EV + +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQSHL 66
Query: 422 QHRNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGL 480
+H N+++L+G + R+ L+ EY P ++ + L K + D + I +A L
Sbjct: 67 RHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANAL 122
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMA 540
Y H R+IHRDIK N+LL + KI+DFG + H SR + GT Y+
Sbjct: 123 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTD--LCGTLDYLP 175
Query: 541 PEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
PE K D++S GVL E + G+
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 48/229 (20%), Positives = 86/229 (37%), Gaps = 36/229 (15%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFE--NEVRVLLKM-Q 422
T F +G G FG+V+K DG A+K+ +E EV + Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 423 HRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKS-AILDWPKRLNIIMGVARGLL 481
H ++V+ F ++ ++ EY SL + + + + + ++++ V RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKP-------------------KISDFGLAKLFHD 522
Y+H ++H DIK SNI + P KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLS--VKSDVFSFGVLLLEIISGR 569
Q G ++A E ++ + K+D+F+ + ++
Sbjct: 187 PQV------EEGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE----FENEVRVLLKMQHRNLVQLF 430
LG GG TVY ++A+K + + KEE FE EV ++ H+N+V +
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIP-PREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 431 GCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLR 490
++ LV EY+ +L +++ L +N + G+ + H +R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHD---MR 131
Query: 491 IIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLS 550
I+HRDIK NIL+D KI DFG+AK E S +T+ + GT Y +PE A
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 551 VKSDVFSFGVLLLEIISGRKNYD 573
+D++S G++L E++ G ++
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFN 213
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN 425
+ + LG G FG VYK + + G A K + T S + E++ E+ +L H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN------IIMGVARG 479
+V+L G + + ++ E+ P ++D + +L+ + L + +
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVD--------AIMLELDRGLTEPQIQVVCRQMLEA 129
Query: 480 LLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYM 539
L +LH RIIHRD+KA N+L+ + +++DFG++ + + GT +M
Sbjct: 130 LNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWM 184
Query: 540 APEYAIRGFLS-----VKSDVFSFGVLLLEIISG 568
APE + + K+D++S G+ L+E+
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 57/233 (24%), Positives = 107/233 (45%), Gaps = 17/233 (7%)
Query: 346 TNNQGIDMRSFLF-NLDVLIAATDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKL-AT 402
++ +L A ++ +G G G V+K R + G IAVK++ +
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS 61
Query: 403 NSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKS 461
+ + + ++ V+LK +VQ FG + + + E + +K K
Sbjct: 62 GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKL--KKRMQ 118
Query: 462 AILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521
+ + + + + L YL +IHRD+K SNILLD + + K+ DFG++
Sbjct: 119 GPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176
Query: 522 DEQSRHRTHQIAGTFGYMAPE-----YAIRGFLSVKSDVFSFGVLLLEIISGR 569
D++++ R+ AG YMAPE + +++DV+S G+ L+E+ +G+
Sbjct: 177 DDKAKDRS---AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 58/204 (28%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGK-EEFENEVRVLLKMQHR 424
+ F+ +G+G FG V+KG + + +A+K + + + E+ + E+ VL +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLH 484
+ + +G +++ + ++ EYL S D + LD + I+ + +GL YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136
Query: 485 RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYA 544
+ + IHRDIKA+N+LL + K++DFG+A D Q + T GT +MAPE
Sbjct: 137 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 191
Query: 545 IRGFLSVKSDVFSFGVLLLEIISG 568
+ K+D++S G+ +E+ G
Sbjct: 192 KQSAYDSKADIWSLGITAIELARG 215
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 56/217 (25%), Positives = 85/217 (39%), Gaps = 23/217 (10%)
Query: 375 MLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-HRNLVQLFGC 432
+L GGF VY+ + + GRE A+K+L +N + EV + K+ H N+VQ
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 433 CVQERER-------ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+E L+ L L +FL L L I R + ++HR
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIA----------GT 535
IIHRD+K N+LL +Q K+ DFG A + Q T
Sbjct: 155 QKPP-IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 536 FGYMAPE---YAIRGFLSVKSDVFSFGVLLLEIISGR 569
Y PE + K D+++ G +L + +
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-33
Identities = 59/214 (27%), Positives = 89/214 (41%), Gaps = 17/214 (7%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE-FENEVRVLLKMQHR 424
+ K LG GGFG V + G ++A+K+ E + E++++ K+ H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 425 NLVQLF------GCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR 478
N+V +L EY L K+L L ++ ++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLD---HQMKPKISDFGLAKLFHDEQSRHRTHQIAGT 535
L YLH RIIHRD+K NI+L ++ KI D G AK + + GT
Sbjct: 133 ALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGT 186
Query: 536 FGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
Y+APE + +V D +SFG L E I+G
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 10/203 (4%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN 425
+ F LG G +G+VYK + G+ +A+K++ +E E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+V+ +G + + +V EY S+ + + ++ L + I+ +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI 545
R IHRDIKA NILL+ + K++DFG+A D ++ T + GT +MAPE
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQ 198
Query: 546 RGFLSVKSDVFSFGVLLLEIISG 568
+ +D++S G+ +E+ G
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEG 221
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 375 MLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE----FENEVRVLLKMQHRNLVQL 429
+LG GG V+ R L+D R++AVK L + + F E + + H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 430 F--GCCVQERERI--LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+ G + +V EY+ +L + + + + + +I + L + H+
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQ 134
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR-HRTHQIAGTFGYMAPEYA 544
IIHRD+K +NI++ K+ DFG+A+ D + +T + GT Y++PE A
Sbjct: 135 ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 545 IRGFLSVKSDVFSFGVLLLEIISGRKNYD 573
+ +SDV+S G +L E+++G +
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 33/227 (14%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEF---------------- 411
+++ L +G F + +D + A+KK + ++ K +F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 412 -ENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFL-----FDKSKSAILD 465
+NE++++ +++ + G E ++YEY+ N S+ KF DK+ + +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 466 WPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525
II V Y+H + I HRD+K SNIL+D + K+SDFG ++ D+
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-- 205
Query: 526 RHRTHQIAGTFGYMAPEYAIRGFLSV---KSDVFSFGVLLLEIISGR 569
+ GT+ +M PE S K D++S G+ L +
Sbjct: 206 --KIKGSRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 15/199 (7%)
Query: 369 NFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLV 427
S +LG G FG V+K G ++A K + T M+ KEE +NE+ V+ ++ H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFLFDK--SKSAILDWPKRLNIIMGVARGLLYLHR 485
QL+ + + +LV EY+ LFD+ +S L + + + G+ ++H+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 486 DSVLRIIHRDIKASNILLDHQMKP--KISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEY 543
+ I+H D+K NIL ++ KI DFGLA+ + + + GT ++APE
Sbjct: 206 ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEV 259
Query: 544 AIRGFLSVKSDVFSFGVLL 562
F+S +D++S GV+
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 6e-32
Identities = 50/232 (21%), Positives = 99/232 (42%), Gaps = 28/232 (12%)
Query: 375 MLGRGGFGTVYKG---RLQDGREIAVKKL-ATNSMQGKEEFENEVRVLLKMQHRNLVQLF 430
+ GG G +Y + +GR + +K L + + + E + L ++ H ++VQ+F
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 431 GCCVQERERI------LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLH 484
V+ +R +V EY+ +SL + K L + + ++ + L YLH
Sbjct: 146 NF-VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH 199
Query: 485 RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYA 544
+ +++ D+K NI+L + + K+ D G + + GT G+ APE
Sbjct: 200 S---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS------RINSFGYLYGTPGFQAPEIV 249
Query: 545 IRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL 596
R +V +D+++ G L + + + E + + + GRL
Sbjct: 250 -RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRL 300
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVK-----KLATNSMQGKEEFENEVRVLLKM 421
D+F LG+G FG VY R Q+ +A+K +L ++ + E+ + +
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE--HQLRREIEIQSHL 71
Query: 422 QHRNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDK-SKSAILDWPKRLNIIMGVARG 479
+H N+++++ +R+RI L+ E+ P L + + K D + + +A
Sbjct: 72 RHPNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADA 126
Query: 480 LLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYM 539
L Y H ++IHRDIK N+L+ ++ + KI+DFG + H R RT + GT Y+
Sbjct: 127 LHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSV--HAPSLRRRT--MCGTLDYL 179
Query: 540 APEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
PE K D++ GVL E + G
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 29/210 (13%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE-FENEVRVLLKMQHR 424
D F K LG G FG V+ G E +K + + Q E E E+ VL + H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRL---------NIIMG 475
N++++F +V E L ++ I+ R ++
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGE----LLER----IVSAQARGKALSEGYVAELMKQ 132
Query: 476 VARGLLYLHRDSVLRIIHRDIKASNILL---DHQMKPKISDFGLAKLFHDEQSRHRTHQI 532
+ L Y H ++H+D+K NIL KI DFGLA+LF ++ +
Sbjct: 133 MMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNA 186
Query: 533 AGTFGYMAPEYAIRGFLSVKSDVFSFGVLL 562
AGT YMAPE + ++ K D++S GV++
Sbjct: 187 AGTALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 62/345 (17%), Positives = 110/345 (31%), Gaps = 97/345 (28%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQG-KEEFENEVRVLLKMQHRN 425
+F +GRGGFG V++ + D A+K++ + + +E+ EV+ L K++H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDW------------------- 466
+V+ F ++ E D+ S
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 467 -------PKRLNIIMG-------------------------------VARGLLYLHRDSV 488
L I M +A + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--- 182
Query: 489 LRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIA----------GTFGY 538
++HRD+K SNI K+ DFGL ++ GT Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 539 MAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME 598
M+PE S K D+FS G++L E++ + + R+
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYS-------FSTQME-------------RVRI 282
Query: 599 LVDVRIGTYPEEIALRFMQ----IALLCTEDFIEDRPTMSATLSM 639
+ DVR +P ++ Q + + + +RP + +
Sbjct: 283 ITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSP-TERPEATDIIEN 326
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-31
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 35/219 (15%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFE---NEVRVLLKMQ 422
+D + + +LG+G FG V + G+E AVK ++ ++ K + E EV++L ++
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 423 HRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDK---------SKSAILDWPKRLNII 473
H N+++L+ + LV E LFD+ +A II
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAA--------RII 132
Query: 474 MGVARGLLYLHRDSVLRIIHRDIKASNILL---DHQMKPKISDFGLAKLFHDEQSRHRTH 530
V G+ Y+H+ +I+HRD+K N+LL +I DFGL+ F + +
Sbjct: 133 RQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMK 186
Query: 531 QIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
GT Y+APE + G K DV+S GV+L ++SG
Sbjct: 187 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-31
Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE--FENEVRVLLKMQH 423
++ + LG G +G V R E A+K + S+ EV VL + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDK---------SKSAILDWPKRLNIIM 474
N+++L+ +R LV E LFD+ +A II
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGE----LFDEIIHRMKFNEVDAA--------VIIK 143
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILL---DHQMKPKISDFGLAKLFHDEQSRHRTHQ 531
V G+ YLH+ I+HRD+K N+LL + KI DFGL+ +F +++ + +
Sbjct: 144 QVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKE 197
Query: 532 IAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
GT Y+APE +R K DV+S GV+L +++G
Sbjct: 198 RLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 46/206 (22%), Positives = 85/206 (41%), Gaps = 26/206 (12%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN 425
++ +N +GRG +G V A KK+ ++ + F+ E+ ++ + H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN------IIMGVARG 479
+++L+ + LV E LF++ ++ + I+ V
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGE----LFER----VVH-KRVFRESDAARIMKDVLSA 118
Query: 480 LLYLHRDSVLRIIHRDIKASNILL---DHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF 536
+ Y H+ L + HRD+K N L K+ DFGLA F + GT
Sbjct: 119 VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTP 172
Query: 537 GYMAPEYAIRGFLSVKSDVFSFGVLL 562
Y++P+ + G + D +S GV++
Sbjct: 173 YYVSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-31
Identities = 30/222 (13%), Positives = 68/222 (30%), Gaps = 22/222 (9%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR------LQDGREIAVKKLATNSMQGKEEFENEVRVLLK 420
+ ++LG G F VY+ ++ ++ +K + + L
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 421 MQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFL--FDKSKSAILDWPKRLNIIMGVAR 478
++ + + + +LV E +L + + + ++ ++ M +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLDHQMKP-----------KISDFGLAKLFHDEQSRH 527
+ +H IIH DIK N +L + + D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 528 RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
T G+ E + + D F + ++ G
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 44/204 (21%), Positives = 83/204 (40%), Gaps = 13/204 (6%)
Query: 375 MLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE----FENEVRVLLKMQHRNLVQL 429
++GRGG G VY+ R +A+K ++ + + E R ++Q ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSET-LSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
+ + + + L L + L P+ + I+ + L H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA--- 153
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL 549
HRD+K NIL+ + DFG+A ++ + GT YMAPE
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 550 SVKSDVFSFGVLLLEIISGRKNYD 573
+ ++D+++ +L E ++G Y
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQ 236
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN 425
D + LG G FG V++ GR K + T K +NE+ ++ ++ H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDK--SKSAILDWPKRLNIIMGVARGLLYL 483
L+ L + E +L+ E+L LFD+ ++ + + +N + GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKP--KISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP 541
H I+H DIK NI+ + + KI DFGLA + ++ T + AP
Sbjct: 166 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAP 219
Query: 542 EYAIRGFLSVKSDVFSFGVLL 562
E R + +D+++ GVL
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-31
Identities = 67/218 (30%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGK--EEFENEVRVLLKMQH 423
+ ++ MLG+G FG V K + +E AVK + S + K EV +L K+ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDK---------SKSAILDWPKRLNIIM 474
N+++LF +V E LFD+ +A II
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAA--------RIIK 128
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILL---DHQMKPKISDFGLAKLFHDEQSRHRTHQ 531
V G+ Y+H+ I+HRD+K NILL + KI DFGL+ F +
Sbjct: 129 QVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKD 182
Query: 532 IAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
GT Y+APE +RG K DV+S GV+L ++SG
Sbjct: 183 RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHR 424
F ++G G +G VYKGR ++ G+ A+K + +EE + E+ +L K HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHR 81
Query: 425 NLVQLFGCCVQERERI------LVYEYLPNKSL-DKFLFDKSKSAILDWPKRLNIIMGVA 477
N+ +G +++ LV E+ S+ D L +K L I +
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLKEEWIAYICREIL 139
Query: 478 RGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFG 537
RGL +LH+ ++IHRDIK N+LL + K+ DFG++ R T GT
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPY 194
Query: 538 YMAPEYAIRGFLS-----VKSDVFSFGVLLLEIISG 568
+MAPE KSD++S G+ +E+ G
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 54/209 (25%), Positives = 84/209 (40%), Gaps = 32/209 (15%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN 425
F +LG G F V+ + G+ A+K + + ENE+ VL K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDK---------SKSAILDWPKRLNIIMGV 476
+V L LV + + L FD+ ++ +I V
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDAS--------LVIQQV 115
Query: 477 ARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP---KISDFGLAKLFHDEQSRHRTHQIA 533
+ YLH I+HRD+K N+L + I+DFGL+K+ +
Sbjct: 116 LSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTAC 168
Query: 534 GTFGYMAPEYAIRGFLSVKSDVFSFGVLL 562
GT GY+APE + S D +S GV+
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 45/214 (21%), Positives = 88/214 (41%), Gaps = 31/214 (14%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVK-----KLATNSMQGKEEFENEVRVLLK 420
D + ++G+G F V + + G++ AVK K ++ E+ + E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 421 MQHRNLVQLFGCCVQERERILVYEYLP---------NKSLDKFLFDKSKSAILDWPKRLN 471
++H ++V+L + +V+E++ ++ F++ ++ ++ +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS--------H 134
Query: 472 IIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP---KISDFGLAKLFHDEQSRHR 528
+ + L Y H IIHRD+K +LL + K+ FG+A +
Sbjct: 135 YMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG 191
Query: 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLL 562
GT +MAPE R DV+ GV+L
Sbjct: 192 G--RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-30
Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 23/205 (11%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN 425
D++ LG G FG V++ G A K + T KE E++ + ++H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRL------NIIMGVARG 479
LV L + E +++YE++ LF+K + D ++ + V +G
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGE----LFEK----VADEHNKMSEDEAVEYMRQVCKG 267
Query: 480 LLYLHRDSVLRIIHRDIKASNILLDHQMKP--KISDFGLAKLFHDEQSRHRTHQIAGTFG 537
L ++H +H D+K NI+ + K+ DFGL +Q GT
Sbjct: 268 LCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAE 321
Query: 538 YMAPEYAIRGFLSVKSDVFSFGVLL 562
+ APE A + +D++S GVL
Sbjct: 322 FAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE--FENEVRVLLKMQH 423
+ ++ MLG+G FG V K + +E AVK + S + K+ EV +L K+ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN------IIMGVA 477
N+++LF +V E LFD+ I+ KR + II V
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFDE----IIK-RKRFSEHDAARIIKQVF 131
Query: 478 RGLLYLHRDSVLRIIHRDIKASNILLDHQ---MKPKISDFGLAKLFHDEQSRHRTHQIAG 534
G+ Y+H+ I+HRD+K NILL+ + KI DFGL+ F + G
Sbjct: 132 SGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIG 185
Query: 535 TFGYMAPEYAIRGFLSVKSDVFSFGVLL 562
T Y+APE +RG K DV+S GV+L
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 33/211 (15%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGK--EEFENEVRVLLKMQH 423
+DN+ K LG+G F V + G E A K + T + + ++ E E R+ K+QH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDK---------SKSAILDWPKRLNIIM 474
N+V+L +E LV++ + LF+ + ++ + I
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS--------HCIQ 112
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP---KISDFGLAKLFHDEQSRHRTHQ 531
+ + Y H I+HR++K N+LL + K K++DFGLA +D + H
Sbjct: 113 QILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHG 166
Query: 532 IAGTFGYMAPEYAIRGFLSVKSDVFSFGVLL 562
AGT GY++PE + S D+++ GV+L
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 66/215 (30%), Positives = 97/215 (45%), Gaps = 31/215 (14%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFE---NEVRVLLKMQ 422
FS +G G FG VY R +++ +A+KK++ + Q E+++ EVR L K++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 423 HRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN------IIMGV 476
H N +Q GC ++E LV EY + D + K L + G
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD---------LLEVHKKPLQEVEIAAVTHGA 163
Query: 477 ARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF 536
+GL YLH +IHRD+KA NILL K+ DFG A + + GT
Sbjct: 164 LQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS----IMAPANS--FVGTP 214
Query: 537 GYMAPE---YAIRGFLSVKSDVFSFGVLLLEIISG 568
+MAPE G K DV+S G+ +E+
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 28/211 (13%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQG------KEEFENEVRVLL 419
D + LG G F V K R G E A K + + +EE E EV +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 420 KMQHRNLVQLFGCCVQERERILVYEYLPNKSL-DKFLFDKS---KSAILDWPKRLNIIMG 475
++ H N++ L + +L+ E + L D +S + A + I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQ 123
Query: 476 VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP----KISDFGLAKLFHDEQSRHRTHQ 531
+ G+ YLH +I H D+K NI+L + P K+ DFGLA D
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKN 177
Query: 532 IAGTFGYMAPEYAIRGFLSVKSDVFSFGVLL 562
I GT ++APE L +++D++S GV+
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 56/215 (26%), Positives = 89/215 (41%), Gaps = 36/215 (16%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQG------KEEFENEVRVLL 419
D++ LG G F V K R G+E A K + + +EE E EV +L
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 420 KMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDK--------SKSAILDWPKRLN 471
+++H N++ L + + +L+ E + L FD A
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEAT-------Q 112
Query: 472 IIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP----KISDFGLAKLFHDEQSRH 527
+ + G+ YLH RI H D+K NI+L + P K+ DFG+A
Sbjct: 113 FLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--- 166
Query: 528 RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLL 562
I GT ++APE L +++D++S GV+
Sbjct: 167 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 28/211 (13%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQG------KEEFENEVRVLL 419
D + LG G F V K R G E A K + + +EE E EV +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 420 KMQHRNLVQLFGCCVQERERILVYEYLPNKSL-DKFLFDKS---KSAILDWPKRLNIIMG 475
++ H N++ L + +L+ E + L D +S + A + I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQ 123
Query: 476 VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP----KISDFGLAKLFHDEQSRHRTHQ 531
+ G+ YLH +I H D+K NI+L + P K+ DFGLA D
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKN 177
Query: 532 IAGTFGYMAPEYAIRGFLSVKSDVFSFGVLL 562
I GT ++APE L +++D++S GV+
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 45/216 (20%), Positives = 80/216 (37%), Gaps = 18/216 (8%)
Query: 367 TDNFSTKNMLGRG--GFGTVYKGR-LQDGREIAVKK--LATNSMQGKEEFENEVRVLLKM 421
+ ++G+G TV R G + V++ L S + + E+ V
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 422 QHRNLVQLFGCCVQERERILVYEYLPNKSL-DKFLFDKSKSAILDWPKRLNIIMGVARGL 480
H N+V + + E +V ++ S D L ++ I+ GV + L
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYILQGVLKAL 141
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRT-----HQIAGT 535
Y+H +HR +KAS+IL+ K +S R R
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 536 FGYMAPEYAIRGFL--SVKSDVFSFGVLLLEIISGR 569
+++PE + KSD++S G+ E+ +G
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-29
Identities = 58/226 (25%), Positives = 100/226 (44%), Gaps = 39/226 (17%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQG-------------KEEFE 412
+++ LG G +G V + E A+K + + EE
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 413 NEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN- 471
NE+ +L + H N+++LF ++ LV E+ LF++ I++ + +
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQ----IIN-RHKFDE 145
Query: 472 -----IIMGVARGLLYLHRDSVLRIIHRDIKASNILL---DHQMKPKISDFGLAKLFHDE 523
I+ + G+ YLH+ I+HRDIK NILL + + KI DFGL+ F +
Sbjct: 146 CDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202
Query: 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
+ GT Y+APE ++ + K DV+S GV++ ++ G
Sbjct: 203 Y---KLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 42/221 (19%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN---------EVRV 417
+ + +G G +G V+K R G+ +A+KK E ++ E+R+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-------LESEDDPVIKKIALREIRM 55
Query: 418 LLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVA 477
L +++H NLV L ++R LV+EY + ++ L + +I
Sbjct: 56 LKQLKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHEL--DRYQRGVPEHLVKSITWQTL 112
Query: 478 RGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFG 537
+ + + H+ IHRD+K NIL+ K+ DFG A+L S + ++A T
Sbjct: 113 QAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP-SDYYDDEVA-TRW 167
Query: 538 YMAPE-------Y--AIRGFLSVKSDVFSFGVLLLEIISGR 569
Y +PE Y + DV++ G + E++SG
Sbjct: 168 YRSPELLVGDTQYGPPV--------DVWAIGCVFAELLSGV 200
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 33/211 (15%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE--FENEVRVLLKMQH 423
+DN+ K LG+G F V + G E A K + T + ++ E E R+ K+QH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDK---------SKSAILDWPKRLNIIM 474
N+V+L +E LV++ + L F+ + ++ + I
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS--------HCIQ 135
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP---KISDFGLAKLFHDEQSRHRTHQ 531
+ + Y H I+HR++K N+LL + K K++DFGLA +D + H
Sbjct: 136 QILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHG 189
Query: 532 IAGTFGYMAPEYAIRGFLSVKSDVFSFGVLL 562
AGT GY++PE + S D+++ GV+L
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 30/212 (14%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQG------KEEFENEVRVLL 419
D + T LG G F V K R G + A K + + +E+ E EV +L
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 420 KMQHRNLVQLFGCCVQERERILVYEY-----LPNKSLDKFLFDKSKSAILDWPKRLNIIM 474
++QH N++ L + + IL+ E L + +K + ++ +
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT--------EFLK 121
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP----KISDFGLAKLFHDEQSRHRTH 530
+ G+ YLH L+I H D+K NI+L + P KI DFGLA D + +
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEFKN- 176
Query: 531 QIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLL 562
I GT ++APE L +++D++S GV+
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 18/218 (8%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGK-EEFENEVRVLLKMQHRN 425
D++ + ++G G V ++A+K++ Q +E E++ + + H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 426 LVQLFGCCVQERERILVYEYLPNKSL-----DKFLFDKSKSAILDWPKRLNIIMGVARGL 480
+V + V + E LV + L S+ + KS +LD I+ V GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGL-AKLFH----DEQSRHRTHQIAGT 535
YLH++ IHRD+KA NILL +I+DFG+ A L +T GT
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT--FVGT 189
Query: 536 FGYMAPEYAIRGFL-SVKSDVFSFGVLLLEIISGRKNY 572
+MAPE + K+D++SFG+ +E+ +G Y
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 58/253 (22%), Positives = 91/253 (35%), Gaps = 54/253 (21%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVK-----KLATNSMQGKEEFENEVRVLLK 420
+ K +G+G +G V Q A+K K+ + + E + EVR++ K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 421 MQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRL---------- 470
+ H N+ +L+ E+ LV E L L + +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 471 ---------------------------NIIMGVARGLLYLHRDSVLRIIHRDIKASNILL 503
NI+ + L YLH I HRDIK N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201
Query: 504 --DHQMKPKISDFGLAKLFH--DEQSRHRTHQIAGTFGYMAPE---YAIRGFLSVKSDVF 556
+ + K+ DFGL+K F+ + + AGT ++APE + K D +
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAW 260
Query: 557 SFGVLLLEIISGR 569
S GVLL ++ G
Sbjct: 261 SAGVLLHLLLMGA 273
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 43/205 (20%), Positives = 79/205 (38%), Gaps = 24/205 (11%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN 425
+ + LGRG FG V++ + K + + + E+ +L +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRN 62
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRL------NIIMGVARG 479
++ L E ++++E++ +F++ I L + + V
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLD----IFER----INTSAFELNEREIVSYVHQVCEA 114
Query: 480 LLYLHRDSVLRIIHRDIKASNILLDHQMKP--KISDFGLAKLFHDEQSRHRTHQIAGTFG 537
L +LH I H DI+ NI+ + KI +FG A+ +
Sbjct: 115 LQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPE 168
Query: 538 YMAPEYAIRGFLSVKSDVFSFGVLL 562
Y APE +S +D++S G L+
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 34/213 (15%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN----EVRVLLKMQHRNLVQLF 430
LG G +G V + + AVK L ++ E E+++L +++H+N++QL
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 431 GCCVQERER--ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN----------IIMGVAR 478
E ++ +V EY + + D KR +I G+
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPE------KRFPVCQAHGYFCQLIDGLE- 123
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY 538
YLH I+H+DIK N+LL KIS G+A+ H + G+ +
Sbjct: 124 ---YLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 539 MAPEYA--IRGFLSVKSDVFSFGVLLLEIISGR 569
PE A + F K D++S GV L I +G
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 21/230 (9%), Positives = 48/230 (20%), Gaps = 43/230 (18%)
Query: 375 MLGRGGFGTVYKGR-LQDGREIAVK---KLATNSMQGKEEFENEVRVLLKMQHRNLVQLF 430
L G V+ R ++ + A+K A NS E ++ + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 431 GCC--------------------------VQERERILVYEYLP---NKSLDKFLFDKSKS 461
+L+ F
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 462 AILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521
+ + R L ++H N+ + + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSV--KSDVFSFGVLLLEIISGR 569
R + Y E+ + + + G+ + +
Sbjct: 246 T-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 55/220 (25%), Positives = 106/220 (48%), Gaps = 28/220 (12%)
Query: 364 IAATDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN----EVRVL 418
++++ F LG G + TVYKG G +A+K++ + +E + E+ ++
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIREISLM 57
Query: 419 LKMQHRNLVQLFGCCVQERERILVYEYLPN--KSLDKFLFDKSKSAILDWPKRLNIIMGV 476
+++H N+V+L+ E + LV+E++ N K + L+ +
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 477 ARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF 536
+GL + H + +I+HRD+K N+L++ + + K+ DFGLA+ F + ++ T
Sbjct: 118 LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP-VNTFSSEVV-TL 172
Query: 537 GYMAPE-------YAIRGFLSVKSDVFSFGVLLLEIISGR 569
Y AP+ Y S D++S G +L E+I+G+
Sbjct: 173 WYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 33/218 (15%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN--------EVRVL 418
+ + LG G F TVYK R + +A+KK+ + + E ++ E+++L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALREIKLL 66
Query: 419 LKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR 478
++ H N++ L + LV++++ L+ + K S +L ++ +
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVII--KDNSLVLTPSHIKAYMLMTLQ 123
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY 538
GL YLH+ I+HRD+K +N+LLD K++DFGLAK F +R THQ+ T Y
Sbjct: 124 GLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAYTHQVV-TRWY 178
Query: 539 MAPE-------YAIRGFLSVKSDVFSFGVLLLEIISGR 569
APE Y V D+++ G +L E++
Sbjct: 179 RAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFEN----EVRVLLKMQH 423
+ + +G G +G VYK + GR +A+K++ + E + E+ +L ++ H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLD--AEDEGIPSTAIREISLLKELHH 78
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL 483
N+V L ER LV+E++ K L K L L + + + RG+ +
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFME-KDLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE- 542
H+ RI+HRD+K N+L++ K++DFGLA+ F R TH++ T Y AP+
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRSYTHEVV-TLWYRAPDV 190
Query: 543 ------YAIRGFLSVKSDVFSFGVLLLEIISGR 569
Y S D++S G + E+I+G+
Sbjct: 191 LMGSKKY------STSVDIWSIGCIFAEMITGK 217
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN---------EVRV 417
+ + ++G G +G V K R GR +A+KK E ++ E+++
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-------LESDDDKMVKKIAMREIKL 77
Query: 418 LLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVA 477
L +++H NLV L C +++ LV+E++ + ++ L + LD+ + +
Sbjct: 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDL--ELFPNGLDYQVVQKYLFQII 134
Query: 478 RGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFG 537
G+ + H IIHRDIK NIL+ K+ DFG A+ ++A T
Sbjct: 135 NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRW 189
Query: 538 YMAPE-------YAIRGFLSVKSDVFSFGVLLLEIISGR 569
Y APE Y +V DV++ G L+ E+ G
Sbjct: 190 YRAPELLVGDVKYG----KAV--DVWAIGCLVTEMFMGE 222
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 48/215 (22%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN----EVRVLLKMQ 422
+ +G G +GTV+K + + +A+K++ + E + E+ +L +++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD--DDDEGVPSSALREICLLKELK 59
Query: 423 HRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLY 482
H+N+V+L +++ LV+E+ + L K+ S + LD + + + +GL +
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
H ++HRD+K N+L++ + K+++FGLA+ F R + ++ T Y P+
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVV-TLWYRPPD 171
Query: 543 -------YAIRGFLSVKSDVFSFGVLLLEIISGRK 570
Y S D++S G + E+ + +
Sbjct: 172 VLFGAKLY------STSIDMWSAGCIFAELANAGR 200
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 52/217 (23%), Positives = 86/217 (39%), Gaps = 37/217 (17%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE--------FENEVRV 417
D + LG G G V + +++A+K ++ E E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 418 LLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRL------N 471
L K+ H ++++ + +V E + L FDK ++ KRL
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDK----VVG-NKRLKEATCKL 118
Query: 472 IIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP---KISDFGLAKLFHDEQSRHR 528
+ + YLH IIHRD+K N+LL Q + KI+DFG +K+ +
Sbjct: 119 YFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---L 172
Query: 529 THQIAGTFGYMAPE---YAIRGFLSVKSDVFSFGVLL 562
+ GT Y+APE + D +S GV+L
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 56/214 (26%), Positives = 105/214 (49%), Gaps = 29/214 (13%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN----EVRVLLKMQ 422
+ + + LG G + TVYKG+ +A+K++ ++ +E EV +L ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLK 58
Query: 423 HRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLY 482
H N+V L E+ LV+EYL +K L ++L I++ + + RGL Y
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
HR +++HRD+K N+L++ + + K++DFGLA+ ++ +++ T Y P+
Sbjct: 116 CHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTYDNEVV-TLWYRPPD 170
Query: 543 -------YAIRGFLSVKSDVFSFGVLLLEIISGR 569
Y S + D++ G + E+ +GR
Sbjct: 171 ILLGSTDY------STQIDMWGVGCIFYEMATGR 198
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 37/217 (17%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE--------FENEVRV 417
D + LG G G V + +++A++ ++ E E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 418 LLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN------ 471
L K+ H ++++ + +V E + L FDK ++ KRL
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDK----VVG-NKRLKEATCKL 243
Query: 472 IIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP---KISDFGLAKLFHDEQSRHR 528
+ + YLH IIHRD+K N+LL Q + KI+DFG +K+ +
Sbjct: 244 YFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---L 297
Query: 529 THQIAGTFGYMAPE---YAIRGFLSVKSDVFSFGVLL 562
+ GT Y+APE + D +S GV+L
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-27
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFE---NEVRVLLKMQH 423
+ F +LG+GGFG V +++ ++ A KKL ++ ++ NE ++L K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 424 RNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLY 482
R +V L + ++ + LV + L KF A + + + GL
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDL-KFHIYHMGQAGFPEARAVFYAAEICCGLED 301
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
LHR RI++RD+K NILLD +ISD GLA + Q GT GYMAPE
Sbjct: 302 LHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPE 355
Query: 543 YAIRGFLSVKS-DVFSFGVLLLEIISGR 569
++ S D ++ G LL E+I+G+
Sbjct: 356 -VVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 31/220 (14%)
Query: 361 DVLIAATDNFS-----TKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGK--EEFE 412
++ + +NF+ T LGRG F V + G+E A K L E
Sbjct: 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL 76
Query: 413 NEVRVLLKMQHR-NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRL- 470
+E+ VL + ++ L E IL+ EY + F + + + +
Sbjct: 77 HEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSL---CLPELAEMVS 129
Query: 471 -----NIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP---KISDFGLAKLFHD 522
+I + G+ YLH+ I+H D+K NILL KI DFG+++
Sbjct: 130 ENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186
Query: 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLL 562
+I GT Y+APE ++ +D+++ G++
Sbjct: 187 AC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 59/230 (25%), Positives = 89/230 (38%), Gaps = 46/230 (20%)
Query: 365 AATDNFS---------TKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENE 414
+TD+FS +++LG G V L +E AVK + + E
Sbjct: 1 GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE 60
Query: 415 VRVLLKMQ-HRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRL--- 470
V +L + Q HRN+++L +E LV+E + S+ I +R
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LSH----IHK--RRHFNE 110
Query: 471 ----NIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP---KISDFGLAKLFHDE 523
++ VA L +LH I HRD+K NIL +H + KI DF L
Sbjct: 111 LEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 524 QSRHRTHQ-----IAGTFGYMAPEYAIRGFLSV------KSDVFSFGVLL 562
G+ YMAPE + F + D++S GV+L
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPE-VVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-27
Identities = 50/211 (23%), Positives = 96/211 (45%), Gaps = 32/211 (15%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE--FENEVRVLLKMQH 423
T+ + LG+G F V + + G+E A + T + ++ E E R+ ++H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDK---------SKSAILDWPKRLNIIM 474
N+V+L +E L+++ + L F+ + ++ + I
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADAS--------HCIQ 117
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP---KISDFGLAKLFHDEQSRHRTHQ 531
+ +L+ H+ + ++HR++K N+LL ++K K++DFGLA EQ
Sbjct: 118 QILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-- 172
Query: 532 IAGTFGYMAPEYAIRGFLSVKSDVFSFGVLL 562
AGT GY++PE + D+++ GV+L
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 7e-27
Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 27/213 (12%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFEN----EVRVLLKMQH 423
+ + +G G +G VYK + G A+KK+ + E + E+ +L +++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLE--KEDEGIPSTTIREISILKELKH 59
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL 483
N+V+L+ ++ +LV+E+L + L K L L+ + ++ + G+ Y
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE- 542
H R++HRD+K N+L++ + + KI+DFGLA+ F R TH+I T Y AP+
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIV-TLWYRAPDV 171
Query: 543 ------YAIRGFLSVKSDVFSFGVLLLEIISGR 569
Y S D++S G + E+++G
Sbjct: 172 LMGSKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 28/215 (13%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEEFE---NEVRVLLKMQH 423
++F +LG G F TV R RE A+K L + + + E V+ ++ H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 424 RNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR---- 478
V+L+ Q+ E++ Y N L K++ K D R
Sbjct: 90 PFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYI---RKIGSFDET--------CTRFYTA 137
Query: 479 ----GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAG 534
L YLH IIHRD+K NILL+ M +I+DFG AK+ E + R + G
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 535 TFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
T Y++PE SD+++ G ++ ++++G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-27
Identities = 44/343 (12%), Positives = 99/343 (28%), Gaps = 57/343 (16%)
Query: 375 MLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKM------------ 421
+LG+ + + G V + +L++
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 422 -------------QHRNLVQLFGCCVQERERILVYEYLP-------NKSLDKFLFDK-SK 460
+ ++ + ER+ ++ + ++ + L S
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 461 SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520
L RL + + V R L LH ++H ++ +I+LD + ++ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR- 260
Query: 521 HDEQSRHRTHQIAGTFGYMAPEYAI-----RGFLSVKSDVFSFGVLLLEIISGRK-NYDR 574
+ + A ++ D ++ G+ + I N D
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320
Query: 575 QLEAENQELLKLARRLEEEGR--LMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPT 632
++ + + + + + R L + E+ R + + + T ++ + R
Sbjct: 321 AALGGSEWIFRSCKNIPQPVRALLEGFLRYP----KED---RLLPLQAMETPEYEQLRTE 373
Query: 633 MSATLSMLSNSSVPIPSVTESPDHYEGDDDAGDNAGRREQFTR 675
+SA L + P P D AG E T
Sbjct: 374 LSAALPLYQTDGEPTREGGAPP----SGTSQPDEAGAAEAVTA 412
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 38/219 (17%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVK---------KLATNSMQGKEEFENEVR 416
+N+ K +LGRG V + +E AVK A + +E EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 417 VLLKM-QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRL----- 470
+L K+ H N++QL LV++ + L FD + + L
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDY----LTE-KVTLSEKET 126
Query: 471 -NIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRT 529
I+ + + LH+ L I+HRD+K NILLD M K++DFG + + +
Sbjct: 127 RKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KL 180
Query: 530 HQIAGTFGYMAPE------YAIRGFLSVKSDVFSFGVLL 562
++ GT Y+APE + D++S GV++
Sbjct: 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 37/218 (16%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE--------FENEVRV 417
+ K+++GRG V + G E AVK + + + E E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 418 LLKM-QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRL------ 470
L ++ H +++ L LV++ + L FD + + L
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDY----LTE-KVALSEKETR 203
Query: 471 NIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTH 530
+I+ + + +LH I+HRD+K NILLD M+ ++SDFG + + +
Sbjct: 204 SIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLR 257
Query: 531 QIAGTFGYMAPE------YAIRGFLSVKSDVFSFGVLL 562
++ GT GY+APE + D+++ GV+L
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 16/210 (7%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFE---NEVRVLLKMQH 423
D F +LGRGGFG V+ +++ ++ A KKL ++ ++ ++ E ++L K+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 424 RNLVQLFGCCVQERERI-LVYEYLPNKSLDKF--LFDKSKSAILDWPKRLNIIMGVARGL 480
R +V L + + + LV + + ++ + P+ + + GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDI-RYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMA 540
+LH+ II+RD+K N+LLD +ISD GLA Q+ +T AGT G+MA
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMA 357
Query: 541 PEYAIRGFLSVKS-DVFSFGVLLLEIISGR 569
PE + G S D F+ GV L E+I+ R
Sbjct: 358 PE-LLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 55/208 (26%), Positives = 84/208 (40%), Gaps = 30/208 (14%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHR 424
TD + K +G G + + E AVK + + EE + +LL+ QH
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHP 76
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN------IIMGVAR 478
N++ L + +V E + L DK IL K + ++ + +
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGEL----LDK----ILR-QKFFSEREASAVLFTITK 127
Query: 479 GLLYLHRDSVLRIIHRDIKASNILL----DHQMKPKISDFGLAKLFHDEQSRHRTHQIAG 534
+ YLH ++HRD+K SNIL + +I DFG AK E T
Sbjct: 128 TVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCY 182
Query: 535 TFGYMAPEYAIRGFLSVKSDVFSFGVLL 562
T ++APE R D++S GVLL
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 33/209 (15%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN 425
+D F ++ LGRG VY+ + + A+K L K+ E+ VLL++ H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPN 109
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDK---------SKSAILDWPKRLNIIMGV 476
+++L E LV E + L FD+ +A + + +
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAA--------DAVKQI 157
Query: 477 ARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP---KISDFGLAKLFHDEQSRHRTHQIA 533
+ YLH I+HRD+K N+L KI+DFGL+K+ + +
Sbjct: 158 LEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVC 211
Query: 534 GTFGYMAPEYAIRGFLSVKSDVFSFGVLL 562
GT GY APE + D++S G++
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 46/220 (20%)
Query: 375 MLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRV-----LLKM-----QH 423
+LG+GGFGTV+ G L D ++A+K + N + G + V LL H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 424 RNLVQLFGCCVQERER--ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN---------- 471
+++L E + +LV E P + D LFD + L
Sbjct: 98 PGVIRLLD--WFETQEGFMLVLER-PLPAQD--LFDY-----ITEKGPLGEGPSRCFFGQ 147
Query: 472 IIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM-KPKISDFGLAKLFHDEQSRHRTH 530
++ + + H ++HRDIK NIL+D + K+ DFG L HDE
Sbjct: 148 VVAAIQ----HCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YT 196
Query: 531 QIAGTFGYMAPEY-AIRGFLSVKSDVFSFGVLLLEIISGR 569
GT Y PE+ + + ++ + V+S G+LL +++ G
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 29/207 (14%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE-FENEVRVLLKMQHRNLVQLFGCC 433
LG G +G V +AVK + E + E+ + + H N+V+ +G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 434 VQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN----------IIMGVARGLLYL 483
+ + L EY L FD+ + + ++ GV YL
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPD-----IGMPEPDAQRFFHQLMAGVV----YL 121
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE- 542
H + I HRDIK N+LLD + KISDFGLA +F +++ GT Y+APE
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 543 YAIRGFLSVKSDVFSFGVLLLEIISGR 569
R F + DV+S G++L +++G
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 29/240 (12%), Positives = 68/240 (28%), Gaps = 54/240 (22%)
Query: 375 MLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQ----------- 422
+LG+ + + G V + +L+++
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 423 -----------------HRNLVQLFGCC--VQERERILVYEYLPNKSLDKF--LFDK-SK 460
+ ++++ + R +Y + + L S
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 461 SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520
L RL + + V R L LH ++H ++ +I+LD + ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 521 HDEQSRHRTHQIAGTFGYMAPEYAI-----------RGFLSVKSDVFSFGVLLLEIISGR 569
+ + G+ PE R ++ D ++ G+++ I
Sbjct: 257 ------GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 29/207 (14%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE-FENEVRVLLKMQHRNLVQLFGCC 433
LG G +G V +AVK + E + E+ + + H N+V+ +G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 434 VQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN----------IIMGVARGLLYL 483
+ + L EY L FD+ + + ++ GV YL
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPD-----IGMPEPDAQRFFHQLMAGVV----YL 121
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE- 542
H + I HRDIK N+LLD + KISDFGLA +F +++ GT Y+APE
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 543 YAIRGFLSVKSDVFSFGVLLLEIISGR 569
R F + DV+S G++L +++G
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFE---NEVRVLLKM-- 421
++FS ++GRGGFG VY R D ++ A+K L ++ K+ NE +L +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 422 -QHRNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARG 479
+V + +++ + + + L + S+ + + G
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDL---HYHLSQHGVFSEADMRFYAAEIILG 304
Query: 480 LLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYM 539
L ++H +++RD+K +NILLD +ISD GLA F + + H GT GYM
Sbjct: 305 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYM 357
Query: 540 APEYAIRGFLSVKS-DVFSFGVLLLEIISGR 569
APE +G S D FS G +L +++ G
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 56/224 (25%), Positives = 104/224 (46%), Gaps = 44/224 (19%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFEN-EVRVLLKMQHRN 425
++ ++G G FG V++ +L + E+A+KK+ +Q K F+N E++++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV----LQDK-RFKNRELQIMRIVKHPN 93
Query: 426 LVQLFGCCVQERERI------LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMG---- 475
+V L ++ LV EY+P +++ + +K + + +++
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKL-----KQTMPMLLIKLYM 147
Query: 476 --VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP-KISDFGLAKLFHDEQSRHRTHQI 532
+ R L Y+H + I HRDIK N+LLD K+ DFG AK+ I
Sbjct: 148 YQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYI 202
Query: 533 AGTFGYMAPE-------YAIRGFLSVKSDVFSFGVLLLEIISGR 569
+ Y APE Y + D++S G ++ E++ G+
Sbjct: 203 C-SRYYRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQ 239
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 55/238 (23%), Positives = 91/238 (38%), Gaps = 65/238 (27%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN--------------------- 413
+G+G +G V D A+K L+ + + F
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 414 -----EVRVLLKMQHRNLVQLFGCCVQE---RERI-LVYEYLPNKSLDKFLFDKSKSAIL 464
E+ +L K+ H N+V+L V + + + +V+E + + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQGPV----MEVPTL--- 131
Query: 465 DWPKRLN----------IIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDF 514
K L+ +I G+ YLH +IIHRDIK SN+L+ KI+DF
Sbjct: 132 ---KPLSEDQARFYFQDLIKGIE----YLHY---QKIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 515 GLAKLFHDEQSRHRTHQIAGTFGYMAPE---YAIRGFLSVKSDVFSFGVLLLEIISGR 569
G++ F + GT +MAPE + F DV++ GV L + G+
Sbjct: 182 GVSNEFKGSDALLSN--TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 46/218 (21%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN------EVRVLLKMQHR--NL 426
LG GGFG+VY G + D +A+K + + + E N EV +L K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 427 VQLFGCCVQERER--ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN----------IIM 474
++L ER +L+ E P D LFD + L ++
Sbjct: 111 IRLLD--WFERPDSFVLILER-PEPVQD--LFDF-----ITERGALQEELARSFFWQVLE 160
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILLD-HQMKPKISDFGLAKLFHDEQSRHRTHQIA 533
V + H ++HRDIK NIL+D ++ + K+ DFG L D
Sbjct: 161 AVR----HCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFD 209
Query: 534 GTFGYMAPEYAIRG--FLSVKSDVFSFGVLLLEIISGR 569
GT Y PE+ IR + + V+S G+LL +++ G
Sbjct: 210 GTRVYSPPEW-IRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 58/224 (25%), Positives = 92/224 (41%), Gaps = 44/224 (19%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN---------EVRV 417
D + LG G +G VYK +A+K++ + E E EV +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-------RLEHEEEGVPGTAIREVSL 86
Query: 418 LLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVA 477
L ++QHRN+++L L++EY L K++ DK+ + + + +
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYM-DKNPD--VSMRVIKSFLYQLI 142
Query: 478 RGLLYLHRDSVLRIIHRDIKASNILLDHQMKP-----KISDFGLAKLFHDEQSRHRTHQI 532
G+ + H R +HRD+K N+LL KI DFGLA+ F R TH+I
Sbjct: 143 NGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP-IRQFTHEI 198
Query: 533 AGTFGYMAPE-------YAIRGFLSVKSDVFSFGVLLLEIISGR 569
T Y PE Y S D++S + E++
Sbjct: 199 I-TLWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 38/221 (17%)
Query: 369 NFSTKNMLGRGGFGTVYKGR-LQDGREIAVK-----KLATNSMQGKEEFEN---EVRVLL 419
+ST + LG G FG V+ + +E+ VK K+ + + E+ +L
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 420 KMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN-------- 471
+++H N++++ + LV E + LD LF +D RL+
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGS-GLD--LFAF-----IDRHPRLDEPLASYIF 136
Query: 472 --IIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRT 529
++ V YL IIHRDIK NI++ K+ DFG A + +
Sbjct: 137 RQLVSAVG----YLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF 189
Query: 530 HQIAGTFGYMAPE-YAIRGFLSVKSDVFSFGVLLLEIISGR 569
GT Y APE + + +++S GV L ++
Sbjct: 190 ---CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 46/206 (22%), Positives = 81/206 (39%), Gaps = 34/206 (16%)
Query: 371 STKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-HRNLVQ 428
LG G F K + + AVK ++ + + E+ L + H N+V+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVK 70
Query: 429 LFGCCVQERERILVYEYLPNKSLDKFLFDK---------SKSAILDWPKRLNIIMGVARG 479
L + LV E L L F++ ++++ I+ +
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEAS--------YIMRKLVSA 118
Query: 480 LLYLHRDSVLRIIHRDIKASNILLDHQMKP---KISDFGLAKLFHDEQSRHRTHQIAGTF 536
+ ++H + ++HRD+K N+L + KI DFG A+L + +T T
Sbjct: 119 VSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTL 173
Query: 537 GYMAPEYAIRGFLSVKSDVFSFGVLL 562
Y APE + D++S GV+L
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 39/211 (18%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVK-----KLATNSMQGKEEFENEVRVLLKMQHRNLVQL 429
+G+G F V R + GRE+A+K +L S+ ++ EVR++ + H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL---QKLFREVRIMKILNHPNIVKL 79
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN----------IIMGVARG 479
F E+ L+ EY + FD + R+ I+ V
Sbjct: 80 FEVIETEKTLYLIMEYASGGEV----FDYLVAH-----GRMKEKEARSKFRQIVSAVQ-- 128
Query: 480 LLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYM 539
Y H+ RI+HRD+KA N+LLD M KI+DFG + F G Y
Sbjct: 129 --YCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF---CGAPPYA 180
Query: 540 APE-YAIRGFLSVKSDVFSFGVLLLEIISGR 569
APE + + + + DV+S GV+L ++SG
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 40/227 (17%)
Query: 366 ATDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN--------EVR 416
AT + +G G +GTVYK R G +A+K + + EV
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGGGGGGGLPISTVREVA 63
Query: 417 VLLKMQ---HRNLVQLFGCCVQERERI-----LVYEYLPNKSLDKFLFDKSKSAILDWPK 468
+L +++ H N+V+L C R LV+E++ ++ L +L DK+ L
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAET 121
Query: 469 RLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528
+++ RGL +LH + I+HRD+K NIL+ K++DFGLA+++ +
Sbjct: 122 IKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MAL 176
Query: 529 THQIAGTFGYMAPE------YAIRGFLSVKSDVFSFGVLLLEIISGR 569
T + T Y APE Y + D++S G + E+ +
Sbjct: 177 TPVVV-TLWYRAPEVLLQSTY------ATPVDMWSVGCIFAEMFRRK 216
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-24
Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 42/233 (18%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEEFEN-EVRVLLKMQHR 424
+++ ++G G FG VY+ +L D G +A+KK+ +Q K F+N E++++ K+ H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKR-FKNRELQIMRKLDHC 107
Query: 425 NLVQLFGCCVQERERI------LVYEYLPNKSLDKFL--FDKSKSAILDWPKRLNIIMGV 476
N+V+L E+ LV +Y+P +++ + + ++K + +L + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKL-YMYQL 165
Query: 477 ARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP-KISDFGLAKLFHDEQSRHRTHQIAGT 535
R L Y+H I HRDIK N+LLD K+ DFG AK + I +
Sbjct: 166 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYIC-S 219
Query: 536 FGYMAPE-------YAIRGFLSVKSDVFSFGVLLLEIISGR-----KNYDRQL 576
Y APE Y + DV+S G +L E++ G+ + QL
Sbjct: 220 RYYRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 266
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 36/234 (15%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN 425
D F + M G+G FGTV G+ + G +A+KK+ + E + ++ L + H N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPN 80
Query: 426 LVQLFGCCVQERER-------ILVYEYLPNKSLDKFL--FDKSKSAILDWPKRLNIIMGV 476
+VQL ER +V EY+P +L + + + + A ++ + +
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKV-FLFQL 138
Query: 477 ARGLLYLHRDSVLRIIHRDIKASNILLDHQM-KPKISDFGLAKLFHDEQSRHRTHQIAGT 535
R + LH S + + HRDIK N+L++ K+ DFG AK S I
Sbjct: 139 IRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPSEPNVAYICSR 195
Query: 536 FGYMAPE-------YAIRGFLSVKSDVFSFGVLLLEIISGR-----KNYDRQLE 577
+ Y APE Y + D++S G + E++ G N QL
Sbjct: 196 Y-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 38/211 (18%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVK-----KLATNSMQGKEEFENEVRVLLKMQHRNLVQL 429
LG G FG V G G ++AVK K+ + + GK + E++ L +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK--IKREIQNLKLFRHPHIIKL 76
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN----------IIMGVARG 479
+ + +V EY+ L FD + R+ I+ V
Sbjct: 77 YQVISTPTDFFMVMEYVSGGEL----FDY-----ICKHGRVEEMEARRLFQQILSAVD-- 125
Query: 480 LLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYM 539
Y HR ++HRD+K N+LLD M KI+DFGL+ + D + + G+ Y
Sbjct: 126 --YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYA 177
Query: 540 APE-YAIRGFLSVKSDVFSFGVLLLEIISGR 569
APE + R + + D++S GV+L ++ G
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 54/225 (24%), Positives = 102/225 (45%), Gaps = 38/225 (16%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN----EVRVLLKMQ 422
+ +G+G FG V+K R + G+++A+KK+ + KE F E+++L ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALREIKILQLLK 74
Query: 423 HRNLVQLFGCCVQERERI--------LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIM 474
H N+V L C + LV+++ L L + + ++
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLL--SNVLVKFTLSEIKRVMQ 131
Query: 475 GVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR---THQ 531
+ GL Y+HR+ +I+HRD+KA+N+L+ K++DFGLA+ F ++ T++
Sbjct: 132 MLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 532 IAGTFGYMAPE-------YAIRGFLSVKSDVFSFGVLLLEIISGR 569
+ T Y PE Y D++ G ++ E+ +
Sbjct: 189 VV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 52/223 (23%), Positives = 95/223 (42%), Gaps = 39/223 (17%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEE---FENEVRVLLKMQH 423
++F ++GRG FG V +L++ ++ A+K L M + E F E VL+
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 424 RNLVQLFGCCVQERERI-LVYEYLP--------NKSLDKFLFDKSK--SAILDWPKRLNI 472
+ + L Q+ + LV +Y +K D+ + ++ A +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA--------EM 184
Query: 473 IMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQI 532
++ + +H+ L +HRDIK NIL+D +++DFG E ++
Sbjct: 185 VIA----IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLK-LMEDGTVQSSVA 236
Query: 533 AGTFGYMAPEYAIRGFLSVKS------DVFSFGVLLLEIISGR 569
GT Y++PE ++ K D +S GV + E++ G
Sbjct: 237 VGTPDYISPE-ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 5e-23
Identities = 53/227 (23%), Positives = 98/227 (43%), Gaps = 55/227 (24%)
Query: 376 LGRGGFGTVYKGRLQD---GREIAVKKLATNSMQGKEEFEN-------EVRVLLKMQHRN 425
+GRG +G VYK + +D ++ A+K++ E E+ +L +++H N
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI---------EGTGISMSACREIALLRELKHPN 79
Query: 426 LVQLFGCCVQERERI--LVYEYLPNKSLDKFLFDKSKSAILDWPKRLN------IIMGVA 477
++ L + +R L+++Y L + S P +L ++ +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 478 RGLLYLHRDSVLRIIHRDIKASNILLDHQMKP----KISDFGLAKLFHDEQSRHRTHQIA 533
G+ YLH + ++HRD+K +NIL+ + KI+D G A+LF+ +
Sbjct: 139 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP-LKPLADLDP 194
Query: 534 G--TFGYMAPE-------Y--AIRGFLSVKSDVFSFGVLLLEIISGR 569
TF Y APE Y AI D+++ G + E+++
Sbjct: 195 VVVTFWYRAPELLLGARHYTKAI--------DIWAIGCIFAELLTSE 233
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 7e-23
Identities = 59/227 (25%), Positives = 104/227 (45%), Gaps = 46/227 (20%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR--LQDGREIAVKKLATNSMQGKEEFENE------VR--V 417
+ +G G +G V+K R GR +A+K++ + + E +R
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-------RVQTGEEGMPLSTIREVA 63
Query: 418 LLKM----QHRNLVQLFGCCVQERERI-----LVYEYLPNKSLDKFLFDKSKSAILDWPK 468
+L+ +H N+V+LF C R LV+E++ ++ L +L DK +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTET 121
Query: 469 RLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528
+++ + RGL +LH R++HRD+K NIL+ + K++DFGLA+++ +
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MAL 176
Query: 529 THQIAGTFGYMAPE------YAIRGFLSVKSDVFSFGVLLLEIISGR 569
T + T Y APE YA V D++S G + E+ +
Sbjct: 177 TSVVV-TLWYRAPEVLLQSSYA----TPV--DLWSVGCIFAEMFRRK 216
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 39/211 (18%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVK-----KLATNSMQGKEEFENEVRVLLKMQHRNLVQL 429
LG G FG V + +++A+K L + M + E E+ L ++H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR--VEREISYLKLLRHPHIIKL 74
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN----------IIMGVARG 479
+ + ++V EY + LFD + KR+ II +
Sbjct: 75 YDVITTPTDIVMVIEYAGGE-----LFDY-----IVEKKRMTEDEGRRFFQQIICAIE-- 122
Query: 480 LLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYM 539
Y HR +I+HRD+K N+LLD + KI+DFGL+ + D + G+ Y
Sbjct: 123 --YCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---NFLKTSCGSPNYA 174
Query: 540 APE-YAIRGFLSVKSDVFSFGVLLLEIISGR 569
APE + + + DV+S G++L ++ GR
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 61/236 (25%), Positives = 104/236 (44%), Gaps = 38/236 (16%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFEN---EVRVLLKMQH 423
D+F +G+G FG V + D +++ A+K + + E N E++++ ++H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 424 RNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR---- 478
LV L+ Q+ E + +V + L L + ++ +
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDL--R-YHLQQNVHFKEE--------TVKLFIC 122
Query: 479 ----GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAG 534
L YL RIIHRD+K NILLD I+DF +A + E + +AG
Sbjct: 123 ELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAG 176
Query: 535 TFGYMAPE-YAIRGFL----SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLK 585
T YMAPE ++ R +V D +S GV E++ GR+ Y + ++E++
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 55/224 (24%), Positives = 91/224 (40%), Gaps = 39/224 (17%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEE---FENEVRVLLKMQH 423
D+F ++GRG F V +++ ++ A+K + M + E F E VL+
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 424 RNLVQLFGCCVQERERI-LVYEYLP--------NKSLDKFLFDKSK--SAILDWPKRLNI 472
R + QL Q+ + LV EY +K ++ + ++ A I
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA--------EI 171
Query: 473 IMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQI 532
+M + +HR L +HRDIK NILLD +++DFG R+
Sbjct: 172 VM----AIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKL-RADGTVRSLVA 223
Query: 533 AGTFGYMAPE-------YAIRGFLSVKSDVFSFGVLLLEIISGR 569
GT Y++PE G + D ++ GV E+ G+
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-22
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 15/208 (7%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFEN---EVRVLLKMQH 423
+ F +LG+G FG V + + A+K L + K+E + E RVL +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 424 RNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLY 482
L L Q +R+ V EY L F S+ + + + L Y
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDY 263
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
LH S +++RD+K N++LD KI+DFGL K + GT Y+APE
Sbjct: 264 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEYLAPE 319
Query: 543 YAIRGFLSVKS-DVFSFGVLLLEIISGR 569
+ ++ D + GV++ E++ GR
Sbjct: 320 -VLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 4e-22
Identities = 46/207 (22%), Positives = 78/207 (37%), Gaps = 35/207 (16%)
Query: 372 TKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-HRNLVQL 429
T +LG G G V + + + A+K +Q + EV + + ++V++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRI 120
Query: 430 FGCC---VQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRL-------NIIMGVAR 478
R+ + +V E L L F + I D + I+ +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGEL----FSR----IQDRGDQAFTEREASEIMKSIGE 172
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLDHQMKP---KISDFGLAKLFHDEQSRHRTHQIAGT 535
+ YLH + I HRD+K N+L + K++DFG AK T
Sbjct: 173 AIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYT 226
Query: 536 FGYMAPEYAIRGFLSVKSDVFSFGVLL 562
Y+APE D++S GV++
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 51/208 (24%), Positives = 84/208 (40%), Gaps = 34/208 (16%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCV 434
+G G FG R +AVK + + E + E+ ++H N+V+ +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 435 QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN----------IIMGVARGLLYLH 484
++ EY L +++ +A R + ++ GV+ Y H
Sbjct: 87 TPTHLAIIMEYASGGEL----YERICNA-----GRFSEDEARFFFQQLLSGVS----YCH 133
Query: 485 RDSVLRIIHRDIKASNILLDHQMKP--KISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
++I HRD+K N LLD P KI DFG +K + GT Y+APE
Sbjct: 134 S---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPE 187
Query: 543 -YAIRGFLSVKSDVFSFGVLLLEIISGR 569
+ + +DV+S GV L ++ G
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 7e-22
Identities = 43/239 (17%), Positives = 81/239 (33%), Gaps = 41/239 (17%)
Query: 345 LTNNQGIDMRSFLFNLDVLIAATDNFS-----TKNMLGRGGFGTVYKGR-LQDGREIAVK 398
+ ++ + +K +LG G G V + + G++ A+K
Sbjct: 1 MAHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK 60
Query: 399 KLATNSMQGKEEFENEVRVLLK-MQHRNLVQLFGCC----VQERERILVYEYLPNKSLDK 453
L + EV + ++V + +R +++ E + L
Sbjct: 61 LLYD-----SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL-- 113
Query: 454 FLFDKSKSAILDWPKRL-------NIIMGVARGLLYLHRDSVLRIIHRDIKASNILL--- 503
F + I + + I+ + + +LH I HRD+K N+L
Sbjct: 114 --FSR----IQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSK 164
Query: 504 DHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLL 562
+ K++DFG AK T Y+APE D++S GV++
Sbjct: 165 EKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 8e-22
Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 38/211 (18%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVK-----KLATNSMQGKEEFENEVRVLLKMQHRNLVQL 429
LG G FG V G+ G ++AVK K+ + + GK E++ L +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK--IRREIQNLKLFRHPHIIKL 81
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN----------IIMGVARG 479
+ + +V EY+ L FD + RL+ I+ GV
Sbjct: 82 YQVISTPSDIFMVMEYVSGGEL----FDY-----ICKNGRLDEKESRRLFQQILSGVD-- 130
Query: 480 LLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYM 539
Y HR ++HRD+K N+LLD M KI+DFGL+ + D G+ Y
Sbjct: 131 --YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYA 182
Query: 540 APE-YAIRGFLSVKSDVFSFGVLLLEIISGR 569
APE + R + + D++S GV+L ++ G
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 24/224 (10%), Positives = 55/224 (24%), Gaps = 47/224 (20%)
Query: 376 LGRGGFGTVYKGRLQD---GREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQL 429
G ++ D R++A+ + + +E + L ++ + ++
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 430 FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVL 489
++V E++ SL + + + +A HR
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHRAG-- 149
Query: 490 RIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL 549
+ S + +S G L M
Sbjct: 150 -VALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDA------- 179
Query: 550 SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEE 593
+ + D+ G L ++ R L R +
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPE--AGVRSGLAPAERDTAGQ 221
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-21
Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 34/217 (15%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFEN---EVRVLLKMQH 423
++F +LG+G FG V R + A+K L + K+E + E RVL +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 424 RNLVQLFGCCVQERERI-LVYEYLPNKSL-------DKFLFDKSK--SAILDWPKRLNII 473
L L Q +R+ V EY L F ++++ A I+
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA--------EIV 115
Query: 474 MGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIA 533
L YLH +++RDIK N++LD KI+DFGL K + +
Sbjct: 116 SA----LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFC 166
Query: 534 GTFGYMAPEYAIRGFLSVKS-DVFSFGVLLLEIISGR 569
GT Y+APE + ++ D + GV++ E++ GR
Sbjct: 167 GTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 36/219 (16%)
Query: 368 DNFSTKNMLGRGGFGTVY---KGRLQDGREI-AVKKLATNSMQGKEEFE--NEVRVLLKM 421
F +LG+G FG V+ K D R++ A+K L +++ ++ E +L+++
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 422 QHRNLVQLFGCCVQERERI-LVYEYLPNKSL-------DKFLFDKSK--SAILDWPKRLN 471
H +V+L Q ++ L+ ++L L F + K A
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA--------E 134
Query: 472 IIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQ 531
+ + L +LH L II+RD+K NILLD + K++DFGL+K D + + +
Sbjct: 135 LALA----LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYS 185
Query: 532 IAGTFGYMAPEYAIRGFLSVKS-DVFSFGVLLLEIISGR 569
GT YMAPE + +S D +SFGVL+ E+++G
Sbjct: 186 FCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 44/224 (19%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEE---FENEVRVLLKMQH 423
+++ ++GRG FG V R + R++ A+K L+ M + + F E ++
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 424 RNLVQLFGCCVQERERI-LVYEYLPN----KSLDKFLFDKSKSAILDWPKRLNIIMGVAR 478
+VQLF Q+ + +V EY+P + + + AR
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----------------WAR 171
Query: 479 --------GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTH 530
L +H + IHRD+K N+LLD K++DFG +++ R
Sbjct: 172 FYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCM-KMNKEGMVRCD 227
Query: 531 QIAGTFGYMAPEYAIRGFLSVKS-----DVFSFGVLLLEIISGR 569
GT Y++PE ++ D +S GV L E++ G
Sbjct: 228 TAVGTPDYISPE-VLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 7e-20
Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFE---NEVRVLLKMQH 423
+F LG G FG V+ R + A+K L + ++ E +E +L + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 424 RNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR---- 478
+++++G Q+ ++I ++ +Y+ L L KS P VA+
Sbjct: 66 PFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLL---RKSQRFPNP--------VAKFYAA 113
Query: 479 ----GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAG 534
L YLH II+RD+K NILLD KI+DFG AK D T+ + G
Sbjct: 114 EVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCG 165
Query: 535 TFGYMAPEYAIRGFLSVKS-DVFSFGVLLLEIISGR 569
T Y+APE + KS D +SFG+L+ E+++G
Sbjct: 166 TPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 51/231 (22%), Positives = 101/231 (43%), Gaps = 45/231 (19%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-HR 424
D++ LGRG + V++ + + ++ VK L K++ + E+++L ++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGP 91
Query: 425 NLVQLFGCCV---QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLL 481
N++ L V R LV+E++ N + + I R + + + L
Sbjct: 92 NIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI-----RF-YMYEILKALD 144
Query: 482 YLHRDSVLRIIHRDIKASNILLDH-QMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMA 540
Y H + I+HRD+K N+++DH K ++ D+GLA+ +H Q ++A + +
Sbjct: 145 YCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVA-SRYFKG 198
Query: 541 PE---------YAIRGFLSVKSDVFSFGVLLLEIISGR------KNYDRQL 576
PE Y++ D++S G +L +I + + QL
Sbjct: 199 PELLVDYQMYDYSL--------DMWSLGCMLASMIFRKEPFFHGHDNYDQL 241
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 9e-20
Identities = 62/238 (26%), Positives = 99/238 (41%), Gaps = 40/238 (16%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFE---NEVRVLLK-MQ 422
+F ++GRG + V RL+ I A+K + + E+ + E V +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 423 HRNLVQLFGCCVQERERI-LVYEYLPNKSL-------DKFLFDKSK--SAILDWPKRLNI 472
H LV L C Q R+ V EY+ L K + ++ SA
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE--------- 118
Query: 473 IMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQI 532
++ L YLH II+RD+K N+LLD + K++D+G+ K T
Sbjct: 119 ---ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTF 170
Query: 533 AGTFGYMAPEYAIRGFLSVKS-DVFSFGVLLLEIISGR-----KNYDRQLEAENQELL 584
GT Y+APE +RG S D ++ GVL+ E+++GR + ++ L
Sbjct: 171 CGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 227
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFEN---EVRVLLK-MQ 422
DNF +LG+G FG V R+++ ++ AVK L + + ++ E E R+L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 423 HRNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLL 481
H L QLF CC Q +R+ V E++ L +F KS D + + L+
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEIISALM 138
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP 541
+LH II+RD+K N+LLDH+ K++DFG+ K T GT Y+AP
Sbjct: 139 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--TTATFCGTPDYIAP 193
Query: 542 EYAIRGFLSVKS-DVFSFGVLLLEIISGR 569
E ++ L + D ++ GVLL E++ G
Sbjct: 194 E-ILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 35/216 (16%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFE---NEVRVLLKMQH 423
D F LG G FG V + ++ A+K L + ++ E NE R+L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 424 RNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR---- 478
LV+L ++ + +V EY+ + L + P AR
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEP--------HARFYAA 148
Query: 479 ----GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAG 534
YLH L +I+RD+K N+L+D Q +++DFG AK RT + G
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCG 200
Query: 535 TFGYMAPEYAIRGFLSVKS-DVFSFGVLLLEIISGR 569
T +APE I K+ D ++ GVL+ E+ +G
Sbjct: 201 TPEALAPE-IILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 2e-19
Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFE---NEVRVL-LKMQ 422
+F+ +LG+G FG V + E+ AVK L + + ++ E E RVL L +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 423 HRNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLL 481
L QL C Q +R+ V EY+ L ++ + P + +A GL
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLF 456
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP 541
+L II+RD+K N++LD + KI+DFG+ K + T GT Y+AP
Sbjct: 457 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKTFCGTPDYIAP 511
Query: 542 EYAIRGFLSVKS-DVFSFGVLLLEIISGR 569
E I KS D ++FGVLL E+++G+
Sbjct: 512 E-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 40/238 (16%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFE---NEVRVLLK-MQ 422
+F ++GRG + V RL+ I A++ + + E+ + E V +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 423 HRNLVQLFGCCVQERERI-LVYEYLPNKSL-------DKFLFDKSK--SAILDWPKRLNI 472
H LV L C Q R+ V EY+ L K + ++ SA
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE--------- 161
Query: 473 IMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQI 532
++ L YLH II+RD+K N+LLD + K++D+G+ K T
Sbjct: 162 ---ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTF 213
Query: 533 AGTFGYMAPEYAIRGFLSVKS-DVFSFGVLLLEIISGR-----KNYDRQLEAENQELL 584
GT Y+APE +RG S D ++ GVL+ E+++GR + ++ L
Sbjct: 214 CGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFEN---EVRVLLK-MQ 422
++F MLG+G FG V+ + + A+K L + + ++ E E RVL +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 423 HRNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLL 481
H L +F C Q +E + V EYL L ++ D + + GL
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP 541
+LH I++RD+K NILLD KI+DFG+ K + +T+ GT Y+AP
Sbjct: 133 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE--NMLGDAKTNTFCGTPDYIAP 187
Query: 542 EYAIRGFLSVKS-DVFSFGVLLLEIISGR 569
E + G S D +SFGVLL E++ G+
Sbjct: 188 E-ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 65/218 (29%), Positives = 99/218 (45%), Gaps = 35/218 (16%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFEN---EVRVLLKM-Q 422
+F+ +LG+G FG V + E+ AVK L + + ++ E E RVL +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 423 HRNLVQLFGCCVQERERI-LVYEYLPNKSL-------DKFLFDKSK--SAILDWPKRLNI 472
L QL C Q +R+ V EY+ L +F + +A I
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--------EI 130
Query: 473 IMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQI 532
+G L +L II+RD+K N++LD + KI+DFG+ K + T
Sbjct: 131 AIG----LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTF 181
Query: 533 AGTFGYMAPEYAIRGFLSVKS-DVFSFGVLLLEIISGR 569
GT Y+APE I KS D ++FGVLL E+++G+
Sbjct: 182 CGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 35/218 (16%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREI-AVKKLATNSMQGKEEFE---NEVRVLLK-MQ 422
+F ++G+G FG V R + AVK L ++ K+E + +E VLLK ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 423 HRNLVQLFGCCVQERERI-LVYEYLPNKSL-------DKFLFDKSK--SAILDWPKRLNI 472
H LV L Q +++ V +Y+ L FL +++ +A
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA---------- 146
Query: 473 IMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQI 532
+A L YLH L I++RD+K NILLD Q ++DFGL K + S T
Sbjct: 147 --EIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTF 199
Query: 533 AGTFGYMAPEYAIRGFLSVKS-DVFSFGVLLLEIISGR 569
GT Y+APE + ++ D + G +L E++ G
Sbjct: 200 CGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 7e-19
Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 38/221 (17%)
Query: 368 DNFSTKNMLGRGGFGTVY---KGRLQDGREI-AVKKLATNS-MQGKEEFEN---EVRVLL 419
+ F +LG+GG+G V+ K + +I A+K L ++ ++ + E +L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 420 KMQHRNLVQLFGCCVQERERI-LVYEYLPNKSL-------DKFLFDKSK--SAILDWPKR 469
+++H +V L Q ++ L+ EYL L F+ D + A
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA------- 128
Query: 470 LNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRT 529
I M L +LH+ II+RD+K NI+L+HQ K++DFGL K + + T
Sbjct: 129 -EISMA----LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VT 178
Query: 530 HQIAGTFGYMAPEYAIRGFLSVKS-DVFSFGVLLLEIISGR 569
H GT YMAPE + ++ D +S G L+ ++++G
Sbjct: 179 HTFCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 57/264 (21%), Positives = 95/264 (35%), Gaps = 70/264 (26%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEEFEN-EVRVLLKMQHR 424
+ +S LG G FG V + + G+ A+KK+ + ++N E+ ++ + H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHV 60
Query: 425 NLVQL---FGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKR----LNIIMG-- 475
N+++L F E + NK K + + LN+IM
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 476 -----------------------------VARGLLYLHRDSVLRIIHRDIKASNILLDHQ 506
+ R + ++H L I HRDIK N+L++ +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177
Query: 507 M-KPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE-------YAIRGFLSVKSDVFSF 558
K+ DFG AK + I F Y APE Y + D++S
Sbjct: 178 DNTLKLCDFGSAKKLIPSEP--SVAYICSRF-YRAPELMLGATEY------TPSIDLWSI 228
Query: 559 GVLLLEIISGR-----KNYDRQLE 577
G + E+I G+ + QL
Sbjct: 229 GCVFGELILGKPLFSGETSIDQLV 252
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 65/240 (27%), Positives = 109/240 (45%), Gaps = 42/240 (17%)
Query: 368 DNFSTKNMLGRGGFGTVY---KGRLQDGREI-AVKKLATNS-MQGKEEFE---NEVRVLL 419
+NF +LG G +G V+ K D ++ A+K L + +Q + E E +VL
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 420 KMQHRN-LVQLFGCCVQERERI-LVYEYLPNKSL-------DKFLFDKSK--SAILDWPK 468
++ LV L Q ++ L+ +Y+ L ++F + +
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG------ 166
Query: 469 RLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528
I++ L +LH+ L II+RDIK NILLD ++DFGL+K F +++ R
Sbjct: 167 --EIVLA----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-R 216
Query: 529 THQIAGTFGYMAPE---YAIRGFL-SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELL 584
+ GT YMAP+ G +V D +S GVL+ E+++G + E +Q +
Sbjct: 217 AYDFCGTIEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 9e-18
Identities = 49/237 (20%), Positives = 90/237 (37%), Gaps = 39/237 (16%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKL--ATNSMQGKEEFEN---------EV 415
++ + + G +G V G +G +A+K++ + + + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 416 RVLLKMQHRNLVQLFGC-CVQERERI----LVYEYLPNKSLDKFLFDKSKSAILDWPKRL 470
R+L H N++ L E + LV E + L + + + ++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISPQHIQ 137
Query: 471 NIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTH 530
+ + GL LH V +HRD+ NILL I DF LA+ D ++TH
Sbjct: 138 YFMYHILLGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTH 192
Query: 531 QIAGTFGYMAPEYAIRGFLSVKS-----DVFSFGVLLLEIISGR-----KNYDRQLE 577
+ Y APE + K D++S G ++ E+ + + + QL
Sbjct: 193 YVT-HRWYRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 1e-17
Identities = 53/168 (31%), Positives = 74/168 (44%), Gaps = 18/168 (10%)
Query: 476 VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGT 535
VA+G+ +L + + IHRD+ A NILL + KI DFGLA+ + + R
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 536 FGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEG 594
+MAPE +++SDV+SFGVLL EI S G Y ++E + + EG
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKIDEEFCRRLK----EG 312
Query: 595 RLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
M P+ Q L C RPT S + L N
Sbjct: 313 TRMRA--------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 35/174 (20%), Positives = 59/174 (33%), Gaps = 19/174 (10%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRL------QDGREIAVKKLATNSMQG-KEEFENEVRVLLK 420
D LGRG FG V + R +AVK L + +E+++L+
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 421 M-QHRNLVQLFGCCVQERERILV-YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR 478
+ H N+V L G C + ++V E+ +L +L KR + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQI 532
G + + I D+K + S F K D + +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDL 185
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 51/248 (20%), Positives = 100/248 (40%), Gaps = 59/248 (23%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN---------EVR 416
+ LG GG G V+ + +A+KK+ + E++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 417 VLLKMQHRNLVQLF--------------GCCVQERERILVYEYLPNKSLDKFLFDKSKSA 462
++ ++ H N+V++F G + +V EY+ L L +
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVL----EQG 115
Query: 463 ILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ-MKPKISDFGLAKLF- 520
L + + RGL Y+H +V +HRD+K +N+ ++ + + KI DFGLA++
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSANV---LHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 521 -HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKS-----DVFSFGVLLLEIISGR----- 569
H H + + T Y +P LS + D+++ G + E+++G+
Sbjct: 173 PHYSHKGHLSEGLV-TKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAG 227
Query: 570 KNYDRQLE 577
+ Q++
Sbjct: 228 AHELEQMQ 235
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 37/163 (22%), Positives = 64/163 (39%), Gaps = 32/163 (19%)
Query: 372 TKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQL 429
T +LG G G V + + + A+K +Q + EV + + Q ++V++
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRI 76
Query: 430 FGCC----VQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRL-------NIIMGVAR 478
+ ++V E L L F + I D + I+ +
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGEL----FSR----IQDRGDQAFTEREASEIMKSIGE 128
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLDHQMKP---KISDFGLAK 518
+ YLH + I HRD+K N+L + K++DFG AK
Sbjct: 129 AIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 53/281 (18%), Positives = 106/281 (37%), Gaps = 80/281 (28%)
Query: 375 MLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQ----------- 422
LG G F TV+ + + + +A+K + E E+E+++L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 423 HRNLVQLFGC-----------CVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN 471
++++L +V+E L ++L + I L
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVV-------MVFEVL-GENLLALIKKYEHRGI-----PLI 131
Query: 472 IIMGVAR----GLLYLHRDSVLRIIHRDIKASNILLDHQMKP------KISDFGLAKLFH 521
+ +++ GL Y+HR IIH DIK N+L++ P KI+D G A +
Sbjct: 132 YVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189
Query: 522 DE-----QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR---KNYD 573
+ Q+R Y +PE + +D++S L+ E+I+G + +
Sbjct: 190 EHYTNSIQTRE----------YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239
Query: 574 RQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALR 614
++ + + +++EL +G P +
Sbjct: 240 GHSYTKDDDHIA---------QIIEL----LGELPSYLLRN 267
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 56/231 (24%), Positives = 101/231 (43%), Gaps = 39/231 (16%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLA---TNSMQGKEEFENEVRVLLKMQ 422
+ + +G G +G+V + G ++A+KKL+ + + K + E+ +L MQ
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQ 81
Query: 423 HRNLVQLF------GCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGV 476
H N++ L + LV ++ L K + + + ++ +
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM----GLKFSEEKIQY-LVYQM 135
Query: 477 ARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF 536
+GL Y+H V +HRD+K N+ ++ + KI DFGLA+ E T + T
Sbjct: 136 LKGLKYIHSAGV---VHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVV-TR 187
Query: 537 GYMAPEYAIRGFLSVKS-----DVFSFGVLLLEIISGR-----KNYDRQLE 577
Y APE LS D++S G ++ E+++G+ K+Y QL
Sbjct: 188 WYRAPEV----ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 234
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 55/240 (22%), Positives = 94/240 (39%), Gaps = 56/240 (23%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN---------EVR 416
+ +G G G V R +A+KKL+ F+N E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76
Query: 417 VLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKF--------LFDKSKSAILDWPK 468
++ + H+N++ L + P KSL++F L D + ++
Sbjct: 77 LMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVI--QM 122
Query: 469 RLN------IIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522
L+ ++ + G+ +LH + IHRD+K SNI++ KI DFGLA+
Sbjct: 123 ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR--TA 177
Query: 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR-----KNYDRQLE 577
S T + T Y APE + D++S G ++ E+I G ++ Q
Sbjct: 178 GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 236
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 7e-15
Identities = 37/193 (19%), Positives = 81/193 (41%), Gaps = 29/193 (15%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN---------EVR 416
D + ++++G G +G V + + R +A+KK+ FE+ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104
Query: 417 VLLKMQHRNLVQLFGCCVQERERI-----LVYEYLPNKSLDKFLFDKSKSAILDWPKRLN 471
+L ++ H ++V++ + + +V E K ++ + + +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLF--RTPVYLTELHIKT- 160
Query: 472 IIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQ 531
++ + G+ Y+H S I+HRD+K +N L++ K+ DFGLA+ ++ +
Sbjct: 161 LLYNLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217
Query: 532 IAGTFGYMAPEYA 544
I+ M
Sbjct: 218 ISPREDDMNLVTF 230
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 9e-15
Identities = 52/229 (22%), Positives = 92/229 (40%), Gaps = 34/229 (14%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLA---TNSMQGKEEFENEVRVLLKMQ 422
+ +G G G V R +A+KKL+ N K + E+ ++ +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 119
Query: 423 HRNLVQLF------GCCVQERERILVYEYLP---NKSLDKFLFDKSKSAILDWPKRLNII 473
H+N++ L + ++ LV E + + + L + S ++
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLL 170
Query: 474 MGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIA 533
+ G+ +LH IIHRD+K SNI++ KI DFGLA+ S T +
Sbjct: 171 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVV 225
Query: 534 GTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR-----KNYDRQLE 577
T Y APE + D++S G ++ E++ + ++Y Q
Sbjct: 226 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 273
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-15
Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 48/238 (20%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN---------EVR 416
++ + +G G +G V + +A+KK+ FE+ E++
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--------SPFEHQTYCQRTLREIK 77
Query: 417 VLLKMQHRNLVQLFGCCVQE-----RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN 471
+LL+ +H N++ + ++ +V + + L K L K+ L
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICY 132
Query: 472 IIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR--T 529
+ + RGL Y+H +V +HRD+K SN+LL+ KI DFGLA++ + T
Sbjct: 133 FLYQILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 530 HQIAGTFGYMAPEYAIRGFLSVKS-----DVFSFGVLLLEIISGR-----KNYDRQLE 577
+A T Y APE L+ K D++S G +L E++S R K+Y QL
Sbjct: 190 EYVA-TRWYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 56/233 (24%), Positives = 100/233 (42%), Gaps = 42/233 (18%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLA---TNSMQGKEEFENEVRVLLKMQ 422
+ +G G +G V + G ++A+KKL + + K + E+R+L M+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMR 82
Query: 423 HRNLVQLF------GCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGV 476
H N++ L + LV ++ L K + K L + ++ +
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQM 137
Query: 477 ARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF 536
+GL Y+H + IHRD+K N+ ++ + KI DFGLA+ E T + T
Sbjct: 138 LKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQADSEM----TGYVV-TR 189
Query: 537 GYMAPE-------YAIRGFLSVKSDVFSFGVLLLEIISGR-----KNYDRQLE 577
Y APE Y + D++S G ++ E+I+G+ ++ QL+
Sbjct: 190 WYRAPEVILNWMRY------TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 236
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 73.8 bits (180), Expect = 3e-14
Identities = 39/252 (15%), Positives = 77/252 (30%), Gaps = 59/252 (23%)
Query: 366 ATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLA--------TNSMQGKEEFENEVRV 417
T+ +G G FG V++ D +A+K +A + + EE E+ +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 418 LLKMQ---------HRNLVQLFGC-CVQER---ERILVYEY----------LPNKSLDKF 454
++ + L CVQ + +++ P+ D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 455 LF------------DKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNIL 502
LF ++ ++ + +I+ + L LR HRD+ N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 503 LDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAP--EYAIRGFLSVKSDVFSFGV 560
L K+ K + G +Y + VF
Sbjct: 195 LKKTSLKKLHYTLNGKSSTI-----------PSCGLQVSIIDYTLSRLERDGIVVFCDVS 243
Query: 561 LLLEIISGRKNY 572
+ ++ +G +Y
Sbjct: 244 MDEDLFTGDGDY 255
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 56/244 (22%), Positives = 98/244 (40%), Gaps = 53/244 (21%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN---------EVR 416
+ +F K++LG G +G V G +A+KK+ E F+ E++
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--------EPFDKPLFALRTLREIK 61
Query: 417 VLLKMQHRNLVQLF-----GCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLN 471
+L +H N++ +F E ++ E + L + + + +L
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI----STQMLSDDHIQY 116
Query: 472 IIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQ 531
I R + LH +V IHRD+K SN+L++ K+ DFGLA++ + + +
Sbjct: 117 FIYQTLRAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 532 IAGTFG--------YMAPEYAIRGFLSVKS-----DVFSFGVLLLEIISGR-----KNYD 573
+ Y APE L+ DV+S G +L E+ R ++Y
Sbjct: 174 GQQSGMVEFVATRWYRAPEV----MLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR 229
Query: 574 RQLE 577
QL
Sbjct: 230 HQLL 233
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 61/231 (26%), Positives = 105/231 (45%), Gaps = 38/231 (16%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLA---TNSMQGKEEFENEVRVLLKMQ 422
+ + + +G G +G+V + G +AVKKL+ + + K + E+R+L M+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK 86
Query: 423 HRNLVQLF------GCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGV 476
H N++ L + + LV + L+ + K L +I +
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV----KCQKLTDDHVQFLIYQI 141
Query: 477 ARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF 536
RGL Y+H + IHRD+K SN+ ++ + KI DFGLA+ DE T +A T
Sbjct: 142 LRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTADEM----TGYVA-TR 193
Query: 537 GYMAPEYAIRGFLSVKS-----DVFSFGVLLLEIISGR-----KNYDRQLE 577
Y APE L+ D++S G ++ E+++GR ++ QL+
Sbjct: 194 WYRAPEI----MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 240
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 41/198 (20%), Positives = 84/198 (42%), Gaps = 29/198 (14%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN---------EVR 416
DN+ K+++GRG +G VY + +A+KK+ FE+ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREIT 77
Query: 417 VLLKMQHRNLVQLFGCCVQERERI-----LVYEYLPNKSLDKFLFDKSKSAILDWPKRLN 471
+L +++ +++L+ + + +V E L K K+ + + +
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLF--KTPIFLTEEHIKT- 133
Query: 472 IIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQ 531
I+ + G ++H + IHRD+K +N LL+ K+ DFGLA+ + E+ + +
Sbjct: 134 ILYNLLLGENFIHESGI---IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 532 IAGTFGYMAPEYAIRGFL 549
+ ++ L
Sbjct: 191 LEENEEPGPHNKNLKKQL 208
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 52/220 (23%), Positives = 88/220 (40%), Gaps = 52/220 (23%)
Query: 375 MLGRGGFGTVYKGR-LQDGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHR------ 424
++G+G FG V K + + +A+K + Q EE +R+L ++ +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNTM 159
Query: 425 NLVQLFG--------CCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGV 476
N++ + C E + +YE + F S + + +
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGF----SLPLVRKFAHSI------ 209
Query: 477 ARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP--KISDFGLAKLFHDE-----QSRHRT 529
+ L LH+ RIIH D+K NILL Q + K+ DFG + H QSR
Sbjct: 210 LQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-- 264
Query: 530 HQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
Y APE + + D++S G +L E+++G
Sbjct: 265 --------YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 63/272 (23%), Positives = 94/272 (34%), Gaps = 86/272 (31%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQ--- 422
+ LG G F TV+ +Q + +A+K + ++ E +E+R+L ++
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSD 94
Query: 423 -----HRNLVQLFGC-----------CVQERERILVYEYLPNKSLDKFLFDKSKSAILDW 466
+VQL C +V+E L L K++ KS L
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHIC-------MVFEVL-GHHLLKWI-IKSNYQGLPL 145
Query: 467 PKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL----------------------- 503
P II V +GL YLH RIIH DIK NILL
Sbjct: 146 PCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203
Query: 504 --------------------------DHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFG 537
++K KI+D G A H H T I T
Sbjct: 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDI-QTRQ 258
Query: 538 YMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
Y + E I + +D++S + E+ +G
Sbjct: 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 9e-13
Identities = 52/227 (22%), Positives = 95/227 (41%), Gaps = 34/227 (14%)
Query: 360 LDVLIAATDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVL 418
+++ + + + +G G FG +Y G + G E+A+K + + E ++
Sbjct: 3 MELRVG--NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIY 58
Query: 419 LKMQH-RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNI--IMG 475
MQ + + C + ++V E L SL+ LF+ ++ ++ ++
Sbjct: 59 KMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLED-LFNFCS-------RKFSLKTVLL 109
Query: 476 VARGLL----YLHRDSVLRIIHRDIKASNILLDHQMKPK---ISDFGLAKLFHDEQSR-H 527
+A ++ Y+H + IHRD+K N L+ K I DFGLAK + D ++ H
Sbjct: 110 LADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166
Query: 528 R----THQIAGTFGYMAPEYAIRGF-LSVKSDVFSFGVLLLEIISGR 569
+ GT Y A G S + D+ S G +L+ G
Sbjct: 167 IPYRENKNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 52/227 (22%), Positives = 96/227 (42%), Gaps = 34/227 (14%)
Query: 360 LDVLIAATDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVL 418
++ + + F +G G FG +Y G +Q E+A+K + + E ++
Sbjct: 1 MEPRVG--NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIY 56
Query: 419 LKMQHRNLV-QLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNI--IMG 475
+Q + + V+ +LV + L SL+ LF+ ++L++ ++
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLED-LFNFC-------SRKLSLKTVLM 107
Query: 476 VARGLL----YLHRDSVLRIIHRDIKASNILLDHQMKPK---ISDFGLAKLFHDEQS-RH 527
+A ++ ++H S +HRDIK N L+ + I DFGLAK + D + +H
Sbjct: 108 LADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164
Query: 528 R----THQIAGTFGYMAPEYAIRGF-LSVKSDVFSFGVLLLEIISGR 569
+ GT Y A G S + D+ S G +L+ + G
Sbjct: 165 IPYRENKNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 60/257 (23%), Positives = 108/257 (42%), Gaps = 69/257 (26%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFEN---------EVR 416
+ LG+G +G V+K + G +AVKK+ + F+N E+
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60
Query: 417 VLLKMQ-HRNLVQLFGCCVQE--RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNII 473
+L ++ H N+V L + R+ LV++Y+ L + ++ IL+ + ++
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVI----RANILEPVHKQYVV 115
Query: 474 MGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIA 533
+ + + YLH + +HRD+K SNILL+ + K++DFGL++ F + + ++
Sbjct: 116 YQLIKVIKYLHSGGL---LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 534 GTFG-------------------YMAPE-------Y--AIRGFLSVKSDVFSFGVLLLEI 565
Y APE Y I D++S G +L EI
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI--------DMWSLGCILGEI 224
Query: 566 ISGR-----KNYDRQLE 577
+ G+ + QLE
Sbjct: 225 LCGKPIFPGSSTMNQLE 241
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 46/189 (24%), Positives = 79/189 (41%), Gaps = 32/189 (16%)
Query: 369 NFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQH-RNL 426
NF +G G FG + G+ L +A+K S + E R ++ +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGI 67
Query: 427 VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNI--IMGVARGLL--- 481
Q++ + +V E L SL+ LFD + ++ ++ +A L+
Sbjct: 68 PQVYYFGPCGKYNAMVLELL-GPSLED-LFDLCD-------RTFSLKTVLMIAIQLISRM 118
Query: 482 -YLHRDSVLRIIHRDIKASNILLDHQMKPK-----ISDFGLAKLFHDEQS-RH---RTHQ 531
Y+H + +I+RD+K N L+ I DF LAK + D ++ +H R H+
Sbjct: 119 EYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK 175
Query: 532 -IAGTFGYM 539
+ GT YM
Sbjct: 176 SLTGTARYM 184
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 55/229 (24%), Positives = 86/229 (37%), Gaps = 66/229 (28%)
Query: 374 NMLGRGGFGTVYKGR-LQDGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHR----- 424
+++G+G FG V K + +A+K + Q + EVR+L M
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMK 115
Query: 425 -NLVQLFG--------CCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMG 475
+V L C V E +Y+ L N + S + + +++
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGV----SLNLTRKFAQQM----- 166
Query: 476 VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP--KISDFGLAKLFHDE-----QSRHR 528
LL+L L IIH D+K NILL + + KI DFG + QSR
Sbjct: 167 -CTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF- 223
Query: 529 THQIAGTFGYMAPE--------YAIRGFLSVKSDVFSFGVLLLEIISGR 569
Y +PE AI D++S G +L+E+ +G
Sbjct: 224 ---------YRSPEVLLGMPYDLAI--------DMWSLGCILVEMHTGE 255
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 38/190 (20%), Positives = 78/190 (41%), Gaps = 32/190 (16%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQH-RN 425
++ +G G FG +++G L + +++A+K S + +E R +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTG 67
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNI--IMGVARGLL-- 481
+ ++ + +LV + L SL+ L D ++ ++ + A+ +L
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLG-PSLED-LLDLC-------GRKFSVKTVAMAAKQMLAR 118
Query: 482 --YLHRDSVLRIIHRDIKASNILLDHQMKPK-----ISDFGLAKLFHDEQS-RHR----T 529
+H S +++RDIK N L+ + DFG+ K + D + +H
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175
Query: 530 HQIAGTFGYM 539
++GT YM
Sbjct: 176 KNLSGTARYM 185
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 36/202 (17%), Positives = 70/202 (34%), Gaps = 40/202 (19%)
Query: 369 NFSTKNMLGRGGFGTVYKGR---------LQDGREIAVKKLATNSMQGKEEF-------E 412
+ K+ R G +Y+ ++ ++K A + E+
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 413 NEVRVLLKMQHRNLV---QLFGCCVQERE-RILVYEYLPNKSLDKFLFDKSKSAILDWPK 468
+V K+ L+ G V + + R LV L +SL D S +L
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLS--- 157
Query: 469 RLNIIMGVARGLL----YLHRDSVLRIIHRDIKASNILLDHQMKPKI--SDFGLAKLF-- 520
++ VA LL +LH + +H ++ A NI +D + + ++ + +G A +
Sbjct: 158 -ERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213
Query: 521 ---HDEQSRHRTHQIAGTFGYM 539
H G ++
Sbjct: 214 SGKHVAYVEGSRSPHEGDLEFI 235
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 53/292 (18%), Positives = 110/292 (37%), Gaps = 66/292 (22%)
Query: 369 NFSTKNMLGRGGFGTVYKGR------LQDGREIAVKKLATNSMQ-----------GKEEF 411
+ +G+GGFG +Y + VK +++ K E
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 412 ENEVRVLLKMQHRNLVQLFGCCVQERE----RILVYEYLPNKSLDKFLFDKSKSAILDWP 467
+ K+++ + + +G + ++ R ++ + L K +++ +
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEAN-------A 146
Query: 468 KRLNI--IMGVARGLL----YLHRDSVLRIIHRDIKASNILLDHQMKPKI--SDFGLAKL 519
KR + ++ ++ +L Y+H +H DIKASN+LL+++ ++ D+GLA
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
Query: 520 FHDEQSRHRTHQ---------IAGTFGYMAPEYA-I---RGF-LSVKSDVFSFGVLLLEI 565
+ H+ GT E+ I G S + D+ G +++
Sbjct: 204 YCP----EGVHKAYAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQW 254
Query: 566 ISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQ 617
++G ++ L+ R E LM+ P EIA ++M+
Sbjct: 255 LTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAAN-APGEIA-KYME 304
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 38/182 (20%), Positives = 73/182 (40%), Gaps = 42/182 (23%)
Query: 376 LGRGGFGTVYKG-RLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLV------- 427
+G GGFG +Y + A + Q +E++ ++ ++ +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEY-QENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 428 --------QLFGC---CVQERE-RILVYEYLPNKSLDKFLFDK----SKSAILDWPKRLN 471
+G + R R +V E L L K + + KS +L +L
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK-ISGQNGTFKKSTVL----QLG 157
Query: 472 IIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKI--SDFGLAKLFHDEQSRHRT 529
I M + L Y+H + +H DIKA+N+LL ++ ++ +D+GL+ + +
Sbjct: 158 IRM-LDV-LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP----NGN 208
Query: 530 HQ 531
H+
Sbjct: 209 HK 210
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 53/245 (21%), Positives = 87/245 (35%), Gaps = 82/245 (33%)
Query: 375 MLGRGGFGTVYKGR-LQDGREIAVKKL-ATNSM--QGKEEFENEVRVLLKMQHR-----N 425
+G G FG V + + + + AVK + K E +L K+Q+ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNNN 97
Query: 426 LVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLL--- 481
+V+ G + + L++E L SL + + + + + I +L
Sbjct: 98 IVKYHGK-FMYYDHMCLIFEPL-GPSLYEIITRNNYN-----GFHIEDIKLYCIEILKAL 150
Query: 482 -YLHRDSVLRIIHRDIKASNILLDHQMKP-------------------------KISDFG 515
YL + + + H D+K NILLD K+ DFG
Sbjct: 151 NYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
Query: 516 LAKLFHDE------QSRHRTHQIAGTFGYMAPE------YAIRGFLSVKSDVFSFGVLLL 563
A F + +R Y APE + V SD++SFG +L
Sbjct: 208 CA-TFKSDYHGSIINTRQ----------YRAPEVILNLGW------DVSSDMWSFGCVLA 250
Query: 564 EIISG 568
E+ +G
Sbjct: 251 ELYTG 255
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 3e-08
Identities = 59/434 (13%), Positives = 125/434 (28%), Gaps = 112/434 (25%)
Query: 259 VQVNLDPVHKDWETAVDISTLLAPEMPPESETESETGGSHRKLIYLKIGAVAGVGGAVMT 318
+ V D +++ D+ +MP ++ E I + AV+G
Sbjct: 22 LSVFEDAFVDNFDCK-DV-----QDMPKSILSKEEI-----DHIIMSKDAVSGT------ 64
Query: 319 IIVVVLIAVLTRKGRSM--RFVGD--DAN---------ALTNNQGIDMRSFLFNLDVLIA 365
+ L L K M +FV + N + R ++ D L
Sbjct: 65 ---LRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYN 121
Query: 366 ATDNFSTKNMLGRGGFGTVYKGRLQDGREI--AVKKLATNS------MQG--KEEFENEV 415
F+ N V RLQ ++ A+ +L + G K +V
Sbjct: 122 DNQVFAKYN---------VS--RLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDV 170
Query: 416 RVLLKMQHRNLVQLF----GCCVQERERI-----LVYEYLPNKSLDKFLFDKSKSAILDW 466
+ K+Q + ++F C + L+Y+ PN + K I
Sbjct: 171 CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI 230
Query: 467 PKRLNIIM---GVARGLLYLHRD----SVLR---------IIHRDIKASNILLDHQMKPK 510
L ++ LL L + + R + ++ L
Sbjct: 231 QAELRRLLKSKPYENCLLVL-LNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI 289
Query: 511 ISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGF---LSVKSDVFSFGVLLLEIIS 567
D + ++ + + P + LS+ + + ++
Sbjct: 290 SLDH-HSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI------IAESIRDGLA 342
Query: 568 GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT-YPEEIALRFMQIALLCTEDF 626
N+ + + + +L +++ + P E F ++++ F
Sbjct: 343 TWDNW-KHVNCD---------------KLTTIIESSLNVLEPAEYRKMFDRLSV-----F 381
Query: 627 IEDRPTMSATLSML 640
+ LS++
Sbjct: 382 PPSAHIPTILLSLI 395
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 46/251 (18%), Positives = 77/251 (30%), Gaps = 98/251 (39%)
Query: 375 MLGRGGFGTVYKG--RLQDGREIAVKKLATNSMQGKEEFEN----EVRVLLKMQHR---- 424
LG G FG V + + ++A+K ++ ++ E+ VL K++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALK-----IIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 425 --NLVQLFG--------CCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIM 474
V + C E +E+L + + L +
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPY--------------PLPHVR 126
Query: 475 GVARGLL----YLHRDSVLRIIHRDIKASNILLDHQMKP-------------------KI 511
+A L +LH ++ H D+K NIL + ++
Sbjct: 127 HMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 512 SDFGLAKLFHDE------QSRHRTHQIAGTFGYMAPE--------YAIRGFLSVKSDVFS 557
+DFG A F E +RH Y PE DV+S
Sbjct: 184 ADFGSA-TFDHEHHTTIVATRH----------YRPPEVILELGWAQPC--------DVWS 224
Query: 558 FGVLLLEIISG 568
G +L E G
Sbjct: 225 IGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 56/247 (22%), Positives = 83/247 (33%), Gaps = 90/247 (36%)
Query: 375 MLGRGGFGTVYKG--RLQDGREIAVKKL-ATNSM--QGKEEFENEVRVLLKMQHR----- 424
LG G FG V + GR +AVK + + + E ++VL +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE----IQVLEHLNTTDPNST 76
Query: 425 -NLVQLFGC-------CVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGV 476
VQ+ C +V+E L S F+ + P RL+ I +
Sbjct: 77 FRCVQMLEWFEHHGHIC-------IVFELL-GLSTYDFIKENGFL-----PFRLDHIRKM 123
Query: 477 ARGLL----YLHRDSVLRIIHRDIKASNILLDHQMKP-------------------KISD 513
A + +LH ++ H D+K NIL K+ D
Sbjct: 124 AYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 514 FGLAKLFHDE------QSRHRTHQIAGTFGYMAPE------YAIRGFLSVKSDVFSFGVL 561
FG A + DE +RH Y APE + S DV+S G +
Sbjct: 181 FGSA-TYDDEHHSTLVSTRH----------YRAPEVILALGW------SQPCDVWSIGCI 223
Query: 562 LLEIISG 568
L+E G
Sbjct: 224 LIEYYLG 230
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 686 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.93 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.91 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.6 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.92 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.91 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.59 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.48 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.42 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.37 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.29 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.2 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.95 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.88 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.85 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.75 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.63 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.18 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.16 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.15 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.12 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.04 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.93 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.83 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.49 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.48 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.19 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.16 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.43 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.24 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.62 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.25 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-55 Score=450.99 Aligned_cols=260 Identities=27% Similarity=0.475 Sum_probs=221.0
Q ss_pred hCCCcccccccccCcEEEEEEEec------CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
.++|.+.+.||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 467888999999999999999864 47789999998776667788999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeE
Q 005649 441 LVYEYLPNKSLDKFLFDKS----------KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPK 510 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 510 (686)
|||||+++|+|.++|+... ....++|.+++.++.||++||.|||+++ |+||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999997642 2346999999999999999999999987 99999999999999999999
Q ss_pred EEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHH
Q 005649 511 ISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARR 589 (686)
Q Consensus 511 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 589 (686)
|+|||+++...............||+.|||||++.++.++.++|||||||+||||+| |+.||......+....+.
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~---- 244 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT---- 244 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH----
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH----
Confidence 999999997765544444445679999999999999999999999999999999999 999998766544332221
Q ss_pred HHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 590 LEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 590 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
. +... ..|..++..+.+|+.+||+.||++|||++||++.|++..
T Consensus 245 --~-~~~~--------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 245 --Q-GRVL--------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp --H-TCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --c-CCCC--------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1 1111 224556778999999999999999999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-54 Score=452.29 Aligned_cols=260 Identities=26% Similarity=0.455 Sum_probs=213.0
Q ss_pred hCCCcccccccccCcEEEEEEEec------CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
.++|...++||+|+||.||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 356778899999999999999864 47889999998777777789999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC
Q 005649 441 LVYEYLPNKSLDKFLFDKSK------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK 508 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 508 (686)
|||||+++|+|.++++.... ...++|.+++.|+.||++||.|||+++ |+||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 99999999999999976432 246999999999999999999999987 999999999999999999
Q ss_pred eEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHH
Q 005649 509 PKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLA 587 (686)
Q Consensus 509 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 587 (686)
+||+|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||......+....+.
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~-- 274 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT-- 274 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH--
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH--
Confidence 99999999997765544444455689999999999999999999999999999999999 999998766544332221
Q ss_pred HHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 588 RRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 588 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
. +... ..|..++..+.+|+.+||+.||++||||.||++.|+...
T Consensus 275 ----~-g~~~--------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 275 ----Q-GREL--------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp ----H-TCCC--------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----c-CCCC--------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 1 1111 124456678999999999999999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=444.78 Aligned_cols=258 Identities=26% Similarity=0.467 Sum_probs=217.9
Q ss_pred CCCcccccccccCcEEEEEEEec------CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
+++++.++||+|+||.||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677889999999999999863 46789999997543 334678999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 005649 441 LVYEYLPNKSLDKFLFDKSK-------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM 507 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 507 (686)
|||||+++|+|.++|..... ...++|..++.|+.||++||.|||+++ |+||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999975421 245999999999999999999999987 99999999999999999
Q ss_pred CeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHH
Q 005649 508 KPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKL 586 (686)
Q Consensus 508 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 586 (686)
.+||+|||+++...............||+.|||||++.++.++.++|||||||+||||+| |+.||......+....+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~- 261 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR- 261 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH-
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 999999999997765544444556789999999999999999999999999999999999 899998766544332221
Q ss_pred HHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 587 ARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 587 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
.+... ..|.+++..+.+|+.+||+.||++||||+||++.|+..
T Consensus 262 ------~~~~~--------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 262 ------NRQVL--------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ------TTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ------cCCCC--------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 12111 22456677899999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=433.93 Aligned_cols=266 Identities=28% Similarity=0.444 Sum_probs=212.7
Q ss_pred hhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
..+++++.++||+|+||.||+|+++ ..||||+++... ....+.|.+|+.++++++|||||+++|++.+ +..+|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 3567888999999999999999975 369999986543 3345789999999999999999999998864 5789999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.++|+.. ...++|.+++.|+.||++||.|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 111 Ey~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp ECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 999999999999653 345999999999999999999999987 999999999999999999999999999977654
Q ss_pred CccccccccccCCCcCchhhhhc---CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIR---GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
..........||+.|||||++.+ +.++.++|||||||+||||+||+.||......+... .....+ ..
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~------~~~~~~----~~ 255 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII------FMVGRG----YA 255 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------HHHHTT----CC
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH------HHHhcC----CC
Confidence 43334455789999999999864 469999999999999999999999998654432211 111111 12
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCCCC
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPS 649 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~ 649 (686)
.+.+...+.+++..+.+|+.+||+.||++||||.||++.|+....++|.
T Consensus 256 ~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 256 SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 2333334556678899999999999999999999999999877666665
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=426.47 Aligned_cols=250 Identities=22% Similarity=0.357 Sum_probs=206.7
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.|.+|++++++++|||||++++++.+++..+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 78999999999999999999975 79999999996543 3345789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++|+|.+++... +...+++.+++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999654 3345899999999999999999999988 9999999999999999999999999999765322
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
.......||+.|||||++.+..|+.++|||||||+||||++|+.||......+.... ... +..
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~------i~~-~~~-------- 242 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK------IIS-GSF-------- 242 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH------HHH-TCC--------
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH------HHc-CCC--------
Confidence 123346799999999999999999999999999999999999999987655443221 111 111
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
...+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1123345677899999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-51 Score=430.93 Aligned_cols=269 Identities=30% Similarity=0.439 Sum_probs=222.7
Q ss_pred ccCHHHHHHhhCCCcccccccccCcEEEEEEEecC------CCEEEEEEecccCc-ccHHHHHHHHHHHHhcCC-CCccc
Q 005649 357 LFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQD------GREIAVKKLATNSM-QGKEEFENEVRVLLKMQH-RNLVQ 428 (686)
Q Consensus 357 ~~~~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h-~niv~ 428 (686)
.++.+..+...++|++.+.||+|+||.||+|++.. ++.||||++..... ...++|.+|+++|.+++| ||||+
T Consensus 53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 35666777788999999999999999999998652 35799999976543 345789999999999965 89999
Q ss_pred EEEEEEec-CceEEEEeecCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 005649 429 LFGCCVQE-RERILVYEYLPNKSLDKFLFDKSK-------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHR 494 (686)
Q Consensus 429 l~~~~~~~-~~~~lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 494 (686)
++|+|.+. +..+||||||++|+|.++|+.... ...++|.+++.++.|||+||.|||+++ |+||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHR 209 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 209 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecC
Confidence 99999775 568999999999999999976432 345899999999999999999999987 9999
Q ss_pred CCCCCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCc
Q 005649 495 DIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYD 573 (686)
Q Consensus 495 Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~ 573 (686)
||||+||||++++.+||+|||+++.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999998765544444556789999999999999999999999999999999998 999998
Q ss_pred ccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 574 RQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
.....+.. . .....+... ..|..++.++.+++.+||+.||++|||+.||++.|++
T Consensus 290 ~~~~~~~~--~----~~i~~g~~~--------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 290 GVKIDEEF--C----RRLKEGTRM--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp TCCCSHHH--H----HHHHHTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHHHHH--H----HHHHcCCCC--------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 65433211 1 111112111 1244566789999999999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=424.03 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=213.6
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
+.|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56889999999999999999976 79999999997666666678899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++|+|.+++.. ..+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 99999999854 34999999999999999999999998 99999999999999999999999999997754332
Q ss_pred ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCC
Q 005649 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 606 (686)
......||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+. . +. .+.+ .
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~------~-~~-----~~~~-~ 291 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR------D-NL-----PPRL-K 291 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------H-SS-----CCCC-S
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH------c-CC-----CCCC-C
Confidence 2345689999999999999999999999999999999999999998665444322211 1 10 1111 1
Q ss_pred CCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 123456778999999999999999999999873
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=417.09 Aligned_cols=248 Identities=24% Similarity=0.332 Sum_probs=213.6
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN---SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|++.+.||+|+||.||+++.. +|+.||||++.+. .....+.+.+|++++++++|||||++++++.+++..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999975 7899999999653 2334578999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999654 35999999999999999999999988 999999999999999999999999999987654
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
..........||+.|||||++.+..++.++||||+||++|||++|+.||...+..+....+. . +.+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~------~-~~~------- 251 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII------K-LEY------- 251 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------H-TCC-------
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------c-CCC-------
Confidence 44444556789999999999999999999999999999999999999998765544322211 1 111
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHH
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATL 637 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl 637 (686)
.++...+..+.+|+.+||+.||++|||+.|++
T Consensus 252 --~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 --DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 12444567789999999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=416.57 Aligned_cols=252 Identities=22% Similarity=0.264 Sum_probs=208.1
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.+.|+..++||+|+||.||+|+.. +|+.||||+++.... ..+|+.++++++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888899999999999999976 689999999975432 24699999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-CeEEEecCCccccCCcC
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM-KPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~ 524 (686)
+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++ .+||+|||+++.+....
T Consensus 132 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999654 35999999999999999999999987 99999999999999987 69999999999875432
Q ss_pred cc---ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 525 SR---HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 525 ~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
.. .......||+.|||||++.+..++.++|||||||++|||++|+.||......+....+ .....
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~~~------ 273 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI------ASEPP------ 273 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH------HHSCC------
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------HcCCC------
Confidence 21 1223467999999999999999999999999999999999999999865544332211 11111
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
.+...+...+..+.+++.+||+.||++|||+.||++.|..
T Consensus 274 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 274 -PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp -GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 1112345567789999999999999999999999988754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=405.63 Aligned_cols=246 Identities=26% Similarity=0.376 Sum_probs=198.8
Q ss_pred cccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEe----cCceEEEE
Q 005649 371 STKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ----ERERILVY 443 (686)
Q Consensus 371 ~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 443 (686)
+..++||+|+||.||+|+.. +++.||+|++... .....+.|.+|++++++++|||||++++++.+ ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999976 6889999999654 23345789999999999999999999999875 34579999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-CCCCeEEEecCCccccCC
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD-HQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~ 522 (686)
||+++|+|.+++... ..+++..+..++.||++||.|||+++ ++|+||||||+||||+ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999654 35999999999999999999999976 4699999999999998 479999999999986433
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
. ......||+.|||||++.+ .++.++|||||||+||||+||+.||........ +. .....+.....+
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~----~~i~~~~~~~~~-- 251 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IY----RRVTSGVKPASF-- 251 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HH----HHHTTTCCCGGG--
T ss_pred C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HH----HHHHcCCCCCCC--
Confidence 2 2334689999999998764 699999999999999999999999975433221 11 111111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 252 -----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 -----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1223456889999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=424.64 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=214.4
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.+.|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 357999999999999999999976 6999999999876666677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++|+|.+++.. ..+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999999854 24999999999999999999999998 99999999999999999999999999997754332
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+. ... .+.+.
T Consensus 303 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~------~~~------~~~~~ 368 (423)
T 4fie_A 303 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR------DNL------PPRLK 368 (423)
T ss_dssp --CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------HSC------CCCCS
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH------cCC------CCCCc
Confidence 2345689999999999999999999999999999999999999998665443322211 111 11111
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 369 -~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 369 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 123456778999999999999999999999873
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=400.43 Aligned_cols=246 Identities=23% Similarity=0.376 Sum_probs=195.3
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|++.+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999975 79999999996543 233567999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+ +|+|.+++... ..+++.++..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 68999998654 35999999999999999999999998 999999999999999999999999999876543
Q ss_pred CccccccccccCCCcCchhhhhcCCC-ChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFL-SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
. ......||+.|||||++.+..+ +.++||||+||++|||++|+.||......+....+ . .+..
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i------~-~~~~------ 229 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI------S-NGVY------ 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------H-HTCC------
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------H-cCCC------
Confidence 2 2234689999999999988775 68999999999999999999999865544332211 1 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.++...+..+.+++.+||+.||++|||+.|+++.
T Consensus 230 ---~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 ---TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1234456778999999999999999999999873
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=409.51 Aligned_cols=266 Identities=23% Similarity=0.264 Sum_probs=200.6
Q ss_pred CCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecC----ceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER----ERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 443 (686)
++|.+.++||+|+||.||+|++ +|+.||||++...... ...++.|+..+.+++|||||+++|++.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577889999999999999998 5899999999654321 223345666677889999999999998764 579999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS-----VLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
||+++|+|.++|+.. .++|..+++++.|+++||.|||++. .++|+||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999653 4899999999999999999999872 2469999999999999999999999999998
Q ss_pred ccCCcCccc--cccccccCCCcCchhhhhcC------CCChhHHHHHHHHHHHHHHcCCCCCcccchHhH--------HH
Q 005649 519 LFHDEQSRH--RTHQIAGTFGYMAPEYAIRG------FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAEN--------QE 582 (686)
Q Consensus 519 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~--------~~ 582 (686)
......... ......||+.|||||++.+. .++.++|||||||+||||+||+.|+......+. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 765433221 22346799999999998764 467899999999999999999877643221100 00
Q ss_pred HHHHHHHHHhcCccccccccccC--CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 583 LLKLARRLEEEGRLMELVDVRIG--TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..........++ .+++.+. ....+.+..+.+|+.+||+.||++||||.||++.|+++
T Consensus 237 ~~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 237 SVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 001111111111 1222222 11235677899999999999999999999999999764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=406.41 Aligned_cols=247 Identities=25% Similarity=0.350 Sum_probs=201.3
Q ss_pred CCCcccccccccCcEEEEEEEec----CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ----DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
++|++.+.||+|+||.||+++.. .++.||||++..... .....+.+|++++++++|||||++++++.+++..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 478899999965432 234568899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||+++|+|.+++... ..+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999654 35999999999999999999999988 9999999999999999999999999998654
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
.... ......||+.|||||++.+..++.++|||||||++|||++|+.||...+..+....+. . +..
T Consensus 178 ~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~------~-~~~----- 243 (304)
T 3ubd_A 178 DHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL------K-AKL----- 243 (304)
T ss_dssp ---C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------H-CCC-----
T ss_pred CCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH------c-CCC-----
Confidence 3322 2334689999999999999999999999999999999999999998765544332221 1 111
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCC-----HHHHHH
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPT-----MSATLS 638 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 638 (686)
..+...+..+.+|+.+||+.||++||| ++|+++
T Consensus 244 ----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 ----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 124456677899999999999999998 467765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=395.98 Aligned_cols=252 Identities=23% Similarity=0.391 Sum_probs=193.2
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCc-------
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERE------- 438 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------- 438 (686)
++|+..+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999976 789999999965443 345679999999999999999999999976542
Q ss_pred -----eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 005649 439 -----RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISD 513 (686)
Q Consensus 439 -----~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 513 (686)
.++||||+++|+|.+++.........++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 6899999999999999977655555778889999999999999999988 99999999999999999999999
Q ss_pred cCCccccCCcCccc----------cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHH
Q 005649 514 FGLAKLFHDEQSRH----------RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQEL 583 (686)
Q Consensus 514 fgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~ 583 (686)
||+++.+....... ......||+.|||||++.+..++.++|||||||++|||++ ||....+ ....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~~~~ 236 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--RVRT 236 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--HHHH
Confidence 99999775432211 1233579999999999999999999999999999999996 7753221 1111
Q ss_pred HHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 584 LKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 584 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
+. .. ....... ........+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~---~~-~~~~~p~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 237 LT---DV-RNLKFPP--------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HH---HH-HTTCCCH--------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HH---HH-hcCCCCC--------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11 11 1111100 012334557789999999999999999999883
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=386.00 Aligned_cols=283 Identities=40% Similarity=0.665 Sum_probs=243.9
Q ss_pred cCHHHHHHhhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecC
Q 005649 358 FNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER 437 (686)
Q Consensus 358 ~~~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 437 (686)
+.+.++...+++|+..+.||+|+||.||+|+.++|+.||||++........+.+.+|+.++++++||||+++++++.+++
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44445566789999999999999999999998889999999998776666788999999999999999999999999999
Q ss_pred ceEEEEeecCCCChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCC
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSK-SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGL 516 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 516 (686)
..++||||+++|+|.+++..... ...+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999865432 235999999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcc
Q 005649 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL 596 (686)
Q Consensus 517 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (686)
++...............|++.|+|||.+.+..++.++||||||+++|||++|+.||......+......+.......+.+
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 98765433333334456899999999999999999999999999999999999999866554444455555555666667
Q ss_pred ccccccccC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 597 MELVDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 597 ~~~~d~~l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
...+++.+. ..+.+.+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 777777765 66788999999999999999999999999999999763
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=392.18 Aligned_cols=266 Identities=19% Similarity=0.298 Sum_probs=205.8
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEe------cC
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ------ER 437 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~ 437 (686)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 367999999999999999999975 79999999996543 2334678899999999999999999999864 35
Q ss_pred ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCc
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 517 (686)
..+|||||++ |+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999995 779998854 346999999999999999999999988 999999999999999999999999999
Q ss_pred cccCCcCc--cccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcC
Q 005649 518 KLFHDEQS--RHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEG 594 (686)
Q Consensus 518 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 594 (686)
+.+..... ........||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+....+..........
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 87654321 2233456899999999998875 57999999999999999999999998776655443332211100000
Q ss_pred ccccccc-------cccC---CC-----CHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 595 RLMELVD-------VRIG---TY-----PEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 595 ~~~~~~d-------~~l~---~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+...-. ..+. .. ....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 0000 00 01235678899999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=376.50 Aligned_cols=288 Identities=45% Similarity=0.747 Sum_probs=241.7
Q ss_pred cccCHHHHHHhhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEE
Q 005649 356 FLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCV 434 (686)
Q Consensus 356 ~~~~~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 434 (686)
..++++++...+++|+..+.||+|+||.||+|+..+|+.||||++..... .....+.+|+.++++++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 35788999999999999999999999999999988899999999976432 23347899999999999999999999999
Q ss_pred ecCceEEEEeecCCCChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 005649 435 QERERILVYEYLPNKSLDKFLFDKSK-SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISD 513 (686)
Q Consensus 435 ~~~~~~lv~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 513 (686)
+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||++..++|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 99999999999999999999976543 34599999999999999999999998323399999999999999999999999
Q ss_pred cCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchH--hHHHHHHHHHHHH
Q 005649 514 FGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEA--ENQELLKLARRLE 591 (686)
Q Consensus 514 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~--~~~~~~~~~~~~~ 591 (686)
||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||+..... .......+.....
T Consensus 178 fg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 178 FGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred CccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 9999876543322 233456999999999999999999999999999999999999999743221 1222344444455
Q ss_pred hcCccccccccccC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 592 EEGRLMELVDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 592 ~~~~~~~~~d~~l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
.......+.+..+. ..+.+.+..+.+++.+||+.||++|||+.||+++|+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 55566667777665 678889999999999999999999999999999998754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=375.31 Aligned_cols=263 Identities=24% Similarity=0.334 Sum_probs=200.3
Q ss_pred hhCCCcccccccccCcEEEEEEEec----CCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ----DGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 440 (686)
-.++|++.++||+|+||.||+|+.+ .++.||||++.... ...++.+|+++|.++ +||||+++++++.+++..+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 3578999999999999999999853 46789999986543 346788999999998 6999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CCeEEEecCCccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ-MKPKISDFGLAKL 519 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~ 519 (686)
|||||+++|+|.+++. .+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999982 3899999999999999999999998 9999999999999877 7999999999986
Q ss_pred cCCcCcc--------------------------ccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCC
Q 005649 520 FHDEQSR--------------------------HRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNY 572 (686)
Q Consensus 520 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~ 572 (686)
....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 5432211 112235799999999999875 5899999999999999999999999
Q ss_pred cccchHhH-HHHHHHHHH------HHh-cCc------------ccccc------c---ccc----------CCCCHHHHH
Q 005649 573 DRQLEAEN-QELLKLARR------LEE-EGR------------LMELV------D---VRI----------GTYPEEIAL 613 (686)
Q Consensus 573 ~~~~~~~~-~~~~~~~~~------~~~-~~~------------~~~~~------d---~~l----------~~~~~~~~~ 613 (686)
....++.. ...+..... ... .+. ..... + +.+ .......+.
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 65433221 111110000 000 000 00000 0 000 000112356
Q ss_pred HHHHHHHHcccccccCCCCHHHHHHH
Q 005649 614 RFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 614 ~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+.+|+.+||+.||++|||++|+++.
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 78899999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=400.79 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=213.4
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
++|++.+.||+|+||.||+++.+ +|+.||+|++........+.+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 68999999999999999999976 79999999998776666788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC--CCeEEEecCCccccCCcC
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ--MKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfgla~~~~~~~ 524 (686)
++|+|.+++... ...+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 237 ~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 999999998543 345999999999999999999999988 9999999999999854 899999999999875433
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
......||+.|||||++.+..++.++||||+||++|||++|+.||......+....+. . ..+. .-++
T Consensus 312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~------~-~~~~-~~~~-- 378 (573)
T 3uto_A 312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK------S-CDWN-MDDS-- 378 (573)
T ss_dssp ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH------T-TCCC-CCSG--
T ss_pred ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH------h-CCCC-CCcc--
Confidence 2334579999999999999999999999999999999999999998766554432221 1 1110 0001
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 379 --~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 379 --AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp --GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112345678899999999999999999999984
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=394.60 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=204.0
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHH---HHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFEN---EVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
++|++.++||+|+||.||+++.. +|+.||||++.+.. ........+ ++.+++.++|||||++++++.+.+..+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 68999999999999999999976 69999999996532 122233334 456666779999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
|||||+++|+|.++|... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 999999999999999654 35999999999999999999999988 999999999999999999999999999876
Q ss_pred CCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
.... .....||+.|||||++.+ ..|+.++|+|||||+||||++|+.||......+...+... ... ...
T Consensus 343 ~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~---i~~-~~~--- 411 (689)
T 3v5w_A 343 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLT-MAV--- 411 (689)
T ss_dssp SSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH---HHH-CCC---
T ss_pred CCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---hcC-CCC---
Confidence 5432 234689999999999975 5799999999999999999999999986544333222221 111 110
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCC-----HHHHHHH
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPT-----MSATLSM 639 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 639 (686)
.++...+..+.+|+.+||+.||++|++ +.||++.
T Consensus 412 ------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 412 ------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 234456778999999999999999998 6777653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=360.91 Aligned_cols=283 Identities=36% Similarity=0.562 Sum_probs=236.8
Q ss_pred ccccCHHHHHHhhCCCccc------ccccccCcEEEEEEEecCCCEEEEEEecccC----cccHHHHHHHHHHHHhcCCC
Q 005649 355 SFLFNLDVLIAATDNFSTK------NMLGRGGFGTVYKGRLQDGREIAVKKLATNS----MQGKEEFENEVRVLLKMQHR 424 (686)
Q Consensus 355 ~~~~~~~~l~~at~~f~~~------~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h~ 424 (686)
...|+++++..++++|... +.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4568899999999999888 8999999999999987 58899999986532 23357899999999999999
Q ss_pred CcccEEEEEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 005649 425 NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD 504 (686)
Q Consensus 425 niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 504 (686)
||+++++++.+.+..++||||+++++|.+++........+++..++.++.|++.||.|||+++ |+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 999999999999999999999999999999976555567999999999999999999999987 99999999999999
Q ss_pred CCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHH
Q 005649 505 HQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELL 584 (686)
Q Consensus 505 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~ 584 (686)
.++.+||+|||+++...............|++.|+|||.+.+ .++.++||||||+++|||++|+.||..........
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-- 244 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL-- 244 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT--
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH--
Confidence 999999999999987654433333445678999999998764 58999999999999999999999998654432111
Q ss_pred HHHHHHHh-cCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 585 KLARRLEE-EGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 585 ~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
.+...... ...+.+.+++.+...+...+..+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11111111 2234555666666677888999999999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=370.11 Aligned_cols=265 Identities=28% Similarity=0.426 Sum_probs=210.6
Q ss_pred HHhhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 364 IAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 364 ~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
....++|++.+.||+|+||.||+++. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 34467899999999999999999987 588999999976543 334678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||+++|+|.+++........+++..++.++.||++||.|||+++ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999999999976544445999999999999999999999975 459999999999999999999999999998654
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+. .....
T Consensus 191 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~------~~~~~----- 257 (309)
T 3p86_A 191 STFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG------FKCKR----- 257 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH------HSCCC-----
T ss_pred cccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hcCCC-----
Confidence 3221 2234578999999999999999999999999999999999999998665543322111 01110
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCC
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVP 646 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 646 (686)
...+...+..+.+++.+||+.||++|||+.++++.|+..-..
T Consensus 258 ---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 258 ---LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 122445567789999999999999999999999999876433
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=371.81 Aligned_cols=259 Identities=27% Similarity=0.433 Sum_probs=216.6
Q ss_pred hCCCcccccccccCcEEEEEEEec--------CCCEEEEEEecccCc-ccHHHHHHHHHHHHhc-CCCCcccEEEEEEec
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ--------DGREIAVKKLATNSM-QGKEEFENEVRVLLKM-QHRNLVQLFGCCVQE 436 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 436 (686)
.++|+..+.||+|+||.||+|+.. ++..||||+++.... ...+.+.+|+.+++++ +||||+++++++.++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 478899999999999999999863 345799999976533 3456799999999999 899999999999999
Q ss_pred CceEEEEeecCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 005649 437 RERILVYEYLPNKSLDKFLFDKSK-------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL 503 (686)
Q Consensus 437 ~~~~lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 503 (686)
+..++||||+++|+|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999976432 235899999999999999999999987 9999999999999
Q ss_pred cCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHH
Q 005649 504 DHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQE 582 (686)
Q Consensus 504 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~ 582 (686)
+.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999987765443333444567889999999999999999999999999999999 999998765544332
Q ss_pred HHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 583 LLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
.+. .+.. ...+..++..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 317 ~~~-------~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 317 LLK-------EGHR--------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HHH-------TTCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHh-------cCCC--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 1111 112345567799999999999999999999999999763
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=356.81 Aligned_cols=251 Identities=27% Similarity=0.428 Sum_probs=213.2
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.++|+..+.||+|+||.||+++.. +|+.||||++........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 468999999999999999999964 7899999999776666678899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++|+|.+++... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999999653 4899999999999999999999987 99999999999999999999999999987654332
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+ ...+... +
T Consensus 172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------~~~~~~~------~- 236 (297)
T 3fxz_A 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNGTPE------L- 236 (297)
T ss_dssp --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHHCSCC------C-
T ss_pred --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCCCC------C-
Confidence 233457999999999999999999999999999999999999999765543322211 1111110 0
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1234456778999999999999999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=360.54 Aligned_cols=262 Identities=26% Similarity=0.430 Sum_probs=214.5
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.++|+..+.||+|+||.||+++.. +++.||+|++........+.|.+|++++.+++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467889999999999999999976 6899999999776666778899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++|+|.+++... ...+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999753 345999999999999999999999987 99999999999999999999999999987654322
Q ss_pred cc------------cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhc
Q 005649 526 RH------------RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEE 593 (686)
Q Consensus 526 ~~------------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 593 (686)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|..|+..................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--- 240 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--- 240 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH---
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc---
Confidence 11 111457899999999999999999999999999999999999988643221110000000000
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCC
Q 005649 594 GRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVP 646 (686)
Q Consensus 594 ~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 646 (686)
+. ..+...+..+.+++.+||+.||++|||+.|+++.|+.....
T Consensus 241 -------~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 241 -------DR---YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp -------HH---TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------cc---cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00 11334456688999999999999999999999999876533
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=373.79 Aligned_cols=257 Identities=30% Similarity=0.432 Sum_probs=213.4
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.++|+..+.||+|+||.||+|+.. +++.||||++..... ...+.|.+|++++++++||||+++++++.+++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467888999999999999999986 789999999975432 234578899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++|+|.+++.... ..+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 999999999997532 34899999999999999999999987 9999999999999999999999999998654332
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
.........++..|+|||.+.++.++.++||||||+++|||++ |+.||......+....+. .+...
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~------ 334 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-------KGGRL------ 334 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-------TTCCC------
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCC------
Confidence 2222222345778999999999999999999999999999999 999998765544322111 11110
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+..++..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 335 --~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 335 --PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 12344567789999999999999999999999999764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=360.91 Aligned_cols=258 Identities=28% Similarity=0.443 Sum_probs=211.4
Q ss_pred hCCCcccccccccCcEEEEEEEec----CCCEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ----DGREIAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
.++|++.+.||+|+||.||+|+.. .+..||||++... .....+.|.+|+.++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467888999999999999999975 3445999999765 33445789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999999643 345999999999999999999999987 9999999999999999999999999998775
Q ss_pred CcCcc-ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 522 DEQSR-HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 522 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. . +..
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~------~-~~~--- 272 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE------E-GYR--- 272 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH------T-TCC---
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH------c-CCC---
Confidence 43221 12223456778999999999999999999999999999999 999998665544322111 1 100
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
...+...+..+.+++.+||+.||++|||+.||++.|+...
T Consensus 273 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 273 -----LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0123445677999999999999999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=358.55 Aligned_cols=248 Identities=26% Similarity=0.383 Sum_probs=210.4
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 468999999999999999999974 79999999996542 334567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++... ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999999654 34999999999999999999999987 999999999999999999999999999876543
Q ss_pred CccccccccccCCCcCchhhhhcCCCC-hhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLS-VKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
. ......||+.|+|||.+.+..+. .++||||||+++|||++|+.||......+....+ .. +..
T Consensus 168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i------~~-~~~------ 231 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV------LR-GKY------ 231 (328)
T ss_dssp C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HH-CCC------
T ss_pred C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------Hh-CCC------
Confidence 2 23446799999999999988765 8999999999999999999999876554432211 11 111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 232 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ---RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1233456678899999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=355.77 Aligned_cols=264 Identities=24% Similarity=0.375 Sum_probs=219.1
Q ss_pred ccccCHHHHHHhhCC----------CcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCC
Q 005649 355 SFLFNLDVLIAATDN----------FSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQH 423 (686)
Q Consensus 355 ~~~~~~~~l~~at~~----------f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h 423 (686)
+..++.+++..+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 345788888877764 677789999999999999987 799999999987766677889999999999999
Q ss_pred CCcccEEEEEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 005649 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL 503 (686)
Q Consensus 424 ~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 503 (686)
|||+++++++...+..++||||+++++|.+++.. ..+++..++.++.|+++||.|||+.+ |+||||||+|||+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll 174 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILL 174 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999843 35999999999999999999999987 9999999999999
Q ss_pred cCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHH
Q 005649 504 DHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQEL 583 (686)
Q Consensus 504 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~ 583 (686)
+.++.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+...
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~- 251 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK- 251 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-
T ss_pred CCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-
Confidence 9999999999999987654322 2234579999999999999999999999999999999999999997654433221
Q ss_pred HHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 584 LKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 584 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
.... .. .+.+. .....+..+.+++.+||+.||++|||+.|+++.-
T Consensus 252 -----~~~~-~~-----~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 252 -----RLRD-SP-----PPKLK-NSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp -----HHHH-SS-----CCCCT-TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred -----HHhc-CC-----CCCcC-ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 1111 11 11111 1223456788999999999999999999999854
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=363.19 Aligned_cols=256 Identities=27% Similarity=0.453 Sum_probs=205.1
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCE----EEEEEeccc-CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGRE----IAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~----vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
.++|+..++||+|+||.||+|+.. +++. |++|.+... .....+.|.+|+.++++++||||+++++++.+. ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 367899999999999999999965 4443 588887543 334567899999999999999999999999875 478
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+|+||+++|+|.+++.... ..+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 9999999999999997643 45999999999999999999999987 999999999999999999999999999877
Q ss_pred CCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
.............+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+.. +..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-------~~~--- 237 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------GER--- 237 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-------TCC---
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc-------CCC---
Confidence 65444333444567889999999999999999999999999999999 9999987665554322221 110
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
...+...+..+.+++.+||+.||++||++.|+++.|+..
T Consensus 238 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 238 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 012344566789999999999999999999999998653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=347.96 Aligned_cols=256 Identities=30% Similarity=0.469 Sum_probs=215.2
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
.++|+..+.||+|+||.||+++.+++..||+|++..... ..+++.+|++++.+++||||+++++++.++...++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 478899999999999999999998888999999975443 3577999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 9999999996542 34999999999999999999999987 999999999999999999999999999876543322
Q ss_pred ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ......
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~------~~~~~~--------- 224 (268)
T 3sxs_A 161 -SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV------SQGHRL--------- 224 (268)
T ss_dssp -ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH------HTTCCC---------
T ss_pred -cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH------HcCCCC---------
Confidence 2233456778999999999999999999999999999999 99999866554332211 111100
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
..+...+..+.+++.+||+.||++|||+.|+++.|+...
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 112334567889999999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=349.30 Aligned_cols=255 Identities=29% Similarity=0.485 Sum_probs=214.2
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
.++|+..+.||+|+||.||+++..+++.||+|++..... ..+++.+|++++++++||||+++++++.+++..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 467899999999999999999998889999999975443 4577999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++++|.+++... ...+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 88 ~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 999999999653 345899999999999999999999987 999999999999999999999999999876543211
Q ss_pred ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..... .
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~------~~~~~---------~ 226 (269)
T 4hcu_A 163 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI------STGFR---------L 226 (269)
T ss_dssp -STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------HTTCC---------C
T ss_pred -cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH------hcCcc---------C
Confidence 2233456788999999999999999999999999999999 99999866554332211 11100 0
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+...+..+.+++.+||+.||++|||+.|+++.|++.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 11333456789999999999999999999999999764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=358.02 Aligned_cols=265 Identities=27% Similarity=0.414 Sum_probs=209.6
Q ss_pred hCCCcccccccccCcEEEEEEEe-----cCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEec--Cce
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRL-----QDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE--RER 439 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 439 (686)
.++|+..+.||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46889999999999999999984 26889999999877666678899999999999999999999999654 468
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 99999999999999996643 34999999999999999999999987 99999999999999999999999999987
Q ss_pred cCCcCcc-ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHH---------HHHHHHH
Q 005649 520 FHDEQSR-HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQE---------LLKLARR 589 (686)
Q Consensus 520 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~---------~~~~~~~ 589 (686)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.......... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6543221 12233457778999999999999999999999999999999999987543221110 0001111
Q ss_pred HHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 590 LEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 590 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
....+. ....+..++..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 244 ~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 244 LLKNNG--------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHTTC--------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccC--------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 111110 01224456678999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=367.52 Aligned_cols=257 Identities=28% Similarity=0.478 Sum_probs=200.9
Q ss_pred hCCCcccccccccCcEEEEEEEec----CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ----DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
.++|+..+.||+|+||.||+|+.. ++..||||+++... ....++|.+|+.++.+++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 468999999999999999999875 57789999997643 3345689999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||+++|+|.+++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999653 345999999999999999999999987 9999999999999999999999999998765
Q ss_pred CcCccc-cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 522 DEQSRH-RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 522 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+..
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i-------~~~~~--- 268 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV-------DEGYR--- 268 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH-------HTTEE---
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcCCC---
Confidence 432211 1222345778999999999999999999999999999998 99999766544332211 11100
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
...+..++..+.+++.+||+.||++||++.+|+++|+..
T Consensus 269 -----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 269 -----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp -----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 011334567789999999999999999999999999764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=361.80 Aligned_cols=264 Identities=27% Similarity=0.453 Sum_probs=217.8
Q ss_pred HhhCCCcccccccccCcEEEEEEEec------CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecC
Q 005649 365 AATDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQER 437 (686)
Q Consensus 365 ~at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 437 (686)
...++|+..+.||+|+||.||+++.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34688999999999999999999975 347899999976533 33577999999999999999999999999999
Q ss_pred ceEEEEeecCCCChhHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSK---------------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDI 496 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 496 (686)
..++||||+++|+|.+++..... ...+++.+++.++.||++||.|||+++ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 99999999999999999976421 256999999999999999999999987 999999
Q ss_pred CCCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCccc
Q 005649 497 KASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQ 575 (686)
Q Consensus 497 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~ 575 (686)
||+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999987654433233344577899999999999999999999999999999999 99999866
Q ss_pred chHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCC
Q 005649 576 LEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVP 646 (686)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 646 (686)
...+.... . ..+.. ...+...+..+.+++.+||+.||++|||+.++++.|++....
T Consensus 281 ~~~~~~~~------~-~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 281 AHEEVIYY------V-RDGNI--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp CHHHHHHH------H-HTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred ChHHHHHH------H-hCCCc--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 54433221 1 11111 112344567799999999999999999999999999986543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=375.04 Aligned_cols=262 Identities=29% Similarity=0.467 Sum_probs=217.9
Q ss_pred HHHhhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 363 LIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 363 l~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
.+...++|+..+.||+|+||.||+|++++++.||||+++... ...+.|.+|+.++++++||||+++++++. ++..++|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 344567899999999999999999999888999999997644 45788999999999999999999999986 6678999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 261 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp ECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 99999999999996432 234899999999999999999999987 99999999999999999999999999987653
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
.... ......++..|+|||.+..+.++.++||||||+++|||++ |+.||......+....+. ...+.
T Consensus 337 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~------~~~~~----- 404 (454)
T 1qcf_A 337 NEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE------RGYRM----- 404 (454)
T ss_dssp HHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH------HTCCC-----
T ss_pred Ccee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------cCCCC-----
Confidence 2211 1223456788999999999999999999999999999999 999998765544332221 11111
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCC
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVP 646 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 646 (686)
..+..++..+.+++.+||+.||++|||+.+|++.|+.....
T Consensus 405 ----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 405 ----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 12344567899999999999999999999999999986543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=365.76 Aligned_cols=269 Identities=30% Similarity=0.442 Sum_probs=219.2
Q ss_pred ccCHHHHHHhhCCCcccccccccCcEEEEEEEe------cCCCEEEEEEecccCc-ccHHHHHHHHHHHHhc-CCCCccc
Q 005649 357 LFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRL------QDGREIAVKKLATNSM-QGKEEFENEVRVLLKM-QHRNLVQ 428 (686)
Q Consensus 357 ~~~~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~ 428 (686)
.++........++|+..+.||+|+||.||+|++ .+++.||||++..... ...+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 456666777789999999999999999999974 2467899999976433 3456799999999999 8999999
Q ss_pred EEEEEEecCc-eEEEEeecCCCChhHHHhhcCC-----------------------------------------------
Q 005649 429 LFGCCVQERE-RILVYEYLPNKSLDKFLFDKSK----------------------------------------------- 460 (686)
Q Consensus 429 l~~~~~~~~~-~~lv~Ey~~~gsL~~~l~~~~~----------------------------------------------- 460 (686)
+++++.+.+. .++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999988654 8999999999999999976432
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 461 ----------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 461 ----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 122899999999999999999999987 9999999999999999999999999998765544
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
.........||+.|+|||.+.+..++.++||||||+++|||++ |+.||......+... .....+...
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~------~~~~~~~~~------ 315 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RRLKEGTRM------ 315 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH------HHHHHTCCC------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH------HHHHcCCCC------
Confidence 3334445678899999999999999999999999999999998 999998655433211 111111110
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 316 --~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 316 --RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 1233455678999999999999999999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=364.48 Aligned_cols=261 Identities=28% Similarity=0.432 Sum_probs=217.3
Q ss_pred hhCCCcccccccccCcEEEEEEEec--------CCCEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCCcccEEEEEEe
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ--------DGREIAVKKLATNS-MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQ 435 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 435 (686)
..++|.+.+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|+++++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3578899999999999999999863 23579999997653 33447789999999999 99999999999999
Q ss_pred cCceEEEEeecCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 005649 436 ERERILVYEYLPNKSLDKFLFDKSK-------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNIL 502 (686)
Q Consensus 436 ~~~~~lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 502 (686)
++..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999976432 245999999999999999999999987 999999999999
Q ss_pred EcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHH
Q 005649 503 LDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQ 581 (686)
Q Consensus 503 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~ 581 (686)
++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+..
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999987765443334445567889999999999999999999999999999999 99999866544332
Q ss_pred HHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 582 ELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
..+ ..+... ..+...+..+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 304 ~~~-------~~~~~~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 304 KLL-------KEGHRM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp HHH-------HTTCCC--------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH-------HcCCCC--------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 211 111111 123345667899999999999999999999999998753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=365.92 Aligned_cols=259 Identities=30% Similarity=0.459 Sum_probs=213.5
Q ss_pred hCCCcccccccccCcEEEEEEEec------CCCEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCce
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERER 439 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 439 (686)
.++|+..+.||+|+||.||+|++. +++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467899999999999999999853 4668999999654 333456789999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC---CeEEE
Q 005649 440 ILVYEYLPNKSLDKFLFDKSK----SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM---KPKIS 512 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~ 512 (686)
++||||+++|+|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999976432 245999999999999999999999987 99999999999999555 59999
Q ss_pred ecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHH
Q 005649 513 DFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLE 591 (686)
Q Consensus 513 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 591 (686)
|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ .
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i------~ 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV------T 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH------H
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------H
Confidence 9999986644333333344567899999999999999999999999999999998 99999876554432211 1
Q ss_pred hcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 592 EEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 592 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..... ..+...+..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 301 ~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCC---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11110 12334566789999999999999999999999999764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=348.35 Aligned_cols=255 Identities=29% Similarity=0.492 Sum_probs=211.1
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
.++|+..+.||+|+||.||+++..++..||+|++..... ..+++.+|++++.+++||||+++++++.+++..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 578899999999999999999998888999999976543 3577999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 999999999653 234999999999999999999999987 999999999999999999999999999876543211
Q ss_pred ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. . +.. .
T Consensus 177 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~------~-~~~--------~ 240 (283)
T 3gen_A 177 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA------Q-GLR--------L 240 (283)
T ss_dssp -STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH------T-TCC--------C
T ss_pred -cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh------c-ccC--------C
Confidence 2233456788999999999999999999999999999998 999998765543322111 1 100 0
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+...+..+.+++.+||+.+|++|||+.|+++.|++.
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 11233456788999999999999999999999999753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=359.39 Aligned_cols=268 Identities=26% Similarity=0.343 Sum_probs=208.1
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecC----ceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER----ERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv 442 (686)
.++|+..++||+|+||.||+|+.. ++.||||++..... ....+..|+.++.+++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 478999999999999999999885 78999999965432 2345667899999999999999999998754 36999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------CCCeEecCCCCCcEEEcCCCCeEEEecC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS-------VLRIIHRDIKASNILLDHQMKPKISDFG 515 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 515 (686)
|||+++|+|.+++... .+++..++.++.|+++||.|||+.. ..+|+||||||+|||++.++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 9999999999999652 3899999999999999999999970 0139999999999999999999999999
Q ss_pred CccccCCcCccccccccccCCCcCchhhhhc-----CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHH---------
Q 005649 516 LAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR-----GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQ--------- 581 (686)
Q Consensus 516 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~--------- 581 (686)
+++...............||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.........
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 9987765444333444679999999999886 35667899999999999999999999754321100
Q ss_pred -HHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 582 -ELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 582 -~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
......... ........+.... .....+..+.+++.+||+.||++|||+.||++.|+.+
T Consensus 257 ~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 257 PSLEDMQEVV-VHKKKRPVLRDYW--QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CCHHHHHHHH-TTSCCCCCCCGGG--GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Cchhhhhhhh-hcccCCCCccccc--cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000111111 1111111111111 1235667799999999999999999999999999764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=358.94 Aligned_cols=262 Identities=25% Similarity=0.419 Sum_probs=199.6
Q ss_pred HHhhCCCcccccccccCcEEEEEEEecCCC----EEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecC
Q 005649 364 IAATDNFSTKNMLGRGGFGTVYKGRLQDGR----EIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER 437 (686)
Q Consensus 364 ~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~----~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 437 (686)
....++|+..+.||+|+||.||+|+..... .||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 345678999999999999999999876432 7999999765 3344578999999999999999999999998776
Q ss_pred ce------EEEEeecCCCChhHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC
Q 005649 438 ER------ILVYEYLPNKSLDKFLFDKSK---SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK 508 (686)
Q Consensus 438 ~~------~lv~Ey~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 508 (686)
.. ++|+||+++|+|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+|||+++++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence 55 999999999999999965432 225999999999999999999999987 999999999999999999
Q ss_pred eEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHH
Q 005649 509 PKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLA 587 (686)
Q Consensus 509 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 587 (686)
+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+.
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-- 253 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI-- 253 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH--
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh--
Confidence 99999999987655443333344567889999999999999999999999999999999 999998766554332111
Q ss_pred HHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 588 RRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 588 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
.... ...+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 254 ----~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 254 ----GGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp ----TTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----cCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111 112344567789999999999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=354.87 Aligned_cols=255 Identities=24% Similarity=0.343 Sum_probs=207.1
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.++|+..+.||+|+||.||+++.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 378999999999999999999976 789999999965432 234678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999998853 345999999999999999999999987 9999999999999999999999999998765433
Q ss_pred ccccccccccCCCcCchhhhhcCCC-ChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFL-SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
.........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.......... ..+ ...... .
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~-----~~~~~~--~--- 228 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDW-----KEKKTY--L--- 228 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH-HHH-----HTTCTT--S---
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH-HHH-----hccccc--C---
Confidence 3333445689999999999988765 789999999999999999999998655432211 111 111000 0
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
......+..+.+++.+||+.||++|||+.|+++.-
T Consensus 229 --~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 229 --NPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred --CccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 00123456778999999999999999999998764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=354.87 Aligned_cols=260 Identities=30% Similarity=0.441 Sum_probs=217.0
Q ss_pred hhCCCcccccccccCcEEEEEEEe------cCCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCc
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRL------QDGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERE 438 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 438 (686)
..++|...+.||+|+||.||+++. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 357899999999999999999986 245789999997543 3345788999999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 005649 439 RILVYEYLPNKSLDKFLFDKSK---------------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIK 497 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk 497 (686)
.++||||+++|+|.+++..... ...+++..++.++.||++||.|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999976432 234899999999999999999999987 9999999
Q ss_pred CCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccc
Q 005649 498 ASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQL 576 (686)
Q Consensus 498 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~ 576 (686)
|+||+++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987765443333344567889999999999999999999999999999999 999998766
Q ss_pred hHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 577 EAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+....+. .+.. ...+...+..+.+++.+||+.||++|||+.|+++.|++.
T Consensus 258 ~~~~~~~~~-------~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 258 PERLFNLLK-------TGHR--------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GGGHHHHHH-------TTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhh-------cCCc--------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 544332211 1111 112344567789999999999999999999999999763
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=371.71 Aligned_cols=263 Identities=30% Similarity=0.504 Sum_probs=212.4
Q ss_pred HhhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 365 AATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 365 ~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
...++|+..+.||+|+||.||+|+++++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 3457888999999999999999999888889999997644 346789999999999999999999999876 67899999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 259 ~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 259 YMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 999999999996432 235899999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
.. ......++..|+|||.+.++.++.++||||||+++|||++ |+.||......+....+ .. +...
T Consensus 335 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i------~~-~~~~------ 400 (452)
T 1fmk_A 335 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV------ER-GYRM------ 400 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH------HT-TCCC------
T ss_pred ee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH------Hc-CCCC------
Confidence 21 2223456789999999999999999999999999999999 99999876554432211 11 1100
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCCCC
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPS 649 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~ 649 (686)
..+..++..+.+++.+||+.||++|||+.+|++.|+..-....+
T Consensus 401 --~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 401 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 12345667889999999999999999999999999987544433
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=346.81 Aligned_cols=273 Identities=22% Similarity=0.311 Sum_probs=218.8
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecC--ceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER--ERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 442 (686)
.++|+..++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 367899999999999999999986 58999999997543 344678899999999999999999999998765 67999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE----cCCCCeEEEecCCcc
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL----DHQMKPKISDFGLAK 518 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla~ 518 (686)
|||+++++|.+++........+++..++.++.||++||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999987655556999999999999999999999987 9999999999999 788889999999998
Q ss_pred ccCCcCccccccccccCCCcCchhhhh--------cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHh-HHHHHHHHHH
Q 005649 519 LFHDEQSRHRTHQIAGTFGYMAPEYAI--------RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE-NQELLKLARR 589 (686)
Q Consensus 519 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~~ 589 (686)
....... .....||..|+|||.+. +..++.++||||||+++|||++|+.||....... ..........
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 7654332 23356899999999886 5788999999999999999999999997543322 1122221111
Q ss_pred HHhcCcccccc---------cccc---CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCC
Q 005649 590 LEEEGRLMELV---------DVRI---GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSV 645 (686)
Q Consensus 590 ~~~~~~~~~~~---------d~~l---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 645 (686)
......+..+. +..+ ..........+.+++.+||+.||++|||++|+++..++...
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 11111111100 0011 14567888999999999999999999999999999987553
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=345.96 Aligned_cols=275 Identities=16% Similarity=0.254 Sum_probs=218.8
Q ss_pred hCCCcccccccccCcEEEEEEEe-cCCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRL-QDGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.++|+..+.||+|+||.||+|+. .+|+.||||++.... ..+.+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46899999999999999999996 478999999986443 234678899999999 89999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC-----eEEEecCCccc
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK-----PKISDFGLAKL 519 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfgla~~ 519 (686)
|+ +++|.+++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999999654 235999999999999999999999987 999999999999987776 99999999987
Q ss_pred cCCcCcc-----ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcC
Q 005649 520 FHDEQSR-----HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEG 594 (686)
Q Consensus 520 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 594 (686)
....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 7543321 12344679999999999999999999999999999999999999998754333332222222111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCCCCCCCCCCCc
Q 005649 595 RLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPSVTESPDHY 657 (686)
Q Consensus 595 ~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~p~~p~~~ 657 (686)
...+ .....+..+.+++.+||+.||++||++.+|++.|++...........|..|
T Consensus 241 ~~~~--------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 295 (298)
T 1csn_A 241 PLRE--------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 295 (298)
T ss_dssp CHHH--------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred cHHH--------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence 1110 012345678999999999999999999999999987643333324555554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=371.25 Aligned_cols=266 Identities=19% Similarity=0.233 Sum_probs=215.2
Q ss_pred cCHHHHHHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCCcccEEEEE
Q 005649 358 FNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFGCC 433 (686)
Q Consensus 358 ~~~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~ 433 (686)
+.+.++....++|+..++||+|+||.||+++.+ +++.||+|++..... ...+.+.+|..++..++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345566667899999999999999999999987 478899999965321 2233488999999999999999999999
Q ss_pred EecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 005649 434 VQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISD 513 (686)
Q Consensus 434 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 513 (686)
.+++..+|||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcc
Confidence 9999999999999999999999653 345999999999999999999999987 99999999999999999999999
Q ss_pred cCCccccCCcCccccccccccCCCcCchhhhh-----cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH
Q 005649 514 FGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI-----RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR 588 (686)
Q Consensus 514 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 588 (686)
||+++........ ......||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+....
T Consensus 219 FGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 297 (437)
T 4aw2_A 219 FGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 297 (437)
T ss_dssp CTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred hhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc
Confidence 9999876543321 233457999999999987 5678999999999999999999999998766544433222111
Q ss_pred HHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccC--CCCHHHHHHHh
Q 005649 589 RLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIED--RPTMSATLSML 640 (686)
Q Consensus 589 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~L 640 (686)
... .........+..+.+++.+||+.+|++ ||++.|+++.-
T Consensus 298 ~~~-----------~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 298 ERF-----------QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp HHC-----------CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred ccc-----------cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 000 001111234567889999999888888 99999998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=343.98 Aligned_cols=253 Identities=30% Similarity=0.489 Sum_probs=201.0
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCc----ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSM----QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
.++|+..+.||+|+||.||+++.. ++.||||++..... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 478999999999999999999985 88999999865432 2357789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC--------CCCeEEEec
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH--------QMKPKISDF 514 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~Df 514 (686)
|||+++++|.+++. ...+++..++.++.|+++||.|||+++..+|+||||||+||+++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999984 345999999999999999999999988666999999999999986 778999999
Q ss_pred CCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcC
Q 005649 515 GLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEG 594 (686)
Q Consensus 515 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 594 (686)
|+++...... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||.......... ......
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~~~ 230 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY------GVAMNK 230 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------HHHTSC
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------hhhcCC
Confidence 9998654332 223468999999999999999999999999999999999999998655433221 111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 595 RLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 595 ~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
.. ...+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 231 -~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 231 -LA-------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp -CC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred -CC-------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 10 11234456779999999999999999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=350.11 Aligned_cols=259 Identities=18% Similarity=0.249 Sum_probs=211.2
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.++|+..+.||+|+||.||+|+.. +|+.||||++..... .+.+.+|+.+++++ +||||+++++++.+++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 478999999999999999999964 789999999865432 34688999999999 99999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC-----eEEEecCCccc
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK-----PKISDFGLAKL 519 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfgla~~ 519 (686)
|+ +++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999999754 345999999999999999999999987 999999999999998887 99999999987
Q ss_pred cCCcCccc-----cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcC
Q 005649 520 FHDEQSRH-----RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEG 594 (686)
Q Consensus 520 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 594 (686)
+....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+...............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 65433211 1245679999999999999999999999999999999999999998755444333333222111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 595 RLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 595 ~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
... .+ ....+ .+.+++..||+.+|.+||++.+|++.|++
T Consensus 240 ~~~-----~~---~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 240 PIE-----VL---CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp CHH-----HH---TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred CHH-----HH---hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 000 00 01123 89999999999999999999999999974
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=375.09 Aligned_cols=258 Identities=28% Similarity=0.428 Sum_probs=217.2
Q ss_pred hhCCCcccccccccCcEEEEEEEecC-CCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
..++|+..++||+|+||.||+|++.+ ++.||||++.... ...++|.+|+.++++++||||+++++++.+++..+||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 35678889999999999999999874 8899999997543 346789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++|+|.+++.... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999997543 345899999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
. .......++..|+|||.+....++.++||||||+++|||++ |+.||......+....+. .+...
T Consensus 373 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~------ 438 (495)
T 1opk_A 373 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRM------ 438 (495)
T ss_dssp E-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-------TTCCC------
T ss_pred e-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCC------
Confidence 2 12233456788999999999999999999999999999999 999998766544332211 11100
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
..+..++..+.+|+.+||+.||++|||+.+|++.|+..-
T Consensus 439 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 439 --ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 124455678899999999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=344.19 Aligned_cols=260 Identities=24% Similarity=0.382 Sum_probs=209.1
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
.++|+..+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999975 689999999855432 2346789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999654 34999999999999999999999987 99999999999999999999999999987653
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.. ....... .... ..
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~-~~~~-~~ 234 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHIQDS-VPNV-TT 234 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHHSSC-CCCH-HH
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhhcc-CCCc-ch
Confidence 322 1233457899999999999999999999999999999999999999866543321 1111111 1000 00
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCC-CHHHHHHHhcCCC
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRP-TMSATLSMLSNSS 644 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~~~ 644 (686)
..+...+..+.+++.+||+.||++|| +++++.+.|+...
T Consensus 235 ---~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 235 ---DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp ---HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred ---hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 11234567789999999999999998 9999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=367.49 Aligned_cols=251 Identities=30% Similarity=0.443 Sum_probs=210.6
Q ss_pred hhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecC-ceEEEEe
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER-ERILVYE 444 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E 444 (686)
..++|+..+.||+|+||.||+|+.. |+.||||+++... ..+.|.+|+.++++++||||+++++++.+.+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3567889999999999999999985 7899999997643 4578999999999999999999999988765 7899999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++|+|.+++.... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 268 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 999999999997643 334799999999999999999999987 9999999999999999999999999998543221
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. .+...
T Consensus 344 -----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-------~~~~~------ 405 (450)
T 1k9a_A 344 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKM------ 405 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-------TTCCC------
T ss_pred -----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCC------
Confidence 12356889999999999999999999999999999999 999998765544332111 11110
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 406 --~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 406 --DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 12445667899999999999999999999999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.49 Aligned_cols=249 Identities=24% Similarity=0.298 Sum_probs=210.1
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN---SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
.++|+..+.||+|+||.||+++.. +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 368999999999999999999976 6899999999654 233456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9999999999998654 34899999999999999999999987 99999999999999999999999999986432
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ .. +..
T Consensus 158 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~-~~~------ 222 (337)
T 1o6l_A 158 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LM-EEI------ 222 (337)
T ss_dssp TTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HH-CCC------
T ss_pred CCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH------Hc-CCC------
Confidence 221 233467999999999999999999999999999999999999999865544332211 11 110
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRP-----TMSATLSM 639 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 639 (686)
.++...+..+.+++.+||+.||++|| ++.|+++.
T Consensus 223 ---~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 12344567789999999999999999 89999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.41 Aligned_cols=260 Identities=26% Similarity=0.431 Sum_probs=205.0
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
.++|+..+.||+|+||.||+++.. ++.||||++... ...+.|.+|++++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 367889999999999999999985 789999998643 34578999999999999999999999876 4589999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC-eEEEecCCccccCCcCc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK-PKISDFGLAKLFHDEQS 525 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfgla~~~~~~~~ 525 (686)
++|+|.+++........+++..++.++.|+++||.|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999976555456899999999999999999999933234999999999999998886 799999999765432
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||.......... .+.... +...
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~-~~~~-------- 223 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI----MWAVHN-GTRP-------- 223 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH----HHHHHT-TCCC--------
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH----HHHHhc-CCCC--------
Confidence 223468999999999999999999999999999999999999997543322111 111111 1110
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCCCC
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPS 649 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~ 649 (686)
..+...+..+.+++.+||+.||++|||+.++++.|+.....++.
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 11233456788999999999999999999999999876655554
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=356.43 Aligned_cols=264 Identities=29% Similarity=0.431 Sum_probs=215.0
Q ss_pred HHHhhCCCcccccccccCcEEEEEEEecC-C-----CEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCCcccEEEEEE
Q 005649 363 LIAATDNFSTKNMLGRGGFGTVYKGRLQD-G-----REIAVKKLATNS-MQGKEEFENEVRVLLKM-QHRNLVQLFGCCV 434 (686)
Q Consensus 363 l~~at~~f~~~~~LG~G~fG~Vy~~~~~~-g-----~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 434 (686)
+....++|+..+.||+|+||.||+|.... + ..||+|++.... ....+.+.+|+.++.++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34456889999999999999999999752 2 479999997653 23457799999999999 8999999999999
Q ss_pred ecCceEEEEeecCCCChhHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 005649 435 QERERILVYEYLPNKSLDKFLFDKSK-----------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL 503 (686)
Q Consensus 435 ~~~~~~lv~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 503 (686)
+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 99999999999999999999975421 345899999999999999999999987 9999999999999
Q ss_pred cCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHH
Q 005649 504 DHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQE 582 (686)
Q Consensus 504 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~ 582 (686)
+.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||..........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 9999999999999987654433333344567889999999999999999999999999999999 999997654332211
Q ss_pred HHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 583 LLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
.....+.. . ..+...+..+.+++.+||+.||++|||+.||++.|++.
T Consensus 278 ------~~~~~~~~-----~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 278 ------KLVKDGYQ-----M---AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp ------HHHHHTCC-----C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHhcCCC-----C---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 11111100 0 11233456788999999999999999999999999753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=355.72 Aligned_cols=265 Identities=28% Similarity=0.413 Sum_probs=214.4
Q ss_pred HhhCCCcccccccccCcEEEEEEEec------CCCEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCCcccEEEEEEec
Q 005649 365 AATDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNS-MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQE 436 (686)
Q Consensus 365 ~at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 436 (686)
...++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.++ +||||+++++++.+.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 35688999999999999999999962 45679999997542 33457899999999999 899999999999999
Q ss_pred CceEEEEeecCCCChhHHHhhcCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 005649 437 RERILVYEYLPNKSLDKFLFDKSKS--------------------AILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDI 496 (686)
Q Consensus 437 ~~~~lv~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 496 (686)
+..++||||+++|+|.+++...... ..+++..++.++.||+.||.|||+++ |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 9999999999999999999764321 34899999999999999999999987 999999
Q ss_pred CCCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCccc
Q 005649 497 KASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQ 575 (686)
Q Consensus 497 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~ 575 (686)
||+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987654443333445567889999999999999999999999999999998 99999765
Q ss_pred chHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCC
Q 005649 576 LEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVP 646 (686)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 646 (686)
...+... .....+.. ...+...+..+.+++.+||+.||++|||+.|+++.|+.....
T Consensus 279 ~~~~~~~------~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 279 PVDANFY------KLIQNGFK--------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CCSHHHH------HHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CcHHHHH------HHHhcCCC--------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 4332211 11111110 012334567789999999999999999999999999875433
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=344.45 Aligned_cols=265 Identities=21% Similarity=0.302 Sum_probs=205.7
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQ--GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.++|+..++||+|+||.||+++..+|+.||+|++...... ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 4789999999999999999999988999999999654322 24678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|++ |+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FME-KDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCS-EEHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCC-CCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 997 5788887543 345999999999999999999999987 9999999999999999999999999998765332
Q ss_pred ccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc--
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD-- 601 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-- 601 (686)
. ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+...........+....+
T Consensus 174 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 174 R--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred c--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 2 2334578999999999876 5689999999999999999999999987665544332221110000000000000
Q ss_pred ----cc---cCC-----CCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 602 ----VR---IGT-----YPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 602 ----~~---l~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.. ... ........+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 000 011234578899999999999999999999973
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.46 Aligned_cols=260 Identities=27% Similarity=0.433 Sum_probs=214.7
Q ss_pred hhCCCcccccccccCcEEEEEEEec--------CCCEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCCcccEEEEEEe
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ--------DGREIAVKKLATNS-MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQ 435 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 435 (686)
..++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3578999999999999999999863 46789999997553 23456789999999999 89999999999999
Q ss_pred cCceEEEEeecCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 005649 436 ERERILVYEYLPNKSLDKFLFDKSK-------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNIL 502 (686)
Q Consensus 436 ~~~~~lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 502 (686)
.+..++||||+++|+|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999976432 234899999999999999999999987 999999999999
Q ss_pred EcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHH
Q 005649 503 LDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQ 581 (686)
Q Consensus 503 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~ 581 (686)
++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+..
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 99999999999999987765443333344567889999999999999999999999999999999 99999866544432
Q ss_pred HHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 582 ELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+. . +.. ...+...+..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 270 ~~~~------~-~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 270 KLLK------E-GHR--------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHH------H-TCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHh------c-CCC--------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2111 1 110 012334566789999999999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=350.29 Aligned_cols=252 Identities=25% Similarity=0.328 Sum_probs=209.2
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc------cHHHHHHHHHHHHhcCCCCcccEEEEEEecCce
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ------GKEEFENEVRVLLKMQHRNLVQLFGCCVQERER 439 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 439 (686)
.++|++.+.||+|+||.||+++.. +|+.||+|++...... ..+.+.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999976 6899999999764322 357899999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC----CeEEEecC
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM----KPKISDFG 515 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg 515 (686)
++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+++++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999954 345999999999999999999999987 99999999999998877 79999999
Q ss_pred CccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCc
Q 005649 516 LAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGR 595 (686)
Q Consensus 516 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 595 (686)
+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+. .+.
T Consensus 165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~-------~~~ 234 (361)
T 2yab_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT-------AVS 234 (361)
T ss_dssp SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-------TTC
T ss_pred CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hcC
Confidence 998765432 2234579999999999999999999999999999999999999998765544322111 111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 596 LMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 596 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.. .++.. ....+..+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~--~~~~~---~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 235 YD--FDEEF---FSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CC--CCHHH---HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CC--CCchh---ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 00000 11235678899999999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.56 Aligned_cols=261 Identities=28% Similarity=0.433 Sum_probs=215.7
Q ss_pred hhCCCcccccccccCcEEEEEEEe------cCCCEEEEEEecccCc-ccHHHHHHHHHHHHhc-CCCCcccEEEEEEecC
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRL------QDGREIAVKKLATNSM-QGKEEFENEVRVLLKM-QHRNLVQLFGCCVQER 437 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 437 (686)
..++|+..+.||+|+||.||+++. .+++.||||++..... ...+.+.+|+.++.++ +||||+++++++.+++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 357899999999999999999985 2567899999975533 3457899999999999 9999999999999999
Q ss_pred ceEEEEeecCCCChhHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSK---------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNIL 502 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 502 (686)
..++||||+++|+|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999976432 124899999999999999999999987 999999999999
Q ss_pred EcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHH
Q 005649 503 LDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQ 581 (686)
Q Consensus 503 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~ 581 (686)
++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+..
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 99999999999999987765443333444567889999999999999999999999999999999 99999765443221
Q ss_pred HHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 582 ELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
. .....+.. ...+...+..+.+++.+||+.||++|||+.|+++.|++.
T Consensus 258 ~------~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 258 Y------KMIKEGFR--------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp H------HHHHHTCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H------HHhccCCC--------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 1 11111100 011234567789999999999999999999999999763
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=348.42 Aligned_cols=253 Identities=21% Similarity=0.289 Sum_probs=209.1
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.++|+..+.||+|+||.||+++.. +++.+|+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 478999999999999999999976 68889999986543 3456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC--CCCeEEEecCCccccCCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH--QMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~ 523 (686)
+++|+|.+++... ...+++..++.++.||++||.|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999999542 345999999999999999999999987 999999999999987 789999999999876543
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+. .. ... .+..
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------~~-~~~--~~~~ 225 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM------NA-EYT--FDEE 225 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------HT-CCC--CCHH
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH------cC-CCC--CChh
Confidence 2 2234578999999999999889999999999999999999999998765543322111 11 100 0000
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
. ....+..+.+++.+||+.||++|||+.|+++.-
T Consensus 226 ~---~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 226 A---FKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp H---HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred h---hccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 0 012356788999999999999999999999844
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=355.59 Aligned_cols=268 Identities=24% Similarity=0.405 Sum_probs=219.9
Q ss_pred CHHHHHHhhCCCcccccccccCcEEEEEEEec------CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEE
Q 005649 359 NLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFG 431 (686)
Q Consensus 359 ~~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~ 431 (686)
..+++....++|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 33444556789999999999999999999864 36789999997543 234567899999999999999999999
Q ss_pred EEEecCceEEEEeecCCCChhHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 005649 432 CCVQERERILVYEYLPNKSLDKFLFDKSK-------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD 504 (686)
Q Consensus 432 ~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 504 (686)
++.+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+||+++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~ 172 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA 172 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEc
Confidence 99999999999999999999999965321 245799999999999999999999987 99999999999999
Q ss_pred CCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHH
Q 005649 505 HQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQEL 583 (686)
Q Consensus 505 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~ 583 (686)
.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 252 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence 999999999999987654433333344567889999999999999999999999999999999 8999986554332211
Q ss_pred HHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 584 LKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 584 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
.. .+.. ...+...+..+.+++.+||+.||++|||+.|+++.|++.-
T Consensus 253 ------~~-~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 253 ------VM-EGGL--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp ------HH-TTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred ------HH-cCCc--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 11 1111 1123445677899999999999999999999999998753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=340.70 Aligned_cols=255 Identities=29% Similarity=0.479 Sum_probs=213.5
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
.++|+..+.||+|+||.||+++..+++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 467889999999999999999998889999999976543 3578999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++++|.+++... ...+++..++.++.|+++||.|||+++ ++||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 999999999653 245899999999999999999999987 99999999999999999999999999987643221
Q ss_pred ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.... ... +.. .
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~------i~~-~~~--------~ 224 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED------IST-GFR--------L 224 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH------HHT-TCC--------C
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH------Hhc-CCc--------C
Confidence 12233456788999999999999999999999999999999 8999986554432211 111 100 0
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+...+..+.+++.+||+.||++|||+.++++.|++.
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11233456788999999999999999999999999764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=355.38 Aligned_cols=257 Identities=26% Similarity=0.405 Sum_probs=208.0
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCE----EEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGRE----IAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~----vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
.++|+..+.||+|+||.||+|+.. +++. |++|.+.... ....+.+.+|+.++.+++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 367899999999999999999975 4544 7888775432 233456788999999999999999999886 56789
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+|+||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999999653 345899999999999999999999987 999999999999999999999999999987
Q ss_pred CCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+.. +...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-------~~~~-- 236 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK-------GERL-- 236 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT-------TCBC--
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc-------CCCC--
Confidence 65544444455678889999999999999999999999999999999 9999987655443322221 1100
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
..+...+..+.+++.+||+.||++|||+.|+++.|+...
T Consensus 237 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 237 ------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 112234456788999999999999999999999997643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=348.77 Aligned_cols=252 Identities=26% Similarity=0.333 Sum_probs=208.5
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc------ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM------QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
++|+..+.||+|+||.||+++.. +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56899999999999999999976 689999999965432 23678999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC----CeEEEecCC
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM----KPKISDFGL 516 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgl 516 (686)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999999954 345999999999999999999999987 99999999999999887 799999999
Q ss_pred ccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcc
Q 005649 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL 596 (686)
Q Consensus 517 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (686)
++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+. . ...
T Consensus 165 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~------~-~~~ 234 (326)
T 2y0a_A 165 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS------A-VNY 234 (326)
T ss_dssp CEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH------H-TCC
T ss_pred CeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------h-cCC
Confidence 98765332 2234579999999999999999999999999999999999999998655443322111 1 000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 597 MELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 597 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
...+.. ....+..+.+++.+||+.||++|||+.|+++.-
T Consensus 235 -~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 235 -EFEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp -CCCHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred -CcCccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 000000 112356688999999999999999999999853
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=353.01 Aligned_cols=269 Identities=28% Similarity=0.373 Sum_probs=215.0
Q ss_pred hCCCcccccccccCcEEEEEEEe-----cCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEe--cCce
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRL-----QDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ--ERER 439 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 439 (686)
.++|+..+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36889999999999999999984 3688999999987766667789999999999999999999999874 4568
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 89999999999999996532 34999999999999999999999987 99999999999999999999999999987
Q ss_pred cCCcCcc-ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHH--------HHHHHHH
Q 005649 520 FHDEQSR-HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQEL--------LKLARRL 590 (686)
Q Consensus 520 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~--------~~~~~~~ 590 (686)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||........... .......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 7543322 123345678889999999999999999999999999999999999875443221100 0000111
Q ss_pred HhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCCC
Q 005649 591 EEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIP 648 (686)
Q Consensus 591 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 648 (686)
...+. ....+...+..+.+++.+||+.||++|||+.|+++.|+......+
T Consensus 257 ~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 257 LEEGQ--------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred hhccc--------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11110 012344566789999999999999999999999999987654443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.56 Aligned_cols=249 Identities=28% Similarity=0.360 Sum_probs=205.4
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN---SMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 441 (686)
.++|+..+.||+|+||.||+++.+ +|+.||||++... .....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999976 6899999999754 223456788999999988 79999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999999654 34999999999999999999999987 9999999999999999999999999998543
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. . +..
T Consensus 176 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~------~-~~~----- 241 (353)
T 3txo_A 176 CNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL------N-DEV----- 241 (353)
T ss_dssp C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------H-CCC-----
T ss_pred cCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH------c-CCC-----
Confidence 222 12334679999999999999999999999999999999999999998765544322211 1 110
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCCH------HHHHHH
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTM------SATLSM 639 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~evl~~ 639 (686)
.++...+..+.+++.+||+.||++||++ .|+++.
T Consensus 242 ----~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 242 ----VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred ----CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 2234456778899999999999999998 777663
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=347.79 Aligned_cols=253 Identities=21% Similarity=0.357 Sum_probs=203.6
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCc------
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERE------ 438 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------ 438 (686)
.++|+..+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 367899999999999999999987 799999999975433 345789999999999999999999999866432
Q ss_pred ---------------------------------------------------eEEEEeecCCCChhHHHhhcCCCCCCCHH
Q 005649 439 ---------------------------------------------------RILVYEYLPNKSLDKFLFDKSKSAILDWP 467 (686)
Q Consensus 439 ---------------------------------------------------~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~ 467 (686)
.++||||+++|+|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 78999999999999999876666667888
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc----------ccccccccCCC
Q 005649 468 KRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR----------HRTHQIAGTFG 537 (686)
Q Consensus 468 ~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~gt~~ 537 (686)
.++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999987 999999999999999999999999999877643211 12233579999
Q ss_pred cCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHH
Q 005649 538 YMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQ 617 (686)
Q Consensus 538 y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~ 617 (686)
|+|||.+.+..++.++||||||+++|||++|..|+... ..... .. ...... .........+.+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~~---~~-~~~~~~--------~~~~~~~~~~~~ 304 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRIIT---DV-RNLKFP--------LLFTQKYPQEHM 304 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHHH---HH-HTTCCC--------HHHHHHCHHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHHH---Hh-hccCCC--------cccccCChhHHH
Confidence 99999999999999999999999999999988764311 11111 11 111110 012344567789
Q ss_pred HHHHcccccccCCCCHHHHHHH
Q 005649 618 IALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 618 li~~cl~~~p~~RPt~~evl~~ 639 (686)
++.+||+.||++|||+.|+++.
T Consensus 305 li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCCCCcCCCHHHHhhc
Confidence 9999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=353.59 Aligned_cols=257 Identities=27% Similarity=0.448 Sum_probs=204.4
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCE----EEEEEeccc-CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGRE----IAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~----vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
.++|+..+.||+|+||.||+|+.. +++. |++|.+... .....+.+.+|+.++++++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 478999999999999999999965 4554 477777543 3445688999999999999999999999998754 88
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+++||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 9999999999999997643 45999999999999999999999987 999999999999999999999999999877
Q ss_pred CCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
.............+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+.. +..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-------~~~--- 237 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------GER--- 237 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-------TCC---
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------CCC---
Confidence 54443333344567889999999999999999999999999999999 9999987666554332211 110
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
...+...+..+.+++.+||+.||++|||+.|+++.|+...
T Consensus 238 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 238 -----LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 0123345667899999999999999999999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=340.50 Aligned_cols=260 Identities=30% Similarity=0.499 Sum_probs=199.5
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.++|+..++||+|+||.||+|+.. ..+|+|++.... ....+.|.+|+.++++++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 578999999999999999999875 469999996543 33457799999999999999999999965 5567899999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 99999999999543 345999999999999999999999987 9999999999999999999999999998665433
Q ss_pred ccccccccccCCCcCchhhhh---cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAI---RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
.........|++.|+|||.+. +..++.++||||||+++|||++|+.||......+.. .... ..+.. .
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~----~~~~~----~ 244 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IEMV----GRGSL----S 244 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH--HHHH----HHTSC----C
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH--HHHh----ccccc----C
Confidence 333344567899999999986 667899999999999999999999999865443321 1111 11111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
+.+......++..+.+++.+||+.+|++|||+.|+++.|++..
T Consensus 245 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1222223345678999999999999999999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=342.06 Aligned_cols=260 Identities=22% Similarity=0.341 Sum_probs=202.9
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHh--cCCCCcccEEEEEEec----CceE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLK--MQHRNLVQLFGCCVQE----RERI 440 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~~ 440 (686)
.++|+..+.||+|+||.||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 47899999999999999999998 6899999998643 34566677777776 7999999999997653 4578
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCcEEEcCCCCeEEE
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLH--------RDSVLRIIHRDIKASNILLDHQMKPKIS 512 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 512 (686)
+||||+++|+|.+++.. ..+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 99999999999999943 35999999999999999999999 655 9999999999999999999999
Q ss_pred ecCCccccCCcCccc--cccccccCCCcCchhhhhcC------CCChhHHHHHHHHHHHHHHcC----------CCCCcc
Q 005649 513 DFGLAKLFHDEQSRH--RTHQIAGTFGYMAPEYAIRG------FLSVKSDVFSFGVLLLEIISG----------RKNYDR 574 (686)
Q Consensus 513 Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~ksDv~s~Gvvl~elltG----------~~p~~~ 574 (686)
|||+++......... ......||+.|+|||.+.+. .++.++||||||+++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999998765433221 12334789999999999876 455799999999999999999 888864
Q ss_pred cchHhHHHHHHHHHHHHhcCccccccccccC--CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 575 QLEAENQELLKLARRLEEEGRLMELVDVRIG--TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
........ ........... ..+.+. ..+...+..+.+++.+||+.||++|||+.||++.|+++
T Consensus 236 ~~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSF--EDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCH--HHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcch--hhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 32211100 00111111110 011111 12345788899999999999999999999999999764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=348.06 Aligned_cols=271 Identities=18% Similarity=0.254 Sum_probs=205.3
Q ss_pred hCCCcccccccccCcEEEEEEEec----CCCEEEEEEecccCcc-----------cHHHHHHHHHHHHhcCCCCcccEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ----DGREIAVKKLATNSMQ-----------GKEEFENEVRVLLKMQHRNLVQLFG 431 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~ 431 (686)
.++|+..+.||+|+||.||+|+.. ++..+|||+....... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999975 5788999998754321 1234677889999999999999999
Q ss_pred EEEe----cCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 005649 432 CCVQ----ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM 507 (686)
Q Consensus 432 ~~~~----~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 507 (686)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67889999999 999999996543 6999999999999999999999987 99999999999999887
Q ss_pred --CeEEEecCCccccCCcCcc-----ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhH
Q 005649 508 --KPKISDFGLAKLFHDEQSR-----HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAEN 580 (686)
Q Consensus 508 --~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~ 580 (686)
.+||+|||+++.+...... .......||..|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876533211 112345789999999999999999999999999999999999999965332221
Q ss_pred HHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCCCC
Q 005649 581 QELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPS 649 (686)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~ 649 (686)
.. ......... . ....+..... ....+..+.+++.+||+.||++|||+.+|++.|++...+++.
T Consensus 269 ~~-~~~~~~~~~-~-~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 332 (345)
T 2v62_A 269 AV-QTAKTNLLD-E-LPQSVLKWAP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGP 332 (345)
T ss_dssp HH-HHHHHHHHH-T-TTHHHHHHSC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCC
T ss_pred HH-HHHHHhhcc-c-ccHHHHhhcc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccC
Confidence 11 111111111 1 0000000000 113456799999999999999999999999999987654433
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=350.96 Aligned_cols=259 Identities=24% Similarity=0.381 Sum_probs=199.3
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc---cHHHHHHHHHHHHhcCCCCcccEEEEEEecCce---
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ---GKEEFENEVRVLLKMQHRNLVQLFGCCVQERER--- 439 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~--- 439 (686)
.++|++.+.||+|+||.||+++.. +++.||||++...... ..+.+.+|+.++.+++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 478999999999999999999974 7899999999765332 345788999999999999999999999876543
Q ss_pred -EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 440 -ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 440 -~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 9999999999999999654 34999999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCcCcc-ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 519 LFHDEQSR-HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 519 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+... .........
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~------~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHhcCCCCC
Confidence 76543221 22334578999999999999999999999999999999999999998665433221 111111100
Q ss_pred cccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHH-HHhcCC
Q 005649 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATL-SMLSNS 643 (686)
Q Consensus 598 ~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl-~~L~~~ 643 (686)
+. ......+..+.+++.+||+.||++||+..+++ +.|...
T Consensus 239 ----~~--~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 239 ----PS--ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ----HH--HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----cc--cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 00 00122456788999999999999999766554 455443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=354.04 Aligned_cols=254 Identities=21% Similarity=0.298 Sum_probs=206.2
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-----cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-----MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
.++|+..+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357899999999999999999875 68999999985421 224678999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC---eEEEecCC
Q 005649 441 LVYEYLPNKSLDKFLFDKS-KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK---PKISDFGL 516 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgl 516 (686)
+||||+++|+|.+++.... ....+++..++.++.||++||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988886543 3345899999999999999999999987 999999999999986654 99999999
Q ss_pred ccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcc
Q 005649 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL 596 (686)
Q Consensus 517 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (686)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .. .... +..
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~---~i~~-~~~ 249 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL----FE---GIIK-GKY 249 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHH----HH---HHHH-TCC
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHH----HH---HHHc-CCC
Confidence 987654322 2234579999999999999999999999999999999999999998643211 11 1111 111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 597 MELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 597 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
. .++.. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 250 ~--~~~~~---~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 K--MNPRQ---WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C--CCHHH---HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--CCccc---cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00000 0123567889999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=374.02 Aligned_cols=261 Identities=30% Similarity=0.508 Sum_probs=216.4
Q ss_pred HhhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 365 AATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 365 ~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
...++|++.++||+|+||.||+|+++++..||||+++... ...++|.+|++++++++||||+++++++.+ +..+||||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 4467889999999999999999999888889999997654 346789999999999999999999999876 67899999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++|+|.+++.... ...+++..++.++.||++||.|||+++ |+||||||+||||++++.+||+|||+++......
T Consensus 342 ~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 342 YMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 999999999996432 234899999999999999999999987 9999999999999999999999999998765322
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
. .......++..|+|||.+....++.++||||||++||||++ |+.||......+....+ . .+...
T Consensus 418 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i------~-~~~~~------ 483 (535)
T 2h8h_A 418 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV------E-RGYRM------ 483 (535)
T ss_dssp H-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH------H-TTCCC------
T ss_pred e-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------H-cCCCC------
Confidence 1 11223456788999999999999999999999999999999 99999876554432211 1 11110
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCC
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPI 647 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 647 (686)
..+..++..+.+|+.+||+.||++|||+.+|+++|+..-...
T Consensus 484 --~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 484 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 123445677899999999999999999999999999865433
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=339.19 Aligned_cols=261 Identities=19% Similarity=0.273 Sum_probs=203.5
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
++|+..+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999986 689999999975433 234778899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++ +|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9975 555555432 345999999999999999999999987 9999999999999999999999999998764332
Q ss_pred ccccccccccCCCcCchhhhhcCC-CChhHHHHHHHHHHHHHHcCCCCCc-ccchHhHHHHHHHHHHHHhc---Cccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGF-LSVKSDVFSFGVLLLEIISGRKNYD-RQLEAENQELLKLARRLEEE---GRLMEL 599 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~s~Gvvl~elltG~~p~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~ 599 (686)
. ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.|+. .....+.. ......... ..+...
T Consensus 156 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~---~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL---KRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH---HHHHHHHCCCCTTTCTTG
T ss_pred c--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHHhCCCChhhhhhh
Confidence 2 233457899999999998765 8999999999999999999888754 33322221 221111111 111100
Q ss_pred cc-------------cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 600 VD-------------VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 600 ~d-------------~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.. ..+.......+..+.+++.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 00112223456778899999999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=339.12 Aligned_cols=254 Identities=30% Similarity=0.544 Sum_probs=206.3
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCccc-------HHHHHHHHHHHHhcCCCCcccEEEEEEecCc
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQG-------KEEFENEVRVLLKMQHRNLVQLFGCCVQERE 438 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 438 (686)
.++|+..+.||+|+||.||+++.. +++.||+|++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 478999999999999999999975 78999999996543321 267899999999999999999999986544
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC-----eEEEe
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK-----PKISD 513 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~D 513 (686)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||+++ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 7999999999999988653 345999999999999999999999975 45999999999999988776 99999
Q ss_pred cCCccccCCcCccccccccccCCCcCchhhh--hcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHH
Q 005649 514 FGLAKLFHDEQSRHRTHQIAGTFGYMAPEYA--IRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLE 591 (686)
Q Consensus 514 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 591 (686)
||+++..... .....|++.|+|||.+ ....++.++||||||+++|||++|+.||............ ...
T Consensus 173 fg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~ 243 (287)
T 4f0f_A 173 FGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN----MIR 243 (287)
T ss_dssp CTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH----HHH
T ss_pred CCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH----HHh
Confidence 9999854332 2345789999999998 4456899999999999999999999999765443322111 111
Q ss_pred hcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 592 EEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 592 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+ .. ...+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 244 ~~~-~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 EEG-LR-------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HSC-CC-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccC-CC-------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 111 11 12244556789999999999999999999999999976
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=355.93 Aligned_cols=265 Identities=22% Similarity=0.235 Sum_probs=213.6
Q ss_pred cCHHHHHHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEE
Q 005649 358 FNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCC 433 (686)
Q Consensus 358 ~~~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 433 (686)
+.++++....++|+..+.||+|+||.||+++.+ +|+.||+|++.... ....+.+.+|..++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345555567889999999999999999999986 78999999996532 12234588999999999999999999999
Q ss_pred EecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 005649 434 VQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISD 513 (686)
Q Consensus 434 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 513 (686)
.+++..+|||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence 99999999999999999999997542 35999999999999999999999987 99999999999999999999999
Q ss_pred cCCccccCCcCccccccccccCCCcCchhhhh-------cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHH
Q 005649 514 FGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI-------RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKL 586 (686)
Q Consensus 514 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 586 (686)
||+++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+..
T Consensus 206 FGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 206 FGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284 (412)
T ss_dssp CTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred chhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 999987654322 1223457999999999987 35789999999999999999999999987665443322221
Q ss_pred HHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCC---CCHHHHHHHh
Q 005649 587 ARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDR---PTMSATLSML 640 (686)
Q Consensus 587 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~evl~~L 640 (686)
..... .+...+...+..+.+++.+||+ +|++| |++.|+++.-
T Consensus 285 ~~~~~-----------~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 285 YKEHL-----------SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp HHHHC-----------CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred cccCc-----------CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 11100 0011123456778999999999 99998 6899998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=351.57 Aligned_cols=268 Identities=25% Similarity=0.408 Sum_probs=205.7
Q ss_pred CHHHHHHhhCCCcccccccccCcEEEEEEEec----CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEE
Q 005649 359 NLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQ----DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGC 432 (686)
Q Consensus 359 ~~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~ 432 (686)
.++.+....++|...+.||+|+||.||+|+.. .++.||+|++.... ....+.+.+|+.++++++||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 33444456788999999999999999999865 24479999997543 3335679999999999999999999999
Q ss_pred EEecC-----ceEEEEeecCCCChhHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 005649 433 CVQER-----ERILVYEYLPNKSLDKFLFDK---SKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD 504 (686)
Q Consensus 433 ~~~~~-----~~~lv~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 504 (686)
+.+.+ ..++|+||+++|+|.+++... .....+++..++.++.||++||.|||+++ |+||||||+||+++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~ 181 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLR 181 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEEC
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEc
Confidence 98755 359999999999999998543 23356999999999999999999999987 99999999999999
Q ss_pred CCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHH
Q 005649 505 HQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQEL 583 (686)
Q Consensus 505 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~ 583 (686)
.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 261 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence 999999999999987654433333344567889999999999999999999999999999999 8999986655443221
Q ss_pred HHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 584 LKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 584 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
+ .. +.. ...+...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus 262 ~------~~-~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 262 L------LH-GHR--------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp H------HT-TCC--------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H------Hc-CCC--------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 11 110 0123345567899999999999999999999999998754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=342.07 Aligned_cols=255 Identities=23% Similarity=0.336 Sum_probs=199.4
Q ss_pred hCCCcccccccccCcEEEEEEEecC----CCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQD----GREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
.++|+..+.||+|+||.||+|+... +..||+|++.... ....+.+.+|+.++++++||||+++++++ .++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 4788999999999999999998753 4569999987543 33456799999999999999999999997 4567899
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||+++++|.+++... ...+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999999653 335899999999999999999999987 9999999999999999999999999998765
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
..... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. ....
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~------~~~~----- 235 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE------NGER----- 235 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH------TTCC-----
T ss_pred ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH------cCCC-----
Confidence 43221 2233456788999999999999999999999999999997 999998765544322111 1111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
...+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 236 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 236 ----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 012344567789999999999999999999999999753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=350.92 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=207.8
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
.++|+..+.||+|+||.||++... +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 468999999999999999999976 689999999965432 34567899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC---CeEEEecCCcccc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM---KPKISDFGLAKLF 520 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~~~ 520 (686)
||+++|+|.+++... ..+++..++.++.||++||.|||+++ |+||||||+|||++.++ .+||+|||++...
T Consensus 108 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 999999999998543 45899999999999999999999987 99999999999998654 5999999999876
Q ss_pred CCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+. .+.... .
T Consensus 182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~-------~~~~~~-~ 250 (362)
T 2bdw_A 182 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK-------AGAYDY-P 250 (362)
T ss_dssp TTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HTCCCC-C
T ss_pred cCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------hCCCCC-C
Confidence 5432 2234579999999999999999999999999999999999999998655433322111 111100 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+ .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 251 ~~----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 SP----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TT----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 012345678899999999999999999998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=345.09 Aligned_cols=262 Identities=24% Similarity=0.385 Sum_probs=208.2
Q ss_pred CCCcccccccccCcEEEEEEEe-----cCCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEec--Cce
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRL-----QDGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE--RER 439 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 439 (686)
++|+..+.||+|+||.||++++ .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5688899999999999999984 368899999997543 34457899999999999999999999999876 568
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 99999999999999996543 34999999999999999999999987 99999999999999999999999999987
Q ss_pred cCCcCcc-ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHH--------HHHHHHHH
Q 005649 520 FHDEQSR-HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQE--------LLKLARRL 590 (686)
Q Consensus 520 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~--------~~~~~~~~ 590 (686)
....... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+.......... ........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 7544321 22334568888999999999999999999999999999999999865332111000 00001111
Q ss_pred HhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 591 EEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 591 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
...+.. ...+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 256 ~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 256 LKEGKR--------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHTTCC--------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HhccCC--------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 111110 12244556789999999999999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=340.03 Aligned_cols=261 Identities=22% Similarity=0.338 Sum_probs=204.2
Q ss_pred CCCcccccccccCcEEEEEEEecCCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
++|+..+.||+|+||.||+++..+|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57899999999999999999998899999999965432 2347789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++ +|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 975 898888643 245899999999999999999999987 99999999999999999999999999986643221
Q ss_pred cccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcC---cccc---
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEG---RLME--- 598 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~--- 598 (686)
......||+.|+|||.+.+. .++.++||||||+++|||++|+.||......+....+. ...... .+..
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF---RILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCCCCTTTSTTGGG
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHHCCCChhhchhhhc
Confidence 22335689999999998764 58999999999999999999999998765443322111 111100 0000
Q ss_pred --ccccccC--------CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 599 --LVDVRIG--------TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 599 --~~d~~l~--------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
..++... ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0111110 1112346678899999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=339.68 Aligned_cols=256 Identities=32% Similarity=0.507 Sum_probs=212.0
Q ss_pred hhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
..++|+..+.||+|+||.||+|+..+++.||+|++.... ...+.+.+|++++++++||||+++++++. .+..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 357889999999999999999999888899999996543 34678999999999999999999999976 4568999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++.... ...+++..++.++.|++.||.|||+++ |+||||||+||++++++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 89 MENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999999995432 225999999999999999999999987 99999999999999999999999999987654322
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ .. +..
T Consensus 165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~------~~-~~~-------- 228 (279)
T 1qpc_A 165 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ER-GYR-------- 228 (279)
T ss_dssp E-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH------HT-TCC--------
T ss_pred c-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH------hc-ccC--------
Confidence 1 2233456788999999999999999999999999999999 99999865544322211 11 100
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
...+...+..+.+++.+||+.||++|||+.++++.|++.
T Consensus 229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 011334567789999999999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=353.31 Aligned_cols=254 Identities=22% Similarity=0.298 Sum_probs=211.0
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.++|++.+.||+|+||.||+|+.. +|+.+|+|++..........+.+|+.++.+++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 368999999999999999999976 6889999999776655567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC--CCCeEEEecCCccccCCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH--QMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~ 523 (686)
+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999998543 335899999999999999999999987 999999999999974 577999999999876543
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+ .. ..+. .++
T Consensus 205 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i------~~-~~~~--~~~- 271 (387)
T 1kob_A 205 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV------KR-CDWE--FDE- 271 (387)
T ss_dssp SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HH-CCCC--CCS-
T ss_pred cc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH------Hh-CCCC--CCc-
Confidence 22 23347899999999999999999999999999999999999999865543322211 11 1110 011
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
......+..+.+++.+||+.||++|||+.|+++.-
T Consensus 272 --~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 272 --DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp --STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence 11223456788999999999999999999999853
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=355.30 Aligned_cols=263 Identities=22% Similarity=0.248 Sum_probs=213.8
Q ss_pred CHHHHHHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEE
Q 005649 359 NLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCV 434 (686)
Q Consensus 359 ~~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 434 (686)
.+..+....++|+..++||+|+||.||+++.. +++.||+|++.... ....+.+.+|..++..++||||+++++++.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34455556789999999999999999999986 58899999996532 122345889999999999999999999999
Q ss_pred ecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEec
Q 005649 435 QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDF 514 (686)
Q Consensus 435 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 514 (686)
+++..++||||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecc
Confidence 999999999999999999998542 4899999999999999999999987 999999999999999999999999
Q ss_pred CCccccCCcCccccccccccCCCcCchhhhhcCC----CChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHH
Q 005649 515 GLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGF----LSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL 590 (686)
Q Consensus 515 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 590 (686)
|+++....... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+....+......
T Consensus 213 G~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 291 (410)
T 3v8s_A 213 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 291 (410)
T ss_dssp TTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred ceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc
Confidence 99987654322 1233568999999999998765 889999999999999999999999876554433322211110
Q ss_pred HhcCccccccccccCCCCHHHHHHHHHHHHHcccccccC--CCCHHHHHHHhc
Q 005649 591 EEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIED--RPTMSATLSMLS 641 (686)
Q Consensus 591 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~L~ 641 (686)
.. . ......+..+.+++.+||+.+|.+ ||++.||++.--
T Consensus 292 ~~-----------~-p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 292 LT-----------F-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp CC-----------C-CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred cc-----------C-CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 00 0 001134567889999999999998 999999998653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=350.14 Aligned_cols=267 Identities=17% Similarity=0.233 Sum_probs=207.0
Q ss_pred hhCCCcccccccccCcEEEEEEEecC------CCEEEEEEecccCccc-----------HHHHHHHHHHHHhcCCCCccc
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQD------GREIAVKKLATNSMQG-----------KEEFENEVRVLLKMQHRNLVQ 428 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~ 428 (686)
..++|++.+.||+|+||.||+|++.+ ++.||||++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35789999999999999999998864 4789999986553211 122345566677788999999
Q ss_pred EEEEEEec----CceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 005649 429 LFGCCVQE----RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD 504 (686)
Q Consensus 429 l~~~~~~~----~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 504 (686)
+++++... ...+|||||+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999875 4579999999 99999999653 345999999999999999999999987 99999999999999
Q ss_pred --CCCCeEEEecCCccccCCcCccc-----cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccch
Q 005649 505 --HQMKPKISDFGLAKLFHDEQSRH-----RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLE 577 (686)
Q Consensus 505 --~~~~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~ 577 (686)
.++.+||+|||+++.+....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998765432211 11334599999999999999999999999999999999999999986433
Q ss_pred HhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 578 AENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..... ........ ..+.+++++.+. ....+..+.+++..||+.+|++||++.+|++.|++.
T Consensus 267 ~~~~~--~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 267 DPKYV--RDSKIRYR-ENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp CHHHH--HHHHHHHH-HCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CHHHH--HHHHHHhh-hhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 32211 11111111 123333443332 122356788999999999999999999999999764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.51 Aligned_cols=256 Identities=28% Similarity=0.435 Sum_probs=215.9
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
..++|+..+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4678999999999999999999987 47889999997543 346789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++++|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999999654 3355999999999999999999999987 9999999999999999999999999998765433
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
. .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+. ....
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~------~~~~-------- 230 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE------KDYR-------- 230 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH------TTCC--------
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh------ccCC--------
Confidence 2 22334567889999999999999999999999999999999 999998765544332221 1000
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
...+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 231 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 231 -MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 01234456779999999999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=346.69 Aligned_cols=270 Identities=30% Similarity=0.455 Sum_probs=218.8
Q ss_pred ccCHHHHHHhhCCCcccccccccCcEEEEEEEe------cCCCEEEEEEecccCc-ccHHHHHHHHHHHHhc-CCCCccc
Q 005649 357 LFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRL------QDGREIAVKKLATNSM-QGKEEFENEVRVLLKM-QHRNLVQ 428 (686)
Q Consensus 357 ~~~~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~ 428 (686)
.++........++|+..+.||+|+||.||+++. .+++.||||++..... ...+.+.+|+.++.++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 345556666778999999999999999999984 2568899999976533 3456789999999999 7999999
Q ss_pred EEEEEEecC-ceEEEEeecCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 005649 429 LFGCCVQER-ERILVYEYLPNKSLDKFLFDKSK-------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHR 494 (686)
Q Consensus 429 l~~~~~~~~-~~~lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 494 (686)
+++++...+ ..++||||+++|+|.+++..... ...+++..++.++.||++||.|||+++ |+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence 999998765 48999999999999999976433 223889999999999999999999987 9999
Q ss_pred CCCCCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCc
Q 005649 495 DIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYD 573 (686)
Q Consensus 495 Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~ 573 (686)
||||+||+++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999987655443333445667889999999999999999999999999999998 999997
Q ss_pred ccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 574 RQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
.....+... ..... +... ..+...+..+.+++.+||+.||++|||+.|+++.|++.
T Consensus 253 ~~~~~~~~~-----~~~~~-~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 253 GVKIDEEFC-----RRLKE-GTRM--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp TCCCSHHHH-----HHHHH-TCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccchhHHHH-----HHhcc-CccC--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 654332211 11111 1110 11333456789999999999999999999999999753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=343.60 Aligned_cols=249 Identities=23% Similarity=0.320 Sum_probs=199.0
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc--------------------------cHHHHHHHHHHHH
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ--------------------------GKEEFENEVRVLL 419 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--------------------------~~~~~~~e~~~l~ 419 (686)
.++|+..+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999975 6889999998654321 1356889999999
Q ss_pred hcCCCCcccEEEEEEe--cCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 005649 420 KMQHRNLVQLFGCCVQ--ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIK 497 (686)
Q Consensus 420 ~l~h~niv~l~~~~~~--~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk 497 (686)
+++||||+++++++.+ ++..++||||+++++|.+++ ....+++..++.++.||++||.|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999998765 2346999999999999999999999987 9999999
Q ss_pred CCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCC---CChhHHHHHHHHHHHHHHcCCCCCcc
Q 005649 498 ASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGF---LSVKSDVFSFGVLLLEIISGRKNYDR 574 (686)
Q Consensus 498 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDv~s~Gvvl~elltG~~p~~~ 574 (686)
|+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987654322 223457899999999987765 48899999999999999999999986
Q ss_pred cchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 575 QLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
........ .... .... . ......+..+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~------~~~~-~~~~------~-~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERIMCLHS------KIKS-QALE------F-PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSHHHHHH------HHHH-CCCC------C-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccHHHHHH------HHhc-ccCC------C-CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 54432211 1111 1110 0 001234567899999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=351.94 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=208.6
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367999999999999999999976 68899999986532 33457889999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 94 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999999643 45999999999999999999999988 99999999999999999999999999987653
Q ss_pred cCccccccccccCCCcCchhhhhc---CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIR---GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
.. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||................ . .
T Consensus 168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~---~-~----- 235 (384)
T 4fr4_A 168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE---T-T----- 235 (384)
T ss_dssp TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH---H-C-----
T ss_pred CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---h-c-----
Confidence 32 2344679999999999864 458999999999999999999999997654433333222211 1 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCC-HHHHHH
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPT-MSATLS 638 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~ 638 (686)
...++...+..+.+++.+||+.||++||+ +.+|++
T Consensus 236 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 ----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11234456678999999999999999998 777765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=350.67 Aligned_cols=250 Identities=27% Similarity=0.357 Sum_probs=208.4
Q ss_pred HhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCce
Q 005649 365 AATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERER 439 (686)
Q Consensus 365 ~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 439 (686)
...++|+..+.||+|+||.||+++.+ +|+.||+|++.... ....+.+..|..++.++ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34589999999999999999999986 68899999997542 23456788899999887 999999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999999654 34899999999999999999999987 99999999999999999999999999986
Q ss_pred cCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 520 FHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 520 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+. . +.
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~------~-~~---- 234 (345)
T 1xjd_A 168 NMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR------M-DN---- 234 (345)
T ss_dssp CCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------H-CC----
T ss_pred cccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH------h-CC----
Confidence 432221 2344679999999999999999999999999999999999999998765543322111 1 11
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHH-HHHH
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMS-ATLS 638 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-evl~ 638 (686)
..++...+..+.+++.+||+.||++||++. ++++
T Consensus 235 -----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 -----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 012334567789999999999999999998 6653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=341.46 Aligned_cols=267 Identities=23% Similarity=0.350 Sum_probs=195.5
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.++|+..+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999876 689999999965432 334778999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 445 YLPNKSLDKFLFDKS---KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 445 y~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
|++ |+|.+++.... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999886542 2235899999999999999999999987 9999999999999999999999999998764
Q ss_pred CcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
.... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+...........+....
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 3221 2234578999999999876 468999999999999999999999998766554433222111000000010000
Q ss_pred -----ccccC-------------CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 601 -----DVRIG-------------TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 601 -----d~~l~-------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+.+. ..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00000 0011235678999999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=350.25 Aligned_cols=256 Identities=23% Similarity=0.318 Sum_probs=205.2
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 441 (686)
.++|+..++||+|+||.||+++.+ +++.||+|+++.... ...+.+..|..++.++ +||||+++++++.+++..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999976 578899999976432 2234678899999887 89999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999999654 34999999999999999999999987 9999999999999999999999999998633
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHH--HHHHHHHHHHhcCccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQ--ELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 599 (686)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ............+..
T Consensus 205 ~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--- 279 (396)
T 4dc2_A 205 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--- 279 (396)
T ss_dssp CTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---
T ss_pred cCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---
Confidence 222 1234468999999999999999999999999999999999999999643322111 001111111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCH------HHHHHH
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTM------SATLSM 639 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~evl~~ 639 (686)
.++...+..+.+++.+||+.||++||++ .|+++.
T Consensus 280 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 280 ------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 2344566788999999999999999995 566554
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=351.83 Aligned_cols=247 Identities=28% Similarity=0.376 Sum_probs=201.0
Q ss_pred ccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCCCC
Q 005649 372 TKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKS 450 (686)
Q Consensus 372 ~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~gs 450 (686)
..+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++.+++||||+++++++.+.+..+|||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3578999999999999975 689999999987766667889999999999999999999999999999999999999999
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE--cCCCCeEEEecCCccccCCcCcccc
Q 005649 451 LDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL--DHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 451 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+|||+ ++++.+||+|||+++.......
T Consensus 173 L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--- 244 (373)
T 2x4f_A 173 LFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--- 244 (373)
T ss_dssp EHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence 99988653 235899999999999999999999987 9999999999999 6778999999999987654332
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCC
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYP 608 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 608 (686)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ .. ..+. ..+.. .
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i------~~-~~~~-~~~~~----~ 312 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI------LA-CRWD-LEDEE----F 312 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HH-TCCC-SCSGG----G
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hh-ccCC-CChhh----h
Confidence 23346899999999999999999999999999999999999999876554332211 11 1110 00111 1
Q ss_pred HHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 609 EEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 609 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
...+..+.+++.+||+.||++|||+.|+++
T Consensus 313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 313 QDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 234567889999999999999999999987
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=343.85 Aligned_cols=246 Identities=26% Similarity=0.367 Sum_probs=208.7
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
.++|+..+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|..+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367899999999999999999976 78999999996542 23456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999999653 34899999999999999999999987 99999999999999999999999999987543
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+... ..... ..
T Consensus 159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~i~~~-~~------ 220 (318)
T 1fot_A 159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE------KILNA-EL------ 220 (318)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHC-CC------
T ss_pred c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH------HHHhC-CC------
Confidence 2 234579999999999999999999999999999999999999998655433221 11111 10
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRP-----TMSATLSM 639 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 639 (686)
.++...+..+.+++.+||+.||++|| ++.|+++.
T Consensus 221 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 12344567789999999999999999 88998854
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=343.60 Aligned_cols=271 Identities=27% Similarity=0.375 Sum_probs=210.5
Q ss_pred CCcccccccccCcEEEEEEEec-----CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEec--CceE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-----DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE--RERI 440 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-----~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 440 (686)
.|+..+.||+|+||.||++.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 3488999999999999998653 67889999997653 23457799999999999999999999999884 5678
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+||||+++|+|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 112 lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 999999999999999542 3899999999999999999999987 999999999999999999999999999877
Q ss_pred CCcCcc-ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 521 HDEQSR-HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 521 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
...... .......++..|+|||.+.+..++.++||||||+++|||++|+.||.......... ..+...........+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-IGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-HCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhh-hcccccchhHHHHHHH
Confidence 543322 12334567888999999999999999999999999999999999987543321100 0000000000000111
Q ss_pred ccccc-CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCC
Q 005649 600 VDVRI-GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPI 647 (686)
Q Consensus 600 ~d~~l-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 647 (686)
++... ...+...+..+.+++.+||+.||++|||+.|+++.|+.....+
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 11111 1234456678999999999999999999999999998764433
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=357.67 Aligned_cols=253 Identities=21% Similarity=0.309 Sum_probs=207.9
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
.++|+..+.||+|+||.||++... +|+.+|+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 578999999999999999999875 789999999976543 23467899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc---CCCCeEEEecCCcccc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD---HQMKPKISDFGLAKLF 520 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~ 520 (686)
||+++|+|.+++... ..+++..+..++.||++||.|||+++ |+||||||+|||++ +++.+||+|||+++..
T Consensus 90 E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 90 DLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 999999999999654 34999999999999999999999987 99999999999998 5678999999999876
Q ss_pred CCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
..... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+. .+... ..
T Consensus 164 ~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~-------~~~~~-~~ 233 (444)
T 3soa_A 164 EGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK-------AGAYD-FP 233 (444)
T ss_dssp CTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-------HTCCC-CC
T ss_pred cCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-------hCCCC-CC
Confidence 54322 2234679999999999999999999999999999999999999998665444322211 11110 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+ .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 234 SP----EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TT----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cc----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 01 112345678899999999999999999999874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=345.51 Aligned_cols=248 Identities=22% Similarity=0.363 Sum_probs=206.5
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 368999999999999999999974 78999999986432 22346789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+ +|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 78999988654 34999999999999999999999987 99999999999999999999999999987654
Q ss_pred cCccccccccccCCCcCchhhhhcCCC-ChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFL-SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
.. ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......+ ....+.
T Consensus 161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----------------~~~~i~ 221 (336)
T 3h4j_B 161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN----------------LFKKVN 221 (336)
T ss_dssp SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT----------------CBCCCC
T ss_pred Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH----------------HHHHHH
Confidence 32 2234579999999999988765 789999999999999999999997543221 111111
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
......+...+..+.+++.+||+.||++|||+.|+++.-
T Consensus 222 ~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 222 SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 111123445667789999999999999999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.26 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=199.4
Q ss_pred hCCCcccccccccCcEEEEEEEe----cCCCEEEEEEecccC----cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCc
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRL----QDGREIAVKKLATNS----MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERE 438 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 438 (686)
.++|+..+.||+|+||.||+++. .+|+.||+|++.... ......+.+|+.++++++||||+++++++.+++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999987 478999999997643 2234567899999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999999654 34899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 519 LFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 519 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.... ... ...
T Consensus 170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~------i~~-~~~-- 238 (327)
T 3a62_A 170 ESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK------ILK-CKL-- 238 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH------HHH-TCC--
T ss_pred ccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHH------HHh-CCC--
Confidence 6433221 23345789999999999999999999999999999999999999986654432211 111 110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccccccCCC-----CHHHHHHHh
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRP-----TMSATLSML 640 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~L 640 (686)
..+...+..+.+++.+||+.||++|| ++.|+++.-
T Consensus 239 -------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 239 -------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred -------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 12344567789999999999999999 777887643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=342.33 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=206.6
Q ss_pred hCCCcccccccccCcEEEEEEEecC-C-------CEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCc
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQD-G-------REIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERE 438 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~-g-------~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 438 (686)
.++|+..+.||+|+||.||+|+... + ..||+|++........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4678999999999999999998753 3 4699999977666677889999999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC--------eE
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK--------PK 510 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~k 510 (686)
.++||||+++|+|.+++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999653 234899999999999999999999988 999999999999998887 99
Q ss_pred EEecCCccccCCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCC-CCCcccchHhHHHHHHHHH
Q 005649 511 ISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGR-KNYDRQLEAENQELLKLAR 588 (686)
Q Consensus 511 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~ 588 (686)
|+|||++...... ....|+..|+|||.+.+ ..++.++||||||+++|||++|. .|+...........
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~----- 230 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF----- 230 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-----
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH-----
Confidence 9999998755332 22457889999999987 77999999999999999999954 55544333222111
Q ss_pred HHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCC
Q 005649 589 RLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSV 645 (686)
Q Consensus 589 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 645 (686)
..... ..+...+..+.+++.+||+.||++|||+.|+++.|++.-.
T Consensus 231 -~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 231 -YEDRH-----------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp -HHTTC-----------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred -hhccC-----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11100 1122234567899999999999999999999999998654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=347.17 Aligned_cols=252 Identities=21% Similarity=0.337 Sum_probs=199.8
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccC--cccHHHHHHHHHHHHhcCC--CCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNS--MQGKEEFENEVRVLLKMQH--RNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv 442 (686)
.++|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|+.++.+++| +||+++++++.++...++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 46799999999999999999999889999999986543 3334778999999999976 9999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|| +.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++....
T Consensus 88 ~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 5688999999753 35899999999999999999999987 99999999999997 57899999999987755
Q ss_pred cCccccccccccCCCcCchhhhhc-----------CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHH
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIR-----------GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLE 591 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 591 (686)
...........||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ .....
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~~- 233 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KLHAI- 233 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----HHHHH-
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-----HHHHH-
Confidence 443333445679999999999875 6789999999999999999999999975432211 01111
Q ss_pred hcCccccccccccC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 592 EEGRLMELVDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 592 ~~~~~~~~~d~~l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
+++... ..+...+..+.+++.+||+.||++|||+.|+++..
T Consensus 234 --------~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 234 --------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp --------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --------hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 111111 22333456788999999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=338.44 Aligned_cols=257 Identities=28% Similarity=0.434 Sum_probs=211.2
Q ss_pred hCCCcccc-cccccCcEEEEEEEec---CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 367 TDNFSTKN-MLGRGGFGTVYKGRLQ---DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 367 t~~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
.++|.+.+ .||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35666666 9999999999999854 57789999997653 33457899999999999999999999999 5667899
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||+++++|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 87 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 99999999999999643 345999999999999999999999987 9999999999999999999999999998775
Q ss_pred CcCcc-ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 522 DEQSR-HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 522 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. .+..
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-------~~~~--- 231 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGKR--- 231 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-------TTCC---
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-------cCCc---
Confidence 43321 12233456889999999999999999999999999999999 999998665544322111 1111
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
...+...+..+.+++.+||+.||++||++.++++.|+..-
T Consensus 232 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 232 -----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp -----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1223455678999999999999999999999999998753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=337.62 Aligned_cols=256 Identities=25% Similarity=0.400 Sum_probs=206.7
Q ss_pred hhCCCcccccccccCcEEEEEEEecC----CCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQD----GREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
..++|+..+.||+|+||.||+|+..+ +..||+|++.... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 35789999999999999999998653 2359999997653 3446789999999999999999999999764 4678
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+||||+++++|.+++.... ..+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 9999999999999996532 34899999999999999999999987 999999999999999999999999999876
Q ss_pred CCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. .....
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~------~~~~~--- 233 (281)
T 3cc6_A 164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE------KGDRL--- 233 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH------HTCCC---
T ss_pred cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh------cCCCC---
Confidence 543221 2233467889999999999999999999999999999998 999997655544332211 11110
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+...+..+.+++.+||+.||++|||+.|+++.|++.
T Consensus 234 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 234 ------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 11233456789999999999999999999999999753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=346.06 Aligned_cols=257 Identities=27% Similarity=0.478 Sum_probs=204.2
Q ss_pred hCCCcccccccccCcEEEEEEEecC-----CCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQD-----GREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
.++|+..+.||+|+||.||+|+... +..||||++.... ......+.+|+.++.+++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4678888999999999999998753 2359999997543 234567899999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+||||+++|+|.+++... ...+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999999653 345999999999999999999999987 999999999999999999999999999876
Q ss_pred CCcCccc-cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 521 HDEQSRH-RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 521 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ....+.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~------~~~~~~-- 269 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI------NDGFRL-- 269 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------HTTCCC--
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH------HCCCcC--
Confidence 5432211 1223456788999999999999999999999999999999 99999765543322211 111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus 270 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 270 -------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp -------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11334567789999999999999999999999999764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=334.58 Aligned_cols=246 Identities=22% Similarity=0.364 Sum_probs=207.9
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.++|+..+.||+|+||.||+|+.. ++..+++|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 467899999999999999999976 5778999999876666788999999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---cCCCCeEEEecCCccccCC
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL---DHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~ 522 (686)
+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999998654 34899999999999999999999987 9999999999999 7889999999999987654
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
.. ......|++.|+|||.+.+ .++.++||||||+++|||++|+.||......+....+. . +..
T Consensus 162 ~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~-~~~------ 224 (277)
T 3f3z_A 162 GK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR------E-GTF------ 224 (277)
T ss_dssp TS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------H-CCC------
T ss_pred cc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH------h-CCC------
Confidence 32 2234578999999998765 48999999999999999999999998765443322111 1 111
Q ss_pred ccCCCCH----HHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 603 RIGTYPE----EIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 603 ~l~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
..+. ..+..+.+++.+||+.||++|||+.|+++
T Consensus 225 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 ---TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ---CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1122 23567889999999999999999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=343.49 Aligned_cols=255 Identities=23% Similarity=0.322 Sum_probs=205.3
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 442 (686)
++|+..+.||+|+||.||+++.+ +++.||+|++..... ...+.+.+|..++.++ +||||+++++++.+++..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 67899999999999999999986 688999999976432 2345688999999988 899999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999999654 34999999999999999999999987 99999999999999999999999999986432
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHH--HHHHHHHHHHhcCcccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQ--ELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 600 (686)
.. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ...............
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 22 1234467999999999999999999999999999999999999999753221110 001111111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCH------HHHHHH
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTM------SATLSM 639 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~evl~~ 639 (686)
.++...+..+.+++.+||+.||++||++ .|+++.
T Consensus 237 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 237 -----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred -----CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 2244556778999999999999999995 566653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=347.55 Aligned_cols=246 Identities=23% Similarity=0.307 Sum_probs=209.3
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|+..+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 68999999999999999999976 68999999996542 234577899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 9999999999997543 4899999999999999999999987 999999999999999999999999999876432
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.... ... +..
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~------i~~-~~~------- 255 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK------IVS-GKV------- 255 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHH-CCC-------
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHH------HHc-CCC-------
Confidence 2335789999999999999999999999999999999999999986554332221 111 111
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCC-----HHHHHHHh
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPT-----MSATLSML 640 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~L 640 (686)
.++...+..+.+++.+||+.||++||+ +.|+++.-
T Consensus 256 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 123445677899999999999999998 88887643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=336.26 Aligned_cols=254 Identities=22% Similarity=0.364 Sum_probs=208.5
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEec--CceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE--RERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 442 (686)
.++|+..+.||+|+||.||+|+.+ ++.||||++.... ....+.|.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 367899999999999999999985 8899999997653 33456799999999999999999999999887 778999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+++|+|.+++... ....+++..++.++.|+++||.|||+.+ .+|+||||||+||+++.++.++|.|||+......
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999999753 2335899999999999999999999875 4599999999999999999999999998764322
Q ss_pred cCccccccccccCCCcCchhhhhcCCC---ChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFL---SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......+... .....+..
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~~~~~--- 229 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM------KVALEGLR--- 229 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH------HHHHSCCC---
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH------HHHhcCCC---
Confidence 22467899999999987544 448999999999999999999998655443221 11111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
+ ..+...+..+.+++.+||+.||++|||+.|+++.|+...
T Consensus 230 --~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 230 --P---TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp --C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred --C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1 123445677999999999999999999999999998653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=348.74 Aligned_cols=271 Identities=23% Similarity=0.301 Sum_probs=199.1
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcC-CCCcccEEEEEEe--------c
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQ--------E 436 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--------~ 436 (686)
..+|+..++||+|+||.||+++.. +++.||||++........+.+.+|+.++.++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 467899999999999999999975 78999999997766666778999999999995 9999999999953 3
Q ss_pred CceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCC
Q 005649 437 RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGL 516 (686)
Q Consensus 437 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 516 (686)
...++++||++ |+|.+++........+++..++.++.||+.||.|||+++ ++|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 34789999995 799999876555567999999999999999999999975 4599999999999999999999999999
Q ss_pred ccccCCcCccc----------cccccccCCCcCchhhh---hcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHH
Q 005649 517 AKLFHDEQSRH----------RTHQIAGTFGYMAPEYA---IRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQEL 583 (686)
Q Consensus 517 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~ 583 (686)
++......... ......|++.|+|||.+ .+..++.++||||||+++|||++|+.||........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--- 261 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI--- 261 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh---
Confidence 98765432211 11134589999999998 567789999999999999999999999964322110
Q ss_pred HHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCCCCCCCCCCCc
Q 005649 584 LKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPSVTESPDHY 657 (686)
Q Consensus 584 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~p~~p~~~ 657 (686)
. . +... . ..+......+.+++.+||+.||++|||+.|+++.|+......+..|.+|..-
T Consensus 262 ~-------~-~~~~----~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~~~~ 320 (337)
T 3ll6_A 262 V-------N-GKYS----I---PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITE 320 (337)
T ss_dssp ------------CC----C---CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSCCHH
T ss_pred h-------c-Cccc----C---CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCccHHH
Confidence 0 0 0000 0 0111223457899999999999999999999999988654444434444443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=375.04 Aligned_cols=255 Identities=28% Similarity=0.441 Sum_probs=205.8
Q ss_pred CCCcccc-cccccCcEEEEEEEec---CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 368 DNFSTKN-MLGRGGFGTVYKGRLQ---DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 368 ~~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
+++...+ .||+|+||.||+|.+. ++..||||+++... ....++|.+|++++++++||||+++++++.+ +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4444444 7999999999999874 45679999997653 3356889999999999999999999999876 568999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+++|+|.+++... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 414 ~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 9999999999999643 345999999999999999999999987 99999999999999999999999999987654
Q ss_pred cCcc-ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 523 EQSR-HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 523 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
.... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+....+. .+...
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-------~~~~~--- 558 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGKRM--- 558 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-------TTCCC---
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCCCC---
Confidence 3221 11223345789999999999999999999999999999998 999998766554332221 11111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+..++..+.+|+.+||+.+|++||++.+|++.|+..
T Consensus 559 -----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 559 -----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp -----CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 22445667899999999999999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=335.37 Aligned_cols=275 Identities=20% Similarity=0.271 Sum_probs=212.1
Q ss_pred hCCCcccccccccCcEEEEEEEe-cCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEE-EecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRL-QDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCC-VQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~E 444 (686)
.++|+..+.||+|+||.||+|+. .+|+.||||++..... .+.+.+|+.++.+++|++++..++++ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 57899999999999999999997 4789999999865432 34688999999999988877666666 55667899999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---cCCCCeEEEecCCccccC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL---DHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~ 521 (686)
|+ +++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||+ ++++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 999999996432 35999999999999999999999987 9999999999999 588899999999998765
Q ss_pred CcCccc-----cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcc
Q 005649 522 DEQSRH-----RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL 596 (686)
Q Consensus 522 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (686)
...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 433211 124467999999999999999999999999999999999999999864332211111111111000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCCCCCCCCCCCc
Q 005649 597 MELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPSVTESPDHY 657 (686)
Q Consensus 597 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~p~~p~~~ 657 (686)
. .+ ....+..+.+++.+||+.||++|||+.+|++.|++...........|.+|
T Consensus 240 ~-----~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw 292 (296)
T 3uzp_A 240 E-----VL---CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 292 (296)
T ss_dssp H-----HH---TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGG
T ss_pred H-----HH---HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence 0 00 12345678999999999999999999999999987533333323444444
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=345.68 Aligned_cols=259 Identities=30% Similarity=0.454 Sum_probs=208.2
Q ss_pred hCCCcccccccccCcEEEEEEEe------cCCCEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCce
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRL------QDGREIAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERER 439 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 439 (686)
.++|+..+.||+|+||.||+|+. .+++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 57899999999999999999984 25778999999654 333456789999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCCeEEE
Q 005649 440 ILVYEYLPNKSLDKFLFDKSK----SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH---QMKPKIS 512 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 512 (686)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976532 245899999999999999999999987 999999999999984 4569999
Q ss_pred ecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHH
Q 005649 513 DFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLE 591 (686)
Q Consensus 513 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 591 (686)
|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ .
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~------~ 259 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV------T 259 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH------H
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH------h
Confidence 9999986644333333344567899999999999999999999999999999998 99999865543322211 1
Q ss_pred hcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 592 EEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 592 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
. +... ..+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus 260 ~-~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 260 S-GGRM--------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp T-TCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c-CCCC--------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1 1110 11334556788999999999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=333.89 Aligned_cols=254 Identities=27% Similarity=0.398 Sum_probs=205.6
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
++|....+||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 45566679999999999999975 68899999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCCeEEEecCCccccCCcCc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH-QMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~ 525 (686)
++++|.+++........+++..++.++.|++.||.|||+++ |+|+||||+||+++. ++.+||+|||++........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999977655556789999999999999999999987 999999999999987 89999999999987653221
Q ss_pred cccccccccCCCcCchhhhhcCC--CChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGF--LSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
......|+..|+|||.+.+.. ++.++||||||+++|||++|+.||.......... .. ..... ..
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~--~~~~~-------~~-- 244 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM-FK--VGMFK-------VH-- 244 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH-HH--HHHHC-------CC--
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH-Hh--hcccc-------cc--
Confidence 123457899999999987653 8999999999999999999999997543322111 11 01100 00
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
...+...+..+.+++.+||+.||++||++.|+++.
T Consensus 245 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 245 -PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 12234456778999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=338.46 Aligned_cols=266 Identities=25% Similarity=0.328 Sum_probs=203.9
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-----ccHHHHHHHHHHHHhc---CCCCcccEEEEEEec
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-----QGKEEFENEVRVLLKM---QHRNLVQLFGCCVQE 436 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-----~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~ 436 (686)
..++|+..+.||+|+||.||+++.. +++.||||++..... .....+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3679999999999999999999964 789999999864321 1234667777777766 499999999999875
Q ss_pred C-----ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEE
Q 005649 437 R-----ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKI 511 (686)
Q Consensus 437 ~-----~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 511 (686)
. ..+++|||++ ++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999996 69999986543 234999999999999999999999988 999999999999999999999
Q ss_pred EecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHH
Q 005649 512 SDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLE 591 (686)
Q Consensus 512 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 591 (686)
+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+.......
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999998764332 2234678999999999999999999999999999999999999998766554332222111111
Q ss_pred hcCccccccc---cccC--------CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 592 EEGRLMELVD---VRIG--------TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 592 ~~~~~~~~~d---~~l~--------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
....+..... .... ....+.+..+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 1111110000 0000 0012345678899999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=334.98 Aligned_cols=248 Identities=25% Similarity=0.394 Sum_probs=205.9
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
.++|+..+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 478999999999999999999876 57789999985432 22356789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999999654 34899999999999999999999987 99999999999999999999999999865433
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+. . ..
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~-~~------- 223 (279)
T 3fdn_A 162 SR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------R-VE------- 223 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------H-TC-------
T ss_pred cc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH------h-CC-------
Confidence 22 234578999999999999999999999999999999999999998655443322111 1 00
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
...+...+..+.+++.+||+.||++|||+.|+++.-
T Consensus 224 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 224 --FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp --CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred --CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 012334566788999999999999999999999754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=340.30 Aligned_cols=256 Identities=30% Similarity=0.436 Sum_probs=207.1
Q ss_pred hhCCCcccc-cccccCcEEEEEEEec---CCCEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCCcccEEEEEEecCce
Q 005649 366 ATDNFSTKN-MLGRGGFGTVYKGRLQ---DGREIAVKKLATNSMQ--GKEEFENEVRVLLKMQHRNLVQLFGCCVQERER 439 (686)
Q Consensus 366 at~~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 439 (686)
..++|+..+ .||+|+||.||+|... +++.||||++...... ..+.+.+|+.++++++||||+++++++ +.+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 346788877 9999999999999643 4678999999765322 357899999999999999999999999 66788
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++||||+++++|.+++... ..+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 93 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 9999999999999999653 34999999999999999999999987 99999999999999999999999999987
Q ss_pred cCCcCcc-ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 520 FHDEQSR-HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 520 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. .+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~- 238 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGER- 238 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTCC-
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCC-
Confidence 6543322 11223456788999999999999999999999999999999 999998765543322111 1111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 598 ~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
...+...+..+.+++.+||+.||++||++.++++.|++.
T Consensus 239 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 239 -------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 112344567799999999999999999999999999763
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.62 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=191.9
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.++|+..+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 578999999999999999999987 57889999997543 346788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCCeEEEecCCccccCC
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH---QMKPKISDFGLAKLFHD 522 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~~ 522 (686)
+++|+|.+++... ..+++..++.++.||++||.|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 130 VTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 9999999999543 45899999999999999999999987 999999999999975 88999999999986643
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.. . ..... ... ....
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~---~~i~~-~~~-~~~~- 272 (349)
T 2w4o_A 204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM--F---RRILN-CEY-YFIS- 272 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH--H---HHHHT-TCC-CCCT-
T ss_pred cc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH--H---HHHHh-CCC-ccCC-
Confidence 22 223457899999999999999999999999999999999999999755433211 1 11111 111 0001
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
......+..+.+++.+||+.||++|||+.|+++.
T Consensus 273 ---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 273 ---PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ---TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1123456678899999999999999999999874
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=348.76 Aligned_cols=269 Identities=18% Similarity=0.251 Sum_probs=207.2
Q ss_pred hCCCccccccccc--CcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 367 TDNFSTKNMLGRG--GFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G--~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
.++|++.++||+| +||.||+++.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 5789999999999 99999999987 79999999996543 2334678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||.+....
T Consensus 104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999997642 245999999999999999999999987 9999999999999999999999999987543
Q ss_pred CcCc-----cccccccccCCCcCchhhhhc--CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH-H-HHh
Q 005649 522 DEQS-----RHRTHQIAGTFGYMAPEYAIR--GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR-R-LEE 592 (686)
Q Consensus 522 ~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~-~-~~~ 592 (686)
.... ........||..|+|||.+.+ ..++.++|||||||++|||++|+.||......+......... . ...
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 2211 111223478899999999987 579999999999999999999999997654433221100000 0 000
Q ss_pred -----cC-------------cccccc----------ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 593 -----EG-------------RLMELV----------DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 593 -----~~-------------~~~~~~----------d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.. ...+.+ +......+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 000000 000001233456779999999999999999999999865
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=332.59 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=208.3
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
.++|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999976 68999999996543 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC---eEEEecCCcccc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK---PKISDFGLAKLF 520 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla~~~ 520 (686)
||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999999988654 34899999999999999999999987 999999999999986655 999999999876
Q ss_pred CCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
..... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+. .+... ..
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-------~~~~~-~~ 227 (284)
T 3kk8_A 159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK-------AGAYD-YP 227 (284)
T ss_dssp CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HTCCC-CC
T ss_pred ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH-------hcccc-CC
Confidence 54332 234578999999999999999999999999999999999999998655443322111 11110 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+ .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 228 SP----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TT----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ch----hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00 112345678899999999999999999999874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.28 Aligned_cols=264 Identities=22% Similarity=0.317 Sum_probs=203.8
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ--GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
++|+..+.||+|+||.||+++.. +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999986 5899999998654332 24678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 99999999887543 34899999999999999999999987 9999999999999999999999999998765332
Q ss_pred ccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHH--------HHHHhcCc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLA--------RRLEEEGR 595 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 595 (686)
. ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+... ........
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 2 2234578999999999876 67899999999999999999999999876655443322211 01111111
Q ss_pred cccccc-cccCCC------CHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 596 LMELVD-VRIGTY------PEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 596 ~~~~~d-~~l~~~------~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
...... +..... ....+..+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 100000 000000 02345668899999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=342.36 Aligned_cols=268 Identities=24% Similarity=0.327 Sum_probs=211.4
Q ss_pred hhCCCcccccccccCcEEEEEEEe-cCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEe----cCceE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRL-QDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ----ERERI 440 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~ 440 (686)
..++|+..+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 357899999999999999999997 4789999999977666667889999999999999999999999973 34678
Q ss_pred EEEeecCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 441 LVYEYLPNKSLDKFLFDKS-KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
+|+||+++|+|.+++.... ....+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999997532 3456999999999999999999999987 99999999999999999999999999876
Q ss_pred cCCcCcc-------ccccccccCCCcCchhhhhcCC---CChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHH
Q 005649 520 FHDEQSR-------HRTHQIAGTFGYMAPEYAIRGF---LSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARR 589 (686)
Q Consensus 520 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 589 (686)
....... .......|++.|+|||.+.+.. ++.++||||||+++|||++|+.||.......... . .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~----~ 258 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV-A----L 258 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH-H----H
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh-h----H
Confidence 5421111 0112345799999999987553 7899999999999999999999996432211100 0 0
Q ss_pred HHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCCCC
Q 005649 590 LEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPS 649 (686)
Q Consensus 590 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~ 649 (686)
..... . .. ..+...+..+.+++.+||+.||++|||+.++++.|+....+.|.
T Consensus 259 ~~~~~-~------~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 259 AVQNQ-L------SI-PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp HHHCC---------C-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred Hhhcc-C------CC-CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 00000 0 00 11233456799999999999999999999999999987755544
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=346.11 Aligned_cols=261 Identities=23% Similarity=0.262 Sum_probs=205.0
Q ss_pred HHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc-----CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecC
Q 005649 364 IAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN-----SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER 437 (686)
Q Consensus 364 ~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 437 (686)
....++|+..+.||+|+||.||+++.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 345688999999999999999999975 6889999998653 2344578999999999999999999999999999
Q ss_pred ceEEEEeecCCCChhHHHhhcC-------------------------------------CCCCCCHHHHHHHHHHHHHHH
Q 005649 438 ERILVYEYLPNKSLDKFLFDKS-------------------------------------KSAILDWPKRLNIIMGVARGL 480 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~~L 480 (686)
..++||||+++|+|.+++.... ....+++..++.++.||++||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 9999999999999999985210 012246778889999999999
Q ss_pred HHHHhCCCCCeEecCCCCCcEEEcCCC--CeEEEecCCccccCCcCcc--ccccccccCCCcCchhhhhc--CCCChhHH
Q 005649 481 LYLHRDSVLRIIHRDIKASNILLDHQM--KPKISDFGLAKLFHDEQSR--HRTHQIAGTFGYMAPEYAIR--GFLSVKSD 554 (686)
Q Consensus 481 ~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~ksD 554 (686)
.|||+++ |+||||||+|||++.++ .+||+|||+++.+...... .......||+.|+|||.+.+ ..++.++|
T Consensus 182 ~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 9999987 99999999999998776 8999999999876432211 12334678999999999875 67899999
Q ss_pred HHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHH
Q 005649 555 VFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMS 634 (686)
Q Consensus 555 v~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 634 (686)
|||||+++|||++|+.||......+... ......... ..+. ....+..+.+++.+||+.||++|||+.
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~~~------~~~~~~~~~--~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~ 326 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADTIS------QVLNKKLCF--ENPN----YNVLSPLARDLLSNLLNRNVDERFDAM 326 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCCCCT--TSGG----GGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHHHH------HHHhccccc--CCcc----cccCCHHHHHHHHHHcCCChhHCCCHH
Confidence 9999999999999999998665543322 111111100 0010 112456788999999999999999999
Q ss_pred HHHHH
Q 005649 635 ATLSM 639 (686)
Q Consensus 635 evl~~ 639 (686)
|+++.
T Consensus 327 ~~l~h 331 (345)
T 3hko_A 327 RALQH 331 (345)
T ss_dssp HHHHS
T ss_pred HHhcC
Confidence 99874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=336.60 Aligned_cols=258 Identities=23% Similarity=0.321 Sum_probs=200.8
Q ss_pred CCCccc-ccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEEe
Q 005649 368 DNFSTK-NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 368 ~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 444 (686)
+.|++. ++||+|+||.||+++.. +++.||||++........+.+.+|+.++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567774 78999999999999965 7899999999776666678899999999995 79999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC---eEEEecCCccccC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK---PKISDFGLAKLFH 521 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla~~~~ 521 (686)
|+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++...
T Consensus 92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999764 34899999999999999999999987 999999999999998776 9999999988654
Q ss_pred CcCc-----cccccccccCCCcCchhhhhc-----CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhH--------HHH
Q 005649 522 DEQS-----RHRTHQIAGTFGYMAPEYAIR-----GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAEN--------QEL 583 (686)
Q Consensus 522 ~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~--------~~~ 583 (686)
.... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ...
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 111223468999999999875 5688999999999999999999999976432110 000
Q ss_pred HHHHHHHHhcCccccccccccCCCCH----HHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 584 LKLARRLEEEGRLMELVDVRIGTYPE----EIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 584 ~~~~~~~~~~~~~~~~~d~~l~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
..........+.. ..+. ..+..+.+++.+||+.||++|||+.|+++.-
T Consensus 246 ~~~~~~~i~~~~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 246 QNMLFESIQEGKY---------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp HHHHHHHHHHCCC---------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred HHHHHHHHhccCc---------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 0000111111111 1121 2356789999999999999999999999854
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=346.49 Aligned_cols=249 Identities=26% Similarity=0.328 Sum_probs=208.1
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 441 (686)
.++|+..+.||+|+||.||+++.+ +|+.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 578999999999999999999987 47889999997542 23456788999999888 89999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 999999999999996543 4999999999999999999999987 9999999999999999999999999998643
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ .. +..
T Consensus 173 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~-~~~----- 238 (353)
T 2i0e_A 173 WDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------ME-HNV----- 238 (353)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HH-CCC-----
T ss_pred cCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHH------Hh-CCC-----
Confidence 2221 234467999999999999999999999999999999999999999866544332211 11 111
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCC-----HHHHHHH
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPT-----MSATLSM 639 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 639 (686)
.++...+..+.+++.+||+.||++||+ +.|+++.
T Consensus 239 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 239 ----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 124455678899999999999999995 4777654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=343.52 Aligned_cols=264 Identities=22% Similarity=0.345 Sum_probs=200.3
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCccc-HHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQG-KEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
++|+..+.||+|+||.||+|+.. +++.||+|++....... ...+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999986 78999999996543221 22456799999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
++ |+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 97 6898888654 345899999999999999999999987 99999999999999999999999999986543221
Q ss_pred cccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc--
Q 005649 526 RHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV-- 602 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-- 602 (686)
......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+...........+......
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 156 --TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred --ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 2234578999999999876 57899999999999999999999999876655443332221111111111111110
Q ss_pred -------ccC-----CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 603 -------RIG-----TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 603 -------~l~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
... ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 0011245678899999999999999999999883
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=344.81 Aligned_cols=264 Identities=27% Similarity=0.407 Sum_probs=211.2
Q ss_pred hCCCcccccccccCcEEEEEEEe-----cCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecC--ce
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRL-----QDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER--ER 439 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~ 439 (686)
.++|+..+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46788999999999999999984 368899999998766666788999999999999999999999987654 78
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++|+||+++++|.+++.... ..+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 99999999999999996542 35899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCcCccc-cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHH---------HHHHHHHH
Q 005649 520 FHDEQSRH-RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQ---------ELLKLARR 589 (686)
Q Consensus 520 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~---------~~~~~~~~ 589 (686)
........ ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......-.. ........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 75433221 122345677899999999999999999999999999999999988643211100 00000111
Q ss_pred HHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 590 LEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 590 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
....+.. ...+...+..+.+++.+||+.||++|||+.||++.|+++
T Consensus 275 ~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 275 LLKNNGR--------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHTTCC--------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhcCCC--------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111100 012344567899999999999999999999999999764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=341.73 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=208.6
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
.++|...+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 367888999999999999999986 57889999986542 23456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+++++|.+++... ..+++.+++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999988653 34999999999999999999999987 99999999999999999999999999987653
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+....+ .. +..
T Consensus 194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------~~-~~~------ 258 (335)
T 2owb_A 194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI------KK-NEY------ 258 (335)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HH-TCC------
T ss_pred Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------hc-CCC------
Confidence 222 223457899999999999999999999999999999999999999865544322111 11 110
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
..+......+.+++.+||+.||++|||+.|+++.
T Consensus 259 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1133345678899999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=353.12 Aligned_cols=259 Identities=29% Similarity=0.454 Sum_probs=198.4
Q ss_pred CCcccccccccCcEEEEEEEec--CC--CEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEe-cCceEEE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ--DG--REIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ-ERERILV 442 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~--~g--~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv 442 (686)
.|+..+.||+|+||.||+|++. ++ ..||+|.+.... ....++|.+|+.++++++||||+++++++.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4667789999999999999864 22 358999986543 3446789999999999999999999999765 4578999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+++|+|.+++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 9999999999999643 345899999999999999999999987 99999999999999999999999999987644
Q ss_pred cCcc--ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 523 EQSR--HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 523 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
.... .......+++.|+|||.+.+..++.++||||||+++|||++ |.+||......+....+ . .+...
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~------~-~~~~~-- 315 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL------L-QGRRL-- 315 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH------H-TTCCC--
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH------H-cCCCC--
Confidence 3221 11233467789999999999999999999999999999999 77888765444332211 1 11110
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCC
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPI 647 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 647 (686)
..+..++..+.+++.+||+.||++|||+.|+++.|+.+...+
T Consensus 316 ------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 316 ------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 113345667899999999999999999999999998754333
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=349.85 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=200.1
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccC--cccHHHHHHHHHHHHhcC--CCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNS--MQGKEEFENEVRVLLKMQ--HRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv 442 (686)
.++|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|+.++.+++ ||||+++++++..++..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 35699999999999999999998889999999996543 334578999999999996 59999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|| +.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 5688999999754 35899999999999999999999987 99999999999995 57999999999987754
Q ss_pred cCccccccccccCCCcCchhhhhc-----------CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHH
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIR-----------GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLE 591 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 591 (686)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ......
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-----~~~~~~ 281 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KLHAII 281 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-----HHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-----HHHHHh
Confidence 433333345679999999999875 4789999999999999999999999975432211 011111
Q ss_pred hcCccccccccccC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 592 EEGRLMELVDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 592 ~~~~~~~~~d~~l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
++... ..+...+..+.+++.+||+.||++|||+.|+++..
T Consensus 282 ---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 282 ---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp ---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 11111 12223356788999999999999999999998753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.24 Aligned_cols=261 Identities=29% Similarity=0.431 Sum_probs=206.9
Q ss_pred hCCCcccccccccCcEEEEEEEecC----CCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEe-cCceE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQD----GREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ-ERERI 440 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~ 440 (686)
..+|+..+.||+|+||.||+|+..+ ...+++|.+.... ....+.+.+|+.++++++||||+++++++.+ ++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3568888999999999999998643 2258999987543 3345789999999999999999999999755 55789
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+||||+++|+|.+++... ...+++..++.++.|+++||.|||+++ |+||||||+||++++++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999999643 345899999999999999999999987 999999999999999999999999999876
Q ss_pred CCcCcc--ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 521 HDEQSR--HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 521 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||......+....+ .. +..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~------~~-~~~- 250 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL------LQ-GRR- 250 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH------HT-TCC-
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH------hc-CCC-
Confidence 543321 12233567889999999999999999999999999999999 66677655443332211 11 110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCC
Q 005649 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPI 647 (686)
Q Consensus 598 ~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 647 (686)
...+...+..+.+++.+||+.||++|||+.|+++.|+..-..+
T Consensus 251 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 251 -------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred -------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0113334567899999999999999999999999998754333
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=335.70 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=201.6
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
++|...++||+|+||.||+++.. +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 67899999999999999999975 68899999996543 34568899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---cCCCCeEEEecCCccccC
Q 005649 446 LPNKSLDKFLFDKS-KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL---DHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 446 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~ 521 (686)
+++|+|.+++.... ....+++..++.++.|+++||.|||+++ |+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999986532 2356999999999999999999999987 9999999999999 456789999999998665
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
... ......|++.|+|||.+. +.++.++||||||+++|||++|+.||......+...... .....
T Consensus 179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~------~~~~~----- 243 (285)
T 3is5_A 179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT------YKEPN----- 243 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCCCC-----
T ss_pred Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc------cCCcc-----
Confidence 432 223457899999999875 578999999999999999999999998765444322111 11100
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
........+..+.+++.+||+.||++|||+.|+++
T Consensus 244 --~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 244 --YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00001113566889999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=335.50 Aligned_cols=262 Identities=21% Similarity=0.304 Sum_probs=203.4
Q ss_pred hhCCCcccccccccCcEEEEEEEe-cCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEE-EecCceEEEE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRL-QDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCC-VQERERILVY 443 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 443 (686)
..++|+..+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.++.+++|++++..++.+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 357899999999999999999996 4788999998754432 23578899999999988877777666 5566789999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---cCCCCeEEEecCCcccc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL---DHQMKPKISDFGLAKLF 520 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~ 520 (686)
||+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+ ++++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999999643 235999999999999999999999987 9999999999999 78999999999999876
Q ss_pred CCcCcc-----ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCc
Q 005649 521 HDEQSR-----HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGR 595 (686)
Q Consensus 521 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 595 (686)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 543321 122346789999999999999999999999999999999999999986443322111111111110000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 596 LMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 596 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
.. .+ ....+..+.+++.+||+.||++|||+.+|++.|++.
T Consensus 239 ~~-----~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 239 IE-----VL---CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HH-----HH---TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hh-----hh---hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 00 00 122356789999999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=344.65 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=196.1
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.++|+..+.||+|+||.||+++.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 478999999999999999999986 789999999965432 346788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC--eEEEecCCccccCCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK--PKISDFGLAKLFHDE 523 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~~~~~~ 523 (686)
+++|+|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999999996543 4999999999999999999999987 999999999999987765 999999999754322
Q ss_pred CccccccccccCCCcCchhhhhcCCCChh-HHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVK-SDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-sDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
. ......||+.|+|||.+.+..++.+ +||||||+++|||++|+.||.......... ........ ...
T Consensus 172 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--~~~~~~~~-~~~------ 239 (361)
T 3uc3_A 172 S---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR--KTIQRILS-VKY------ 239 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH--HHHHHHHT-TCC------
T ss_pred C---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH--HHHHHHhc-CCC------
Confidence 1 2234579999999999988887766 899999999999999999998644322111 11111111 100
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+ ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 SI-PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CC-CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CC-CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00 0011245678899999999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=338.60 Aligned_cols=245 Identities=25% Similarity=0.275 Sum_probs=195.1
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|+..++||+|+||+||+|+.. +|+.||||++..... .....+..|+..+.++ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999987 799999999865432 2334455666666555 9999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 779998886643 45999999999999999999999987 999999999999999999999999999876533
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
. ......||+.|+|||++.+ .++.++||||||+++|||++|..|+...... .....+... +.
T Consensus 211 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~----------~~~~~~~~~----~~ 272 (311)
T 3p1a_A 211 G---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW----------QQLRQGYLP----PE 272 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH----------HHHTTTCCC----HH
T ss_pred C---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH----------HHHhccCCC----cc
Confidence 2 2234568999999998875 7999999999999999999997766532111 111111110 00
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 273 ---~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 273 ---FTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ---HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 012345678999999999999999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=341.56 Aligned_cols=259 Identities=21% Similarity=0.282 Sum_probs=207.4
Q ss_pred HHhhCCCccc-ccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCc
Q 005649 364 IAATDNFSTK-NMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERE 438 (686)
Q Consensus 364 ~~at~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 438 (686)
..-.++|.+. +.||+|+||.||+++.. +++.||+|++... .......+.+|+.++.++ +||||+++++++.+.+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3345667776 89999999999999976 6899999999654 233467899999999999 56999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCCeEEEecC
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH---QMKPKISDFG 515 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg 515 (686)
.++||||+++|+|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred EEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 99999999999999988543 2356999999999999999999999987 999999999999987 7899999999
Q ss_pred CccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCc
Q 005649 516 LAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGR 595 (686)
Q Consensus 516 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 595 (686)
+++...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+... ...
T Consensus 180 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-----~~~ 251 (327)
T 3lm5_A 180 MSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV-----NVD 251 (327)
T ss_dssp GCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----CCC
T ss_pred cccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc-----ccc
Confidence 998765332 123457899999999999999999999999999999999999999876554432211110 000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 596 LMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 596 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
.. .......+..+.+++.+||+.||++|||+.|+++.--
T Consensus 252 ~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 252 YS-------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp CC-------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred cC-------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 00 0112335567889999999999999999999987643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=340.47 Aligned_cols=252 Identities=26% Similarity=0.333 Sum_probs=208.7
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc------cHHHHHHHHHHHHhcCCCCcccEEEEEEecCce
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ------GKEEFENEVRVLLKMQHRNLVQLFGCCVQERER 439 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 439 (686)
.++|+..+.||+|+||.||+++.. +|+.||+|++...... ..+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467899999999999999999976 6899999999654322 367899999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC----CeEEEecC
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM----KPKISDFG 515 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg 515 (686)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 9999999999999999643 45899999999999999999999987 99999999999999888 79999999
Q ss_pred CccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCc
Q 005649 516 LAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGR 595 (686)
Q Consensus 516 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 595 (686)
+++...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+. ...
T Consensus 165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~-------~~~ 234 (321)
T 2a2a_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT-------SVS 234 (321)
T ss_dssp TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-------TTC
T ss_pred cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------hcc
Confidence 998765432 2234578999999999999999999999999999999999999998655443322111 110
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 596 LMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 596 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
. ..++.. ....+..+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~--~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 Y--DFDEEF---FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp C--CCCHHH---HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred c--ccChhh---hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 000000 01234668899999999999999999999974
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=336.11 Aligned_cols=256 Identities=26% Similarity=0.369 Sum_probs=205.3
Q ss_pred CCcccccccccCcEEEEEEEecC-C---CEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCce-EEE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQD-G---REIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERER-ILV 442 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv 442 (686)
.|...++||+|+||.||+|+..+ + ..+|+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45566899999999999998642 2 2699999875433 3457889999999999999999999999876655 999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
+||+.+|+|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 9999999999999653 345899999999999999999999987 99999999999999999999999999986654
Q ss_pred cCc--cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCC-CCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 523 EQS--RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRK-NYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 523 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
... ........++..|+|||.+.+..++.++||||||+++|||++|.. ||......+....+. .+..
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-------~~~~--- 246 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-------QGRR--- 246 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-------TTCC---
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-------cCCC---
Confidence 321 122334567889999999999999999999999999999999554 454444333222111 1110
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
...+...+..+.+++.+||+.||++|||+.++++.|++..
T Consensus 247 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 247 -----LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0113344567899999999999999999999999998753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=359.80 Aligned_cols=250 Identities=24% Similarity=0.287 Sum_probs=200.3
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN---SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
.++|+..++||+|+||.||+++.. +|+.||||++... .......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999975 6899999999754 233345678899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR-DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999999654 359999999999999999999998 76 9999999999999999999999999998643
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+. ... .
T Consensus 301 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~------~~~-~----- 366 (446)
T 4ejn_A 301 KDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------MEE-I----- 366 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC-C-----
T ss_pred CCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH------hCC-C-----
Confidence 3221 2334679999999999999999999999999999999999999998665543322211 111 0
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCC-----CHHHHHHHh
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRP-----TMSATLSML 640 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~L 640 (686)
.++...+..+.+++.+||+.||++|| ++.|+++.-
T Consensus 367 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 367 ----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 12344567789999999999999999 999998743
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=332.35 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=207.9
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.++|+..+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999976 78999999996543 3345788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++++|.+++.. ...+++..++.++.|+++||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999998843 345999999999999999999999987 9999999999999999999999999998764333
Q ss_pred ccccccccccCCCcCchhhhhcCCC-ChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFL-SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
.........|+..|+|||.+.+..+ +.++||||||+++|||++|+.||......... ...+ ......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~-----~~~~~~------ 227 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW-----KEKKTY------ 227 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHH-----HTTCTT------
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHh-----hhcccc------
Confidence 2223345678999999999987765 78999999999999999999999865543221 1111 111100
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
. ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 228 ~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 228 L-NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp S-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c-CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0 0112345678899999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=339.81 Aligned_cols=265 Identities=22% Similarity=0.388 Sum_probs=202.4
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|++.+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 57899999999999999999974 78999999997532 334567899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 444 EYLPNKSLDKFLFDKS-KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
||+++++|.+++.... ....+++..++.++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999999996532 3455899999999999999999999987 99999999999999999999999999986643
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||........ .. ..... ......
T Consensus 189 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~---~~~~~-~~~~~~---- 257 (310)
T 2wqm_A 189 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SL---CKKIE-QCDYPP---- 257 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HH---HHHHH-TTCSCC----
T ss_pred CCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HH---HHHhh-cccCCC----
Confidence 321 22335689999999999999999999999999999999999999975432211 11 11111 111111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCCCC
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPS 649 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~ 649 (686)
+ .....+..+.+++.+||+.||++|||+.+|++.|++.......
T Consensus 258 -~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 258 -L--PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp -C--CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -C--cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 0 0123456788999999999999999999999999887544444
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=348.73 Aligned_cols=267 Identities=23% Similarity=0.335 Sum_probs=214.6
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecC--ceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER--ERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 442 (686)
.++|+..++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 367899999999999999999986 58999999997543 334677889999999999999999999998765 67999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE----cCCCCeEEEecCCcc
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL----DHQMKPKISDFGLAK 518 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla~ 518 (686)
|||+++|+|.+++........+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976655555999999999999999999999987 9999999999999 788889999999998
Q ss_pred ccCCcCccccccccccCCCcCchhhhhc--------CCCChhHHHHHHHHHHHHHHcCCCCCcccchHh-HHHHHHHHHH
Q 005649 519 LFHDEQSRHRTHQIAGTFGYMAPEYAIR--------GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE-NQELLKLARR 589 (686)
Q Consensus 519 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~~ 589 (686)
...... ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ..... ..
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~---~~ 238 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM---YK 238 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH---HH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH---HH
Confidence 765432 2234578999999999875 567889999999999999999999997543221 11111 11
Q ss_pred HHhcCc---ccccc---------cccc---CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 590 LEEEGR---LMELV---------DVRI---GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 590 ~~~~~~---~~~~~---------d~~l---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
...... +..+. +..+ ..........+.+++.+||+.||++||++.|+++.++.
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 111111 10000 0011 13457888999999999999999999999999888865
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=342.19 Aligned_cols=270 Identities=23% Similarity=0.257 Sum_probs=210.3
Q ss_pred cCHHHHHHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcC-----CCCcccEEE
Q 005649 358 FNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-----HRNLVQLFG 431 (686)
Q Consensus 358 ~~~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~~ 431 (686)
+++++.....++|++.++||+|+||.||+++.. +++.||||++... ....+.+..|+.++.+++ ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 344444445789999999999999999999975 7889999999642 233566788999999996 999999999
Q ss_pred EEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC------
Q 005649 432 CCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH------ 505 (686)
Q Consensus 432 ~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~------ 505 (686)
++...+..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccc
Confidence 999999999999999 999999997643 235899999999999999999999987 999999999999975
Q ss_pred -------------------CCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHH
Q 005649 506 -------------------QMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEII 566 (686)
Q Consensus 506 -------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ell 566 (686)
++.+||+|||+++...... ....||+.|+|||.+.+..++.++||||||+++|||+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 7899999999998654322 2457899999999999999999999999999999999
Q ss_pred cCCCCCcccchHhHHHHHHHHHH--------HHhcCccccccccc-----cC--C---------------CCHHHHHHHH
Q 005649 567 SGRKNYDRQLEAENQELLKLARR--------LEEEGRLMELVDVR-----IG--T---------------YPEEIALRFM 616 (686)
Q Consensus 567 tG~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~d~~-----l~--~---------------~~~~~~~~l~ 616 (686)
+|+.||......+....+..... ..........++.. .. . ++......+.
T Consensus 254 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 333 (360)
T 3llt_A 254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333 (360)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred HCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence 99999987665443332221110 00000000000000 00 0 0001125678
Q ss_pred HHHHHcccccccCCCCHHHHHH
Q 005649 617 QIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 617 ~li~~cl~~~p~~RPt~~evl~ 638 (686)
+++.+||+.||++|||+.|+++
T Consensus 334 ~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 334 DFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHhcCChhhCCCHHHHhc
Confidence 9999999999999999999985
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=341.49 Aligned_cols=251 Identities=20% Similarity=0.231 Sum_probs=181.0
Q ss_pred cccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcC-CCCcccEEEEEEecCceEEEEeecCCCC
Q 005649 373 KNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQERERILVYEYLPNKS 450 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~Ey~~~gs 450 (686)
.+.||+|+||.||+++.. +++.||||++... ....+.+|+.++.++. ||||+++++++.++...++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999986 6899999999643 3467789999999997 9999999999999999999999999999
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC---CeEEEecCCccccCCcCccc
Q 005649 451 LDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM---KPKISDFGLAKLFHDEQSRH 527 (686)
Q Consensus 451 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~~~~~~~~~~ 527 (686)
|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 164 (325)
T 3kn6_A 93 LFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-- 164 (325)
T ss_dssp HHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence 99999654 45999999999999999999999987 99999999999997665 799999999986543322
Q ss_pred cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCC
Q 005649 528 RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTY 607 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 607 (686)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....................+.... +. ..
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~--~~---~~ 239 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF--EG---EA 239 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC--CS---HH
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC--Cc---cc
Confidence 22345689999999999999999999999999999999999999975443211000011111111111100 00 00
Q ss_pred CHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 608 PEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 608 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
....+..+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 12346778999999999999999999998754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=334.91 Aligned_cols=260 Identities=25% Similarity=0.357 Sum_probs=209.0
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEe--cCceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ--ERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 441 (686)
.++|+..+.||+|+||.||+++.. +++.|++|++.... ....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999986 78999999997543 3345679999999999999999999998865 567899
Q ss_pred EEeecCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 442 VYEYLPNKSLDKFLFDKS-KSAILDWPKRLNIIMGVARGLLYLHRDS--VLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+++ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997543 2345999999999999999999999975 1239999999999999999999999999998
Q ss_pred ccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 519 LFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 519 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ..+...
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i-------~~~~~~- 234 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-------REGKFR- 234 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTCCC-
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHH-------hhcccc-
Confidence 7653321 122356899999999999999999999999999999999999999866543322111 111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+...+..+.+++.+||+.||++|||+.||++.+...
T Consensus 235 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 235 -------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred -------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 12334567789999999999999999999999877543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=371.19 Aligned_cols=247 Identities=32% Similarity=0.456 Sum_probs=201.4
Q ss_pred ccccccCcEEEEEEEec---CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCC
Q 005649 374 NMLGRGGFGTVYKGRLQ---DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
+.||+|+||.||+|.+. .++.||||+++.... ...++|.+|++++.+++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 467899999976433 34678999999999999999999999986 4568899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc-c
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR-H 527 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~ 527 (686)
|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 9999999643 35999999999999999999999987 999999999999999999999999999877543321 1
Q ss_pred cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCC
Q 005649 528 RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 606 (686)
......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+. .+... .
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-------~~~~~--------~ 592 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERM--------G 592 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTCCC--------C
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCC--------C
Confidence 2233456789999999999999999999999999999999 999998766554332221 11111 2
Q ss_pred CCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
.+..++..+.+++.+||+.||++||++.+|++.|++
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 244566789999999999999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=332.59 Aligned_cols=250 Identities=23% Similarity=0.363 Sum_probs=209.4
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
.++|...+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467899999999999999999986 57889999986542 23456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+++++|.+++... ..+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999988653 34899999999999999999999987 99999999999999999999999999987643
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+.... .. .+..
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------~~-~~~~------ 232 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR------IK-KNEY------ 232 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HH-TTCC------
T ss_pred Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------Hh-hccC------
Confidence 222 22345789999999999999999999999999999999999999986654432211 11 1110
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
..+...+..+.+++.+||+.||++|||+.|+++.-
T Consensus 233 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 233 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ---CCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 12334456788999999999999999999999754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=346.02 Aligned_cols=276 Identities=16% Similarity=0.203 Sum_probs=212.8
Q ss_pred hCCCcccccccccCcEEEEEEEecC---------CCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCccc---------
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQD---------GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQ--------- 428 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~--------- 428 (686)
.++|+..+.||+|+||.||+|+... ++.||+|++... +.+.+|++++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4789999999999999999999763 789999998654 46789999999999999887
Q ss_pred ------EEEEEEe-cCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcE
Q 005649 429 ------LFGCCVQ-ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNI 501 (686)
Q Consensus 429 ------l~~~~~~-~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 501 (686)
+++++.. +...++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6778876 67889999999 999999997542 356999999999999999999999987 99999999999
Q ss_pred EEcCCC--CeEEEecCCccccCCcCcc-----ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcc
Q 005649 502 LLDHQM--KPKISDFGLAKLFHDEQSR-----HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDR 574 (686)
Q Consensus 502 ll~~~~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~ 574 (686)
|++.++ .+||+|||+++.+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999876543221 112335789999999999999999999999999999999999999986
Q ss_pred cchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCCCCCCCCC
Q 005649 575 QLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPSVTESP 654 (686)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~p~~p 654 (686)
...... ........... ....+.+.... ....+..+.+++.+||+.||++|||+.+|++.|++.-......+..|
T Consensus 271 ~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~ 345 (352)
T 2jii_A 271 CLPNTE-DIMKQKQKFVD--KPGPFVGPCGH--WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDP 345 (352)
T ss_dssp GTTCHH-HHHHHHHHHHH--SCCCEECTTSC--EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSC
T ss_pred CCcCHH-HHHHHHHhccC--Chhhhhhhccc--cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCcc
Confidence 542221 11121111111 11111111110 01235678899999999999999999999999987543333323444
Q ss_pred CCc
Q 005649 655 DHY 657 (686)
Q Consensus 655 ~~~ 657 (686)
..|
T Consensus 346 ~dw 348 (352)
T 2jii_A 346 IGL 348 (352)
T ss_dssp CCC
T ss_pred ccC
Confidence 444
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=342.35 Aligned_cols=256 Identities=30% Similarity=0.452 Sum_probs=206.7
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCE--EEEEEeccc-CcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGRE--IAVKKLATN-SMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~--vavK~l~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 441 (686)
.++|+..+.||+|+||.||+++.. ++.. +++|++... .....+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 378999999999999999999975 5554 489988653 233456789999999999 99999999999999999999
Q ss_pred EEeecCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC
Q 005649 442 VYEYLPNKSLDKFLFDKS-------------KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK 508 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 508 (686)
||||+++|+|.+++.... ....+++..++.++.||++||.|||+++ |+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 999999999999997542 2346999999999999999999999987 999999999999999999
Q ss_pred eEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHH
Q 005649 509 PKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLA 587 (686)
Q Consensus 509 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 587 (686)
+||+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....
T Consensus 181 ~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~---- 253 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK---- 253 (327)
T ss_dssp EEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----
T ss_pred EEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH----
Confidence 9999999987433211 1223456889999999999999999999999999999998 9999986654332211
Q ss_pred HHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 588 RRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 588 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
. ..+.. ...+...+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 254 --~-~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 254 --L-PQGYR--------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp --G-GGTCC--------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --h-hcCCC--------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 11100 012334567789999999999999999999999999764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=343.97 Aligned_cols=247 Identities=29% Similarity=0.415 Sum_probs=203.0
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
+.|+..+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45888999999999999999964 789999999965432 23467899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||++ |+|.+++... ...+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 6888887543 245999999999999999999999987 999999999999999999999999999865432
Q ss_pred CccccccccccCCCcCchhhhh---cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAI---RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
....||+.|+|||.+. .+.++.++||||||+++|||++|+.||......+... .......
T Consensus 208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~------~~~~~~~----- 270 (348)
T 1u5q_A 208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQNES----- 270 (348)
T ss_dssp ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHSCC-----
T ss_pred ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHHhcCC-----
Confidence 2347899999999985 5678999999999999999999999997654433211 1111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
+.+ .+...+..+.+++.+||+.||++|||+.++++..
T Consensus 271 -~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 271 -PAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp -CCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred -CCC--CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 111 1223456688999999999999999999998754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=334.05 Aligned_cols=250 Identities=26% Similarity=0.393 Sum_probs=209.7
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.+.|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 467899999999999999999875 68999999996543 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999843 45999999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
. ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+....+ .. +.. +
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~-~~~-----~-- 237 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI------PK-NNP-----P-- 237 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HH-SCC-----C--
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh------hc-CCC-----C--
Confidence 2 223457899999999999999999999999999999999999999865443322111 11 110 1
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
..+...+..+.+++.+||+.||++|||+.|+++..
T Consensus 238 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 238 -TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp -CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred -CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 11233456688999999999999999999998753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=326.19 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=204.2
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc------ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM------QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
++|+..+.||+|+||.||+++.. +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56889999999999999999987 689999999865432 23678999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC----CeEEEecCC
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM----KPKISDFGL 516 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgl 516 (686)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 999999999999999653 34899999999999999999999987 99999999999998877 899999999
Q ss_pred ccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcc
Q 005649 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL 596 (686)
Q Consensus 517 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (686)
+....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+. ....
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~~ 228 (283)
T 3bhy_A 159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS-------AVNY 228 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-------TTCC
T ss_pred ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH-------hccc
Confidence 98764432 1234568999999999999999999999999999999999999998665433221111 1110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 597 MELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 597 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
. .+... ....+..+.+++.+||+.||++|||+.|+++
T Consensus 229 ~--~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 D--FDEEY---FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp C--CCHHH---HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--Ccchh---cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 00000 1123566889999999999999999999987
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=338.63 Aligned_cols=258 Identities=21% Similarity=0.287 Sum_probs=202.2
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc---cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ---GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
.++|+..+.||+|+||.||+++.. +++.||+|++...... ..+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999976 6889999999754332 246789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
+||+++++|.+++... ..+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999999654 34999999999999999999999987 99999999999999999999999999986654
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.......... .........
T Consensus 187 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~~~~~----- 254 (309)
T 2h34_A 187 EKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGA------HINQAIPRP----- 254 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHH------HHHSCCCCG-----
T ss_pred cccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHH------HhccCCCCc-----
Confidence 3221 2234568999999999999999999999999999999999999998654332111 111111100
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCC-CHHHHHHHhcCCC
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRP-TMSATLSMLSNSS 644 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~~~ 644 (686)
...+...+..+.+++.+||+.||++|| ++.++++.|++.-
T Consensus 255 --~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 255 --STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp --GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred --cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 112334456788999999999999999 9999999998753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=355.81 Aligned_cols=246 Identities=24% Similarity=0.415 Sum_probs=207.7
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 67899999999999999999976 79999999996542 223567899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999954 345999999999999999999999987 999999999999999999999999999876543
Q ss_pred CccccccccccCCCcCchhhhhcCCC-ChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFL-SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
. ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......+... ... .+..
T Consensus 170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~------~i~-~~~~------ 233 (476)
T 2y94_A 170 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK------KIC-DGIF------ 233 (476)
T ss_dssp C---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH------HHH-TTCC------
T ss_pred c---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH------HHh-cCCc------
Confidence 2 2234579999999999988765 789999999999999999999998655433221 111 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 234 ---~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 ---YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 113334567889999999999999999999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=331.13 Aligned_cols=249 Identities=25% Similarity=0.424 Sum_probs=206.3
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEe----------
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ---------- 435 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------- 435 (686)
.++|+..+.||+|+||.||+++.. +++.||+|++.... +.+.+|++++.+++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 467899999999999999999986 79999999997543 356789999999999999999998864
Q ss_pred ------cCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCe
Q 005649 436 ------ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP 509 (686)
Q Consensus 436 ------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 509 (686)
....++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+||++++++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 345799999999999999997542 345999999999999999999999987 9999999999999999999
Q ss_pred EEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHH
Q 005649 510 KISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARR 589 (686)
Q Consensus 510 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 589 (686)
||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+.... . ...
T Consensus 162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~---~~~- 229 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----K---FFT- 229 (284)
T ss_dssp EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----H---HHH-
T ss_pred EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----H---HHH-
Confidence 9999999987654322 233568999999999999999999999999999999999998874211 1 111
Q ss_pred HHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCC
Q 005649 590 LEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVP 646 (686)
Q Consensus 590 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 646 (686)
....+. .+...+..+.+++.+||+.||++|||+.|+++.|......
T Consensus 230 ~~~~~~-----------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 230 DLRDGI-----------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHTTC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred Hhhccc-----------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 111111 1223345688999999999999999999999999876543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=350.19 Aligned_cols=261 Identities=22% Similarity=0.329 Sum_probs=195.3
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcC-CCCcccEEEEEEecC--ceE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQER--ERI 440 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~ 440 (686)
.++|+..+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++.++. ||||+++++++...+ ..+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 478999999999999999999875 7899999998643 3334567889999999997 999999999998654 689
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+||||++ ++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 88 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 9999997 689888854 35899999999999999999999987 999999999999999999999999999876
Q ss_pred CCcC-------------------ccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhH
Q 005649 521 HDEQ-------------------SRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAEN 580 (686)
Q Consensus 521 ~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~ 580 (686)
.... .........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 4311 0112234579999999999886 6799999999999999999999999987655443
Q ss_pred HHHHHHHHHHHhcCcccccc----------------------ccccCC-------------CCHHHHHHHHHHHHHcccc
Q 005649 581 QELLKLARRLEEEGRLMELV----------------------DVRIGT-------------YPEEIALRFMQIALLCTED 625 (686)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~----------------------d~~l~~-------------~~~~~~~~l~~li~~cl~~ 625 (686)
...+... ... +..+.+ ...... .....+..+.+++.+||+.
T Consensus 240 ~~~i~~~---~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 240 LERIIGV---IDF-PSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HHHHHHH---HCC-CCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HHHHHHh---cCC-CCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 3222110 000 000000 000000 0012356788999999999
Q ss_pred cccCCCCHHHHHHH
Q 005649 626 FIEDRPTMSATLSM 639 (686)
Q Consensus 626 ~p~~RPt~~evl~~ 639 (686)
||++|||+.|+++.
T Consensus 316 dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 316 NPNKRISANDALKH 329 (388)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999876
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=334.72 Aligned_cols=250 Identities=30% Similarity=0.429 Sum_probs=201.5
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEec-CceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE-RERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~Ey 445 (686)
.++|+..+.||+|+||.||+++.. |+.||||++.... ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 478999999999999999999885 8899999996543 457899999999999999999999997655 478999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++.... ...+++..++.++.|+++||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 99999999996532 234889999999999999999999987 9999999999999999999999999988654322
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+..
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~-------~~~~~-------- 232 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKGYK-------- 232 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-------TTTCC--------
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------hcCCC--------
Confidence 22356889999999999999999999999999999998 99999866544332211 11100
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
...+...+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 112334567789999999999999999999999999764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=347.24 Aligned_cols=244 Identities=25% Similarity=0.291 Sum_probs=195.7
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHH-HHhcCCCCcccEEEEEEecCceEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRV-LLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
++|+..+.||+|+||.||+++.+ +++.||+|++..... .....+..|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 67899999999999999999986 588899999976532 223456667666 4668999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 9999999999999654 34899999999999999999999987 99999999999999999999999999986432
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ .. +..
T Consensus 192 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~-~~~------ 256 (373)
T 2r5t_A 192 HN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI------LN-KPL------ 256 (373)
T ss_dssp CC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH------HH-SCC------
T ss_pred CC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------Hh-ccc------
Confidence 22 1234568999999999999999999999999999999999999999876554432211 11 111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSA 635 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e 635 (686)
.++...+..+.+++.+||+.||++||++.+
T Consensus 257 ---~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 257 ---QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ---CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ---CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 123345667899999999999999999854
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=358.33 Aligned_cols=254 Identities=26% Similarity=0.374 Sum_probs=210.3
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
.++|+..+.||+|+||.||+++.. +|+.||+|++.... ......+.+|+.++.+++||||+++++++.+++..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999986 79999999996532 23456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999996543 344999999999999999999999987 99999999999999999999999999987654
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. ..... ..
T Consensus 339 ~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~--~~i~~-~~------- 405 (576)
T 2acx_A 339 GQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--RLVKE-VP------- 405 (576)
T ss_dssp TCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH--HHHHH-CC-------
T ss_pred Ccc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH--HHhhc-cc-------
Confidence 322 233579999999999999999999999999999999999999998654321111111 11111 10
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRP-----TMSATLSM 639 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 639 (686)
..++...+..+.+++.+||+.||++|| ++.||++.
T Consensus 406 --~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 406 --EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 122344567889999999999999999 77888764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=335.10 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=206.0
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.++|+..+.||+|+||.||+++.. +|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 367899999999999999999976 7899999999866555567789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---cCCCCeEEEecCCccccCC
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL---DHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~ 522 (686)
+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||++ ++++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999998654 34899999999999999999999987 9999999999999 7889999999999876443
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ . .+... . +
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i------~-~~~~~-~-~- 227 (304)
T 2jam_A 162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI------K-EGYYE-F-E- 227 (304)
T ss_dssp B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------H-HCCCC-C-C-
T ss_pred C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------H-cCCCC-C-C-
Confidence 2 123346899999999999999999999999999999999999999865543322111 1 11110 0 0
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.......+..+.+++.+||+.||++|||+.|+++.
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 228 --SPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp --TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred --ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01123445778999999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=337.82 Aligned_cols=271 Identities=23% Similarity=0.324 Sum_probs=204.0
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCccc-----HHHHHHHHHHHHhcCCCCcccEEEEEEecCce
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQG-----KEEFENEVRVLLKMQHRNLVQLFGCCVQERER 439 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 439 (686)
..++|+..+.||+|+||.||+++.. +|+.||||++....... .+.+.+|+.++++++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3578999999999999999999976 68999999996533221 24688999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++||||+++ +|.+++... ...+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999975 888888543 345899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCcCccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 520 FHDEQSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 520 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
...... ......||+.|+|||.+.+. .++.++||||||+++|||++|..||......+....+...........+.+
T Consensus 162 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 162 FGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp TTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred ccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 653322 23345789999999998764 589999999999999999999999987654433221111110000111111
Q ss_pred cc---cc----ccCCCC-----HHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 599 LV---DV----RIGTYP-----EEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 599 ~~---d~----~l~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
.. +. .....+ ...+..+.+++.+||+.||++|||+.|+++.---..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 00 00 000011 234577999999999999999999999998764433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=329.96 Aligned_cols=250 Identities=26% Similarity=0.464 Sum_probs=186.8
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
.++|+..+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 367999999999999999999974 78999999996432 22347789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
+||+++++|.+++... ...+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999999653 345899999999999999999999987 99999999999999999999999999987653
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+... .+...
T Consensus 165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~~~ 227 (278)
T 3cok_A 165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN---------------KVVLA 227 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSS
T ss_pred CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH---------------HHhhc
Confidence 222 1223568999999999999999999999999999999999999997544322110 00000
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.. ..+...+..+.+++.+||+.||++|||+.++++.
T Consensus 228 ~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 228 DY-EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CC-CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cc-CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 00 1233456678899999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=330.45 Aligned_cols=246 Identities=23% Similarity=0.330 Sum_probs=202.6
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 442 (686)
.++|+..+.||+|+||.||+++.. +++.||+|++.... ......+.+|+..+.++ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999986 79999999997542 33456788999999999 999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC----------------
Q 005649 443 YEYLPNKSLDKFLFDKSK-SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH---------------- 505 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---------------- 505 (686)
|||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999975422 245899999999999999999999987 999999999999984
Q ss_pred ---CCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHH
Q 005649 506 ---QMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQ 581 (686)
Q Consensus 506 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~ 581 (686)
...+||+|||++....... ...|+..|+|||.+.+. .++.++||||||+++|||++|.+++......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--- 237 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW--- 237 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---
Confidence 4479999999998765432 23589999999999876 6778999999999999999999876533211
Q ss_pred HHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 582 ELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.....+.. ...+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 238 -------~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 238 -------HEIRQGRL--------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -------HHHHTTCC--------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -------HHHHcCCC--------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 01111111 12233456778999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=330.47 Aligned_cols=246 Identities=23% Similarity=0.366 Sum_probs=207.6
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|+..+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67999999999999999999976 57889999986432 223567899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++.... .+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999999996543 4899999999999999999999987 999999999999999999999999998765432
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
. .....|+..|+|||.+.+..++.++||||||+++|||++|+.||......+.... ... .. .
T Consensus 168 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~------~~~-~~------~- 229 (284)
T 2vgo_A 168 R----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR------IVN-VD------L- 229 (284)
T ss_dssp C----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHT-TC------C-
T ss_pred c----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH------Hhc-cc------c-
Confidence 2 2335789999999999999999999999999999999999999986554432211 111 11 0
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.++...+..+.+++.+||+.||++|||+.|+++.
T Consensus 230 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 230 --KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred --CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 1233456678899999999999999999999873
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=340.50 Aligned_cols=263 Identities=25% Similarity=0.337 Sum_probs=207.8
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.++|+..+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999986 68999999997653 3345778999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD-SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
|+++++|.+++.... .+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999996543 489999999999999999999985 6 999999999999999999999999998755322
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHH-------------
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL------------- 590 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~------------- 590 (686)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+...........
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 123357899999999999999999999999999999999999999876554433221100000
Q ss_pred ----------HhcCccccccccc----cC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 591 ----------EEEGRLMELVDVR----IG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 591 ----------~~~~~~~~~~d~~----l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.......+.++.. .. ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000000111100 00 1112245678999999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=342.69 Aligned_cols=258 Identities=26% Similarity=0.345 Sum_probs=207.8
Q ss_pred hCCCcccccccccCcEEEEEEEe----cCCCEEEEEEecccC----cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecC
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRL----QDGREIAVKKLATNS----MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQER 437 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 437 (686)
.++|+..+.||+|+||.||+++. .+++.||||++.... ....+.+.+|++++.++ +||||+++++++.+++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999997 378999999996542 22345678899999999 6999999999999999
Q ss_pred ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCc
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 517 (686)
..++||||+++|+|.+++.... .+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999997543 4899999999999999999999987 999999999999999999999999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhc--CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCc
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIR--GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGR 595 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 595 (686)
+........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+ ........
T Consensus 207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~~~~- 282 (355)
T 1vzo_A 207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSE- 282 (355)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHHCC-
T ss_pred eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--HHHHhccC-
Confidence 876433222 2334579999999999986 35789999999999999999999999754332211111 11111110
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHcccccccCCC-----CHHHHHHHhcCC
Q 005649 596 LMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRP-----TMSATLSMLSNS 643 (686)
Q Consensus 596 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~L~~~ 643 (686)
..++...+..+.+++.+||+.||++|| ++.|+++..--.
T Consensus 283 ---------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~ 326 (355)
T 1vzo_A 283 ---------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326 (355)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred ---------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence 122445567788999999999999999 999999876443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=338.94 Aligned_cols=265 Identities=23% Similarity=0.376 Sum_probs=203.9
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ--GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
-++|+..+.||+|+||.||+++.. +|+.||||++...... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 368999999999999999999986 5899999998654332 3456889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 104 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999999998886533 34999999999999999999999987 999999999999999999999999999866433
Q ss_pred CccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHH--------HHHHhcC
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLA--------RRLEEEG 594 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~ 594 (686)
.. ......|+..|+|||.+.+. .++.++||||||+++|||++|+.||......+....+... .......
T Consensus 178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 22 22345789999999998875 7899999999999999999999999876554433222110 1111111
Q ss_pred c-cccccccccC-CC-----CHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 595 R-LMELVDVRIG-TY-----PEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 595 ~-~~~~~d~~l~-~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
. ......+.+. .. ....+..+.+++.+||+.||++|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1 1111111111 00 11346779999999999999999999998763
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=339.35 Aligned_cols=243 Identities=24% Similarity=0.334 Sum_probs=204.1
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc--------cHHHHHHHHHHHHhcCCCCcccEEEEEEecC
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ--------GKEEFENEVRVLLKMQHRNLVQLFGCCVQER 437 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 437 (686)
.++|+..+.||+|+||.||+++.. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 468999999999999999999865 7889999999764321 2346778999999999999999999999999
Q ss_pred ceEEEEeecCCC-ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCC
Q 005649 438 ERILVYEYLPNK-SLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGL 516 (686)
Q Consensus 438 ~~~lv~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 516 (686)
..++||||+.+| +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence 999999999777 999998643 34999999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCcCccccccccccCCCcCchhhhhcCCC-ChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCc
Q 005649 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL-SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGR 595 (686)
Q Consensus 517 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 595 (686)
++....... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......
T Consensus 177 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------- 236 (335)
T 3dls_A 177 AAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------- 236 (335)
T ss_dssp CEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------
T ss_pred ceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------
Confidence 987654332 233578999999999988876 89999999999999999999999742211
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 596 LMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 596 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
+.... ..+...+..+.+++.+||+.||++|||+.|+++.-
T Consensus 237 ----~~~~~-~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 237 ----VEAAI-HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp ----TTTCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred ----Hhhcc-CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 00001 11223456789999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.77 Aligned_cols=248 Identities=23% Similarity=0.385 Sum_probs=200.2
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
.++|++.+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 368999999999999999999986 78999999986532 23456889999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+++++|.+++.... .+++..++.++.|+++||.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999996543 4899999999999999999999987 99999999999999999999999999987654
Q ss_pred cCccccccccccCCCcCchhhhhcCCC-ChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFL-SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
... .....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||......+....+ ..+.
T Consensus 164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------~~~~------ 227 (276)
T 2h6d_A 164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI-------RGGV------ 227 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCC------
T ss_pred Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh-------hcCc------
Confidence 321 233568999999999988765 68999999999999999999999865443322111 1111
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
...+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 228 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 ---FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01233345678899999999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=351.61 Aligned_cols=262 Identities=20% Similarity=0.213 Sum_probs=198.9
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEec------C
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE------R 437 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 437 (686)
.++|+..+.||+|+||.||+++.. +|+.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999875 6889999999754 333456788999999999999999999999764 3
Q ss_pred ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCc
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 517 (686)
..+|||||++++ |.+.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 569999999765 6565532 3899999999999999999999987 999999999999999999999999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH---------
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR--------- 588 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------- 588 (686)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+....
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 8764322 2334678999999999999999999999999999999999999998765443322221100
Q ss_pred -------HHHhcC-c-----cccccccccC----CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 589 -------RLEEEG-R-----LMELVDVRIG----TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 589 -------~~~~~~-~-----~~~~~d~~l~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
...... . +...+...+. .........+.+|+.+||+.||++|||+.|+++.-
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 000000 0 0000000000 00122367799999999999999999999998753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=329.79 Aligned_cols=253 Identities=22% Similarity=0.290 Sum_probs=204.0
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC----cccHHHHHHHHHHHHhcCCCCcccEEEEEE--ecCce
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS----MQGKEEFENEVRVLLKMQHRNLVQLFGCCV--QERER 439 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~ 439 (686)
.++|++.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 378999999999999999999975 68899999996542 234578999999999999999999999985 44578
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++||||++++ |.+++... ....+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999877 77777543 3356999999999999999999999987 99999999999999999999999999987
Q ss_pred cCCcCccccccccccCCCcCchhhhhcCC--CChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 520 FHDEQSRHRTHQIAGTFGYMAPEYAIRGF--LSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 520 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
..............|+..|+|||.+.+.. .+.++||||||+++|||++|+.||......+....+ .. +..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i------~~-~~~- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI------GK-GSY- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HH-CCC-
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH------hc-CCC-
Confidence 65433333334567899999999987654 488999999999999999999999865543322211 11 111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 598 ~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
..+...+..+.+++.+||+.||++|||+.|+++.-
T Consensus 231 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 231 --------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp --------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred --------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 12334456788999999999999999999999753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=353.87 Aligned_cols=254 Identities=29% Similarity=0.413 Sum_probs=209.8
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
.++|+..+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999986 69999999996542 23456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 443 YEYLPNKSLDKFLFDKSK-SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
|||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999976432 346999999999999999999999987 9999999999999999999999999998765
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHh-HHHHHHHHHHHHhcCcccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE-NQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 600 (686)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+.. .... ..
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~---~i~~-~~----- 409 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---RVLE-QA----- 409 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH---HHHH-CC-----
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH---HHhh-cc-----
Confidence 4332 2233579999999999999999999999999999999999999997653221 111111 1111 11
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCH-----HHHHH
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTM-----SATLS 638 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~ 638 (686)
..++...+..+.+++.+||+.||++||++ .++++
T Consensus 410 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 ----VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ----cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 12344566788999999999999999976 56664
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=339.87 Aligned_cols=252 Identities=14% Similarity=0.136 Sum_probs=207.2
Q ss_pred HhhCCCcccccccccCcEEEEEEE------ecCCCEEEEEEecccCcccHHHHHHHHHHHHhcC---CCCcccEEEEEEe
Q 005649 365 AATDNFSTKNMLGRGGFGTVYKGR------LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQ---HRNLVQLFGCCVQ 435 (686)
Q Consensus 365 ~at~~f~~~~~LG~G~fG~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~ 435 (686)
...++|...++||+|+||.||+|. ..+++.||||++... ...++..|++++.+++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999994 447899999999654 3557888888888886 9999999999999
Q ss_pred cCceEEEEeecCCCChhHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC--------
Q 005649 436 ERERILVYEYLPNKSLDKFLFDKS--KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH-------- 505 (686)
Q Consensus 436 ~~~~~lv~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------- 505 (686)
++..++||||+++|+|.+++.... ....+++..++.++.||++||.|||+++ |+||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 999999999999999999997532 3456999999999999999999999987 999999999999998
Q ss_pred ---CCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHH
Q 005649 506 ---QMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQE 582 (686)
Q Consensus 506 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~ 582 (686)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 89999999999986643333334455679999999999999999999999999999999999999996543211
Q ss_pred HHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCC-CCHHHHHHHhcC
Q 005649 583 LLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDR-PTMSATLSMLSN 642 (686)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~R-Pt~~evl~~L~~ 642 (686)
..++..+..++ ..+.+.+++..|++.+|.+| |+++++.+.|++
T Consensus 293 ---------------~~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 293 ---------------CKPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp ---------------EEECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred ---------------eeechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 01111122121 25567789999999999999 678888877765
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.99 Aligned_cols=270 Identities=18% Similarity=0.246 Sum_probs=204.1
Q ss_pred CHHHHHHhhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcc-----------cHHHHHHHHHHHHhcCCCCcc
Q 005649 359 NLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQ-----------GKEEFENEVRVLLKMQHRNLV 427 (686)
Q Consensus 359 ~~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~-----------~~~~~~~e~~~l~~l~h~niv 427 (686)
...++....++|+..+.||+|+||.||+|...+|+.||||++...... ..+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 456677788999999999999999999999888999999998653221 137789999999999999999
Q ss_pred cEEEEEEec-----CceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 005649 428 QLFGCCVQE-----RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNIL 502 (686)
Q Consensus 428 ~l~~~~~~~-----~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 502 (686)
++++++... ...++||||++ |+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999999653 35799999997 6888888643 346999999999999999999999987 999999999999
Q ss_pred EcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHH
Q 005649 503 LDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQ 581 (686)
Q Consensus 503 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~ 581 (686)
++.++.+||+|||+++...... ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999998544322 2234578899999999877 67999999999999999999999999876554432
Q ss_pred HHHHHHHHHHhcCcc-----------ccccccccC--------CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 582 ELLKLARRLEEEGRL-----------MELVDVRIG--------TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 582 ~~~~~~~~~~~~~~~-----------~~~~d~~l~--------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
..+.. ....... .+.+...+. ......+..+.+++.+||+.||++|||+.|+++.-
T Consensus 244 ~~i~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 318 (362)
T 3pg1_A 244 NKIVE---VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318 (362)
T ss_dssp HHHHH---HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHHHH---HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence 22211 0000000 000000000 01123356688999999999999999999999754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=347.37 Aligned_cols=260 Identities=20% Similarity=0.291 Sum_probs=208.0
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCC-CCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQH-RNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E 444 (686)
.++|++.++||+|+||.||+|+.. +++.||||++..... .+++..|++++..++| +++..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 478999999999999999999964 789999998865432 2357899999999977 566666667777888899999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---cCCCCeEEEecCCccccC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL---DHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~ 521 (686)
|+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999999643 235999999999999999999999987 9999999999999 688999999999998776
Q ss_pred CcCcc-----ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcc
Q 005649 522 DEQSR-----HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL 596 (686)
Q Consensus 522 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (686)
..... .......||..|+|||.+.+..++.++||||||++||||++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 43321 1223567999999999999999999999999999999999999999875544333333222221111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 597 MELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 597 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
. .. ...++..+.+++..||+.+|++||++.+|+++|+.
T Consensus 238 ~----~l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 238 E----AL----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp H----HH----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred H----HH----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 1 00 11235678999999999999999999999998875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=338.03 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=202.8
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.++|+..+.||+|+||.||+++.+ +|+.||||++...... ..+|++++.++ +||||+++++++.+++..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 467999999999999999999976 6889999999765432 35688888887 79999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC----CCeEEEecCCcccc
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ----MKPKISDFGLAKLF 520 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~~~ 520 (686)
|+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+.++ +.+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999999643 35999999999999999999999987 9999999999998543 35999999999876
Q ss_pred CCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||............... . .+....
T Consensus 171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i---~-~~~~~~-- 242 (342)
T 2qr7_A 171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI---G-SGKFSL-- 242 (342)
T ss_dssp BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH---H-HCCCCC--
T ss_pred cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH---c-cCCccc--
Confidence 54322 233457899999999998888999999999999999999999999864332222222211 1 111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
........+..+.+++.+||+.||++|||+.|+++.
T Consensus 243 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 243 ---SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ---CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011223456778999999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=337.35 Aligned_cols=265 Identities=20% Similarity=0.273 Sum_probs=197.8
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ--GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
..++|+..++||+|+||.||+++.. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3578999999999999999999865 7889999999654332 245678999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-----CCCCeEEEecCCc
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD-----HQMKPKISDFGLA 517 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-----~~~~~kl~Dfgla 517 (686)
|||++ |+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++
T Consensus 112 ~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99997 59999986543 4999999999999999999999987 99999999999994 5556999999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcc
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL 596 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (686)
+....... ......||..|+|||.+.+. .++.++||||||+++|||++|+.||......+....+...........+
T Consensus 185 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 185 RAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 87653321 22345679999999999874 5899999999999999999999999876554332222111100000000
Q ss_pred ccccc--------cccCC------CCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 597 MELVD--------VRIGT------YPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 597 ~~~~d--------~~l~~------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
..... +.... .+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00000 00000 011135678899999999999999999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=333.05 Aligned_cols=258 Identities=28% Similarity=0.426 Sum_probs=201.4
Q ss_pred hCCCcccccccccCcEEEEEEEec--CCC--EEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCce
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ--DGR--EIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERER 439 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~--~g~--~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 439 (686)
.++|+..+.||+|+||.||+|++. +++ .||||++.... ....+.+.+|++++++++||||+++++++.++. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 468999999999999999999864 333 58999986542 234578999999999999999999999998754 8
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++|+||+++++|.+++.... ..+++..++.++.|+++||.|||+++ |+|+||||+||+++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 89999999999999997542 34899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCcCccc-cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 520 FHDEQSRH-RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 520 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+... .........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~~~~~~~~~ 244 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH------KIDKEGERL 244 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HHHTSCCCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH------HHHccCCCC
Confidence 75433221 2234567888999999999999999999999999999999 999998665443221 111111100
Q ss_pred cccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 598 ~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
..+...+..+.+++.+||+.||++|||+.++++.|++..
T Consensus 245 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 245 --------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred --------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 113345677999999999999999999999999998754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=334.65 Aligned_cols=266 Identities=23% Similarity=0.338 Sum_probs=200.3
Q ss_pred hhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhc--CCCCcccEEEEEEec----Cce
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKM--QHRNLVQLFGCCVQE----RER 439 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~----~~~ 439 (686)
..++|+..+.||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +||||+++++++.+. ...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 3578999999999999999999985 899999998543 234445555555554 999999999999887 678
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCcEEEcCCCCeEEEec
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS-----VLRIIHRDIKASNILLDHQMKPKISDF 514 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Df 514 (686)
++||||+++|+|.+++... .+++..++.++.|++.||.|||++. ..+|+||||||+|||++.++.+||+||
T Consensus 111 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 9999999999999999543 4899999999999999999999871 113999999999999999999999999
Q ss_pred CCccccCCcCccc--cccccccCCCcCchhhhhcCCCChh------HHHHHHHHHHHHHHcC----------CCCCcccc
Q 005649 515 GLAKLFHDEQSRH--RTHQIAGTFGYMAPEYAIRGFLSVK------SDVFSFGVLLLEIISG----------RKNYDRQL 576 (686)
Q Consensus 515 gla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k------sDv~s~Gvvl~elltG----------~~p~~~~~ 576 (686)
|+++......... ......||+.|+|||.+.+.....+ +||||||+++|||++| +.||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 9998765432221 1224578999999999987766554 9999999999999999 66765432
Q ss_pred hHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 577 EAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
...... ...............+... ..+..++..+.+++.+||+.||++|||+.||++.|+..
T Consensus 267 ~~~~~~--~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 267 PSDPSY--EDMREIVCIKKLRPSFPNR--WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CSSCCH--HHHHHHHTTSCCCCCCCGG--GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCch--hhhHHHHhhhccCcccccc--chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 211100 0011111111111111000 11236788899999999999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=336.17 Aligned_cols=268 Identities=21% Similarity=0.305 Sum_probs=206.5
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEec-------
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQE------- 436 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 436 (686)
.++|+..+.||+|+||.||+++.. +|+.||||++..... .....+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 368999999999999999999985 789999999865432 2346788999999999999999999999873
Q ss_pred -CceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecC
Q 005649 437 -RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFG 515 (686)
Q Consensus 437 -~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 515 (686)
+..++||||+++ +|.+.+... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999975 777777543 234999999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCcCc--cccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHh
Q 005649 516 LAKLFHDEQS--RHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEE 592 (686)
Q Consensus 516 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 592 (686)
+++....... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9987653221 222344678999999998876 4689999999999999999999999987665544433332211111
Q ss_pred cCccccccccc----c----C---CCCHH-----HHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 593 EGRLMELVDVR----I----G---TYPEE-----IALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 593 ~~~~~~~~d~~----l----~---~~~~~-----~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
...+...-+.. + . ..... ....+.+++.+||+.||++|||+.|+++.-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 11111110000 0 0 00000 134588999999999999999999999854
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=344.05 Aligned_cols=252 Identities=20% Similarity=0.245 Sum_probs=193.1
Q ss_pred CCCccc-ccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHh-cCCCCcccEEEEEEe----cCceE
Q 005649 368 DNFSTK-NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLK-MQHRNLVQLFGCCVQ----ERERI 440 (686)
Q Consensus 368 ~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~~ 440 (686)
++|... ++||+|+||.||+++.. +|+.||||++.. ...+.+|+.++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 68999999999999976 688999999853 2456788888754 589999999999876 56789
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCCeEEEecCCc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH---QMKPKISDFGLA 517 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla 517 (686)
|||||+++|+|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999997532 345999999999999999999999987 999999999999997 789999999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHH-HHHHHHHHHHhcCcc
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQ-ELLKLARRLEEEGRL 596 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 596 (686)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .... .. ..+..
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~i-~~~~~ 284 (400)
T 1nxk_A 212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT---RI-RMGQY 284 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH---HH-HHTCC
T ss_pred cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH---HH-HcCcc
Confidence 8654322 223457899999999999999999999999999999999999999755432210 0000 00 11111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 597 MELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 597 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
. .-.+ .....+..+.+++.+||+.||++|||+.|+++.-
T Consensus 285 ~-~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 285 E-FPNP----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp C-CCTT----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred c-CCCc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0 0000 0123456789999999999999999999999854
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=349.85 Aligned_cols=266 Identities=19% Similarity=0.293 Sum_probs=188.5
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEec-----Cc
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE-----RE 438 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 438 (686)
.++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 378999999999999999999876 7899999999653 233457789999999999999999999999543 46
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.++||||+ +++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 5789888854 345999999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCcCcc-------------------------ccccccccCCCcCchhhh-hcCCCChhHHHHHHHHHHHHHHc-----
Q 005649 519 LFHDEQSR-------------------------HRTHQIAGTFGYMAPEYA-IRGFLSVKSDVFSFGVLLLEIIS----- 567 (686)
Q Consensus 519 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDv~s~Gvvl~ellt----- 567 (686)
........ .......||+.|+|||++ ....++.++|||||||++|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 76532211 122345789999999976 45679999999999999999999
Q ss_pred ------CCCCCcccchH-----------------hHHHHHHHHHHHHhcCcccccc---------------c----cccC
Q 005649 568 ------GRKNYDRQLEA-----------------ENQELLKLARRLEEEGRLMELV---------------D----VRIG 605 (686)
Q Consensus 568 ------G~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~---------------d----~~l~ 605 (686)
|+++|.+.... ...+.+......... ...+.+ . ..+.
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGT-PSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCC-CCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCC-CCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 66666543210 001111111111100 000000 0 0000
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
......+..+.+|+.+||+.||++|||+.|+++.-
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp 398 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHP 398 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCH
Confidence 01122366788999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=336.56 Aligned_cols=269 Identities=27% Similarity=0.365 Sum_probs=197.0
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHH--HHhcCCCCcccEEEEEEe-----cCce
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRV--LLKMQHRNLVQLFGCCVQ-----ERER 439 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~~~~ 439 (686)
.++|+..+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 47899999999999999999987 68999999996432 3344444444 445899999999987653 2256
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCcEEEcCCCCeEEEe
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS------VLRIIHRDIKASNILLDHQMKPKISD 513 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~kl~D 513 (686)
++||||+++|+|.+++... ..++..++.++.||++||.|||+.. ..+|+||||||+|||++.++.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 8999999999999999543 2589999999999999999999981 01399999999999999999999999
Q ss_pred cCCccccCCcCc------cccccccccCCCcCchhhhhc-------CCCChhHHHHHHHHHHHHHHcCCCCCcccch-Hh
Q 005649 514 FGLAKLFHDEQS------RHRTHQIAGTFGYMAPEYAIR-------GFLSVKSDVFSFGVLLLEIISGRKNYDRQLE-AE 579 (686)
Q Consensus 514 fgla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~-~~ 579 (686)
||+++.+..... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.|+..... .+
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 999987654321 112234569999999999876 4567899999999999999999776532211 10
Q ss_pred HHH----------HHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 580 NQE----------LLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 580 ~~~----------~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
... .................+.... ......+..+.+++.+||+.||++|||+.|+++.|+++-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW-KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC-CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCccc-ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 000 0000111111111111111111 113356778999999999999999999999999998753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=329.63 Aligned_cols=257 Identities=19% Similarity=0.322 Sum_probs=201.7
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcC-CCCcccEEEEEEe--cCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQ--ERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 442 (686)
.++|+..+.||+|+||.||+++.. +++.||||++... ..+.+.+|+.++.+++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 378999999999999999999864 7899999998643 3578899999999997 9999999999988 5678999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-CeEEEecCCccccC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM-KPKISDFGLAKLFH 521 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~ 521 (686)
|||+++++|.+++. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999883 2899999999999999999999987 99999999999999776 89999999998765
Q ss_pred CcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH--------HHHh
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR--------RLEE 592 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~ 592 (686)
.... .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......... +..... ....
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHH
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHHH
Confidence 4332 234578899999999887 67999999999999999999999999543322111 111000 0000
Q ss_pred cCcc--------------ccccccccC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 593 EGRL--------------MELVDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 593 ~~~~--------------~~~~d~~l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.... ....+.... ..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 000000000 1122256789999999999999999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=332.94 Aligned_cols=253 Identities=23% Similarity=0.374 Sum_probs=203.0
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.++|++.+.||+|+||.||+|+.. +++.|++|++........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 478999999999999999999986 5889999999877667778999999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++++|.+++.... ..+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 98 CPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp CTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 99999999986532 34999999999999999999999987 9999999999999999999999999876432111
Q ss_pred cccccccccCCCcCchhhhh-----cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAI-----RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
.......|+..|+|||.+. +..++.++||||||+++|||++|+.||......+... ..........
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~~~~~-- 242 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL------KIAKSDPPTL-- 242 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHSCCCCC--
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH------HHhccCCccc--
Confidence 1122346899999999884 5678999999999999999999999998655433211 1111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 243 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 243 -----LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp -----SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred -----CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1123445678999999999999999999999763
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=335.17 Aligned_cols=255 Identities=22% Similarity=0.357 Sum_probs=206.8
Q ss_pred HHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc--------cHHHHHHHHHHHHhc-CCCCcccEEEEE
Q 005649 364 IAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ--------GKEEFENEVRVLLKM-QHRNLVQLFGCC 433 (686)
Q Consensus 364 ~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l-~h~niv~l~~~~ 433 (686)
....++|+..+.||+|+||.||+++.. +|+.||||++...... ..+.+.+|+.++.++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 334578999999999999999999986 7999999998654321 135678999999999 899999999999
Q ss_pred EecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 005649 434 VQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISD 513 (686)
Q Consensus 434 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 513 (686)
......++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEe
Confidence 9999999999999999999999654 34999999999999999999999987 99999999999999999999999
Q ss_pred cCCccccCCcCccccccccccCCCcCchhhhhc------CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHH
Q 005649 514 FGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR------GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLA 587 (686)
Q Consensus 514 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 587 (686)
||++..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+
T Consensus 244 fG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i--- 317 (365)
T 2y7j_A 244 FGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--- 317 (365)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---
T ss_pred cCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH---
Confidence 99998765432 2234678999999999864 35889999999999999999999999765443322111
Q ss_pred HHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 588 RRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 588 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
. .+.... ..+.. ...+..+.+++.+||+.||++|||+.|+++.
T Consensus 318 ---~-~~~~~~-~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 318 ---M-EGQYQF-SSPEW----DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp ---H-HTCCCC-CHHHH----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---H-hCCCCC-CCccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 111100 00000 1234568899999999999999999999873
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.51 Aligned_cols=263 Identities=25% Similarity=0.391 Sum_probs=190.5
Q ss_pred HhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 365 AATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 365 ~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
...++|+..+.||+|+||.||+++.. +++.||||++.... ....+++.+|+.++.+++||||+++++++..++..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34689999999999999999999865 68999999986543 33456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCc
Q 005649 443 YEYLPNKSLDKFLFDK-----SKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 517 (686)
|||+++++|.+++... .....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998642 12455999999999999999999999987 999999999999999999999999999
Q ss_pred cccCCcCc---cccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhc
Q 005649 518 KLFHDEQS---RHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEE 593 (686)
Q Consensus 518 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 593 (686)
........ ........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||........... ....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~------~~~~ 242 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML------TLQN 242 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH------HHTS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH------Hhcc
Confidence 86643221 111234578999999999876 5789999999999999999999999986554432211 1111
Q ss_pred Ccc---ccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 594 GRL---MELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 594 ~~~---~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
... ....++ ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 DPPSLETGVQDK---EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SCCCTTC--------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCccccccccc---hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 100 000111 1122345678899999999999999999999873
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=334.01 Aligned_cols=264 Identities=21% Similarity=0.300 Sum_probs=198.8
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEE-----------
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCV----------- 434 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----------- 434 (686)
.++|+..+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 478999999999999999999987 58999999998766666788999999999999999999999874
Q ss_pred ---ecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-CCCCeE
Q 005649 435 ---QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD-HQMKPK 510 (686)
Q Consensus 435 ---~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k 510 (686)
+....++||||++ |+|.+++.. ..+++..++.++.|+++||.|||+++ |+||||||+||+++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3457799999997 699998843 45899999999999999999999987 99999999999997 567999
Q ss_pred EEecCCccccCCcCc-cccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH
Q 005649 511 ISDFGLAKLFHDEQS-RHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR 588 (686)
Q Consensus 511 l~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 588 (686)
|+|||+++....... ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999987643221 112234567899999998876 689999999999999999999999998766543322221100
Q ss_pred --------HHHhcCccccccccccC-------CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 589 --------RLEEEGRLMELVDVRIG-------TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 589 --------~~~~~~~~~~~~d~~l~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.... ......+..... ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 242 PVVHEEDRQELL-SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCCCHHHHHHHH-TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCchhhhhhhh-hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0000 000000000000 0112346778999999999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=326.18 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=200.4
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEe----cCceE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ----ERERI 440 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~ 440 (686)
+.|+..+.||+|+||.||+|... ++..|++|++.... ....+.+.+|+.++++++||||+++++++.. +...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45788889999999999999875 67889999986542 3345778999999999999999999999876 34579
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-CCCCeEEEecCCccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD-HQMKPKISDFGLAKL 519 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~ 519 (686)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ .+|+||||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999999654 34899999999999999999999975 3599999999999997 789999999999975
Q ss_pred cCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 520 FHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 520 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
..... .....|++.|+|||.+. +.++.++||||||+++|||++|+.||......... . .....+.....
T Consensus 182 ~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~----~~~~~~~~~~~ 250 (290)
T 1t4h_A 182 KRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--Y----RRVTSGVKPAS 250 (290)
T ss_dssp CCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--H----HHHTTTCCCGG
T ss_pred ccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--H----HHHhccCCccc
Confidence 44322 23356899999999876 56999999999999999999999999764432221 1 11111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 251 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 251 -------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 112223568899999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=329.82 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=203.4
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
..++|+..+.||+|+||.||+|+.. +|+.||+|++.... ..+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999986 58999999996543 35678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999998642 345899999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
. ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......... ....... . ..
T Consensus 180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~~-~-----~~ 245 (314)
T 3com_A 180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF------MIPTNPP-P-----TF 245 (314)
T ss_dssp S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHSCC-C-----CC
T ss_pred c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHhcCCC-c-----cc
Confidence 2 2234578999999999999999999999999999999999999998654432211 1111110 0 00
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
..+...+..+.+++.+||+.||++|||+.++++
T Consensus 246 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 -RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 112334567889999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=349.36 Aligned_cols=242 Identities=16% Similarity=0.172 Sum_probs=191.2
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc---CcccHHHHHHHH---HHHHhcCCCCcccEE-------EE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN---SMQGKEEFENEV---RVLLKMQHRNLVQLF-------GC 432 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~ 432 (686)
.++|+..+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467889999999999999999964 6999999999743 333457889999 555566899999998 66
Q ss_pred EEecC-----------------ceEEEEeecCCCChhHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 005649 433 CVQER-----------------ERILVYEYLPNKSLDKFLFDKSK----SAILDWPKRLNIIMGVARGLLYLHRDSVLRI 491 (686)
Q Consensus 433 ~~~~~-----------------~~~lv~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 491 (686)
+.+.+ ..+++|||+ +|+|.+++..... ...+++..++.++.||++||.|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 66553 278999999 6899999975421 123446888999999999999999987 9
Q ss_pred EecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcC-----------CCChhHHHHHHHH
Q 005649 492 IHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG-----------FLSVKSDVFSFGV 560 (686)
Q Consensus 492 vH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDv~s~Gv 560 (686)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||.+.+. .++.++||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 2234567 999999999887 8999999999999
Q ss_pred HHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 561 LLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 561 vl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
++|||++|+.||......+ ....+. .. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~---------------~~~~~~-~~----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALG---------------GSEWIF-RS----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------C---------------CSGGGG-SS----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCccccccc---------------chhhhh-hh----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999996432211 111111 11 1233567889999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=325.96 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=206.0
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---------ccHHHHHHHHHHHHhcC-CCCcccEEEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---------QGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQ 435 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 435 (686)
.++|+..+.||+|+||.||+++.. +|+.||||++..... ...+.+.+|+.++.++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 478999999999999999999986 688999999965431 12456889999999995 9999999999999
Q ss_pred cCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecC
Q 005649 436 ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFG 515 (686)
Q Consensus 436 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 515 (686)
++..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999999999654 34899999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCcCccccccccccCCCcCchhhhh------cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHH
Q 005649 516 LAKLFHDEQSRHRTHQIAGTFGYMAPEYAI------RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARR 589 (686)
Q Consensus 516 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 589 (686)
++....... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||......+....+
T Consensus 170 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----- 241 (298)
T 1phk_A 170 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI----- 241 (298)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----
T ss_pred chhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHH-----
Confidence 998765432 223457899999999885 456899999999999999999999999765543322111
Q ss_pred HHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 590 LEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 590 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
.. +.... .. ......+..+.+++.+||+.||++|||+.|+++
T Consensus 242 -~~-~~~~~-~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 242 -MS-GNYQF-GS----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -HH-TCCCC-CT----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -hc-CCccc-Cc----ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11 11100 00 111234667899999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=338.26 Aligned_cols=260 Identities=22% Similarity=0.301 Sum_probs=199.0
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecC------
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER------ 437 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 437 (686)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999975 78999999995532 233567899999999999999999999998753
Q ss_pred ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCc
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 517 (686)
..++||||+ +++|.+++.. ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899999864 34899999999999999999999987 999999999999999999999999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHH-----HH
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARR-----LE 591 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~-----~~ 591 (686)
+..... .....+|..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+..... ..
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 875432 233578999999999887 6899999999999999999999999987654433222211100 00
Q ss_pred hcC----------ccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 592 EEG----------RLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 592 ~~~----------~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
..- .........+.......+..+.+++.+||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000 000000001111123345678999999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=350.95 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=201.9
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
.++|+..+.||+|+||.||+++.. +++.+|+|++.... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 357899999999999999999986 68899999997543 334578899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC---CCeEEEecCCcccc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ---MKPKISDFGLAKLF 520 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~ 520 (686)
||+++|+|.+++... ..+++..++.++.||++||.|||+++ |+||||||+|||++.+ +.+||+|||+++..
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999999988654 34899999999999999999999987 9999999999999764 45999999999876
Q ss_pred CCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
.... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||......+....+. . +... ..
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------~-~~~~-~~ 257 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE------K-GKYT-FD 257 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------H-TCCC-CC
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------h-CCCC-CC
Confidence 5432 233457999999999876 569999999999999999999999998766544322221 1 1110 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+.. ...+..+.+++.+||+.||++|||+.|+++.
T Consensus 258 ~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 SPEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp SGGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred chhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0111 1245678899999999999999999999853
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=349.13 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=204.0
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-------------ccHHHHHHHHHHHHhcCCCCcccEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-------------QGKEEFENEVRVLLKMQHRNLVQLFGC 432 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~~ 432 (686)
.++|+..++||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 478999999999999999999976 678999999965432 235678999999999999999999999
Q ss_pred EEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC---Ce
Q 005649 433 CVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM---KP 509 (686)
Q Consensus 433 ~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~ 509 (686)
+.+....++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence 99999999999999999999998654 34999999999999999999999987 99999999999998776 69
Q ss_pred EEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHH
Q 005649 510 KISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARR 589 (686)
Q Consensus 510 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 589 (686)
||+|||++....... ......||+.|+|||.+. +.++.++||||||+++|+|++|+.||......+....+.
T Consensus 189 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---- 260 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE---- 260 (504)
T ss_dssp EECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----
T ss_pred EEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----
Confidence 999999998765432 223457999999999876 568999999999999999999999998766544332221
Q ss_pred HHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 590 LEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 590 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
. +...... +. ....+..+.+++.+||+.||.+|||+.|+++.
T Consensus 261 --~-~~~~~~~-~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 261 --K-GKYYFDF-ND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp --H-CCCCCCH-HH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --c-CCCCCCc-cc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1 1110000 00 01235678999999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=336.49 Aligned_cols=272 Identities=21% Similarity=0.251 Sum_probs=195.6
Q ss_pred HHHHHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCc-
Q 005649 361 DVLIAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERE- 438 (686)
Q Consensus 361 ~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~- 438 (686)
+......++|+..+.||+|+||.||+|+.. +|+.||||++..... ....+.++++.+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 344566789999999999999999999985 689999999865432 23456788888999999999999999976443
Q ss_pred ------eEEEEeecCCCChhHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCcEEEcC-CCC
Q 005649 439 ------RILVYEYLPNKSLDKFLFD-KSKSAILDWPKRLNIIMGVARGLLYLH--RDSVLRIIHRDIKASNILLDH-QMK 508 (686)
Q Consensus 439 ------~~lv~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~ivH~Dlkp~NIll~~-~~~ 508 (686)
.++||||++++ |.+.+.. ......+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 78999999764 4444432 234556899999999999999999999 766 999999999999996 899
Q ss_pred eEEEecCCccccCCcCccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHH
Q 005649 509 PKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLA 587 (686)
Q Consensus 509 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 587 (686)
+||+|||+++....... .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||......+....+...
T Consensus 171 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp EEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 99999999987654332 2335689999999998765 4899999999999999999999999876654433222111
Q ss_pred H--------HHHhc-Cccccccc-------cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 588 R--------RLEEE-GRLMELVD-------VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 588 ~--------~~~~~-~~~~~~~d-------~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
. ..... .......+ ..+.......+..+.+++.+||+.||++|||+.|+++.-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence 0 00000 00000000 000111223567899999999999999999999998753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=331.16 Aligned_cols=261 Identities=23% Similarity=0.330 Sum_probs=207.1
Q ss_pred HHhhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHh--cCCCCcccEEEEEEecC----
Q 005649 364 IAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLK--MQHRNLVQLFGCCVQER---- 437 (686)
Q Consensus 364 ~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~---- 437 (686)
....++|+..+.||+|+||.||+|+. +|+.||||++... ..+.+.+|.+++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 33457899999999999999999998 5899999998543 35677889998888 79999999999998876
Q ss_pred ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCcEEEcCCCCe
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLH--------RDSVLRIIHRDIKASNILLDHQMKP 509 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~ 509 (686)
..++||||+++|+|.+++... .+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 789999999999999999642 4899999999999999999999 655 9999999999999999999
Q ss_pred EEEecCCccccCCcCccc--cccccccCCCcCchhhhhcC------CCChhHHHHHHHHHHHHHHcC----------CCC
Q 005649 510 KISDFGLAKLFHDEQSRH--RTHQIAGTFGYMAPEYAIRG------FLSVKSDVFSFGVLLLEIISG----------RKN 571 (686)
Q Consensus 510 kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~ksDv~s~Gvvl~elltG----------~~p 571 (686)
||+|||+++......... ......|++.|+|||.+.+. .++.++||||||+++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998765433211 22345789999999998876 234789999999999999999 778
Q ss_pred CcccchHh--HHHHHHHHHHHHhcCccccccccccC--CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 572 YDRQLEAE--NQELLKLARRLEEEGRLMELVDVRIG--TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 572 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
|....... ..... ........ .+.+. ....+....+.+++.+||+.||++|||+.||++.|+++
T Consensus 267 ~~~~~~~~~~~~~~~----~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMR----KVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTTTSCSSCCHHHHH----HHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCcCcccHHHHH----HHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 86542211 11111 11111111 11111 01236778899999999999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=349.37 Aligned_cols=251 Identities=26% Similarity=0.352 Sum_probs=206.0
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
.++|++.++||+|+||.||+++.. +++.||||++... .......+.+|++++++++||||+++++++.+....++|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999976 7899999998643 2334678999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc---CCCCeEEEecCCcccc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD---HQMKPKISDFGLAKLF 520 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~ 520 (686)
||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++..
T Consensus 101 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 999999999988654 34999999999999999999999987 99999999999995 5567999999999876
Q ss_pred CCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
.... ......||+.|+|||.+.+ .++.++|||||||++|+|++|+.||......+....+. .+......
T Consensus 175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-------~~~~~~~~ 243 (486)
T 3mwu_A 175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE-------TGKYAFDL 243 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HTCCCSCS
T ss_pred CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCCCCCC
Confidence 5432 2234579999999998875 59999999999999999999999998765544322211 11111000
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
+. ....+..+.+++.+||+.||++|||+.|+++.
T Consensus 244 -~~----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 -PQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -GG----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -cc----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 12345678899999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=351.57 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=208.1
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
.++|+..+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999986 78999999996542 34567899999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---cCCCCeEEEecCCccc
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL---DHQMKPKISDFGLAKL 519 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~ 519 (686)
+||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999998653 35999999999999999999999987 9999999999999 5678999999999987
Q ss_pred cCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 520 FHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 520 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
..... ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||......+....+. . +.....
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------~-~~~~~~ 247 (484)
T 3nyv_A 179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE------K-GKYTFE 247 (484)
T ss_dssp BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------H-CCCCCC
T ss_pred ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------c-CCCCCC
Confidence 65432 2234579999999998876 69999999999999999999999998765544322111 1 111100
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
. +. ....+..+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~-~~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 248 L-PQ----WKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp S-GG----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C-cc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0 00 12345678899999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=360.41 Aligned_cols=249 Identities=26% Similarity=0.326 Sum_probs=209.4
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN---SMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 440 (686)
..++|+..++||+|+||.||+++.. +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3578999999999999999999976 6888999999753 223456788899999987 7999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
|||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999997643 4999999999999999999999987 999999999999999999999999999864
Q ss_pred CCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
..... ......||+.|+|||++.+..++.++||||||++||||++|+.||......+....+ .. +.
T Consensus 493 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~-~~----- 558 (674)
T 3pfq_A 493 IWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------ME-HN----- 558 (674)
T ss_dssp CCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HS-SC-----
T ss_pred ccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH------Hh-CC-----
Confidence 33221 234568999999999999999999999999999999999999999876554432211 11 11
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCH-----HHHHH
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTM-----SATLS 638 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~ 638 (686)
..++...+..+.+|+.+||+.||++||++ .||++
T Consensus 559 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 12345567789999999999999999998 77765
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=336.24 Aligned_cols=262 Identities=26% Similarity=0.320 Sum_probs=203.7
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcC--------CCCcccEEEEEE---
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQ--------HRNLVQLFGCCV--- 434 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~--- 434 (686)
.++|++.++||+|+||.||+++.. +++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999865 6889999999643 234567889999999985 788999999987
Q ss_pred -ecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCC-----
Q 005649 435 -QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD-SVLRIIHRDIKASNILLDHQM----- 507 (686)
Q Consensus 435 -~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dlkp~NIll~~~~----- 507 (686)
+....++||||+ +++|.+++... ....+++..++.++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 456789999999 66666666543 224599999999999999999999998 6 99999999999999775
Q ss_pred --------------------------------------------CeEEEecCCccccCCcCccccccccccCCCcCchhh
Q 005649 508 --------------------------------------------KPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEY 543 (686)
Q Consensus 508 --------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~ 543 (686)
.+||+|||+++..... .....||..|+|||.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 7999999999876432 233478999999999
Q ss_pred hhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHh---HHHHHHHHHHHHh--------cCcc-cccccc---------
Q 005649 544 AIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE---NQELLKLARRLEE--------EGRL-MELVDV--------- 602 (686)
Q Consensus 544 ~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~---~~~~~~~~~~~~~--------~~~~-~~~~d~--------- 602 (686)
+.+..++.++|||||||++|||++|+.||......+ ....+........ .+.. .+....
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 999999999999999999999999999997544321 1111111111110 0100 000000
Q ss_pred -----------ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 603 -----------RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 603 -----------~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.....+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0013457788899999999999999999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=332.32 Aligned_cols=256 Identities=21% Similarity=0.328 Sum_probs=200.6
Q ss_pred HHHhhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccC--cccHHHHHHHHHHHHhcC--CCCcccEEEEEEecCc
Q 005649 363 LIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNS--MQGKEEFENEVRVLLKMQ--HRNLVQLFGCCVQERE 438 (686)
Q Consensus 363 l~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~ 438 (686)
+....++|+..+.||+|+||.||+++..+++.||||++.... ....+.+.+|+.++.+++ |+||+++++++.+++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 334567899999999999999999999889999999996543 334578899999999997 5999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.++||| +.+++|.+++... ..+++..++.++.|+++||.|||+++ |+||||||+|||+++ +.+||+|||+++
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccc
Confidence 999999 5688999999754 35899999999999999999999987 999999999999975 899999999998
Q ss_pred ccCCcCccccccccccCCCcCchhhhhc-----------CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHH
Q 005649 519 LFHDEQSRHRTHQIAGTFGYMAPEYAIR-----------GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLA 587 (686)
Q Consensus 519 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 587 (686)
...............|++.|+|||.+.+ ..++.++||||||+++|||++|+.||......... .
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-----~ 249 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-----L 249 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-----H
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH-----H
Confidence 7654433323344578999999999875 47899999999999999999999999754332111 1
Q ss_pred HHHHhcCccccccccccC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 588 RRLEEEGRLMELVDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 588 ~~~~~~~~~~~~~d~~l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
.... ++... ..+...+..+.+++.+||+.||++||++.|+++.-
T Consensus 250 ~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 250 HAII---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp HHHH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHH---------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 1111 11111 12223356788999999999999999999998754
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=337.85 Aligned_cols=263 Identities=24% Similarity=0.386 Sum_probs=203.9
Q ss_pred HhhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 365 AATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 365 ~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
...++|+..+.||+|+||.||+|+.++ .+++|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 346889999999999999999999853 59999986542 22345678899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
+||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||+++ ++.+||+|||+++....
T Consensus 108 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred eecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999999543 345999999999999999999999987 99999999999998 67999999999876532
Q ss_pred cC---ccccccccccCCCcCchhhhhc---------CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHH
Q 005649 523 EQ---SRHRTHQIAGTFGYMAPEYAIR---------GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL 590 (686)
Q Consensus 523 ~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 590 (686)
.. .........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+... ..
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~ 255 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW------QM 255 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH------HH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------Hh
Confidence 21 1112234568999999999864 458999999999999999999999998665443321 11
Q ss_pred HhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCCCC
Q 005649 591 EEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPS 649 (686)
Q Consensus 591 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~ 649 (686)
.. +.. +.+. +...+..+.+++.+||+.||++|||+.+++++|+........
T Consensus 256 ~~-~~~-----~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 256 GT-GMK-----PNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp HT-TCC-----CCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred cc-CCC-----CCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 11 111 1111 112345688999999999999999999999999998766555
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=329.30 Aligned_cols=266 Identities=24% Similarity=0.367 Sum_probs=204.7
Q ss_pred hhCCCcccccccccCcEEEEEEEe--cCCCEEEEEEecccCc--ccHHHHHHHHHHHHhc---CCCCcccEEEEEE----
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRL--QDGREIAVKKLATNSM--QGKEEFENEVRVLLKM---QHRNLVQLFGCCV---- 434 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~--~~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~---- 434 (686)
+.++|+..+.||+|+||.||+++. .+|+.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 3678899999864322 2233566777776666 8999999999997
Q ss_pred -ecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 005649 435 -QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISD 513 (686)
Q Consensus 435 -~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 513 (686)
.....++|+||++ |+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999997 69999986543 234899999999999999999999987 99999999999999999999999
Q ss_pred cCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhc
Q 005649 514 FGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEE 593 (686)
Q Consensus 514 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 593 (686)
||+++...... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+....+.........
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 99998664322 233457899999999999999999999999999999999999999876554332221111000000
Q ss_pred Ccccccc-----------ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 594 GRLMELV-----------DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 594 ~~~~~~~-----------d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
..+.... ...+.......+..+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0010000 000111223456778899999999999999999999963
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=343.68 Aligned_cols=252 Identities=21% Similarity=0.296 Sum_probs=193.5
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--------ccHHHHHHHHHHHHhcCCCCcccEEEEEEec
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--------QGKEEFENEVRVLLKMQHRNLVQLFGCCVQE 436 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 436 (686)
..++|...+.||+|+||.||+|... +++.||||++..... .....+.+|+.++++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 3689999999999999999999876 689999999865321 11235889999999999999999999975 4
Q ss_pred CceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC---CCeEEEe
Q 005649 437 RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ---MKPKISD 513 (686)
Q Consensus 437 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~D 513 (686)
+..++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.+ +.+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 568999999999999988854 345999999999999999999999987 9999999999999754 4599999
Q ss_pred cCCccccCCcCccccccccccCCCcCchhhhhc---CCCChhHHHHHHHHHHHHHHcCCCCCcccchHh-HHHHHHHHHH
Q 005649 514 FGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR---GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE-NQELLKLARR 589 (686)
Q Consensus 514 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~~ 589 (686)
||+++...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ....
T Consensus 286 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~------ 356 (419)
T 3i6u_A 286 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ------ 356 (419)
T ss_dssp SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHH------
T ss_pred cccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHH------
Confidence 99998765432 2234678999999999853 678999999999999999999999997543321 1111
Q ss_pred HHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 590 LEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 590 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
...+.... .... ....+..+.+++.+||+.||++|||+.|+++.
T Consensus 357 -i~~~~~~~-~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 357 -ITSGKYNF-IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp -HHTTCCCC-CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -HhcCCCCC-Cchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11111100 0000 01235678999999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=331.02 Aligned_cols=262 Identities=21% Similarity=0.237 Sum_probs=196.0
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecC------
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER------ 437 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 437 (686)
.++|+..+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 378999999999999999999875 6889999999653 2334567889999999999999999999997654
Q ss_pred ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCc
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 517 (686)
..++||||++ ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 6799999996 57887774 23899999999999999999999987 999999999999999999999999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHH-----------
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKL----------- 586 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~----------- 586 (686)
+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+..
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 8654322 22345789999999999999999999999999999999999999987654332221110
Q ss_pred -----HHHHHhcC-c-----ccccccccc-C---CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 587 -----ARRLEEEG-R-----LMELVDVRI-G---TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 587 -----~~~~~~~~-~-----~~~~~d~~l-~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
........ . +...+...+ . ......+..+.+++.+||+.||++|||+.|+++.-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 00000000 0 000000000 0 01123467899999999999999999999998854
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=334.48 Aligned_cols=265 Identities=20% Similarity=0.254 Sum_probs=199.7
Q ss_pred HHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEec------
Q 005649 364 IAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE------ 436 (686)
Q Consensus 364 ~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 436 (686)
....++|+..+.||+|+||.||+++.. +|+.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 345789999999999999999999874 7899999998654322 24799999999999999999998543
Q ss_pred --------------------------------CceEEEEeecCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 005649 437 --------------------------------RERILVYEYLPNKSLDKFLFDK-SKSAILDWPKRLNIIMGVARGLLYL 483 (686)
Q Consensus 437 --------------------------------~~~~lv~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~L 483 (686)
...++||||++ |+|.+.+... .....+++..+..++.||++||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 23789999997 5887777542 2345699999999999999999999
Q ss_pred HhCCCCCeEecCCCCCcEEEc-CCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHH
Q 005649 484 HRDSVLRIIHRDIKASNILLD-HQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVL 561 (686)
Q Consensus 484 H~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvv 561 (686)
|+.+ |+||||||+|||++ .++.+||+|||+++....... .....++..|+|||.+.+. .++.++||||||++
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9987 99999999999998 688999999999987654332 2234679999999998775 59999999999999
Q ss_pred HHHHHcCCCCCcccchHhHHHHHHHHH------HHHh-cCccccccccccC------CCCHHHHHHHHHHHHHccccccc
Q 005649 562 LLEIISGRKNYDRQLEAENQELLKLAR------RLEE-EGRLMELVDVRIG------TYPEEIALRFMQIALLCTEDFIE 628 (686)
Q Consensus 562 l~elltG~~p~~~~~~~~~~~~~~~~~------~~~~-~~~~~~~~d~~l~------~~~~~~~~~l~~li~~cl~~~p~ 628 (686)
+|||++|+.||......+....+.... .... .....+..-+.+. ..+...+..+.+++.+||+.||+
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999999998765544322221100 0000 0000110001110 12334566789999999999999
Q ss_pred CCCCHHHHHHH
Q 005649 629 DRPTMSATLSM 639 (686)
Q Consensus 629 ~RPt~~evl~~ 639 (686)
+|||+.|+++.
T Consensus 312 ~R~t~~e~l~h 322 (383)
T 3eb0_A 312 LRINPYEAMAH 322 (383)
T ss_dssp GSCCHHHHHTS
T ss_pred hCCCHHHHhcC
Confidence 99999999853
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=329.68 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=201.8
Q ss_pred HHHHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEe----
Q 005649 362 VLIAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQ---- 435 (686)
Q Consensus 362 ~l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~---- 435 (686)
.+....++|+..+.||+|+||.||+|+.. +|+.||||++.... ...+.+.+|+.++.++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 34446789999999999999999999975 78999999986543 3457889999999999 89999999999987
Q ss_pred --cCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 005649 436 --ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISD 513 (686)
Q Consensus 436 --~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 513 (686)
.+..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEee
Confidence 457899999999999999997542 346899999999999999999999987 99999999999999999999999
Q ss_pred cCCccccCCcCccccccccccCCCcCchhhhh-----cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH
Q 005649 514 FGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI-----RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR 588 (686)
Q Consensus 514 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 588 (686)
||++........ ......|++.|+|||.+. +..++.++||||||+++|||++|+.||..........
T Consensus 173 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------ 244 (326)
T 2x7f_A 173 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------ 244 (326)
T ss_dssp CTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------
T ss_pred CcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH------
Confidence 999986643221 223356899999999987 5678999999999999999999999997654433221
Q ss_pred HHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 589 RLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 589 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.... .... .+ .+...+..+.+++.+||+.||++||++.++++.
T Consensus 245 ~~~~-~~~~-----~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 245 LIPR-NPAP-----RL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHH-SCCC-----CC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred Hhhc-Cccc-----cC--CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111 1111 11 122335678899999999999999999999873
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=327.07 Aligned_cols=252 Identities=27% Similarity=0.383 Sum_probs=188.5
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc-cH-HHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ-GK-EEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-~~-~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
.++|+..+.||+|+||.||+++.. +|+.||+|++...... .. +.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 578999999999999999999975 7899999999754322 22 33445555677789999999999999999999999
Q ss_pred eecCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 444 EYLPNKSLDKFLFDK-SKSAILDWPKRLNIIMGVARGLLYLHRD-SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||++ |+|.+++... .....+++..++.++.|++.||.|||++ + |+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 5888877542 2345699999999999999999999997 6 9999999999999999999999999998765
Q ss_pred CcCccccccccccCCCcCchhhh----hcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYA----IRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
.... .....|++.|+|||.+ .+..++.++||||||+++|||++|+.||......... . ..........
T Consensus 162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~----~~~~~~~~~~ 233 (290)
T 3fme_A 162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-L----KQVVEEPSPQ 233 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-H----HHHHHSCCCC
T ss_pred cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-H----HHHhccCCCC
Confidence 4322 2234689999999996 5667999999999999999999999999753322111 1 1111111100
Q ss_pred cccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 598 ~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 234 --------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 --------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 112234567899999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=338.40 Aligned_cols=263 Identities=21% Similarity=0.260 Sum_probs=204.8
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhc------CCCCcccEEEEEEecCce
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKM------QHRNLVQLFGCCVQERER 439 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~ 439 (686)
.++|++.++||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++..+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 467999999999999999999876 5889999999653 23346678888888887 577999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC--eEEEecCCc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK--PKISDFGLA 517 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla 517 (686)
++||||++ ++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999995 68999886543 244999999999999999999999987 999999999999999887 999999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHH-----HHh
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARR-----LEE 592 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~-----~~~ 592 (686)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..... ...
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 765432 2235789999999999999999999999999999999999999987665543322221100 000
Q ss_pred -cCccccccccc--------------------------------cC-C----CCHHHHHHHHHHHHHcccccccCCCCHH
Q 005649 593 -EGRLMELVDVR--------------------------------IG-T----YPEEIALRFMQIALLCTEDFIEDRPTMS 634 (686)
Q Consensus 593 -~~~~~~~~d~~--------------------------------l~-~----~~~~~~~~l~~li~~cl~~~p~~RPt~~ 634 (686)
.......++.. .. . .+......+.+++.+||+.||++|||+.
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 00000000000 00 0 0111246688999999999999999999
Q ss_pred HHHHHh
Q 005649 635 ATLSML 640 (686)
Q Consensus 635 evl~~L 640 (686)
|+++.-
T Consensus 405 e~L~Hp 410 (429)
T 3kvw_A 405 QALRHP 410 (429)
T ss_dssp HHHTST
T ss_pred HHhCCh
Confidence 998743
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=335.03 Aligned_cols=261 Identities=22% Similarity=0.285 Sum_probs=196.7
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecC------ceE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER------ERI 440 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~ 440 (686)
.+|+..+.||+|+||.||+|+.. +|+.||||++..... .+.+|++++++++||||+++++++.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888899999999999999986 689999999865322 2347999999999999999999986532 257
Q ss_pred EEEeecCCCChhHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CCeEEEecCCcc
Q 005649 441 LVYEYLPNKSLDKFLFD-KSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ-MKPKISDFGLAK 518 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~ 518 (686)
+||||+++ +|.+.+.. ......+++..++.++.||++||.|||+++ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 56555543 223456999999999999999999999987 9999999999999965 568999999998
Q ss_pred ccCCcCccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH------HHH
Q 005649 519 LFHDEQSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR------RLE 591 (686)
Q Consensus 519 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~------~~~ 591 (686)
....... .....||..|+|||++.+. .++.++|||||||++|||++|+.||......+....+.... ...
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 7654322 2235789999999998765 79999999999999999999999998765433222111100 000
Q ss_pred -hcCccccccccccCC------CCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 592 -EEGRLMELVDVRIGT------YPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 592 -~~~~~~~~~d~~l~~------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
......+...+.+.. ++...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 001111111111111 122345779999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=339.61 Aligned_cols=261 Identities=21% Similarity=0.283 Sum_probs=199.4
Q ss_pred CCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCc------eEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERE------RIL 441 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~l 441 (686)
.+|+..++||+|+||.||+++..++..+|+|++...... ..+|++++++++||||+++++++..... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 568889999999999999999987777999988643322 2369999999999999999999976443 789
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-CCCCeEEEecCCcccc
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD-HQMKPKISDFGLAKLF 520 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~ 520 (686)
||||++++.+............+++..+..++.||++||.|||+++ |+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999987655544433334556999999999999999999999987 99999999999999 7999999999999876
Q ss_pred CCcCccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHH--------HHH
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLAR--------RLE 591 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~~ 591 (686)
..... .....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+.... ...
T Consensus 193 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 193 IAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 44332 2234679999999998765 59999999999999999999999998765543322221110 000
Q ss_pred hcCccccccccccC------CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 592 EEGRLMELVDVRIG------TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 592 ~~~~~~~~~d~~l~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
. ....+..-+... .++...+..+.+++.+||+.||++|||+.|+++.
T Consensus 270 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 270 N-PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp C-GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred C-hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0 000000001110 1122345679999999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.48 Aligned_cols=266 Identities=20% Similarity=0.295 Sum_probs=205.4
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEec-----Cce
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQE-----RER 439 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 439 (686)
.++|+..+.||+|+||.||+++.. +++.||||++..... ...+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999976 688899999975432 3347789999999999999999999999764 367
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++|+||++ |+|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 589998854 34999999999999999999999987 99999999999999999999999999987
Q ss_pred cCCcCcc-ccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 520 FHDEQSR-HRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 520 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
....... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+...........+.
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 6543221 12234578999999998765 458999999999999999999999998766554433222110000000000
Q ss_pred cccc-------ccc---CC-----CCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 598 ELVD-------VRI---GT-----YPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 598 ~~~d-------~~l---~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
...+ ..+ .. .....+..+.+++.+||+.||++|||+.|+++.-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 0000 000 00 0122356788999999999999999999999854
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=338.82 Aligned_cols=261 Identities=23% Similarity=0.306 Sum_probs=187.2
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEec------C
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE------R 437 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 437 (686)
.++|+..+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999865 7899999999653 233456788999999999999999999999754 5
Q ss_pred ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCc
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 517 (686)
..++++|++ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 7899988843 45999999999999999999999987 999999999999999999999999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHH-----H
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL-----E 591 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-----~ 591 (686)
+..... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+...... .
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 865432 233578999999999887 68999999999999999999999999876554333222111000 0
Q ss_pred hcC---cccccccc--ccCCC-----CHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 592 EEG---RLMELVDV--RIGTY-----PEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 592 ~~~---~~~~~~d~--~l~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
..- .....+.. ..... ....+..+.+|+.+||+.||++|||+.|+++.-
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 000 00000000 00000 012346688999999999999999999999753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=329.38 Aligned_cols=263 Identities=22% Similarity=0.314 Sum_probs=203.3
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEec-----Cce
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE-----RER 439 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 439 (686)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 478999999999999999999976 68899999996543 23346788999999999999999999998764 578
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++|+||++ ++|.+++.. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999996 689998854 35999999999999999999999987 99999999999999999999999999987
Q ss_pred cCCcCccc--------cccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHH
Q 005649 520 FHDEQSRH--------RTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL 590 (686)
Q Consensus 520 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 590 (686)
........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+. ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~ 238 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF---GI 238 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---HH
Confidence 65322111 1223478999999998765 789999999999999999999999998765443322211 11
Q ss_pred HhcCc----cc--------cccc-------cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 591 EEEGR----LM--------ELVD-------VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 591 ~~~~~----~~--------~~~d-------~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
..... .. +.+. ..+.......+..+.+++.+||+.||++|||+.|+++.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 10000 00 0000 000000123456788999999999999999999999843
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=358.83 Aligned_cols=257 Identities=24% Similarity=0.347 Sum_probs=207.4
Q ss_pred HhhCCCcccccccccCcEEEEEEEecC----CCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCce
Q 005649 365 AATDNFSTKNMLGRGGFGTVYKGRLQD----GREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERER 439 (686)
Q Consensus 365 ~at~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 439 (686)
...++|+..+.||+|+||.||+|+... +..||+|++.... ....+.|.+|+.++++++||||+++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 345778899999999999999998752 4569999986543 333478999999999999999999999984 4678
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++||||+++|+|.+++... ...+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 466 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999999653 335899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 520 FHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 520 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ......
T Consensus 541 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i------~~~~~~-- 611 (656)
T 2j0j_A 541 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI------ENGERL-- 611 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------HHTCCC--
T ss_pred cCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------HcCCCC--
Confidence 6543221 2233456789999999999999999999999999999997 99999866554332211 111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+...+..+.+++.+||+.||++|||+.||++.|+++
T Consensus 612 -------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 612 -------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 12344567889999999999999999999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=341.83 Aligned_cols=199 Identities=25% Similarity=0.433 Sum_probs=166.6
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEec-----Cc
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE-----RE 438 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 438 (686)
.++|+..+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 478999999999999999999976 6888999999653 233457889999999999999999999999876 57
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.++||||++ |+|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 699999854 345999999999999999999999987 9999999999999999999999999999
Q ss_pred ccCCcCcc--------------------ccccccccCCCcCchhhh-hcCCCChhHHHHHHHHHHHHHHcCCCCC
Q 005649 519 LFHDEQSR--------------------HRTHQIAGTFGYMAPEYA-IRGFLSVKSDVFSFGVLLLEIISGRKNY 572 (686)
Q Consensus 519 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDv~s~Gvvl~elltG~~p~ 572 (686)
........ .......||..|+|||.+ ....++.++|||||||++|||++|..||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76543211 123456789999999986 5567999999999999999999854443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=339.57 Aligned_cols=253 Identities=8% Similarity=0.001 Sum_probs=184.6
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhc--CCCCcccEE-------EEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKM--QHRNLVQLF-------GCC 433 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~ 433 (686)
..+|+..+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888999999999999999976 789999999977543 2345677885545444 699988755 455
Q ss_pred Eec-----------------CceEEEEeecCCCChhHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 005649 434 VQE-----------------RERILVYEYLPNKSLDKFLFDKSKSAILDWPKR------LNIIMGVARGLLYLHRDSVLR 490 (686)
Q Consensus 434 ~~~-----------------~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~ 490 (686)
... ...+|||||++ |+|.+++..... .+.+..+ +.++.||++||.|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 433 23799999998 899999976422 3566666 788899999999999987
Q ss_pred eEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhc--CCCChhHHHHHHHHHHHHHHcC
Q 005649 491 IIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR--GFLSVKSDVFSFGVLLLEIISG 568 (686)
Q Consensus 491 ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~s~Gvvl~elltG 568 (686)
|+||||||+|||++.++.+||+|||+++...... ....+++.|+|||.+.+ ..++.++||||||+++|||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998664321 13456799999999987 6899999999999999999999
Q ss_pred CCCCcccchHhHHHHHHHHHHHHhcCccccccccccC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 569 RKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 569 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
+.||.......... +............+. ......+..+.+++.+||+.||++|||+.|+++
T Consensus 290 ~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99998654321100 000000000011111 111245678999999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=336.46 Aligned_cols=257 Identities=22% Similarity=0.334 Sum_probs=206.6
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCccc-----------------HHHHHHHHHHHHhcCCCCcccE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQG-----------------KEEFENEVRVLLKMQHRNLVQL 429 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~l 429 (686)
.++|+..+.||+|+||.||+++. +|+.||||++....... .+.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47899999999999999999999 89999999996542211 1789999999999999999999
Q ss_pred EEEEEecCceEEEEeecCCCChhHH------HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEE
Q 005649 430 FGCCVQERERILVYEYLPNKSLDKF------LFDKSKSAILDWPKRLNIIMGVARGLLYLHR-DSVLRIIHRDIKASNIL 502 (686)
Q Consensus 430 ~~~~~~~~~~~lv~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIl 502 (686)
++++.+.+..++||||+++|+|.++ +.. .....+++..++.++.|++.||.|||+ .+ |+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 432 124569999999999999999999999 76 999999999999
Q ss_pred EcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcC-CCCh-hHHHHHHHHHHHHHHcCCCCCcccch-Hh
Q 005649 503 LDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG-FLSV-KSDVFSFGVLLLEIISGRKNYDRQLE-AE 579 (686)
Q Consensus 503 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDv~s~Gvvl~elltG~~p~~~~~~-~~ 579 (686)
++.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||..... .+
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999999876433 23345789999999999887 6666 99999999999999999999986554 22
Q ss_pred HHHHHHHHHHHHhcCccccccc------cc----cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 580 NQELLKLARRLEEEGRLMELVD------VR----IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~~~~d------~~----l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.... ...+......+ +. ........+..+.+++.+||+.||++|||+.|+++.
T Consensus 261 ~~~~-------i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 261 LFNN-------IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHH-------HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHH-------HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2111 11111110000 00 001113456778999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=325.74 Aligned_cols=262 Identities=21% Similarity=0.268 Sum_probs=207.2
Q ss_pred hCCCcccccccccCcEEEEEEEe-c-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCC------CcccEEEEEEecCc
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRL-Q-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHR------NLVQLFGCCVQERE 438 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~-~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~~~~ 438 (686)
.++|++.+.||+|+||.||++.. . +++.||||++... ....+.+.+|++++..++|+ +++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999987 3 6889999999643 23356788999999998765 49999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-------------
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH------------- 505 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~------------- 505 (686)
.++||||+ +++|.+++.... ...+++..++.++.||++||.|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 899999996543 245899999999999999999999987 999999999999987
Q ss_pred ------CCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHh
Q 005649 506 ------QMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE 579 (686)
Q Consensus 506 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~ 579 (686)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999865432 223578999999999999999999999999999999999999998766554
Q ss_pred HHHHHHHHHH-----HHhcCccccc---------------------ccc--ccCCCCHHHHHHHHHHHHHcccccccCCC
Q 005649 580 NQELLKLARR-----LEEEGRLMEL---------------------VDV--RIGTYPEEIALRFMQIALLCTEDFIEDRP 631 (686)
Q Consensus 580 ~~~~~~~~~~-----~~~~~~~~~~---------------------~d~--~l~~~~~~~~~~l~~li~~cl~~~p~~RP 631 (686)
....+..... .......... ..+ .....+...+..+.+++.+||+.||++||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 4332222110 0000000000 000 00112345678899999999999999999
Q ss_pred CHHHHHHH
Q 005649 632 TMSATLSM 639 (686)
Q Consensus 632 t~~evl~~ 639 (686)
|+.|+++.
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.11 Aligned_cols=250 Identities=22% Similarity=0.322 Sum_probs=196.8
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--------ccHHHHHHHHHHHHhcCCCCcccEEEEEEecC
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--------QGKEEFENEVRVLLKMQHRNLVQLFGCCVQER 437 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 437 (686)
.++|++.+.||+|+||.||+++.. +++.||||++..... .....+.+|++++++++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 468999999999999999999976 678999999865321 12345889999999999999999999987654
Q ss_pred ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC---eEEEec
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK---PKISDF 514 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Df 514 (686)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 8999999999999998854 345999999999999999999999987 999999999999987664 999999
Q ss_pred CCccccCCcCccccccccccCCCcCchhhhh---cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHh-HHHHHHHHHHH
Q 005649 515 GLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI---RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE-NQELLKLARRL 590 (686)
Q Consensus 515 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~ 590 (686)
|+++...... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||....... ....+.
T Consensus 162 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----- 233 (322)
T 2ycf_A 162 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT----- 233 (322)
T ss_dssp TTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH-----
T ss_pred ccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH-----
Confidence 9998764322 123356899999999874 4678999999999999999999999997543321 111111
Q ss_pred HhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 591 EEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 591 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
.+.... . +.. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 234 --~~~~~~-~-~~~---~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 --SGKYNF-I-PEV---WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --HTCCCC-C-HHH---HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --hCcccc-C-chh---hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111100 0 000 1123567889999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=319.86 Aligned_cols=250 Identities=27% Similarity=0.362 Sum_probs=204.4
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 478999999999999999999986 78999999986543 345678999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC---CCeEEEecCCcccc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ---MKPKISDFGLAKLF 520 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~ 520 (686)
||+++++|.+++.... .+++..++.++.||+.||.|||+++ ++||||||+||+++.+ +.+||+|||++...
T Consensus 101 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 9999999999886543 4899999999999999999999987 9999999999999754 46999999999866
Q ss_pred CCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
..... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||......+.... .. .+......
T Consensus 175 ~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------~~-~~~~~~~~ 243 (287)
T 2wei_A 175 QQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR------VE-TGKYAFDL 243 (287)
T ss_dssp CCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HH-HCCCCCCS
T ss_pred cCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH------HH-cCCCCCCc
Confidence 43321 223457899999998865 489999999999999999999999986654432211 11 11111000
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
+.. ...+..+.+++.+||+.||++|||+.|+++
T Consensus 244 -~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 244 -PQW----RTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -GGG----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hhh----hhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 011 223567889999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=330.84 Aligned_cols=256 Identities=21% Similarity=0.304 Sum_probs=199.7
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCce----
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERER---- 439 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---- 439 (686)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 478999999999999999999876 689999999976432 2356789999999999999999999999877654
Q ss_pred --EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCc
Q 005649 440 --ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517 (686)
Q Consensus 440 --~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 517 (686)
++||||++ ++|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 68887772 23999999999999999999999987 999999999999999999999999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcc
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL 596 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (686)
+..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.... . ...
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---~-~~~ 262 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT---G-VPG 262 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH---C-CCC
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh---C-CCc
Confidence 865432 233568999999999887 689999999999999999999999998765443322221100 0 000
Q ss_pred ccccc-----------ccc--------CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 597 MELVD-----------VRI--------GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 597 ~~~~d-----------~~l--------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
.+..+ ..+ .......+..+.+++.+||+.||++|||+.|+++.-
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 325 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 325 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence 00000 000 001123367789999999999999999999998764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=320.61 Aligned_cols=254 Identities=25% Similarity=0.391 Sum_probs=195.4
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEe----------
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ---------- 435 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------- 435 (686)
.++|+..+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467899999999999999999975 7899999999543 2345678999999999999999999999865
Q ss_pred ---cCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEE
Q 005649 436 ---ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKIS 512 (686)
Q Consensus 436 ---~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 512 (686)
....++||||+++|+|.+++... ...+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 34678999999999999999753 245788999999999999999999987 9999999999999999999999
Q ss_pred ecCCccccCCcCc------------cccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHh
Q 005649 513 DFGLAKLFHDEQS------------RHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE 579 (686)
Q Consensus 513 Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~ 579 (686)
|||++........ ........|+..|+|||.+.+. .++.++||||||+++|||++ ||.....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-- 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-- 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH--
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh--
Confidence 9999987643210 1122345689999999998864 79999999999999999998 5542211
Q ss_pred HHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 580 NQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
...... .... ... .+. ..++...+..+.+++.+||+.||++|||+.|+++.-
T Consensus 234 ~~~~~~---~~~~-~~~--~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 234 RVNILK---KLRS-VSI--EFP---PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285 (303)
T ss_dssp HHHHHH---HHHS-TTC--CCC---TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred HHHHHH---hccc-ccc--ccC---ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence 111111 1111 100 011 123445566789999999999999999999999743
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=325.40 Aligned_cols=263 Identities=19% Similarity=0.282 Sum_probs=202.4
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcC-----------CCCcccEEEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-----------HRNLVQLFGCCV 434 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~ 434 (686)
.++|+..+.||+|+||.||+++.. +++.||||++... ....+.+.+|+.++.+++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 368999999999999999999974 7899999999643 233567889999999886 899999999998
Q ss_pred ecC----ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEc-----
Q 005649 435 QER----ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD-SVLRIIHRDIKASNILLD----- 504 (686)
Q Consensus 435 ~~~----~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dlkp~NIll~----- 504 (686)
..+ ..+++|||+ +++|.+++.... ...+++..++.++.||+.||.|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 754 789999999 899999997543 34499999999999999999999997 7 99999999999994
Q ss_pred -CCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhH---
Q 005649 505 -HQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAEN--- 580 (686)
Q Consensus 505 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~--- 580 (686)
..+.+||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4457999999999876432 2234789999999999999999999999999999999999999986542211
Q ss_pred HHHHHHHHHHHh--------cCccc-cccc--------------------cccCCCCHHHHHHHHHHHHHcccccccCCC
Q 005649 581 QELLKLARRLEE--------EGRLM-ELVD--------------------VRIGTYPEEIALRFMQIALLCTEDFIEDRP 631 (686)
Q Consensus 581 ~~~~~~~~~~~~--------~~~~~-~~~d--------------------~~l~~~~~~~~~~l~~li~~cl~~~p~~RP 631 (686)
...+........ .+... ..++ .....++...+..+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 111111111100 00000 0000 000134678889999999999999999999
Q ss_pred CHHHHHHHh
Q 005649 632 TMSATLSML 640 (686)
Q Consensus 632 t~~evl~~L 640 (686)
|+.|+++.-
T Consensus 327 t~~ell~hp 335 (373)
T 1q8y_A 327 DAGGLVNHP 335 (373)
T ss_dssp CHHHHHTCG
T ss_pred CHHHHhhCh
Confidence 999999843
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=328.92 Aligned_cols=260 Identities=20% Similarity=0.296 Sum_probs=200.5
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCc-----
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERE----- 438 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 438 (686)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 368999999999999999999975 689999999965432 234678999999999999999999999987654
Q ss_pred -eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCc
Q 005649 439 -RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517 (686)
Q Consensus 439 -~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 517 (686)
.++||||++ ++|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 68887763 23899999999999999999999987 999999999999999999999999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHH-----HH
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARR-----LE 591 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~-----~~ 591 (686)
+..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+..... ..
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 865432 223568999999999887 6789999999999999999999999987654433222111000 00
Q ss_pred hc----------CccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 592 EE----------GRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 592 ~~----------~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
.. ..+.......+.......+..+.+++.+||+.||++|||+.|+++.-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 307 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 00 00000000111122334567899999999999999999999998753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=323.63 Aligned_cols=242 Identities=27% Similarity=0.448 Sum_probs=194.8
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc------cHHHHHHHHHHHHhc----CCCCcccEEEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ------GKEEFENEVRVLLKM----QHRNLVQLFGCCVQ 435 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~e~~~l~~l----~h~niv~l~~~~~~ 435 (686)
.++|+..+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++.++ +||||+++++++.+
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 578999999999999999999875 7889999999655332 223456799999998 89999999999999
Q ss_pred cCceEEEEee-cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-CCCCeEEEe
Q 005649 436 ERERILVYEY-LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD-HQMKPKISD 513 (686)
Q Consensus 436 ~~~~~lv~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~D 513 (686)
.+..++|+|| +++++|.+++... ..+++..++.++.||++||.|||+++ |+||||||+||+++ .++.+||+|
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred CCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEE
Confidence 9999999999 7899999999754 34999999999999999999999987 99999999999999 889999999
Q ss_pred cCCccccCCcCccccccccccCCCcCchhhhhcCCCC-hhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHh
Q 005649 514 FGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLS-VKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEE 592 (686)
Q Consensus 514 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 592 (686)
||+++...... .....|+..|+|||.+.+..+. .++||||||+++|||++|+.||..... ...
T Consensus 184 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~~ 247 (312)
T 2iwi_A 184 FGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------------ILE 247 (312)
T ss_dssp CSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHH
T ss_pred cchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------------Hhh
Confidence 99998765432 2345689999999998877664 599999999999999999999974321 000
Q ss_pred cCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 593 EGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 593 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
.. ...+...+..+.+++.+||+.||++|||+.|+++.-
T Consensus 248 -~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 248 -AE---------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp -TC---------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred -hc---------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00 012334566788999999999999999999999843
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=332.01 Aligned_cols=270 Identities=20% Similarity=0.300 Sum_probs=186.6
Q ss_pred CCcc-cccccccCcEEEEEEEec---CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEe--cCceEEE
Q 005649 369 NFST-KNMLGRGGFGTVYKGRLQ---DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ--ERERILV 442 (686)
Q Consensus 369 ~f~~-~~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 442 (686)
.|+. .++||+|+||.||+|+.. +++.||||++.... ....+.+|+.++++++||||+++++++.. ....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3554 458999999999999975 57889999996543 23578899999999999999999999965 5678999
Q ss_pred EeecCCCChhHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE----cCCCCeEEE
Q 005649 443 YEYLPNKSLDKFLFDKS------KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL----DHQMKPKIS 512 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~ 512 (686)
|||++ |+|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99996 57877775321 2234999999999999999999999988 9999999999999 778899999
Q ss_pred ecCCccccCCcCc-cccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhH------HHHH
Q 005649 513 DFGLAKLFHDEQS-RHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAEN------QELL 584 (686)
Q Consensus 513 Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~------~~~~ 584 (686)
|||+++....... ........||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ ...+
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999987654321 1223446789999999999874 599999999999999999999999975543210 0111
Q ss_pred HHHHHHHh---cCccccccc-------------cccCCC---------CHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 585 KLARRLEE---EGRLMELVD-------------VRIGTY---------PEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 585 ~~~~~~~~---~~~~~~~~d-------------~~l~~~---------~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
........ ...+..+.. ...... .......+.+|+.+||+.||++|||+.|+++.
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11111110 000111000 000000 00114568899999999999999999999986
Q ss_pred hcCCC
Q 005649 640 LSNSS 644 (686)
Q Consensus 640 L~~~~ 644 (686)
---..
T Consensus 335 p~f~~ 339 (405)
T 3rgf_A 335 PYFLE 339 (405)
T ss_dssp GGGTS
T ss_pred hhhcc
Confidence 54433
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=323.91 Aligned_cols=254 Identities=19% Similarity=0.229 Sum_probs=175.2
Q ss_pred hCCCccc-ccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEe----cCceE
Q 005649 367 TDNFSTK-NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ----ERERI 440 (686)
Q Consensus 367 t~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~ 440 (686)
.++|.+. ++||+|+||.||+++.. +|+.||||++... ..........+..++||||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4788885 46999999999999987 6899999998642 1222233344666799999999999976 44589
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCCeEEEecCCc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH---QMKPKISDFGLA 517 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla 517 (686)
+||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999997543 346999999999999999999999987 999999999999976 455999999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
+...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.............. ....+..
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~~- 250 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR---RIRLGQY- 250 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH---hhhcccc-
Confidence 8654322 2345789999999999888999999999999999999999999975443322111000 0000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 598 ~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
... .......+..+.+++.+||+.||++|||+.|+++.-
T Consensus 251 ~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 251 GFP----NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp CCC----TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred ccC----chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 000 011123566789999999999999999999999843
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.47 Aligned_cols=265 Identities=22% Similarity=0.264 Sum_probs=204.4
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcC-CC-----CcccEEEEEEecCc
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-HR-----NLVQLFGCCVQERE 438 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~~ 438 (686)
..++|+..+.||+|+||.||+|+.. +++.||||++... ....+++..|+.++..++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3589999999999999999999976 6788999999643 233466788999988885 55 49999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc--CCCCeEEEecCC
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD--HQMKPKISDFGL 516 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgl 516 (686)
.++||||++ |+|.+++.... ...+++..+..++.|++.||.|||++. .+|+||||||+|||++ .++.+||+|||+
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999999995 59999997643 234899999999999999999999532 3499999999999994 578899999999
Q ss_pred ccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHH-----HH
Q 005649 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARR-----LE 591 (686)
Q Consensus 517 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~-----~~ 591 (686)
++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..... ..
T Consensus 208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9876432 2235789999999999999999999999999999999999999987665443332221110 00
Q ss_pred hc-Ccccccccc----------------------------------------cc--CCCCHHHHHHHHHHHHHccccccc
Q 005649 592 EE-GRLMELVDV----------------------------------------RI--GTYPEEIALRFMQIALLCTEDFIE 628 (686)
Q Consensus 592 ~~-~~~~~~~d~----------------------------------------~l--~~~~~~~~~~l~~li~~cl~~~p~ 628 (686)
.. ....+.++. .. ..........+.+|+.+||+.||+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 00 000000000 00 011234456899999999999999
Q ss_pred CCCCHHHHHHH
Q 005649 629 DRPTMSATLSM 639 (686)
Q Consensus 629 ~RPt~~evl~~ 639 (686)
+|||+.|+++.
T Consensus 363 ~Rpta~e~L~h 373 (382)
T 2vx3_A 363 TRIQPYYALQH 373 (382)
T ss_dssp TSCCHHHHTTS
T ss_pred hCCCHHHHhcC
Confidence 99999999863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=318.05 Aligned_cols=262 Identities=20% Similarity=0.268 Sum_probs=203.7
Q ss_pred hCCCcccccccccCcEEEEEEEec-CC-CEEEEEEecccCcccHHHHHHHHHHHHhcCCCC------cccEEEEEEecCc
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DG-REIAVKKLATNSMQGKEEFENEVRVLLKMQHRN------LVQLFGCCVQERE 438 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g-~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~ 438 (686)
.++|++.+.||+|+||.||+++.. ++ +.||+|++... ....+.+.+|+.++++++|++ ++.+.+++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 478999999999999999999975 34 68999999643 234567889999999997665 8999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---------------
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILL--------------- 503 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll--------------- 503 (686)
.++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 667777775532 245999999999999999999999987 9999999999999
Q ss_pred ----cCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHh
Q 005649 504 ----DHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE 579 (686)
Q Consensus 504 ----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~ 579 (686)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 67889999999999864432 223578999999999999999999999999999999999999998765544
Q ss_pred HHHHHHHHHH-----HHhcCccccc-cc--------------------c--ccCCCCHHHHHHHHHHHHHcccccccCCC
Q 005649 580 NQELLKLARR-----LEEEGRLMEL-VD--------------------V--RIGTYPEEIALRFMQIALLCTEDFIEDRP 631 (686)
Q Consensus 580 ~~~~~~~~~~-----~~~~~~~~~~-~d--------------------~--~l~~~~~~~~~~l~~li~~cl~~~p~~RP 631 (686)
....+..... .......... .. + ............+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 3322221110 0000000000 00 0 00012234567899999999999999999
Q ss_pred CHHHHHHH
Q 005649 632 TMSATLSM 639 (686)
Q Consensus 632 t~~evl~~ 639 (686)
|+.|+++.
T Consensus 327 t~~e~l~h 334 (355)
T 2eu9_A 327 TLAEALLH 334 (355)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999853
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=326.03 Aligned_cols=244 Identities=23% Similarity=0.397 Sum_probs=202.2
Q ss_pred HhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc------cHHHHHHHHHHHHhcC--CCCcccEEEEEEe
Q 005649 365 AATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ------GKEEFENEVRVLLKMQ--HRNLVQLFGCCVQ 435 (686)
Q Consensus 365 ~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~ 435 (686)
...++|+..+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++++++ |+||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 34578999999999999999999865 7889999999654322 2245778999999996 5999999999999
Q ss_pred cCceEEEEeecCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-CCCCeEEEe
Q 005649 436 ERERILVYEYLPN-KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD-HQMKPKISD 513 (686)
Q Consensus 436 ~~~~~lv~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~D 513 (686)
.+..++|+|++.+ ++|.+++... ..+++..++.++.||++||.|||+.+ |+||||||+|||++ +++.+||+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999986 8999999653 34899999999999999999999987 99999999999999 788999999
Q ss_pred cCCccccCCcCccccccccccCCCcCchhhhhcCCC-ChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHh
Q 005649 514 FGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL-SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEE 592 (686)
Q Consensus 514 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 592 (686)
||+++...... .....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||..... ...
T Consensus 194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------~~~ 257 (320)
T 3a99_A 194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIR 257 (320)
T ss_dssp CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHH
T ss_pred Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------hhc
Confidence 99998765432 233568999999999987765 7889999999999999999999974321 011
Q ss_pred cCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHh
Q 005649 593 EGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640 (686)
Q Consensus 593 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 640 (686)
+.. ..+...+..+.+++.+||+.||++|||+.|+++.-
T Consensus 258 -~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 258 -GQV---------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp -CCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred -ccc---------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 100 11223456788999999999999999999999854
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=321.77 Aligned_cols=254 Identities=27% Similarity=0.402 Sum_probs=180.2
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHH-HHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVR-VLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
.++|+..+.||+|+||.||++... +|+.||||++..... ....++..|+. +++.++||||+++++++.+++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 478899999999999999999986 789999999976432 33445666666 666779999999999999999999999
Q ss_pred eecCCCChhHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 444 EYLPNKSLDKFLFDK--SKSAILDWPKRLNIIMGVARGLLYLHRD-SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
||+++ +|.+++... .....+++..++.++.|++.||.|||++ + |+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 787777531 2245699999999999999999999997 6 999999999999999999999999999876
Q ss_pred CCcCccccccccccCCCcCchhhh----hcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYA----IRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL 596 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (686)
..... .....|+..|+|||.+ .+..++.++||||||+++|||++|+.||........ . . ...
T Consensus 177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~---~---~~~ 242 (327)
T 3aln_A 177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----Q---L---TQV 242 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCC
T ss_pred ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----H---H---HHH
Confidence 43321 2234689999999998 456789999999999999999999999975322110 0 0 000
Q ss_pred ccccccccC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 597 MELVDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 597 ~~~~d~~l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
..-..+.+. ......+..+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000011111 112234667899999999999999999999965
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=331.79 Aligned_cols=253 Identities=25% Similarity=0.343 Sum_probs=190.4
Q ss_pred CCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEEeec
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
+.|...++||+|+||+||.....+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+++..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 445567889999999998776678999999998643 245678999999886 8999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-------------CCe
Q 005649 447 PNKSLDKFLFDKSKSA----ILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQ-------------MKP 509 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~~ 509 (686)
+ |+|.+++....... ..++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 69999997543211 1234456789999999999999987 9999999999999754 489
Q ss_pred EEEecCCccccCCcCcc--ccccccccCCCcCchhhhhc-------CCCChhHHHHHHHHHHHHHHc-CCCCCcccchHh
Q 005649 510 KISDFGLAKLFHDEQSR--HRTHQIAGTFGYMAPEYAIR-------GFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAE 579 (686)
Q Consensus 510 kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~ 579 (686)
||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999977543321 12234579999999999875 678999999999999999999 999997544332
Q ss_pred HHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 580 NQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
. . ... +... .+......+...+..+.+++.+||+.||++|||+.|+++
T Consensus 248 ~-~-------i~~-~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 S-N-------IIR-GIFS--LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H-H-------HHH-TCCC--CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-H-------Hhc-CCCC--cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 1 111 1000 000001224567889999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=316.09 Aligned_cols=252 Identities=24% Similarity=0.372 Sum_probs=181.2
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc-c-HHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ-G-KEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
.++|+..+.||+|+||.||+++.. +|+.||||++...... . .+.+.++..+++.++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467889999999999999999986 7899999999755332 2 233445556788889999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD-SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
||+ ++.+..+.... ...+++..++.++.|+++||.|||++ + |+||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 55555554332 34589999999999999999999985 6 99999999999999999999999999976644
Q ss_pred cCccccccccccCCCcCchhhhh-----cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAI-----RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
... .....|++.|+|||.+. ...++.++||||||+++|||++|+.||........ ... .......
T Consensus 178 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~---~~~~~~~-- 247 (318)
T 2dyl_A 178 DKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VLT---KVLQEEP-- 247 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHH---HHHHSCC--
T ss_pred Ccc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HHH---HHhccCC--
Confidence 321 23356899999999984 56789999999999999999999999975332211 111 1111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 598 ~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
+.+. .....+..+.+++.+||+.||++||++.|+++.
T Consensus 248 ----~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 248 ----PLLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp ----CCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ----CCCC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0010 011245678899999999999999999999763
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=330.09 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=190.8
Q ss_pred hhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEEe
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 444 (686)
...+|+..++||+|+||+||.....+|+.||||++...... .+.+|+++++++ +||||+++++++.+....++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 34578889999999999976655668999999999654332 356899999999 89999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-----CCCeEEEecCCccc
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH-----QMKPKISDFGLAKL 519 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgla~~ 519 (686)
|++ |+|.+++.... ..+.+..++.++.||++||.|||+++ |+||||||+|||++. ...+||+|||+++.
T Consensus 99 ~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 99 LCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 995 69999996543 23555667889999999999999987 999999999999943 34688999999987
Q ss_pred cCCcCc-cccccccccCCCcCchhhhh---cCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcC
Q 005649 520 FHDEQS-RHRTHQIAGTFGYMAPEYAI---RGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEG 594 (686)
Q Consensus 520 ~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 594 (686)
...... ........||+.|+|||.+. ...++.++|||||||++|||++ |+.||.......... ... .
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-------~~~-~ 244 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-------LLG-A 244 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-------HTT-C
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-------Hhc-c
Confidence 654321 12233467999999999987 4678889999999999999999 999996543332211 111 1
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 595 RLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 595 ~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
.... ....+......+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 CSLD-----CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCT-----TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcc-----ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0000 00112345667889999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=341.49 Aligned_cols=257 Identities=25% Similarity=0.334 Sum_probs=201.5
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCCcccEEEEEEe------cCce
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ------ERER 439 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~ 439 (686)
++|++.+.||+|+||.||++... +|+.||||++... .....+.+.+|+.++.+++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 78999999999999999999975 6899999998654 33345779999999999999999999999765 6678
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC---eEEEecCC
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK---PKISDFGL 516 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgl 516 (686)
++||||+++|+|.+++........+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 999999999999999987655556999999999999999999999987 999999999999997765 99999999
Q ss_pred ccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHH----Hh
Q 005649 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL----EE 592 (686)
Q Consensus 517 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~----~~ 592 (686)
+........ .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .|.... ..
T Consensus 171 a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~~~~ 242 (676)
T 3qa8_A 171 AKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREKSNE 242 (676)
T ss_dssp CCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC-----
T ss_pred ccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhcccch
Confidence 987654332 234578999999999999999999999999999999999999997543221 110000 00
Q ss_pred cCcccccccc------c---cCCCCHHHHHHHHHHHHHcccccccCCCCHHH
Q 005649 593 EGRLMELVDV------R---IGTYPEEIALRFMQIALLCTEDFIEDRPTMSA 635 (686)
Q Consensus 593 ~~~~~~~~d~------~---l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e 635 (686)
.....+.... . ........+..+.+++.+||+.||++|||+.|
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0000111110 1 11344567889999999999999999999966
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=341.63 Aligned_cols=237 Identities=20% Similarity=0.301 Sum_probs=193.2
Q ss_pred hCCCcccccccccCcEEEEEEEec--CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCc-----
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ--DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERE----- 438 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 438 (686)
.++|++.+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|++++.+++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999975 68999999986543 3345678999999999999999999999988765
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.+|||||+++++|.+++.. .+++.+++.++.||++||.|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999987733 5999999999999999999999987 9999999999999986 89999999998
Q ss_pred ccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 519 LFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 519 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
..... ....||+.|+|||++.++. +.++||||||+++|||++|..|+......... +
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~----------------~ 286 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------------E 286 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC----------------T
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc----------------c
Confidence 76432 3357899999999987765 99999999999999999999887643211100 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccccccCCCC-HHHHHHHhc
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPT-MSATLSMLS 641 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~~L~ 641 (686)
..........+.+++.+||+.||++||+ ++++.+.|.
T Consensus 287 ------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 287 ------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp ------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0001223467889999999999999995 555655554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=303.90 Aligned_cols=227 Identities=10% Similarity=0.052 Sum_probs=183.3
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc---cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ---GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+..+.+++||||+++++++.+++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 67999999999999999999986 5899999999765332 2477899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++++|.+++.. . ....++..++.|++.||.|||+++ |+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999999843 1 456678899999999999999988 9999999999999999999997443
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
|++| ++.++||||||+++|||++|+.||......+... .....+...
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------~~~~~~~~~ 221 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDTAGQ 221 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------ECCBCTTSC
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------HHHHHhccC
Confidence 3333 6899999999999999999999998543321000 000000000
Q ss_pred c---CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 604 I---GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 604 l---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
. .......+..+.+++.+||+.||++| |+.|+++.|+...
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 0 01122345678999999999999999 9999999998743
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=297.43 Aligned_cols=227 Identities=20% Similarity=0.278 Sum_probs=180.0
Q ss_pred CCCccc-ccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHH-HhcCCCCcccEEEEEEe----cCceE
Q 005649 368 DNFSTK-NMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVL-LKMQHRNLVQLFGCCVQ----ERERI 440 (686)
Q Consensus 368 ~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~ 440 (686)
++|... +.||+|+||.||+++.. +++.||+|++.. ...+.+|+.++ +.++||||+++++++.. +...+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 567666 78999999999999975 789999999853 34677888887 55699999999999987 66789
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCCeEEEecCCc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH---QMKPKISDFGLA 517 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla 517 (686)
+||||+++|+|.+++.... ...+++..++.++.|++.||.|||+++ |+||||||+||+++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999997643 345999999999999999999999987 999999999999998 788999999998
Q ss_pred cccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
..... ..++.++||||||+++|||++|+.||......+.. .. ..
T Consensus 168 ~~~~~------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~-~~ 211 (299)
T 3m2w_A 168 KETTG------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PG-MK 211 (299)
T ss_dssp EECTT------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CC-SC
T ss_pred ccccc------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HH-HH
Confidence 75431 34577999999999999999999999754322110 00 00
Q ss_pred cccccccCCCC----HHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 598 ELVDVRIGTYP----EEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 598 ~~~d~~l~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
..+.......+ ...+..+.+++.+||+.||++|||+.|+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 212 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000001112 2346779999999999999999999999974
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=317.58 Aligned_cols=241 Identities=16% Similarity=0.141 Sum_probs=180.8
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCC-CCcc---------c----
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQH-RNLV---------Q---- 428 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h-~niv---------~---- 428 (686)
+.+|...++||+|+||.||+|+.. +|+.||||++..... ...+.|.+|+.++..++| +|.. .
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345777889999999999999965 799999999874332 235789999999999977 3211 1
Q ss_pred --------EEEEEEe-----cCceEEEEeecCCCChhHHHhh----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 005649 429 --------LFGCCVQ-----ERERILVYEYLPNKSLDKFLFD----KSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRI 491 (686)
Q Consensus 429 --------l~~~~~~-----~~~~~lv~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 491 (686)
+..+... ....+++|+++ +++|.+++.. ......+++..++.++.||++||.|||+++ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 1111111 12456777765 7899988842 123445889999999999999999999987 9
Q ss_pred EecCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhh----------hcCCCChhHHHHHHHHH
Q 005649 492 IHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYA----------IRGFLSVKSDVFSFGVL 561 (686)
Q Consensus 492 vH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDv~s~Gvv 561 (686)
+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999998865432 234567 999999998 45568899999999999
Q ss_pred HHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHH
Q 005649 562 LLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATL 637 (686)
Q Consensus 562 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl 637 (686)
+|||++|+.||......+. .. ..+.. ....+..+.+++.+||+.||++||++.|++
T Consensus 307 l~elltg~~Pf~~~~~~~~---------------~~----~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGG---------------SE----WIFRS-CKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSC---------------SG----GGGSS-CCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHCCCCCCCcchhhh---------------HH----HHHhh-cccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999999975432211 11 11110 112346789999999999999999976654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=302.54 Aligned_cols=242 Identities=15% Similarity=0.138 Sum_probs=186.7
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccC--------cccHHHHHHHHHHHHhcC---------CCCcccE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNS--------MQGKEEFENEVRVLLKMQ---------HRNLVQL 429 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~l 429 (686)
.++|+..+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788999999999999999998 68999999997543 223478899999999885 8888888
Q ss_pred EEEEE------------------------------ecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHH
Q 005649 430 FGCCV------------------------------QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARG 479 (686)
Q Consensus 430 ~~~~~------------------------------~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~ 479 (686)
.+.+. +++..+|||||+++|++.+.+.. ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 88753 25788999999999977666632 458999999999999999
Q ss_pred HHHHH-hCCCCCeEecCCCCCcEEEcCCC--------------------CeEEEecCCccccCCcCccccccccccCCCc
Q 005649 480 LLYLH-RDSVLRIIHRDIKASNILLDHQM--------------------KPKISDFGLAKLFHDEQSRHRTHQIAGTFGY 538 (686)
Q Consensus 480 L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y 538 (686)
|.||| +.+ |+||||||+||||+.++ .+||+|||+++..... ...||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 877 99999999999999887 8999999999876432 24789999
Q ss_pred CchhhhhcCCCChhHHHHHHHHH-HHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHH
Q 005649 539 MAPEYAIRGFLSVKSDVFSFGVL-LLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQ 617 (686)
Q Consensus 539 ~aPE~~~~~~~s~ksDv~s~Gvv-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~ 617 (686)
+|||.+.+.. +.++||||++++ .+++++|..||...... . .............. ..........+..+.+
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~---~~~~~~~~~~~~~~---~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--H---YLTDKMLKQMTFKT---KCNTPAMKQIKRKIQE 314 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--H---HHHHHHHHTCCCSS---CCCSHHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh--h---HHHHhhhhhhccCc---ccchhhhhhcCHHHHH
Confidence 9999998766 999999998777 77788899998532100 0 00111111100000 0001123467889999
Q ss_pred HHHHcccccccCCCCHHHHH
Q 005649 618 IALLCTEDFIEDRPTMSATL 637 (686)
Q Consensus 618 li~~cl~~~p~~RPt~~evl 637 (686)
++.+||+.| |+.|++
T Consensus 315 li~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHGGGSS-----SHHHHH
T ss_pred HHHHHhccC-----CHHHHH
Confidence 999999965 899988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=268.53 Aligned_cols=184 Identities=19% Similarity=0.175 Sum_probs=129.0
Q ss_pred ccccCcEEEEEEEe-cCCCEEEEEEecccC----------cccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEEE
Q 005649 376 LGRGGFGTVYKGRL-QDGREIAVKKLATNS----------MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 376 LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++.|++|.+..++. --|+.+++|.+.... ....++|.+|+++|+++ +|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 45566666655442 258899999996542 12235799999999999 7999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||++|++|.+.+... ..++.. +|+.||+.||.|||+++ ||||||||+||||++++.+||+|||+++.....
T Consensus 322 Eyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 999999999999653 346654 47899999999999998 999999999999999999999999999876543
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCC
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKN 571 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p 571 (686)
.. ......||+.|||||++.+ .+..++|+|++|++++++.++..+
T Consensus 393 ~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Cc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 32 2334679999999998875 467789999999998887665443
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-26 Score=198.59 Aligned_cols=106 Identities=28% Similarity=0.526 Sum_probs=93.5
Q ss_pred CCCcccccCCCCCccCCCChHHHHHHHHHHHhhhhcCCCCcceeeecC-CCCCCcEEEEEeccCCCChhhhHHHHHHHHH
Q 005649 48 EDDPRIKVCDSSTNNTLDSAFSSNLGIALKTLQNNTAQTGFSFTTISA-SNSSQPVTALALCRATITQSECQECMDSAVL 126 (686)
Q Consensus 48 ~~~~~~~~C~~~~~~~~~s~~~~nl~~l~~~l~~~~~~~~f~~~~~~~-~~~~~~vyg~~~Cr~d~~~~~C~~Cl~~a~~ 126 (686)
.+.++++.|++ ++|+++|+|++||+.||++|+++++..++.+.+.+. +.++++|||++|||||+++++|..||+.|+.
T Consensus 2 ~t~~v~~~Cn~-~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~ 80 (108)
T 3a2e_A 2 NTAFVSSACNT-QKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVN 80 (108)
T ss_dssp CCCEEEEEECS-SBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHT
T ss_pred CcceeeeecCC-CccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHH
Confidence 34567889965 699999999999999999999998655555444443 3467899999999999999999999999999
Q ss_pred HHHhhCCCCcceEEEcceEEEEEcCCcc
Q 005649 127 SIRRVCPDQTTAQIWHTYCMIRYSSRKF 154 (686)
Q Consensus 127 ~~~~~C~~~~~a~i~~~~C~~ry~~~~f 154 (686)
++.+.||++++|+||++.|+||||+++|
T Consensus 81 ~~~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 81 RIFSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp THHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence 9999999999999999999999999998
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=250.88 Aligned_cols=186 Identities=18% Similarity=0.258 Sum_probs=148.2
Q ss_pred cccccccccCcEEEEEEEecCCCEEEEEEecccCcc--------cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 371 STKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQ--------GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 371 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
...++||+|+||.||+++. .++.+++|+....... ..+++.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999955 5788999987543221 134589999999999999999777777788888999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+++++|.+++.. ++.++.|+++||.|||+++ |+||||||+|||+++ .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999854 4689999999999999987 999999999999999 999999999998765
Q ss_pred cCccc-----cccccccCCCcCchhhhhc--CCCChhHHHHHHHHHHHHHHcCCCCCc
Q 005649 523 EQSRH-----RTHQIAGTFGYMAPEYAIR--GFLSVKSDVFSFGVLLLEIISGRKNYD 573 (686)
Q Consensus 523 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~s~Gvvl~elltG~~p~~ 573 (686)
..... ......||+.|||||++.. ..|+...|+|+..+-..+-+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 33221 1234679999999999987 568888999999999999888777764
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=188.03 Aligned_cols=107 Identities=17% Similarity=0.396 Sum_probs=97.7
Q ss_pred ccccccccccccCCCCcchHHHHHHHHHHHHHHHhccCCCccccceeeeccCCceeEEEEeeeccCCccChhhHHHHHHh
Q 005649 159 DSSLAFSLFDQREVPNPTTFDQTVNSLTVNLAVLAGKSGKRFAVAKMKVISSDIYLYGYVECTRDVNGESCTKCLLSLRS 238 (686)
Q Consensus 159 d~~~~~~~~~~~~~~~~~~f~~~~~~ll~~l~~~a~~~~~~fa~~~~~~~~~~~~vyglaQC~~Dls~~dC~~CL~~a~~ 238 (686)
++...+..|+.++++.++.|+++++.||..|...|+.++.+|+++..+. .+.++||||+||+|||+++||+.||+.++.
T Consensus 2 ~t~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~-~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~ 80 (108)
T 3a2e_A 2 NTAFVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGS-GGAPTAYGRATCKQSISQSDCTACLSNLVN 80 (108)
T ss_dssp CCCEEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCS-TTCCCEEEEEEECTTSCHHHHHHHHHHHHT
T ss_pred CcceeeeecCCCccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccC-CCCceEEEEEEEcCCCCHHHHHHHHHHHHH
Confidence 3455678899999999999999999999999999988888888877764 455789999999999999999999999999
Q ss_pred hhhccCCCCcceEEeccccceeeccCCC
Q 005649 239 YMMTCCSGRWAIWVGAPTCSVQVNLDPV 266 (686)
Q Consensus 239 ~~~~~c~~~~g~~v~~~~C~lRy~~~~f 266 (686)
+++++|++++||+|++++|+||||+++|
T Consensus 81 ~~~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 81 RIFSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp THHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence 9999999999999999999999999998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.4e-22 Score=204.71 Aligned_cols=153 Identities=17% Similarity=0.120 Sum_probs=122.7
Q ss_pred HHHHHHhhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCc------------------ccHHHHHHHHHHHHhc
Q 005649 360 LDVLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSM------------------QGKEEFENEVRVLLKM 421 (686)
Q Consensus 360 ~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~e~~~l~~l 421 (686)
+..+......|...+.||+|+||.||+|+..+|+.||||++..... .....+.+|+.+++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3445556677888899999999999999997799999999964321 1245689999999999
Q ss_pred CCCCcccEEEEEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcE
Q 005649 422 QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNI 501 (686)
Q Consensus 422 ~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 501 (686)
+ | +++.+++. .+..++||||+++|+|.+ +.. .....++.|+++||.|||+.+ |+||||||+||
T Consensus 162 ~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 162 Q--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp T--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred c--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 9 4 56666443 356799999999999988 411 234579999999999999987 99999999999
Q ss_pred EEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhh
Q 005649 502 LLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI 545 (686)
Q Consensus 502 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 545 (686)
|++ ++.+||+|||+++.. ..++|||++.
T Consensus 225 Ll~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~ 252 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVEV---------------GEEGWREILE 252 (282)
T ss_dssp EEE-TTEEEECCCTTCEET---------------TSTTHHHHHH
T ss_pred EEE-CCcEEEEECCCCeEC---------------CCCCHHHHHH
Confidence 999 999999999998732 3468999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=3.3e-18 Score=173.43 Aligned_cols=138 Identities=20% Similarity=0.207 Sum_probs=108.3
Q ss_pred CCCcccccccccCcEEEEEEEe-cCCCE--EEEEEecccCcc------------------------cHHHHHHHHHHHHh
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRL-QDGRE--IAVKKLATNSMQ------------------------GKEEFENEVRVLLK 420 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~--vavK~l~~~~~~------------------------~~~~~~~e~~~l~~ 420 (686)
.-|+..+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+..+.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3367789999999999999998 68889 999987543111 11368899999999
Q ss_pred cCCCCc--ccEEEEEEecCceEEEEeecCC-C----ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeE
Q 005649 421 MQHRNL--VQLFGCCVQERERILVYEYLPN-K----SLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLH-RDSVLRII 492 (686)
Q Consensus 421 l~h~ni--v~l~~~~~~~~~~~lv~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~iv 492 (686)
+.|+++ +.++++ ...+|||||+.+ | +|.++... .++.....++.|++.+|.||| +.+ |+
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 988764 444443 367899999942 4 67665432 234567889999999999999 876 99
Q ss_pred ecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 493 HRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 493 H~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
||||||+|||+++ .++|+|||++...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.60 E-value=3.6e-16 Score=165.09 Aligned_cols=141 Identities=14% Similarity=0.172 Sum_probs=101.7
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcc--------------cHHH--------HHHHHHHHHhcCCC
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQ--------------GKEE--------FENEVRVLLKMQHR 424 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--------------~~~~--------~~~e~~~l~~l~h~ 424 (686)
..=|++.+.||+|++|.||+|...+|+.||||+++..... .... ...|...|.++.+.
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 3348999999999999999999999999999987532110 0111 23466666666544
Q ss_pred CcccEEEEEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 005649 425 NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD 504 (686)
Q Consensus 425 niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 504 (686)
++.-..-+.. ...+|||||+++++|.++.. ......++.|++.+|.+||+.+ ||||||||.|||++
T Consensus 174 gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 174 GFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR 239 (397)
T ss_dssp TCSCCCEEEE--ETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCCCeeeec--cCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence 4322211111 23479999999988865431 1234567899999999999987 99999999999998
Q ss_pred CCC----------CeEEEecCCccccC
Q 005649 505 HQM----------KPKISDFGLAKLFH 521 (686)
Q Consensus 505 ~~~----------~~kl~Dfgla~~~~ 521 (686)
+++ .+.|+||+.+....
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCCcccccccccceEEEEeCCcccCC
Confidence 776 38999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1.7e-11 Score=124.07 Aligned_cols=144 Identities=15% Similarity=0.071 Sum_probs=114.2
Q ss_pred hhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcC-CCCcccEEEEEEecCceEEEEe
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 444 (686)
.-+.|+....++.|+.+.||+.... ++.+++|+...........+.+|..+++.+. +.+++++++++.+.+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3467888888898999999999864 6899999986532233456889999999984 6788899999998889999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS------------------------------------- 487 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------- 487 (686)
|++|.+|.+.+. +......++.+++++|..||+-.
T Consensus 91 ~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 91 EADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred ecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999887631 11223478889999999999811
Q ss_pred -------------------CCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 488 -------------------VLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 488 -------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
...++|+|+++.|||++++..+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1349999999999999876666799998765
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=1.9e-10 Score=115.88 Aligned_cols=137 Identities=15% Similarity=0.118 Sum_probs=101.7
Q ss_pred CCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCC--cccEEEEEEecCceEEEEee
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN--LVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~Ey 445 (686)
.++....+.+.|..+.||+....+|+.+++|+.... ....+..|+.+++.+.+.+ +++++++...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 445544444456669999998877888999997543 2345788999999885544 56789888887889999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS-------------------------------------- 487 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------- 487 (686)
+++.+|. . .. .+ ...++.++++.|..||+..
T Consensus 97 i~G~~l~--~-~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--S-SH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--T-SC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--c-Cc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9998884 2 11 11 2356777888888888643
Q ss_pred -----------------CCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 488 -----------------VLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 488 -----------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1229999999999999887667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.92 E-value=2.9e-09 Score=112.86 Aligned_cols=143 Identities=15% Similarity=0.257 Sum_probs=108.2
Q ss_pred cccccccccCcEEEEEEEecCCCEEEEEEec--ccC-cccHHHHHHHHHHHHhcC--CCCcccEEEEEEec---CceEEE
Q 005649 371 STKNMLGRGGFGTVYKGRLQDGREIAVKKLA--TNS-MQGKEEFENEVRVLLKMQ--HRNLVQLFGCCVQE---RERILV 442 (686)
Q Consensus 371 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv 442 (686)
...+.|+.|.++.||+.... +..+++|+.. ... ......+.+|..+++.+. +.++++++.++.+. +..++|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 34678899999999999875 4678888875 322 123457888999999996 45688999988776 458999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS----------------------------------- 487 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------------------- 487 (686)
|||+++..+.+.. ...++...+..++.++++.|..||+..
T Consensus 120 me~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 120 MEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999998774321 123778888999999999999999731
Q ss_pred --------------------CCCeEecCCCCCcEEEcCCCC--eEEEecCCccc
Q 005649 488 --------------------VLRIIHRDIKASNILLDHQMK--PKISDFGLAKL 519 (686)
Q Consensus 488 --------------------~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~~ 519 (686)
...++|||+++.|||++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.91 E-value=2.1e-09 Score=111.12 Aligned_cols=184 Identities=18% Similarity=0.227 Sum_probs=124.1
Q ss_pred cccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCC--cccEEEEEEecC---ceEEEEeec
Q 005649 373 KNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRN--LVQLFGCCVQER---ERILVYEYL 446 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~Ey~ 446 (686)
.+.++.|....||+.. +.+++|+.... .....+.+|...+..+ .+.. +++++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999853 56888886432 3356788999999888 3333 455655544333 458999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS--------------------------------------- 487 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------- 487 (686)
++.+|...... .++..++..++.++++.|..||+-.
T Consensus 99 ~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99888754431 2677778888888888888888611
Q ss_pred ----------------CCCeEecCCCCCcEEEcC--CCCeEEEecCCccccCCcCccccccccccCCCc---Cchhhhhc
Q 005649 488 ----------------VLRIIHRDIKASNILLDH--QMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY---MAPEYAIR 546 (686)
Q Consensus 488 ----------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~ 546 (686)
.+.++|+|+++.||++++ +..+.|+||+.+..-..... ......+ ..|+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccccCHHHHHH
Confidence 135899999999999998 45678999999875321100 0000111 22332110
Q ss_pred -----CCC---------ChhHHHHHHHHHHHHHHcCCCCCc
Q 005649 547 -----GFL---------SVKSDVFSFGVLLLEIISGRKNYD 573 (686)
Q Consensus 547 -----~~~---------s~ksDv~s~Gvvl~elltG~~p~~ 573 (686)
+.. ....+.|+++.++|++.+|..+|.
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 111 223689999999999999987663
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=4.2e-06 Score=86.33 Aligned_cols=137 Identities=20% Similarity=0.189 Sum_probs=95.7
Q ss_pred ccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCC---CcccEEEEEE-ecCceEEEEeecC
Q 005649 372 TKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHR---NLVQLFGCCV-QERERILVYEYLP 447 (686)
Q Consensus 372 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~Ey~~ 447 (686)
..+.++.|....||+. |+.+++|+-. .......+..|..+|..+.+. .+++++.++. ..+..++||||++
T Consensus 23 ~v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp CEEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 3456888888899987 5778888842 223356789999999999653 3677777775 3456789999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 005649 448 NKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD----------------------------------------- 486 (686)
Q Consensus 448 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------------------------------------- 486 (686)
+..+.+.... .++......++.++++.|..||+-
T Consensus 97 G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 97 GQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp SEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred CeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 9888763221 134444455555555555555532
Q ss_pred ----------------CCCCeEecCCCCCcEEEcC---CCC-eEEEecCCccc
Q 005649 487 ----------------SVLRIIHRDIKASNILLDH---QMK-PKISDFGLAKL 519 (686)
Q Consensus 487 ----------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~Dfgla~~ 519 (686)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 455 48999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=7.2e-06 Score=82.69 Aligned_cols=133 Identities=19% Similarity=0.126 Sum_probs=96.2
Q ss_pred ccccCcE-EEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcC-CCCcccEEEEEEecCceEEEEeecCCCChh
Q 005649 376 LGRGGFG-TVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQERERILVYEYLPNKSLD 452 (686)
Q Consensus 376 LG~G~fG-~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 452 (686)
+..|..| .||+.... ++..+++|+-... ....+..|...|+.+. +-.+.++++++.+.+..++|||++++.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 3445444 68987765 5678899986432 3456788999998884 445788999999999999999999998887
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 005649 453 KFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS--------------------------------------------- 487 (686)
Q Consensus 453 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------------- 487 (686)
+..... ......+..+++..|..||.-.
T Consensus 109 ~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 109 QVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 655321 1223345666667777776411
Q ss_pred ----------CCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 488 ----------VLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 488 ----------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.+.++|+|+++.|||+++++.+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1238999999999999988777899998875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=2.7e-06 Score=89.68 Aligned_cols=80 Identities=4% Similarity=-0.010 Sum_probs=56.7
Q ss_pred cccc-cccCcEEEEEEEec-------CCCEEEEEEecccC---cccHHHHHHHHHHHHhcC-C--CCcccEEEEEEec--
Q 005649 373 KNML-GRGGFGTVYKGRLQ-------DGREIAVKKLATNS---MQGKEEFENEVRVLLKMQ-H--RNLVQLFGCCVQE-- 436 (686)
Q Consensus 373 ~~~L-G~G~fG~Vy~~~~~-------~g~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~-- 436 (686)
.+.| +.|....+|+.... +++.+++|+..... ......+..|..+++.+. + -.+++++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88888999998764 26788888765432 111245778888888874 2 3578888887665
Q ss_pred -CceEEEEeecCCCChh
Q 005649 437 -RERILVYEYLPNKSLD 452 (686)
Q Consensus 437 -~~~~lv~Ey~~~gsL~ 452 (686)
+..++||||+++..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3578999999887654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=4e-05 Score=81.95 Aligned_cols=75 Identities=16% Similarity=0.183 Sum_probs=50.6
Q ss_pred cccccccCcEEEEEEEec-CCCEEEEEEecccCc-------ccHHHHHHHHHHHHhcCC--C-CcccEEEEEEecCceEE
Q 005649 373 KNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-------QGKEEFENEVRVLLKMQH--R-NLVQLFGCCVQERERIL 441 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~l~~~~~~~~~~~l 441 (686)
.+.||.|..+.||++... +++.++||....... ...+.+..|.+++..+.. + .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567999999999999764 568899998643211 123456778888887742 3 34456644 4556789
Q ss_pred EEeecCCC
Q 005649 442 VYEYLPNK 449 (686)
Q Consensus 442 v~Ey~~~g 449 (686)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.88 E-value=6.1e-05 Score=78.46 Aligned_cols=141 Identities=13% Similarity=0.199 Sum_probs=80.4
Q ss_pred cccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcC--CCCcccEEE------EEEecCceEEEEe
Q 005649 373 KNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQ--HRNLVQLFG------CCVQERERILVYE 444 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~------~~~~~~~~~lv~E 444 (686)
.+.|+.|..+.||+....+| .+++|+.... ...+..|..++..+. .-.+++++. +....+..++++|
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34566667889999988655 5889988652 233444555555442 113344443 1234567889999
Q ss_pred ecCCCChh--------------HHHhhcCCC-----------CCCCHHHHH-----------------------------
Q 005649 445 YLPNKSLD--------------KFLFDKSKS-----------AILDWPKRL----------------------------- 470 (686)
Q Consensus 445 y~~~gsL~--------------~~l~~~~~~-----------~~l~~~~~~----------------------------- 470 (686)
|+++..+. ..+|..... ..-.|...+
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 111211110 012332211
Q ss_pred --HHHHHHHHHHHHHHh--------C--CCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 471 --NIIMGVARGLLYLHR--------D--SVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 471 --~i~~~ia~~L~~LH~--------~--~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.+...+..++.+|+. . ....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445666663 1 23469999999999999888899999999765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.85 E-value=0.0001 Score=74.97 Aligned_cols=81 Identities=20% Similarity=0.219 Sum_probs=61.8
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcC-C--CCcccEEEEEEecCceEEEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-H--RNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lv~ 443 (686)
......++.+|.|..+.||+.++.||+.+++|+-..........|..|...|+.|. . -.+++++++ +..++||
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~ 89 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAM 89 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEE
Confidence 34566778899999999999999999999999876554444567889999999884 2 235566654 2457899
Q ss_pred eecCCCCh
Q 005649 444 EYLPNKSL 451 (686)
Q Consensus 444 Ey~~~gsL 451 (686)
||++.+..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00022 Score=73.29 Aligned_cols=141 Identities=15% Similarity=0.130 Sum_probs=94.5
Q ss_pred CcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcC---CCCcccEEEEEEecCceEEEEeec
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQ---HRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
....+.|+.|....+|+... +++.+++|+.... ....+..|...|+.|. ...+++++.++...+..++||||+
T Consensus 38 i~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp CCEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 34557789999999999886 4678899987542 3567888998888883 367889999988888899999999
Q ss_pred CCCChhH-----------HHhhcCC-C------------------CCCCHHHHH---HHH----------------HHHH
Q 005649 447 PNKSLDK-----------FLFDKSK-S------------------AILDWPKRL---NII----------------MGVA 477 (686)
Q Consensus 447 ~~gsL~~-----------~l~~~~~-~------------------~~l~~~~~~---~i~----------------~~ia 477 (686)
++..+.. -||.... . -.-+|.... ++. ..+.
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 9876521 1222211 0 012454321 111 1111
Q ss_pred HHH-HHHHh-CCCCCeEecCCCCCcEEEcCCCCeEEEecC
Q 005649 478 RGL-LYLHR-DSVLRIIHRDIKASNILLDHQMKPKISDFG 515 (686)
Q Consensus 478 ~~L-~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 515 (686)
.-+ ..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 111 23422 2346799999999999999887 8898874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00033 Score=75.39 Aligned_cols=74 Identities=14% Similarity=0.198 Sum_probs=48.2
Q ss_pred ccccccccCcEEEEEEEecCCCEEEEEEeccc------C---cccHHHHHHHHHHHHh-cCCCCcccEEEEEEecCceEE
Q 005649 372 TKNMLGRGGFGTVYKGRLQDGREIAVKKLATN------S---MQGKEEFENEVRVLLK-MQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 372 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~------~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~l 441 (686)
..+.||.|....||+... +++.++||..... . ......++.|+..+.. .....+++++.+. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 456789999999999965 5678999943211 1 1123345555544332 2335677777765 567899
Q ss_pred EEeec-CC
Q 005649 442 VYEYL-PN 448 (686)
Q Consensus 442 v~Ey~-~~ 448 (686)
||||+ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.001 Score=67.96 Aligned_cols=74 Identities=8% Similarity=0.143 Sum_probs=46.3
Q ss_pred CcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCc-ccEEEEEEecCceEEEEeec-C
Q 005649 370 FSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL-VQLFGCCVQERERILVYEYL-P 447 (686)
Q Consensus 370 f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~Ey~-~ 447 (686)
+...+.|+.|....+|+. +.+++|+....... ..+..+|...+..+...++ ++++++ +.+.-++++||+ +
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG 91 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC
Confidence 333678888999999998 56888887543211 1123467777776642222 566654 444567899999 6
Q ss_pred CCCh
Q 005649 448 NKSL 451 (686)
Q Consensus 448 ~gsL 451 (686)
+.++
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 5554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0023 Score=65.83 Aligned_cols=157 Identities=11% Similarity=0.083 Sum_probs=85.7
Q ss_pred CHHHHHHhhCCCcc-----cccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCC--cccEEE
Q 005649 359 NLDVLIAATDNFST-----KNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN--LVQLFG 431 (686)
Q Consensus 359 ~~~~l~~at~~f~~-----~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~ 431 (686)
+.+++...-..|.. .+.|+.|....+|+....+| .+++|+..... ..+.+..|+.++..+...+ +++++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 44444444444543 34566788889999988655 68899886521 2234556777776663212 333332
Q ss_pred E------EEecCceEEEEeecCCCChhH--------------HHhhcCCC------CC---CCHHHHHHH----------
Q 005649 432 C------CVQERERILVYEYLPNKSLDK--------------FLFDKSKS------AI---LDWPKRLNI---------- 472 (686)
Q Consensus 432 ~------~~~~~~~~lv~Ey~~~gsL~~--------------~l~~~~~~------~~---l~~~~~~~i---------- 472 (686)
. ....+..++++||+++..+.. -+|..... .. ..|...+.-
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 123456789999998865421 11211100 00 123221110
Q ss_pred --HHHHHHHHHHHHhC----CCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 473 --IMGVARGLLYLHRD----SVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 473 --~~~ia~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
...+.+.+..+++. ....++|+|+++.|||++++..+.|+||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 11234455555532 12459999999999999987666899998765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0033 Score=65.07 Aligned_cols=142 Identities=15% Similarity=0.142 Sum_probs=73.3
Q ss_pred cccccccCcEE-EEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCC--CCcccEEEEEEecCceEEEEeecCCC
Q 005649 373 KNMLGRGGFGT-VYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQH--RNLVQLFGCCVQERERILVYEYLPNK 449 (686)
Q Consensus 373 ~~~LG~G~fG~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~Ey~~~g 449 (686)
.+.|+.|.... +|+....+|+.+++|....... +++..|+.++..+.. -.+++++.+..+ .-+++||++++.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCc
Confidence 34565554444 6677654477788876543221 233455666665532 345677766433 237899999876
Q ss_pred ChhHHHhhcC---------------------CC--CCCCHHHHH-------H-------------HHHHHHHHHHHHH--
Q 005649 450 SLDKFLFDKS---------------------KS--AILDWPKRL-------N-------------IIMGVARGLLYLH-- 484 (686)
Q Consensus 450 sL~~~l~~~~---------------------~~--~~l~~~~~~-------~-------------i~~~ia~~L~~LH-- 484 (686)
.+.+++.... .. ..++..... . ....+...+..|.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 6655442210 00 111111100 0 0011112222221
Q ss_pred -hCCCCCeEecCCCCCcEEEcCC----CCeEEEecCCccc
Q 005649 485 -RDSVLRIIHRDIKASNILLDHQ----MKPKISDFGLAKL 519 (686)
Q Consensus 485 -~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~~ 519 (686)
......++|||+++.|||++.+ ..+.|+||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123469999999999999875 6789999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00086 Score=72.31 Aligned_cols=73 Identities=16% Similarity=0.301 Sum_probs=50.0
Q ss_pred cccccccCcEEEEEEEecC--------CCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCc-ccEEEEEEecCceEEEE
Q 005649 373 KNMLGRGGFGTVYKGRLQD--------GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL-VQLFGCCVQERERILVY 443 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 443 (686)
.+.|+.|....+|+....+ ++.+++|+.... ...+.+..|..++..+...++ +++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567788889999998753 478899988432 112556689888888843333 677766532 3899
Q ss_pred eecCCCCh
Q 005649 444 EYLPNKSL 451 (686)
Q Consensus 444 Ey~~~gsL 451 (686)
||+++.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0016 Score=68.67 Aligned_cols=141 Identities=17% Similarity=0.222 Sum_probs=83.3
Q ss_pred ccccccCcEEEEEEEec--------CCCEEEEEEecccCcccHHHHHHHHHHHHhcC-CCCcccEEEEEEecCceEEEEe
Q 005649 374 NMLGRGGFGTVYKGRLQ--------DGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 444 (686)
+.|..|-...+|+.... +++.+++|+... .........+|..+++.+. +.-.+++++.+.+ .+|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45666777889998874 247889988633 2234566778999888884 3334677766543 39999
Q ss_pred ecCCCChhHH-----------------HhhcC--CCCCCC--HHHHHHHHHHHHH-------------------HHHH--
Q 005649 445 YLPNKSLDKF-----------------LFDKS--KSAILD--WPKRLNIIMGVAR-------------------GLLY-- 482 (686)
Q Consensus 445 y~~~gsL~~~-----------------l~~~~--~~~~l~--~~~~~~i~~~ia~-------------------~L~~-- 482 (686)
|+++..|..- ||... -..... |.++.++..++.. .+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9987655311 01110 011122 3444444443321 1223
Q ss_pred --HHhC-CCCCeEecCCCCCcEEEcCC----CCeEEEecCCccc
Q 005649 483 --LHRD-SVLRIIHRDIKASNILLDHQ----MKPKISDFGLAKL 519 (686)
Q Consensus 483 --LH~~-~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~~ 519 (686)
|... ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3222 23469999999999999876 7899999998763
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0077 Score=62.02 Aligned_cols=142 Identities=14% Similarity=0.171 Sum_probs=81.4
Q ss_pred ccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCC--CcccEEEE-----EEecCceEEEEeec
Q 005649 374 NMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHR--NLVQLFGC-----CVQERERILVYEYL 446 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~Ey~ 446 (686)
..|+ |....||+....+|+.+++|+..... .....+..|..++..+... .+++++.. ...++..++++||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4466 77789999887778889999986332 2345667788877777322 23444432 12244567899999
Q ss_pred CCCChh-----HH---------HhhcC------CCCCCCHHHH----HHH---------------HHHHHHHHHHHHh--
Q 005649 447 PNKSLD-----KF---------LFDKS------KSAILDWPKR----LNI---------------IMGVARGLLYLHR-- 485 (686)
Q Consensus 447 ~~gsL~-----~~---------l~~~~------~~~~l~~~~~----~~i---------------~~~ia~~L~~LH~-- 485 (686)
++..+. .. +|... .....++... ..+ ...+...+..+..
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875432 11 11110 0111232211 001 0111122223322
Q ss_pred --CCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 486 --DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 486 --~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
.....++|||+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1224589999999999999 4 899999987753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0045 Score=67.05 Aligned_cols=74 Identities=9% Similarity=0.116 Sum_probs=47.8
Q ss_pred cccccccCcEEEEEEEecC-CCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCc-ccEEEEEEecCceEEEEeecCCCC
Q 005649 373 KNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL-VQLFGCCVQERERILVYEYLPNKS 450 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~Ey~~~gs 450 (686)
.+.|+.|-...+|+....+ +..+++|+....... .-+-..|..++..|...++ +++++.+. + .+|+||+++..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4567788889999998865 477888887432211 1112578888888865444 57777662 2 35999998755
Q ss_pred h
Q 005649 451 L 451 (686)
Q Consensus 451 L 451 (686)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.49 E-value=0.012 Score=56.13 Aligned_cols=99 Identities=14% Similarity=0.079 Sum_probs=65.5
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcccc
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHR 528 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 528 (686)
-+|.+.|... +.++++.++|.++.|.++.|.-+-.+.. + ..+=+.|..|++..+|+|.+.+ +.+.
T Consensus 33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence 4788888653 4579999999999999999887632110 1 1233457999999999988753 1110
Q ss_pred ccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc
Q 005649 529 THQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS 567 (686)
Q Consensus 529 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt 567 (686)
.....+.+||... ...+.+.=|||+|++||.-+-
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1122456888653 455789999999999999987
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0042 Score=65.38 Aligned_cols=74 Identities=14% Similarity=0.110 Sum_probs=44.0
Q ss_pred cccccccCcEEEEEEEecC---------CCEEEEEEecccCcccHHHHHHHHHHHHhcCCCC-cccEEEEEEecCceEEE
Q 005649 373 KNMLGRGGFGTVYKGRLQD---------GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN-LVQLFGCCVQERERILV 442 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 442 (686)
.+.|+.|..-.+|+....+ ++.+++|+....... ..+...|..++..+...+ .+++++.. .-++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 3467778778899988754 267888887543211 112356777777774333 45676543 23789
Q ss_pred EeecCCCCh
Q 005649 443 YEYLPNKSL 451 (686)
Q Consensus 443 ~Ey~~~gsL 451 (686)
+||+++..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.19 E-value=0.026 Score=58.56 Aligned_cols=31 Identities=29% Similarity=0.403 Sum_probs=27.7
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 489 LRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 489 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888899999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.43 E-value=0.21 Score=53.22 Aligned_cols=74 Identities=8% Similarity=0.035 Sum_probs=47.8
Q ss_pred cccccccCcEEEEEEEecC--------CCEEEEEEecccCcccHHHHHHHHHHHHhcC-CCCcccEEEEEEecCceEEEE
Q 005649 373 KNMLGRGGFGTVYKGRLQD--------GREIAVKKLATNSMQGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 443 (686)
.+.|..|-...+|+....+ ++.+++|+....... .-+-.+|..+++.+. +.-.+++++.+ .-++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 4566677788899998763 578999986443211 112356788777774 33345666533 237899
Q ss_pred eecCCCCh
Q 005649 444 EYLPNKSL 451 (686)
Q Consensus 444 Ey~~~gsL 451 (686)
||+++..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.24 E-value=0.65 Score=49.06 Aligned_cols=30 Identities=30% Similarity=0.440 Sum_probs=25.3
Q ss_pred CeEecCCCCCcEEE------cCCCCeEEEecCCccc
Q 005649 490 RIIHRDIKASNILL------DHQMKPKISDFGLAKL 519 (686)
Q Consensus 490 ~ivH~Dlkp~NIll------~~~~~~kl~Dfgla~~ 519 (686)
.++|+|+.+.|||+ +++..++++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999988764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.62 E-value=0.99 Score=42.85 Aligned_cols=117 Identities=9% Similarity=0.108 Sum_probs=79.7
Q ss_pred CCCCcccEEEEEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcE
Q 005649 422 QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNI 501 (686)
Q Consensus 422 ~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 501 (686)
.||+++.. .+..+++...+.|+.-+.+ ..|- .-..++...+++++.+|+....+++. -+|--|+|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~--~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNH--TPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTS--EEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCccc--CCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 68888866 4556666666666654322 2222 11237888999999999988876665 37889999999
Q ss_pred EEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcc
Q 005649 502 LLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDR 574 (686)
Q Consensus 502 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~ 574 (686)
+++.++.+++.-.|+-..+ +|. ..+...=.-.+=+++..+++++..|+.
T Consensus 111 ~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp EECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999999766653221 221 122223334678899999999998863
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.25 E-value=2.6 Score=40.12 Aligned_cols=115 Identities=11% Similarity=0.106 Sum_probs=77.2
Q ss_pred CCCCcccEEEEEEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEecCCCCCc
Q 005649 422 QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLL-YLHRDSVLRIIHRDIKASN 500 (686)
Q Consensus 422 ~h~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~ivH~Dlkp~N 500 (686)
.||++ -...-.+++...+.++.-+++.=...+ ..++...+++++.+|+.... +++. -+|--|+|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 67887 444456677777777765443222233 22788899999998887776 5554 4788999999
Q ss_pred EEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCc
Q 005649 501 ILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYD 573 (686)
Q Consensus 501 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~ 573 (686)
+++|.++.+++.-.|+-.. ++|.- .++..=.-.+=+++..++.++..|+
T Consensus 115 L~f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999976665322 22221 1112222367788888999988875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 686 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-73 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-69 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-66 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-63 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-62 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-62 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-62 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-58 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-57 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-52 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-47 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-46 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-25 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (603), Expect = 2e-73
Identities = 72/284 (25%), Positives = 127/284 (44%), Gaps = 21/284 (7%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLV 427
+ +G G FGTVYKG+ + + + + Q + F+NEV VL K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
G + +V ++ SL L + K ++I A+G+ YLH S
Sbjct: 68 LFMGYST-APQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS 124
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYA--- 544
IIHRD+K++NI L + KI DFGLA + H+ Q++G+ +MAPE
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 545 IRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604
+ S +SDV++FG++L E+++G+ Y +++ + R + +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSN--INNRDQIIFMVGR--------GYLSPDL 231
Query: 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN--SSVP 646
++ C + ++RP L+ + S+P
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (573), Expect = 4e-69
Identities = 82/275 (29%), Positives = 132/275 (48%), Gaps = 21/275 (7%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLV 427
+ LG G FG V+ G ++AVK L SM + F E ++ ++QH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
+L+ QE ++ EY+ N SL FL S L K L++ +A G+ ++ +
Sbjct: 72 RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN 129
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG 547
IHRD++A+NIL+ + KI+DFGLA+L D + R + APE G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYG 185
Query: 548 FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTY 607
++KSDV+SFG+LL EI++ + + ++ + LE R++
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLERGYRMV---------R 231
Query: 608 PEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
P+ Q+ LC ++ EDRPT S+L +
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 5e-66
Identities = 73/274 (26%), Positives = 123/274 (44%), Gaps = 21/274 (7%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLV 427
+ +G G FG V+ G + ++A+K + +E+F E V++K+ H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
QL+G C+++ LV+E++ + L + +++ + L + + V G+ YL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG 547
+IHRD+ A N L+ K+SDFG+ + D+Q + + +PE
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFS 177
Query: 548 FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTY 607
S KSDV+SFGVL+ E+ S K EN+ ++ + RL
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPY-----ENRSNSEVVEDISTGFRLY---------K 223
Query: 608 PEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641
P + QI C ++ EDRP S L L+
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 1e-65
Identities = 65/278 (23%), Positives = 115/278 (41%), Gaps = 12/278 (4%)
Query: 366 ATDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQG-KEEFENEVRVLLKMQH 423
D+F + LG G G V+K G +A K + + + E++VL +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL 483
+V +G + E + E++ SLD+ L + + + + V +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEY 543
+I+HRD+K SNIL++ + + K+ DFG++ D + GT YM+PE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPER 174
Query: 544 AIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603
SV+SD++S G+ L+E+ GR +A+ EL+ + +
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP-DAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641
+A+ D+I + P + S
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFS 271
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 3e-65
Identities = 74/276 (26%), Positives = 127/276 (46%), Gaps = 23/276 (8%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLV 427
+ + LG G FG V G+ + ++A+K + SM ++EF E +V++ + H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLV 62
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
QL+G C ++R ++ EY+ N L +L + + L + V + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK- 119
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG 547
+ +HRD+ A N L++ Q K+SDFGL++ D++ + + PE +
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYS 176
Query: 548 FLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606
S KSD+++FGVL+ EI S G+ Y+R +E E + RL
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY--------------- 221
Query: 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
P + + I C + ++RPT LS + +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 2e-64
Identities = 77/275 (28%), Positives = 130/275 (47%), Gaps = 21/275 (7%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLV 427
++ + LG+G FG V+ G +A+K L +M E F E +V+ K++H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 75
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
QL+ +E +V EY+ SL FL ++ + P+ +++ +A G+ Y+ R
Sbjct: 76 QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVER-- 131
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG 547
+ +HRD++A+NIL+ + K++DFGLA+L D + R + APE A+ G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189
Query: 548 FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTY 607
++KSDV+SFG+LL E+ + + + N+E+L R
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVERGYRM------------PC 235
Query: 608 PEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
P E + C E+RPT + L +
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 212 bits (539), Expect = 6e-64
Identities = 70/301 (23%), Positives = 118/301 (39%), Gaps = 45/301 (14%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRL------QDGREIAVKKLATNSMQG-KEEFENEVRVLLK 420
+N +G G FG V++ R + +AVK L + + +F+ E ++ +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 421 MQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAI----------------- 463
+ N+V+L G C + L++EY+ L++FL S +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 464 ----LDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519
L ++L I VA G+ YL + +HRD+ N L+ M KI+DFGL++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 520 FHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE 579
+ A +M PE + +SDV+++GV+L EI S + E
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 580 NQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639
+ + D I PE L + LC DRP+ + +
Sbjct: 250 EV--------------IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295
Query: 640 L 640
L
Sbjct: 296 L 296
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 1e-63
Identities = 77/302 (25%), Positives = 125/302 (41%), Gaps = 28/302 (9%)
Query: 363 LIAATDNFSTKNM-LGRGGFGTVYKGRLQ---DGREIAVKKLATNSMQG-KEEFENEVRV 417
L DN ++ LG G FG+V +G + ++A+K L + + EE E ++
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 418 LLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVA 477
+ ++ + +V+L G C Q +LV E L KFL K + + ++ V+
Sbjct: 63 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVS 119
Query: 478 RGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS-RHRTHQIAGTF 536
G+ YL +HRD+ A N+LL ++ KISDFGL+K + S
Sbjct: 120 MGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 537 GYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGR 595
+ APE S +SDV+S+GV + E +S G+K Y + E ++ +R+E
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---- 232
Query: 596 LMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIPSVTESPD 655
P E + C EDRP + + S E
Sbjct: 233 -----------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 281
Query: 656 HY 657
H+
Sbjct: 282 HH 283
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 4e-63
Identities = 71/276 (25%), Positives = 119/276 (43%), Gaps = 27/276 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLV 427
+G+G FG V G G ++AVK + ++ + F E V+ +++H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 428 QLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD 486
QL G V+E+ + +V EY+ SL +L + +S +L L + V + YL +
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 487 SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR 546
+HRD+ A N+L+ K+SDFGL K Q + + APE
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALRE 174
Query: 547 GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606
S KSDV+SFG+LL EI S + ++ ++ + R+E+ ++
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPRVEKGYKM---------D 220
Query: 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
P+ ++ C RP+ L +
Sbjct: 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (530), Expect = 1e-62
Identities = 70/276 (25%), Positives = 126/276 (45%), Gaps = 21/276 (7%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQD-GREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL 426
+ + K+ LG G +G VY+G + +AVK L ++M+ EEF E V+ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 427 VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD 486
VQL G C +E ++ E++ +L +L + ++ + L + ++ + YL +
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEK- 133
Query: 487 SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIR 546
IHRD+ A N L+ K++DFGL++L + + APE
Sbjct: 134 --KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190
Query: 547 GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606
S+KSDV++FGVLL EI + + ++ ++ LE++ R+
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYELLEKDYRM---------E 236
Query: 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
PE + ++ C + DRP+ +
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 3e-62
Identities = 78/276 (28%), Positives = 119/276 (43%), Gaps = 29/276 (10%)
Query: 374 NMLGRGGFGTVYKGRLQD---GREIAVKKLATNSMQG--KEEFENEVRVLLKMQHRNLVQ 428
LG G FGTV KG Q + +AVK L + K+E E V+ ++ + +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 429 LFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488
+ G C E +LV E L+K+L + + ++ V+ G+ YL
Sbjct: 73 MIGICEAE-SWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES-- 126
Query: 489 LRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRT-HQIAGTFGYMAPEYAIRG 547
+HRD+ A N+LL Q KISDFGL+K +++ ++ + APE
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 548 FLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606
S KSDV+SFGVL+ E S G+K Y +E +L+ R+
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG--------------- 230
Query: 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
P + LC +E+RP +A L N
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 207 bits (527), Expect = 4e-62
Identities = 66/300 (22%), Positives = 127/300 (42%), Gaps = 36/300 (12%)
Query: 358 FNLDVLIAATDNFSTK---------NMLGRGGFGTVYKGRL----QDGREIAVKKLATN- 403
F + A F+ + ++G G FG V G L + +A+K L +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 404 SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAI 463
+ + + +F +E ++ + H N++ L G + +++ E++ N SLD FL
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 464 LDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523
+ + ++ G+A G+ YL + +HRD+ A NIL++ + K+SDFGL++ D+
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 524 QSRH---RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAEN 580
S + APE + SDV+S+G+++ E++S + +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPYWD 236
Query: 581 QELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640
+ +E++ RL P + Q+ L C + RP ++ L
Sbjct: 237 MTNQDVINAIEQDYRL---------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 6e-62
Identities = 74/296 (25%), Positives = 117/296 (39%), Gaps = 39/296 (13%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRL------QDGREIAVKKLATNSMQG-KEEFENEVRVLLK 420
+ S LG G FG V + +AVK L ++ +E +E++VL
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 421 M-QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAI---------------L 464
+ H N+V L G C +++ EY L FL K S I L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 465 DWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524
D L+ VA+G+ +L IHRD+ A NILL H KI DFGLA+ ++
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELL 584
+ +MAPE + +SDV+S+G+ L E+ S + + +++
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256
Query: 585 KLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640
+ ++E R+ PE I C + RPT + ++
Sbjct: 257 -FYKMIKEGFRM---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 1e-61
Identities = 70/278 (25%), Positives = 119/278 (42%), Gaps = 25/278 (8%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHR 424
+++ +G G +G K R DG+ + K+L SM K+ +EV +L +++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 425 NLVQLFGCCVQERERIL--VYEYLPNKSLDKFLFDKSKS-AILDWPKRLNIIMGVARGLL 481
N+V+ + + L V EY L + +K LD L ++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 482 YLHR--DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYM 539
HR D ++HRD+K +N+ LD + K+ DFGLA++ + + S + GT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYM 181
Query: 540 APEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599
+PE R + KSD++S G LL E+ + + +EL R EG+ +
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQKELAGKIR----EGKFRRI 234
Query: 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATL 637
P + +I RP++ L
Sbjct: 235 --------PYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-60
Identities = 63/274 (22%), Positives = 111/274 (40%), Gaps = 22/274 (8%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKL-ATNSMQGKEEFENEVRVLLKMQHRN 425
+++ LG G +G V +AVK + ++ E + E+ + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+V+ +G + + L EY L + + P + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI 545
+ I HRDIK N+LLD + KISDFGLA +F +++ GT Y+APE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 546 RG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604
R F + DV+S G++L +++G +D + + + E++ L +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWD----QPSDSCQEYSDWKEKKTYLNPWKKI-- 232
Query: 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638
+ L + +L R T+
Sbjct: 233 ----DSAPLALLH-KILVEN--PSARITIPDIKK 259
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-60
Identities = 79/309 (25%), Positives = 136/309 (44%), Gaps = 32/309 (10%)
Query: 341 DANALTNNQGIDMRSFLFNLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQD----GREIA 396
D +AL ++ + LI +F ++GRG FG VY G L D A
Sbjct: 5 DLSALNPELVQAVQHVVIGPSSLI---VHF--NEVIGRGHFGCVYHGTLLDNDGKKIHCA 59
Query: 397 VKKLATNSMQGK-EEFENEVRVLLKMQHRNLVQLFGCCVQ-ERERILVYEYLPNKSLDKF 454
VK L + G+ +F E ++ H N++ L G C++ E ++V Y+ + L F
Sbjct: 60 VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 119
Query: 455 LFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDF 514
+ +++ + + + VA+G+ + + +HRD+ A N +LD + K++DF
Sbjct: 120 IRNETHN--PTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADF 174
Query: 515 GLAKLFHDEQ--SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNY 572
GLA+ +D++ S H +MA E + KSDV+SFGVLL E+++
Sbjct: 175 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 234
Query: 573 DRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPT 632
+ + L + RL++ PE ++ L C E RP+
Sbjct: 235 Y-----PDVNTFDITVYLLQGRRLLQ---------PEYCPDPLYEVMLKCWHPKAEMRPS 280
Query: 633 MSATLSMLS 641
S +S +S
Sbjct: 281 FSELVSRIS 289
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 3e-60
Identities = 69/280 (24%), Positives = 133/280 (47%), Gaps = 26/280 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDG-----REIAVKKLATNSMQG-KEEFENEVRVLLKM 421
+ + ++G G FG VYKG L+ +A+K L + + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 422 QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLL 481
H N+++L G + + +++ EY+ N +LDKFL +K + + ++ G+A G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMK 124
Query: 482 YLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF-HDEQSRHRTHQIAGTFGYMA 540
YL + +HRD+ A NIL++ + K+SDFGL+++ D ++ + T + A
Sbjct: 125 YLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 541 PEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600
PE + SDV+SFG+++ E+++ + +L N E++K +
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKA------------IN 227
Query: 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640
D P + Q+ + C + RP + +S+L
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-60
Identities = 62/293 (21%), Positives = 109/293 (37%), Gaps = 29/293 (9%)
Query: 373 KNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGC 432
+ +G+G FG V++G+ G E+AVK ++ + E E+ + ++H N++
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAA 65
Query: 433 CVQER----ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488
++ + LV +Y + SL +L + + + + + A GL +LH + V
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 121
Query: 489 -----LRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS--RHRTHQIAGTFGYMAP 541
I HRD+K+ NIL+ I+D GLA + GT YMAP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 542 EY------AIRGFLSVKSDVFSFGVLLLEIISGRKNY----DRQLEAENQELLKLARRLE 591
E ++D+++ G++ EI D QL + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 592 EEGRLMELVDVRI--GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
+ + + I E +I C R T LS
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 6e-60
Identities = 71/303 (23%), Positives = 116/303 (38%), Gaps = 48/303 (15%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQD------GREIAVKKLATNSMQG-KEEFENEVRVLLK 420
+N +LG G FG V ++AVK L + +E +E++++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 421 M-QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKS------------------ 461
+ H N+V L G C L++EY L +L K +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 462 --AILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519
+L + L VA+G+ +L +HRD+ A N+L+ H KI DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 520 FHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKN--YDRQLE 577
+ + +MAPE G ++KSDV+S+G+LL EI S N ++
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 578 AENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATL 637
A +L++ +++ P I C RP+
Sbjct: 274 ANFYKLIQNGFKMD---------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
Query: 638 SML 640
S L
Sbjct: 319 SFL 321
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-59
Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 33/284 (11%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRL-QDGREIAVKKLATNSMQGK---EEFENEVRVLLKMQH 423
++F LG+G FG VY R Q +A+K L ++ + EV + ++H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL 483
N+++L+G L+ EY P ++ + L SK D + I +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEY 543
H R+IHRDIK N+LL + KI+DFG + R + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEM 175
Query: 544 AIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603
K D++S GVL E + G+ ++ QE K R+E
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRISRVE------------ 220
Query: 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS---MLSNSS 644
T+P+ + + + RP + L + +NSS
Sbjct: 221 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 263
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 2e-59
Identities = 66/278 (23%), Positives = 108/278 (38%), Gaps = 26/278 (9%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN 425
D + LG G FG VYK + + A K + T S + E++ E+ +L H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+V+L E ++ E+ ++D + + + L + + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHD 128
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI 545
+IIHRD+KA NIL K++DFG++ R + GT +MAPE +
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183
Query: 546 -----RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600
K+DV+S G+ L+E+ + L + + E +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-----VLLKIAKSEPPTLA-- 236
Query: 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638
P + F C E ++ R T S L
Sbjct: 237 ------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 4e-59
Identities = 74/292 (25%), Positives = 120/292 (41%), Gaps = 38/292 (13%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDG---REIAVKKL-ATNSMQGKEEFENEVRVLLKM-Q 422
++ ++++G G FG V K R++ + A+K++ S +F E+ VL K+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 423 HRNLVQLFGCCVQERERILVYEYLPNKSLDKFL-------------FDKSKSAILDWPKR 469
H N++ L G C L EY P+ +L FL S ++ L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 470 LNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRT 529
L+ VARG+ YL + + IHRD+ A NIL+ KI+DFGL++ +
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKK 183
Query: 530 HQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARR 589
+MA E + SDV+S+GVLL EI+S +L +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY-----CGMTCAELYEK 238
Query: 590 LEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641
L + RL P + C + +RP+ + L L+
Sbjct: 239 LPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (505), Expect = 8e-59
Identities = 74/279 (26%), Positives = 111/279 (39%), Gaps = 33/279 (11%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKE---EFENEVRVLLKMQ 422
FS +G G FG VY R +++ +A+KK++ + Q E + EVR L K++
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 423 HRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLY 482
H N +Q GC ++E LV EY + D K L + + G +GL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
LH +IHRD+KA NILL K+ DFG A + + GT +MAPE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPE 181
Query: 543 YAI---RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599
+ G K DV+S G+ +E+ + N + + +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPL------FNMNAMSALYHIAQNESPAL- 234
Query: 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638
+ F C + +DRPT L
Sbjct: 235 -------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-58
Identities = 65/271 (23%), Positives = 114/271 (42%), Gaps = 30/271 (11%)
Query: 376 LGRGGFGTVYKGRL-QDGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGC 432
+GRG F TVYKG + E+A +L + ++ F+ E +L +QH N+V+ +
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 433 CV----QERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSV 488
++ +LV E + + +L +L + + + +GL +LH +
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTRTP 133
Query: 489 LRIIHRDIKASNILLDHQ-MKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG 547
IIHRD+K NI + KI D GLA L + GT +MAPE
Sbjct: 134 -PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEM-YEE 187
Query: 548 FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGTY 607
DV++FG+ +LE+ + Y E Q ++ RR+ V+ ++
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYS-----ECQNAAQIYRRVTS--------GVKPASF 234
Query: 608 PEEIALRFMQIALLCTEDFIEDRPTMSATLS 638
+ +I C ++R ++ L+
Sbjct: 235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 3e-58
Identities = 67/273 (24%), Positives = 115/273 (42%), Gaps = 23/273 (8%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRN 425
++ +G+G GTVY + G+E+A++++ KE NE+ V+ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+V + E +V EYL SL + + D + + + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS 134
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI 545
++IHRDIK+ NILL K++DFG EQ + + GT +MAPE
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVT 189
Query: 546 RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605
R K D++S G++ +E+I G Y + L+ E +
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ------------ 237
Query: 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638
PE+++ F C + +E R + L
Sbjct: 238 -NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 4e-58
Identities = 73/286 (25%), Positives = 128/286 (44%), Gaps = 29/286 (10%)
Query: 363 LIAATDNFSTKNMLGRGGFGTVYKGR-LQDGRE----IAVKKL-ATNSMQGKEEFENEVR 416
++ T+ F +LG G FGTVYKG + +G + +A+K+L S + +E +E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 417 VLLKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGV 476
V+ + + ++ +L G C L+ + +P L ++ + + LN + +
Sbjct: 64 VMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQI 120
Query: 477 ARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF 536
A+G+ YL R++HRD+ A N+L+ KI+DFGLAKL E+ +
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 537 GYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGR 595
+MA E + + +SDV+S+GV + E+++ G K YD +E +L+ RL
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---- 233
Query: 596 LMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641
P + I + C + RP + S
Sbjct: 234 -----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 7e-57
Identities = 71/281 (25%), Positives = 108/281 (38%), Gaps = 27/281 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRL----QDGREIAVKKL---ATNSMQGKEEFENEVRVLLK 420
+ LG G FG V +G +AVK L + + ++F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 421 MQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGL 480
+ HRNL++L+G + ++ V E P SL L + VA G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGM 124
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH-RTHQIAGTFGYM 539
YL R IHRD+ A N+LL + KI DFGL + + F +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 540 APEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599
APE S SD + FGV L E+ + + L ++ ++++EG +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QILHKIDKEGERLPR 236
Query: 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640
PE+ + + C EDRPT A L
Sbjct: 237 --------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 9e-57
Identities = 65/287 (22%), Positives = 127/287 (44%), Gaps = 31/287 (10%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRL------QDGREIAVKKL-ATNSMQGKEEFENEVRVLLK 420
+ + LG+G FG VY+G + +A+K + SM+ + EF NE V+ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 421 MQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLF-------DKSKSAILDWPKRLNII 473
++V+L G Q + +++ E + L +L + A K + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 474 MGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIA 533
+A G+ YL+ + + +HRD+ A N ++ KI DFG+ + ++ + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 534 GTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEE 593
+M+PE G + SDV+SFGV+L EI + + + L N+++L+ E
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVLRFVM----E 250
Query: 594 GRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSML 640
G L++ P+ ++ +C + + RP+ +S +
Sbjct: 251 GGLLDK--------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 6e-55
Identities = 78/297 (26%), Positives = 120/297 (40%), Gaps = 38/297 (12%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR------LQDGREIAVKKLATNSMQG-KEEFENEVRVLLK 420
D LGRG FG V + R +AVK L + +E+++L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 421 MQHR-NLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAI-------------LD 465
+ H N+V L G C + + ++ E+ +L +L K + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 466 WPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525
+ VA+G+ +L + IHRD+ A NILL + KI DFGLA+ + +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLK 585
R +MAPE +++SDV+SFGVLL EI S + ++ + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---- 245
Query: 586 LARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
RRL+E R+ P+ Q L C RPT S + L N
Sbjct: 246 FCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 4e-54
Identities = 62/280 (22%), Positives = 104/280 (37%), Gaps = 26/280 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRL----QDGREIAVKKLATNSMQG-KEEFENEVRVLLKMQ 422
+ +G G FG V++G +A+K + +E+F E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 423 HRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLY 482
H ++V+L G E ++ E L FL + S LD + ++ L Y
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
L R +HRDI A N+L+ K+ DFGL++ D ++ + +MAPE
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPE 179
Query: 543 YAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602
+ SDV+ FGV + EI+ + ++ + R+E RL
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIENGERL------ 228
Query: 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
P + C RP + + LS
Sbjct: 229 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-53
Identities = 73/298 (24%), Positives = 119/298 (39%), Gaps = 40/298 (13%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRL--------QDGREIAVKKLATNSMQ-GKEEFENEVRVL 418
D LG G FG V ++AVK L +++ + + +E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 419 LKM-QHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAI-------------L 464
+ +H+N++ L G C Q+ ++ EY +L ++L + + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 465 DWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524
++ VARG+ YL + IHRD+ A N+L+ KI+DFGLA+ H
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELL 584
+T +MAPE + +SDV+SFGVLL EI + + + +EL
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELF 247
Query: 585 KLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
KL + EG M+ P + C RPT + L
Sbjct: 248 KLLK----EGHRMD--------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-53
Identities = 61/271 (22%), Positives = 102/271 (37%), Gaps = 26/271 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSM---QGKEEFENEVRVLLKMQH 423
++F +LG G F TV R L RE A+K L + E V+ ++ H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL 483
V+L+ + + Y N L K++ D + L YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYL 124
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEY 543
H IIHRD+K NILL+ M +I+DFG AK+ E + R + GT Y++PE
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 544 AIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603
SD+++ G ++ ++++G + + + +LE
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFR---AGNEYLIFQKIIKLE------------ 226
Query: 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMS 634
+PE+ + + R
Sbjct: 227 -YDFPEKFFPKARDLVEKLLVLDATKRLGCE 256
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 185 bits (470), Expect = 2e-53
Identities = 63/274 (22%), Positives = 114/274 (41%), Gaps = 23/274 (8%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL 426
D++ LG G FG V++ G A K + T KE E++ + ++H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 427 VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD 486
V L + E +++YE++ L + + D+ + + + + V +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHE- 142
Query: 487 SVLRIIHRDIKASNILLDHQM--KPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYA 544
+H D+K NI+ + + K+ DFGL +QS T GT + APE A
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 197
Query: 545 IRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604
+ +D++S GVL ++SG + + E L+ + + + D
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFG---GENDDETLRNVKSCD-----WNMDDSAF 249
Query: 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638
E+ F++ LL + R T+ L
Sbjct: 250 SGISED-GKDFIR-KLLLAD--PNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 181 bits (459), Expect = 8e-52
Identities = 58/274 (21%), Positives = 108/274 (39%), Gaps = 23/274 (8%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL 426
D + LG G FG V++ GR K + T K +NE+ ++ ++ H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 427 VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD 486
+ L + E +L+ E+L L + ++ + + +N + GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE- 145
Query: 487 SVLRIIHRDIKASNILLDHQMKP--KISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYA 544
I+H DIK NI+ + + KI DFGLA + ++ T + APE
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIV 200
Query: 545 IRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604
R + +D+++ GVL ++SG + + ++ E L+ +R + E
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGE---DDLETLQNVKRCDWEFDE-------- 249
Query: 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638
++ + R T+ L
Sbjct: 250 -DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (430), Expect = 2e-48
Identities = 58/284 (20%), Positives = 101/284 (35%), Gaps = 24/284 (8%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL 426
+ + +G G FG +Y G + G E+A+K + + E ++ MQ
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 427 VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD 486
+ C E + ++ L SL+ S+ L + + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS- 121
Query: 487 SVLRIIHRDIKASNIL---LDHQMKPKISDFGLAKLFHDEQS-----RHRTHQIAGTFGY 538
IHRD+K N L I DFGLAK + D ++ + GT Y
Sbjct: 122 --KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 539 MAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME 598
+ + S + D+ S G +L+ G + A ++ + E ++
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE----RISEKKMST 235
Query: 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
++V YP E F C +D+P S + N
Sbjct: 236 PIEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 171 bits (435), Expect = 2e-48
Identities = 60/234 (25%), Positives = 100/234 (42%), Gaps = 18/234 (7%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSM---QGKEEFENEVRVLLKMQ- 422
++FS ++GRGGFG VY R G+ A+K L + QG+ NE +L +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 423 --HRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGL 480
+V + + + + + L L + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGL 120
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMA 540
++H +++RD+K +NILLD +ISD GLA F S+ + H GT GYMA
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMA 173
Query: 541 PEYAIRGF-LSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEE 593
PE +G +D FS G +L +++ G + + + E+ ++ + E
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 227
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 3e-48
Identities = 57/291 (19%), Positives = 116/291 (39%), Gaps = 22/291 (7%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQG-KEEFENEVRVLLKMQHR 424
++ + +G G +G V + +A+KK++ Q + E+++LL+ +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLH 484
N++ + + YL + L+ K+ L + + RGL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 485 RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTH-QIAGTFGYMAPEY 543
++HRD+K SN+LL+ KI DFGLA++ + + T Y APE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 544 AIRGFLSVKS-DVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602
+ KS D++S G +L E++S R + + + + + L ++++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 603 RIGTY----PEEIALRFMQIALLCTEDFI-----------EDRPTMSATLS 638
+ Y P + + + ++ + R + L+
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (427), Expect = 7e-48
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 8/215 (3%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE-FENEVRVLLKMQHR 424
D + +++LG G F V + + +A+K +A +++GKE ENE+ VL K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLH 484
N+V L L+ + + L + +K +I V + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH 124
Query: 485 RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYA 544
++ + LD K ISDFGL+K+ GT GY+APE
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGTPGYVAPEVL 181
Query: 545 IRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE 579
+ S D +S GV+ ++ G + + +A+
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK 216
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 167 bits (423), Expect = 1e-47
Identities = 61/284 (21%), Positives = 116/284 (40%), Gaps = 28/284 (9%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGK---EEFENEVRVLLKMQ 422
+D + +LG GG V+ R L+ R++AVK L + + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 423 HRNLVQLFGCCVQERERI----LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR 478
H +V ++ E +V EY+ +L + + + + + +I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR-HRTHQIAGTFG 537
L + H+ IIHRD+K +NI++ K+ DFG+A+ D + +T + GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 538 YMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM 597
Y++PE A + +SDV+S G +L E+++G + + + E+
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-----VAYQHVREDPIPP 234
Query: 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRP-TMSATLSML 640
E ++ + L E+R T + + L
Sbjct: 235 S-------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 167 bits (424), Expect = 1e-47
Identities = 46/286 (16%), Positives = 96/286 (33%), Gaps = 26/286 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL 426
++ +G G FG +++G L + +++A+K + +E R +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTG 62
Query: 427 VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD 486
+ QE ++ L SL+ L + + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIHE- 119
Query: 487 SVLRIIHRDIKASNILLDHQMKP-----KISDFGLAKLFHDEQSR-----HRTHQIAGTF 536
+++RDIK N L+ + DFG+ K + D ++ ++GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 537 GYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL 596
YM+ + S + D+ + G + + + G + A N++ + ++ L
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 597 MELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642
EL +PEE + + P + S
Sbjct: 238 RELCA----GFPEEFY----KYMHYARNLAFDATPDYDYLQGLFSK 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 4e-47
Identities = 66/238 (27%), Positives = 105/238 (44%), Gaps = 18/238 (7%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFE---NEVRVL-LKMQ 422
++F MLG+G FG V+ + + A+K L + + ++ E E RVL L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 423 HRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLY 482
H L +F + V EYL L + K D + + GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
LH I++RD+K NILLD KI+DFG+ K ++ T GT Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 543 YAIRGFLSVKSDVFSFGVLLLEIISGR-----KNYDRQLEAENQELLKLARRLEEEGR 595
+ + D +SFGVLL E++ G+ ++ + + + R LE+E +
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAK 231
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 6e-47
Identities = 43/209 (20%), Positives = 87/209 (41%), Gaps = 12/209 (5%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL 426
+ + LGRG FG V++ + K + + + E+ +L +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNI 63
Query: 427 VQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD 486
+ L E ++++E++ + + + + + L+ + ++ + V L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 487 SVLRIIHRDIKASNILLDHQ--MKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYA 544
I H DI+ NI+ + KI +FG A+ + Y APE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPEVH 175
Query: 545 IRGFLSVKSDVFSFGVLLLEIISGRKNYD 573
+S +D++S G L+ ++SG +
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFL 204
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 165 bits (418), Expect = 7e-47
Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 26/219 (11%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKL---------ATNSMQGKEEFENEVRV 417
+N+ K +LGRG V + +E AVK + A + +E EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 418 LLKMQ-HRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGV 476
L K+ H N++QL LV++ + L +L +K L + I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRAL 119
Query: 477 ARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTF 536
+ LH+ L I+HRD+K NILLD M K++DFG + + ++ GT
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGTP 173
Query: 537 GYMAPEYA------IRGFLSVKSDVFSFGVLLLEIISGR 569
Y+APE + D++S GV++ +++G
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 1e-46
Identities = 70/304 (23%), Positives = 128/304 (42%), Gaps = 30/304 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKL--ATNSMQGKEEFENEVRVLLKMQHR 424
+NF +G G +G VYK R G +A+KK+ T + E+ +L ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLH 484
N+V+L E + LV+E+L D S + P + + + +GL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 485 RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE-Y 543
R++HRD+K N+L++ + K++DFGLA+ F + T Y APE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE--VVTLWYRAPEIL 174
Query: 544 AIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603
+ S D++S G + E+++ R + ++E +L ++ R L ++
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPG--DSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 604 IGTY----PEEIALRFMQIALLCTEDFI-----------EDRPTMSATLSM--LSNSSVP 646
+ Y P+ F ++ ED R + A L+ + + P
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292
Query: 647 IPSV 650
+P +
Sbjct: 293 VPHL 296
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 163 bits (413), Expect = 9e-46
Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 15/210 (7%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKL---ATNSMQGKEEFENEVRVLLKMQH 423
+F LG G FG V+ R +GR A+K L ++ E +E +L + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL 483
+++++G ++ ++ +Y+ L L + P V L YL
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---PNPVAKFYAAEVCLALEYL 120
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEY 543
H II+RD+K NILLD KI+DFG AK D + + GT Y+APE
Sbjct: 121 HS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEV 172
Query: 544 AIRGFLSVKSDVFSFGVLLLEIISGRKNYD 573
+ D +SFG+L+ E+++G +
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFY 202
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 5e-45
Identities = 68/322 (21%), Positives = 120/322 (37%), Gaps = 37/322 (11%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRL-QDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL 426
+++ ++G G FG VY+ +L G +A+KK+ +Q K E++++ K+ H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNI 75
Query: 427 VQLFGCCVQERER------ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGL 480
V+L E+ LV +Y+P L + + R L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQ-MKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYM 539
Y+H I HRDIK N+LLD K+ DFG AK + Y
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS---RYYR 189
Query: 540 APEYAIRGF-LSVKSDVFSFGVLLLEIISGRKNYDRQLEAEN-QELLKLARRLEEEGRLM 597
APE + DV+S G +L E++ G+ + + E++K+ E
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 598 ELVDVRIGTYPEEIALRFMQIALLCTE----DFI--------EDRPTMSATLSM-----L 640
+ +P+ A + ++ T R T + L
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 641 SNSSVPIPSVTESPDHYEGDDD 662
+ +V +P+ ++P +
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQ 331
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 158 bits (400), Expect = 2e-44
Identities = 56/286 (19%), Positives = 110/286 (38%), Gaps = 22/286 (7%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKL--ATNSMQGKEEFENEVRVLLKMQHRN 425
+ + +G G +G VYK + G A+KK+ E+ +L +++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 426 LVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+V+L+ ++ +LV+E+L + L+ + ++ + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 486 DSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAI 545
R++HRD+K N+L++ + + KI+DFGLA+ F ++ +I +
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMG 174
Query: 546 RGFLSVKSDVFSFGVLLLEIISGR-----KNYDRQLEAENQELLKLARRLEEEGRLMELV 600
S D++S G + E+++G + QL + L + +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 601 DVRIGTYPEEIALRFMQIALLCTEDFI--------EDRPTMSATLS 638
D Y F++ D + R T L
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-44
Identities = 62/294 (21%), Positives = 115/294 (39%), Gaps = 27/294 (9%)
Query: 366 ATDNFSTKNMLGRGGFGTVYKGR--LQDGREIAVKKLATNSMQGK--EEFENEVRVLLKM 421
A + +G G +G V+K R GR +A+K++ + + EV VL +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 422 ---QHRNLVQLFGCCVQERERILVYEYLPNKSLDK---FLFDKSKSAILDWPKRLNIIMG 475
+H N+V+LF C R L + +D+ DK + +++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 476 VARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGT 535
+ RGL +LH R++HRD+K NIL+ + K++DFGLA+++ + + T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVT 178
Query: 536 FGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGR 595
Y APE ++ + D++S G + E+ + + + + + L E
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 596 LMELVDVRIGTYPEEIALRFMQIALLCTEDFI-----------EDRPTMSATLS 638
V + + + A + E R + + LS
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-43
Identities = 65/304 (21%), Positives = 114/304 (37%), Gaps = 36/304 (11%)
Query: 374 NMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE-----FENEVRVLLKMQHRNLV 427
+ LG G F TVYK R + +A+KK+ ++ E+++L ++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 428 QLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS 487
L + LV++++ K S +L ++ +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 488 VLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRG 547
I+HRD+K +N+LLD K++DFGLAK F + T Y APE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGA 175
Query: 548 FL-SVKSDVFSFGVLLLEIISGRKNYDRQLEAEN-QELLKLARRLEEEGRLMELVDVRIG 605
+ V D+++ G +L E++ + + + + EE
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 606 TYPEEIALRFMQIALLCTEDFI-----------EDRPTMSATLSM---------LSNSSV 645
T+ + I +D + R T + L M +
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 295
Query: 646 PIPS 649
P P+
Sbjct: 296 PRPN 299
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-42
Identities = 70/282 (24%), Positives = 111/282 (39%), Gaps = 32/282 (11%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQG------KEEFENEVRVLLK 420
D + T LG G F V K R G + A K + + +E+ E EV +L +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 421 MQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGL 480
+QH N++ L + + IL+ E + L FL +K L + + + G+
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGV 126
Query: 481 LYLHRDSVLRIIHRDIKASNILLDHQMKP----KISDFGLAKLFHDEQSRHRTHQIAGTF 536
YLH L+I H D+K NI+L + P KI DFGLA + I GT
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTP 180
Query: 537 GYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL 596
++APE L +++D++S GV+ ++SG + QE L + E
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYEFED 237
Query: 597 MELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638
Y + + R T+ +L
Sbjct: 238 ---------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 4e-42
Identities = 62/295 (21%), Positives = 112/295 (37%), Gaps = 32/295 (10%)
Query: 372 TKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQL 429
T +LG G G V + + + A+K L Q + EV + + Q ++V++
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRI 70
Query: 430 FGCC----VQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR 485
+ ++V E L L + D+ A + I+ + + YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHS 129
Query: 486 DSVLRIIHRDIKASNILLDHQMKP---KISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
+ I HRD+K N+L + K++DFG AK S T Y+APE
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPE 183
Query: 543 YAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602
D++S GV++ ++ G + +K R+ + E +
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ----YEFPNP 239
Query: 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS---MLSNSSVPIPSVTESP 654
EE ++ LL TE R T++ ++ ++ ++ VP + S
Sbjct: 240 EWSEVSEE-VKMLIR-NLLKTE--PTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 290
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-41
Identities = 64/237 (27%), Positives = 97/237 (40%), Gaps = 17/237 (7%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE---FENEVRVLLKMQH 423
++F +LG+G FG V R GR A+K L + K+E E RVL +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL 483
L L V EY L L S+ + + + L YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEY 543
H +++RDIK N++LD KI+DFGL K + + GT Y+APE
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEV 176
Query: 544 AIRGFLSVKSDVFSFGVLLLEIISGR-----KNYDRQLEAENQELLKLARRLEEEGR 595
D + GV++ E++ GR ++++R E E ++ R L E +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 233
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-41
Identities = 54/282 (19%), Positives = 101/282 (35%), Gaps = 42/282 (14%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE------FENEVRVL-- 418
+ +LG GGFG+VY G + D +A+K + + + E EV +L
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 419 LKMQHRNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR 478
+ +++L + +L+ E + + L + V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLE 121
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLD-HQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFG 537
+ + H ++HRDIK NIL+D ++ + K+ DFG L D GT
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRV 174
Query: 538 YMAPEY-AIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL 596
Y PE+ + + V+S G+LL +++ G ++ E ++
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF------------ 222
Query: 597 MELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638
+ + ++ + C DRPT +
Sbjct: 223 ----------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-39
Identities = 60/312 (19%), Positives = 119/312 (38%), Gaps = 36/312 (11%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGK--EEFENEVRVLLKMQHR 424
+ +G+G FG V+K R + G+++A+KK+ + + E+++L ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 425 NLVQLFGCCVQERERI--------LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGV 476
N+V L C + LV+++ + K + ++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 477 ARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQ--IAG 534
GL Y+HR+ +I+HRD+KA+N+L+ K++DFGLA+ F ++
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 535 TFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGR-----KNYDRQLEAENQELLKLAR 588
T Y PE + D++ G ++ E+ + QL +Q +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 589 RLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFI-----------EDRPTMSATL 637
+ EL + ++ ++ A + + R L
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
Query: 638 SMLSNSSVPIPS 649
+ S P+PS
Sbjct: 304 NHDFFWSDPMPS 315
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-38
Identities = 40/206 (19%), Positives = 90/206 (43%), Gaps = 10/206 (4%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKL--ATNSMQGKEEFENEVRVLLKMQHR 424
+ +G G +GTV+K + + +A+K++ + E+ +L +++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 425 NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLH 484
N+V+L +++ LV+E+ F D + + + +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCH 118
Query: 485 RDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYA 544
++HRD+K N+L++ + K+++FGLA+ F R + ++ +
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLF 174
Query: 545 IRGFLSVKSDVFSFGVLLLEIISGRK 570
S D++S G + E+ + +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (358), Expect = 6e-38
Identities = 54/206 (26%), Positives = 85/206 (41%), Gaps = 15/206 (7%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEE---FENEVRVLLKMQH 423
D F LG G FG V + + G A+K L + ++ NE R+L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL 483
LV+L +V EY+ + L + P + YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEY 543
H L +I+RD+K N+L+D Q +++DFG AK RT + GT +APE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWTLCGTPEALAPEI 209
Query: 544 AIRGFLSVKSDVFSFGVLLLEIISGR 569
+ + D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 6e-36
Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 13/207 (6%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKL--ATNSMQGKEEFENEVRVLLKMQHR 424
+ +G G +G V + G ++A+KKL S + E+R+L M+H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 425 NLVQLFGCCVQERERILVYE-YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL 483
N++ L + + YL + L K L + ++ + +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEY 543
H IIHRD+K N+ ++ + KI DFGLA+ E + + + Y APE
Sbjct: 138 HA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR-----WYRAPEV 189
Query: 544 AI-RGFLSVKSDVFSFGVLLLEIISGR 569
+ + D++S G ++ E+I+G+
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 134 bits (338), Expect = 2e-35
Identities = 45/208 (21%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-HRN 425
D++ LGRG + V++ + + ++ VK L K++ + E+++L ++ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPN 91
Query: 426 LVQLFGCCVQERER--ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL 483
++ L R LV+E++ N + L + + + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 484 HRDSVLRIIHRDIKASNILLDHQ-MKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
H + I+HRD+K N+++DH+ K ++ D+GLA+ +H Q + + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPE 199
Query: 543 YAIR-GFLSVKSDVFSFGVLLLEIISGR 569
+ D++S G +L +I +
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 1e-34
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 18/229 (7%)
Query: 368 DNFSTKNMLGRGGFGTVYKGRL----QDGREIAVKKL----ATNSMQGKEEFENEVRVLL 419
+NF +LG G +G V+ R G+ A+K L + E E +VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 420 KMQHR-NLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR 478
++ LV L E + L+ +Y+ L L + + + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVL 140
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY 538
L +LH+ L II+RDIK NILLD ++DFGL+K F +++ R + GT Y
Sbjct: 141 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEY 196
Query: 539 MAPEYAIRGF--LSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLK 585
MAP+ G D +S GVL+ E+++G + E +Q +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 245
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-33
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 367 TDNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKL--ATNSMQGKEEFENEVRVLLKMQH 423
+ + + +G G +G+V + G +AVKKL S+ + E+R+L M+H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 424 RNLVQLFGCCVQERERI-LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLY 482
N++ L R YL + L + K L +I + RGL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 483 LHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPE 542
+H IIHRD+K SN+ ++ + KI DFGLA+ DE + + T Y APE
Sbjct: 137 IHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPE 188
Query: 543 YAIR-GFLSVKSDVFSFGVLLLEIISGR 569
+ + D++S G ++ E+++GR
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-31
Identities = 45/211 (21%), Positives = 81/211 (38%), Gaps = 21/211 (9%)
Query: 368 DNFSTKNMLGRGGFGTVYKGR-LQDGREIAVKKL--ATNSMQGKEEFENEVRVLLKMQHR 424
+ +G G G V R +A+KKL + + E+ ++ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 425 NLVQLFGCCVQER------ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVAR 478
N++ L ++ + LV E + + D + ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130
Query: 479 GLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGY 538
G+ +LH IIHRD+K SNI++ KI DFGLA+ T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYY 184
Query: 539 MAPEYAIRGFLSVKSDVFSFGVLLLEIISGR 569
APE + D++S G ++ E++ +
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 121 bits (304), Expect = 1e-30
Identities = 41/213 (19%), Positives = 82/213 (38%), Gaps = 18/213 (8%)
Query: 376 LGRGGFGTVYKGR-LQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCV 434
LG G F TV+ + + + +A+K + + + E E+E+++L ++ + +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 435 QERERILVYEYLPNKSLDKF-------------LFDKSKSAILDWPKRLNIIMGVARGLL 481
++L + + L K + + I + GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 482 YLHRDSVLRIIHRDIKASNILLD-HQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMA 540
Y+HR IIH DIK N+L++ + +A L + T Y +
Sbjct: 140 YMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 541 PEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYD 573
PE + +D++S L+ E+I+G ++
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 101 bits (253), Expect = 2e-25
Identities = 33/204 (16%), Positives = 61/204 (29%), Gaps = 31/204 (15%)
Query: 374 NMLGRGGFGTVYKGRLQDGREIAVK----------KLATNSMQGKEEFENEVRVLLKMQH 423
++G G V+ + E VK K+ G F + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 424 RNLVQLFGCCVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYL 483
R L +L G V + Y + N L + + K + ++ + +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119
Query: 484 HRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEY 543
+ I+H D+ N+L+ + I DF QS +
Sbjct: 120 YHR---GIVHGDLSQYNVLV-SEEGIWIIDFP--------QSVEVGEEGWREILERDVRN 167
Query: 544 AIRGF---LSVKSDVFSFGVLLLE 564
I F + D+ S +L+
Sbjct: 168 IITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 686 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.55 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.88 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.44 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.68 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.52 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.57 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-51 Score=416.03 Aligned_cols=265 Identities=28% Similarity=0.466 Sum_probs=209.4
Q ss_pred hhCCCcccccccccCcEEEEEEEecCCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
..++|++.+.||+|+||.||+|+++ ..||||+++.. .....+.|.+|+.++.+++||||+++++++. ++..+|||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEE
Confidence 3578999999999999999999875 36999999654 3344678999999999999999999999875 45789999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 83 Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 83 QWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp ECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred ecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999999653 245999999999999999999999987 999999999999999999999999999877654
Q ss_pred CccccccccccCCCcCchhhhhc---CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIR---GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
..........||+.|||||++.+ +.++.++|||||||++|||+||+.||.......... ... ..+. .
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~--~~~----~~~~----~ 227 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII--FMV----GRGY----L 227 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHH----HHTS----C
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH--HHH----hcCC----C
Confidence 44444556789999999999864 458999999999999999999999998654433211 111 1111 1
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCCCCC
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSVPIP 648 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 648 (686)
.+.+...+.+++..+.+++.+||+.||++|||++||++.|+.....+|
T Consensus 228 ~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 228 SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 122222344556789999999999999999999999999987654443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=411.95 Aligned_cols=255 Identities=29% Similarity=0.490 Sum_probs=204.5
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
.++|+..+.||+|+||.||+|++.+++.||||++.... ...++|.+|++++++++||||++++|++.+++..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 36788999999999999999999888999999997543 44678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++|+|.+++... ...++|..++.++.||++||.|||+++ |+||||||+||||++++.+||+|||+++........
T Consensus 83 ~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 83 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 999999998653 345899999999999999999999987 999999999999999999999999999876543322
Q ss_pred ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......||+.|+|||++.+..++.++|||||||++|||+| |++|+......+....+. ...+.
T Consensus 158 -~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~------~~~~~--------- 221 (263)
T d1sm2a_ 158 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS------TGFRL--------- 221 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH------HTCCC---------
T ss_pred -eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH------hcCCC---------
Confidence 2234578999999999999999999999999999999999 566666544433322211 11110
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+..++..+.+++.+||+.||++||||+||++.|+++
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 12344567789999999999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=401.75 Aligned_cols=254 Identities=29% Similarity=0.503 Sum_probs=217.8
Q ss_pred CCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecC
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLP 447 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 447 (686)
++|+..++||+|+||.||+|++++++.||||+++.... ..++|++|+.++++++||||++++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 68999999999999999999998888999999976443 46789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCccc
Q 005649 448 NKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSRH 527 (686)
Q Consensus 448 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 527 (686)
+|+|.+++... ...+++..+++++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 99999997653 345899999999999999999999987 999999999999999999999999999877654332
Q ss_pred cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCC
Q 005649 528 RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 606 (686)
......||+.|+|||.+.+..++.|+||||||+++|||+| |+.||......+....+. .+... .
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-------~~~~~--------~ 221 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGLRL--------Y 221 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-------TTCCC--------C
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-------hCCCC--------C
Confidence 2334578999999999999999999999999999999998 899998776655433221 11110 1
Q ss_pred CCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
.+...+..+.+++.+||+.||++|||++|+++.|.++
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 2344557789999999999999999999999998653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=410.46 Aligned_cols=255 Identities=32% Similarity=0.509 Sum_probs=210.2
Q ss_pred hhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
..++|++.+.||+|+||.||+|++++++.||||++.... ...+.|.+|++++.+++|||||+++|++.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 357888999999999999999999888899999997543 446789999999999999999999998754 567999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++|+|.+++.... ...++|..++.++.||++||.|||+++ |+||||||+||||++++.+||+|||+++.......
T Consensus 89 ~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 89 MENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc
Confidence 99999999885432 235999999999999999999999987 99999999999999999999999999998764332
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCC-CCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRK-NYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
. ......||+.|+|||.+.++.++.++|||||||++|||+||.. |+......+.... .. .+.. +
T Consensus 165 ~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~------i~-~~~~-----~-- 229 (272)
T d1qpca_ 165 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN------LE-RGYR-----M-- 229 (272)
T ss_dssp E-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH------HH-TTCC-----C--
T ss_pred c-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH------HH-hcCC-----C--
Confidence 2 2334678999999999999999999999999999999999655 4544433332211 11 1110 0
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+...+..+.+|+.+||+.||++||||+||+++|++
T Consensus 230 -~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 230 -VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 1234456778999999999999999999999999874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=405.56 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=207.3
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++.+++..+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 368999999999999999999975 789999999965432 334678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+++|+|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 y~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999999853 345999999999999999999999987 9999999999999999999999999999876544
Q ss_pred ccccccccccCCCcCchhhhhcCCC-ChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFL-SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
.........||+.|||||++.+..+ +.++|||||||++|||++|+.||............ . ......
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-----~-~~~~~~------ 225 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-----W-KEKKTY------ 225 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-----H-HTTCTT------
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-----H-hcCCCC------
Confidence 3334455789999999999988775 67899999999999999999999765543321111 1 111100
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
.......+..+.+++.+||+.||++|||++|+++
T Consensus 226 -~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 -LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111234567889999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.4e-50 Score=409.94 Aligned_cols=260 Identities=27% Similarity=0.386 Sum_probs=216.2
Q ss_pred HHHhhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 363 LIAATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 363 l~~at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
++...++|+..+.||+|+||.||+|++. +|+.||||+++... ...++|.+|++++++++|||||+++|++.+++..++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 3345678999999999999999999986 58899999986543 456789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||+++|+|.+++... ....+++..++.++.||++||.|||+++ |+||||||+||||++++.+||+|||+++...
T Consensus 91 v~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 91 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred EeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecC
Confidence 99999999999999754 3356999999999999999999999987 9999999999999999999999999999775
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCc-ccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYD-RQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
..... ......|++.|+|||++.++.++.++|||||||++|||++|+.|+. .....+....+ ..+..
T Consensus 167 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i-------~~~~~---- 234 (287)
T d1opja_ 167 GDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EKDYR---- 234 (287)
T ss_dssp SSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-------HTTCC----
T ss_pred CCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH-------hcCCC----
Confidence 43322 2334568899999999999999999999999999999999766654 33332222111 11111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
...+...+..+.+|+.+||+.||++|||+.||++.|+..
T Consensus 235 ----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 235 ----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ----CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 022445567899999999999999999999999999765
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-49 Score=410.89 Aligned_cols=256 Identities=25% Similarity=0.465 Sum_probs=200.5
Q ss_pred CCCcccccccccCcEEEEEEEec-CCC---EEEEEEeccc-CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGR---EIAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~---~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 442 (686)
++|+..++||+|+||.||+|+++ +++ .||||++... .....++|.+|+++|++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45777889999999999999975 332 5889988654 334457899999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+++|+|.+++... ...++|.+++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 9999999999988653 345999999999999999999999987 99999999999999999999999999997754
Q ss_pred cCccc---cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 523 EQSRH---RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 523 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
..... ......||+.|+|||.+.++.++.++|||||||++|||+| |+.||......+....+. ...+.
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~------~~~~~-- 252 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE------QDYRL-- 252 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH------TTCCC--
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH------cCCCC--
Confidence 33221 1223467899999999999999999999999999999998 899998765544322211 11111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+.+.+..+.+|+.+||+.||++|||+.||++.|+++
T Consensus 253 -------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 253 -------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 12445667899999999999999999999999999753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=402.26 Aligned_cols=249 Identities=27% Similarity=0.432 Sum_probs=212.5
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
++|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999965 79999999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++|+|.+++.+ ..+++.++..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 99999998754 24999999999999999999999987 99999999999999999999999999997754332
Q ss_pred ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCC
Q 005649 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 606 (686)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.... ....+... + .
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------~~~~~~~~------~-~ 237 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------IATNGTPE------L-Q 237 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HHHHCSCC------C-S
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHH------HHhCCCCC------C-C
Confidence 23446799999999999999999999999999999999999999976554332211 11111110 0 1
Q ss_pred CCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
.+...+..+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 23445677899999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=399.55 Aligned_cols=245 Identities=25% Similarity=0.414 Sum_probs=210.1
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN---SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|++.+.||+|+||.||+|+.+ +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999986 6889999998643 2334577899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++... ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999999654 34999999999999999999999987 999999999999999999999999999866543
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ .. ...
T Consensus 160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~-~~~------- 221 (263)
T d2j4za1 160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI------SR-VEF------- 221 (263)
T ss_dssp C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HT-TCC-------
T ss_pred c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH------Hc-CCC-------
Confidence 2 23467999999999999999999999999999999999999999866544432211 11 111
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
..+...+..+.+++.+||+.||++|||++|+++
T Consensus 222 --~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 --TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 124445678899999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-49 Score=403.22 Aligned_cols=256 Identities=28% Similarity=0.449 Sum_probs=211.3
Q ss_pred hCCCccccc-ccccCcEEEEEEEec---CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 367 TDNFSTKNM-LGRGGFGTVYKGRLQ---DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 367 t~~f~~~~~-LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
.++|...+. ||+|+||.||+|.++ ++..||||+++... ....++|.+|++++++++|||||+++|++.+ +..+|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 456677774 999999999999864 34579999997553 3345789999999999999999999999864 56899
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
||||+++|+|.+++... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 86 vmE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 99999999999998543 345999999999999999999999987 9999999999999999999999999999876
Q ss_pred CcCcc-ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 522 DEQSR-HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 522 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
..... .......||+.|+|||.+.++.++.++|||||||++|||+| |+.||......+....+. .+...
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-------~~~~~-- 231 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGKRM-- 231 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-------TTCCC--
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCC--
Confidence 54322 22334568999999999999999999999999999999998 999998766544332221 12111
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+..++..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 232 ------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 232 ------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 12445667889999999999999999999999998753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=402.55 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=200.2
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEe--cCceEE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQ--ERERIL 441 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 441 (686)
.++|++.+.||+|+||.||+|+.+ +|+.||||++..... ...+.+.+|++++++++||||+++++++.+ ++..++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 368999999999999999999975 789999999976532 335678999999999999999999999975 356799
Q ss_pred EEeecCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC--CCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 442 VYEYLPNKSLDKFLFDKS-KSAILDWPKRLNIIMGVARGLLYLHRDSV--LRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~--~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
||||+++|+|.+++.... ....+++..++.++.||+.||.|||+++. .+|+||||||+||||+.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999986532 34569999999999999999999998652 359999999999999999999999999999
Q ss_pred ccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 519 LFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 519 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
.+..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ ..+...
T Consensus 163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i-------~~~~~~- 232 (269)
T d2java1 163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-------REGKFR- 232 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-------HHTCCC-
T ss_pred ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHH-------HcCCCC-
Confidence 8754322 233468999999999999999999999999999999999999999876554332211 112111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 233 -------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 -------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 123445677999999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=399.13 Aligned_cols=247 Identities=32% Similarity=0.456 Sum_probs=202.0
Q ss_pred ccccccCcEEEEEEEecC---CCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeecCC
Q 005649 374 NMLGRGGFGTVYKGRLQD---GREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYLPN 448 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~---g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~ 448 (686)
++||+|+||.||+|.+++ ++.||||+++.... ...++|.+|++++++++|||||+++|++.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998653 46799999965432 235689999999999999999999999864 567899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc-c
Q 005649 449 KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR-H 527 (686)
Q Consensus 449 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~ 527 (686)
|+|.+++... ..+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 9999999653 34999999999999999999999987 999999999999999999999999999977544332 2
Q ss_pred cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccccccccCC
Q 005649 528 RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRIGT 606 (686)
Q Consensus 528 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 606 (686)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+....+. .+... .
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-------~~~~~--------~ 230 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERM--------G 230 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTCCC--------C
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-------cCCCC--------C
Confidence 2334678999999999999999999999999999999998 999998765544322221 11111 1
Q ss_pred CCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 607 YPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 607 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
.+..++..+.+|+.+||+.||++|||+++|+++|+.
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 244556788999999999999999999999998865
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=399.28 Aligned_cols=256 Identities=29% Similarity=0.478 Sum_probs=206.0
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
.++|++.+.||+|+||.||+|++++++.||||++... ....+.|.+|+.++++++|||||+++|++. ++..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 4679999999999999999999998889999999654 345678999999999999999999999985 45689999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++|+|..++.... ...++|.+++.++.||+.||.|||+++ |+||||||+|||||+++.+||+|||+++........
T Consensus 94 ~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 9999999886543 235999999999999999999999987 999999999999999999999999999876543322
Q ss_pred ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCC-cccchHhHHHHHHHHHHHHhcCccccccccccC
Q 005649 527 HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNY-DRQLEAENQELLKLARRLEEEGRLMELVDVRIG 605 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 605 (686)
......||+.|+|||++..+.++.++||||||+++|||++|+.|+ ......+....+. .+.. .
T Consensus 170 -~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-------~~~~--------~ 233 (285)
T d1fmka3 170 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYR--------M 233 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTCC--------C
T ss_pred -eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-------hcCC--------C
Confidence 233457899999999999999999999999999999999965554 4433333222111 1110 0
Q ss_pred CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 606 TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 606 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
..+..+++.+.+++.+||+.||++|||+++|+++|+..-
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 124455678999999999999999999999999998754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=408.41 Aligned_cols=259 Identities=29% Similarity=0.442 Sum_probs=211.9
Q ss_pred hhCCCcccccccccCcEEEEEEEecC-C-----CEEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecC
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQD-G-----REIAVKKLATN-SMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQER 437 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~-g-----~~vavK~l~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 437 (686)
..++|++.++||+|+||.||+|+... + ..||+|++... .......+.+|+.++.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 45789999999999999999998753 2 25899998654 334456899999999998 8999999999999999
Q ss_pred ceEEEEeecCCCChhHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSK--------------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIK 497 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk 497 (686)
..++||||+++|+|.+++..... ...+++..++.++.||++||.|||+++ |+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 99999999999999999976432 235899999999999999999999987 9999999
Q ss_pred CCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccc
Q 005649 498 ASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQL 576 (686)
Q Consensus 498 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~ 576 (686)
|+|||++.++.+||+|||+++...............||+.|||||.+.++.++.++|||||||++|||+| |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987665444334445678999999999999999999999999999999998 899998654
Q ss_pred hHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 577 EAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
..+... .....+... ..+...+..+.+|+.+||+.||++|||++||++.|.
T Consensus 272 ~~~~~~------~~~~~~~~~--------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDANFY------KLIQNGFKM--------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSHHHH------HHHHTTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHH------HHHhcCCCC--------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 433211 111111100 224455678999999999999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=400.95 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=211.4
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
+.|++.+.||+|+||.||+|+.. +|+.||||++........+.|.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999975 68999999998776667788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++|+|.+++.+.. ..+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 9999999986532 35999999999999999999999987 9999999999999999999999999997654321
Q ss_pred ccccccccCCCcCchhhhh-----cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 527 HRTHQIAGTFGYMAPEYAI-----RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 527 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
.......||+.|+|||++. +..++.++|||||||++|||++|+.||......+.... .......
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~------i~~~~~~----- 233 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK------IAKSEPP----- 233 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH------HHHSCCC-----
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH------HHcCCCC-----
Confidence 1233467999999999984 45689999999999999999999999987655443221 1111110
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
.+ ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 234 -~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 -TL-AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -CC-SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CC-CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01 123445678899999999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=401.06 Aligned_cols=248 Identities=24% Similarity=0.330 Sum_probs=207.4
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN---SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999975 7899999998643 2334578999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999998654 34999999999999999999999987 999999999999999999999999999987654
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ .. +.+
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i------~~-~~~------- 227 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------IK-LEY------- 227 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HT-TCC-------
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH------Hc-CCC-------
Confidence 4444445568999999999999999999999999999999999999999876544332211 11 111
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCCHHHHH
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPTMSATL 637 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl 637 (686)
.++...+..+.+++.+||+.||++|||++|++
T Consensus 228 --~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 228 --DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp --CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 12344567789999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-48 Score=405.18 Aligned_cols=265 Identities=27% Similarity=0.451 Sum_probs=219.1
Q ss_pred HHHHhhCCCcccccccccCcEEEEEEEec------CCCEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCCcccEEEEEE
Q 005649 362 VLIAATDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNSMQ-GKEEFENEVRVLLKMQHRNLVQLFGCCV 434 (686)
Q Consensus 362 ~l~~at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~ 434 (686)
+++..+++|++.+.||+|+||.||+|+.+ +++.||||++...... ..++|.+|+.++++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34556789999999999999999999864 3578999999754433 3567999999999999999999999999
Q ss_pred ecCceEEEEeecCCCChhHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 005649 435 QERERILVYEYLPNKSLDKFLFDKSK---------------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIH 493 (686)
Q Consensus 435 ~~~~~~lv~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 493 (686)
+.+..++++||+++|+|.+++..... ...+++..++.++.|++.||+|||+++ |+|
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 99999999999999999999965321 234899999999999999999999987 999
Q ss_pred cCCCCCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCC-CCC
Q 005649 494 RDIKASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR-KNY 572 (686)
Q Consensus 494 ~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~-~p~ 572 (686)
|||||+|||||.++.+||+|||+++...............|++.|+|||.+.+..++.++|||||||++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998775544444445567889999999999999999999999999999999985 678
Q ss_pred cccchHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 573 DRQLEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
......+....+ ..+... ..+..++.++.+|+.+||+.+|++||||.||+++|+++.
T Consensus 244 ~~~~~~e~~~~v-------~~~~~~--------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEEVIYYV-------RDGNIL--------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHHHHHHH-------HTTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHHHHHHH-------HcCCCC--------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 766555433221 122211 224455677999999999999999999999999998753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=398.81 Aligned_cols=257 Identities=26% Similarity=0.448 Sum_probs=202.1
Q ss_pred hCCCcccccccccCcEEEEEEEecCC-----CEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDG-----REIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g-----~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
.+.|+..++||+|+||.||+|.++++ ..||||++..... ....+|.+|+.++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 45688899999999999999987632 3699999965433 33467999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+||||+.+|++.+++... ...++|.+++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 86 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 999999999999888653 345999999999999999999999987 999999999999999999999999999876
Q ss_pred CCcCcc-ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCC-CcccchHhHHHHHHHHHHHHhcCcccc
Q 005649 521 HDEQSR-HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKN-YDRQLEAENQELLKLARRLEEEGRLME 598 (686)
Q Consensus 521 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (686)
...... .......||+.|+|||++.++.++.++|||||||++|||++|..| +......+.... ...+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~-------i~~~~~-- 231 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-------INDGFR-- 231 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-------HHTTCC--
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHH-------HhccCC--
Confidence 543222 223345689999999999999999999999999999999996555 443333322211 111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 599 LVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 599 ~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
...+.+.+..+.+|+.+||+.||++||||.||+++|+..
T Consensus 232 ------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 232 ------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp ------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 122445667899999999999999999999999999753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=397.77 Aligned_cols=255 Identities=28% Similarity=0.462 Sum_probs=207.6
Q ss_pred CCCcccccccccCcEEEEEEEec-CCC----EEEEEEeccc-CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGR----EIAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERIL 441 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 441 (686)
++|+..++||+|+||.||+|++. +|+ .||+|++... .....++|.+|++++++++|||||+++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 57999999999999999999875 444 5899988653 344567899999999999999999999999864 5678
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFH 521 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 521 (686)
++||+.+|+|.+++... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 89999999999988654 345999999999999999999999987 9999999999999999999999999999876
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
............||+.|+|||.+.++.++.++|||||||++|||+| |+.||......+....+.. ..+.
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~------~~~~---- 232 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------GERL---- 232 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH------TCCC----
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc------CCCC----
Confidence 5554444445678999999999999999999999999999999999 8999987666554333321 1111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+..++..+.+|+.+||+.||++|||+.||++.|+..
T Consensus 233 -----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 233 -----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 12445667899999999999999999999999988653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-47 Score=383.84 Aligned_cols=246 Identities=25% Similarity=0.372 Sum_probs=198.3
Q ss_pred cccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEe----cCceEEEE
Q 005649 371 STKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ----ERERILVY 443 (686)
Q Consensus 371 ~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 443 (686)
+..++||+|+||.||+|+.. +++.||+|++... .....+.|.+|++++++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999976 6889999998654 33345679999999999999999999999875 34578999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-CCCCeEEEecCCccccCC
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD-HQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~ 522 (686)
||+++|+|.+++... ..+++..+..++.||++||.|||+++ ++|+||||||+||||+ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999999999654 34999999999999999999999976 5699999999999996 578999999999986543
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
.. .....||+.|+|||.+.+ +++.++|||||||++|||++|+.||......+.. .. ....+....
T Consensus 168 ~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~--~~----~i~~~~~~~---- 232 (270)
T d1t4ha_ 168 SF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YR----RVTSGVKPA---- 232 (270)
T ss_dssp TS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HH----HHTTTCCCG----
T ss_pred Cc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH--HH----HHHcCCCCc----
Confidence 22 234689999999998865 6999999999999999999999999754332211 11 111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
.+ +...+..+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~---~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 SF---DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GG---GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc---CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11 1223456889999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-48 Score=401.98 Aligned_cols=263 Identities=25% Similarity=0.370 Sum_probs=207.5
Q ss_pred hhCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
..++|+..++||+|+||.||+|+.. +|+.||+|+++.... ...+.+.+|+.+|++++|||||++++++.+++..+|||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999975 789999999975533 33567899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRD-SVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
||+++|+|.+++.+. ..+++..+..++.|+++||.|||++ + |+||||||+||||++++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999999999999754 3499999999999999999999974 5 99999999999999999999999999987643
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHH-Hhc--------
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL-EEE-------- 593 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-~~~-------- 593 (686)
.. .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+........... ...
T Consensus 158 ~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 158 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred Cc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 22 23458999999999999999999999999999999999999999765543322111000000 000
Q ss_pred --------------CccccccccccC----CCC-HHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 594 --------------GRLMELVDVRIG----TYP-EEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 594 --------------~~~~~~~d~~l~----~~~-~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
....+..+.... ..+ ...+..+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000000000000 000 123467889999999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.3e-47 Score=398.50 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=212.6
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+++..+|||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 58999999999999999999975 78999999998776666788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc--CCCCeEEEecCCccccCCcC
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD--HQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgla~~~~~~~ 524 (686)
++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 106 ~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 999999998543 345999999999999999999999988 99999999999995 46789999999998775433
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
. .....||+.|||||++.+..++.++|||||||++|||++|+.||......+....+.. .......
T Consensus 181 ~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~-----~~~~~~~------ 246 (350)
T d1koaa2 181 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS-----CDWNMDD------ 246 (350)
T ss_dssp C---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----TCCCSCC------
T ss_pred c---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh-----CCCCCCc------
Confidence 2 2346789999999999999999999999999999999999999987655443222111 0111100
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
......+..+.+++.+||+.||++|||++|+++.
T Consensus 247 -~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 -SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0112345678899999999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-47 Score=394.36 Aligned_cols=252 Identities=26% Similarity=0.340 Sum_probs=194.3
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM-QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
.+.|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++.+++..+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 367999999999999999999976 689999999975433 234568899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc---CCCCeEEEecCCccccC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD---HQMKPKISDFGLAKLFH 521 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~ 521 (686)
|+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+. +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999643 45999999999999999999999987 99999999999994 57899999999998764
Q ss_pred CcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc
Q 005649 522 DEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD 601 (686)
Q Consensus 522 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 601 (686)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ .. +... .+
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i------~~-~~~~--~~ 229 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI------LK-AEYE--FD 229 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HT-TCCC--CC
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH------hc-cCCC--CC
Confidence 332 223467999999999999999999999999999999999999999866544432211 11 1100 00
Q ss_pred cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 602 VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 602 ~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.......+..+.+++.+||+.||++|||+.|+++.
T Consensus 230 ---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 230 ---SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ---TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01223456778999999999999999999999984
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.7e-47 Score=391.25 Aligned_cols=245 Identities=29% Similarity=0.429 Sum_probs=203.7
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc---cHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ---GKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
+.|+..+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35899999999999999999975 7889999999765432 3357899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|..++... ..+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 999999998766543 45999999999999999999999988 999999999999999999999999999865432
Q ss_pred CccccccccccCCCcCchhhhhc---CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIR---GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV 600 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (686)
....||+.|||||++.+ +.++.++|||||||++|||++|+.||......+... .......
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~------~i~~~~~----- 231 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQNES----- 231 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHSCC-----
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH------HHHhCCC-----
Confidence 23579999999999864 468999999999999999999999997654433221 1111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 601 DVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 601 d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
+.+ .+...+..+.+++.+||+.||++|||+.|+++
T Consensus 232 -~~~--~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 -PAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -CCC--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCC--CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 011 12234567899999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-46 Score=396.53 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=212.6
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEeec
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEYL 446 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 446 (686)
++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++.+++..+|||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999975 79999999998766666678899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc--CCCCeEEEecCCccccCCcC
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD--HQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgla~~~~~~~ 524 (686)
++|+|.+++... ...+++.+++.++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+++.+....
T Consensus 109 ~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 999999887542 345999999999999999999999987 99999999999998 67899999999999876433
Q ss_pred ccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. . +... .+
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~------~-~~~~--~~--- 248 (352)
T d1koba_ 184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK------R-CDWE--FD--- 248 (352)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH------H-CCCC--CC---
T ss_pred ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------h-CCCC--CC---
Confidence 2334678999999999999999999999999999999999999998765544322111 1 1100 00
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01123456778999999999999999999999884
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=387.32 Aligned_cols=251 Identities=26% Similarity=0.346 Sum_probs=208.9
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc------ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM------QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.|.+|+.++++++|||||++++++.+++..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 67999999999999999999975 789999999864322 23578999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC----CeEEEecCC
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM----KPKISDFGL 516 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgl 516 (686)
|||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999999654 35999999999999999999999987 99999999999998776 499999999
Q ss_pred ccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcc
Q 005649 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL 596 (686)
Q Consensus 517 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (686)
++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+. ....
T Consensus 164 a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~-------~~~~ 233 (293)
T d1jksa_ 164 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS-------AVNY 233 (293)
T ss_dssp CEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------TTCC
T ss_pred hhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHH-------hcCC
Confidence 98765432 2334578999999999999999999999999999999999999998765544322111 1110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 597 MELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 597 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
. . .. ..+...+..+.+++.+||+.||++|||++|+++.
T Consensus 234 ~-~-~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 E-F-ED---EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp C-C-CH---HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C-C-Cc---hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0 00 0012245678899999999999999999999873
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=385.26 Aligned_cols=250 Identities=30% Similarity=0.435 Sum_probs=202.7
Q ss_pred hCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEec-CceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE-RERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~Ey 445 (686)
-++|+..+.||+|+||.||+|+++ |+.||||+++.. ...+.|.+|++++++++||||++++|++.++ +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 357888899999999999999985 789999999653 3457899999999999999999999999664 568999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+++|+|.+++.... ...++|..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~- 157 (262)
T d1byga_ 83 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 157 (262)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC-
Confidence 99999999996542 234899999999999999999999987 9999999999999999999999999998654322
Q ss_pred cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
....++..|+|||++.++.++.++||||||+++|||+| |+.||......+....+. .+...
T Consensus 158 ----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-------~~~~~------- 219 (262)
T d1byga_ 158 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKM------- 219 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-------TTCCC-------
T ss_pred ----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCCCC-------
Confidence 23467889999999999999999999999999999998 788887665554432221 11111
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+...+..+.+++.+||+.||++|||+.||+++|+++
T Consensus 220 -~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 220 -DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 22444567789999999999999999999999999764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=384.99 Aligned_cols=255 Identities=23% Similarity=0.350 Sum_probs=200.8
Q ss_pred hhCCCcccccccccCcEEEEEEEecC----CCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceE
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQD----GREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
..++|++.+.||+|+||.||+|++.. +..||||++.... ....+.|.+|+.++++++||||++++|++. ++..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 35789999999999999999998752 3468899886543 334577999999999999999999999985 56789
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+||||+++|+|.+++... ...+++..++.++.||++||.|||+++ |+||||||+||++++++.+||+|||+++..
T Consensus 84 iv~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 999999999999987653 345899999999999999999999987 999999999999999999999999999876
Q ss_pred CCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
...... ......||+.|+|||.+.+..++.++|||||||++|||++ |++||......+....+. . +...
T Consensus 159 ~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~------~-~~~~-- 228 (273)
T d1mp8a_ 159 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE------N-GERL-- 228 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH------T-TCCC--
T ss_pred cCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH------c-CCCC--
Confidence 543322 2344578999999999999999999999999999999998 899998766655432221 1 1111
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+...+..+.+|+.+||+.||++|||+.||++.|+.
T Consensus 229 ------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 229 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1244566789999999999999999999999998875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=388.80 Aligned_cols=267 Identities=30% Similarity=0.427 Sum_probs=206.7
Q ss_pred CHHHHHHhhCCCcccccccccCcEEEEEEEec------CCCEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCCcccEE
Q 005649 359 NLDVLIAATDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNS-MQGKEEFENEVRVLLKM-QHRNLVQLF 430 (686)
Q Consensus 359 ~~~~l~~at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~ 430 (686)
+.+..+...++|+..++||+|+||.||+|+.. +++.||||+++... ....+.+.+|...+.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 34445555688999999999999999999864 34679999997543 33456788888888887 689999999
Q ss_pred EEEEecC-ceEEEEeecCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 005649 431 GCCVQER-ERILVYEYLPNKSLDKFLFDKSK-------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDI 496 (686)
Q Consensus 431 ~~~~~~~-~~~lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 496 (686)
+++.+.+ ..++||||+++|+|.+++..... ...+++..++.++.||++||.|||+++ |+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcC
Confidence 9987654 68999999999999999975432 245899999999999999999999987 999999
Q ss_pred CCCcEEEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcC-CCCCccc
Q 005649 497 KASNILLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISG-RKNYDRQ 575 (686)
Q Consensus 497 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG-~~p~~~~ 575 (686)
||+||||++++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||++| +.||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999877655444444556899999999999999999999999999999999996 5678654
Q ss_pred chHhHHHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 576 LEAENQELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
...+.. . .....+... ..+...+..+.+++.+||+.||++|||+.||++.|++
T Consensus 241 ~~~~~~--~----~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 241 KIDEEF--C----RRLKEGTRM--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp CCSHHH--H----HHHHHTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHHH--H----HHHhcCCCC--------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 433221 1 111111111 1234456778999999999999999999999999975
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=391.60 Aligned_cols=264 Identities=24% Similarity=0.415 Sum_probs=219.5
Q ss_pred HHHhhCCCcccccccccCcEEEEEEEec------CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEe
Q 005649 363 LIAATDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ 435 (686)
Q Consensus 363 l~~at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 435 (686)
++...++|+..+.||+|+||.||+|.++ +++.||||++.... ......|.+|+.++++++||||++++|++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3445688999999999999999999864 35789999997543 3344678999999999999999999999999
Q ss_pred cCceEEEEeecCCCChhHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCC
Q 005649 436 ERERILVYEYLPNKSLDKFLFDKS-------KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMK 508 (686)
Q Consensus 436 ~~~~~lv~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 508 (686)
++..++||||+++|+|.+++.... ....+++..+..++.|+++||.|||+++ |+||||||+||||+++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCce
Confidence 999999999999999999986532 2234799999999999999999999987 999999999999999999
Q ss_pred eEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcC-CCCCcccchHhHHHHHHHH
Q 005649 509 PKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISG-RKNYDRQLEAENQELLKLA 587 (686)
Q Consensus 509 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~ 587 (686)
+||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+|| +.||......+....+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i--- 248 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV--- 248 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH---
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH---
Confidence 999999999987665544445556789999999999999999999999999999999997 5778765554433222
Q ss_pred HHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCC
Q 005649 588 RRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSS 644 (686)
Q Consensus 588 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 644 (686)
.+ +... ..+...+..+.+++.+||+.+|++||||.||+++|++..
T Consensus 249 ---~~-~~~~--------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 249 ---ME-GGLL--------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp ---HT-TCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred ---Hh-CCCC--------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11 1111 123445678999999999999999999999999998753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-47 Score=385.01 Aligned_cols=256 Identities=28% Similarity=0.422 Sum_probs=201.3
Q ss_pred hCCCcccccccccCcEEEEEEEec--CC--CEEEEEEecccC---cccHHHHHHHHHHHHhcCCCCcccEEEEEEecCce
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ--DG--REIAVKKLATNS---MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERER 439 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~--~g--~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 439 (686)
.++|++.+.||+|+||.||+|++. ++ ..||||++.... ....++|.+|+.++++++||||++++|++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 367899999999999999999864 23 368999986542 2335689999999999999999999999965 467
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccc
Q 005649 440 ILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKL 519 (686)
Q Consensus 440 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 519 (686)
++||||+++|+|.+++.... ..+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 89999999999999886543 35999999999999999999999987 99999999999999999999999999998
Q ss_pred cCCcCccc-cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 520 FHDEQSRH-RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 520 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
+....... ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||......+... .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~------~i~~~~~~~ 234 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH------KIDKEGERL 234 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HHHTSCCCC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH------HHHhCCCCC
Confidence 76543322 2334567889999999999999999999999999999998 899998766554322 122221111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 598 ~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
..+...+..+.+++.+||+.||++|||+.||+++|++
T Consensus 235 --------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 235 --------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1133455678999999999999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=387.75 Aligned_cols=260 Identities=28% Similarity=0.428 Sum_probs=212.7
Q ss_pred hhCCCcccccccccCcEEEEEEEecC--------CCEEEEEEecccCc-ccHHHHHHHHHHHHhc-CCCCcccEEEEEEe
Q 005649 366 ATDNFSTKNMLGRGGFGTVYKGRLQD--------GREIAVKKLATNSM-QGKEEFENEVRVLLKM-QHRNLVQLFGCCVQ 435 (686)
Q Consensus 366 at~~f~~~~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 435 (686)
..++|++.+.||+|+||.||+|+... +..||||++..... ....++.+|...+.++ +|||||++++++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 35788999999999999999998642 24699999976543 3457889999999888 89999999999999
Q ss_pred cCceEEEEeecCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 005649 436 ERERILVYEYLPNKSLDKFLFDKSK-------------SAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNIL 502 (686)
Q Consensus 436 ~~~~~lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 502 (686)
++..++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+++ |+||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence 9999999999999999999975432 245899999999999999999999987 999999999999
Q ss_pred EcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhHH
Q 005649 503 LDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAENQ 581 (686)
Q Consensus 503 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~ 581 (686)
++.++.+||+|||+++...............|++.|+|||.+.++.++.++||||||+++|||++ |+.||......+..
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 99999999999999998776555555556788999999999999999999999999999999998 78888765554322
Q ss_pred HHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 582 ELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
. ....+... ..+...+..+.+|+.+||+.||++|||+.||+++|+++
T Consensus 248 ~-------~i~~~~~~--------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 248 K-------LLKEGHRM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp H-------HHHTTCCC--------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-------HHHcCCCC--------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 2 11122111 12334567799999999999999999999999999764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=387.34 Aligned_cols=247 Identities=24% Similarity=0.302 Sum_probs=210.9
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN---SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|++.+.||+|+||.||+++.+ +|+.||||++.+. .....+.+.+|+.+|++++||||+++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 68999999999999999999975 7999999999654 2334677899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999986543 4899999999999999999999988 999999999999999999999999999876433
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+ . .+.+
T Consensus 159 ~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i------~-~~~~------- 222 (337)
T d1o6la_ 159 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------L-MEEI------- 222 (337)
T ss_dssp TC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------H-HCCC-------
T ss_pred Cc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH------h-cCCC-------
Confidence 22 234468999999999999999999999999999999999999999876654432211 1 1111
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCCC-----HHHHHH
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRPT-----MSATLS 638 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 638 (686)
.++...+..+.+|+.+||+.||++||+ +.|+++
T Consensus 223 --~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 224456677899999999999999995 778876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-46 Score=385.87 Aligned_cols=261 Identities=29% Similarity=0.441 Sum_probs=215.7
Q ss_pred HhhCCCcccccccccCcEEEEEEEec------CCCEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCCcccEEEEEEec
Q 005649 365 AATDNFSTKNMLGRGGFGTVYKGRLQ------DGREIAVKKLATNS-MQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQE 436 (686)
Q Consensus 365 ~at~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 436 (686)
...++|++.++||+|+||.||+|++. +++.||||+++... ......|.+|+.+++++ +|||||+++|++.++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 34578899999999999999999852 45689999997643 33456799999999999 799999999999999
Q ss_pred CceEEEEeecCCCChhHHHhhcC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcE
Q 005649 437 RERILVYEYLPNKSLDKFLFDKS---------------KSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNI 501 (686)
Q Consensus 437 ~~~~lv~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 501 (686)
+..++||||+++|+|.+++.... ....+++..++.++.||++||.|||+++ ++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence 99999999999999999997643 2235899999999999999999999988 99999999999
Q ss_pred EEcCCCCeEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHc-CCCCCcccchHhH
Q 005649 502 LLDHQMKPKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIIS-GRKNYDRQLEAEN 580 (686)
Q Consensus 502 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~ 580 (686)
+++.++.+||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+| |++|+......+.
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999998766554445556789999999999999999999999999999999999 6666655444332
Q ss_pred HHHHHHHHHHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 581 QELLKLARRLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
.. .....+... ..+...+..+.+|+.+||+.||++|||+.||+++|++
T Consensus 257 ~~------~~i~~~~~~--------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 257 FY------KMIKEGFRM--------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HH------HHHHHTCCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH------HHHhcCCCC--------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11 111111100 1234456779999999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-45 Score=383.97 Aligned_cols=245 Identities=25% Similarity=0.364 Sum_probs=209.2
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN---SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|++.+.||+|+||.||+++.+ +|+.||||++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999975 6999999999653 2334678999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999999988654 34889999999999999999999987 999999999999999999999999999876543
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
. ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ .. +..
T Consensus 158 ~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~-~~~------- 218 (316)
T d1fota_ 158 T-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------LN-AEL------- 218 (316)
T ss_dssp B-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HH-CCC-------
T ss_pred c-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH------Hc-CCC-------
Confidence 2 3468999999999999999999999999999999999999999876554432211 11 111
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCC-----CHHHHHHH
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRP-----TMSATLSM 639 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 639 (686)
.++...+..+.+++.+||+.||++|| |++|+++.
T Consensus 219 --~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 12344566789999999999999996 89999863
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-46 Score=386.67 Aligned_cols=255 Identities=30% Similarity=0.442 Sum_probs=206.8
Q ss_pred CCCcccccccccCcEEEEEEEecC-CC--EEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCCcccEEEEEEecCceEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQD-GR--EIAVKKLATN-SMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 442 (686)
++|++.++||+|+||.||+|++++ |. .||||++... .....+.|.+|++++.++ +||||++++|++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 788899999999999999999863 44 4778887543 333456899999999999 799999999999999999999
Q ss_pred EeecCCCChhHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCe
Q 005649 443 YEYLPNKSLDKFLFDK-------------SKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKP 509 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 509 (686)
|||+++|+|.++++.. .....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999653 23456999999999999999999999987 9999999999999999999
Q ss_pred EEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCC-CCCcccchHhHHHHHHHHH
Q 005649 510 KISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGR-KNYDRQLEAENQELLKLAR 588 (686)
Q Consensus 510 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~ 588 (686)
||+|||+++....... .....||..|+|||.+.++.++.++|||||||++|||++|. .||......+....+
T Consensus 167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i---- 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---- 239 (309)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG----
T ss_pred EEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH----
Confidence 9999999986543322 23356899999999999999999999999999999999965 567655544432211
Q ss_pred HHHhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 589 RLEEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 589 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
..+.. ...+...+..+.+|+.+||+.||++||||.||++.|+++
T Consensus 240 ---~~~~~--------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 240 ---PQGYR--------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp ---GGTCC--------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HhcCC--------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11110 122445667899999999999999999999999998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.9e-45 Score=376.55 Aligned_cols=258 Identities=23% Similarity=0.361 Sum_probs=204.1
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCc----
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM---QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERE---- 438 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 438 (686)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.... ...+.|.+|++++++++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 477999999999999999999975 789999999976433 234578999999999999999999999987543
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.+|||||+++|+|.+++... ..+++.+++.++.||++||.|||+++ |+||||||+|||++.++..+|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 78999999999999988654 34999999999999999999999987 9999999999999999999999999987
Q ss_pred ccCCcCc-cccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 519 LFHDEQS-RHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 519 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||......+... .....+...
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~------~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH------HHHhcCCCC
Confidence 6643322 223345679999999999999999999999999999999999999998655443221 122222111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHcccccccCCC-CHHHHHHHhcC
Q 005649 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRP-TMSATLSMLSN 642 (686)
Q Consensus 598 ~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~ 642 (686)
+. ......+..+.+++.+||+.||++|| |++++++.|.+
T Consensus 234 ----~~--~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 ----PS--ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ----GG--GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----Cc--hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 00 11223457789999999999999999 89999888764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=380.07 Aligned_cols=254 Identities=28% Similarity=0.433 Sum_probs=203.9
Q ss_pred cccccccCcEEEEEEEecCC----CEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCCcccEEEEEEec-CceEEEEeec
Q 005649 373 KNMLGRGGFGTVYKGRLQDG----REIAVKKLATN-SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE-RERILVYEYL 446 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~g----~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~Ey~ 446 (686)
.++||+|+||+||+|++.++ ..||||++... +....++|.+|++++++++||||++++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999997532 25899999643 444557899999999999999999999998764 5789999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCcc
Q 005649 447 PNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQSR 526 (686)
Q Consensus 447 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 526 (686)
++|+|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999998653 345789999999999999999999987 999999999999999999999999999977543322
Q ss_pred c--cccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccccc
Q 005649 527 H--RTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVRI 604 (686)
Q Consensus 527 ~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 604 (686)
. ......||+.|+|||.+.++.++.++||||||+++|||+||+.||....... . ....... +...
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~---~~~~i~~-g~~~------- 253 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--D---ITVYLLQ-GRRL------- 253 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHT-TCCC-------
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--H---HHHHHHc-CCCC-------
Confidence 1 2234578999999999999999999999999999999999887776432211 1 1111111 2111
Q ss_pred CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCCCC
Q 005649 605 GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNSSV 645 (686)
Q Consensus 605 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 645 (686)
..+...+..+.+++.+||+.||++||+|.||++.|+++..
T Consensus 254 -~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 254 -LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1233456678999999999999999999999999987643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.8e-45 Score=373.06 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=207.6
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc---------cHHHHHHHHHHHHhcC-CCCcccEEEEEEec
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ---------GKEEFENEVRVLLKMQ-HRNLVQLFGCCVQE 436 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~---------~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 436 (686)
++|++.+.||+|+||+||+++.. +|+.||||++...... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999975 7899999999654321 1246889999999996 99999999999999
Q ss_pred CceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCC
Q 005649 437 RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGL 516 (686)
Q Consensus 437 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 516 (686)
+..+|||||+++|+|.+++... ..+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 9999999999999999999754 35999999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCcCccccccccccCCCcCchhhhhc------CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHH
Q 005649 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIR------GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL 590 (686)
Q Consensus 517 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 590 (686)
++...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+.
T Consensus 157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~----- 228 (277)
T d1phka_ 157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM----- 228 (277)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----
T ss_pred eeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHH-----
Confidence 98775432 2334679999999998863 357889999999999999999999998765444322111
Q ss_pred HhcCccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 591 EEEGRLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 591 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
. +... ... ......+..+.+++.+||+.||++|||+.||++.
T Consensus 229 -~-~~~~-~~~----~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 229 -S-GNYQ-FGS----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp -H-TCCC-CCT----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -h-CCCC-CCC----cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1 1111 000 1122456779999999999999999999999763
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-44 Score=381.59 Aligned_cols=244 Identities=23% Similarity=0.314 Sum_probs=208.8
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN---SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 443 (686)
++|++.+.||+|+||.||+++.+ +|+.||||++... .....+.+.+|+++|++++||||+++++++.+....++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 7999999998643 2334577899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCc
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 523 (686)
||+.+|+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999996543 4999999999999999999999987 999999999999999999999999999976532
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDVR 603 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 603 (686)
.....||+.|||||++.+..++.++|||||||++|||++|+.||......+....+ .. +..
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~-~~~------- 255 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI------VS-GKV------- 255 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HH-CCC-------
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH------hc-CCC-------
Confidence 23457999999999999999999999999999999999999999865543322211 11 111
Q ss_pred cCCCCHHHHHHHHHHHHHcccccccCCC-----CHHHHHH
Q 005649 604 IGTYPEEIALRFMQIALLCTEDFIEDRP-----TMSATLS 638 (686)
Q Consensus 604 l~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 638 (686)
..+...+..+.+++.+||+.||.+|+ |++|+++
T Consensus 256 --~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 12344567789999999999999994 8999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=381.33 Aligned_cols=247 Identities=27% Similarity=0.366 Sum_probs=207.5
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHHHHHHH-hcCCCCcccEEEEEEecCceEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENEVRVLL-KMQHRNLVQLFGCCVQERERILV 442 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 442 (686)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999976 68999999996532 234566777777765 68999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCC
Q 005649 443 YEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 443 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 522 (686)
|||+++|+|.+++.... .+++.++..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999997543 4899999999999999999999987 99999999999999999999999999986654
Q ss_pred cCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccccc
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVDV 602 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 602 (686)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. . +..
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~------~-~~~------ 220 (320)
T d1xjda_ 156 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR------M-DNP------ 220 (320)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------H-CCC------
T ss_pred ccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH------c-CCC------
Confidence 332 2344689999999999999999999999999999999999999998766544332221 1 111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHH-HHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMS-ATLS 638 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-evl~ 638 (686)
.++...+..+.+|+.+||+.||++|||+. |+++
T Consensus 221 ---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 12344567789999999999999999996 7764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=372.86 Aligned_cols=263 Identities=23% Similarity=0.303 Sum_probs=200.8
Q ss_pred ccccccccCcEEEEEEEec-CCCEEEEEEecccCccc-----HHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 372 TKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQG-----KEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 372 ~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
..++||+|+||+||+|+.. +|+.||||++....... .+.+.+|+.++++++|||||++++++.+++..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4578999999999999975 68999999996543222 24688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
++++++..+.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 98887766553 3345999999999999999999999988 99999999999999999999999999987654332
Q ss_pred cccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc---
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD--- 601 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--- 601 (686)
. .....||+.|+|||.+... .++.++|||||||++|||++|+.||......+....+...........+.....
T Consensus 156 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 156 A--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp C--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred c--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 2 2335789999999988754 689999999999999999999999987665443322221110000000000000
Q ss_pred ----cccCCCC-----HHHHHHHHHHHHHcccccccCCCCHHHHHHH--hcC
Q 005649 602 ----VRIGTYP-----EEIALRFMQIALLCTEDFIEDRPTMSATLSM--LSN 642 (686)
Q Consensus 602 ----~~l~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~ 642 (686)
......+ ...+..+.+|+.+||+.||++|||++|+++. +++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 0000111 1235678999999999999999999999974 544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=372.53 Aligned_cols=274 Identities=23% Similarity=0.349 Sum_probs=209.1
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
++|+..++||+|+||+||+|+.. +|+.||||+++.... ...+++.+|++++++++||||+++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999975 789999999965432 235789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
|+.++ +.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~-~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQD-LKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEE-HHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCc-hhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99655 44444332 3345999999999999999999999988 9999999999999999999999999998765433
Q ss_pred ccccccccccCCCcCchhhhhcCC-CChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccccc-c
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGF-LSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELVD-V 602 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~ 602 (686)
. ......||+.|+|||.+.... ++.++|||||||++|||++|+.||......+....+........+..+..... +
T Consensus 157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 2 233457999999999877654 58999999999999999999999986654433222111110000111111000 0
Q ss_pred cc-CCC-----------CHHHHHHHHHHHHHcccccccCCCCHHHHHHH--hcCCCCCCC
Q 005649 603 RI-GTY-----------PEEIALRFMQIALLCTEDFIEDRPTMSATLSM--LSNSSVPIP 648 (686)
Q Consensus 603 ~l-~~~-----------~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~~~~~ 648 (686)
.. ... ....+..+.+++.+||+.||++|||+.|+++. ++++..++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p 294 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCC
Confidence 00 000 01234678999999999999999999999985 666655544
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=374.61 Aligned_cols=250 Identities=21% Similarity=0.292 Sum_probs=207.7
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.... ....+.+|+++|++++||||+++++++.+++..+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 378999999999999999999976 688999999976543 345688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC--CCCeEEEecCCccccCCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH--QMKPKISDFGLAKLFHDE 523 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~ 523 (686)
+++|+|.+++... ...+++.++..++.||++||.|||+.+ |+||||||+|||++. ...+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999999543 235999999999999999999999987 999999999999985 458999999999876543
Q ss_pred CccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcC-cccccccc
Q 005649 524 QSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEG-RLMELVDV 602 (686)
Q Consensus 524 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~ 602 (686)
. ......+++.|+|||.+.+..++.++||||+||++|||++|+.||......+....+. ... .+.+ +
T Consensus 158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~------~~~~~~~~---~ 225 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM------NAEYTFDE---E 225 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------HTCCCCCH---H
T ss_pred C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCCCCCCh---h
Confidence 2 2334578999999999999999999999999999999999999998766544322211 111 0000 0
Q ss_pred ccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 603 RIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 603 ~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 226 ~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 A----FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp H----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred h----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0123566889999999999999999999997
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.5e-45 Score=384.96 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=202.0
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC---cccHHHHHHH---HHHHHhcCCCCcccEEEEEEecCceE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS---MQGKEEFENE---VRVLLKMQHRNLVQLFGCCVQERERI 440 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~e---~~~l~~l~h~niv~l~~~~~~~~~~~ 440 (686)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+| +.+++.++||||+++++++.+++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 68999999999999999999976 69999999986432 1223334444 66677778999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999999654 34899999999999999999999988 999999999999999999999999999876
Q ss_pred CCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccccc
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMEL 599 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (686)
.... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||......+....... .....
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~----~~~~~---- 225 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----TLTMA---- 225 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH----SSSCC----
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----cccCC----
Confidence 5432 234579999999999875 5689999999999999999999999986554433221111 00000
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccccccCCCC-----HHHHHH
Q 005649 600 VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPT-----MSATLS 638 (686)
Q Consensus 600 ~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 638 (686)
...+...+..+.+++.+||+.||++||| ++|+++
T Consensus 226 -----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 -----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -----CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -----CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1223345677899999999999999999 588875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=374.50 Aligned_cols=264 Identities=23% Similarity=0.300 Sum_probs=199.7
Q ss_pred CCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHH--HHHHHHHHhcCCCCcccEEEEEEecC----ceEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEF--ENEVRVLLKMQHRNLVQLFGCCVQER----ERIL 441 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~--~~e~~~l~~l~h~niv~l~~~~~~~~----~~~l 441 (686)
++|...+.||+|+||.||+|++ +|+.||||++.... .+++ +.|+..+.+++||||+++++++.+++ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4677788999999999999997 58999999986432 3333 44555556789999999999998754 5789
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCcEEEcCCCCeEEEecCC
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS-----VLRIIHRDIKASNILLDHQMKPKISDFGL 516 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 516 (686)
||||+++|+|.+++... .++|..++.++.|++.||.|||+.. ..+|+||||||+||||++++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 99999999999999653 4899999999999999999999742 24599999999999999999999999999
Q ss_pred ccccCCcCcc--ccccccccCCCcCchhhhhcCC------CChhHHHHHHHHHHHHHHcCCCCCcccchHhH--------
Q 005649 517 AKLFHDEQSR--HRTHQIAGTFGYMAPEYAIRGF------LSVKSDVFSFGVLLLEIISGRKNYDRQLEAEN-------- 580 (686)
Q Consensus 517 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~-------- 580 (686)
++........ .......||+.|+|||++.+.. ++.|+|||||||+||||+||..|+......+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9977543322 2234568999999999987643 67899999999999999999887743221100
Q ss_pred HHHHHHHHHHHhcCccccccccccC--CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcCC
Q 005649 581 QELLKLARRLEEEGRLMELVDVRIG--TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSNS 643 (686)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 643 (686)
.............+. .++.+. ..+.+....+.+++.+||+.||++|||+.||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SCCHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 000111111211111 122221 11235667799999999999999999999999999754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-44 Score=375.29 Aligned_cols=251 Identities=20% Similarity=0.238 Sum_probs=199.9
Q ss_pred CCCcccc-cccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhc-CCCCcccEEEEEEe----cCceE
Q 005649 368 DNFSTKN-MLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKM-QHRNLVQLFGCCVQ----ERERI 440 (686)
Q Consensus 368 ~~f~~~~-~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~~ 440 (686)
++|++.+ .||+|+||.||+|+.. +++.||||+++. .+.+.+|+.++.++ +||||+++++++.+ +...+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 6788765 5999999999999974 789999999853 35678899987655 89999999999876 45689
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCCeEEEecCCc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH---QMKPKISDFGLA 517 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla 517 (686)
+||||+++|+|.+++.... ...+++.++..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 86 ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 9999999999999997532 346999999999999999999999987 999999999999985 557999999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
+....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+....+. .....+.
T Consensus 162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~---~~i~~~~-- 233 (335)
T d2ozaa1 162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TRIRMGQ-- 233 (335)
T ss_dssp EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS--
T ss_pred eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH---HHHhcCC--
Confidence 87654332 334679999999999999999999999999999999999999997654433211110 0000000
Q ss_pred cccccccC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 598 ELVDVRIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 598 ~~~d~~l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.... ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 234 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 234 ----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ----SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000 1113456789999999999999999999999883
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-43 Score=364.39 Aligned_cols=263 Identities=21% Similarity=0.313 Sum_probs=204.2
Q ss_pred CCCcccccccccCcEEEEEEEecCCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEee
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYEY 445 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 445 (686)
++|+..++||+|+||+||+|+.++|+.||||++..... ...+.+.+|+.++++++||||+++++++.+++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999999999999999965432 3357899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcCc
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQS 525 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 525 (686)
+.++.+..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 98777766653 3355999999999999999999999987 99999999999999999999999999987654332
Q ss_pred cccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcccccc----
Q 005649 526 RHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLMELV---- 600 (686)
Q Consensus 526 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 600 (686)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+...........+....
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 22334688999999998764 57999999999999999999999998765444322221111000000000000
Q ss_pred -cccc--------CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 601 -DVRI--------GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 601 -d~~l--------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
+... .......+..+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0112234567889999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=362.46 Aligned_cols=240 Identities=23% Similarity=0.390 Sum_probs=198.3
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcc------cHHHHHHHHHHHHhcC--CCCcccEEEEEEecCc
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQ------GKEEFENEVRVLLKMQ--HRNLVQLFGCCVQERE 438 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~ 438 (686)
++|++.++||+|+||.||+|+.. +|+.||||++...... ...++.+|+.++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 67999999999999999999975 7899999998653221 1234678999999996 8999999999999999
Q ss_pred eEEEEeecCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCCeEEEecCC
Q 005649 439 RILVYEYLPN-KSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH-QMKPKISDFGL 516 (686)
Q Consensus 439 ~~lv~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgl 516 (686)
.++||||+.+ +++.+++... ..+++.++..++.||++||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 5777777543 34999999999999999999999987 999999999999985 47999999999
Q ss_pred ccccCCcCccccccccccCCCcCchhhhhcCCC-ChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCc
Q 005649 517 AKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFL-SVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGR 595 (686)
Q Consensus 517 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 595 (686)
++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .....
T Consensus 158 a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------i~~~~- 220 (273)
T d1xwsa_ 158 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQ- 220 (273)
T ss_dssp CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHHCC-
T ss_pred ceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------------Hhhcc-
Confidence 98754332 234679999999999987765 6779999999999999999999974321 11111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 596 LMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 596 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
. .++...+.++.+++.+||+.||++|||++|+++.
T Consensus 221 ~---------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 V---------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp C---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c---------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 1233345678999999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-43 Score=364.24 Aligned_cols=265 Identities=23% Similarity=0.331 Sum_probs=201.4
Q ss_pred hCCCcccccccccCcEEEEEEEec-C-CCEEEEEEecccCc--ccHHHHHHHHHHHHhc---CCCCcccEEEEEEe----
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-D-GREIAVKKLATNSM--QGKEEFENEVRVLLKM---QHRNLVQLFGCCVQ---- 435 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~-g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---- 435 (686)
.++|++.++||+|+||+||+|+.. + ++.||||++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999974 4 56799999865422 2233456777776665 89999999999864
Q ss_pred -cCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEec
Q 005649 436 -ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDF 514 (686)
Q Consensus 436 -~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 514 (686)
....++++||++++++...... ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 2467899999988877654432 3455899999999999999999999987 999999999999999999999999
Q ss_pred CCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcC
Q 005649 515 GLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEG 594 (686)
Q Consensus 515 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 594 (686)
|+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+..........
T Consensus 161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 9988654332 2345689999999999999999999999999999999999999998766544333222111000000
Q ss_pred cccc-------c----cccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 595 RLME-------L----VDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 595 ~~~~-------~----~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+.. . ....+.......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 0 0000011223345678899999999999999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1e-41 Score=351.31 Aligned_cols=260 Identities=17% Similarity=0.272 Sum_probs=207.7
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCC-CCcccEEEEEEecCceEEEEe
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQH-RNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E 444 (686)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ..+.+.+|++.+..++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 368999999999999999999975 68899999885543 23457789999999965 899999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-----CCCeEEEecCCccc
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDH-----QMKPKISDFGLAKL 519 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgla~~ 519 (686)
|+ +++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 789998886533 45999999999999999999999988 999999999999974 56899999999998
Q ss_pred cCCcCcc-----ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcC
Q 005649 520 FHDEQSR-----HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEG 594 (686)
Q Consensus 520 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 594 (686)
+...... .......||+.|||||.+.+..++.++||||||+++|||++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 7543221 12334679999999999999999999999999999999999999998655443332222211111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 595 RLMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 595 ~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
...+ + ....+.++.+++..|++.+|++||+++.+.+.|++
T Consensus 236 ~~~~-----l---~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 236 PLRE-----L---CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp CHHH-----H---TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ChHH-----h---cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1111 1 12234668899999999999999999999888765
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=355.61 Aligned_cols=269 Identities=20% Similarity=0.270 Sum_probs=202.4
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCCcccEEEEEEe--------
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATN--SMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQ-------- 435 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 435 (686)
-++|++.++||+|+||+||+|+.. +|+.||||++... .....+++.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 378999999999999999999975 7999999998554 23345778999999999999999999999865
Q ss_pred cCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecC
Q 005649 436 ERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFG 515 (686)
Q Consensus 436 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 515 (686)
+...++||||++++.+..+.. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 346789999998887765542 3345899999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCcCcc--ccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHh
Q 005649 516 LAKLFHDEQSR--HRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEE 592 (686)
Q Consensus 516 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 592 (686)
+++.+...... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99876543221 122335799999999998765 689999999999999999999999987665544433332211111
Q ss_pred cCcccccccccc--------C-CCCH-------HHHHHHHHHHHHcccccccCCCCHHHHHHHhc
Q 005649 593 EGRLMELVDVRI--------G-TYPE-------EIALRFMQIALLCTEDFIEDRPTMSATLSMLS 641 (686)
Q Consensus 593 ~~~~~~~~d~~l--------~-~~~~-------~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 641 (686)
............ . .... .....+.+|+.+||+.||++|||++|+++.=-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence 110100000000 0 0000 11345678999999999999999999997643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-41 Score=350.99 Aligned_cols=259 Identities=21% Similarity=0.298 Sum_probs=198.7
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccE-EEEEEecCceEEEEee
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQL-FGCCVQERERILVYEY 445 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l-~~~~~~~~~~~lv~Ey 445 (686)
++|++.+.||+|+||.||+|+.. +|+.||||++..... .+++..|++++++++|+|++.. .++..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999975 689999999865432 3457899999999987765555 5555667788999999
Q ss_pred cCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc---CCCCeEEEecCCccccCC
Q 005649 446 LPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLD---HQMKPKISDFGLAKLFHD 522 (686)
Q Consensus 446 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~~ 522 (686)
+ +++|.+.+... ...+++..++.++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+++.+..
T Consensus 85 ~-~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9 55666665442 345999999999999999999999988 99999999999986 455799999999998764
Q ss_pred cCcc-----ccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCccc
Q 005649 523 EQSR-----HRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRLM 597 (686)
Q Consensus 523 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (686)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 3322 12344679999999999999999999999999999999999999998665544333222221111111000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHHhcC
Q 005649 598 ELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSMLSN 642 (686)
Q Consensus 598 ~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 642 (686)
.+ ....+..+.+++..||+.+|++||++.++.+.|+.
T Consensus 239 -----~~---~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 239 -----VL---CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp -----HH---TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred -----Hh---ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 00 12345678999999999999999999999888875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=358.24 Aligned_cols=260 Identities=23% Similarity=0.273 Sum_probs=198.1
Q ss_pred CCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCcccEEEEEEec------CceEE
Q 005649 369 NFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE------RERIL 441 (686)
Q Consensus 369 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l 441 (686)
+|+..++||+|+||+||+|+.. +|+.||||++...... +.+|+++|++++||||+++++++... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778899999999999999986 6899999999654322 34799999999999999999998643 24689
Q ss_pred EEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-CeEEEecCCcccc
Q 005649 442 VYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM-KPKISDFGLAKLF 520 (686)
Q Consensus 442 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~ 520 (686)
||||++++.+............+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987655554443344566999999999999999999999987 99999999999999775 8999999999877
Q ss_pred CCcCccccccccccCCCcCchhhhhc-CCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHH--------HHHH
Q 005649 521 HDEQSRHRTHQIAGTFGYMAPEYAIR-GFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLA--------RRLE 591 (686)
Q Consensus 521 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~ 591 (686)
..... .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+... +...
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 54332 233578999999998775 57899999999999999999999999876554432222110 0110
Q ss_pred hcCcccccccccc------CCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 592 EEGRLMELVDVRI------GTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 592 ~~~~~~~~~d~~l------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
... ..+..-+.. .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 251 ~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 251 NPN-YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CC----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccc-hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000000000 01122346678999999999999999999999963
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=357.13 Aligned_cols=266 Identities=19% Similarity=0.250 Sum_probs=200.5
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC-cccHHHHHHHHHHHHhcCCCCcccEEEEEEecC----ceE
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS-MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQER----ERI 440 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~ 440 (686)
+++|+..++||+|+||+||+|+.. +|+.||||++.... ....+.+++|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 467999999999999999999864 89999999996543 334568899999999999999999999997653 235
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcccc
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLF 520 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 520 (686)
++++|+.+|+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 556677799999999542 4999999999999999999999987 999999999999999999999999999876
Q ss_pred CCcCcc-ccccccccCCCcCchhhhh-cCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHH-----hc
Q 005649 521 HDEQSR-HRTHQIAGTFGYMAPEYAI-RGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLE-----EE 593 (686)
Q Consensus 521 ~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~-----~~ 593 (686)
...... .......||+.|+|||.+. +..++.++||||+||++|||++|+.||......+............ ..
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 543322 2234567899999999885 4567999999999999999999999998665443322211110000 00
Q ss_pred Cccccc-----cccccCCC-----CHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 594 GRLMEL-----VDVRIGTY-----PEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 594 ~~~~~~-----~d~~l~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
...... ..+..... ....+.++.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 00000000 11234568899999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-41 Score=355.53 Aligned_cols=265 Identities=22% Similarity=0.300 Sum_probs=199.8
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecC------
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQER------ 437 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 437 (686)
.++|+..++||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 478999999999999999999975 699999999975432 33467899999999999999999999998654
Q ss_pred ceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCc
Q 005649 438 ERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLA 517 (686)
Q Consensus 438 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 517 (686)
+.++||||+ +.+|..+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 569999999 5677776643 34999999999999999999999988 999999999999999999999999999
Q ss_pred cccCCcCccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHH-----HH
Q 005649 518 KLFHDEQSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARR-----LE 591 (686)
Q Consensus 518 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~-----~~ 591 (686)
+..... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||................. .+
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 876543 2345789999999998764 679999999999999999999999987654433222211110 00
Q ss_pred hcCc----------cccccccccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH--hcCCC
Q 005649 592 EEGR----------LMELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM--LSNSS 644 (686)
Q Consensus 592 ~~~~----------~~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~ 644 (686)
.... ..+.....+.......+..+.+|+.+||+.||++|||+.|+++. +++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000 00000001111122345668899999999999999999999985 55543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=352.28 Aligned_cols=252 Identities=26% Similarity=0.339 Sum_probs=205.3
Q ss_pred CCCcccccccccCcEEEEEEEec----CCCEEEEEEecccC----cccHHHHHHHHHHHHhcCC-CCcccEEEEEEecCc
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ----DGREIAVKKLATNS----MQGKEEFENEVRVLLKMQH-RNLVQLFGCCVQERE 438 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 438 (686)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999852 47899999986532 2335678899999999966 899999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.++++||+.+|+|.+++.... .+.+.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999996554 3788899999999999999999987 9999999999999999999999999998
Q ss_pred ccCCcCccccccccccCCCcCchhhhhcC--CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHHHhcCcc
Q 005649 519 LFHDEQSRHRTHQIAGTFGYMAPEYAIRG--FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRLEEEGRL 596 (686)
Q Consensus 519 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (686)
.+...... ......|++.|++||.+.+. .++.++|||||||+||||++|+.||......+....+.... .. ..
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--~~-~~- 252 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LK-SE- 252 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HH-CC-
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--cc-CC-
Confidence 76543322 23346789999999998764 57889999999999999999999998665444332222111 11 10
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHcccccccCCCC-----HHHHHH
Q 005649 597 MELVDVRIGTYPEEIALRFMQIALLCTEDFIEDRPT-----MSATLS 638 (686)
Q Consensus 597 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 638 (686)
..++...+..+.+++.+||+.||++||| ++|+++
T Consensus 253 --------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 --------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0224456788999999999999999994 788886
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-41 Score=344.64 Aligned_cols=264 Identities=18% Similarity=0.249 Sum_probs=205.6
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCCcccEEEEEEecCceEEEEe
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSM--QGKEEFENEVRVLLKMQHRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 444 (686)
++|+..++||+|+||+||+|+.. +|+.||||+++.... ...+++.+|+.++++++||||+++++++.+....++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999975 788999999965432 335789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCccccCCcC
Q 005649 445 YLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAKLFHDEQ 524 (686)
Q Consensus 445 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 524 (686)
++.+++|..++.. ...+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999988887753 345899999999999999999999987 9999999999999999999999999998765433
Q ss_pred ccccccccccCCCcCchhhhhcCC-CChhHHHHHHHHHHHHHHcCCCCCcccch-HhHHHHHHHHHHHHhcCccc---cc
Q 005649 525 SRHRTHQIAGTFGYMAPEYAIRGF-LSVKSDVFSFGVLLLEIISGRKNYDRQLE-AENQELLKLARRLEEEGRLM---EL 599 (686)
Q Consensus 525 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~s~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~---~~ 599 (686)
. ......++..|+|||.+.... ++.++|||||||++|||++|+.||..... .+....+........+..+. ..
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 2 223346778899999887654 69999999999999999999998654332 22222111111000000000 00
Q ss_pred cc----------cccCCCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 600 VD----------VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 600 ~d----------~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
.+ ..........+..+.+|+.+||+.||.+|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00112233456678899999999999999999999873
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.8e-40 Score=344.12 Aligned_cols=256 Identities=19% Similarity=0.302 Sum_probs=198.7
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcC-CCCcccEEEEEEec--CceEEEE
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQE--RERILVY 443 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 443 (686)
++|++.++||+|+||+||+|+.. +|+.||||+++.. ..+++.+|+.+|.+++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 68999999999999999999975 7899999998643 3567899999999995 99999999999854 4689999
Q ss_pred eecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-CeEEEecCCccccCC
Q 005649 444 EYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQM-KPKISDFGLAKLFHD 522 (686)
Q Consensus 444 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~ 522 (686)
||+++++|..+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987654 34999999999999999999999988 99999999999998655 699999999987654
Q ss_pred cCccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHH-HHHH------HHHHHhcC
Q 005649 523 EQSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQE-LLKL------ARRLEEEG 594 (686)
Q Consensus 523 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~-~~~~------~~~~~~~~ 594 (686)
... .....+|..|+|||.+.+. .++.++||||+||+++||++|+.||.......... .+.. ........
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 332 3345789999999998765 57999999999999999999999997554322111 1100 00000000
Q ss_pred cc------cccccc--------ccC-CCCHHHHHHHHHHHHHcccccccCCCCHHHHHH
Q 005649 595 RL------MELVDV--------RIG-TYPEEIALRFMQIALLCTEDFIEDRPTMSATLS 638 (686)
Q Consensus 595 ~~------~~~~d~--------~l~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 638 (686)
.. ...... ... ......+.++.+|+.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000000 000 112234567899999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-40 Score=348.61 Aligned_cols=260 Identities=20% Similarity=0.222 Sum_probs=193.3
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEec------Cc
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE------RE 438 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 438 (686)
++|++.++||+|+||+||+|+.. +|+.||||++.... ....+++.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999976 69999999997543 33346789999999999999999999999643 57
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.++||||+.++.+. .+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999765544 442 24899999999999999999999988 9999999999999999999999999988
Q ss_pred ccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHH-----------
Q 005649 519 LFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLA----------- 587 (686)
Q Consensus 519 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~----------- 587 (686)
...... ......+|+.|+|||.+.+..++.++||||+||+++||++|+.||...........+...
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 665432 234457899999999999999999999999999999999999999765543322211100
Q ss_pred -----HHHHhcC-cc-----cccccccc-C---CCCHHHHHHHHHHHHHcccccccCCCCHHHHHHH
Q 005649 588 -----RRLEEEG-RL-----MELVDVRI-G---TYPEEIALRFMQIALLCTEDFIEDRPTMSATLSM 639 (686)
Q Consensus 588 -----~~~~~~~-~~-----~~~~d~~l-~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 639 (686)
....... .. ........ . ......+..+.+|+.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 00 00111111 1 1123457789999999999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-40 Score=346.56 Aligned_cols=265 Identities=22% Similarity=0.272 Sum_probs=201.1
Q ss_pred hCCCcccccccccCcEEEEEEEec-CCCEEEEEEecccC--cccHHHHHHHHHHHHhcCCCCcccEEEEEEec-----Cc
Q 005649 367 TDNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNS--MQGKEEFENEVRVLLKMQHRNLVQLFGCCVQE-----RE 438 (686)
Q Consensus 367 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 438 (686)
.++|+..++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 578999999999999999999965 79999999997543 23446789999999999999999999998643 34
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 439 RILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 439 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.+++++|+.+|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 5677888899999999843 35999999999999999999999988 9999999999999999999999999987
Q ss_pred ccCCcCccccccccccCCCcCchhhhhcC-CCChhHHHHHHHHHHHHHHcCCCCCcccchHhHHHHHHHHHHH-----Hh
Q 005649 519 LFHDEQSRHRTHQIAGTFGYMAPEYAIRG-FLSVKSDVFSFGVLLLEIISGRKNYDRQLEAENQELLKLARRL-----EE 592 (686)
Q Consensus 519 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-----~~ 592 (686)
..... .....|+..|+|||...+. .++.++|||||||++|||++|+.||...........+...... ..
T Consensus 170 ~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 170 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 65432 2345788999999987765 5689999999999999999999999876654443332211100 00
Q ss_pred cCccc--ccccccc---CCC-----CHHHHHHHHHHHHHcccccccCCCCHHHHHH--HhcCC
Q 005649 593 EGRLM--ELVDVRI---GTY-----PEEIALRFMQIALLCTEDFIEDRPTMSATLS--MLSNS 643 (686)
Q Consensus 593 ~~~~~--~~~d~~l---~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~ 643 (686)
..... ......+ ... ....+..+.+|+.+||+.||++|||+.|+++ .+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00000 0000000 000 1123566889999999999999999999998 45544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-35 Score=314.14 Aligned_cols=263 Identities=18% Similarity=0.234 Sum_probs=194.9
Q ss_pred CCCcccccccccCcEEEEEEEec-CCCEEEEEEecccCcccHHHHHHHHHHHHhcC-----------CCCcccEEEEEEe
Q 005649 368 DNFSTKNMLGRGGFGTVYKGRLQ-DGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-----------HRNLVQLFGCCVQ 435 (686)
Q Consensus 368 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~ 435 (686)
++|++.++||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 45999999999999999999975 799999999975432 3467788999888875 5789999998865
Q ss_pred c--CceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCC----
Q 005649 436 E--RERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHR-DSVLRIIHRDIKASNILLDHQMK---- 508 (686)
Q Consensus 436 ~--~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~---- 508 (686)
. ...++++++...+..............+++..+..++.||++||.|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 4 4566777777665544444444555678999999999999999999998 55 999999999999986553
Q ss_pred --eEEEecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHHHHHcCCCCCcccchHh----HHH
Q 005649 509 --PKISDFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLLEIISGRKNYDRQLEAE----NQE 582 (686)
Q Consensus 509 --~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~----~~~ 582 (686)
+|++|||.+...... .....||+.|+|||.+....++.++|+||+||+++||++|+.||....... ...
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 999999999865432 234578999999999999999999999999999999999999997543221 111
Q ss_pred HHHHHHHH--------HhcCccccccc--------------------cccCCCCHHHHHHHHHHHHHcccccccCCCCHH
Q 005649 583 LLKLARRL--------EEEGRLMELVD--------------------VRIGTYPEEIALRFMQIALLCTEDFIEDRPTMS 634 (686)
Q Consensus 583 ~~~~~~~~--------~~~~~~~~~~d--------------------~~l~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 634 (686)
+....+.+ ..........+ ..........+..+.+|+.+||+.||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 11111110 00000000000 001133567788999999999999999999999
Q ss_pred HHHHH
Q 005649 635 ATLSM 639 (686)
Q Consensus 635 evl~~ 639 (686)
|+++.
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99985
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=3.9e-22 Score=190.61 Aligned_cols=170 Identities=17% Similarity=0.177 Sum_probs=121.8
Q ss_pred cccccccccCcEEEEEEEecCCCEEEEEEecccCcc------------------cHHHHHHHHHHHHhcCCCCcccEEEE
Q 005649 371 STKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQ------------------GKEEFENEVRVLLKMQHRNLVQLFGC 432 (686)
Q Consensus 371 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~------------------~~~~~~~e~~~l~~l~h~niv~l~~~ 432 (686)
.+.++||+|+||.||+|+..+|+.||||+++..... .......|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356899999999999999989999999987532110 01234568889999999999998765
Q ss_pred EEecCceEEEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCCeEEE
Q 005649 433 CVQERERILVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDSVLRIIHRDIKASNILLDHQMKPKIS 512 (686)
Q Consensus 433 ~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 512 (686)
. ..+++|||++++.+.+ +++.....++.|++++|.|||+++ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 3 3479999998765432 444556789999999999999988 9999999999999965 58999
Q ss_pred ecCCccccCCcCccccccccccCCCcCchhhhhcCCCChhHHHHHHHHHHH
Q 005649 513 DFGLAKLFHDEQSRHRTHQIAGTFGYMAPEYAIRGFLSVKSDVFSFGVLLL 563 (686)
Q Consensus 513 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ 563 (686)
|||+++....+........ .... -.|. ..+.|+.++|+||..--+.
T Consensus 145 DFG~a~~~~~~~~~~~l~r---d~~~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWREILER---DVRN-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHHHHHHH---HHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHHH---HHHH-HHHH-HcCCCCCcccHHHHHHHHh
Confidence 9999986543322110000 0000 0111 2356778899999875543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.55 E-value=2.1e-07 Score=91.16 Aligned_cols=148 Identities=15% Similarity=0.083 Sum_probs=103.1
Q ss_pred HHHHhhCCCcccccccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcC-CCCcccEEEEEEecCceE
Q 005649 362 VLIAATDNFSTKNMLGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQERERI 440 (686)
Q Consensus 362 ~l~~at~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 440 (686)
++..--..|+..+..+-+....||+... +++.+++|+...........+.+|...+..+. +-.+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3444456777766655455578998865 56778899886655444556788888888773 444688898888888999
Q ss_pred EEEeecCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 005649 441 LVYEYLPNKSLDKFLFDKSKSAILDWPKRLNIIMGVARGLLYLHRDS--------------------------------- 487 (686)
Q Consensus 441 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------- 487 (686)
+|||++++.++.+..... .....++.++++.+..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999998876544211 112334555566666666311
Q ss_pred -----------------------CCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 488 -----------------------VLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 488 -----------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
...++|+|+.|.|||++++...-|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1238999999999999987667799998865
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.88 E-value=3.2e-05 Score=74.62 Aligned_cols=74 Identities=15% Similarity=0.146 Sum_probs=53.2
Q ss_pred ccccC-cEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcC--CCCcccEEEEEEecCceEEEEeecCCCChh
Q 005649 376 LGRGG-FGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQ--HRNLVQLFGCCVQERERILVYEYLPNKSLD 452 (686)
Q Consensus 376 LG~G~-fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 452 (686)
+..|. .+.||+...+++..+++|....... ..+..|...++.+. .-.+++++.+..+.+..++|||++++.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 34444 3679999988888889998754432 24566777776663 334678888888888899999999876653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.44 E-value=0.00042 Score=71.26 Aligned_cols=76 Identities=18% Similarity=0.234 Sum_probs=48.6
Q ss_pred cccccccCcEEEEEEEecC-CCEEEEEEeccc------C-cccHHHHHHHHHHHHhc-CC--CCcccEEEEEEecCceEE
Q 005649 373 KNMLGRGGFGTVYKGRLQD-GREIAVKKLATN------S-MQGKEEFENEVRVLLKM-QH--RNLVQLFGCCVQERERIL 441 (686)
Q Consensus 373 ~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~------~-~~~~~~~~~e~~~l~~l-~h--~niv~l~~~~~~~~~~~l 441 (686)
.+.||.|....||+....+ ++.++||.-... . ....++...|.+.|..+ .+ ..+++++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4568999999999998764 678999864321 1 11233455677777766 22 345666644 5667789
Q ss_pred EEeecCCCC
Q 005649 442 VYEYLPNKS 450 (686)
Q Consensus 442 v~Ey~~~gs 450 (686)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.68 E-value=0.0014 Score=65.36 Aligned_cols=68 Identities=13% Similarity=0.137 Sum_probs=45.2
Q ss_pred EEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCc--ccEE-----EEEEecCceEEEEeecCCCC
Q 005649 382 GTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL--VQLF-----GCCVQERERILVYEYLPNKS 450 (686)
Q Consensus 382 G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~Ey~~~gs 450 (686)
-.||+.+.++|+.+++|+.... ....+++..|...+..|...++ +..+ .....++..+.++++++|..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 3799999999999999998643 2345677888888887743222 1111 11234556788999987643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.52 E-value=0.0046 Score=63.21 Aligned_cols=72 Identities=15% Similarity=0.240 Sum_probs=48.3
Q ss_pred ccccccCcEEEEEEEecCC--------CEEEEEEecccCcccHHHHHHHHHHHHhcC-CCCcccEEEEEEecCceEEEEe
Q 005649 374 NMLGRGGFGTVYKGRLQDG--------REIAVKKLATNSMQGKEEFENEVRVLLKMQ-HRNLVQLFGCCVQERERILVYE 444 (686)
Q Consensus 374 ~~LG~G~fG~Vy~~~~~~g--------~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 444 (686)
+.|+-|-.=.+|+...+++ +.|.+++.. . .....+..+|..+++.+. +.-.+++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5677788888999987543 456666654 2 223345568888888884 4334578877643 68999
Q ss_pred ecCCCCh
Q 005649 445 YLPNKSL 451 (686)
Q Consensus 445 y~~~gsL 451 (686)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.57 E-value=0.061 Score=52.42 Aligned_cols=157 Identities=11% Similarity=0.028 Sum_probs=78.3
Q ss_pred CHHHHHHhhCCCccccc-----ccccCcEEEEEEEecCCCEEEEEEecccCcccHHHHHHHHHHHHhcCCCCc--ccEEE
Q 005649 359 NLDVLIAATDNFSTKNM-----LGRGGFGTVYKGRLQDGREIAVKKLATNSMQGKEEFENEVRVLLKMQHRNL--VQLFG 431 (686)
Q Consensus 359 ~~~~l~~at~~f~~~~~-----LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~ 431 (686)
+.+++..-..+|...+. |..|---+.|+.+.++| .+++|+...... .+++..|+.++..|...++ +..+-
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccce
Confidence 45566666667766443 33455567899888765 589998865322 2344455666666532221 11110
Q ss_pred ------EEEecCceEEEEeecCCCChhH---H-----------HhhcCCC------C------------------CCCHH
Q 005649 432 ------CCVQERERILVYEYLPNKSLDK---F-----------LFDKSKS------A------------------ILDWP 467 (686)
Q Consensus 432 ------~~~~~~~~~lv~Ey~~~gsL~~---~-----------l~~~~~~------~------------------~l~~~ 467 (686)
+.........++.+..+..... . ++..... . .....
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 1122344556666665433211 0 0000000 0 00011
Q ss_pred HHHHHHHHHHHHHHHHHhCC-CCCeEecCCCCCcEEEcCCCCeEEEecCCcc
Q 005649 468 KRLNIIMGVARGLLYLHRDS-VLRIIHRDIKASNILLDHQMKPKISDFGLAK 518 (686)
Q Consensus 468 ~~~~i~~~ia~~L~~LH~~~-~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 518 (686)
.....+..+...+.-.+... ...++|+|+.++||+++++...-|.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 11122222222233222211 2359999999999999988777899999875
|